,uniprot_id,wildtype,position,mutation,pdb_id,pdb_pos,phenotypic_annotation,interaction,binding,function,phosphorylation,ubiquination,glycosylation,sumoylation,acetylation,other_ptm,methylation,ribosylation,subcell_localization_change,mimetic_ptm,folding,expression,identifier
0,P31749,K,8,R,1unp:A,8,"Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation as well as IGF1-induced membrane recruitment. Decrease in ubiquitination and phosphorylation at T-308 as well as impaired association with the membrane",,,1.0,-1.0,-1.0,,,,,,,1.0,,,,P31749_K_8_R
1,P31749,K,14,A,1unp:A,14,"Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.",,-1.0,-999.0,,,,,,,,,,,,,P31749_K_14_A
2,P31749,K,14,Q,1unp:A,14,"Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment.",,-1.0,1.0,-1.0,,,,,,,,1.0,,,,P31749_K_14_Q
3,P31749,K,14,R,1unp:A,14,"Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment.",,-1.0,1.0,-1.0,-1.0,,,,,,,1.0,,,,P31749_K_14_R
4,P31749,E,17,K,1unp:A,17,No effect on membrane localization. Loss of membrane localization,,,-999.0,,,,,,,,,,,,,P31749_E_17_K
5,P31749,K,20,Q,1unp:A,20,"Substantial reduction of phosphorylation at T-308 and S-473, reduced AKT activation, and reduced binding to PIP3 as well as IGF1-induced membrane recruitment. Loss of membrane localization",,-1.0,1.0,-1.0,,,,,,,,1.0,,,,P31749_K_20_Q
6,P31749,K,20,R,1unp:A,20,Slight increase of phosphorylation at T-308 and S-473.,,,-999.0,1.0,,,,,,,,,,,,P31749_K_20_R
7,P31749,R,25,A,1unp:A,25,"Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.",,-1.0,-999.0,,,,,,,,,,,,,P31749_R_25_A
7,P31749,R,25,C,1unp:A,25,"Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.",,-1.0,-999.0,,,,,,,,,,,,,P31749_R_25_C
8,P31749,R,86,A,1unp:A,86,"Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.",,-1.0,-999.0,,,,,,,,,,,,,P31749_R_86_A
9,P31749,Y,176,F,6npz:B,176,Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473.,-1.0,,-999.0,-1.0,,,,,,,,1.0,,,,P31749_Y_176_F
10,P31749,T,305,A,6npz:B,305,Reduces O-GlcNAc levels,,,-999.0,,,,,,-1.0,,,,,,,P31749_T_305_A
11,P31749,T,305,Y,6npz:B,305,Abolishes phosphorylation at Thr-308.,,,-999.0,-1.0,,,,,,,,,,,,P31749_T_305_Y
12,P31749,T,308,D,6npz:B,308,5-fold activation and 18-fold activation,,,1.0,,,,,,,,,,,,,P31749_T_308_D
13,P31749,T,312,A,6npz:B,312,Reduces O-GlcNAc levels,,,-999.0,,,,,,-1.0,,,,,,,P31749_T_312_A
14,P31749,T,312,Y,6npz:B,312,Abolishes phosphorylation at Thr-308.,,,-999.0,-1.0,,,,,,,,,,,,P31749_T_312_Y
15,P34998,F,232,A,6pb0:R,203,Nearly abolishes antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_F_232_A
16,P34998,M,235,A,6pb0:R,206,Strongly reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_M_235_A
17,P34998,L,309,A,6pb0:R,280,Nearly abolishes antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_L_309_A
18,P34998,N,312,A,6pb0:R,283,Nearly abolishes antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_N_312_A
19,P34998,F,313,A,6pb0:R,284,Slightly reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_F_313_A
20,P34998,L,316,A,6pb0:R,287,Strongly reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_L_316_A
21,P34998,I,319,A,6pb0:R,290,Strongly reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_I_319_A
22,P34998,Y,356,A,6pb0:R,327,Strongly reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P34998_Y_356_A
23,P34998,Q,384,A,6pb0:R,355,Increases antagonist binding.,,1.0,-999.0,,,,,,,,,,,,,P34998_Q_384_A
24,P60880,Q,152,A,2n1t:D,152,"Decreased cleavage by C.botulinum BoNT/C, no change in cleavage by C.botulinum BoNT/A (botA).",-1.0,,-999.0,,,,,,,,,,,,,P60880_Q_152_A
25,P60880,I,156,E,2n1t:D,156,"Small decrease in affinity for C.botulinum BoNT/A, increased efficiency of BoNT/C cleavage.",,,-999.0,,,,,,,,,,,,,P60880_I_156_E
26,P60880,D,166,A,2n1t:D,166,"Decreased cleavage by BoNT/C, no change in cleavage by BoNT/A.",,,-999.0,,,,,,,,,,,,,P60880_D_166_A
27,P60880,M,167,E,2n1t:D,167,Small decrease in affinity for C.botulinum BoNT/A.,-1.0,,-999.0,,,,,,,,,,,,,P60880_M_167_E
28,P60880,A,199,R,2n1t:D,199,Not cleaved by BoNT/C.,-1.0,,-999.0,,,,,,,,,,,,,P60880_A_199_R
29,P60880,M,202,Y,2n1t:D,202,"Slight decrease in affinity for BoNT/A, increases kcat for BoNT/A.",-1.0,,-999.0,,,,,,,,,,,,,P60880_M_202_Y
30,Q86WA6,S,139,A,2oci:A,122,<0.1% of wild type activity.,,,1.0,,,,,,,,,,,,,Q86WA6_S_139_A
31,Q86WA6,D,244,N,2oci:A,227,<0.1% of wild type activity.,,,1.0,,,,,,,,,,,,,Q86WA6_D_244_N
32,Q86WA6,H,272,A,2oci:A,255,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q86WA6_H_272_A
33,Q8N4E7,S,204,A,5z8j:A,144,Increases ferroxidase activity and iron binding.,,1.0,1.0,,,,,,,,,,,,,Q8N4E7_S_204_A
34,Q01973,C,482,G,6tu9:A,482,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q01973_C_482_G
35,Q01974,D,482,G,3zzw:B,482,Slight increase in kinase activity.,,,1.0,,,,,,,,,,,,,Q01974_D_482_G
36,Q00535,S,159,A,1unl:A,159,No phenotype.,0.0,,0.0,,,,,,,,,,,,,Q00535_S_159_A
37,Q00535,S,159,T,1unl:A,159,Impaired p35/p25 (CDK5R1) binding.,-1.0,,-999.0,,,,,,,,,,,,,Q00535_S_159_T
38,Q00536,K,194,A,5g6v:A,194,Loss of kinase activity. Abolishes effect on insulin secretion.,,,1.0,,,,,,,,,,,,,Q00536_K_194_A
39,Q00536,K,194,R,5g6v:A,194,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q00536_K_194_R
40,O95257,A,47,R,2wal:A,47,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,1.0,,,,,,,,,,,,,O95257_A_47_R
41,O95257,I,76,E,2wal:A,76,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,1.0,,,,,,,,,,,,,O95257_I_76_E
42,O95257,L,80,E,2wal:A,80,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,1.0,,,,,,,,,,,,,O95257_L_80_E
43,O95257,A,83,R,2wal:A,83,30-fold reduction in homodimerization affinity and 90% decrease in growth inhibition activity and ability to stop cell cycle,-1.0,,1.0,,,,,,,,,,,,,O95257_A_83_R
44,O95257,E,87,K,2wal:A,87,Reduced growth inhibition activity,,,1.0,,,,,,,,,,,,,O95257_E_87_K
45,O95257,D,89,K,2wal:A,89,Reduced growth inhibition activity,,,1.0,,,,,,,,,,,,,O95257_D_89_K
46,P21673,Y,140,F,2b4b:B,140,Reduces activity by 95%.,,,1.0,,,,,,,,,,,,,P21673_Y_140_F
47,P07711,C,138,S,3of9:A,26,Catalytically inactive. Unable to autocleave procathepsin L.,,,1.0,,,,,,,,,,,,,P07711_C_138_S
48,P02545,K,201,L,6jlb:C,201,Decreased sumoylation,,,-999.0,,,,-1.0,,,,,,,,,P02545_K_201_L
49,P17050,N,201,Q,4do4:B,201,Loss of glycosylation site,,,-999.0,,,-1.0,,,,,,,,,,P17050_N_201_Q
50,P40429,S,77,A,4v6x:CO,77,Loss of interferon-gamma induced phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P40429_S_77_A
51,Q7Z3T8,C,753,S,3t7l:A,753,Abolishes localization to endosomes and association with PI3P.,,-1.0,-999.0,,,,,,,,,1.0,,,,Q7Z3T8_C_753_S
52,Q12834,S,92,A,6q6h:R,92,Loss of BUB1-mediated phosphorylation and inhibition and partially defective spindle-assembly checkpoint,,,-999.0,-1.0,,,,,,,,,,,,Q12834_S_92_A
53,Q12834,R,132,A,6tlj:Q,132,Loss of interaction with MAD2L1.,-1.0,,-999.0,,,,,,,,,,,,,Q12834_R_132_A
54,Q12834,S,153,A,6tlj:Q,153,Loss of BUB1-mediated phosphorylation and inhibition and partially defective spindle-assembly checkpoint,,,-999.0,-1.0,,,,,,,,,,,,Q12834_S_153_A
55,Q12834,T,157,A,6tlj:Q,157,Loss of BUB1-mediated phosphorylation and inhibition and partially defective spindle-assembly checkpoint,,,-999.0,-1.0,,,,,,,,,,,,Q12834_T_157_A
56,Q12834,S,161,A,6tlj:Q,161,Loss of BUB1-mediated phosphorylation and inhibition and partially defective spindle-assembly checkpoint,,,-999.0,-1.0,,,,,,,,,,,,Q12834_S_161_A
57,P51857,Y,58,A,3cas:A,58,Loss of activity.,,,1.0,,,,,,,,,,,,,P51857_Y_58_A
58,P51857,E,120,A,3cas:A,120,Loss of activity.,,,1.0,,,,,,,,,,,,,P51857_E_120_A
59,P13747,R,83,A,3bzf:A,62,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_R_83_A
60,P13747,R,86,A,3bzf:A,65,Reduces the affinity for KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_R_86_A
61,P13747,D,90,A,3bzf:A,69,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_D_90_A
62,P13747,Q,93,A,3bzf:A,72,Impairs the recognition by KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_Q_93_A
63,P13747,R,96,A,3bzf:A,75,Abolishes the recognition by KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_R_96_A
64,P13747,V,97,A,3bzf:A,76,Impairs the recognition by KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_V_97_A
65,P13747,R,100,A,3bzf:A,79,Reduces the affinity for KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_R_100_A
66,P13747,E,110,A,3bzf:A,89,Has no impact on the affinity for KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_E_110_A
67,P13747,R,129,A,3bzf:A,108,Has no impact on the affinity for KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_R_129_A
68,P13747,K,167,A,3bzf:A,146,Impairs folding.,,,-999.0,,,,,,,,,,,-1.0,,P13747_K_167_A
69,P13747,D,170,A,3bzf:A,149,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_D_170_A
70,P13747,E,173,A,3bzf:A,152,Impairs the recognition by KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_E_173_A
71,P13747,E,175,A,3bzf:A,154,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_E_175_A
72,P13747,H,176,A,3bzf:A,155,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_H_176_A
73,P13747,D,183,A,3bzf:A,162,Impairs the recognition by KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_D_183_A
74,P13747,E,187,A,3bzf:A,166,Reduces the affinity for KLRD1-KLRC1.,-1.0,,-999.0,,,,,,,,,,,,,P13747_E_187_A
75,P13747,T,235,A,3bzf:A,214,Has no impact on the affinity for KLRD1-KLRC1.,0.0,,-999.0,,,,,,,,,,,,,P13747_T_235_A
76,P49789,I,10,W,2fit:A,10,Strongly reduces affinity for substrates and impairs apoptosis,,-1.0,1.0,,,,,,,,,,,,,P49789_I_10_W
77,P49789,L,25,W,2fit:A,25,Reduces affinity for substrates and impairs apoptosis. Strongly reduces affinity for substrates and impairs apoptosis,,-1.0,1.0,,,,,,,,,,,,,P49789_L_25_W
78,P49789,H,35,N,2fit:A,35,50% decrease in catalytic activity. No loss in substrate binding.,,0.0,1.0,,,,,,,,,,,,,P49789_H_35_N
79,P49789,H,94,N,2fit:A,94,75% decrease in catalytic activity. No loss in substrate binding.,,0.0,1.0,,,,,,,,,,,,,P49789_H_94_N
80,P49789,H,96,D,2fit:A,96,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P49789_H_96_D
81,P49789,H,96,G,2fit:A,96,Total loss of catalytic activity. Rescuable with free imidazole.,,,1.0,,,,,,,,,,,,,P49789_H_96_G
82,P49789,H,96,N,2fit:A,96,Total loss of catalytic activity. No loss in substrate binding.,,0.0,1.0,,,,,,,,,,,,,P49789_H_96_N
83,P49789,H,98,N,2fit:A,98,98% decrease in catalytic activity.,,,1.0,,,,,,,,,,,,,P49789_H_98_N
84,P02768,H,91,A,7jwn:A,67,Impairs metal binding.,,-1.0,-999.0,,,,,,,,,,,,,P02768_H_91_A
85,P05231,A,173,V,4cni:C,145,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P05231_A_173_V
86,P05231,W,185,R,4cni:C,157,No loss of activity.,,,0.0,,,,,,,,,,,,,P05231_W_185_R
87,P05231,S,204,P,4cni:C,176,87% loss of activity.,,,1.0,,,,,,,,,,,,,P05231_S_204_P
88,P05231,R,210,K,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_K
88,P05231,R,210,E,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_E
88,P05231,R,210,Q,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_Q
88,P05231,R,210,T,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_T
88,P05231,R,210,A,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_A
88,P05231,R,210,P,4cni:C,182,Loss of activity.,,,1.0,,,,,,,,,,,,,P05231_R_210_P
89,P78347,Y,398,F,2dn4:A,45,Abolishes BTK-mediated transcriptional activation. Abolishes BTK-mediated phosphorylation and impairs BTK-mediated transcriptional activation,-1.0,,-999.0,-1.0,,,,,,,,,,,,P78347_Y_398_F
90,P78347,Y,503,F,2ed2:A,45,Impairs BTK-mediated transcriptional activation. Abolishes BTK-mediated phosphorylation and impairs BTK-mediated transcriptional activation,-1.0,,-999.0,-1.0,,,,,,,,,,,,P78347_Y_503_F
91,P62979,K,48,R,3axc:A,48,No effect on HLTF-mediated polyubiquitination of PCNA.,,,0.0,,,,,,,,,,,,,P62979_K_48_R
92,P62979,K,63,R,3axc:A,63,Abolishes HLTF-mediated polyubiquitination of PCNA.,,,1.0,,,,,,,,,,,,,P62979_K_63_R
93,P62979,S,65,A,3axc:A,65,Prevents phosphorylation in case of mitophagy.,,,-999.0,-1.0,,,,,,,,,,,,P62979_S_65_A
94,P62979,S,65,D,3axc:A,65,Phosphomimetic mutant that binds and activates PRKN.,1.0,,1.0,,,,,,,,,,1.0,,,P62979_S_65_D
95,P62979,H,68,G,3axc:A,68,Loss of DTX3L-mediated polyubiquitination of histone H3 and H4.,-1.0,,1.0,,,,,,,,,,,,,P62979_H_68_G
96,P62979,R,72,G,3axc:A,72,No effect on ADP-ribosylation.,,,0.0,,,,,,,,0.0,,,,,P62979_R_72_G
97,P62979,R,72,K,3axc:A,72,"No effect on ADP-ribosylation, when associated with K-74.",,,-999.0,,,,,,,,0.0,,,,,P62979_R_72_K
98,P62979,R,74,G,3axc:A,74,No effect on ADP-ribosylation.,,,-999.0,,,,,,,,0.0,,,,,P62979_R_74_G
99,P62979,R,74,K,3axc:A,74,"No effect on ADP-ribosylation, when associated with K-72.",,,-999.0,,,,,,,,0.0,,,,,P62979_R_74_K
100,P62979,G,76,A,3axc:A,76,Loss of ADP-ribosylation.,,,-999.0,,,,,,,,-1.0,,,,,P62979_G_76_A
101,P02766,F,107,M,2try:A,87,Loss of tetramerization,-1.0,,-999.0,,,,,,,,,,,,,P02766_F_107_M
102,P02766,L,130,M,2try:A,110,Loss of tetramerization,-1.0,,-999.0,,,,,,,,,,,,,P02766_L_130_M
103,Q7L266,T,168,A,4o0d:A,168,Abolishes activation by autocleavage. Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q7L266_T_168_A
103,Q7L266,T,168,C,4o0d:A,168,Abolishes activation by autocleavage. Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q7L266_T_168_C
104,Q7L266,T,168,S,4o0d:A,168,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q7L266_T_168_S
105,P10275,L,702,A,1xj7:A,701,"Alters receptor specificity, so that transcription is activated by the antiandrogen cyproterone acetate.",,1.0,-999.0,,,,,,,,,,,,,P10275_L_702_A
106,P10275,K,721,A,1xj7:A,720,Loss of transcription activation in the presence of androgen and of interaction with NCOA2.,-1.0,,-999.0,,,,,,,,,,,,,P10275_K_721_A
107,P10275,W,742,L,1xj7:A,741,Strongly decreased transcription activation in the presence of androgen.,,,-999.0,,,,,,,,,,,,,P10275_W_742_L
108,P10275,K,846,R,1xj7:A,845,Prevents ubiquitination by RNF6. Prevents AR transcriptional activation by RNF14 in absence of hormone.,-1.0,,-999.0,,-1.0,,,,,,,,,,,P10275_K_846_R
109,P10275,K,848,R,1xj7:A,847,Partially prevents ubiquitination by RNF6.,,,-999.0,,-1.0,,,,,,,,,,,P10275_K_848_R
110,P10275,E,898,A,1xj7:A,897,Reduced transcription activation in the presence of androgen.,,,1.0,,,,,,,,,,,,,P10275_E_898_A
110,P10275,E,898,Q,1xj7:A,897,Reduced transcription activation in the presence of androgen.,,,1.0,,,,,,,,,,,,,P10275_E_898_Q
111,P10275,E,898,K,1xj7:A,897,Loss of transcription activation in the presence of androgen.,,,1.0,,,,,,,,,,,,,P10275_E_898_K
111,P10275,E,898,R,1xj7:A,897,Loss of transcription activation in the presence of androgen.,,,1.0,,,,,,,,,,,,,P10275_E_898_R
112,P10275,Y,916,F,1xj7:A,915,Decrease in CSK-induced phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P10275_Y_916_F
113,Q9UJ71,E,285,A,3kqg:A,285,Loss of binding to 6'-sulfo-LacNAc and invertase.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UJ71_E_285_A
114,Q9UJ71,N,287,A,3kqg:A,287,Loss of binding to 6'-sulfo-LacNAc and invertase.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UJ71_N_287_A
115,Q9UJ71,K,299,A,3kqg:A,299,Loss of binding to 6'-sulfo-LacNAc.,,-1.0,-999.0,,,,,,,,,,,,,Q9UJ71_K_299_A
116,Q9UJ71,K,313,A,3kqg:A,313,Loss of binding to 6'-sulfo-LacNAc and 6-sulfo-GlcNAc.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UJ71_K_313_A
117,P0C7P0,H,75,C,6avj:A,75,Increases iron-sulfur cluster stability,,1.0,-999.0,,,,,,,,,,,,,P0C7P0_H_75_C
118,P0C7P0,H,113,C,6avj:A,113,Increases iron-sulfur cluster stability,,1.0,-999.0,,,,,,,,,,,,,P0C7P0_H_113_C
119,Q8TDX7,Y,28,A,6s75:A,28,Significant decrease in catalytic activity,,,1.0,,,,,,,,,,,,,Q8TDX7_Y_28_A
120,Q8TDX7,L,31,A,6s75:A,31,Significant decrease in catalytic activity,,,1.0,,,,,,,,,,,,,Q8TDX7_L_31_A
121,Q8TDX7,N,33,D,6s75:A,33,Significant decrease in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8TDX7_N_33_D
122,Q8TDX7,Y,97,A,6s75:A,97,5-fold increase in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8TDX7_Y_97_A
123,Q8TDX7,Y,97,F,6s75:A,97,Moderate increase in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8TDX7_Y_97_F
123,Q8TDX7,Y,97,L,6s75:A,97,Moderate increase in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8TDX7_Y_97_L
124,O15259,L,180,P,1s1n:A,180,Loss of SH3 domain fold.,,,-999.0,,,,,,,,,,,-1.0,,O15259_L_180_P
125,O15259,P,203,L,1s1n:A,203,"Does not affect fold stability, as assessed by circular dichroism thermal denaturation melting curves and by NMR spectroscopy. Affects interaction with PKD1.",-1.0,,-999.0,,,,,,,,,,,0.0,,O15259_P_203_L
126,Q9BT30,L,110,Q,4qkb:A,110,Does not affect ability to trigger programmed necrosis.,,,0.0,,,,,,,,,,,,,Q9BT30_L_110_Q
127,Q9UMS0,G,189,A,2m5o:A,39,Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.,-1.0,-1.0,1.0,,,,,,,,,,,-1.0,,Q9UMS0_G_189_A
128,Q9UMS0,G,189,K,2m5o:A,39,Alters protein structure. Increases likelihood of existing as monomer. Decreases ability to receive a Fe/S clusters from donor proteins. Decreases delivery rates of [2Fe-2S] cluster to target proteins.,-1.0,-1.0,1.0,,,,,,,,,,,-1.0,,Q9UMS0_G_189_K
129,O15091,D,409,N,4rou:A,409,Abolishes ribonuclease activity.,,,1.0,,,,,,,,,,,,,O15091_D_409_N
130,O15091,D,478,N,4rou:A,478,Abolishes ribonuclease activity.,,,1.0,,,,,,,,,,,,,O15091_D_478_N
131,O15091,D,479,N,4rou:A,479,Abolishes ribonuclease activity.,,,1.0,,,,,,,,,,,,,O15091_D_479_N
132,O15091,P,480,G,4rou:A,480,Does not affect ribonuclease activity.,,,0.0,,,,,,,,,,,,,O15091_P_480_G
133,P35240,L,64,P,6cds:A,64,Abolishes binding to AGAP2 and interaction with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.,-1.0,,-999.0,,,,,,,,,,,,,P35240_L_64_P
134,P35240,S,518,A,4zrj:B,518,Loss of phosphorylation. Significant accumulation in the nucleus and no effect on binding to DCAF1.,0.0,,-999.0,-1.0,,,,,,,,1.0,,,,P35240_S_518_A
135,P35240,S,518,D,4zrj:B,518,No effect on phosphorylation. Defective nuclear accumulation. Significant decrease in binding to DCAF1 and in ability to inhibit cell proliferation.,-1.0,,1.0,0.0,,,,,,,,1.0,,,,P35240_S_518_D
136,Q9NVP2,D,36,A,5bnx:D,36,Abolishes CDAN1 interaction.,-1.0,,-999.0,,,,,,,,,,,,,Q9NVP2_D_36_A
137,Q9NVP2,D,37,A,5bnx:D,37,Abolishes CDAN1 interaction.,-1.0,,-999.0,,,,,,,,,,,,,Q9NVP2_D_37_A
138,P62805,K,13,A,6l9z:P,12,Impaired methylation by N6AMT1.,,,-999.0,,,,,,,,,,,,,P62805_K_13_A
139,P62805,K,32,R,6l9z:P,31,Abolished ufmylation.,,,-999.0,,,,,,-1.0,,,,,,,P62805_K_32_R
140,Q9P212,Q,2140,E,2byf:A,10,Increases 2.8-fold the affinity for HRAS.,1.0,,-999.0,,,,,,,,,,,,,Q9P212_Q_2140_E
141,Q9P212,Q,2148,E,2byf:A,18,Decreases 17.5-fold the affinity for HRAS.,-1.0,,-999.0,,,,,,,,,,,,,Q9P212_Q_2148_E
142,Q9P212,Q,2148,K,2byf:A,18,Increases 1.4-fold the affinity for HRAS.,1.0,,-999.0,,,,,,,,,,,,,Q9P212_Q_2148_K
143,Q9P212,R,2150,L,2byf:A,20,Abolishes interaction with HRAS.,-1.0,,-999.0,,,,,,,,,,,,,Q9P212_R_2150_L
144,Q9P212,K,2171,L,2byf:A,41,No effect on HRAS-binding.,0.0,,-999.0,,,,,,,,,,,,,Q9P212_K_2171_L
145,Q9P212,Y,2174,L,2byf:A,44,Reduces HRAS-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P212_Y_2174_L
146,O00763,R,277,A,3jrx:A,277,Loss of regulation of oligomerization by phosphorylation at S-222.,-1.0,,-999.0,,,,,,,,,,,,,O00763_R_277_A
147,Q92831,V,752,A,1wum:A,752,Reduced acetyl-lysine binding.,,-1.0,-999.0,,,,,,,,,,,,,Q92831_V_752_A
148,Q92831,Y,760,A,1wum:A,760,Reduced acetyl-lysine binding.,,-1.0,-999.0,,,,,,,,,,,,,Q92831_Y_760_A
149,Q92831,Y,802,A,1wum:A,802,Reduced acetyl-lysine binding.,,-1.0,-999.0,,,,,,,,,,,,,Q92831_Y_802_A
150,Q92831,Y,809,A,1wum:A,809,Complete loss of acetyl-lysine binding.,,-1.0,-999.0,,,,,,,,,,,,,Q92831_Y_809_A
151,Q92830,E,575,A,5h86:A,81,Catalytically dead mutant,,,1.0,,,,,,,,,,,,,Q92830_E_575_A
152,Q92830,D,615,A,5h86:A,121,Catalytically dead mutant,,,1.0,,,,,,,,,,,,,Q92830_D_615_A
153,Q92830,Y,645,A,5h86:A,151,Reduced histone succinylation without affecting histone acetylation. Reduced gene expression.,,,-999.0,,,,,,,,,,,,-1.0,Q92830_Y_645_A
154,Q9UKL6,C,63,A,1ln2:A,63,Reduces activity by 20%.,,,1.0,,,,,,,,,,,,,Q9UKL6_C_63_A
155,P21453,R,120,A,3v2y:A,120,Drastically reduced affinity for sphingosine 1-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P21453_R_120_A
156,P21453,E,121,A,3v2y:A,121,Drastically reduced affinity for sphingosine 1-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P21453_E_121_A
157,P21453,E,121,Q,3v2y:A,121,Slight activation of the receptor at maximal ligand concentration.,,,1.0,,,,,,,,,,,,,P21453_E_121_Q
158,P21453,F,210,L,3v2w:A,210,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,1.0,,,,,,,,,,,,,P21453_F_210_L
159,P21453,F,265,L,3v2y:A,265,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,1.0,,,,,,,,,,,,,P21453_F_265_L
160,P21453,W,269,F,3v2y:A,269,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,1.0,,,,,,,,,,,,,P21453_W_269_F
160,P21453,W,269,L,3v2y:A,269,Impairs sphingosine 1-phosphate binding and signaling.,,-1.0,1.0,,,,,,,,,,,,,P21453_W_269_L
161,P21453,R,292,A,3v2y:A,292,Drastically reduced affinity for sphingosine 1-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P21453_R_292_A
161,P21453,R,292,V,3v2y:A,292,Drastically reduced affinity for sphingosine 1-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P21453_R_292_V
162,Q9Y6E0,K,65,A,4qmx:A,53,Loss of activity and autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,Q9Y6E0_K_65_A
163,Q9Y6E0,T,190,A,4qmx:A,178,Loss of activity and autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,Q9Y6E0_T_190_A
164,P01236,G,157,D,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_D
164,P01236,G,157,F,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_F
164,P01236,G,157,L,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_L
164,P01236,G,157,N,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_N
164,P01236,G,157,R,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_R
164,P01236,G,157,V,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_V
164,P01236,G,157,Y,1rw5:A,129,Inhibits signaling via PRLR,,,1.0,,,,,,,,,,,,,P01236_G_157_Y
165,Q71DI3,C,111,A,3av1:E,110,Abolishes S-palmitoylation.,,,-999.0,,,,,,-1.0,,,,,,,Q71DI3_C_111_A
166,O75381,F,52,A,4bxu:A,52,"Reduced interaction with PEX19, minor effect on interaction with PEX5.",-1.0,,-999.0,,,,,,,,,,,,,O75381_F_52_A
166,O75381,F,52,W,4bxu:A,52,"Reduced interaction with PEX19, minor effect on interaction with PEX5.",-1.0,,-999.0,,,,,,,,,,,,,O75381_F_52_W
167,O75381,K,56,A,4bxu:A,56,"Reduced interaction with PEX19, minor effect on interaction with PEX5.",-1.0,,-999.0,,,,,,,,,,,,,O75381_K_56_A
167,O75381,K,56,E,4bxu:A,56,"Reduced interaction with PEX19, minor effect on interaction with PEX5.",-1.0,,-999.0,,,,,,,,,,,,,O75381_K_56_E
168,P52655,S,316,A,6o9l:N,316,Strongly reduces phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,P52655_S_316_A
169,P52655,S,321,A,6o9l:N,321,Strongly reduces phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,P52655_S_321_A
170,P78560,L,27,F,3crd:A,27,Loss of interaction with CASP2.,-1.0,,-999.0,,,,,,,,,,,,,P78560_L_27_F
171,P78560,G,65,A,3crd:A,65,Loss of interaction with CASP2.,-1.0,,-999.0,,,,,,,,,,,,,P78560_G_65_A
172,P78560,N,121,D,2of5:A,121,Loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_N_121_D
173,P78560,Q,125,A,2of5:A,125,Loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_Q_125_A
174,P78560,L,136,E,2of5:A,136,Partial loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_L_136_E
175,P78560,Q,142,E,2of5:A,142,Partial loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_Q_142_E
176,P78560,Y,146,A,2of5:A,146,Loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,P78560_Y_146_A
177,P78560,R,147,A,2of5:A,147,Loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,P78560_R_147_A
178,P78560,R,147,E,2of5:A,147,Loss of interaction with PIDD1. Loss of PIDDosome assembly. Loss of CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,P78560_R_147_E
179,P78560,K,149,E,2of5:A,149,Loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_K_149_E
180,P78560,H,154,A,2of5:A,154,Partial loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_H_154_A
181,P78560,V,156,D,2of5:A,156,Loss of interaction with PIDD1. Loss of PIDDosome assembly. Loss of CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,P78560_V_156_D
182,P78560,Q,169,A,2of5:A,169,Partial loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,P78560_Q_169_A
183,P78560,Q,169,E,2of5:A,169,Loss of interaction with PIDD1.,-1.0,,-999.0,,,,,,,,,,,,,P78560_Q_169_E
184,P78560,R,170,A,2of5:A,170,Partial loss of interaction with PIDD1.,0.0,,-999.0,,,,,,,,,,,,,P78560_R_170_A
185,P78560,E,188,K,2of5:A,188,No effect on interaction with PIDD1.,0.0,,-999.0,,,,,,,,,,,,,P78560_E_188_K
186,P78560,V,189,W,2of5:A,189,No effect on interaction with PIDD1.,0.0,,-999.0,,,,,,,,,,,,,P78560_V_189_W
186,P78560,V,189,D,2of5:A,189,No effect on interaction with PIDD1.,0.0,,-999.0,,,,,,,,,,,,,P78560_V_189_D
187,P60520,R,47,A,4co7:A,47,Strongly reduced interaction with UBA5.,-1.0,,-999.0,,,,,,,,,,,,,P60520_R_47_A
188,P60520,G,116,A,4co7:A,116,Impairs localization at the autophagosomal membrane.,,,-999.0,,,,,,,,,1.0,,,,P60520_G_116_A
189,Q5MNZ6,R,225,A,6klr:A,216,Loss of PtdIns3P binding,,-1.0,-999.0,,,,,,,,,,,,,Q5MNZ6_R_225_A
190,Q5MNZ6,R,226,A,6klr:A,217,Loss of PtdIns3P binding,,-1.0,-999.0,,,,,,,,,,,,,Q5MNZ6_R_226_A
191,P01215,N,76,D,1e9j:A,52,Increases from 1 to 3 the number of FSH binding a single FSHR receptor.,1.0,,-999.0,,,,,,,,,,,,,P01215_N_76_D
192,O60760,D,93,N,6w58:A,93,Loss of activation by calcium or magnesium ions.,,-1.0,-999.0,,,,,,,,,,,,,O60760_D_93_N
193,O60760,D,96,N,6w58:A,96,Increases PGD2 synthesis. Loss of activation by calcium or magnesium ions.,,-1.0,1.0,,,,,,,,,,,,,O60760_D_96_N
194,O60760,D,97,N,6w58:A,97,Reduces PGD2 synthesis by 99%. Loss of activation by calcium or magnesium ions.,,-1.0,1.0,,,,,,,,,,,,,O60760_D_97_N
195,Q14562,K,594,E,6qdv:V,594,In GET,,,-999.0,,,,,,,,,,,,,Q14562_K_594_E
196,Q14562,S,717,L,6qdv:V,717,In LAT,,,-999.0,,,,,,,,,,,,,Q14562_S_717_L
197,Q14566,E,757,A,2le8:A,54,Impairs interaction with CTD1.,-1.0,,-999.0,,,,,,,,,,,,,Q14566_E_757_A
197,Q14566,E,757,D,2le8:A,54,Impairs interaction with CTD1.,-1.0,,-999.0,,,,,,,,,,,,,Q14566_E_757_D
198,Q14566,E,763,A,2le8:A,60,Impairs interaction with CTD1.,-1.0,,-999.0,,,,,,,,,,,,,Q14566_E_763_A
198,Q14566,E,763,D,2le8:A,60,Impairs interaction with CTD1.,-1.0,,-999.0,,,,,,,,,,,,,Q14566_E_763_D
199,Q14566,L,766,A,2le8:A,63,Impairs interaction with CTD1.,-1.0,,-999.0,,,,,,,,,,,,,Q14566_L_766_A
200,P18074,K,48,R,6nmi:B,48,Decreased transcriptional activity of the reconstituted TFIIH complex.,,,-999.0,,,,,,,,,,,,,P18074_K_48_R
201,P18074,C,190,S,6nmi:B,190,Reduced iron-sulfur-binding. Iron-sulfur-binding is further decreased in absence of MMS19.,,-1.0,-999.0,,,,,,,,,,,,,P18074_C_190_S
202,P17844,K,53,R,4a4d:A,53,"Abolishes sumoylation, abolishes interaction with HDAC1, increases TP53 coactivation and promotes polyubiquitination.",-1.0,,1.0,,1.0,,-1.0,,,,,,,,,P17844_K_53_R
203,P17844,E,55,A,4a4d:A,55,Abolishes sumoylation.,,,-999.0,,,,-1.0,,,,,,,,,P17844_E_55_A
204,P17844,K,144,R,4a4d:A,144,Abolishes RNA helicase activity.,,,1.0,,,,,,,,,,,,,P17844_K_144_R
205,P17735,I,294,A,3dyd:A,294,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,P17735_I_294_A
206,Q9NRH2,T,173,A,5yks:B,173,Prevents phosphorylation and activation by STK11/LKB1 complex.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q9NRH2_T_173_A
206,Q9NRH2,T,173,E,5yks:B,173,Prevents phosphorylation and activation by STK11/LKB1 complex.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q9NRH2_T_173_E
207,P25774,N,104,Q,2c0y:A,89,Abolishes glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,P25774_N_104_Q
208,Q09013,K,100,A,2vd5:A,100,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q09013_K_100_A
209,Q9NYG5,C,23,S,6q6h:C,23,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_23_S
210,Q9NYG5,C,26,S,6q6h:C,26,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_26_S
211,Q9NYG5,C,34,S,6q6h:C,34,Slightly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_34_S
212,Q9NYG5,C,37,S,6q6h:C,37,Slightly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_37_S
213,Q9NYG5,C,44,S,6q6h:C,44,Slightly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_44_S
214,Q9NYG5,C,51,S,6q6h:C,51,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_51_S
215,Q9NYG5,H,53,S,6q6h:C,53,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_53_S
216,Q9NYG5,H,56,S,6q6h:C,56,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_56_S
217,Q9NYG5,H,58,S,6q6h:C,58,Slightly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_H_58_S
218,Q9NYG5,C,59,S,6q6h:C,59,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_59_S
219,Q9NYG5,C,73,S,6q6h:C,73,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_73_S
220,Q9NYG5,C,76,S,6q6h:C,76,Greatly reduces autoubiquitination activity,,,1.0,,-1.0,,,,,,,,,,,Q9NYG5_C_76_S
221,Q96LI5,E,240,A,3ngo:A,240,Loss of deadenylase activity.,,,1.0,,,,,,,,,,,,,Q96LI5_E_240_A
222,Q96LI5,F,484,A,3ngq:A,484,Loss of deadenylase activity.,,,1.0,,,,,,,,,,,,,Q96LI5_F_484_A
223,Q96LI5,D,489,A,3ngq:A,489,Loss of deadenylase activity.,,,1.0,,,,,,,,,,,,,Q96LI5_D_489_A
224,Q96LI5,H,529,A,3ngq:A,529,Loss of deadenylase activity.,,,1.0,,,,,,,,,,,,,Q96LI5_H_529_A
225,Q9NYG8,G,98,I,4rue:B,124,"Strongly increases basal level of channel activity, decreases further activation by pressure and abolishes further activation by arachidonic acid.",,-1.0,1.0,,,,,,,,,,,,,Q9NYG8_G_98_I
226,Q9NYG8,W,236,S,4rue:B,262,"Increases basal level of channel activity and decreases further activation by pressure, but has little effect on further activation by arachidonic acid.",,0.0,1.0,,,,,,,,,,,,,Q9NYG8_W_236_S
227,P04908,S,2,A,2rvq:C,1,Blocks the inhibition of transcription by RPS6KA5/MSK1.,-1.0,,-999.0,,,,,,,,,,,,,P04908_S_2_A
228,Q9NRF2,R,555,A,5w3r:A,555,Abolishes self-association and interaction with INSR and IGF1R.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRF2_R_555_A
229,O75762,K,620,A,6pqp:A,620,Important decrease in electrophile-evoked response.,,-1.0,-999.0,,,,,,,,,,,,,O75762_K_620_A
230,O75762,C,621,A,6pqp:A,621,Decrease in electrophile-evoked response. No change in answer to hyperoxia and diallyl disulfide. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_621_A
230,O75762,C,621,S,6pqp:A,621,Decrease in electrophile-evoked response. No change in answer to hyperoxia and diallyl disulfide. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_621_S
231,O75762,P,622,A,6pqp:A,622,Loss of activation by the scorpion wasabi receptor toxin.,,-1.0,-999.0,,,,,,,,,,,,,O75762_P_622_A
232,O75762,C,633,S,6pqp:A,633,Decrease in activation by hyperoxia and diallyl disulfide. Important decrease in activation by hyperoxia and diallyl disulfide,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_633_S
233,O75762,M,634,L,6pqp:A,634,Loss of activation by the scorpion wasabi receptor toxin.,-1.0,,-999.0,,,,,,,,,,,,,O75762_M_634_L
234,O75762,C,641,A,6pqp:A,641,Decrease in electrophile-evoked and hyperoxia response. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_641_A
234,O75762,C,641,S,6pqp:A,641,Decrease in electrophile-evoked and hyperoxia response. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_641_S
235,O75762,T,646,P,6pqp:A,646,Loss of activation by the scorpion wasabi receptor toxin.,-1.0,,-999.0,,,,,,,,,,,,,O75762_T_646_P
236,O75762,C,665,A,6pqp:A,665,Decrease in electrophile-evoked and hyperoxia response. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_665_A
236,O75762,C,665,L,6pqp:A,665,Decrease in electrophile-evoked and hyperoxia response. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_665_L
236,O75762,C,665,S,6pqp:A,665,Decrease in electrophile-evoked and hyperoxia response. In TRPA1-3C-K708R/Q,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_665_S
237,O75762,K,710,R,6pqp:A,710,No change in electrophile sensitivity. In TRPA1-3C-K708R/Q,,0.0,-999.0,,,,,,,,,,,,,O75762_K_710_R
237,O75762,K,710,Q,6pqp:A,710,No change in electrophile sensitivity. In TRPA1-3C-K708R/Q,,0.0,-999.0,,,,,,,,,,,,,O75762_K_710_Q
238,O75762,C,856,S,6pqp:A,856,Decrease in activation by hyperoxia and diallyl disulfide. Important decrease in activation by hyperoxia and diallyl disulfide,,-1.0,-999.0,,,,,,,,,,,,,O75762_C_856_S
239,O75762,F,909,A,6pqp:A,909,"Loss of inhibition by A-967079, AP-18, and ASD. Increase in activation by cinnamaldehyde, AITC and acrolein.",,-1.0,-999.0,,,,,,,,,,,,,O75762_F_909_A
239,O75762,F,909,T,6pqp:A,909,"Loss of inhibition by A-967079, AP-18, and ASD. Increase in activation by cinnamaldehyde, AITC and acrolein.",,-1.0,-999.0,,,,,,,,,,,,,O75762_F_909_T
240,O75762,F,944,A,6pqp:A,944,"Loss of inhibition by A-967079, AP-18, and ASD. Weak or no change in activation by cinnamaldehyde, AITC and acrolein.",,-1.0,-999.0,,,,,,,,,,,,,O75762_F_944_A
241,O43791,Y,87,A,2cr2:A,67,Strongly reduced affinity for substrate proteins.,-1.0,,-999.0,,,,,,,,,,,,,O43791_Y_87_A
242,O43791,Y,123,A,2cr2:A,103,Strongly reduced affinity for substrate proteins.,-1.0,,-999.0,,,,,,,,,,,,,O43791_Y_123_A
243,O43791,D,130,A,2cr2:A,110,Strongly reduced affinity for substrate proteins.,-1.0,,-999.0,,,,,,,,,,,,,O43791_D_130_A
244,O43791,W,131,A,2cr2:A,111,Strongly reduced affinity for substrate proteins.,-1.0,,-999.0,,,,,,,,,,,,,O43791_W_131_A
245,O43791,F,133,A,2cr2:A,113,Strongly reduced affinity for substrate proteins.,-1.0,,-999.0,,,,,,,,,,,,,O43791_F_133_A
246,O43791,L,186,D,4j8z:A,186,Strongly reduced homodimerization. Reduces the activity of the cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex.,-1.0,,-999.0,,,,,,,,,,,,,O43791_L_186_D
247,O43791,L,190,D,4j8z:A,190,Strongly reduced homodimerization. Reduces the activity of the cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex.,-1.0,,-999.0,,,,,,,,,,,,,O43791_L_190_D
248,O43791,L,193,D,4j8z:A,193,Strongly reduced homodimerization. Reduces the activity of the cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex.,-1.0,,-999.0,,,,,,,,,,,,,O43791_L_193_D
249,O43791,I,217,K,4j8z:A,217,Strongly reduced homodimerization. Reduces the activity of the cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex.,-1.0,,-999.0,,,,,,,,,,,,,O43791_I_217_K
250,Q96RG2,K,1028,R,3dls:A,1028,Loss of autophosphorylating activity.,,,1.0,-1.0,,,,,,,,,,,,Q96RG2_K_1028_R
251,Q96RG2,R,1058,A,3dls:A,1058,Induces lower protein kinase activity.,,,1.0,,,,,,,,,,,,,Q96RG2_R_1058_A
252,Q96RG2,R,1058,K,3dls:A,1058,Does not affect protein kinase activity.,,,0.0,,,,,,,,,,,,,Q96RG2_R_1058_K
253,Q96RG2,A,1151,K,3dls:A,1151,Induces lower protein kinase activity and ability to autophosphorylate.,,,1.0,-1.0,,,,,,,,,,,,Q96RG2_A_1151_K
254,Q96RG2,Y,1152,F,3dls:A,1152,Induces lower protein kinase activity.,,,1.0,,,,,,,,,,,,,Q96RG2_Y_1152_F
255,Q96RG2,T,1161,A,3dls:A,1161,Loss of catalytic activity (PubMed,,,1.0,,,,,,,,,,,,,Q96RG2_T_1161_A
256,Q96RG2,T,1165,A,3dls:A,1165,Loss of catalytic activity. Does not affect protein translation.,,,1.0,,,,,,,,,,,,,Q96RG2_T_1165_A
257,Q9UGB7,K,127,S,2ibn:A,127,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9UGB7_K_127_S
258,O43189,W,41,A,5xfo:A,41,Abolishes histone H3K36me3-binding and localization at double-strand breaks (DSBs).,-1.0,,-999.0,,,,,,,,,,,,,O43189_W_41_A
259,O43189,Y,47,A,5xfo:A,47,Abolishes histone H3K36me3-binding.,-1.0,,-999.0,,,,,,,,,,,,,O43189_Y_47_A
260,O43189,F,65,A,5xfo:A,65,Abolishes histone H3K36me3-binding.,-1.0,,-999.0,,,,,,,,,,,,,O43189_F_65_A
261,O43189,E,66,K,5xfo:A,66,Impairs histone H3K36me3-binding.,-1.0,,-999.0,,,,,,,,,,,,,O43189_E_66_K
262,O43189,F,71,A,5xfo:A,71,Abolishes histone H3K36me3-binding.,-1.0,,-999.0,,,,,,,,,,,,,O43189_F_71_A
263,P15428,Q,148,A,2gdz:A,148,Loss of activity.,,,1.0,,,,,,,,,,,,,P15428_Q_148_A
264,P15428,Q,148,E,2gdz:A,148,Reduced affinity for NAD and prostaglandin E2.,,-1.0,-999.0,,,,,,,,,,,,,P15428_Q_148_E
264,P15428,Q,148,H,2gdz:A,148,Reduced affinity for NAD and prostaglandin E2.,,-1.0,-999.0,,,,,,,,,,,,,P15428_Q_148_H
264,P15428,Q,148,N,2gdz:A,148,Reduced affinity for NAD and prostaglandin E2.,,-1.0,-999.0,,,,,,,,,,,,,P15428_Q_148_N
265,P15428,Y,151,A,2gdz:A,151,Loss of activity.,,,1.0,,,,,,,,,,,,,P15428_Y_151_A
266,P15428,Y,151,F,2gdz:A,151,Loss 15-hydroxyprostaglandin dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P15428_Y_151_F
267,P15428,K,155,Q,2gdz:A,155,Loss 15-hydroxyprostaglandin dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P15428_K_155_Q
268,Q9Y3Y4,E,349,A,2vp7:A,349,Reduces interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_E_349_A
269,Q9Y3Y4,V,350,E,2vp7:A,350,Almost complete loss of interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_V_350_E
270,Q9Y3Y4,N,351,A,2vp7:A,351,Reduces interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_N_351_A
271,Q9Y3Y4,Q,354,A,2vp7:A,354,Reduces interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_Q_354_A
272,Q9Y3Y4,A,356,E,2vp7:A,356,Almost complete loss of interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_A_356_E
273,Q9Y3Y4,I,357,R,2vp7:A,357,Loss of interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_I_357_R
274,Q9Y3Y4,E,360,A,2vp7:A,360,Loss of interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_E_360_A
275,Q9Y3Y4,W,366,E,2vp7:A,366,Loss of interaction with H3K4me2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3Y4_W_366_E
276,Q96Q83,R,122,A,2iuw:A,122,Decreases activity towards ssDNA by 25%. Loss of activity towards dsDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q96Q83_R_122_A
277,Q96Q83,E,123,A,2iuw:A,123,"Strongly increases activity towards dsDNA, possibly by facilitating access to the active site.",,-1.0,-999.0,,,,,,,,,,,,,Q96Q83_E_123_A
278,Q96Q83,R,131,A,2iuw:A,131,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_R_131_A
279,Q96Q83,L,177,A,2iuw:A,177,Loss of activity against 1-methyladenine.,,,1.0,,,,,,,,,,,,,Q96Q83_L_177_A
279,Q96Q83,L,177,N,2iuw:A,177,Loss of activity against 1-methyladenine.,,,1.0,,,,,,,,,,,,,Q96Q83_L_177_N
280,Q96Q83,L,177,E,2iuw:A,177,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_L_177_E
280,Q96Q83,L,177,Q,2iuw:A,177,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_L_177_Q
281,Q96Q83,L,177,I,2iuw:A,177,Decreases activity against 1-methyladenine.,,,1.0,,,,,,,,,,,,,Q96Q83_L_177_I
282,Q96Q83,L,177,M,2iuw:A,177,No effect.,,,0.0,,,,,,,,,,,,,Q96Q83_L_177_M
283,Q96Q83,N,179,A,2iuw:A,179,Decreases activity by about 60%.,,,1.0,,,,,,,,,,,,,Q96Q83_N_179_A
284,Q96Q83,Y,181,A,2iuw:A,181,Strong decrease of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_Y_181_A
285,Q96Q83,D,189,A,2iuw:A,189,"Strongly increases activity towards dsDNA, possibly by facilitating access to the active site.",,1.0,1.0,,,,,,,,,,,,,Q96Q83_D_189_A
286,Q96Q83,H,191,A,2iuw:A,191,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_H_191_A
287,Q96Q83,D,193,A,2iuw:A,193,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96Q83_D_193_A
288,P27448,T,211,A,3fe3:A,211,Prevents phosphorylation and activation by STK11/LKB1 complex.,-1.0,,-999.0,-1.0,,,,,,,,,,,,P27448_T_211_A
289,O43424,S,25,A,5kca:A,511,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_S_25_A
290,O43424,I,26,A,5kca:A,512,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_I_26_A
291,O43424,T,60,A,5kca:A,546,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_T_60_A
292,O43424,E,61,A,5kca:A,547,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_E_61_A
293,O43424,F,76,D,5kca:A,562,Monomeric form. Does not dimerize. Weakly interacts with C1q domain of CBLN1. Forms intermediate synapse. Abolishes cerebellar parallel fiber-Purkinje cell synapse formation. Abolishes D-Serine?dependent long term synaptic depression at PF-PC synapses. Does not recover motor coordination in experiment of transfection in Grid2-null mice.,-1.0,,-999.0,,,,,,,,,,,,,O43424_F_76_D
294,O43424,L,342,A,5kca:A,828,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_L_342_A
295,O43424,E,343,A,5kca:A,829,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_E_343_A
296,O43424,D,344,A,5kca:A,830,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_D_344_A
297,O43424,R,345,A,5kca:A,831,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_R_345_A
298,O43424,K,346,A,5kca:A,832,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_K_346_A
299,O43424,H,348,A,5kca:A,834,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_H_348_A
300,O43424,S,349,A,5kca:A,835,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_S_349_A
301,O43424,M,350,A,5kca:A,836,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_M_350_A
302,O43424,S,352,A,5kca:A,838,Reduces binding to CBLN1,-1.0,,-999.0,,,,,,,,,,,,,O43424_S_352_A
303,O43424,Q,364,A,5kca:A,850,No effect on CBLN1 interaction,0.0,,-999.0,,,,,,,,,,,,,O43424_Q_364_A
304,O60704,R,78,A,3ap1:A,78,Strongly reduced enzymatic activity.,,,1.0,,,,,,,,,,,,,O60704_R_78_A
305,O60704,E,99,A,3ap1:A,99,Loss of sulfotransferase activity.,,,1.0,,,,,,,,,,,,,O60704_E_99_A
306,O60704,R,101,A,3ap1:A,101,Prevents dimerization and strongly decreases enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,O60704_R_101_A
307,O60704,W,113,A,3ap1:A,113,Prevents dimerization and decreases enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,O60704_W_113_A
308,O60704,K,158,A,3ap1:A,158,Nearly complete loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,O60704_K_158_A
309,O60704,T,198,A,3ap1:A,198,Slightly decreased sulfotransferase activity.,,,1.0,,,,,,,,,,,,,O60704_T_198_A
310,O60704,S,285,A,3ap1:A,285,Abolishes sulfotransferase activity.,,,1.0,,,,,,,,,,,,,O60704_S_285_A
311,Q16853,M,211,V,4btw:A,211,"Increased activity towards 2-phenylethylamine, and decreased activity towards methylamine",,,-999.0,,,,,,,,,,,,,Q16853_M_211_V
312,Q16853,Y,394,N,4btw:A,394,"Increased activity towards 2-phenylethylamine, and decreased activity towards methylamine",,,-999.0,,,,,,,,,,,,,Q16853_Y_394_N
313,Q16853,L,469,G,4btw:A,469,"Increased activity towards 2-phenylethylamine, and decreased activity towards methylamine",,,-999.0,,,,,,,,,,,,,Q16853_L_469_G
314,Q9UGP5,K,312,A,3hx0:A,312,Reduces dRP lyase activity by over 90%.,,,1.0,,,,,,,,,,,,,Q9UGP5_K_312_A
315,Q9UGP5,D,427,A,3hx0:A,427,Loss of polymerase activity,,,1.0,,,,,,,,,,,,,Q9UGP5_D_427_A
316,Q9UGP5,D,429,A,3hx0:A,429,Loss of polymerase activity,,,1.0,,,,,,,,,,,,,Q9UGP5_D_429_A
317,Q9UGP5,Y,505,A,3hx0:A,505,No effect on polymerase activity. Reduces terminal transferase activities.,,,1.0,,,,,,,,,,,,,Q9UGP5_Y_505_A
318,Q9UGP5,F,506,G,3hx0:A,506,Strongly reduces polymerase and terminal transferase activities.,,,1.0,,,,,,,,,,,,,Q9UGP5_F_506_G
318,Q9UGP5,F,506,R,3hx0:A,506,Strongly reduces polymerase and terminal transferase activities.,,,1.0,,,,,,,,,,,,,Q9UGP5_F_506_R
319,P54762,K,651,R,5mjb:A,651,"Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL.",-1.0,,1.0,-1.0,-1.0,,,,,,,,,,,P54762_K_651_R
320,P54762,Y,778,F,5mjb:B,778,Loss of interaction with SHC1.,-1.0,,-999.0,,,,,,,,,,,,,P54762_Y_778_F
321,P54762,Y,928,F,2eao:A,37,"Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1.",-1.0,,-999.0,1.0,,,,,,,,,,,,P54762_Y_928_F
322,P19474,C,16,A,5olm:B,16,Loss of E3 ubiquitin-protein ligase activity. Does not inhibit NF-kappa-B-induced gene expression.,,,1.0,,,,,,,,,,,,,P19474_C_16_A
323,P54760,L,95,R,2bba:A,95,Reduces binding affinity for EFNB2.,-1.0,,-999.0,,,,,,,,,,,,,P54760_L_95_R
324,Q00987,C,438,L,5mnj:G,438,No loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_C_438_L
325,Q00987,C,441,G,5mnj:G,441,Fails to interact with MDM4.,-1.0,,-999.0,,,,,,,,,,,,,Q00987_C_441_G
326,Q00987,C,449,A,5mnj:G,449,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_C_449_A
327,Q00987,C,449,S,5mnj:G,449,No substantial decrease of ubiquitin ligase E3 activity.,,,0.0,,,,,,,,,,,,,Q00987_C_449_S
328,Q00987,H,452,A,5mnj:G,452,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_H_452_A
329,Q00987,T,455,A,5mnj:G,455,Significant decrease of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_T_455_A
330,Q00987,H,457,S,5mnj:G,457,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_H_457_S
331,Q00987,C,461,S,5mnj:G,461,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_C_461_S
332,Q00987,C,464,A,5mnj:G,464,"Loss of ubiquitin ligase E3 activity, enhances protein stability. Does not inhibit interaction with APEX1, but inhibits its ubiquitin ligase E3 activity on APEX1.",0.0,,1.0,,,,,,,,,,,1.0,,Q00987_C_464_A
333,Q00987,C,475,G,5mnj:G,475,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_C_475_G
334,Q00987,C,478,R,5mnj:G,478,Fails to interact with MDM4.,-1.0,,-999.0,,,,,,,,,,,,,Q00987_C_478_R
335,Q00987,C,478,S,5mnj:G,478,Loss of ubiquitin ligase E3 activity.,,,1.0,,,,,,,,,,,,,Q00987_C_478_S
336,P54764,Q,40,A,4m4r:A,40,10-fold reduced affinity for EFNB2,-1.0,,-999.0,,,,,,,,,,,,,P54764_Q_40_A
337,P54764,E,42,A,4m4r:A,42,10-fold reduced affinity for EFNB2,-1.0,,-999.0,,,,,,,,,,,,,P54764_E_42_A
338,A5YKK6,K,1208,E,5anr:A,1203,Impairs interaction with CNOT7,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_K_1208_E
339,A5YKK6,P,1209,Y,5anr:A,1204,Abolishes interaction with CNOT7,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_P_1209_Y
340,A5YKK6,H,1212,Y,5anr:A,1207,Impairs interaction with CNOT7,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_H_1212_Y
341,A5YKK6,K,1218,E,5anr:A,1213,Impairs interaction with CNOT7,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_K_1218_E
342,A5YKK6,V,1251,R,5anr:A,1246,Abolishes interaction with CNOT7.,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_V_1251_R
343,A5YKK6,P,1257,Y,5anr:A,1252,Abolishes interaction with CNOT7,-1.0,,-999.0,,,,,,,,,,,,,A5YKK6_P_1257_Y
344,O75365,C,49,A,1r6h:A,52,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,O75365_C_49_A
345,O75365,D,71,A,1r6h:A,74,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,O75365_D_71_A
346,O75365,D,72,A,1r6h:A,75,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,O75365_D_72_A
347,O75365,C,104,A,1r6h:A,107,95% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,O75365_C_104_A
347,O75365,C,104,S,1r6h:A,107,95% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,O75365_C_104_S
349,O75365,A,111,S,1r6h:A,114,Enhances catalytic activity.,,,1.0,,,,,,,,,,,,,O75365_A_111_S
350,Q13237,D,412,A,5jiz:A,412,Reduces cGMP binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q13237_D_412_A
351,Q13237,R,415,A,5jiz:A,415,Reduces cGMP binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q13237_R_415_A
352,O75369,K,2468,R,2eec:A,105,Cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O75369_K_2468_R
353,P60709,Y,69,A,6anu:A,69,Decreased interaction with SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_Y_69_A
354,P60709,I,71,A,6anu:A,71,Decreased interaction with SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_I_71_A
356,P60709,H,73,A,6anu:A,73,Abolished methylation by SETD3.,,,-999.0,,,,,,,,,,,,,P60709_H_73_A
357,P60709,G,74,A,6anu:A,74,Impaired methylation by SETD3.,,,-999.0,,,,,,,,,,,,,P60709_G_74_A
358,P60709,W,79,E,6anu:A,79,Does not affect methylation by SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_W_79_E
359,P60709,D,80,A,6anu:A,80,Decreased interaction with SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_D_80_A
360,P60709,D,81,A,6anu:A,81,Decreased interaction with SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_D_81_A
361,P60709,M,82,A,6anu:A,82,Decreased interaction with SETD3.,-1.0,,-999.0,,,,,,,,,,,,,P60709_M_82_A
362,P12104,L,39,G,6l7k:A,38,Reduced stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_L_39_G
363,P12104,E,64,G,6l7k:A,63,Localized reduction in stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_E_64_G
364,P12104,L,65,A,6l7k:A,64,Reduced stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_L_65_A
365,P12104,L,65,G,6l7k:A,64,Reduced stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_L_65_G
366,P12104,V,67,G,6l7k:A,66,Localized reduction in stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_V_67_G
367,P12104,L,90,G,6l7k:A,89,Reduced stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_L_90_G
368,P12104,V,123,G,6l7k:A,122,Reduced stability.,,,-999.0,,,,,,,,,,,-1.0,,P12104_V_123_G
369,P41146,Q,107,A,5dhh:B,1171,Impairs G protein-mediated inhibition of adenylate cyclase.,,,1.0,,,,,,,,,,,,,P41146_Q_107_A
370,P41146,D,110,A,5dhh:B,1174,Abolishes G protein-mediated inhibition of adenylate cyclase. No effect on antagonist-mediated inhibition of G protein-mediated signaling.,,,1.0,,,,,,,,,,,,,P41146_D_110_A
371,P41146,D,130,A,5dhh:B,1194,Abolishes G protein-mediated inhibition of adenylate cyclase. Abolishes antagonist-mediated inhibition of G protein-mediated signaling.,,,1.0,,,,,,,,,,,,,P41146_D_130_A
372,P41146,Y,131,A,5dhh:B,1195,Impairs G protein-mediated inhibition of adenylate cyclase.,,,1.0,,,,,,,,,,,,,P41146_Y_131_A
373,P41146,Q,280,A,5dhh:A,280,Impairs G protein-mediated inhibition of adenylate cyclase.,,,1.0,,,,,,,,,,,,,P41146_Q_280_A
374,P41146,Y,309,A,5dhh:A,309,Mildly impairs G protein-mediated inhibition of adenylate cyclase. Abolishes antagonist-mediated inhibition of G protein-mediated signaling.,,,1.0,,,,,,,,,,,,,P41146_Y_309_A
375,O14788,R,223,A,3urf:A,223,Reduces affinity for TNFRSF11B.,-1.0,,-999.0,,,,,,,,,,,,,O14788_R_223_A
376,O14788,K,257,A,3urf:A,257,Reduces affinity for TNFRSF11B.,-1.0,,-999.0,,,,,,,,,,,,,O14788_K_257_A
377,P23743,E,134,Q,6iie:A,134,Binds calcium but with decreased affinity.,,-1.0,-999.0,,,,,,,,,,,,,P23743_E_134_Q
378,P23743,E,179,Q,6iie:A,179,Loss of calcium-binding.,,-1.0,-999.0,,,,,,,,,,,,,P23743_E_179_Q
379,Q02297,K,181,E,1hre:A,181,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,1.0,,,,,,,,,,,,,Q02297_K_181_E
380,Q02297,K,185,E,1hre:A,185,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,1.0,,,,,,,,,,,,,Q02297_K_185_E
381,Q02297,K,187,E,1hre:A,187,Defective in integrin-binding and in inducing ERBB3 phosphorylation,-1.0,,1.0,,,,,,,,,,,,,Q02297_K_187_E
382,P30048,T,146,A,5jcg:A,85,Impairs phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P30048_T_146_A
383,P16083,N,162,H,4fgl:D,161,"Loss of activity toward CB1954, no effect toward menadione.",,-1.0,-999.0,,,,,,,,,,,,,P16083_N_162_H
384,P21980,C,277,V,4pyg:A,277,Dominant negatif. Abolishes WDR54 cross-linking.,-1.0,,-999.0,,,,,,,,,,,,,P21980_C_277_V
385,Q96RU2,C,171,A,6h4h:A,171,Abolishes deubiquitinase activity.,,,1.0,,,,,,,,,,,,,Q96RU2_C_171_A
386,P62491,K,13,N,6djl:F,13,Abolishes SH3BP5-mediated guanine nucleotide exchange.,-1.0,,-999.0,,,,,,,,,,,,,P62491_K_13_N
387,P62491,V,22,M,6djl:F,22,Impairs protein folding.,,,-999.0,,,,,,,,,,,-1.0,,P62491_V_22_M
388,P62491,K,24,R,6djl:F,24,Impairs protein folding and decreases affinity for guanine nucleotides.,,-1.0,-999.0,,,,,,,,,,,-1.0,,P62491_K_24_R
389,P62491,S,25,N,6djl:F,25,"Dominant-negative mutant. Induces increased number of binucleated cells, indicating defects in cytokinesis. Inhibits the transport of NPC1L1 to the plama membrane. Disrupts the trafficking of CDH1 to the plasma membrane and promotes accumulation of CDH1 in RAB11A endosomes in nonpolarized cells. Promotes mistargeting of CDH1 to the apical membrane in polarized cells.",,,1.0,,,,,,,,,,,,,P62491_S_25_N
390,P62491,F,36,A,6djl:F,36,Nearly abolishes SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_F_36_A
391,P62491,L,38,P,6djl:F,38,Decreases SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_L_38_P
393,P62491,S,40,F,6djl:F,40,Nearly abolishes SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_S_40_F
394,P62491,K,41,A,6djl:F,41,Mildly decreases SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_K_41_A
395,P62491,K,41,P,6djl:F,41,Abolishes SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_K_41_P
396,P62491,I,44,A,6djl:F,44,Abolishes SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_I_44_A
397,P62491,Q,70,L,6djl:F,70,Constitutively active mutant. Decreases GTPase activity. Disrupts the trafficking of CDH1 to the plasma membrane and promotes accumulation of CDH1 in RAB11A endosomes in nonpolarized cells. Promotes mistargeting of CDH1 to the apical membrane in polarized cells.,,,1.0,,,,,,,,,,,,,P62491_Q_70_L
398,P62491,R,82,C,6djl:F,82,Decreases SH3BP5-mediated guanine nucleotide exchange.,,,1.0,,,,,,,,,,,,,P62491_R_82_C
399,P62491,S,154,L,6djl:F,154,Impairs protein folding.,,,-999.0,,,,,,,,,,,-1.0,,P62491_S_154_L
400,P61619,Y,344,H,6w6l:1,344,Reduces cotranslational translocation of APLN precursor/preproapelin.,,,1.0,,,,,,,,,,,,,P61619_Y_344_H
401,P62495,K,63,A,4d61:h,63,Loss of hydroxylation.,,,-999.0,,,,,,-1.0,,,,,,,P62495_K_63_A
401,P62495,K,63,R,4d61:h,63,Loss of hydroxylation.,,,-999.0,,,,,,-1.0,,,,,,,P62495_K_63_R
402,P62495,Q,185,R,4d61:h,185,Abolishes methylation by N6AMT1.,,,-999.0,,,,,,,,,,,,,P62495_Q_185_R
402,P62495,Q,185,I,4d61:h,185,Abolishes methylation by N6AMT1.,,,-999.0,,,,,,,,,,,,,P62495_Q_185_I
402,P62495,Q,185,N,4d61:h,185,Abolishes methylation by N6AMT1.,,,-999.0,,,,,,,,,,,,,P62495_Q_185_N
403,Q9Y2H1,T,75,A,5xqz:D,75,Decreased kinase activity. Reduced binding of S100B.,-1.0,,1.0,,,,,,,,,,,,,Q9Y2H1_T_75_A
404,Q9NWS0,F,54,A,7avc:AAA,24,Abolishes binding to histone H4.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWS0_F_54_A
405,Q9NWS0,C,55,A,7avc:AAA,25,No effect on binding to histone H4.,,0.0,-999.0,,,,,,,,,,,,,Q9NWS0_C_55_A
406,Q9NWS0,K,57,A,7avc:AAA,27,Abolishes binding to TELO2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_K_57_A
407,Q9NWS0,K,64,A,7avc:AAA,34,"Abolishes binding to ECD, EFTUD2, RPB1, TELO2 and UBR5.",-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_K_64_A
408,Q9NWS0,K,113,A,7avc:AAA,83,Reduces binding to TELO2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_K_113_A
409,Q9NWS0,R,163,A,7avc:AAA,133,Reduces binding to TELO2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_R_163_A
410,Q9NWS0,K,166,A,7avc:AAA,136,Reduces binding to TELO2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_K_166_A
411,Q9NWS0,R,168,A,7avc:AAA,138,Abolishes binding to TELO2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NWS0_R_168_A
412,O94766,E,281,A,1fgg:A,281,Absence of enzymatic activity in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA). Does not increase PXYLP1-induced 2-phosphoxylose phosphatase activity in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA).,,,1.0,,,,,,,,,,,,,O94766_E_281_A
413,O94766,C,301,A,1fgg:A,301,Enzyme inactivation and loss of glycosylation.,,,1.0,,,-1.0,,,,,,,,,,O94766_C_301_A
414,P16333,W,38,K,2jw4:A,41,Small decrease in RASA1-binding. Almost complete loss of RASA1-binding,-1.0,,-999.0,,,,,,,,,,,,,P16333_W_38_K
415,P16333,W,143,K,2cub:A,52,No effect on RASA1-binding. Almost complete loss of RASA1-binding,,,-999.0,,,,,,,,,,,,,P16333_W_143_K
416,P16333,R,308,K,2ci9:A,308,No effect on RASA1-binding.,-1.0,,-999.0,,,,,,,,,,,,,P16333_R_308_K
417,Q9BYP7,D,294,A,5o2c:A,294,Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters.,,,1.0,,,,,,,,,,,,,Q9BYP7_D_294_A
418,Q9BQ50,D,14,A,1y97:B,14,Loss of enzyme activity,,,1.0,,,,,,,,,,,,,Q9BQ50_D_14_A
419,Q9BQ50,E,16,A,1y97:B,16,Loss of enzyme activity,,,1.0,,,,,,,,,,,,,Q9BQ50_E_16_A
420,Q9BQ50,D,123,A,1y97:B,123,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BQ50_D_123_A
421,Q13641,K,76,A,4cnc:B,76,Strongly reduces Wnt inhibitory function.,,,1.0,,,,,,,,,,,,,Q13641_K_76_A
422,Q13641,F,97,T,4cnc:B,97,Strongly reduces Wnt inhibitory function.,,,1.0,,,,,,,,,,,,,Q13641_F_97_T
423,Q13641,N,124,Q,4cnc:B,124,Impaired trafficking to the cell surface.,,,-999.0,,,,,,,,,1.0,,,,Q13641_N_124_Q
424,Q13641,R,214,E,4cnm:A,214,Impaired trafficking to the cell surface.,,,-999.0,,,,,,,,,1.0,,,,Q13641_R_214_E
425,Q13641,Y,325,A,4cnm:A,325,Reduces Wnt inhibitory function.,,,1.0,,,,,,,,,,,,,Q13641_Y_325_A
426,Q9Y5A9,R,411,A,4wqn:A,411,Slightly decreased binding to RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_R_411_A
427,Q9Y5A9,K,416,A,4wqn:A,416,Decreased binding to RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_K_416_A
428,Q9Y5A9,W,432,A,4wqn:A,432,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_W_432_A
429,Q9Y5A9,R,441,A,4wqn:A,441,Slightly decreased binding to RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_R_441_A
430,Q9Y5A9,W,486,A,4wqn:A,486,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_W_486_A
431,Q9Y5A9,W,491,A,4wqn:A,491,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_W_491_A
432,Q9Y5A9,R,527,A,4wqn:A,527,Decreased binding to RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5A9_R_527_A
433,Q9ULV0,Y,1714,E,4lx0:B,1714,Abolishes interaction with RAB11A,-1.0,,-999.0,,,,,,,,,,,,,Q9ULV0_Y_1714_E
434,Q9ULV0,Q,1748,R,4lx0:B,1748,Abolishes interaction with RAB11A,-1.0,,-999.0,,,,,,,,,,,,,Q9ULV0_Q_1748_R
435,O15527,K,249,Q,2xhi:A,249,Loss of activity.,,,1.0,,,,,,,,,,,,,O15527_K_249_Q
436,O15527,D,268,E,2xhi:A,268,No effect on activity.,,,0.0,,,,,,,,,,,,,O15527_D_268_E
436,O15527,D,268,Q,2xhi:A,268,No effect on activity.,,,0.0,,,,,,,,,,,,,O15527_D_268_Q
437,O15527,D,268,N,2xhi:A,268,Decreases activity about 65-fold.,,,1.0,,,,,,,,,,,,,O15527_D_268_N
438,Q6XQN6,D,19,A,4yub:A,19,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_D_19_A
439,Q6XQN6,Y,21,A,4yub:A,21,"Partial loss of activity in the presence of ATP, complete loss in the absence of ATP.",,,1.0,,,,,,,,,,,,,Q6XQN6_Y_21_A
440,Q6XQN6,G,169,A,4yub:A,169,Partial loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_G_169_A
441,Q6XQN6,G,209,A,4yub:A,209,Partial loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_G_209_A
442,Q6XQN6,H,213,A,4yub:A,213,Partial loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_H_213_A
443,Q6XQN6,D,288,A,4yub:A,288,Partial loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_D_288_A
444,Q6XQN6,R,318,A,4yub:A,318,"Partial loss of activity in the presence of ATP, almost complete loss in the absence of ATP.",,,1.0,,,,,,,,,,,,,Q6XQN6_R_318_A
445,Q6XQN6,N,357,A,4yub:A,357,Small loss of activity.,,,1.0,,,,,,,,,,,,,Q6XQN6_N_357_A
446,O95630,D,348,A,3rzv:A,348,"Promotes accumulation of ubiquitin on endosomes, ablates enzymatic activity toward polyubiquitin substrate and allows ubiquitinated STAM stabilization.",,,-999.0,,,,,,,,,,,,,O95630_D_348_A
447,P46060,K,524,R,5d2m:C,524,"Loss of cross-link to SUMO1. Abolishes association with nuclear pores during interphase, and with mitotic spindles during mitosis.",-1.0,,-999.0,,,,,,,,,,,,,P46060_K_524_R
448,Q96MU7,K,361,L,2yud:A,32,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_K_361_L
449,Q96MU7,S,362,A,2yud:A,33,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_S_362_A
450,Q96MU7,N,367,D,2yud:A,38,Abolished binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_N_367_D
451,Q96MU7,W,377,A,2yud:A,48,Abolishes binding to N6-methyladenosine (m6A)-containing RNAs. Abolishes binding to m6A-containing mRNAs,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_W_377_A
452,Q96MU7,W,377,D,2yud:A,48,Abolishes RNA-binding and ability to influence alternative splice site selection.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_W_377_D
453,Q96MU7,L,380,T,2yud:A,51,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_L_380_T
454,Q96MU7,L,387,E,2yud:A,58,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_L_387_E
455,Q96MU7,L,399,E,2yud:A,70,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_L_399_E
456,Q96MU7,F,401,D,2yud:A,72,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_F_401_D
457,Q96MU7,S,402,A,2yud:A,73,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_S_402_A
458,Q96MU7,F,409,D,2yud:A,80,Abolishes RNA-binding and ability to influence alternative splice site selection.,,-1.0,1.0,,,,,,,,,,,,,Q96MU7_F_409_D
459,Q96MU7,G,411,I,2yud:A,82,Abolishes RNA-binding and ability to influence alternative splice site selection.,,-1.0,1.0,,,,,,,,,,,,,Q96MU7_G_411_I
460,Q96MU7,W,428,A,2yud:A,99,Abolishes binding to N6-methyladenosine (m6A)-containing RNAs. Abolishes binding to m6A-containing mRNAs,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_W_428_A
461,Q96MU7,W,428,D,2yud:A,99,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_W_428_D
462,Q96MU7,M,438,A,2yud:A,109,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_M_438_A
463,Q96MU7,W,447,D,2yud:A,118,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_W_447_D
464,Q96MU7,N,466,D,2yud:A,137,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_N_466_D
465,Q96MU7,R,475,A,2yud:A,146,Reduced binding affinity for N6-methyladenosine (m6A)-containing RNAs by 100-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_R_475_A
466,Q96MU7,R,475,D,2yud:A,146,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_R_475_D
467,Q96MU7,R,475,F,2yud:A,146,Reduced binding affinity for N6-methyladenosine (m6A)-containing RNAs by 9-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q96MU7_R_475_F
468,Q96MU7,D,476,K,2yud:A,147,Does not affect ability to influence alternative splice site selection.,,,0.0,,,,,,,,,,,,,Q96MU7_D_476_K
469,Q16678,V,395,L,6iq5:A,395,Invertes the 4OH E2,,,-999.0,,,,,,,,,,,,,Q16678_V_395_L
470,Q9NX09,S,103,L,3lq9:B,103,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_103_L
470,Q9NX09,S,103,W,3lq9:B,103,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_103_W
471,Q9NX09,R,133,A,3lq9:B,133,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_R_133_A
472,Q9NX09,S,137,A,3lq9:B,137,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_137_A
472,Q9NX09,S,137,D,3lq9:B,137,No effect on inhibition of mTORC1.,,,0.0,,,,,,,,,,,,,Q9NX09_S_137_D
473,Q9NX09,P,139,A,3lq9:B,139,Abolishes inhibition of mTORC1.,,,1.0,,,,,,,,,,,,,Q9NX09_P_139_A
474,Q9NX09,C,140,S,3lq9:B,140,Mildly reduces inhibition of mTORC1.,,,1.0,,,,,,,,,,,,,Q9NX09_C_140_S
475,Q96HS1,H,105,A,5muf:A,105,Loss of phosphatase activity.,,,1.0,,,,,,,,,,,,,Q96HS1_H_105_A
476,Q9BYN0,C,99,S,2b6f:A,99,"No effect on association with PRDX1, PRDX2, PRDX3 or PRDX4.",-1.0,,-999.0,,,,,,,,,,,,,Q9BYN0_C_99_S
477,Q9NXA8,T,69,A,4hda:B,69,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NXA8_T_69_A
478,Q9NXA8,Y,102,F,4hda:B,102,Increases the KM for desuccinylation.,,-1.0,-999.0,,,,,,,,,,,,,Q9NXA8_Y_102_F
479,Q9NXA8,R,105,M,4hda:B,105,Increases the KM for desuccinylation. Does not affect deacetylase activity.,,-1.0,0.0,,,,,,,,,,,,,Q9NXA8_R_105_M
480,Q9NXA8,H,158,A,4hda:B,158,Abolishes desuccinylation and deglutarylation activity.,,,1.0,,,,,,,,,,,,,Q9NXA8_H_158_A
481,P06702,C,3,A,5i8n:A,3,Disrupts interaction with NOS2 and inhibits LDL(ox)-induced GAPDH S-nitrosylation,-1.0,,-999.0,,,,,,,,,,,,,P06702_C_3_A
482,P06702,E,36,Q,5i8n:A,36,Loss of resistance to bacterial invasion,,,1.0,,,,,,,,,,,,,P06702_E_36_Q
483,P06702,M,63,A,5i8n:A,63,Loss of antifungal activity.,,,1.0,,,,,,,,,,,,,P06702_M_63_A
484,P06702,E,78,Q,5i8n:A,78,Loss of resistance to bacterial invasion,,,1.0,,,,,,,,,,,,,P06702_E_78_Q
485,P06702,M,81,A,5i8n:A,81,No effect on antifungal activity.,,,0.0,,,,,,,,,,,,,P06702_M_81_A
486,P06702,M,83,A,5i8n:A,83,Loss of antifungal activity.,,,1.0,,,,,,,,,,,,,P06702_M_83_A
487,P10646,K,64,I,4bqd:A,36,Abolishes inhibition of VII(a)/TF.,,,1.0,,,,,,,,,,,,,P10646_K_64_I
488,P10646,R,135,L,1adz:A,24,Abolishes inhibition of X(a).,,,1.0,,,,,,,,,,,,,P10646_R_135_L
489,P10646,R,227,L,1irh:A,18,Abolishes inhibition of VII(a)/TF.,,,1.0,,,,,,,,,,,,,P10646_R_227_L
490,P20138,N,100,A,5j06:A,100,Significant loss of binding to peripheral blood granulocytes.,,-1.0,-999.0,,,,,,,,,,,,,P20138_N_100_A
491,P60891,S,132,A,3efh:A,132,Reduces catalytic activity.,,,1.0,,,,,,,,,,,,,P60891_S_132_A
492,P60891,S,132,F,3efh:A,132,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_S_132_F
493,P60891,N,144,H,3efh:A,144,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_N_144_H
494,P60891,Y,146,F,3efh:A,146,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P60891_Y_146_F
495,P60891,Y,146,M,3efh:A,146,Reduces catalytic activity.,,,1.0,,,,,,,,,,,,,P60891_Y_146_M
496,O95747,K,46,A,3dak:D,46,Loss of autophosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,O95747_K_46_A
497,O95747,K,46,M,3dak:D,46,"Loss of RELT, RELL1 and RELL2 phosphorylation. Retention of some autophosphorylation activity may be due to complex formation with other endogenous kinases in the assay.",,,1.0,-1.0,,,,,,,,,,,,O95747_K_46_M
498,Q9UBZ9,D,570,A,3gqc:B,570,Abolishes transferase activity,,,1.0,,,,,,,,,,,,,Q9UBZ9_D_570_A
499,Q9UBZ9,E,571,A,3gqc:B,571,Abolishes transferase activity,,,1.0,,,,,,,,,,,,,Q9UBZ9_E_571_A
500,P16422,N,74,A,4mzv:A,74,Changed glycosylation pattern. Complete loss of glycosylation and substantial decrease in protein expression,,,-999.0,,,-1.0,,,,,,,,,-1.0,P16422_N_74_A
501,P16422,N,111,A,4mzv:A,111,Changed glycosylation pattern. Complete loss of glycosylation and substantial decrease in protein expression,,,-999.0,,,-1.0,,,,,,,,,-1.0,P16422_N_111_A
502,P16422,N,198,A,4mzv:A,198,"Decreased glycosyation, reduced protein stability and significant decrease in protein expression. Complete loss of glycosylation and substantial decrease in protein expression",,,-999.0,,,-1.0,,,,,,,,,-1.0,P16422_N_198_A
503,Q01968,D,422,A,4cmn:A,422,Does not affect interaction with RAB8A.,0.0,,-999.0,,,,,,,,,,,,,Q01968_D_422_A
504,Q01968,D,499,A,4cmn:A,499,Does not affect interaction with RAB8A.,0.0,,-999.0,,,,,,,,,,,,,Q01968_D_499_A
505,Q01968,F,668,V,3qbt:F,668,Does not interact with RAB8A. Does not localize to cilia.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q01968_F_668_V
506,Q7L523,T,21,N,6s6d:A,21,"Reduced affinity for all nucleotides, but with preferential binding of GDP over GTP.",,-1.0,-999.0,,,,,,,,,,,,,Q7L523_T_21_N
507,Q7L523,K,142,R,6s6d:A,142,Prevents RRAGA ubiquitination and alters interaction and regulation by GATOR1,-1.0,,-999.0,,-1.0,,,,,,,,,,,Q7L523_K_142_R
508,Q7L523,K,220,R,6s6d:A,220,Prevents RRAGA ubiquitination and alters interaction and regulation by GATOR1,-1.0,,-999.0,,-1.0,,,,,,,,,,,Q7L523_K_220_R
509,Q7L523,K,230,R,6s6d:A,230,Prevents RRAGA ubiquitination and alters interaction and regulation by GATOR1,-1.0,,-999.0,,-1.0,,,,,,,,,,,Q7L523_K_230_R
510,Q7L523,K,244,R,6s6d:A,244,Prevents RRAGA ubiquitination and alters interaction and regulation by GATOR1,-1.0,,-999.0,,-1.0,,,,,,,,,,,Q7L523_K_244_R
522,Q9NW64,K,170,R,6id0:O,170,Accumulates in speckle-like structures.,,,-999.0,,,,,,,,,,,,,Q9NW64_K_170_R
531,Q92466,L,258,A,4e54:B,258,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_L_258_A
532,Q92466,S,262,A,4e54:B,262,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_S_262_A
533,Q92466,D,264,A,4e54:B,264,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_D_264_A
534,Q92466,I,269,A,4e54:B,269,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_I_269_A
535,Q92466,W,270,A,4e54:B,270,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_W_270_A
536,Q92466,L,272,A,4e54:B,272,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_L_272_A
537,Q92466,R,273,A,4e54:B,273,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_R_273_A
538,Q92466,L,350,P,4e54:B,350,Impairs interaction with DDB1.,-1.0,,-999.0,,,,,,,,,,,,,Q92466_L_350_P
539,Q96GX9,S,84,A,4m6r:A,84,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_84_A
539,Q96GX9,S,84,D,4m6r:A,84,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_84_D
540,Q96GX9,S,87,A,4m6r:A,87,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_87_A
540,Q96GX9,S,87,D,4m6r:A,87,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_87_D
541,Q96GX9,S,89,A,4m6r:A,89,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_89_A
541,Q96GX9,S,89,D,4m6r:A,89,Does not affect ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_S_89_D
542,Q96GX9,Q,96,A,4m6r:A,96,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q96GX9_Q_96_A
543,Q96GX9,C,97,A,4m6r:A,97,Acts as a dominant negative mutant,,,-999.0,,,,,,,,,,,,,Q96GX9_C_97_A
545,Q96GX9,H,115,A,4m6r:A,115,Almost complete loss of enzyme activity. Abolishes protection against pyroptosis. No effect on anti-apoptotic activity.,,,1.0,,,,,,,,,,,,,Q96GX9_H_115_A
547,Q96GX9,H,117,A,4m6r:A,117,Impaired ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_H_117_A
548,Q96GX9,E,139,A,4m6r:A,139,Almost complete loss of enzyme activity. Abolishes protection against pyroptosis. No effect on anti-apoptotic activity.,,,1.0,,,,,,,,,,,,,Q96GX9_E_139_A
549,Q96GX9,H,195,A,4m6r:A,195,Impaired ability of cells to grow in media where methionine is replaced by 5-methylthioadenosine,,,-999.0,,,,,,,,,,,,,Q96GX9_H_195_A
550,Q86V24,H,202,A,6ks1:A,202,Abolishes response to ADIPOQ binding,-1.0,,-999.0,,,,,,,,,,,,,Q86V24_H_202_A
551,Q86V24,D,219,A,6ks1:A,219,Impairs response to ADIPOQ binding. Abolishes response to ADIPOQ binding,-1.0,,-999.0,,,,,,,,,,,,,Q86V24_D_219_A
552,Q86V24,H,348,A,6ks1:A,348,Impairs response to ADIPOQ binding. Abolishes response to ADIPOQ binding,-1.0,,-999.0,,,,,,,,,,,,,Q86V24_H_348_A
553,Q86V24,H,352,A,6ks1:A,352,Abolishes response to ADIPOQ binding,-1.0,,-999.0,,,,,,,,,,,,,Q86V24_H_352_A
554,P27144,R,7,G,2ar7:A,7,Abolishes mitochondrial import,,,-999.0,,,,,,,,,1.0,,,,P27144_R_7_G
555,Q9UBL3,R,296,K,6pwv:D,202,Abolishes methylation.,,,1.0,,,,,,,,,,,,,Q9UBL3_R_296_K
556,Q9UBL3,R,300,K,6pwv:D,206,Slightly decreased methylation.,,,1.0,,,,,,,,,,,,,Q9UBL3_R_300_K
557,Q9H0H5,F,289,G,4b6d:A,289,Cytokinesis failure.,,,1.0,,,,,,,,,,,,,Q9H0H5_F_289_G
558,Q9H0H5,K,292,L,4b6d:A,292,Cytokinesis failure. Abolishes localization at the cell membrane.,,,1.0,,,,,,,,,1.0,,,,Q9H0H5_K_292_L
559,Q9H0H5,R,306,L,4b6d:A,306,Cytokinesis failure. Abolishes localization at the cell membrane.,,,1.0,,,,,,,,,1.0,,,,Q9H0H5_R_306_L
560,Q9H0H5,F,309,A,4b6d:A,309,Cytokinesis failure. Abolishes localization at the cell membrane.,,,1.0,,,,,,,,,1.0,,,,Q9H0H5_F_309_A
561,Q9H0H5,C,316,G,4b6d:A,316,Cytokinesis failure.,,,1.0,,,,,,,,,,,,,Q9H0H5_C_316_G
562,Q9H0H5,R,385,A,5c2j:A,385,Abolishes GAP activity towards RAC1. Abolishes GAP activity towards CDC42 in prometaphase. Induces multiple blebs during cytokinesis.,,,1.0,,,,,,,,,,,,,Q9H0H5_R_385_A
563,Q13822,S,170,E,4zg9:B,170,Reduces lysophospholipase activity by about 70%.,,,1.0,,,,,,,,,,,,,Q13822_S_170_E
564,Q13822,T,210,A,4zg9:B,210,Loss of lysophospholipase activity and ability to hydrolyze sphingosylphosphorylcholine.,,,1.0,,,,,,,,,,,,,Q13822_T_210_A
565,Q13822,F,211,Y,4zg9:B,211,Reduces lysophospholipase activity by about 70%.,,,1.0,,,,,,,,,,,,,Q13822_F_211_Y
566,Q13822,A,218,V,4zg9:B,218,Reduces lysophospholipase activity by about 50%.,,,1.0,,,,,,,,,,,,,Q13822_A_218_V
567,Q13822,N,231,A,4zg9:B,231,Strongly reduced lysophospholipase activity.,,,1.0,,,,,,,,,,,,,Q13822_N_231_A
568,Q13822,Y,307,Q,4zg9:B,307,Reduces lysophospholipase activity by about 70%.,,,1.0,,,,,,,,,,,,,Q13822_Y_307_Q
569,Q13822,H,316,Q,4zg9:B,316,Loss of ability to hydrolyze sphingosylphosphorylcholine.,,,1.0,,,,,,,,,,,,,Q13822_H_316_Q
570,Q13822,H,360,Q,4zg9:B,360,Loss of ability to hydrolyze sphingosylphosphorylcholine.,,,1.0,,,,,,,,,,,,,Q13822_H_360_Q
571,P48426,G,131,L,2ybx:B,131,Abolishes catalytic activity,,,1.0,,,,,,,,,,,,,P48426_G_131_L
572,P48426,Y,138,F,2ybx:A,138,Abolishes catalytic activity,,,1.0,,,,,,,,,,,,,P48426_Y_138_F
573,P49795,S,151,A,1cmz:A,151,Diminishes gap activity towards G(i)-alpha3 and autophagy in colon cancer cells.,-1.0,,-999.0,,,,,,,,,,,,,P49795_S_151_A
591,Q9Y2Z4,S,200,E,2pid:B,200,Loss of tRNA ligase activity.,,,1.0,,,,,,,,,,,,,Q9Y2Z4_S_200_E
592,Q9Y2Z4,Q,202,A,2pid:B,202,Mildly decreased tRNA ligase activity.,,,1.0,,,,,,,,,,,,,Q9Y2Z4_Q_202_A
593,Q93009,D,164,A,2f1z:B,164,Decreased binding to p53/TP53 and MDM2.,-1.0,,-999.0,,,,,,,,,,,,,Q93009_D_164_A
594,Q93009,W,165,A,2f1z:B,165,Loss of binding to p53/TP53 and MDM2.,-1.0,,-999.0,,,,,,,,,,,,,Q93009_W_165_A
595,Q93009,C,223,A,5j7t:A,223,Complete loss of activity. Localized in the nucleus and does not inhibit FOXO4-dependent transcriptional activity. Loss of ability to deubiquitinate CRY2.,,,1.0,,,,,,,,,1.0,,,,Q93009_C_223_A
596,Q93009,C,223,S,5j7t:A,223,Catalytically inactive mutant. No effect on p53/TP53 and PTEN binding but is defective in deubiquitinating p53/TP53 and PTEN. Partial loss of KMT2E/mml5 deubiquitination. Decreases deubiquitinase activity toward 'Lys-48'-polyubiquitinated ALKBH3. Reduced deubiquitination of REST.,0.0,,1.0,,,,,,,,,,,,,Q93009_C_223_S
597,Q93009,H,456,A,5j7t:A,456,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q93009_H_456_A
598,Q93009,H,464,A,5j7t:A,464,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q93009_H_464_A
599,O14493,F,35,A,5b2g:C,35,Decreases interaction with Clostridium perfringens CPE.,,-1.0,-999.0,,,,,,,,,,,,,O14493_F_35_A
600,O14493,F,35,D,5b2g:C,35,Abolishes interaction with Clostridium perfringens CPE.,,-1.0,-999.0,,,,,,,,,,,,,O14493_F_35_D
601,O14493,I,40,A,5b2g:C,40,No effect on interaction with Clostridium perfringens CPE.,,0.0,-999.0,,,,,,,,,,,,,O14493_I_40_A
602,O14493,I,40,D,5b2g:C,40,Strongly decreases interaction with Clostridium perfringens CPE.,,-1.0,-999.0,,,,,,,,,,,,,O14493_I_40_D
603,O14493,N,53,A,5b2g:C,53,Decreases interaction with Clostridium perfringens CPE.,,-1.0,-999.0,,,,,,,,,,,,,O14493_N_53_A
603,O14493,N,53,D,5b2g:C,53,Decreases interaction with Clostridium perfringens CPE.,,-1.0,-999.0,,,,,,,,,,,,,O14493_N_53_D
604,Q00613,L,22,A,2ldu:A,24,Inhibits HSE DNA-binding activity and transcriptional activation.,,-1.0,-999.0,,,,,,,,,,,,,Q00613_L_22_A
605,Q00613,K,80,Q,2ldu:A,82,Loss of nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock. No change in homotrimerization upon heat shock.,0.0,-1.0,1.0,,,,,,,,,1.0,,,,Q00613_K_80_Q
606,Q00613,K,80,R,2ldu:A,82,Does not change interaction with XRCC5 and XRCC6. Loss of nuclear stress bodies localization. Decreased nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock.,0.0,-1.0,1.0,,,,,,,,,1.0,,,,Q00613_K_80_R
607,Q00613,K,91,R,2ldu:A,93,No effect on sumoylation.,,,-999.0,,,,0.0,,,,,,,,,Q00613_K_91_R
608,Q00613,K,118,Q,2ldu:A,120,Loss of nuclear stress bodies localization. No change in protein abundance.,,,-999.0,,,,,,,,,1.0,,,,Q00613_K_118_Q
609,Q00613,K,118,R,2ldu:A,120,No change in nuclear stress bodies localization.,,,-999.0,,,,,,,,,0.0,,,,Q00613_K_118_R
610,Q00613,T,120,A,2ldu:A,122,No effect on binding HSE nor on transcriptional activity.,0.0,,0.0,,,,,,,,,,,,,Q00613_T_120_A
611,Q00613,S,121,A,2ldu:A,123,Increased binding HSE and transcriptional activity. Greatly reduced binding to HSP90AA1. No effect on MAPKAPK2 binding.,-1.0,,0.0,,,,,,,,,,,,,Q00613_S_121_A
612,Q00613,S,121,D,2ldu:A,123,Some inhibition of binding HSE and transcriptional activity. No change in binding HSP90AA1. Inhibits MAPKAPK2 binding. Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner,-1.0,,1.0,,,,,,,,,,,,,Q00613_S_121_D
613,P35813,D,239,N,3fxm:A,239,No effect on binding SMAD2.,0.0,,-999.0,,,,,,,,,,,,,P35813_D_239_N
614,Q9NZU0,D,38,A,5cmp:A,38,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_D_38_A
615,Q9NZU0,Y,43,A,5cmp:A,43,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_Y_43_A
616,Q9NZU0,N,45,A,5cmp:A,45,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_N_45_A
617,Q9NZU0,R,47,A,5cmp:A,47,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_R_47_A
618,Q9NZU0,Y,64,A,5cmp:A,64,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_Y_64_A
619,Q9NZU0,Y,89,A,5cmp:A,89,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_Y_89_A
620,Q9NZU0,Y,91,A,5cmp:A,91,Abolishes ADGRL3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU0_Y_91_A
621,Q9NZU0,R,181,A,5cmp:A,181,No effect on homodimerization,0.0,,-999.0,,,,,,,,,,,,,Q9NZU0_R_181_A
622,Q9NZU0,R,181,N,5cmp:A,181,Adds a glycosylation site that strongly reduces homodimerization,-1.0,,-999.0,,,1.0,,,,,,,,,,Q9NZU0_R_181_N
623,Q9NZU0,D,183,A,5cmp:A,183,No effect on homodimerization,0.0,,-999.0,,,,,,,,,,,,,Q9NZU0_D_183_A
624,Q9NZU0,D,183,T,5cmp:A,183,Adds a glycosylation site that strongly reduces homodimerization,-1.0,,-999.0,,,1.0,,,,,,,,,,Q9NZU0_D_183_T
625,Q9BVM4,E,82,A,3juc:A,82,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9BVM4_E_82_A
625,Q9BVM4,E,82,Q,3juc:A,82,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9BVM4_E_82_Q
626,P09493,K,15,N,6kn8:P,15,Impairs interaction with LMOD2 and TMOD1.,-1.0,,-999.0,,,,,,,,,,,,,P09493_K_15_N
627,P09493,S,283,A,6kn8:P,283,Loss of phosphorylation and decreased formation of actin stress fibers.,,,-999.0,-1.0,,,,,,,,,,,,P09493_S_283_A
628,P09493,S,283,E,6kn8:P,283,Increased formation of actin stress fibers.,,,-999.0,,,,,,,,,,,,,P09493_S_283_E
629,Q9H0P0,D,88,N,2jga:A,38,Loss of nucleotidase and phosphotransferase activity.,,,1.0,,,,,,,,,,,,,Q9H0P0_D_88_N
630,Q9H0P0,F,89,A,2jga:A,39,Almost complete loss of nucleotidase and phosphotransferase activity.,,,1.0,,,,,,,,,,,,,Q9H0P0_F_89_A
631,Q9H0P0,D,90,N,2jga:A,40,Loss of nucleotidase and phosphotransferase activity.,,,1.0,,,,,,,,,,,,,Q9H0P0_D_90_N
632,Q9H0P0,E,135,D,2jga:A,85,No effect on nucleotidase activity. Almost complete loss of phosphotransferase activity.,,,1.0,,,,,,,,,,,,,Q9H0P0_E_135_D
633,Q9H0P0,D,232,N,2jga:A,182,No effect on nucleotidase and phosphotransferase activity.,,,0.0,,,,,,,,,,,,,Q9H0P0_D_232_N
634,Q9H0P0,F,233,A,2jga:A,183,Almost complete loss of nucleotidase and phosphotransferase activity.,,,1.0,,,,,,,,,,,,,Q9H0P0_F_233_A
635,Q9H0P0,D,234,N,2jga:A,184,No effect on nucleotidase and phosphotransferase activity.,,,0.0,,,,,,,,,,,,,Q9H0P0_D_234_N
636,O15217,Y,9,F,3ik7:A,9,Reduces catalytic activity 70-fold.,,,1.0,,,,,,,,,,,,,O15217_Y_9_F
637,O15217,Y,212,A,3ik7:A,212,"Strongly reduced activity towards 4-hydroxynon-2-enal and 1-chloro-2,4-dinitrobenzene.",,-1.0,-999.0,,,,,,,,,,,,,O15217_Y_212_A
637,O15217,Y,212,F,3ik7:A,212,"Strongly reduced activity towards 4-hydroxynon-2-enal and 1-chloro-2,4-dinitrobenzene.",,-1.0,-999.0,,,,,,,,,,,,,O15217_Y_212_F
637,O15217,Y,212,S,3ik7:A,212,"Strongly reduced activity towards 4-hydroxynon-2-enal and 1-chloro-2,4-dinitrobenzene.",,-1.0,-999.0,,,,,,,,,,,,,O15217_Y_212_S
638,Q86TM6,C,294,A,6a3z:A,16,"No effect on interaction with FAM8A1, HERPUD1, OS9, SEL1L and UBE2J1.",0.0,,-999.0,,,,,,,,,,,,,Q86TM6_C_294_A
639,Q86TM6,C,329,S,6a3z:A,51,Abolishes E3 ligase activity.,,,1.0,,,,,,,,,,,,,Q86TM6_C_329_S
640,Q9P0L0,K,94,D,6tqr:A,94,Alters interaction with ZFYVE27 and prevents binding to the FFAT motif in target proteins,-1.0,,-999.0,,,,,,,,,,,,,Q9P0L0_K_94_D
641,Q9P0L0,M,96,D,6tqr:A,96,Alters interaction with ZFYVE27 and prevents binding to the FFAT motif in target proteins,-1.0,,-999.0,,,,,,,,,,,,,Q9P0L0_M_96_D
642,Q92730,T,27,N,2cls:A,27,Impairs interaction with UBXD5.,-1.0,,-999.0,,,,,,,,,,,,,Q92730_T_27_N
643,Q92730,T,45,A,2cls:A,45,Abolishes interaction with UBXD5.,-1.0,,-999.0,,,,,,,,,,,,,Q92730_T_45_A
644,Q9UGM1,I,86,T,4uxu:A,61,The CHRNA9-CHRNA10 receptor is 250-fold more potently inhibited by the alpha-conotoxin RgIA.,,1.0,-999.0,,,,,,,,,,,,,Q9UGM1_I_86_T
645,Q96AB6,C,75,A,6a0i:A,75,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AB6_C_75_A
645,Q96AB6,C,75,S,6a0i:A,75,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AB6_C_75_S
645,Q96AB6,C,75,T,6a0i:A,75,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AB6_C_75_T
646,P08631,K,290,E,5h09:A,295,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P08631_K_290_E
647,P08631,E,305,A,5h09:A,310,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P08631_E_305_A
648,P08631,D,381,E,5h09:A,386,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P08631_D_381_E
649,P08631,Y,411,A,5h09:A,416,Reduced catalytic activity and higher affinity for target peptides.,,1.0,1.0,,,,,,,,,,,,,P08631_Y_411_A
650,P08631,Y,522,F,5h09:A,527,"Constitutively activated kinase, leading to cellular transformation.",,,1.0,,,,,,,,,,,,,P08631_Y_522_F
651,P43026,Y,490,N,6z3j:B,490,Resitant to NOG inhibition.,-1.0,,-999.0,,,,,,,,,,,,,P43026_Y_490_N
652,Q8IYV9,E,71,A,5f4v:A,71,Mildly decreases interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_E_71_A
652,Q8IYV9,E,71,K,5f4v:A,71,Mildly decreases interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_E_71_K
653,Q8IYV9,W,148,A,5f4v:A,148,Abolishes interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_W_148_A
654,Q8IYV9,H,157,A,5f4v:A,157,Nearly abolishes interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_H_157_A
655,Q8IYV9,R,160,A,5f4v:A,160,Nearly abolishes interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_R_160_A
655,Q8IYV9,R,160,E,5f4v:A,160,Nearly abolishes interaction with IZUMO1R.,-1.0,,-999.0,,,,,,,,,,,,,Q8IYV9_R_160_E
656,Q9Y5P4,E,472,A,5zym:A,446,Reduces ceramide transfer.,,,1.0,,,,,,,,,,,,,Q9Y5P4_E_472_A
657,Q9Y5P4,Q,493,A,5zym:A,467,No effect on ceramide transfer activity.,,,0.0,,,,,,,,,,,,,Q9Y5P4_Q_493_A
658,Q9Y5P4,W,499,A,5zym:A,473,Reduces affinity for membranes. Abolishes ceramide transfer,,,1.0,,,,,,,,,,,,,Q9Y5P4_W_499_A
659,Q9Y5P4,N,530,A,5zym:A,504,Reduces ceramide transfer.,,,1.0,,,,,,,,,,,,,Q9Y5P4_N_530_A
660,Q9Y5P4,W,588,A,5zym:A,562,Abolishes ceramide transfer,,,1.0,,,,,,,,,,,,,Q9Y5P4_W_588_A
661,Q8IVV7,Q,132,A,6ccr:A,132,Loss of interaction with peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_Q_132_A
662,Q8IVV7,E,237,A,6ccr:A,237,Loss of interaction with peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_E_237_A
663,Q8IVV7,S,253,D,6ccr:A,253,Strongly decreased affinity for peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_S_253_D
664,Q8IVV7,Y,258,A,6ccr:A,258,Loss of interaction with peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_Y_258_A
665,Q8IVV7,Y,273,A,6ccr:A,273,Loss of interaction with peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_Y_273_A
666,Q8IVV7,Q,282,A,6ccr:A,282,Loss of interaction with peptides with a Pro/N-degron.,,-1.0,-999.0,,,,,,,,,,,,,Q8IVV7_Q_282_A
667,Q9UKM7,E,330,Q,5kk7:A,330,"About 44-fold reduction in K(cat), slight reduction in K(m), about 100-fold increase in binding affinity for Man(9)GlcnAc(2) but no change in binding affinity for the inhibitor, dMNJ. Even further greater reduction in K(cat) and increase in K(m)",,,-999.0,,,,,,,,,,,,,Q9UKM7_E_330_Q
668,Q9UKM7,D,463,N,5kk7:A,463,"Some reduction in K(cat) but no change in K(m), abolishes almost all binding to Man(9)GlcnAc(2) but reduced binding to the inhibitor dMNJ by about 73-fold. Further reduction in K(m) but slight increase in K(m)",,,-999.0,,,,,,,,,,,,,Q9UKM7_D_463_N
669,Q9UKM7,H,524,A,5kk7:A,524,About 4-fold reduction in K(cat).,,,-999.0,,,,,,,,,,,,,Q9UKM7_H_524_A
670,Q9UKM7,E,599,Q,5kk7:A,599,"Very significant reduction in K(cat), 4-fold weaker binding affinity for Man(9)GlcnAc(2) but about 1000-fold reduction in binding affinity for the inhibitor, dMNJ. Significant reductions in K(cat) and slight increase in K(m)",,-1.0,-999.0,,,,,,,,,,,,,Q9UKM7_E_599_Q
671,P20132,C,303,A,1p5j:A,303,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P20132_C_303_A
672,Q9H3L0,F,165,A,5cv0:A,165,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_F_165_A
673,Q9H3L0,M,186,A,5cv0:A,186,Decreases methylcobalamin levels. No effect on interaction with MMACHC.,0.0,,1.0,,,,,,,,,,,,,Q9H3L0_M_186_A
674,Q9H3L0,W,189,A,5cv0:A,189,Decreases methylcobalamin levels. Impairs interaction with MMACHC.,-1.0,,1.0,,,,,,,,,,,,,Q9H3L0_W_189_A
675,Q9H3L0,R,197,A,5cv0:A,197,"Decreases methylcobalamin levels, but increases adenosylcobalamin levels.",,,-999.0,,,,,,,,,,,,,Q9H3L0_R_197_A
676,Q9H3L0,F,204,A,5cv0:A,204,Decreases methylcobalamin levels and mildly increases adenosylcobalamin levels.,,,-999.0,,,,,,,,,,,,,Q9H3L0_F_204_A
677,Q9H3L0,C,212,A,5cv0:A,212,No effect on cobalamin levels.,,,0.0,,,,,,,,,,,,,Q9H3L0_C_212_A
678,Q9H3L0,D,226,A,5cv0:A,226,"Decreases methylcobalamin levels, but increases adenosylcobalamin levels. No effect on interaction with MMACHC.",0.0,,-999.0,,,,,,,,,,,,,Q9H3L0_D_226_A
679,Q9H3L0,Y,237,A,5cv0:A,237,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_Y_237_A
680,Q9H3L0,R,266,A,5cv0:A,266,Mildly decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_R_266_A
681,Q9H3L0,W,270,A,5cv0:A,270,Decreases methylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_W_270_A
682,Q9H3L0,S,278,A,5cv0:A,278,Marginally decreases methylcobalamin levels and strongly increases adenosylcobalamin levels.,,,1.0,,,,,,,,,,,,,Q9H3L0_S_278_A
683,Q9H3L0,F,280,A,5cv0:A,280,No effect on cobalamin levels.,,,0.0,,,,,,,,,,,,,Q9H3L0_F_280_A
684,Q5VVQ6,C,160,S,4boq:A,160,Abolishes deubiquitinase activity without affecting interaction with VCP. Specifically blocks a step in the course of dislocation and/or degradation of endoplasmic reticulum-resident proteins destined for proteasomal degradation. Prevents the macroautophagy of damaged lysosome membranes decorated with K48-linked ubiquitin chains.,,,1.0,,,,,,,,,,,,,Q5VVQ6_C_160_S
685,Q5VVQ6,I,292,Q,4boq:A,292,Does not affect activity or specificity. Impairs ability to cleave longer 'Lys-11'-linked ubiquitin chains,,,-999.0,,,,,,,,,,,,,Q5VVQ6_I_292_Q
686,Q5VVQ6,V,295,Q,4boq:A,295,Does not affect activity or specificity. Impairs ability to cleave longer 'Lys-11'-linked ubiquitin chains,,,-999.0,,,,,,,,,,,,,Q5VVQ6_V_295_Q
687,Q9Y4P1,C,74,S,2cy7:A,74,Complete loss of protease activity.,,,1.0,,,,,,,,,,,,,Q9Y4P1_C_74_S
688,Q9Y4P1,C,78,A,2cy7:A,78,Reduces the redox sensitivity and retains activity in presence of H(2)O(2).,,,-999.0,,,,,,,,,,,,,Q9Y4P1_C_78_A
689,Q9Y4P1,W,142,A,2cy7:A,142,Strongly reduced protease activity.,,,1.0,,,,,,,,,,,,,Q9Y4P1_W_142_A
690,Q9Y4P1,R,229,A,2d1i:A,229,Strongly reduced protease activity.,,,1.0,,,,,,,,,,,,,Q9Y4P1_R_229_A
691,Q9Y4P1,D,278,A,2d1i:A,278,Complete loss of protease activity.,,,1.0,,,,,,,,,,,,,Q9Y4P1_D_278_A
692,Q9Y4P1,H,280,A,2d1i:A,280,Complete loss of protease activity.,,,1.0,,,,,,,,,,,,,Q9Y4P1_H_280_A
693,Q9Y6D5,E,738,K,3swv:A,738,"Disturbs membrane organization at the TGN, impairs association of the AP-1 complex and GGA1 with the TGN membranes.",-1.0,,-999.0,,,,,,,,,,,,,Q9Y6D5_E_738_K
694,P01008,A,414,K,1e03:L,382,Reduces interaction with thrombin by 99%.,-1.0,,-999.0,,,,,,,,,,,,,P01008_A_414_K
695,P01008,A,414,Q,1e03:L,382,Reduces interaction with thrombin by 80%.,-1.0,,-999.0,,,,,,,,,,,,,P01008_A_414_Q
696,P08709,S,112,A,4ylq:L,52,Complete loss of O-glycosylation and O-xylosylation by POGLUT1.,,,-999.0,,,-1.0,,,-1.0,,,,,,,P08709_S_112_A
697,P08709,S,113,A,4ylq:L,53,No effect on O-glycosylation by POGLUT1. Drastic decrease in O-xylosylation.,,,-999.0,,,0.0,,,-1.0,,,,,,,P08709_S_113_A
698,Q01581,C,129,A,2p8u:A,129,Loss of activity.,,,1.0,,,,,,,,,,,,,Q01581_C_129_A
698,Q01581,C,129,S,2p8u:A,129,Loss of activity.,,,1.0,,,,,,,,,,,,,Q01581_C_129_S
699,P43155,Y,452,A,1s5o:A,431,Increases the KM for carnitine 100-fold.,,-1.0,-999.0,,,,,,,,,,,,,P43155_Y_452_A
700,P43155,Y,452,F,1s5o:A,431,Increases the KM for carnitine 320-fold and reduces enzyme activity 10000-fold.,,-1.0,1.0,,,,,,,,,,,,,P43155_Y_452_F
701,P43155,T,465,A,1s5o:A,444,Increases the KM for carnitine almost 70-fold and reduces enzyme activity 450-fold.,,-1.0,1.0,,,,,,,,,,,,,P43155_T_465_A
702,P43155,R,518,Q,1s5o:A,497,Increases the KM for carnitine 230-fold and reduces enzyme activity almost 100-fold.,,-1.0,1.0,,,,,,,,,,,,,P43155_R_518_Q
703,P43155,F,566,A,1s5o:A,545,Increases the KM for carnitine 18-fold and reduces enzyme activity 100-fold.,,-1.0,1.0,,,,,,,,,,,,,P43155_F_566_A
704,P43155,F,566,Y,1s5o:A,545,No effect.,0.0,0.0,0.0,0.0,,,,,,,,,,,,P43155_F_566_Y
705,Q92600,R,227,E,4ct7:B,227,Loss of DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q92600_R_227_E
706,Q99856,Y,325,A,2kk0:A,119,Abolishes DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q99856_Y_325_A
707,Q13009,K,879,E,2d8i:A,52,Strongly reduces affinity for SDC1.,-1.0,,-999.0,,,,,,,,,,,,,Q13009_K_879_E
708,Q13009,K,912,E,2d8i:A,85,Strongly reduces affinity for SDC1.,-1.0,,-999.0,,,,,,,,,,,,,Q13009_K_912_E
709,O75390,K,393,R,5uzp:A,393,Does not inhibit methylation.,,,-999.0,,,,,,,,,,,,,O75390_K_393_R
710,O75390,K,395,R,5uzp:A,395,Inhibits methylation.,,,-999.0,,,,,,,,,,,,,O75390_K_395_R
711,Q6NYC1,W,85,A,6mev:A,85,Decreases interaction with the NET domain of BRD4.,-1.0,,-999.0,,,,,,,,,,,,,Q6NYC1_W_85_A
712,Q6NYC1,L,90,A,6mev:A,90,Nearly abolishes the interaction with the NET domain of BRD4.,-1.0,,-999.0,,,,,,,,,,,,,Q6NYC1_L_90_A
713,Q6NYC1,K,91,A,6mev:A,91,Nearly abolishes the interaction with the NET domain of BRD4.,-1.0,,-999.0,,,,,,,,,,,,,Q6NYC1_K_91_A
714,Q6NYC1,R,95,A,6mev:A,95,Nearly abolishes the interaction with the NET domain of BRD4.,-1.0,,-999.0,,,,,,,,,,,,,Q6NYC1_R_95_A
715,Q6NYC1,Y,131,F,6mev:A,131,Abolishes 2-oxoglutarate-binding and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q6NYC1_Y_131_F
716,Q6NYC1,H,187,A,6mev:A,187,Loss of histone arginine demethylase and lysyl-hydroxylase activities. Abolishes homooligomerisation. Loss of arginine demethylase and a lysyl-hydroxylase activities,-1.0,,1.0,,,,,,,,,,,,,Q6NYC1_H_187_A
717,Q6NYC1,D,189,A,6mev:A,189,Loss of arginine demethylase and a lysyl-hydroxylase activities,,,1.0,,,,,,,,,,,,,Q6NYC1_D_189_A
718,Q6NYC1,K,204,A,6mev:A,204,Impairs enzyme activity without affecting 2-oxoglutarate-binding.,,0.0,1.0,,,,,,,,,,,,,Q6NYC1_K_204_A
719,Q6NYC1,E,231,A,6mev:A,231,Impairs both hydroxylation activity and 2-oxoglutarate turnover assays.,,,1.0,,,,,,,,,,,,,Q6NYC1_E_231_A
720,Q6NYC1,H,273,A,6mev:A,273,Loss of arginine demethylase and a lysyl-hydroxylase activities,,,1.0,,,,,,,,,,,,,Q6NYC1_H_273_A
721,Q6NYC1,T,285,A,6mev:A,285,Impairs enzyme activity and 2-oxoglutarate-binding.,,-1.0,1.0,,,,,,,,,,,,,Q6NYC1_T_285_A
722,Q6NYC1,N,287,A,6mev:A,287,Impairs enzyme activity.,,,1.0,,,,,,,,,,,,,Q6NYC1_N_287_A
723,Q9H1R2,C,85,S,1yz4:A,88,Loss of phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9H1R2_C_85_S
724,P10074,H,596,A,5yj3:C,596,Abolishes binding to the telomeric double-stranded 5'-TTAGGG-3' repeat.,,-1.0,-999.0,,,,,,,,,,,,,P10074_H_596_A
725,O75554,W,150,A,2jxw:A,29,Nearly abolishes activation of pre-mRNA splicing. Abolishes interaction with WBP11.,-1.0,,1.0,,,,,,,,,,,,,O75554_W_150_A
726,O75554,W,191,A,2jxw:A,70,Nearly abolishes activation of pre-mRNA splicing. Abolishes interaction with WBP11.,-1.0,,1.0,,,,,,,,,,,,,O75554_W_191_A
727,P28907,C,119,K,6vua:A,119,Loss of cADPr hydrolase activity.,,,1.0,,,,,,,,,,,,,P28907_C_119_K
728,P28907,C,119,R,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_119_R
728,P28907,C,119,E,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_119_E
728,P28907,C,119,A,6vua:A,119,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_119_A
729,P28907,C,160,A,6vua:A,160,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_160_A
730,P28907,C,173,A,6vua:A,173,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_173_A
731,P28907,C,201,D,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_201_D
731,P28907,C,201,K,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_201_K
731,P28907,C,201,A,6vua:A,201,Loss of cADPr hydrolase and ADP-ribosyl cyclase activity.,,,1.0,,,,,,,,,,,,,P28907_C_201_A
732,P28907,C,201,E,6vua:A,201,Loss of cADPr hydrolase activity.,,,1.0,,,,,,,,,,,,,P28907_C_201_E
733,Q93015,W,83,F,6nbe:N,105,In NAA80mut,,,-999.0,,,,,,,,,,,,,Q93015_W_83_F
734,Q93015,R,148,Q,6nbe:N,170,In NAA80mut,,,-999.0,,,,,,,,,,,,,Q93015_R_148_Q
735,Q93015,G,151,D,6nbe:N,173,In NAA80mut,,,-999.0,,,,,,,,,,,,,Q93015_G_151_D
736,Q93015,Y,183,F,6nbe:N,205,In NAA80mut,,,-999.0,,,,,,,,,,,,,Q93015_Y_183_F
737,P23219,S,529,N,6y3c:A,530,Abolishes cyclooxygenase activity.,,,1.0,,,,,,,,,,,,,P23219_S_529_N
738,Q99986,S,14,A,2rsv:A,14,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_S_14_A
739,Q99986,T,102,A,2rsv:A,102,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_T_102_A
740,Q99986,S,125,A,2rsv:A,125,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_S_125_A
741,Q99986,S,150,A,2rsv:A,150,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_S_150_A
742,Q99986,S,158,A,2rsv:A,158,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_S_158_A
743,Q99986,K,179,A,2rsv:A,179,Does not affect phosphorylation at S-342.,,,-999.0,0.0,,,,,,,,,,,,Q99986_K_179_A
744,Q99986,S,239,A,2rsv:A,239,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_S_239_A
745,Q99986,T,305,A,2rsv:A,305,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_T_305_A
746,Q99986,T,312,A,2rsv:A,312,Does not abolish autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q99986_T_312_A
747,Q99986,S,342,A,2rsv:A,342,Abolishes phosphorylation by PLK3 and induction of Golgi fragmentation during mitosis. Strongly reduced autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q99986_S_342_A
748,Q99986,T,353,A,2rsv:A,353,Strongly reduced autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q99986_T_353_A
749,Q99986,T,355,A,2rsv:A,355,Does not abolish autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q99986_T_355_A
750,Q99986,T,390,A,2rsv:A,390,Does not abolish autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q99986_T_390_A
751,P35658,V,353,A,2oit:A,353,Reduced binding to DDX19B.,-1.0,,-999.0,,,,,,,,,,,,,P35658_V_353_A
752,P35658,D,359,R,2oit:A,359,Impairs interaction with DDX19B.,-1.0,,-999.0,,,,,,,,,,,,,P35658_D_359_R
753,Q99988,W,225,A,5vt2:A,29,No effect on interaction with GFRAL. Attenuates GDF15-mediated food-intake inhibition.,0.0,,-999.0,,,,,,,,,,,,,Q99988_W_225_A
754,Q99988,V,283,A,5vt2:A,87,Reduces cellular signaling mediated by GFRAL and RET.,-1.0,,-999.0,,,,,,,,,,,,,Q99988_V_283_A
755,Q99988,V,283,R,5vt2:A,87,Abolishes interaction with GFRAL. Abolishes RET phosphorylation and cellular signaling mediated by GFRAL and RET.,-1.0,,-999.0,,,,,,,,,,,,,Q99988_V_283_R
756,Q99988,I,285,A,5vt2:A,89,Reduces cellular signaling mediated by GFRAL and RET. Abolishes interaction with GFRAL and GDF15-mediated food-intake inhibition.,-1.0,,-999.0,,,,,,,,,,,,,Q99988_I_285_A
757,P27694,R,41,E,4ipg:A,41,Loss of HELB-binding,-1.0,,-999.0,,,,,,,,,,,,,P27694_R_41_E
758,P27694,R,43,E,4ipg:A,43,Loss of HELB-binding,-1.0,,-999.0,,,,,,,,,,,,,P27694_R_43_E
759,P27694,K,449,R,1l1o:C,449,Significant reduction of sumoylation. Loss of sumoylation,,,-999.0,,,,-1.0,,,,,,,,,P27694_K_449_R
760,P27694,C,500,S,1l1o:C,500,Loss of function in DNA replication and mismatch repair without effect on DNA-binding activity,,0.0,1.0,,,,,,,,,,,,,P27694_C_500_S
761,P27694,C,503,S,1l1o:C,503,Loss of function in DNA replication and mismatch repair without effect on DNA-binding activity,,0.0,1.0,,,,,,,,,,,,,P27694_C_503_S
762,P27694,K,577,R,1l1o:C,577,Slight sumoylation decrease. Loss of sumoylation,,,-999.0,,,,-1.0,,,,,,,,,P27694_K_577_R
763,P27695,C,65,A,4qh9:A,65,Abolishes the redox activity. Does not abolish the AP endodeoxyribonuclease and phosphodiesterase activities. Reduces protection from granzyme A-mediated cell death,,,1.0,,,,,,,,,,,,,P27695_C_65_A
764,P27695,C,65,S,4qh9:A,65,Does not abolish NO-induced nitrosylation. Enhances NO-induced nuclear export.,,,1.0,,,,,,,,,,,,,P27695_C_65_S
765,P27695,N,68,A,4qh9:A,68,Nearly abolishes AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_N_68_A
766,P27695,D,70,A,4qh9:A,70,Strongly reduces AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_D_70_A
767,P27695,C,93,A,4qh9:A,93,Abolishes partially the redox activity.,,,1.0,,,,,,,,,,,,,P27695_C_93_A
768,P27695,C,93,S,4qh9:A,93,Does not abolish NO-induced nitrosylation. Abolishes NO-induced nitrosylation and translocation from the nucleus to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,P27695_C_93_S
769,P27695,E,96,A,4qh9:A,96,Lacks MYC CRD RNA cleavage activity.,,,1.0,,,,,,,,,,,,,P27695_E_96_A
770,P27695,C,99,A,4qh9:A,99,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_99_A
771,P27695,C,138,A,4qh9:A,138,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_138_A
772,P27695,Y,171,A,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_Y_171_A
772,P27695,Y,171,F,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_Y_171_F
772,P27695,Y,171,H,4qh9:A,171,Abolishes the AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_Y_171_H
773,P27695,C,208,A,4qh9:A,208,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_208_A
774,P27695,D,210,A,4qh9:A,210,Abolishes the AP endodeoxyribonuclease activity. Reduces protection from granzyme A-mediated cell death,,,1.0,,,,,,,,,,,,,P27695_D_210_A
774,P27695,D,210,N,4qh9:A,210,Abolishes the AP endodeoxyribonuclease activity. Reduces protection from granzyme A-mediated cell death,,,1.0,,,,,,,,,,,,,P27695_D_210_N
775,P27695,N,212,A,4qh9:A,212,Abolishes AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_N_212_A
776,P27695,N,212,Q,4qh9:A,212,Decreases AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_N_212_Q
776,P27695,N,212,D,4qh9:A,212,Decreases AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_N_212_D
777,P27695,F,266,A,4qh9:A,266,Strongly reduces AP endodeoxyribonuclease activity.,,,1.0,,,,,,,,,,,,,P27695_F_266_A
778,P27695,D,283,A,4qh9:A,283,"Strongly reduces AP endodeoxyribonuclease activity, but does not affect RNA cleavage activity. Nearly abolishes AP endodeoxyribonuclease activity",,,1.0,,,,,,,,,,,,,P27695_D_283_A
779,P27695,C,296,A,4qh9:A,296,Does not abolish the redox activity.,,,1.0,,,,,,,,,,,,,P27695_C_296_A
780,P27695,K,299,A,4qh9:A,299,Reduces the interaction with TOMM20. Abolishes localization in the mitochondria,-1.0,,-999.0,,,,,,,,,1.0,,,,P27695_K_299_A
781,P27695,R,301,A,4qh9:A,301,Reduces the interaction with TOMM20. Abolishes localization in the mitochondria,-1.0,,-999.0,,,,,,,,,1.0,,,,P27695_R_301_A
782,P27695,K,303,A,4qh9:A,303,Reduces the interaction with TOMM20.,-1.0,,-999.0,,,,,,,,,,,,,P27695_K_303_A
783,P27695,D,308,A,4qh9:A,308,Reduces AP endodeoxyribonuclease activity. Nearly abolishes AP endodeoxyribonuclease activity,,,1.0,,,,,,,,,,,,,P27695_D_308_A
784,P27695,H,309,N,4qh9:A,309,Abolishes AP endodeoxyribonuclease activity. Lacks MYC CRD RNA cleavage activity.,,,1.0,,,,,,,,,,,,,P27695_H_309_N
784,P27695,H,309,S,4qh9:A,309,Abolishes AP endodeoxyribonuclease activity. Lacks MYC CRD RNA cleavage activity.,,,1.0,,,,,,,,,,,,,P27695_H_309_S
785,P27695,C,310,A,4qh9:A,310,Does not abolish the redox activity.,,,0.0,,,,,,,,,,,,,P27695_C_310_A
786,P27695,C,310,S,4qh9:A,310,Does not abolish NO-induced nitrosylation. Abolishes NO-induced nitrosylation and translocation from the nucleus to the cytoplasm,,,0.0,,,,,,,,,1.0,,,,P27695_C_310_S
787,Q9H7Z6,K,274,A,3qah:A,274,Abolishes histone acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H7Z6_K_274_A
788,Q9H7Z6,K,274,R,3qah:A,274,Abolishes histone acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H7Z6_K_274_R
789,Q9H7Z6,C,316,S,3qah:A,316,Strongly reduces histone acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H7Z6_C_316_S
790,Q9H7Z6,E,350,Q,3qah:A,350,Abolishes histone acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H7Z6_E_350_Q
791,Q9BSD7,E,114,T,2i3b:A,113,"Reduced activity, especially towards ATP, GTP and TTP.",,,1.0,,,,,,,,,,,,,Q9BSD7_E_114_T
792,Q9BSD7,G,116,H,2i3b:A,115,"Reduced activity, especially towards ATP, GTP and TTP.",,,1.0,,,,,,,,,,,,,Q9BSD7_G_116_H
793,Q05086,F,750,D,1d5f:A,727,"Disrupt trimer formation, 50-fold reduction in E3 ligase activity.",-1.0,,1.0,,,,,,,,,,,,,Q05086_F_750_D
794,Q9NRG4,E,187,K,5v3h:A,187,Abolishes methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_E_187_K
795,Q9NRG4,E,189,K,5v3h:A,189,Strongly reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_E_189_K
796,Q9NRG4,E,190,K,5v3h:A,190,Strongly reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_E_190_K
797,Q9NRG4,H,207,A,5v3h:A,207,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9NRG4_H_207_A
798,Q9NRG4,Y,240,F,5v3h:A,240,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9NRG4_Y_240_F
799,Q9NRG4,Y,245,F,5v3h:A,245,Strongly reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_Y_245_F
800,Q9NRG4,D,252,R,5v3h:A,252,Slightly reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_D_252_R
801,Q9NRG4,R,253,Q,5v3h:A,253,No effect on methyltransferase activity on p53/TP53.,,,0.0,,,,,,,,,,,,,Q9NRG4_R_253_Q
802,Q9NRG4,R,306,E,5v3h:A,306,No effect on methyltransferase activity on p53/TP53.,,,0.0,,,,,,,,,,,,,Q9NRG4_R_306_E
803,Q9NRG4,Y,374,A,5v3h:A,374,Abolishes methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_Y_374_A
804,Q9NRG4,E,429,K,5v3h:A,429,Reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_E_429_K
805,Q9NRG4,E,431,K,5v3h:A,431,Strongly reduces methyltransferase activity on p53/TP53.,,,1.0,,,,,,,,,,,,,Q9NRG4_E_431_K
806,P14174,N,111,C,1gif:A,111,Causes formation of interchain disulfide bonds with Cys-81 from another subunit.,,,-999.0,,,,,,1.0,,,,,,,P14174_N_111_C
807,Q5TA45,E,203,Q,7cun:K,209,Abolishes the ability of the Integrator complex to process U1 and U2 snRNA genes.,,-1.0,-999.0,,,,,,,,,,,,,Q5TA45_E_203_Q
808,P53602,N,17,A,3d4j:A,17,15-fold inflation in KM for mevalonate diphosphate.,,-1.0,1.0,,,,,,,,,,,,,P53602_N_17_A
809,Q99685,Y,194,F,3hju:A,194,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_Y_194_F
810,Q99685,C,201,A,3hju:A,201,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_C_201_A
811,Q99685,C,208,A,3hju:A,208,Does not affect ability to hydrolyze 1- or 2-monoacylglycerol.,,,0.0,,,,,,,,,,,,,Q99685_C_208_A
812,Q99685,C,242,A,3hju:A,242,Reduced 1-monoacylglycerol lipase activity.,,,1.0,,,,,,,,,,,,,Q99685_C_242_A
813,Q13131,V,307,G,4red:B,298,Activates the kinase activity.,,,1.0,,,,,,,,,,,,,Q13131_V_307_G
813,Q13131,V,307,Q,4red:B,298,Activates the kinase activity.,,,1.0,,,,,,,,,,,,,Q13131_V_307_Q
814,Q96RD7,N,255,Q,6wbf:A,255,Impaired glycosylation. Loss of GLY1 and GLY2 forms. No effect on oocyte survival.,,,-999.0,,,-1.0,,,,,,,,,,Q96RD7_N_255_Q
815,Q96RD7,N,338,Q,6wbf:A,338,Impaired glycosylation,,,-999.0,,,-1.0,,,,,,,,,,Q96RD7_N_338_Q
816,Q6NT76,R,271,A,4j19:A,271,Abolishes binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_R_271_A
817,Q6NT76,K,325,E,4j19:A,325,Abolishes binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_K_325_E
818,Q6NT76,Y,327,A,4j19:A,327,Impairs binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_Y_327_A
819,Q6NT76,R,334,A,4j19:A,334,Impairs binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_R_334_A
820,Q6NT76,K,335,A,4j19:A,335,Abolishes binding to telomeric 5'-TTAGGG-3' motif. Confers binding to the non-telomeric 5'-GTGAGT-3' motif.,,,-999.0,,,,,,,,,,,,,Q6NT76_K_335_A
821,Q6NT76,K,338,A,4j19:A,338,Impairs binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_K_338_A
822,Q6NT76,R,339,A,4j19:A,339,Abolishes binding to telomeric 5'-TTAGGG-3' motif.,,-1.0,-999.0,,,,,,,,,,,,,Q6NT76_R_339_A
823,P23368,R,67,S,1gz3:A,67,Abolishes activation by fumarate.,,-1.0,-999.0,,,,,,,,,,,,,P23368_R_67_S
824,P23368,R,91,T,1gz3:A,91,Abolishes activation by fumarate.,,-1.0,-999.0,,,,,,,,,,,,,P23368_R_91_T
825,Q6UXN8,W,131,A,3vpp:A,131,Abolishes binding to damaged cells,,-1.0,-999.0,,,,,,,,,,,,,Q6UXN8_W_131_A
826,Q9HAS3,S,568,P,6ksw:A,569,Decreased uridine transport. Normal localization to the cell membrane.,,,1.0,,,,,,,,,0.0,,,,Q9HAS3_S_568_P
827,Q9UIS9,R,22,A,1ig4:A,22,Abolishes binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_22_A
827,Q9UIS9,R,22,K,1ig4:A,22,Abolishes binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_22_K
828,Q9UIS9,R,30,A,1ig4:A,30,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_30_A
829,Q9UIS9,R,30,K,1ig4:A,30,No loss of binding to methylated DNA.,,0.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_30_K
830,Q9UIS9,D,32,A,1ig4:A,32,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_D_32_A
831,Q9UIS9,Y,34,A,1ig4:A,34,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_Y_34_A
831,Q9UIS9,Y,34,F,1ig4:A,34,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_Y_34_F
832,Q9UIS9,R,44,A,1ig4:A,44,Abolishes binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_44_A
832,Q9UIS9,R,44,K,1ig4:A,44,Abolishes binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_R_44_K
833,Q9UIS9,S,45,A,1ig4:A,45,Reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_S_45_A
834,Q9UIS9,K,46,A,1ig4:A,46,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_K_46_A
835,Q9UIS9,Y,52,A,1ig4:A,52,No loss of binding to methylated DNA.,,0.0,-999.0,,,,,,,,,,,,,Q9UIS9_Y_52_A
836,Q9UIS9,F,64,A,1ig4:A,64,Disrupts tertiary structure and abolishes DNA binding.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9UIS9_F_64_A
837,Q9UIS9,K,65,A,1ig4:A,65,Strongly reduces binding to methylated DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9UIS9_K_65_A
838,P61956,K,11,R,2awt:A,11,Abolishes the formation of poly(SUMO) chains.,,,1.0,,,,,,,,,,,,,P61956_K_11_R
839,P61956,K,33,E,2awt:A,33,Significantly impairs sumoylation of MTA1.,,,1.0,,,,,,,,,,,,,P61956_K_33_E
840,P61956,K,35,E,2awt:A,35,Significantly impairs sumoylation of MTA1.,,,1.0,,,,,,,,,,,,,P61956_K_35_E
841,P61956,K,42,E,2awt:A,42,Significantly impairs sumoylation of MTA1.,,,1.0,,,,,,,,,,,,,P61956_K_42_E
842,O94804,K,65,I,6eim:B,65,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O94804_K_65_I
843,Q9H221,G,216,D,5do7:D,216,Loss of ATPase activity.,,,1.0,,,,,,,,,,,,,Q9H221_G_216_D
844,Q9H227,E,165,D,2e9m:A,165,2-fold decreased glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_E_165_D
845,Q9H227,E,165,Q,2e9m:A,165,Loss of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_E_165_Q
846,Q9H227,V,168,Y,2e9m:A,168,No change in temperature or pH dependence. Decreased glucosidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_V_168_Y
847,Q9H227,F,225,S,2e9m:A,225,Decreased glucosidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_F_225_S
848,Q9H227,Y,308,F,2e9m:A,308,Decreased glucosidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_Y_308_F
848,Q9H227,Y,308,A,2e9m:A,308,Decreased glucosidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_Y_308_A
849,Q9H227,E,373,D,2e9m:A,373,2-fold decreased glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_E_373_D
850,Q9H227,E,373,Q,2e9m:A,373,Loss of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,Q9H227_E_373_Q
851,P19440,K,100,N,4gg2:A,100,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_K_100_N
852,P19440,E,102,Q,4gg2:A,102,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_E_102_Q
853,P19440,R,107,K,4gg2:A,107,Reduces enzyme gamma-glutamyltranspeptidase activity by 99%.,,,1.0,,,,,,,,,,,,,P19440_R_107_K
854,P19440,R,107,Q,4gg2:A,107,Abolishes gamma-glutamyltranspeptidase activity.,,,1.0,,,,,,,,,,,,,P19440_R_107_Q
854,P19440,R,107,H,4gg2:A,107,Abolishes gamma-glutamyltranspeptidase activity.,,,1.0,,,,,,,,,,,,,P19440_R_107_H
855,P19440,E,108,Q,4gg2:A,108,Reduces gamma-glutamyltranspeptidase activity by 98%.,,,1.0,,,,,,,,,,,,,P19440_E_108_Q
856,P19440,R,112,Q,4gg2:A,112,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_112_Q
857,P19440,R,139,Q,4gg2:A,139,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_139_Q
858,P19440,R,147,Q,4gg2:A,147,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_147_Q
859,P19440,R,150,Q,4gg2:A,150,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_R_150_Q
860,P19440,C,192,W,4gg2:A,192,"Loss of autocatalytic cleavage, cell membrane localization and decrease in gamma-glutamyltranspeptidase activity",,,1.0,,,,,,,,,1.0,,,,P19440_C_192_W
861,P19440,E,193,Y,4gg2:A,193,"Loss of autocatalytic cleavage, cell membrane localization and decrease in gamma-glutamyltranspeptidase activity",,,1.0,,,,,,,,,1.0,,,,P19440_E_193_Y
862,P19440,H,383,A,6xpb:B,383,Reduces gamma-glutamyltranspeptidase activity by 66%.,,,1.0,,,,,,,,,,,,,P19440_H_383_A
863,P19440,S,385,A,6xpb:B,385,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_385_A
864,P19440,S,413,A,6xpb:B,413,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_413_A
865,P19440,D,422,A,6xpb:B,422,Reduces enzyme gamma-glutamyltranspeptidase activity by 90%.,,,1.0,,,,,,,,,,,,,P19440_D_422_A
866,P19440,D,423,A,6xpb:B,423,Abolishes gamma-glutamyltranspeptidase activity. Increases KM for D-gamma-glutamyl-p-nitroanalide by over 1000-fold.,,-1.0,1.0,,,,,,,,,,,,,P19440_D_423_A
867,P19440,S,425,A,6xpb:B,425,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_S_425_A
868,P19440,S,451,A,6xpb:B,451,Reduces gamma-glutamyltranspeptidase activity by 99%. Abolishes activity,,,1.0,,,,,,,,,,,,,P19440_S_451_A
869,P19440,S,452,A,6xpb:B,452,Reduces gamma-glutamyltranspeptidase activity by 99%. Abolishes activity,,,1.0,,,,,,,,,,,,,P19440_S_452_A
870,P19440,C,454,A,6xpb:B,454,No effect on gamma-glutamyltranspeptidase activity.,,,0.0,,,,,,,,,,,,,P19440_C_454_A
871,P19440,H,505,A,6xpb:B,505,Reduces gamma-glutamyltranspeptidase activity by 90%.,,,0.0,,,,,,,,,,,,,P19440_H_505_A
872,P19440,Q,545,K,6xpb:B,545,Reduces enzyme activity by 97%.,,,1.0,,,,,,,,,,,,,P19440_Q_545_K
873,Q99459,W,31,G,6id0:L,31,Abolishes DNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q99459_W_31_G
874,Q99459,W,53,G,6id0:L,53,Abolishes DNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q99459_W_53_G
875,Q99459,W,82,G,6id0:L,82,Abolishes DNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q99459_W_82_G
876,Q99459,T,227,A,6id0:L,227,Abolishes phosphorylation. No effect on homodimerization nor on nuclear localization,0.0,,-999.0,-1.0,,,,,,,,0.0,,,,Q99459_T_227_A
879,Q16512,R,181,A,1urf:A,181,Abolishes interaction with bacterial SspH1.,-1.0,,-999.0,,,,,,,,,,,,,Q16512_R_181_A
880,Q16512,R,181,K,1urf:A,181,Decreases interaction with bacterial SspH1.,-1.0,,-999.0,,,,,,,,,,,,,Q16512_R_181_K
881,Q16512,R,185,A,1urf:A,185,Abolishes interaction with bacterial SspH1.,-1.0,,-999.0,,,,,,,,,,,,,Q16512_R_185_A
882,Q16512,K,644,E,4otd:A,650,Abolishes Serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q16512_K_644_E
883,Q16512,K,644,R,4otd:A,650,Substantial reduction of autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q16512_K_644_R
884,Q16513,K,686,R,4crs:A,686,Does not inhibit interaction with PTPN13.,0.0,,-999.0,,,,,,,,,,,,,Q16513_K_686_R
885,Q16513,D,700,E,4crs:A,700,Prevents proteolytic processing by caspase-3 during apoptosis. Diminishes pro-apoptotic function,,,1.0,,,,,,,,,,,,,Q16513_D_700_E
886,Q16513,T,816,A,4crs:A,816,Reduces catalytic activity.,,,1.0,,,,,,,,,,,,,Q16513_T_816_A
887,Q16513,T,958,A,4crs:A,958,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q16513_T_958_A
888,P20823,N,127,W,1ic8:B,127,Abolishes transcription activation.,,,1.0,,,,,,,,,,,,,P20823_N_127_W
889,P20823,E,132,K,1ic8:B,132,Abolishes transcription activation.,,,1.0,,,,,,,,,,,,,P20823_E_132_K
890,P20823,F,177,S,1ic8:B,177,No significant effect on transcription activation.,,,0.0,,,,,,,,,,,,,P20823_F_177_S
891,P20823,N,202,D,1ic8:B,202,Reduces transcription activation by 70%.,,,1.0,,,,,,,,,,,,,P20823_N_202_D
892,P20823,V,246,D,1ic8:B,246,Reduces transcription activation by 75%.,,,1.0,,,,,,,,,,,,,P20823_V_246_D
893,P20823,N,257,W,1ic8:B,257,Reduces transcription activation by 70%.,,,1.0,,,,,,,,,,,,,P20823_N_257_W
894,Q9BTC0,W,291,T,2m3h:A,30,Abolishes binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q9BTC0_W_291_T
895,O60583,N,260,C,2ivx:A,260,Activation of HIV-1 Tat function.,,,-999.0,,,,,,,,,,,,,O60583_N_260_C
896,Q9H816,D,14,N,7a1f:L,14,In Apm3: abolishes exonuclease activity and function on telomere maintenance. Impairs interaction with SPAG5,-1.0,,1.0,,,,,,,,,,,,,Q9H816_D_14_N
897,Q9H816,H,33,A,7a1f:L,33,In Apm1: abolishes exonuclease activity and function on telomere maintenance; when associated with N-35,,,1.0,,,,,,,,,,,,,Q9H816_H_33_A
898,Q9H816,D,35,N,7a1f:L,35,In Apm2:abolishes exonuclease activity and function on  telomere maintenance. In Apm1; abolishes exonuclease activity and  function on telomere maintenance; when associated with A-33,,,1.0,,,,,,,,,,,,,Q9H816_D_35_N
899,Q9H816,H,276,A,7a1f:L,276,Slightly affects interaction with SPAG5.,-1.0,,-999.0,,,,,,,,,,,,,Q9H816_H_276_A
900,Q9BWF3,Y,37,A,2dnq:A,37,Abrogates regulation of alternative splice site selection,,,1.0,,,,,,,,,,,,,Q9BWF3_Y_37_A
901,Q9BWF3,F,39,A,2dnq:A,39,Abrogates regulation of alternative splice site selection,,,1.0,,,,,,,,,,,,,Q9BWF3_F_39_A
902,O43324,A,69,R,5y6l:B,69,Disrupts interaction with MARS1.,-1.0,,-999.0,,,,,,,,,,,,,O43324_A_69_R
903,O43324,Q,73,R,5y6l:B,73,Disrupts interaction with MARS1.,-1.0,,-999.0,,,,,,,,,,,,,O43324_Q_73_R
904,O43324,R,144,A,5y6l:B,144,Disrupts interaction with EPRS1.,-1.0,,-999.0,,,,,,,,,,,,,O43324_R_144_A
905,P31941,R,28,E,2m65:A,28,No effect on deaminase activity despite an altered restriction activity towards genetic invaders.,,,0.0,,,,,,,,,,,,,P31941_R_28_E
906,P31941,H,29,A,2m65:A,29,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_H_29_A
907,P31941,K,30,F,2m65:A,30,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_K_30_F
908,P31941,N,57,A,2m65:A,57,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_N_57_A
909,P31941,K,60,A,2m65:A,60,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_K_60_A
910,P31941,R,69,A,2m65:A,69,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_R_69_A
911,P31941,H,70,R,2m65:A,70,Altered deaminase activity.,,,1.0,,,,,,,,,,,,,P31941_H_70_R
912,P31941,E,72,Q,2m65:A,72,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_E_72_Q
913,P31941,W,98,L,2m65:A,98,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_W_98_L
914,P31941,C,106,S,2m65:A,106,Altered deaminase activity.,,,1.0,,,,,,,,,,,,,P31941_C_106_S
915,P31941,R,128,A,2m65:A,128,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_R_128_A
916,P31941,Y,130,A,2m65:A,130,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_Y_130_A
917,P31941,D,131,N,2m65:A,131,No effect on deaminase activity despite an altered restriction activity towards genetic invaders.,,,0.0,,,,,,,,,,,,,P31941_D_131_N
918,P31941,D,133,N,2m65:A,133,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_D_133_N
919,P31941,Y,136,A,2m65:A,136,Altered deaminase activity and restriction activity towards genetic invaders.,,,1.0,,,,,,,,,,,,,P31941_Y_136_A
920,Q13356,Y,389,H,1zkc:A,389,No peptidyl-prolyl cis-trans isomerase activity,,,1.0,,,,,,,,,,,,,Q13356_Y_389_H
921,Q13356,Y,389,W,1zkc:A,389,Gain of a peptidyl-prolyl cis-trans isomerase activity,,,1.0,,,,,,,,,,,,,Q13356_Y_389_W
922,P14598,R,43,Q,1kq6:A,43,"Reduces affinity for membranes enriched in phosphatidylinositol 3,4-bisphosphate.",,-1.0,-999.0,,,,,,,,,,,,,P14598_R_43_Q
923,P14598,R,90,A,1kq6:A,90,"Reduces affinity for membranes enriched in phosphatidylinositol 3,4-bisphosphate.",,-1.0,-999.0,,,,,,,,,,,,,P14598_R_90_A
924,P14598,W,263,R,1ng2:A,263,Abolishes autoinhibition and promotes phospholipid binding.,,1.0,-999.0,,,,,,,,,,,,,P14598_W_263_R
925,P14598,S,303,E,1ng2:A,303,Abolishes autoinhibition and promotes phospholipid binding,,1.0,-999.0,,,,,,,,,,,,,P14598_S_303_E
926,P14598,S,304,E,1ng2:A,304,Abolishes autoinhibition and promotes phospholipid binding,,1.0,-999.0,,,,,,,,,,,,,P14598_S_304_E
927,P14598,S,328,E,1ng2:A,328,Abolishes autoinhibition and promotes phospholipid binding,,1.0,-999.0,,,,,,,,,,,,,P14598_S_328_E
928,Q96DA2,S,22,N,6s5f:A,22,Dominant negative mutant.,,,-999.0,,,,,,,,,,,,,Q96DA2_S_22_N
929,Q96DA2,Q,68,L,6s5f:A,68,Constitutively active mutant locked in the active GTP-bound form.,,,1.0,,,,,,,,,,,,,Q96DA2_Q_68_L
930,Q9UG22,S,54,A,2xtm:A,54,Abolishes GTP-induced dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UG22_S_54_A
931,Q9UG22,R,117,D,2xtm:A,117,Abolishes GTP-induced dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UG22_R_117_D
932,Q96MF7,C,169,A,2yu4:A,10,Induces a strong decrease in SUMO ligase activity.,,,1.0,,,,,,,,,,,,,Q96MF7_C_169_A
933,Q96MF7,C,185,A,2yu4:A,26,Induces a strong decrease in SUMO ligase activity.,,,1.0,,,,,,,,,,,,,Q96MF7_C_185_A
934,Q96MF7,H,187,A,2yu4:A,28,Induces a strong decrease in SUMO ligase activity.,,,1.0,,,,,,,,,,,,,Q96MF7_H_187_A
935,Q96MF7,C,210,A,2yu4:A,51,Induces a strong decrease in SUMO ligase activity.,,,1.0,,,,,,,,,,,,,Q96MF7_C_210_A
936,Q96MF7,C,215,A,2yu4:A,56,Induces a strong decrease in SUMO ligase activity.,,,1.0,,,,,,,,,,,,,Q96MF7_C_215_A
937,P40337,Y,98,N,6r7f:V,98,No interaction with HIF1A. No HIF1A degradation.,-1.0,,-999.0,,,,,,,,,,,,,P40337_Y_98_N
938,P17213,S,49,C,1ewf:A,18,No impairment of secretion and increased propensity for dimer formation.,1.0,,-999.0,,,,,,,,,0.0,,,,P17213_S_49_C
939,P17213,C,163,A,1ewf:A,132,No impairment of secretion and/or biological activity. Loss of dimer formation.,-1.0,,0.0,,,,,,,,,0.0,,,,P17213_C_163_A
940,P17213,C,166,S,1ewf:A,135,Poorly secreted. Loss of LPS-binding and biological activity.,-1.0,,1.0,,,,,,,,,1.0,,,,P17213_C_166_S
941,P17213,C,206,A,1ewf:A,175,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P17213_C_206_A
942,Q14914,R,56,A,1zsv:A,56,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2.,,,1.0,,,,,,,,,,,,,Q14914_R_56_A
943,Q14914,Y,245,A,1zsv:A,245,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2 and (3E)-3-nonen-2-one.,,,1.0,,,,,,,,,,,,,Q14914_Y_245_A
943,Q14914,Y,245,F,1zsv:A,245,Markedly decreases the catalytic efficiency toward 15-oxoprostaglandin E2 and (3E)-3-nonen-2-one.,,,1.0,,,,,,,,,,,,,Q14914_Y_245_F
944,Q9UMS4,Y,405,A,4lg8:A,405,Loss of interaction with the RPA complex and loss of recruitment to sites of DNA damage.,-1.0,,-999.0,,,,,,,,,,,,,Q9UMS4_Y_405_A
945,P37088,C,394,S,6bqn:A,394,Increased channel activity.,,,1.0,,,,,,,,,,,,,P37088_C_394_S
946,P60953,G,12,V,2ngr:A,12,Constitutively active. Interacts with PARD6 proteins. Does not inhibit filopodia formation. No effect on NR3C2 transcriptional activity.,1.0,,1.0,,,,,,,,,,,,,P60953_G_12_V
947,P60953,T,17,N,2ngr:A,17,Constitutively inactive. Does not interact with PARD6 proteins. Inhibits filopodia formation. No effect on NR3C2 transcriptional activity.,-1.0,,1.0,,,,,,,,,,,,,P60953_T_17_N
948,P60953,Y,32,F,2ngr:A,32,Abolishes AMPylation by Haemophilus IbpA.,,,-999.0,,,,,,-1.0,,,,,,,P60953_Y_32_F
949,P60953,Q,61,L,2ngr:A,61,Constitutively active. Interacts with PARD6 proteins.,1.0,,1.0,,,,,,,,,,,,,P60953_Q_61_L
950,Q9NYZ4,R,72,A,2n7b:A,56,Strongly impaired binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_R_72_A
951,Q9NYZ4,Y,74,A,2n7b:A,58,Modestly affected binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_Y_74_A
952,Q9NYZ4,Q,75,A,2n7b:A,59,Modestly affected binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_Q_75_A
953,Q9NYZ4,R,125,A,2n7b:A,109,Abolishes binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_R_125_A
954,Q9NYZ4,K,132,A,2n7b:A,116,Strongly impaired binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_K_132_A
955,Q9NYZ4,K,136,A,2n7b:A,120,Strongly impaired binding to 6'-sulfo sialyl-Lewis X.,,-1.0,-999.0,,,,,,,,,,,,,Q9NYZ4_K_136_A
956,Q9NYZ4,Q,138,A,2n7b:A,122,Minor effects on binding to 6'-sulfo sialyl-Lewis X.,,0.0,-999.0,,,,,,,,,,,,,Q9NYZ4_Q_138_A
957,Q9HCP0,N,169,A,2cmw:A,169,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9HCP0_N_169_A
958,O14684,Q,36,E,4yl1:A,36,Keeps about 40-50% of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_Q_36_E
959,O14684,D,49,A,4yl1:A,49,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_D_49_A
960,O14684,D,49,N,4yl1:A,49,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_D_49_N
961,O14684,E,66,A,4yl1:A,66,Reduces protaglandin-E synthase activity by 50%.,,,1.0,,,,,,,,,,,,,O14684_E_66_A
962,O14684,R,67,A,4yl1:A,67,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_67_A
963,O14684,R,70,A,4yl1:A,70,Slightly reduced protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_70_A
964,O14684,R,70,S,4yl1:A,70,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_R_70_S
965,O14684,H,72,A,4yl1:A,72,Reduces protaglandin-E synthase activity by 70%.,,,1.0,,,,,,,,,,,,,O14684_H_72_A
966,O14684,R,73,A,4yl1:A,73,Retains partial of protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_R_73_A
967,O14684,R,73,L,4yl1:A,73,Loss of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_73_L
968,O14684,R,110,A,4yl1:A,110,Loss of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_110_A
968,O14684,R,110,S,4yl1:A,110,Loss of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_110_S
969,O14684,R,110,T,4yl1:A,110,Retains 17.8% of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_110_T
970,O14684,T,114,V,4yl1:A,114,Retains 21.3% activity of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_T_114_V
971,O14684,Y,117,A,4yl1:A,117,Loss of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_Y_117_A
972,O14684,Y,117,F,4yl1:A,117,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_Y_117_F
973,O14684,R,126,A,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_126_A
973,O14684,R,126,L,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_126_L
974,O14684,R,126,K,4yl1:A,126,Loss of prostaglandin-E synthase activity. Transforms prostaglandin-E synthase activity to prostaglandin-F(2alpha)synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_126_K
975,O14684,R,126,Q,4yl1:A,126,Loss of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_R_126_Q
976,O14684,S,127,A,4yl1:A,127,No effect on protaglandin-E synthase activity.,,,0.0,,,,,,,,,,,,,O14684_S_127_A
977,O14684,Y,130,I,4yl1:A,130,Loss of protaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_Y_130_I
978,O14684,Q,134,E,4yl1:A,134,Keeps about 40-50% of prostaglandin-E synthase activity.,,,1.0,,,,,,,,,,,,,O14684_Q_134_E
979,Q16644,K,73,M,3r1n:A,73,Higher affinity toward PCH2.,1.0,,-999.0,,,,,,,,,,,,,Q16644_K_73_M
980,O95628,L,16,A,1e4u:A,16,Abolishes interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_L_16_A
980,O95628,L,16,E,1e4u:A,16,Abolishes interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_L_16_E
981,O95628,C,17,A,1e4u:A,17,Abolishes interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_C_17_A
982,O95628,M,18,A,1e4u:A,18,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_M_18_A
983,O95628,C,33,R,1e4u:A,33,Abolishes interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_C_33_R
984,O95628,W,42,A,1e4u:A,42,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_W_42_A
985,O95628,R,44,A,1e4u:A,44,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_R_44_A
985,O95628,R,44,E,1e4u:A,44,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_R_44_E
986,O95628,I,45,A,1e4u:A,45,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_I_45_A
986,O95628,I,45,W,1e4u:A,45,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_I_45_W
987,O95628,E,49,A,1e4u:A,49,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_E_49_A
988,O95628,E,49,K,1e4u:A,49,Strongly reduced interaction with UBE2D2.,-1.0,,-999.0,,,,,,,,,,,,,O95628_E_49_K
989,O95628,P,54,A,1e4u:A,54,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_P_54_A
990,O95628,R,57,A,1e4u:A,57,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_R_57_A
990,O95628,R,57,E,1e4u:A,57,Strongly reduces interaction with E2 ubiquitin ligases.,-1.0,,-999.0,,,,,,,,,,,,,O95628_R_57_E
991,Q16647,C,441,H,2iag:A,441,Abolishes prostaglandin-I synthase activity.,,,1.0,,,,,,,,,,,,,Q16647_C_441_H
992,O15530,S,241,A,4xx9:A,241,No activation.,,,1.0,,,,,,,,,,,,,O15530_S_241_A
993,O15530,A,277,V,4xx9:A,277,3-fold increase in kinase activity.,,,1.0,,,,,,,,,,,,,O15530_A_277_V
994,O15530,T,354,A,4xx9:A,354,Abolishes phosphorylation by MELK.,,,-999.0,-1.0,,,,,,,,,,,,O15530_T_354_A
995,O15530,S,410,A,1w1h:B,410,No effect.,0.0,,0.0,0.0,,,,,,,,,,,,O15530_S_410_A
996,O15530,R,474,A,1w1h:B,474,No PDGF-dependent translocation to the membrane.,,,-999.0,,,,,,,,,1.0,,,,O15530_R_474_A
997,O15530,T,513,E,1w1h:B,513,Enhanced kinase activity towards PKB.,,,1.0,,,,,,,,,,,,,O15530_T_513_E
998,O15533,C,115,A,3f8u:D,95,"Abolishes the recruitment of PDIA3, CALR and B2M to the peptide-loading complex.",-1.0,,-999.0,,,,,,,,,,,,,O15533_C_115_A
999,O15533,N,253,Q,3f8u:B,233,Reduces the recruitment of PDIA3 to TAP1-TAP2 transporter.,-1.0,,-999.0,,,,,,,,,,,,,O15533_N_253_Q
1000,Q16643,R,10,D,5y1z:B,10,Loss of binding to ZMYND8. Loss of ZMYND8 cytoplasmic localization.,-1.0,,-999.0,,,,,,,,,,,,,Q16643_R_10_D
1000,Q16643,R,10,G,5y1z:B,10,Loss of binding to ZMYND8. Loss of ZMYND8 cytoplasmic localization.,-1.0,,-999.0,,,,,,,,,,,,,Q16643_R_10_G
1001,Q16643,C,96,Q,5y1z:B,96,Decreased binding to ZMYND8.,-1.0,,-999.0,,,,,,,,,,,,,Q16643_C_96_Q
1002,Q9UNE7,K,30,A,6efk:A,30,"Loss of interaction with FOXP3 and its ability to ubiquitinate FOXP3. Loss of interaction with SMAD3, HSPA8, HSP90AA1 and HSP90AB1.",-1.0,,1.0,,,,,,,,,,,,,Q9UNE7_K_30_A
1003,Q16878,R,60,Q,6bgf:A,60,Reduces enzyme activity by 70%. Reduces iron and zinc incorporation by 50%.,,-1.0,1.0,,,,,,,,,,,,,Q16878_R_60_Q
1004,Q16878,C,93,S,6bgf:A,93,Reduces enzyme activity and iron incorporation by 50%. Zinc incorporation increased by 20%.,,,1.0,,,,,,,,,,,,,Q16878_C_93_S
1005,Q16878,Y,157,F,6bgf:A,157,Almost total loss of enzyme activity and iron incorporation. Reduces zinc incorporation by 20%.,,-1.0,1.0,,,,,,,,,,,,,Q16878_Y_157_F
1006,Q16878,C,164,S,6bgf:A,164,Reduces enzyme activity by 20%. Little effect on iron incorporation. No effect on zinc incorporation.,,,1.0,,,,,,,,,,,,,Q16878_C_164_S
1007,O15151,C,437,G,5mnj:H,437,Fails to interact with MDM2.,-1.0,,-999.0,,,,,,,,,,,,,O15151_C_437_G
1008,P09936,Q,73,R,4jkj:A,73,No effect on enzymatic parameters.,,,0.0,,,,,,,,,,,,,P09936_Q_73_R
1009,P09936,C,90,S,4jkj:A,90,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P09936_C_90_S
1010,P09936,H,97,Q,4jkj:A,97,"2-fold increase in affinity for ubiquitin ethyl ester, slight reduction in enzymatic activity.",,-1.0,1.0,,,,,,,,,,,,,P09936_H_97_Q
1010,P09936,H,97,N,4jkj:A,97,"2-fold increase in affinity for ubiquitin ethyl ester, slight reduction in enzymatic activity.",,-1.0,1.0,,,,,,,,,,,,,P09936_H_97_N
1011,P09936,H,161,D,4jkj:A,161,10000-fold decrease in enzymatic activity,,,1.0,,,,,,,,,,,,,P09936_H_161_D
1012,P09936,H,161,K,4jkj:A,161,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P09936_H_161_K
1012,P09936,H,161,Q,4jkj:A,161,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P09936_H_161_Q
1012,P09936,H,161,N,4jkj:A,161,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P09936_H_161_N
1012,P09936,H,161,Y,4jkj:A,161,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P09936_H_161_Y
1013,P09936,D,176,N,4jkj:A,176,6-fold decrease in affinity for ubiquitin ethyl ester,,-1.0,-999.0,,,,,,,,,,,,,P09936_D_176_N
1014,P09936,F,204,A,4jkj:A,204,Almost complete loss of activity.,,,1.0,,,,,,,,,,,,,P09936_F_204_A
1015,Q03426,E,19,D,2r3v:A,19,No change in protein stability. Weak decrease in kinase activity. Approximately 2-fold decrease in Vmax. Approximately 2-fold decrease affinity for ATP and mevalonate.,,-1.0,1.0,,,,,,,,,,,0.0,,Q03426_E_19_D
1016,Q03426,I,56,A,2r3v:A,56,"No effect on kinase activity. Approximately 4- and 5-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_I_56_A
1017,Q03426,T,104,A,2r3v:A,104,No effect on kinase activity. Approximately 4-fold increase affinity for ATP. Normal affinity for mevalonate.,,1.0,0.0,,,,,,,,,,,,,Q03426_T_104_A
1018,Q03426,S,145,A,2r3v:A,145,Modest changes in KM for ATP. 20-fold increase in KM for mevalonate. Approximately 2-fold decrease in Vmax.,,-1.0,1.0,,,,,,,,,,,,,Q03426_S_145_A
1019,Q03426,S,146,A,2r3v:A,146,Modest changes in KM for ATP. 20-fold increase in KM for mevalonate. 4000-fold decrease in Vmax.,,-1.0,1.0,,,,,,,,,,,,,Q03426_S_146_A
1020,Q03426,Y,149,A,2r3v:A,149,"No effect on kinase activity. Approximately 4- and 8-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_Y_149_A
1021,Q03426,E,193,Q,2r3v:A,193,"No change in protein stability. Decreased kinase activity. Approximately 50-fold decrease in Vmax. Approximately 20- and 40-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,1.0,,,,,,,,,,,0.0,,Q03426_E_193_Q
1022,Q03426,I,196,A,2r3v:A,196,"No effect on kinase activity. Approximately 2- and 3-fold decrease affinities for ATP and mevalonate, respectively.",,-1.0,0.0,,,,,,,,,,,,,Q03426_I_196_A
1023,Q03426,S,201,A,2r3v:A,201,Modest changes in KM for ATP. 100-fold increase in KM for mevalonate. Approximately 2-fold increase in Vmax.,,-1.0,1.0,,,,,,,,,,,,,Q03426_S_201_A
1024,Q03426,D,204,A,2r3v:A,204,No change in protein stability. Loss of kinase activity. Normal affinities for ATP and mevalonate.,,0.0,1.0,,,,,,,,,,,0.0,,Q03426_D_204_A
1025,Q03426,D,204,N,2r3v:A,204,No change in protein stability. Loss of kinase activity. Normal affinities for ATP and mevalonate.,,0.0,1.0,,,,,,,,,,,0.0,,Q03426_D_204_N
1026,Q03426,T,243,A,2r3v:A,243,Modest changes in KM for ATP. 40-fold increase in KM for mevalonate. Approximately 2-fold decrease in Vmax.,,-1.0,1.0,,,,,,,,,,,,,Q03426_T_243_A
1027,Q03426,E,296,Q,2r3v:A,296,No change in protein stability. No effect on kinase activity.,,,0.0,,,,,,,,,,,0.0,,Q03426_E_296_Q
1028,Q9NS91,I,27,A,2y43:A,27,Lower activity toward PCNA monoubiquitination.,,,1.0,,,,,,,,,,,,,Q9NS91_I_27_A
1029,P80192,K,171,A,4uy9:B,171,Loss of kinase activity and threonine phosphorylation.,,,1.0,,,,,,,,,,,,,P80192_K_171_A
1030,P80192,T,304,A,4uy9:B,304,Reduces threonine phosphorylation. Impairs JNK activation.,-1.0,,1.0,,,,,,,,,,,,,P80192_T_304_A
1031,P80192,T,305,A,4uy9:B,305,Little effect on threonine phosphorylation. Mildly impairs JNK activation.,-1.0,,0.0,,,,,,,,,,,,,P80192_T_305_A
1032,P80192,S,308,A,4uy9:B,308,Impairs JNK activation.,-1.0,,-999.0,,,,,,,,,,,,,P80192_S_308_A
1033,P80192,T,312,A,4uy9:B,312,Loss of threonine phosphorylation. Strongly impairs JNK activation.,-1.0,,1.0,,,,,,,,,,,,,P80192_T_312_A
1034,Q9H6S0,W,1360,A,2yu6:A,80,Abolished ability to bind N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9H6S0_W_1360_A
1035,O14757,K,38,R,2ydi:A,38,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,O14757_K_38_R
1036,O14757,D,130,A,2ydi:A,130,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,O14757_D_130_A
1037,O14757,R,379,E,5wi2:A,379,"In 3RE mutant. Disrupts the folding and/or conformation, allowing increased accessibility to FBXO6 component of SCF-type E3 ubiquitin ligase complex",,,-999.0,,,,,,,,,,,-1.0,,O14757_R_379_E
1038,O14757,K,436,R,5wi2:A,436,"Enhances stability of the protein, probably by preventing ubiquitination at this site.",,,-999.0,,-1.0,,,,,,,,,1.0,,O14757_K_436_R
1039,Q9BUD6,E,122,A,3d34:B,96,Strongly reduced metal-dependent interaction with integrin,-1.0,,-999.0,,,,,,,,,,,,,Q9BUD6_E_122_A
1040,Q9BUD6,E,141,A,3d34:B,115,Strongly reduced metal-dependent interaction with integrin,-1.0,,-999.0,,,,,,,,,,,,,Q9BUD6_E_141_A
1041,P21333,K,42,R,3hop:B,42,Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding,,,-999.0,,,,,,,,,,,,,P21333_K_42_R
1042,P21333,K,43,R,3hop:B,43,Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding,,,-999.0,,,,,,,,,,,,,P21333_K_43_R
1043,P21333,K,135,R,3hop:B,135,Abrogates ASB2alpha-mediated degradation without altering ASB2alpha binding,,,-999.0,,,,,,,,,,,,,P21333_K_135_R
1044,P16455,Y,114,A,1eh6:A,114,Decreases activity towards methylated DNA over 1000-fold. Slightly reduced reactivity with O6-benzylguanine.,,-1.0,1.0,,,,,,,,,,,,,P16455_Y_114_A
1045,P16455,Y,114,E,1eh6:A,114,Loss of DNA repair activity. Slightly reduced reactivity with O6-benzylguanine.,,-1.0,1.0,,,,,,,,,,,,,P16455_Y_114_E
1046,P16455,R,128,A,1eh6:A,128,Decreases activity towards methylated DNA over 1000-fold. No effect on reactivity with O6-benzylguanine.,,0.0,1.0,,,,,,,,,,,,,P16455_R_128_A
1046,P16455,R,128,D,1eh6:A,128,Decreases activity towards methylated DNA over 1000-fold. No effect on reactivity with O6-benzylguanine.,,0.0,1.0,,,,,,,,,,,,,P16455_R_128_D
1047,P16455,R,128,G,1eh6:A,128,Loss of DNA repair activity.,,,1.0,,,,,,,,,,,,,P16455_R_128_G
1048,P16455,R,128,K,1eh6:A,128,Slightly reduced DNA repair activity.,,,1.0,,,,,,,,,,,,,P16455_R_128_K
1048,P16455,R,128,L,1eh6:A,128,Slightly reduced DNA repair activity.,,,1.0,,,,,,,,,,,,,P16455_R_128_L
1049,P16455,P,138,K,1eh6:A,138,Decreased reactivity with O6-benzylguanine.,,-1.0,-999.0,,,,,,,,,,,,,P16455_P_138_K
1050,P16455,P,140,A,1eh6:A,140,Decreased reactivity with O6-benzylguanine.,,-1.0,-999.0,,,,,,,,,,,,,P16455_P_140_A
1051,P16455,C,145,A,1eh6:A,145,Loss of DNA repair activity.,,,1.0,,,,,,,,,,,,,P16455_C_145_A
1052,P16455,G,156,A,1eh6:A,156,Decreased reactivity with O6-benzylguanine.,,-1.0,-999.0,,,,,,,,,,,,,P16455_G_156_A
1053,P16455,Y,158,A,1eh6:A,158,Reduced DNA repair activity. Decreased reactivity with O6-benzylguanine.,,-1.0,1.0,,,,,,,,,,,,,P16455_Y_158_A
1054,P16455,Y,158,F,1eh6:A,158,Slightly reduced DNA repair activity.,,,1.0,,,,,,,,,,,,,P16455_Y_158_F
1055,O95931,K,31,A,2l12:A,25,Loss of cellular lifespan extension.,,,-999.0,,,,,,,,,,,,,O95931_K_31_A
1056,O95931,W,32,A,2l12:A,26,Loss of cellular lifespan extension.,,,-999.0,,,,,,,,,,,,,O95931_W_32_A
1057,Q8NHV1,R,103,D,3zjc:E,103,Abolishes GTPase activity. No effect on GTP binding and on dimerization.,0.0,0.0,1.0,,,,,,,,,,,,,Q8NHV1_R_103_D
1058,Q8NHV1,E,136,W,3zjc:E,136,Impairs dimerization and abolishes GTPase activity. No effect on GTP binding.,-1.0,0.0,1.0,,,,,,,,,,,,,Q8NHV1_E_136_W
1059,Q9UM82,T,94,K,5ljm:A,94,Weak or no effect on interaction with CYLD.,0.0,,-999.0,,,,,,,,,,,,,Q9UM82_T_94_K
1060,Q9UM82,N,98,A,5ljm:A,98,Weak or no effect on interaction with CYLD.,0.0,,-999.0,,,,,,,,,,,,,Q9UM82_N_98_A
1061,Q9UM82,F,108,A,5ljm:A,108,Abolished interaction with CYLD.,-1.0,,-999.0,,,,,,,,,,,,,Q9UM82_F_108_A
1062,Q9UM82,Y,114,A,5ljm:A,114,Reduced interaction with CYLD.,-1.0,,-999.0,,,,,,,,,,,,,Q9UM82_Y_114_A
1063,Q9UM82,T,115,A,5ljm:A,115,Reduced interaction with CYLD.,-1.0,,-999.0,,,,,,,,,,,,,Q9UM82_T_115_A
1063,Q9UM82,T,115,N,5ljm:A,115,Reduced interaction with CYLD.,-1.0,,-999.0,,,,,,,,,,,,,Q9UM82_T_115_N
1064,Q9Y6U3,M,310,D,5a1m:A,310,Increases calcium-independent actin-severing activity.,,,1.0,,,,,,,,,,,,,Q9Y6U3_M_310_D
1065,Q9Y6U3,E,314,S,5a1m:A,314,Increases calcium-independent actin-severing activity.,,,1.0,,,,,,,,,,,,,Q9Y6U3_E_314_S
1066,Q9Y6U3,F,455,D,3fg6:A,455,Loss of actin-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6U3_F_455_D
1067,P10586,C,1548,S,6kr4:C,1548,Loss of activity.,,,1.0,,,,,,,,,,,,,P10586_C_1548_S
1068,P38159,K,22,A,2mb0:B,22,Promotes cell proliferation. Inhibits transcriptional up-regulation of the TXNIP promoter.,,,-999.0,,,,,,,,,,,,,P38159_K_22_A
1069,P05019,R,84,E,3lri:A,49,"Dominant-negative mutant, no effect on IGFR1-binding, defective in integrin-binding and the formation of ternary complex with integrins and IGFR1, defective in inducing IGF1 signaling and cell proliferation, and suppresses activation of IGF1R by insulin and tumorigenesis in vivo",-1.0,-1.0,-999.0,,,,,,,,,,,,,P05019_R_84_E
1070,P05019,R,85,E,3lri:A,50,"Dominant-negative mutant, no effect on IGFR1-binding, defective in integrin-binding and the formation of ternary complex with integrins and IGFR1, defective in inducing IGF1 signaling and cell proliferation, and suppresses activation of IGF1R by insulin and tumorigenesis in vivo",-1.0,-1.0,-999.0,,,,,,,,,,,,,P05019_R_85_E
1071,P51617,D,340,N,6bfn:A,340,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51617_D_340_N
1072,P51617,T,387,A,6bfn:A,387,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51617_T_387_A
1073,O00267,R,696,A,2e70:A,696,Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation,1.0,1.0,-999.0,,,,,,,,,,,,,O00267_R_696_A
1074,O00267,R,696,K,2e70:A,696,Increases promoter association and enhances transcriptional elongation,,1.0,1.0,,,,,,,,,,,,,O00267_R_696_K
1075,O00267,R,698,A,2e70:A,698,Enhances transcriptional elongation. Enhances interactions with CDK9 and RNA polymerase II and enhances transcriptional elongation,1.0,,1.0,,,,,,,,,,,,,O00267_R_698_A
1076,O00267,R,698,K,2e70:A,698,Increases promoter association and enhances transcriptional elongation,,1.0,1.0,,,,,,,,,,,,,O00267_R_698_K
1077,O00267,G,1002,D,6er0:A,42,Defective in regulation of transcriptional elongation.,,,1.0,,,,,,,,,,,,,O00267_G_1002_D
1078,O00264,Y,113,F,4x8y:A,113,Abolishes interaction with CYP1A1 and CYP3A4.,-1.0,,-999.0,,,,,,,,,,,,,O00264_Y_113_F
1079,Q6P3W2,C,139,S,2l6l:A,139,Loss of iron-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q6P3W2_C_139_S
1080,Q9H2K2,H,553,D,5bxo:B,553,Enhanced hydroxylation by HIF1AN.,,,-999.0,,,,,,1.0,,,,,,,Q9H2K2_H_553_D
1081,Q9H2K2,H,553,N,5bxo:B,553,Enhanced hydroxylation by HIF1AN.,,,-999.0,,,,,,1.0,,,,,,,Q9H2K2_H_553_N
1082,Q9H2K2,M,1054,V,4hyf:A,1054,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9H2K2_M_1054_V
1083,Q08AE8,I,131,K,2yle:A,131,Strongly reduces interaction with FMN2.,-1.0,,-999.0,,,,,,,,,,,,,Q08AE8_I_131_K
1084,Q08AE8,Y,134,K,2yle:A,134,Abolishes interaction with FMN2.,-1.0,,-999.0,,,,,,,,,,,,,Q08AE8_Y_134_K
1085,Q08AE8,D,138,N,2yle:A,138,Abolishes interaction with FMN2.,-1.0,,-999.0,,,,,,,,,,,,,Q08AE8_D_138_N
1086,Q08AE8,E,146,A,2yle:A,146,Abolishes interaction with FMN2.,-1.0,,-999.0,,,,,,,,,,,,,Q08AE8_E_146_A
1086,Q08AE8,E,146,K,2yle:A,146,Abolishes interaction with FMN2.,-1.0,,-999.0,,,,,,,,,,,,,Q08AE8_E_146_K
1087,Q15208,K,118,A,6bxi:A,118,Loss of autophosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,Q15208_K_118_A
1088,Q15208,S,281,A,6bxi:A,281,Loss of autophosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,Q15208_S_281_A
1089,Q9H2K8,D,165,A,6bdn:A,165,Loss of serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q9H2K8_D_165_A
1090,Q9H2K8,T,181,A,6bdn:A,181,No autophosphorylation and no kinase activity,,,1.0,-1.0,,,,,,,,,,,,Q9H2K8_T_181_A
1091,Q9H2K8,Y,183,F,6bdn:A,183,No autophosphorylation and no kinase activity,,,1.0,-1.0,,,,,,,,,,,,Q9H2K8_Y_183_F
1092,Q06124,C,459,S,4rdd:A,459,Abolishes phosphatase activity.,,,1.0,,,,,,,,,,,,,Q06124_C_459_S
1093,Q00059,T,77,A,6hb4:A,77,Moderate reduction in DNA bending.,,-1.0,-999.0,,,,,,,,,,,,,Q00059_T_77_A
1094,Q00059,Y,162,A,6hb4:A,162,Moderate reduction in DNA bending.,,-1.0,-999.0,,,,,,,,,,,,,Q00059_Y_162_A
1095,Q7L1W4,T,44,C,6m04:A,44,Alters channel anion selectivity.,,,1.0,,,,,,,,,,,,,Q7L1W4_T_44_C
1096,Q96C10,K,634,E,3eqt:B,634,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96C10_K_634_E
1097,Q96C10,K,651,E,3eqt:B,651,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96C10_K_651_E
1098,Q9Y4D1,I,698,A,2j1d:G,698,Abolishes actin-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y4D1_I_698_A
1099,Q00604,C,95,A,4my2:A,1095,Impairs oligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q00604_C_95_A
1100,Q9NRX4,K,21,A,2ozw:A,21,Decreased affinity for substrate and strongly reduced catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,Q9NRX4_K_21_A
1101,Q9NRX4,R,45,A,2ozw:A,45,"Slightly decreased affinity for substrate, but no effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q9NRX4_R_45_A
1102,Q9NRX4,H,53,A,2ozw:A,53,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NRX4_H_53_A
1103,Q9NRX4,R,78,A,2ozw:A,78,Decreased affinity for substrate and reduced catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,Q9NRX4_R_78_A
1104,Q9NRX4,S,94,A,2ozw:A,94,Decreased affinity for substrate and strongly reduced catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,Q9NRX4_S_94_A
1105,Q9NRX4,H,102,A,2ozw:A,102,Decreased affinity for substrate and slightly reduced catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,Q9NRX4_H_102_A
1106,Q53EZ4,W,184,A,3wuv:K,184,Abolishes interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,Q53EZ4_W_184_A
1107,Q53EZ4,Y,187,A,3wuv:K,187,Abolishes interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,Q53EZ4_Y_187_A
1108,Q53EZ4,D,188,A,3wuv:K,188,Diminishes interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,Q53EZ4_D_188_A
1109,Q53EZ4,R,191,A,3wuv:K,191,Abolishes interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,Q53EZ4_R_191_A
1110,Q53EZ4,E,192,A,3wuv:K,192,Abolishes interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,Q53EZ4_E_192_A
1111,P09488,Y,7,F,2f3m:A,6,Reduces catalytic activity 100-fold.,,,1.0,,,,,,,,,,,,,P09488_Y_7_F
1112,P09488,H,108,Q,2f3m:A,107,Reduces catalytic activity by half.,,,1.0,,,,,,,,,,,,,P09488_H_108_Q
1113,P09488,H,108,S,2f3m:A,107,Changes the properties of the enzyme toward some substrates.,,,1.0,,,,,,,,,,,,,P09488_H_108_S
1114,P09488,M,109,I,2f3m:A,108,Reduces catalytic activity by half.,,,1.0,,,,,,,,,,,,,P09488_M_109_I
1115,P09488,Y,116,A,2f3m:A,115,Reduces catalytic activity 10-fold.,,,1.0,,,,,,,,,,,,,P09488_Y_116_A
1116,P09488,Y,116,F,2f3m:A,115,Slight increase of catalytic activity.,,,1.0,,,,,,,,,,,,,P09488_Y_116_F
1117,P05121,Q,197,C,4aqh:A,174,Increased half-life of the active form when associated with C-355.,,,-999.0,,,,,,,,,,,,,P05121_Q_197_C
1118,P05121,G,355,C,4aqh:A,332,Increased half-life of the active form when associated with C-197.,,,-999.0,,,,,,,,,,,,,P05121_G_355_C
1119,P09486,R,166,A,1bmo:A,149,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_R_166_A
1119,P09486,R,166,L,1bmo:A,149,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_R_166_L
1119,P09486,R,166,K,1bmo:A,149,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_R_166_K
1120,P09486,N,173,A,1bmo:A,156,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_N_173_A
1120,P09486,N,173,Q,1bmo:A,156,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_N_173_Q
1121,P09486,L,259,A,1bmo:A,242,Loss of collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_L_259_A
1122,P09486,M,262,A,1bmo:A,245,Strongly reduced collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_M_262_A
1123,P09486,E,263,A,1bmo:A,246,Loss of collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,P09486_E_263_A
1124,P38398,I,26,A,1jm7:A,26,"Disrupts the interaction with E2 enzymes, thereby abolishing the E3 ubiquitin-protein ligase activity.",-1.0,,1.0,,,,,,,,,,,,,P38398_I_26_A
1125,P38398,I,26,E,1jm7:A,26,No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage.,,,1.0,,,,,,,,,,,,,P38398_I_26_E
1126,P38398,R,71,G,1jm7:A,71,No effect on interaction with BAP1.,0.0,,-999.0,,,,,,,,,,,,,P38398_R_71_G
1127,P38398,S,1655,A,4u4a:A,1655,Abolishes interaction with BRIP1.,-1.0,,-999.0,,,,,,,,,,,,,P38398_S_1655_A
1128,P38398,G,1656,D,4u4a:A,1656,No effect on affinity for a BRIP1 phosphopeptide.,0.0,,-999.0,,,,,,,,,,,,,P38398_G_1656_D
1129,P38398,F,1662,S,4u4a:A,1662,"Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1.",-1.0,,-999.0,,,,,,,,,,,,,P38398_F_1662_S
1130,P38398,M,1663,K,4u4a:A,1663,"Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1.",-1.0,,-999.0,,,,,,,,,,,,,P38398_M_1663_K
1131,P38398,Y,1666,A,4u4a:A,1666,"Does not abolish ABRAXAS1 binding, but impairs formation of a heterotetramer with ABRAXAS1.",-1.0,,-999.0,,,,,,,,,,,,,P38398_Y_1666_A
1132,P38398,R,1670,E,4u4a:A,1670,Impairs formation of a heterotetramer with ABRAXAS1.,-1.0,,-999.0,,,,,,,,,,,,,P38398_R_1670_E
1133,P38398,K,1671,E,4u4a:A,1671,Impairs formation of a heterotetramer with ABRAXAS1.,-1.0,,-999.0,,,,,,,,,,,,,P38398_K_1671_E
1134,P38398,T,1700,A,4u4a:A,1700,Strongly reduces affinity for a BRIP1 phosphopeptide.,-1.0,,-999.0,,,,,,,,,,,,,P38398_T_1700_A
1135,P38398,K,1702,M,4u4a:A,1702,Abolishes interaction with BRIP1.,-1.0,,-999.0,,,,,,,,,,,,,P38398_K_1702_M
1136,P38398,G,1738,E,4u4a:A,1738,Abolishes interaction with BRIP1.,-1.0,,-999.0,,,,,,,,,,,,,P38398_G_1738_E
1137,P38398,S,1755,A,4u4a:A,1755,No effect on in vitro phosphorylation by ATR.,,,-999.0,0.0,,,,,,,,,,,,P38398_S_1755_A
1138,P38398,R,1835,P,4u4a:A,1835,Mildly reduces affinity for a BRIP1 phosphopeptide.,-1.0,,-999.0,,,,,,,,,,,,,P38398_R_1835_P
1139,P38398,E,1836,K,4u4a:A,1836,Slightly reduces affinity for a BRIP1 phosphopeptide.,-1.0,,-999.0,,,,,,,,,,,,,P38398_E_1836_K
1140,P29466,C,285,A,6f6r:A,285,Loss of protease activity. Loss of SPHK2 cleavage and release in apoptotic cells.,,,1.0,,,,,,,,,,,,,P29466_C_285_A
1140,P29466,C,285,S,6f6r:A,285,Loss of protease activity. Loss of SPHK2 cleavage and release in apoptotic cells.,,,1.0,,,,,,,,,,,,,P29466_C_285_S
1141,P29466,W,294,A,6f6r:A,294,Mediates autoprocessing but is unable to interact with Gasdermin-D (GSDMD) and mediate its cleavage.,-1.0,,1.0,,,,,,,,,,,,,P29466_W_294_A
1142,P29466,I,318,N,3e4c:A,318,Mediates autoprocessing but is unable to interact with Gasdermin-D (GSDMD) and mediate its cleavage.,-1.0,,1.0,,,,,,,,,,,,,P29466_I_318_N
1143,P29466,K,320,A,3e4c:A,320,Abolishes cleavage of Gasdermin-D (GSDMD).,,,1.0,,,,,,,,,,,,,P29466_K_320_A
1144,Q9Y606,D,146,A,4nz6:B,146,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y606_D_146_A
1145,Q9BRR9,K,343,A,2p0f:A,343,Strongly reduced affinity for phosphoinositides.,,-1.0,-999.0,,,,,,,,,,,,,Q9BRR9_K_343_A
1146,Q9BRR9,R,399,A,2p0f:A,399,Reduced affinity for phosphoinositides.,,-1.0,-999.0,,,,,,,,,,,,,Q9BRR9_R_399_A
1147,Q9Y3I1,V,253,E,4l9h:A,253,Abolishes interaction with PSMF1.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3I1_V_253_E
1148,Q8NBK3,S,333,A,1y1g:X,333,Loss of activity.,,,1.0,,,,,,,,,,,,,Q8NBK3_S_333_A
1149,Q8NBK3,S,333,T,1y1g:X,333,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q8NBK3_S_333_T
1150,Q8NBK3,C,336,S,1y1g:X,336,Loss of activity.,,,1.0,,,,,,,,,,,,,Q8NBK3_C_336_S
1151,Q8NBK3,H,337,A,1y1g:X,337,Reduces activity 5-fold.,,,1.0,,,,,,,,,,,,,Q8NBK3_H_337_A
1152,Q8NBK3,Y,340,F,1y1g:X,340,No effect.,,,0.0,,,,,,,,,,,,,Q8NBK3_Y_340_F
1153,Q8NBK3,C,341,S,1y1g:X,341,Loss of activity.,,,1.0,,,,,,,,,,,,,Q8NBK3_C_341_S
1154,P28335,P,159,A,6bqh:A,159,Decreases interaction with ARRB2.,-1.0,,-999.0,,,,,,,,,,,,,P28335_P_159_A
1155,Q9UIB8,T,55,A,2pkd:E,35,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_T_55_A
1156,Q9UIB8,Y,62,A,2pkd:E,42,No effect.,0.0,,-999.0,,,,,,,,,,,,,Q9UIB8_Y_62_A
1157,Q9UIB8,Y,62,D,2pkd:E,42,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_Y_62_D
1158,Q9UIB8,T,77,A,2pkd:E,57,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_T_77_A
1159,Q9UIB8,H,78,A,2pkd:E,58,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_H_78_A
1160,Q9UIB8,D,110,A,2pkd:E,90,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_D_110_A
1161,Q9UIB8,N,112,A,2pkd:E,92,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_N_112_A
1162,Q9UIB8,T,119,A,2pkd:E,99,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIB8_T_119_A
1163,P62820,N,124,I,3sfv:A,124,Dominant negative mutant. Strongly reduces the levels of CASR present at the cell-surface.,,,1.0,,,,,,,,,,,,,P62820_N_124_I
1164,Q6ZW49,R,910,Q,3sqd:A,910,Abolishes interaction with TP53BP1,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW49_R_910_Q
1165,Q6ZW49,W,929,A,3sqd:A,929,Abolishes interaction with TP53BP1,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW49_W_929_A
1166,Q8IYU8,D,185,A,6k7y:J,185,Abolishes mitochondrial Ca(2+) uptake,,,1.0,,,,,,,,,,,,,Q8IYU8_D_185_A
1167,Q8IYU8,D,375,A,6k7y:J,375,Abolishes mitochondrial Ca(2+) uptake,,,1.0,,,,,,,,,,,,,Q8IYU8_D_375_A
1168,Q8IYU8,E,386,A,6k7y:J,386,Abolishes mitochondrial Ca(2+) uptake,,,1.0,,,,,,,,,,,,,Q8IYU8_E_386_A
1169,P01588,S,127,E,1buy:A,100,Decreased erythrocyte proliferation,,,1.0,,,,,,,,,,,,,P01588_S_127_E
1170,P50402,S,49,A,1jei:A,48,Abolishes phosphorylation. No effect on targeting to nuclear envelope nor on interaction with LMNA.,0.0,,-999.0,,,,,,,,,,,,,P50402_S_49_A
1171,P50402,S,49,E,1jei:A,48,Mimics phosphorylation. No effect on targeting to nuclear envelope nor on interaction with LMNA.,0.0,,-999.0,,,,,,,,,,,,,P50402_S_49_E
1172,O95989,G,50,A,6pcl:A,50,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_50_A
1172,O95989,G,50,V,6pcl:A,50,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_50_V
1173,O95989,G,51,A,6pcl:A,51,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_51_A
1174,O95989,G,52,A,6pcl:A,52,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_52_A
1174,O95989,G,52,V,6pcl:A,52,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_52_V
1175,O95989,E,66,Q,6pcl:A,66,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_E_66_Q
1176,O95989,E,70,Q,6pcl:A,70,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_E_70_Q
1177,O95989,G,72,A,6pcl:A,72,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_72_A
1178,O95989,G,75,A,6pcl:A,75,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_75_A
1179,O95989,G,78,A,6pcl:A,78,No effect.,,,0.0,,,,,,,,,,,,,O95989_G_78_A
1180,O95989,G,78,V,6pcl:A,78,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_78_V
1181,O95989,G,82,A,6pcl:A,82,Loss of function.,,,1.0,,,,,,,,,,,,,O95989_G_82_A
1182,O95989,F,84,Y,6pcl:A,84,"Induces a strong decrease in Ap6A and [PP]-InsP4 hydrolysis, while it only weakly affects PP-InsP5 hydrolysis.",,,1.0,,,,,,,,,,,,,O95989_F_84_Y
1183,O95989,H,91,L,6pcl:A,91,"Induces a strong decrease in Ap6A and [PP]-InsP4 hydrolysis, while it only weakly affects PP-InsP5 hydrolysis.",,,1.0,,,,,,,,,,,,,O95989_H_91_L
1184,Q6DN90,E,620,K,5nly:B,498,Abolishes guanosine nucleotide exchange factor activity.,,,1.0,,,,,,,,,,,,,Q6DN90_E_620_K
1185,P01584,K,171,E,1iob:A,55,Suppression of integrin binding,-1.0,,-999.0,,,,,,,,,,,,,P01584_K_171_E
1186,P01584,K,179,E,1iob:A,63,Suppression of integrin binding,-1.0,,-999.0,,,,,,,,,,,,,P01584_K_179_E
1187,P01584,K,181,E,1iob:A,65,Suppression of integrin binding,-1.0,,-999.0,,,,,,,,,,,,,P01584_K_181_E
1188,P01584,K,190,E,1iob:A,74,Suppression of integrin binding,-1.0,,-999.0,,,,,,,,,,,,,P01584_K_190_E
1189,P01584,K,204,E,1iob:A,88,Suppression of integrin binding,-1.0,,-999.0,,,,,,,,,,,,,P01584_K_204_E
1190,P01584,E,221,K,1iob:A,105,Enhanced integrin binding.,1.0,,-999.0,,,,,,,,,,,,,P01584_E_221_K
1191,P01584,F,233,C,1iob:A,117,No effect on binding to IL1R or on IL1B activity. Markedly reduced activity,-1.0,,1.0,,,,,,,,,,,,,P01584_F_233_C
1192,P01584,E,244,K,1iob:A,128,Increased affinity for integrin ITGAV,1.0,,-999.0,,,,,,,,,,,,,P01584_E_244_K
1193,O95983,H,30,K,6cc8:A,30,No effect. Confers strong binding to methylated CpG (in vitro),0.0,1.0,0.0,,,,,,,,,,,,,O95983_H_30_K
1194,O95983,F,34,A,6cc8:A,34,"Augments DNA binding activity, irrespective of DNA methylation.",,1.0,-999.0,,,,,,,,,,,,,O95983_F_34_A
1195,O95983,F,34,Y,6cc8:A,34,Confers weak binding to methylated CpG (in vitro). Confers strong binding to methylated CpG (in vitro),,,-999.0,,,,,,,,,,,,,O95983_F_34_Y
1196,O95292,K,87,D,3ikk:A,87,Prevents binding to the FFAT motif in target proteins,-1.0,,-999.0,,,,,,,,,,,,,O95292_K_87_D
1197,O95292,M,89,D,3ikk:A,89,Prevents binding to the FFAT motif in target proteins,-1.0,,-999.0,,,,,,,,,,,,,O95292_M_89_D
1198,P06731,F,63,I,1e07:A,29,No effect on dimerization. Reduced affinity for E.coli Dr adhesins.,0.0,,-999.0,,,,,,,,,,,,,P06731_F_63_I
1199,P06731,F,63,R,1e07:A,29,Abolishes dimerization. Reduced affinity for E.coli Dr adhesins.,-1.0,,-999.0,,,,,,,,,,,,,P06731_F_63_R
1200,P06731,S,66,N,1e07:A,32,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_S_66_N
1201,P06731,Y,68,A,1e07:A,34,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_Y_68_A
1202,P06731,Y,68,F,1e07:A,34,No effect on dimerization.,0.0,,-999.0,,,,,,,,,,,,,P06731_Y_68_F
1203,P06731,K,69,A,1e07:A,35,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_K_69_A
1204,P06731,V,73,A,1e07:A,39,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_V_73_A
1205,P06731,D,74,A,1e07:A,40,No effect on dimerization.,0.0,,-999.0,,,,,,,,,,,,,P06731_D_74_A
1206,P06731,D,74,L,1e07:A,40,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_D_74_L
1206,P06731,D,74,R,1e07:A,40,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_D_74_R
1207,P06731,Q,78,L,1e07:A,44,Abolishes dimerization. Reduced affinity for E.coli Dr adhesins.,-1.0,,-999.0,,,,,,,,,,,,,P06731_Q_78_L
1207,P06731,Q,78,R,1e07:A,44,Abolishes dimerization. Reduced affinity for E.coli Dr adhesins.,-1.0,,-999.0,,,,,,,,,,,,,P06731_Q_78_R
1208,P06731,I,125,A,1e07:A,91,Abolishes dimerization. Reduced affinity for E.coli Dr adhesins.,-1.0,,-999.0,,,,,,,,,,,,,P06731_I_125_A
1209,P06731,L,129,A,1e07:A,95,No effect on dimerization. Reduced affinity for E.coli Dr adhesins.,0.0,,-999.0,,,,,,,,,,,,,P06731_L_129_A
1209,P06731,L,129,C,1e07:A,95,No effect on dimerization. Reduced affinity for E.coli Dr adhesins.,0.0,,-999.0,,,,,,,,,,,,,P06731_L_129_C
1210,P06731,L,129,S,1e07:A,95,Abolishes dimerization. Reduced affinity for E.coli Dr adhesins.,-1.0,,-999.0,,,,,,,,,,,,,P06731_L_129_S
1211,P06731,E,133,A,1e07:A,99,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P06731_E_133_A
1212,P01033,T,25,E,1uea:B,2,Reduced interaction with metalloproteinase.,-1.0,,-999.0,,,,,,,,,,,,,P01033_T_25_E
1212,P01033,T,25,G,1uea:B,2,Reduced interaction with metalloproteinase.,-1.0,,-999.0,,,,,,,,,,,,,P01033_T_25_G
1212,P01033,T,25,K,1uea:B,2,Reduced interaction with metalloproteinase.,-1.0,,-999.0,,,,,,,,,,,,,P01033_T_25_K
1212,P01033,T,25,Q,1uea:B,2,Reduced interaction with metalloproteinase.,-1.0,,-999.0,,,,,,,,,,,,,P01033_T_25_Q
1212,P01033,T,25,R,1uea:B,2,Reduced interaction with metalloproteinase.,-1.0,,-999.0,,,,,,,,,,,,,P01033_T_25_R
1213,P01033,T,25,V,1uea:B,2,Normal interaction with metalloproteinase.,0.0,,-999.0,,,,,,,,,,,,,P01033_T_25_V
1214,P01033,H,30,A,1uea:B,7,Nearly abolishes metalloproteinase inhibition.,,,1.0,,,,,,,,,,,,,P01033_H_30_A
1215,P01033,Q,32,A,1uea:B,9,Nearly abolishes metalloproteinase inhibition.,,,1.0,,,,,,,,,,,,,P01033_Q_32_A
1216,P01033,T,121,L,1uea:B,98,Decreases protein flexibility and increases affinity for MMP14.,1.0,,-999.0,,,,,,,,,,,,,P01033_T_121_L
1217,Q93038,L,354,A,5ygs:A,394,"Suppresses homodimerization, TNFR1 interaction, and apoptosis induction.",-1.0,,-999.0,,,,,,,,,,,,,Q93038_L_354_A
1218,Q93038,L,356,A,5ygs:A,396,"Suppresses homodimerization, and TNFR1 interaction.",-1.0,,-999.0,,,,,,,,,,,,,Q93038_L_356_A
1219,Q93038,D,373,A,5ygs:A,413,"Suppresses homodimerization, and TNFR1 interaction.",-1.0,,-999.0,,,,,,,,,,,,,Q93038_D_373_A
1220,P33981,D,664,A,6gvj:A,664,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P33981_D_664_A
1221,P33981,T,686,A,6gvj:A,686,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P33981_T_686_A
1222,Q9Y4E8,C,298,A,6crn:A,298,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y4E8_C_298_A
1223,Q9Y4E8,C,812,A,6crn:D,502,Loss of activity towards polyubiquitin.,,,1.0,,,,,,,,,,,,,Q9Y4E8_C_812_A
1224,Q6PHW0,R,101,A,5yak:E,101,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,Q6PHW0_R_101_A
1225,Q6PHW0,R,101,H,5yak:E,101,Reduces activity.,,,1.0,,,,,,,,,,,,,Q6PHW0_R_101_H
1226,Q6PHW0,F,105,A,5yak:E,105,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_F_105_A
1227,Q6PHW0,F,105,Y,5yak:E,105,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_F_105_Y
1228,Q6PHW0,I,116,V,5yak:E,116,Activity as the wild type.,,,0.0,,,,,,,,,,,,,Q6PHW0_I_116_V
1229,P43490,D,219,N,4kfn:B,219,"No effect on activity towards nicotinamide. Alters specificity, so that the enzyme acquires activity towards nicotinic acid.",,1.0,1.0,,,,,,,,,,,,,P43490_D_219_N
1229,P43490,D,219,S,4kfn:B,219,"No effect on activity towards nicotinamide. Alters specificity, so that the enzyme acquires activity towards nicotinic acid.",,1.0,1.0,,,,,,,,,,,,,P43490_D_219_S
1230,P43490,H,247,A,4kfn:B,247,Reduces activity towards nicotinamide.,,-1.0,1.0,,,,,,,,,,,,,P43490_H_247_A
1231,P43490,R,311,D,4kfn:B,311,Reduces activity towards nicotinamide.,,-1.0,1.0,,,,,,,,,,,,,P43490_R_311_D
1232,P78543,H,53,A,3dju:B,53,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P78543_H_53_A
1233,P78543,Y,65,A,3dju:B,65,Abolishes interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P78543_Y_65_A
1234,P78543,D,75,A,3dju:B,75,Abolishes interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P78543_D_75_A
1235,P78543,W,103,A,3dju:B,103,Abolishes interaction with CNOT7 and CNOT8,-1.0,,-999.0,,,,,,,,,,,,,P78543_W_103_A
1236,P78543,D,105,A,3dju:B,105,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P78543_D_105_A
1237,P78543,E,115,A,3dju:B,115,Impairs interaction with CNOT7. Inhibits CNOT7 mRNA deadenylase activity.,-1.0,,-999.0,,,,,,,,,,,,,P78543_E_115_A
1238,P15531,F,60,W,3l7u:A,60,No loss of activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P15531_F_60_W
1239,P15531,P,96,S,3l7u:A,96,Increased motility of carcinoma cells.,,,-999.0,,,,,,,,,,,,,P15531_P_96_S
1240,P15531,H,118,F,3l7u:A,118,Loss of serine/threonine kinase activity. Some loss of motility of carcinoma cells.,,,1.0,,,,,,,,,,,,,P15531_H_118_F
1241,P15531,H,118,G,3l7u:A,118,Loss of activity.,,,1.0,,,,,,,,,,,,,P15531_H_118_G
1242,P15531,S,120,A,3l7u:A,120,Limited increase in motility of carcinoma cells.,,,-999.0,,,,,,,,,,,,,P15531_S_120_A
1243,P46063,K,119,A,2wwy:A,119,Abrogates helicase activity.,,,1.0,,,,,,,,,,,,,P46063_K_119_A
1244,P21549,K,209,R,3r9a:C,209,Affects pyridoxal phosphate binding,,-1.0,-999.0,,,,,,,,,,,,,P21549_K_209_R
1245,P01100,K,192,R,1fos:E,192,No change in sumoylation.,,,-999.0,,,,0.0,,,,,,,,,P01100_K_192_R
1246,Q92729,C,1085,S,6sub:A,1085,Loss of phosphatase activity toward CTNNB1. Loss of the inhibitory effect on CTNNB1 transcriptional activity without effect on interaction with CTNNB1,-1.0,,1.0,,,,,,,,,,,,,Q92729_C_1085_S
1247,P42765,C,92,A,4c2k:D,92,Decreased acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,P42765_C_92_A
1248,P42765,C,92,S,4c2k:D,92,Decreased acyl-CoA hydrolase activity,,,1.0,,,,,,,,,,,,,P42765_C_92_S
1249,P42765,C,382,S,4c2k:D,382,Decreased acyl-CoA hydrolase activity,,,1.0,,,,,,,,,,,,,P42765_C_382_S
1250,Q15831,K,48,Q,2wtk:F,48,"No effect on basal nucleocytoplasmic localization, but fails to translocate to the cytoplasm when coexpressed with SIRT1.",,,-999.0,,,,,,,,,1.0,,,,Q15831_K_48_Q
1251,Q15831,K,48,R,2wtk:F,48,"Enhanced phosphorylation at Thr-336 and Ser-428, enhanced cytoplasmic localization and increased kinase activity.",,,1.0,1.0,,,,,,,,1.0,,,,Q15831_K_48_R
1252,Q15831,R,74,A,2wtk:F,74,Impaired formation of a heterotrimeric complex with STRADA and CAB39,-1.0,,-999.0,,,,,,,,,,,,,Q15831_R_74_A
1253,Q15831,K,78,I,2wtk:F,78,"Loss of kinase activity, leading to greatly reduced autophosphorylation.",,,1.0,-1.0,,,,,,,,,,,,Q15831_K_78_I
1254,Q15831,K,78,M,2wtk:F,78,"Loss of kinase activity, leading to reduced autophosphorylation and acting as a dominant-negative mutant.",,,1.0,-1.0,,,,,,,,,,,,Q15831_K_78_M
1255,Q15831,K,96,R,2wtk:F,96,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q15831_K_96_R
1256,Q15831,K,97,R,2wtk:F,97,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q15831_K_97_R
1257,Q15831,T,189,A,2wtk:C,189,Reduced phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q15831_T_189_A
1258,Q15831,D,194,A,2wtk:C,194,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q15831_D_194_A
1259,Q15831,F,204,A,2wtk:C,204,No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39,-1.0,,0.0,,,,,,,,,,,,,Q15831_F_204_A
1260,Q9UHD2,K,30,R,6o8b:B,30,"Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity",,,1.0,-1.0,-1.0,,,,,,,,,,,Q9UHD2_K_30_R
1261,Q9UHD2,D,33,A,6o8b:B,33,Decreases phosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_D_33_A
1262,Q9UHD2,K,38,A,6o8b:B,38,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9UHD2_K_38_A
1263,Q9UHD2,D,135,N,6o8b:B,135,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9UHD2_D_135_N
1264,Q9UHD2,S,172,A,6o8b:B,172,Loss of kinase activity. No effect on dimerization.,0.0,,1.0,,,,,,,,,,,,,Q9UHD2_S_172_A
1265,Q9UHD2,S,172,E,6o8b:B,172,Decreased kinase activity.,,,1.0,,,,,,,,,,,,,Q9UHD2_S_172_E
1266,Q9UHD2,L,316,E,6o8b:B,316,Decreases kinase activity. No effect on phosphorylation.,,,1.0,0.0,,,,,,,,,,,,Q9UHD2_L_316_E
1267,Q9UHD2,Y,325,E,6o8b:B,325,Abolishes phosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_Y_325_E
1268,Q9UHD2,E,355,R,6o8b:B,355,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_E_355_R
1269,Q9UHD2,R,357,A,6o8b:B,357,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_R_357_A
1270,Q9UHD2,K,401,R,6o8b:B,401,"Decreases ubiquitination. Abolishes ubiquitination, phosphorylation and kinase activity",,,1.0,-1.0,-1.0,,,,,,,,,,,Q9UHD2_K_401_R
1271,Q9UHD2,E,448,R,6o8b:B,448,Decreases phosphorylation and kinase activity. Abolishes dimerization,-1.0,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_E_448_R
1272,Q9UHD2,H,459,E,6o8b:B,459,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,1.0,0.0,,,,,,,,,,,,Q9UHD2_H_459_E
1273,Q9UHD2,I,466,E,6o8b:B,466,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,1.0,0.0,,,,,,,,,,,,Q9UHD2_I_466_E
1274,Q9UHD2,F,470,E,6o8b:B,470,Abolishes dimerization and decreases kinase activity but no effect on phosphorylation,-1.0,,1.0,0.0,,,,,,,,,,,,Q9UHD2_F_470_E
1275,Q9UHD2,R,547,D,6o8b:B,547,Decreases phosphorylation and kinase activity. Abolishes dimerization.,-1.0,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_R_547_D
1276,Q9UHD2,Y,577,A,6o8b:B,577,Decreases kinase activity. Reduced phosphorylation of STING1.,,,1.0,,,,,,,,,,,,,Q9UHD2_Y_577_A
1277,Q9UHD2,N,578,A,6o8b:B,578,Reduced phosphorylation of STING1.,,,1.0,,,,,,,,,,,,,Q9UHD2_N_578_A
1278,Q9UHD2,E,580,A,6o8b:B,580,Decreases kinase activity.,,,1.0,,,,,,,,,,,,,Q9UHD2_E_580_A
1279,Q9UHD2,Q,581,A,6o8b:B,581,Reduced phosphorylation of STING1.,,,1.0,,,,,,,,,,,,,Q9UHD2_Q_581_A
1280,Q9UHD2,I,582,A,6o8b:B,582,Decreases kinase activity.,,,1.0,,,,,,,,,,,,,Q9UHD2_I_582_A
1281,Q9UHD2,K,589,D,6o8b:B,589,Decreases phosphorylation and kinase activity.,,,1.0,-1.0,,,,,,,,,,,,Q9UHD2_K_589_D
1282,Q9NPH0,R,58,A,4jod:A,58,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_R_58_A
1283,Q9NPH0,H,59,A,4jod:A,59,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_H_59_A
1284,Q9NPH0,R,62,A,4jod:A,62,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_R_62_A
1285,Q9NPH0,Y,106,F,4jod:A,106,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_Y_106_F
1286,Q9NPH0,Y,110,F,4jod:A,110,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_Y_110_F
1287,Q9NPH0,R,168,A,4jod:A,168,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_R_168_A
1288,Q9NPH0,A,257,F,4jod:A,257,Decreases enzyme activity by interfering with water access to the active site cavity.,,,1.0,,,,,,,,,,,,,Q9NPH0_A_257_F
1288,Q9NPH0,A,257,L,4jod:A,257,Decreases enzyme activity by interfering with water access to the active site cavity.,,,1.0,,,,,,,,,,,,,Q9NPH0_A_257_L
1289,Q9NPH0,A,257,W,4jod:A,257,Abolishes enzyme activity by interfering with water access to the active site cavity.,,,1.0,,,,,,,,,,,,,Q9NPH0_A_257_W
1290,Q9NPH0,S,285,W,4jod:A,285,"Decreases activity toward substrates with medium and long aliphatic chains, but not toward substrates with short aliphatic chains.",,,1.0,,,,,,,,,,,,,Q9NPH0_S_285_W
1291,Q9NPH0,L,289,W,4jod:A,289,"Decreases activity toward substrates with medium and long aliphatic chains, but not toward substrates with short aliphatic chains.",,,1.0,,,,,,,,,,,,,Q9NPH0_L_289_W
1292,Q9NPH0,H,334,A,4jod:A,334,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_H_334_A
1293,Q9NPH0,D,335,A,4jod:A,335,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NPH0_D_335_A
1294,Q92506,D,42,A,4cql:I,42,"Reduced NADH-dependent reductase activity with acetoacetyl-CoA. Reduced NADH-dependent reductase activity with 9,10-phenanthrene quinone. Increases NADPH-dependent reductase activities. No effect on the ability to restore growth of an OAR1-deficient yeast mutant.",,,-999.0,,,,,,,,,,,,,Q92506_D_42_A
1295,Q92506,R,148,E,4cqm:A,148,No effect on the ability to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q92506_R_148_E
1296,Q92506,Y,169,A,4cqm:A,169,"Strongly reduced NADH-dependent reductase activity with acetoacetyl-CoA. Strongly reduced NADH-dependent reductase activity with 9,10-phenanthrene quinone. Decreases NADPH-dependent reductase activity with acetoacetyl-CoA, but increases NADPH-dependent reductase activity with 9,10-phenanthrene quinone. No effect on the ability to restore growth of an OAR1-deficient yeast mutant.",,,-999.0,,,,,,,,,,,,,Q92506_Y_169_A
1297,Q92506,K,173,A,4cqm:A,173,"Abolishes NADH-dependent reductase activity with acetoacetyl-CoA. Strongly reduced NADH-dependent reductase activity with 9,10-phenanthrene quinone. Slightly decreases NADPH-dependent reductase activity with acetoacetyl-CoA, but increases NADPH-dependent reductase activity with 9,10-phenanthrene quinone. No effect on the ability to restore growth of an OAR1-deficient yeast mutant.",,,-999.0,,,,,,,,,,,,,Q92506_K_173_A
1298,Q92506,R,189,E,4cqm:A,189,No effect on the ability to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q92506_R_189_E
1299,P61964,A,47,E,6ujh:A,47,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_A_47_E
1300,P61964,S,91,F,6ujh:A,91,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_S_91_F
1301,P61964,D,107,A,6ujh:A,107,Strongly reduced affinity for histone H3. Significant decrease in interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,P61964_D_107_A
1302,P61964,D,107,N,6ujh:A,107,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_D_107_N
1303,P61964,F,133,A,6ujh:A,133,Strongly reduced affinity for histone H3. Significant decrease in interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_133_A
1304,P61964,F,133,D,6ujh:A,133,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_133_D
1305,P61964,F,133,L,6ujh:A,133,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_133_L
1306,P61964,F,149,A,6ujh:A,149,Significant decrease in interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_149_A
1307,P61964,N,225,A,6ujh:A,225,Loss of interaction with RBBP5 and reduced ability to stimulate KMT2A methyltransferase activity in association with RBBP5 and ASH2L.,-1.0,,-999.0,,,,,,,,,,,,,P61964_N_225_A
1308,P61964,L,240,K,6ujh:A,240,Loss of interaction with RBBP5 and reduced ability to stimulate KMT2A methyltransferase activity in association with RBBP5 and ASH2L.,-1.0,,-999.0,,,,,,,,,,,,,P61964_L_240_K
1309,P61964,F,263,A,6ujh:A,263,Strongly reduced affinity for histone H3. Significant decrease in interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_263_A
1310,P61964,F,263,W,6ujh:A,263,Strongly reduced affinity for histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P61964_F_263_W
1311,P61964,Q,289,A,6ujh:A,289,Reduced interaction with RBBP5 and reduced ability to stimulate KMT2A methyltransferase activity in association with RBBP5 and ASH2L.,-1.0,,-999.0,,,,,,,,,,,,,P61964_Q_289_A
1312,P61964,L,321,A,6ujh:A,321,Abolishes histone H3 binding.,-1.0,,-999.0,,,,,,,,,,,,,P61964_L_321_A
1313,P61964,E,322,A,6ujh:A,322,Strongly reduced affinity for histone H3. No effect on interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,P61964_E_322_A
1314,P61960,L,21,A,1wxs:A,21,Abolished ability to be activated by UBA5.,-1.0,,-999.0,,,,,,,,,,,,,P61960_L_21_A
1315,P61960,E,38,A,1wxs:A,38,Abolished ability to be activated by UBA5.,-1.0,,-999.0,,,,,,,,,,,,,P61960_E_38_A
1316,P61960,A,48,F,1wxs:A,48,Abolished ability to be activated by UBA5.,-1.0,,-999.0,,,,,,,,,,,,,P61960_A_48_F
1316,P61960,A,48,Q,1wxs:A,48,Abolished ability to be activated by UBA5.,-1.0,,-999.0,,,,,,,,,,,,,P61960_A_48_Q
1317,P61960,R,79,A,1wxs:A,79,Slightly reduced interaction with UFM1.,-1.0,,-999.0,,,,,,,,,,,,,P61960_R_79_A
1318,Q9HC16,R,213,A,2kem:A,23,Slightly reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_213_A
1319,Q9HC16,R,213,E,2kem:A,23,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_213_E
1320,Q9HC16,R,215,A,2kem:A,25,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_215_A
1320,Q9HC16,R,215,E,2kem:A,25,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_215_E
1321,Q9HC16,E,217,K,2kem:A,27,Modifies the spectrum of action against mobile genetic elements,,-1.0,-999.0,,,,,,,,,,,,,Q9HC16_E_217_K
1322,Q9HC16,T,218,A,2kem:A,28,Loss of phosphorylation. No effect on cytidine deaminase activity or HIV-1 restriction activity.,,,0.0,-1.0,,,,,,,,,,,,Q9HC16_T_218_A
1323,Q9HC16,T,218,E,2kem:A,28,Phosphomimetic mutant which shows loss of cytidine deaminase activity and HIV-1 restriction activity.,,,1.0,,,,,,,,,,1.0,,,Q9HC16_T_218_E
1324,Q9HC16,C,221,S,2kem:A,31,Does not decrease cytidine deaminase activity.,,,0.0,,,,,,,,,,,,,Q9HC16_C_221_S
1325,Q9HC16,N,244,A,2kem:A,54,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_N_244_A
1326,Q9HC16,P,247,K,2kem:A,57,Modifies the spectrum of action against mobile genetic elements,,-1.0,-999.0,,,,,,,,,,,,,Q9HC16_P_247_K
1327,Q9HC16,R,256,E,2kem:A,66,Strongly reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_256_E
1328,Q9HC16,H,257,A,2kem:A,67,Decreases cytidine deaminase activity.,,,1.0,,,,,,,,,,,,,Q9HC16_H_257_A
1329,Q9HC16,E,259,A,2kem:A,69,Loss of cytidine deaminase activity and significant decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q9HC16_E_259_A
1331,Q9HC16,E,259,Q,2kem:A,69,Decreases cytidine deaminase activity and antiviral activity.,,,1.0,,,,,,,,,,,,,Q9HC16_E_259_Q
1332,Q9HC16,W,285,A,2kem:A,95,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_W_285_A
1333,Q9HC16,C,288,A,2kem:A,98,Decreases cytidine deaminase activity.,,,1.0,,,,,,,,,,,,,Q9HC16_C_288_A
1334,Q9HC16,C,291,A,2kem:A,101,Decreases cytidine deaminase activity.,,,1.0,,,,,,,,,,,,,Q9HC16_C_291_A
1334,Q9HC16,C,291,S,2kem:A,101,Decreases cytidine deaminase activity.,,,1.0,,,,,,,,,,,,,Q9HC16_C_291_S
1335,Q9HC16,R,313,A,2kem:A,123,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_313_A
1335,Q9HC16,R,313,E,2kem:A,123,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_313_E
1336,Q9HC16,Y,315,A,2kem:A,125,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_Y_315_A
1337,Q9HC16,R,320,A,2kem:A,130,Slightly reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_320_A
1338,Q9HC16,R,320,E,2kem:A,130,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9HC16_R_320_E
1339,Q9HC16,E,323,Q,2kem:A,133,Does not decrease cytidine deaminase activity.,,,0.0,,,,,,,,,,,,,Q9HC16_E_323_Q
1340,P10114,K,5,R,1kao:A,5,Reduced NEDD4-dependent ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P10114_K_5_R
1341,P10114,G,12,V,1kao:A,12,Dominant active. 2-fold decrease in GDP dissociation rate constant and GTPase activity. No change in interaction with TNIK.,0.0,-1.0,1.0,,,,,,,,,,,,,P10114_G_12_V
1342,P10114,S,17,N,1kao:A,17,"Dominant negative. Severely impairs GTP-binding and partial loss of interaction with MAP4K4, MINK1 and TNIK.",-1.0,-1.0,-999.0,,,,,,,,,,,,,P10114_S_17_N
1343,P10114,T,35,A,1kao:A,35,Decreases affinity for GTP and 3-fold reduction of GTPase activity.,,-1.0,1.0,,,,,,,,,,,,,P10114_T_35_A
1344,P10114,F,39,S,1kao:A,39,"Loss of RASGEF1A- and RASGEF1B-mediated GDP to GTP exchange. Complete loss of interaction with MAP4K4, MINK1 and TNIK, and loss of ubiquitination by NEDD4.",-1.0,,-999.0,,-1.0,,,,,,,,,,,P10114_F_39_S
1345,P10114,K,94,R,1kao:A,94,Reduced NEDD4-dependent ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P10114_K_94_R
1346,P10114,T,145,I,1kao:A,145,Imperfect binding of guanyl nucleotides.,,-1.0,-999.0,,,,,,,,,,,,,P10114_T_145_I
1347,P10114,K,148,R,1kao:A,148,Reduced NEDD4-dependent ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P10114_K_148_R
1348,P10114,K,150,R,1kao:A,150,Reduced NEDD4-dependent ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P10114_K_150_R
1349,Q8N539,D,393,N,4m7f:A,393,Complete loss of binding to acetylated bovine serum albumin and reduced binding to chitin,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_D_393_N
1350,Q8N539,D,395,A,4m7f:A,395,Complete loss of binding to acetylated bovine serum albumin and reduced binding to chitin,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_D_395_A
1351,Q8N539,Y,405,S,4m7f:A,405,Significantly reduced binding to acetylated bovine serum albumin and loss of binding to chitin,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_Y_405_S
1352,Q8N539,H,415,G,4m7f:A,415,Complete loss of binding to acetylated bovine serum albumin and chitin.,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_H_415_G
1353,Q8N539,Y,431,S,4m7f:A,431,Significantly reduced binding to acetylated bovine serum albumin and loss of binding to chitin,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_Y_431_S
1354,Q8N539,A,432,V,4m7f:A,432,Complete loss of binding to acetylated bovine serum albumin and chitin.,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_A_432_V
1355,Q8N539,W,443,S,4m7f:A,443,Slight reduction in binding to acetylated bovine serum albumin and no effect on binding to chitin.,,-1.0,-999.0,,,,,,,,,,,,,Q8N539_W_443_S
1356,P04746,R,210,A,1u33:A,195,Abolishes chloride binding,,-1.0,-999.0,,,,,,,,,,,,,P04746_R_210_A
1356,P04746,R,210,Q,1u33:A,195,Abolishes chloride binding,,-1.0,-999.0,,,,,,,,,,,,,P04746_R_210_Q
1357,P04746,D,212,A,1u33:A,197,Abolishes activity.,,,1.0,,,,,,,,,,,,,P04746_D_212_A
1357,P04746,D,212,N,1u33:A,197,Abolishes activity.,,,1.0,,,,,,,,,,,,,P04746_D_212_N
1358,P04746,E,248,A,1u33:A,233,Reduces activity.,,,1.0,,,,,,,,,,,,,P04746_E_248_A
1358,P04746,E,248,Q,1u33:A,233,Reduces activity.,,,1.0,,,,,,,,,,,,,P04746_E_248_Q
1359,P04746,N,313,S,1u33:A,298,Reduces affinity for chloride,,-1.0,-999.0,,,,,,,,,,,,,P04746_N_313_S
1360,P04746,D,315,A,1u33:A,300,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,P04746_D_315_A
1360,P04746,D,315,N,1u33:A,300,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,P04746_D_315_N
1361,P04746,R,352,A,1u33:A,337,Abolishes chloride binding,,-1.0,-999.0,,,,,,,,,,,,,P04746_R_352_A
1362,P24666,C,13,S,4z99:A,12,Inactive.,,,1.0,-1.0,,,,,,,,,,,,P24666_C_13_S
1363,P24666,Y,132,F,4z99:A,131,Reduced phosphorylation and activity.,,,0.0,-1.0,,,,,,,,,,,,P24666_Y_132_F
1364,P24666,Y,133,F,4z99:A,132,Reduced phosphorylation. No effect on activity.,,,1.0,,,,,,,,,,,,,P24666_Y_133_F
1365,O94817,K,54,D,4gdk:A,54,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_K_54_D
1366,O94817,V,62,R,4gdk:A,62,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_V_62_R
1367,O94817,G,63,D,4gdk:A,63,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_G_63_D
1368,O94817,K,72,D,4gdk:A,72,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_K_72_D
1369,O94817,W,73,A,4gdk:A,73,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_W_73_A
1370,O94817,F,108,A,4gdk:A,108,Impairs ATG12 stability.,,,-999.0,,,,,,,,,,,-1.0,,O94817_F_108_A
1370,O94817,F,108,D,4gdk:A,108,Impairs ATG12 stability.,,,-999.0,,,,,,,,,,,-1.0,,O94817_F_108_D
1370,O94817,F,108,R,4gdk:A,108,Impairs ATG12 stability.,,,-999.0,,,,,,,,,,,-1.0,,O94817_F_108_R
1371,O94817,D,113,V,4gdk:A,113,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_D_113_V
1372,O94817,C,122,W,4gdk:A,122,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_C_122_W
1373,O94817,F,123,D,4gdk:A,123,Impairs ATG12 stability.,,,-999.0,,,,,,,,,,,-1.0,,O94817_F_123_D
1374,O94817,A,138,R,4gdk:A,138,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_A_138_R
1375,O94817,W,139,F,4gdk:A,139,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_W_139_F
1375,O94817,W,139,Y,4gdk:A,139,Impairs E3 activity of the ATG12-ATG5 conjugate.,,,1.0,,,,,,,,,,,,,O94817_W_139_Y
1376,Q14654,V,64,M,6c3o:A,64,Displays gain of function,,,1.0,,,,,,,,,,,,,Q14654_V_64_M
1377,O95433,Y,223,E,1x53:A,27,Phosphomimetic mutant. Increases the binding to HSP90AA1 resulting in TSC1 dissociation from HSP90AA1.,1.0,,-999.0,,,,,,,,,,1.0,,,O95433_Y_223_E
1378,O43681,G,46,R,6so5:A,46,"Abolishes ATPase activity, dominantly inhibits the TA protein insertion pathway.",,,1.0,,,,,,,,,,,,,O43681_G_46_R
1379,O43681,K,86,D,6so5:A,86,Reduces TA protein insertion pathway.,,,1.0,,,,,,,,,,,,,O43681_K_86_D
1380,Q99873,V,92,A,6nt2:A,92,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,1.0,,,,,,,,,1.0,,,,Q99873_V_92_A
1381,Q99873,L,93,A,6nt2:A,93,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,1.0,,,,,,,,,1.0,,,,Q99873_L_93_A
1382,Q99873,D,94,A,6nt2:A,94,"Loss of FOXO1 methylation, its nuclear retention, and transcriptional activity.",,,1.0,,,,,,,,,1.0,,,,Q99873_D_94_A
1383,Q99873,Y,280,A,6nt2:A,280,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,1.0,,,,,,,,,,,,,Q99873_Y_280_A
1384,Q99873,Y,322,A,6nt2:A,322,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,1.0,,,,,,,,,,,,,Q99873_Y_322_A
1385,Q99873,L,359,A,6nt2:A,359,No effect on S-adenosyl-L-methionine binding but reduced EWS protein methylation,,0.0,1.0,,,,,,,,,,,,,Q99873_L_359_A
1386,O43683,A,106,D,2lah:A,116,Loss of interaction with KNL1.,-1.0,,-999.0,,,,,,,,,,,,,O43683_A_106_D
1386,O43683,A,106,W,2lah:A,116,Loss of interaction with KNL1.,-1.0,,-999.0,,,,,,,,,,,,,O43683_A_106_W
1387,O43683,L,122,G,2lah:A,132,Loss of interaction with KNL1.,-1.0,,-999.0,,,,,,,,,,,,,O43683_L_122_G
1388,O43683,A,130,S,2lah:A,140,"Partial rescue of the spindle-assembly checkpoint activity. Increased rate of chromosome congression errors. Impaired localization to kinetochores and loss of kinetochore binding of CENPF, SGO1 and BUBR1 but not of MCAK, MAD1L1 or MAD2L1.",,,-999.0,,,,,,,,,,,,,O43683_A_130_S
1389,O43683,K,821,A,5dmz:A,821,Loss of activity.,,,1.0,,,,,,,,,,,,,O43683_K_821_A
1390,Q16873,S,36,E,2uui:A,36,Reduced leukotriene-C4 synthase activity by nearly 80%.,,,1.0,,,,,,,,,,,,,Q16873_S_36_E
1391,Q16873,T,40,A,2uui:A,40,Leukotriene-C4 synthaseactivity is reduced by 30%.,,,1.0,,,,,,,,,,,,,Q16873_T_40_A
1392,Q16873,R,51,T,2uui:A,51,Loss of leukotriene-C4 synthase activity.,,,1.0,,,,,,,,,,,,,Q16873_R_51_T
1392,Q16873,R,51,I,2uui:A,51,Loss of leukotriene-C4 synthase activity.,,,1.0,,,,,,,,,,,,,Q16873_R_51_I
1393,Q16873,N,55,A,2uui:A,55,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_N_55_A
1394,Q16873,Y,59,F,2uui:A,59,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_Y_59_F
1395,Q16873,Y,93,F,2uui:A,93,Reduces Leukotriene-C4 synthase activity and increases the optimum for pH-dependent activity.,,,1.0,,,,,,,,,,,,,Q16873_Y_93_F
1396,Q16873,Y,97,F,2uui:A,97,Does not affect leukotriene-C4 synthase activity but substantially increased KM for GSH.,,-1.0,0.0,,,,,,,,,,,,,Q16873_Y_97_F
1397,Q9NZN9,R,53,W,5u9a:A,53,No interaction with NUB1.,-1.0,,-999.0,,,,,,,,,,,,,Q9NZN9_R_53_W
1398,Q9NZN9,M,79,T,5u9a:A,79,No interaction with NUB1.,-1.0,,-999.0,,,,,,,,,,,,,Q9NZN9_M_79_T
1399,Q9NZN9,V,96,I,5u9a:A,96,No interaction with NUB1.,-1.0,,-999.0,,,,,,,,,,,,,Q9NZN9_V_96_I
1400,Q9NZN9,A,197,P,6px0:A,197,No significant effect on interaction with NUB1.,0.0,,-999.0,,,,,,,,,,,,,Q9NZN9_A_197_P
1401,Q9NZN9,I,206,N,6px0:A,206,No significant effect on interaction with NUB1.,0.0,,-999.0,,,,,,,,,,,,,Q9NZN9_I_206_N
1402,Q9NZN9,G,262,S,6px0:A,262,No interaction with NUB1.,-1.0,,-999.0,,,,,,,,,,,,,Q9NZN9_G_262_S
1403,Q0JRZ9,F,10,E,2v0o:A,10,Binds preferentially to larger liposomes.,,,-999.0,,,,,,,,,,,,,Q0JRZ9_F_10_E
1404,O75340,E,47,A,2zn9:B,47,"Loss of interaction with SEC31A and PLSCR3, and loss of localization to the endoplasmic reticulum",-1.0,,-999.0,,,,,,,,,1.0,,,,O75340_E_47_A
1405,O75340,L,52,A,2zn9:B,52,Stronly impaired interaction with SEC31A. Slightly reduced interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,O75340_L_52_A
1406,O75340,S,53,G,2zn9:B,53,Slightly reduced interaction with SEC31A. Does not affect interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,O75340_S_53_G
1407,O75340,W,57,A,2zn9:B,57,"Does not affect interaction with SEC31A. Reduces the interaction with HEBP2, PDCD6IP and ANXA7.",-1.0,,-999.0,,,,,,,,,,,,,O75340_W_57_A
1408,O75340,F,60,A,2zn9:B,60,"Abolishes the interaction with SEC31A, PDCD6IP, ANXA7 and ANXA11.",-1.0,,-999.0,,,,,,,,,,,,,O75340_F_60_A
1409,O75340,F,85,A,2zn9:B,85,Stronly impaired interaction with SEC31A and TFG. Does not affect interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,O75340_F_85_A
1410,O75340,W,89,A,2zn9:B,89,Does not affect interaction with SEC31A. Does not affect interaction with PDCD6IP.,0.0,,-999.0,,,,,,,,,,,,,O75340_W_89_A
1411,O75340,Y,91,A,2zn9:B,91,"Abolishes the interaction with PDCD6IP, ANXA7 and ANXA11.",-1.0,,-999.0,,,,,,,,,,,,,O75340_Y_91_A
1412,O75340,I,92,A,2zn9:B,92,Does not affect interaction with SEC31A. Does not affect interaction with PDCD6IP.,0.0,,-999.0,,,,,,,,,,,,,O75340_I_92_A
1413,O75340,W,95,A,2zn9:B,95,"Abolishes the interaction with PDCD6IP, ANXA7 and ANXA11.",-1.0,,-999.0,,,,,,,,,,,,,O75340_W_95_A
1414,O75340,E,114,A,2zn9:B,114,"Loss of interaction with SEC31A and PLSCR3, and loss of localization to the endoplasmic reticulum",-1.0,,-999.0,,,,,,,,,1.0,,,,O75340_E_114_A
1415,O75340,F,122,A,2zn9:B,122,Increases interaction with PDCD6IP and ANXA7. Impairs interaction with ANXA11. Augments stauroporine-induced cell death.,-1.0,,-999.0,,,,,,,,,,,,,O75340_F_122_A
1416,O75340,F,122,G,2zn9:B,122,Increases interaction with PDCD6IP. Impairs interaction with ANXA11.,,,-999.0,,,,,,,,,,,,,O75340_F_122_G
1417,O75340,F,122,S,2zn9:B,122,Increases interaction with PDCD6IP. Impairs interaction with ANAX7 and ANXA11.,,,-999.0,,,,,,,,,,,,,O75340_F_122_S
1418,O75340,F,122,W,2zn9:B,122,Impairs interaction with ANXA11.,-1.0,,-999.0,,,,,,,,,,,,,O75340_F_122_W
1419,O75340,F,148,S,2zn9:B,148,Slightly reduced interaction with SEC31A. Does not affect interaction with PDCD6IP.,-1.0,,-999.0,,,,,,,,,,,,,O75340_F_148_S
1420,O75340,Y,180,A,2zn9:B,180,"Abolishes the interaction with PDCD6IP, TSG101, ANXA7 and ANXA11. Does not affect interaction with TFG and SEC31A.",-1.0,,-999.0,,,,,,,,,,,,,O75340_Y_180_A
1421,Q4FZB7,G,229,F,3s8p:B,229,Km for H4K20me1rise to 17 uM. 8-fold decrease in catalytic efficiency.,,-1.0,1.0,,,,,,,,,,,,,Q4FZB7_G_229_F
1422,Q4FZB7,G,229,Y,3s8p:B,229,Abolishes histone methyltransferase activity (H4-K20 specific).,,,1.0,,,,,,,,,,,,,Q4FZB7_G_229_Y
1423,Q4FZB7,S,251,A,3s8p:B,251,Abolishes histone methyltransferase activity (H4-K20 specific).,,,1.0,,,,,,,,,,,,,Q4FZB7_S_251_A
1424,Q4FZB7,W,264,A,3s8p:B,264,Abolishes histone methyltransferase activity (H4-K20 specific).,,,1.0,,,,,,,,,,,,,Q4FZB7_W_264_A
1425,Q4FZB7,F,281,A,3s8p:B,281,Abolishes histone methyltransferase activity (H4-K20 specific).,,,1.0,,,,,,,,,,,,,Q4FZB7_F_281_A
1426,Q4FZB7,F,311,A,3s8p:B,311,Km for H4K20me1rise to 8.5 uM. 3-fold decrease in catalytic efficiency.,,-1.0,1.0,,,,,,,,,,,,,Q4FZB7_F_311_A
1427,Q99683,K,709,M,5vil:A,709,Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX.,-1.0,,1.0,,,,,,,,,,,,,Q99683_K_709_M
1428,Q99683,K,709,R,5vil:A,709,Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Loss of RC3H2-mediated ubiquitination.,,,1.0,,-1.0,,,,,,,,,,,Q99683_K_709_R
1429,P63010,Y,815,A,2iv9:A,815,"Strongly reduces interaction with SNAP91, EPS15, AMPH and BIN1 and clathrin heavy chain.",-1.0,,-999.0,,,,,,,,,,,,,P63010_Y_815_A
1430,P63010,W,841,A,2iv9:A,841,Abolishes interaction with LDLRAP1 and ARRB1. Greatly reduces DENND1B-binding.,-1.0,,-999.0,,,,,,,,,,,,,P63010_W_841_A
1431,P63010,K,842,E,2iv9:A,842,Strongly reduces interaction with ARRB1.,-1.0,,-999.0,,,,,,,,,,,,,P63010_K_842_E
1432,P63010,E,849,A,2iv9:A,849,"Strongly reduces interaction with LDLRAP1, ARRB1 and EPN1. No effect on DENND1B-binding.",-1.0,,-999.0,,,,,,,,,,,,,P63010_E_849_A
1433,P63010,Q,851,A,2iv9:A,851,Strongly reduces interaction with ARRB1.,-1.0,,-999.0,,,,,,,,,,,,,P63010_Q_851_A
1434,P63010,R,879,A,2iv9:A,879,No effect on interaction with ARRB1.,0.0,,-999.0,,,,,,,,,,,,,P63010_R_879_A
1435,P63010,R,879,E,2iv9:A,879,Strongly reduces interaction with EPN1. Reduces interaction with SNAP91 and clathrin. No effect on EPS15 binding.,-1.0,,-999.0,,,,,,,,,,,,,P63010_R_879_E
1436,P63010,Y,888,V,2iv9:A,888,"Strongly reduces interaction with SNAP91, EPN1 and clathrin. No effect on EPS15 binding. Abolishes interaction with ARRB1 and with DENND1B.",-1.0,,-999.0,,,,,,,,,,,,,P63010_Y_888_V
1437,P63010,E,902,A,2iv9:A,902,Strongly reduces interaction with LDLRAP1 and ARRB1. No effect on DENND1B-binding.,-1.0,,-999.0,,,,,,,,,,,,,P63010_E_902_A
1438,P63010,K,917,Q,2iv9:A,917,Strongly reduces interaction with LDLRAP1. SNAP91 and clathrin. Reduces interaction with EPN1. No effect on EPS15 binding.,-1.0,,-999.0,,,,,,,,,,,,,P63010_K_917_Q
1439,Q14019,K,75,A,1wnj:A,78,Abolishes actin-binding activity.,-1.0,,1.0,,,,,,,,,,,,,Q14019_K_75_A
1440,Q14019,K,130,A,1wnj:A,133,No effect on 5LO-binding activity.,0.0,,0.0,,,,,,,,,,,,,Q14019_K_130_A
1441,Q14019,K,131,A,1wnj:A,134,Abolishes 5LO-binding activity.,-1.0,,1.0,,,,,,,,,,,,,Q14019_K_131_A
1442,Q14019,K,131,E,1wnj:A,134,Abolishes 5LO-binding activity.,-1.0,,1.0,,,,,,,,,,,,,Q14019_K_131_E
1443,Q14019,K,131,R,1wnj:A,134,No effect on 5LO-binding activity.,0.0,,0.0,,,,,,,,,,,,,Q14019_K_131_R
1444,P02489,N,123,D,6t1r:A,123,Impairs chaperone activity.,,,1.0,,,,,,,,,,,,,P02489_N_123_D
1445,Q8N159,Y,441,F,4k30:A,441,15% reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N159_Y_441_F
1446,Q8N159,N,479,A,4k30:A,479,7-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N159_N_479_A
1447,Q8N159,Y,485,F,4k30:A,485,10-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N159_Y_485_F
1448,Q14012,T,177,A,4fgb:A,177,Loss of activation by CaMKK1.,-1.0,,-999.0,,,,,,,,,,,,,Q14012_T_177_A
1449,Q14012,T,177,D,4fgb:A,177,Partial activation in absence of CaMKK1.,,,-999.0,,,,,,,,,,,,,Q14012_T_177_D
1450,Q9HBH9,D,228,G,2ac3:A,228,Reduced phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q9HBH9_D_228_G
1451,Q96BR1,R,90,A,6edx:A,84,Partially localized to the membrane.,,,-999.0,,,,,,,,,1.0,,,,Q96BR1_R_90_A
1452,P19235,T,114,A,1cn4:B,90,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_T_114_A
1453,P19235,S,115,A,1cn4:B,91,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_S_115_A
1454,P19235,S,116,A,1cn4:B,92,10-fold reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_S_116_A
1455,P19235,F,117,A,1cn4:B,93,Greatly reduced EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_F_117_A
1455,P19235,F,117,L,1cn4:B,93,Greatly reduced EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_F_117_L
1456,P19235,F,117,W,1cn4:B,93,60-fold reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_F_117_W
1457,P19235,F,117,Y,1cn4:B,93,8-fold reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_F_117_Y
1458,P19235,V,118,A,1cn4:B,94,16-fold reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_V_118_A
1459,P19235,L,120,A,1cn4:B,96,Some reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_L_120_A
1460,P19235,E,121,A,1cn4:B,97,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_E_121_A
1461,P19235,R,165,A,1cn4:B,141,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_R_165_A
1462,P19235,M,174,A,1cn4:B,150,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_M_174_A
1463,P19235,S,176,A,1cn4:B,152,16-fold reduction in EPO binding.,,-1.0,-999.0,,,,,,,,,,,,,P19235_S_176_A
1464,P19235,H,177,A,1cn4:B,153,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_H_177_A
1465,P19235,R,179,A,1cn4:B,155,Little effect on EPO binding.,,0.0,-999.0,,,,,,,,,,,,,P19235_R_179_A
1466,P40926,K,185,R,2dfd:A,167,No activation of enzyme activity on treatment with TSA or NAM,,,-999.0,,,,,,,,,,,,,P40926_K_185_R
1467,P40926,K,301,R,2dfd:A,283,No activation of enzyme activity on treatment with TSA or NAM,,,-999.0,,,,,,,,,,,,,P40926_K_301_R
1468,P40926,K,307,R,2dfd:A,289,No activation of enzyme activity on treatment with TSA or NAM,,,-999.0,,,,,,,,,,,,,P40926_K_307_R
1469,P40926,K,314,R,2dfd:A,296,No activation of enzyme activity on treatment with TSA or NAM,,,-999.0,,,,,,,,,,,,,P40926_K_314_R
1470,O14929,D,62,A,6vo5:A,62,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_D_62_A
1471,O14929,E,64,A,6vo5:A,64,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_E_64_A
1472,O14929,E,187,Q,6vo5:A,187,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_E_187_Q
1473,O14929,W,199,A,6vo5:A,199,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_W_199_A
1474,O14929,E,276,Q,6vo5:A,276,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_E_276_Q
1475,O14929,D,277,N,6vo5:A,277,Strongly reduces HAT activity.,,,1.0,,,,,,,,,,,,,O14929_D_277_N
1476,O43353,K,47,A,5ng3:A,47,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,O43353_K_47_A
1477,O43353,K,47,M,5ng3:A,47,Reduces FAS-mediated apoptosis.,,,-999.0,,,,,,,,,,,,,O43353_K_47_M
1478,O43353,D,146,N,5ng3:A,146,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,O43353_D_146_N
1479,O43353,K,209,R,4c8b:B,209,Complete loss of polyubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,O43353_K_209_R
1480,O43353,Q,437,E,2n7z:A,4,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_Q_437_E
1481,O43353,R,444,E,2n7z:A,11,Abolishes interaction with NOD1.,-1.0,,-999.0,,,,,,,,,,,,,O43353_R_444_E
1482,O43353,D,467,R,2n7z:A,34,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_D_467_R
1483,O43353,K,471,E,2n7z:A,38,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_K_471_E
1484,O43353,Y,474,F,2n7z:A,41,Decreases interaction with NOD2.,-1.0,,-999.0,,,,,,,,,,,,,O43353_Y_474_F
1485,O43353,R,483,E,2n7z:A,50,Abolishes interaction with NOD1.,-1.0,,-999.0,,,,,,,,,,,,,O43353_R_483_E
1486,O43353,R,488,E,2n7z:A,55,Abolishes interaction with NOD1.,-1.0,,-999.0,,,,,,,,,,,,,O43353_R_488_E
1487,O43353,I,496,A,2n7z:A,63,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_I_496_A
1488,O43353,E,500,R,2n7z:A,67,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_E_500_R
1489,O43353,R,528,E,2n7z:A,95,Decreased interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,O43353_R_528_E
1490,O95503,I,16,F,3gv6:A,16,Reduced interaction with H3C15 and H3C1.,-1.0,,-999.0,,,,,,,,,,,,,O95503_I_16_F
1491,Q9ULZ3,I,8,A,2kn6:A,8,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_I_8_A
1492,Q9ULZ3,L,12,A,2kn6:A,12,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_12_A
1493,Q9ULZ3,L,12,Q,2kn6:A,12,Abolishes promotion of apoptosis and NF-kappa-B activation.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_12_Q
1494,Q9ULZ3,E,13,A,2kn6:A,13,Abolishes interaction with PYDC1.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_E_13_A
1495,Q9ULZ3,E,13,W,2kn6:A,13,Abolishes interaction with NLRP2.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_E_13_W
1496,Q9ULZ3,L,15,A,2kn6:A,15,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_15_A
1497,Q9ULZ3,E,19,A,2kn6:A,19,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_E_19_A
1498,Q9ULZ3,L,20,A,2kn6:A,20,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_20_A
1499,Q9ULZ3,K,21,A,2kn6:A,21,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_K_21_A
1499,Q9ULZ3,K,21,E,2kn6:A,21,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_K_21_E
1499,Q9ULZ3,K,21,Q,2kn6:A,21,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_K_21_Q
1500,Q9ULZ3,F,23,A,2kn6:A,23,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_F_23_A
1501,Q9ULZ3,L,25,A,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_A
1501,Q9ULZ3,L,25,E,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_E
1501,Q9ULZ3,L,25,G,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_G
1501,Q9ULZ3,L,25,K,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_K
1501,Q9ULZ3,L,25,N,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_N
1501,Q9ULZ3,L,25,Q,2kn6:A,25,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_25_Q
1502,Q9ULZ3,K,26,A,2kn6:A,26,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_K_26_A
1502,Q9ULZ3,K,26,Q,2kn6:A,26,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_K_26_Q
1503,Q9ULZ3,L,27,A,2kn6:A,27,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_27_A
1504,Q9ULZ3,Y,36,A,2kn6:A,36,Abolishes interaction with PYDC1.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_Y_36_A
1505,Q9ULZ3,P,40,A,2kn6:A,40,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_P_40_A
1506,Q9ULZ3,R,41,A,2kn6:A,41,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_R_41_A
1506,Q9ULZ3,R,41,Q,2kn6:A,41,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_R_41_Q
1506,Q9ULZ3,R,41,W,2kn6:A,41,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_R_41_W
1507,Q9ULZ3,L,45,A,2kn6:A,45,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_45_A
1508,Q9ULZ3,M,47,A,2kn6:A,47,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_M_47_A
1508,Q9ULZ3,M,47,N,2kn6:A,47,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_M_47_N
1508,Q9ULZ3,M,47,Q,2kn6:A,47,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_M_47_Q
1509,Q9ULZ3,D,48,A,2kn6:A,48,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_D_48_A
1509,Q9ULZ3,D,48,K,2kn6:A,48,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_D_48_K
1511,Q9ULZ3,L,52,A,2kn6:A,52,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_52_A
1512,Q9ULZ3,L,56,A,2kn6:A,56,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_56_A
1513,Q9ULZ3,E,62,A,2kn6:A,62,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_E_62_A
1514,Q9ULZ3,E,67,A,2kn6:A,67,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_E_67_A
1515,Q9ULZ3,L,68,A,2kn6:A,68,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_L_68_A
1516,Q9ULZ3,V,72,A,2kn6:A,72,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_V_72_A
1517,Q9ULZ3,M,76,A,2kn6:A,76,Abolishes homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9ULZ3_M_76_A
1518,P24394,Y,38,A,3bpl:B,13,700-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_38_A
1519,P24394,Y,38,F,3bpl:B,13,25-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_38_F
1520,P24394,M,39,A,3bpl:B,14,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_M_39_A
1521,P24394,S,40,A,3bpl:B,15,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_S_40_A
1522,P24394,L,64,A,3bpl:B,39,100-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_L_64_A
1523,P24394,F,66,A,3bpl:B,41,45-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_F_66_A
1524,P24394,L,67,A,3bpl:B,42,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_L_67_A
1525,P24394,L,68,A,3bpl:B,43,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_L_68_A
1526,P24394,D,91,A,3bpl:B,66,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_D_91_A
1527,P24394,D,92,A,3bpl:B,67,50-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_D_92_A
1528,P24394,V,93,A,3bpl:B,68,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_V_93_A
1529,P24394,V,94,A,3bpl:B,69,35-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_V_94_A
1530,P24394,S,95,A,3bpl:B,70,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_S_95_A
1531,P24394,D,97,A,3bpl:B,72,>150-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_D_97_A
1531,P24394,D,97,N,3bpl:B,72,>150-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_D_97_N
1532,P24394,N,98,A,3bpl:B,73,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_N_98_A
1533,P24394,Y,99,A,3bpl:B,74,10-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_99_A
1534,P24394,K,116,A,3bpl:B,91,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_K_116_A
1535,P24394,P,117,A,3bpl:B,92,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_P_117_A
1536,P24394,S,118,A,3bpl:B,93,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_S_118_A
1537,P24394,E,119,A,3bpl:B,94,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_E_119_A
1538,P24394,D,150,A,3bpl:B,125,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_D_150_A
1539,P24394,N,151,A,3bpl:B,126,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_N_151_A
1540,P24394,Y,152,A,3bpl:B,127,40-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_152_A
1541,P24394,Y,152,F,3bpl:B,127,No effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_Y_152_F
1542,P24394,L,153,A,3bpl:B,128,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_L_153_A
1543,P24394,Y,154,A,3bpl:B,129,Little effect on IL4 binding.,0.0,,-999.0,,,,,,,,,,,,,P24394_Y_154_A
1544,P24394,Y,208,A,3bpl:B,183,500-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_208_A
1545,P24394,Y,208,F,3bpl:B,183,200-fold reduction in IL4 binding.,-1.0,,-999.0,,,,,,,,,,,,,P24394_Y_208_F
1546,Q86YS6,T,82,A,2hup:A,82,Loss of phosphorylation. No effect on binding of GDI1 and GDI2.,0.0,,-999.0,-1.0,,,,,,,,,,,,Q86YS6_T_82_A
1547,Q86YS6,T,82,E,2hup:A,82,"Phosphomimetic mutant. Loss of binding to GDI1, GDI2, CHM and CHML.",-1.0,,-999.0,,,,,,,,,,1.0,,,Q86YS6_T_82_E
1548,Q96FJ0,E,292,A,2znr:A,292,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96FJ0_E_292_A
1549,Q96FJ0,E,329,A,2znr:A,329,3-fold decrease in substrate affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q96FJ0_E_329_A
1550,Q96FJ0,F,332,A,2znr:A,332,"12-fold decrease in substrate affinity, little effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q96FJ0_F_332_A
1551,Q96FJ0,T,353,A,2znr:A,353,"19-fold decrease in activity, no change in substrate affinity.",,0.0,1.0,,,,,,,,,,,,,Q96FJ0_T_353_A
1552,Q96FJ0,F,355,A,2znr:A,355,"161-fold decrease in activity, no change in substrate affinity.",,0.0,1.0,,,,,,,,,,,,,Q96FJ0_F_355_A
1553,Q96FJ0,S,357,A,2znr:A,357,34-fold decrease in activity.,,,1.0,,,,,,,,,,,,,Q96FJ0_S_357_A
1554,Q96FJ0,S,358,A,2znr:A,358,"10-fold decrease in activity, no change in substrate affinity.",,0.0,1.0,,,,,,,,,,,,,Q96FJ0_S_358_A
1555,Q96FJ0,D,360,A,2znr:A,360,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96FJ0_D_360_A
1556,Q96FJ0,M,370,A,2znr:A,370,"18-fold decrease in substrate affinity, little effect on catalytic activity.",,-1.0,0.0,,,,,,,,,,,,,Q96FJ0_M_370_A
1557,Q96FJ0,C,402,S,2znr:A,402,"402-fold decrease in activity, slight increase in substrate affinity.",,1.0,1.0,,,,,,,,,,,,,Q96FJ0_C_402_S
1558,Q96FJ0,F,407,A,2znr:A,407,"35-fold decrease in activity, slight increase in substrate affinity.",,1.0,1.0,,,,,,,,,,,,,Q96FJ0_F_407_A
1559,Q99538,E,190,K,4fgu:A,190,Increases catalytic activity at pH 5.5.,,,1.0,,,,,,,,,,,,,Q99538_E_190_K
1560,Q99538,N,323,D,4fgu:A,323,Loss of autoactivation.,,,1.0,,,,,,,,,,,,,Q99538_N_323_D
1560,Q99538,N,323,Q,4fgu:A,323,Loss of autoactivation.,,,1.0,,,,,,,,,,,,,Q99538_N_323_Q
1560,Q99538,N,323,S,4fgu:A,323,Loss of autoactivation.,,,1.0,,,,,,,,,,,,,Q99538_N_323_S
1561,Q8N1G2,K,203,A,4n4a:A,203,Reduces both mRNA cap binding and catalytic activity of the enzyme.,,-1.0,1.0,,,,,,,,,,,,,Q8N1G2_K_203_A
1562,Q8N1G2,R,228,A,4n4a:A,228,No effect.,,0.0,0.0,,,,,,,,,,,,,Q8N1G2_R_228_A
1563,Q8N1G2,K,239,A,4n4a:A,239,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N1G2_K_239_A
1564,Q8N1G2,D,364,A,4n48:B,364,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N1G2_D_364_A
1565,Q8N1G2,K,404,A,4n48:B,404,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q8N1G2_K_404_A
1566,P11086,Y,35,F,2obf:B,535,Strongly increases KM for substrate and S-adenosyl-L-methionine.,,-1.0,-999.0,,,,,,,,,,,,,P11086_Y_35_F
1567,P11086,E,185,A,2obf:B,685,Strongly reduced enzyme activity. Increases affinity for S-adenosyl-L-methionine.,,1.0,1.0,,,,,,,,,,,,,P11086_E_185_A
1567,P11086,E,185,Q,2obf:B,685,Strongly reduced enzyme activity. Increases affinity for S-adenosyl-L-methionine.,,1.0,1.0,,,,,,,,,,,,,P11086_E_185_Q
1568,P11086,E,185,D,2obf:B,685,Strongly reduced enzyme activity. Decreases affinity for substrate and S-adenosyl-L-methionine 3-fold.,,-1.0,1.0,,,,,,,,,,,,,P11086_E_185_D
1569,P11086,E,219,A,2obf:B,719,Reduced enzyme activity. Decreases affinity for substrate 6-fold. Decreases affinity for S-adenosyl-L-methionine 2-fold.,,-1.0,1.0,,,,,,,,,,,,,P11086_E_219_A
1570,P11086,D,267,A,2obf:B,767,Strongly reduced enzyme activity. Decreases affinity for substrate 200-fold. Decreases affinity for S-adenosyl-L-methionine 3-fold.,,-1.0,1.0,,,,,,,,,,,,,P11086_D_267_A
1570,P11086,D,267,N,2obf:B,767,Strongly reduced enzyme activity. Decreases affinity for substrate 200-fold. Decreases affinity for S-adenosyl-L-methionine 3-fold.,,-1.0,1.0,,,,,,,,,,,,,P11086_D_267_N
1571,Q96RS0,F,655,A,3gdh:A,655,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96RS0_F_655_A
1572,Q96RS0,T,673,A,3gdh:A,673,Decreases catalytic activity to 13 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_T_673_A
1573,Q96RS0,D,696,A,3gdh:A,696,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96RS0_D_696_A
1574,Q96RS0,N,704,A,3gdh:A,704,Decreases catalytic activity to 5 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_N_704_A
1575,Q96RS0,D,719,A,3gdh:A,719,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96RS0_D_719_A
1576,Q96RS0,N,731,A,3gdh:A,731,Decreases catalytic activity to 4 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_N_731_A
1577,Q96RS0,S,763,A,3gdh:A,763,Decreases catalytic activity to 26 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_S_763_A
1578,Q96RS0,W,766,A,3gdh:A,766,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96RS0_W_766_A
1579,Q96RS0,R,807,A,3gdh:A,807,Decreases catalytic activity to 6 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_R_807_A
1580,Q96RS0,N,808,A,3gdh:A,808,Decreases catalytic activity to 11 percent of wild type.,,,1.0,,,,,,,,,,,,,Q96RS0_N_808_A
1581,O60231,K,428,A,6ff7:q,429,Impairs pre-mRNA splicing activity.,,,1.0,,,,,,,,,,,,,O60231_K_428_A
1582,O60231,D,520,A,6ff7:q,521,Impairs pre-mRNA splicing activity.,,,1.0,,,,,,,,,,,,,O60231_D_520_A
1583,O60231,H,523,A,6ff7:q,524,No loss of pre-mRNA splicing activity.,,,0.0,,,,,,,,,,,,,O60231_H_523_A
1584,O60231,S,552,L,6ff7:q,553,Dominant-negative mutant. Impairs pre-mRNA splicing activity.,,,1.0,,,,,,,,,,,,,O60231_S_552_L
1585,O60231,G,724,N,6ff7:q,725,Dominant-negative mutant. Impairs pre-mRNA splicing activity.,,,1.0,,,,,,,,,,,,,O60231_G_724_N
1586,Q9Y2J8,D,123,N,4n2l:A,123,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_123_N
1587,Q9Y2J8,D,125,A,4n2l:A,125,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_125_A
1588,Q9Y2J8,D,166,A,4n2l:A,166,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_166_A
1589,Q9Y2J8,D,169,A,4n2l:A,169,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_169_A
1590,Q9Y2J8,D,177,A,4n2l:A,177,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_177_A
1591,Q9Y2J8,W,348,A,4n2i:A,348,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_W_348_A
1592,Q9Y2J8,Q,350,A,4n2i:A,350,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_Q_350_A
1593,Q9Y2J8,E,354,A,4n2i:A,354,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_E_354_A
1594,Q9Y2J8,D,370,A,4n2i:A,370,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_370_A
1595,Q9Y2J8,R,373,A,4n2i:A,373,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_R_373_A
1596,Q9Y2J8,D,374,A,4n2i:A,374,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_374_A
1597,Q9Y2J8,D,389,A,4n2i:A,389,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_D_389_A
1598,Q9Y2J8,E,412,A,4n2i:A,412,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_E_412_A
1599,Q9Y2J8,C,647,A,4n2i:A,647,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2J8_C_647_A
1600,Q8N1Q8,G,160,A,4ae7:A,160,Strongly reduces enzyme activity. Abolishes enzyme activity,,,1.0,,,,,,,,,,,,,Q8N1Q8_G_160_A
1601,Q8N1Q8,D,167,A,4ae7:A,167,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q8N1Q8_D_167_A
1602,Q8N1Q8,T,183,A,4ae7:A,183,Reduces enzyme activity. Abolishes enzyme activity,,,1.0,,,,,,,,,,,,,Q8N1Q8_T_183_A
1603,Q9NYY3,N,210,A,4i6b:A,210,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9NYY3_N_210_A
1604,Q9NYY3,W,503,F,4rs6:A,503,Impairs localization to the centrosome and centriole duplication,,,-999.0,,,,,,,,,1.0,,,,Q9NYY3_W_503_F
1605,Q9NYY3,H,629,A,4rs6:A,629,Impairs localization to the centrosome and centriole duplication,,,-999.0,,,,,,,,,1.0,,,,Q9NYY3_H_629_A
1606,Q9NYY3,K,631,M,4rs6:A,631,Impairs localization to the centrosome and centriole duplication,,,-999.0,,,,,,,,,1.0,,,,Q9NYY3_K_631_M
1607,O75899,Y,118,A,6uo8:B,118,Impairs interaction with GABBR1. Decreases signaling via G-proteins.,-1.0,,-999.0,,,,,,,,,,,,,O75899_Y_118_A
1608,O95619,H,43,A,5xtz:A,43,Impaired binding to histone H3 succinylated at 'Lys-122' (H3K122succ).,-1.0,,-999.0,,,,,,,,,,,,,O95619_H_43_A
1609,O95619,Y,74,A,5xtz:A,74,"Impaired binding to histone H3 diacetylated at 'Lys-14' and 'Lys-27' (H3K14ac and H3K27ac), and subsequent deposition of histone H2AZ1/H2A.Z into specific chromatin regions",-1.0,,-999.0,,,,,,,,,,,,,O95619_Y_74_A
1610,O95619,W,93,A,5xtz:A,93,"Impaired binding to histone H3 diacetylated at 'Lys-14' and 'Lys-27' (H3K14ac and H3K27ac), and subsequent deposition of histone H2AZ1/H2A.Z into specific chromatin regions",-1.0,,-999.0,,,,,,,,,,,,,O95619_W_93_A
1611,Q16654,Y,157,F,2e0a:A,157,Loss of activity.,,,1.0,,,,,,,,,,,,,Q16654_Y_157_F
1612,Q16654,R,161,A,2e0a:A,161,Loss of activity.,,,1.0,,,,,,,,,,,,,Q16654_R_161_A
1613,P48059,F,42,A,2kbx:B,42,Loss of interaction with ILK and loss of localization to focal adhesion.,-1.0,,1.0,,,,,,,,,1.0,,,,P48059_F_42_A
1614,P48059,R,56,A,2kbx:B,56,Alters interaction with ILK.,-1.0,,-999.0,,,,,,,,,,,,,P48059_R_56_A
1615,P48059,H,61,D,2kbx:B,61,Alters interaction with ILK.,-1.0,,-999.0,,,,,,,,,,,,,P48059_H_61_D
1616,P48059,D,62,A,2kbx:B,62,Alters interaction with ILK.,-1.0,,-999.0,,,,,,,,,,,,,P48059_D_62_A
1617,P48059,L,66,D,2kbx:B,66,Alters interaction with ILK.,-1.0,,-999.0,,,,,,,,,,,,,P48059_L_66_D
1618,P03372,V,364,E,3q95:B,364,Has higher transcriptional activity in the absence of wild type ER. Inhibits transcriptional activity when coexpressed with the wild type receptor.,,,-999.0,,,,,,,,,,,,,P03372_V_364_E
1619,P03372,I,386,C,3q95:B,386,"Loss of transmembrane localization, no effect on peripheral membrane localization. Impairs activation of estrogen-induced activation of NOS3 and production of nitric oxide. No effect on binding to ERES.",0.0,,1.0,,,,,,,,,1.0,,,,P03372_I_386_C
1620,P03372,C,447,A,3q95:B,447,Loss of hormone binding capacity and temperature-sensitive loss in DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P03372_C_447_A
1621,P03372,L,539,A,3q95:B,539,"Abolishes interaction with NCOA1, NCOA2 and NCOA3.",-1.0,,-999.0,,,,,,,,,,,,,P03372_L_539_A
1622,Q8IZI9,K,57,A,3hhc:A,24,51 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_K_57_A
1623,Q8IZI9,D,58,A,3hhc:A,25,43 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_D_58_A
1624,Q8IZI9,V,118,A,3hhc:A,85,68 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_V_118_A
1625,Q8IZI9,Q,121,A,3hhc:A,88,46 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_Q_121_A
1626,Q8IZI9,F,176,A,3hhc:B,143,40 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_F_176_A
1627,Q8IZI9,F,179,A,3hhc:B,146,650 fold decrease in antiviral activity.,,,1.0,,,,,,,,,,,,,Q8IZI9_F_179_A
1628,Q03431,I,135,K,6nbh:R,135,Abolishes hormone binding and homodimerization.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q03431_I_135_K
1629,Q03431,D,137,A,6nbh:R,137,Abolishes hormone binding. No effect on homodimerization.,0.0,-1.0,-999.0,,,,,,,,,,,,,Q03431_D_137_A
1630,Q3SYG4,S,142,G,6xt9:I,142,Fails to restore protein stability,,,-999.0,,,,,,,,,,,-1.0,,Q3SYG4_S_142_G
1631,Q3SYG4,Y,186,A,6xt9:I,186,Fails to restore protein stability,,,-999.0,,,,,,,,,,,-1.0,,Q3SYG4_Y_186_A
1632,Q9BX68,H,149,A,6ypx:AAA,149,Loss of adenosine phosphoramidase activity.,,,1.0,,,,,,,,,,,,,Q9BX68_H_149_A
1633,Q9BV86,Y,19,A,5cvd:A,19,Decreased methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_Y_19_A
1633,Q9BV86,Y,19,F,5cvd:A,19,Decreased methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_Y_19_F
1635,Q9BV86,W,20,A,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_W_20_A
1635,Q9BV86,W,20,M,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_W_20_M
1635,Q9BV86,W,20,Y,5cvd:A,20,Nearly abolishes methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_W_20_Y
1636,Q9BV86,W,136,L,5cvd:A,136,Strongly reduces methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_W_136_L
1637,Q9BV86,D,167,A,5cvd:A,167,Does not affect methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q9BV86_D_167_A
1638,Q9BV86,D,167,N,5cvd:A,167,Abolishes methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_D_167_N
1638,Q9BV86,D,167,Q,5cvd:A,167,Abolishes methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_D_167_Q
1639,Q9BV86,N,168,A,5cvd:A,168,Decreased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_N_168_A
1640,Q9BV86,N,168,K,5cvd:A,168,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_N_168_K
1641,Q9BV86,D,177,A,5cvd:A,177,Induces a slight decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_D_177_A
1642,Q9BV86,D,177,K,5cvd:A,177,Induces a strong decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_D_177_K
1643,Q9BV86,D,177,N,5cvd:A,177,Strongly reduces methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_D_177_N
1644,Q9BV86,D,180,A,5cvd:A,180,Induces a decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_D_180_A
1645,Q9BV86,D,180,K,5cvd:A,180,Induces a strong decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_D_180_K
1646,Q9BV86,D,180,N,5cvd:A,180,Reduced methyltransferase activity with CENPA.,,,1.0,,,,,,,,,,,,,Q9BV86_D_180_N
1647,Q9BV86,S,182,A,5cvd:A,182,Induces a slight decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_S_182_A
1648,Q9BV86,S,182,K,5cvd:A,182,Induces a strong decrease in methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BV86_S_182_K
1649,P80188,K,145,A,1ngl:A,126,Strongly reduced affinity for catecholate-type ferric siderophores,,-1.0,-999.0,,,,,,,,,,,,,P80188_K_145_A
1650,P80188,K,154,A,1ngl:A,135,Strongly reduced affinity for catecholate-type ferric siderophores,,-1.0,-999.0,,,,,,,,,,,,,P80188_K_154_A
1651,P49888,K,85,A,4jvl:A,85,Does not have decreased sulfonation activity towards the estrogens and DHEA.,,,0.0,,,,,,,,,,,,,P49888_K_85_A
1652,P49888,H,107,A,4jvl:A,107,Complete loss of sulfonation activity towards all substrates tested.,,,1.0,,,,,,,,,,,,,P49888_H_107_A
1653,P49888,S,137,A,4jvl:A,137,Decreased gradually the sulfotransferase activity.,,,1.0,,,,,,,,,,,,,P49888_S_137_A
1654,P49888,S,137,C,4jvl:A,137,Decreased gradually the sulfotransferase activity.,,,1.0,,,,,,,,,,,,,P49888_S_137_C
1655,P49888,V,145,E,4jvl:A,145,Substrate specificity constants for estradiol and estrone are reduced. Dramatic 400-fold increase in the ability to sulfonate dopamine.,,,1.0,,,,,,,,,,,,,P49888_V_145_E
1656,P49888,V,269,E,4jvl:A,269,Does not prevent the formation of homodimer.,0.0,,-999.0,,,,,,,,,,,,,P49888_V_269_E
1657,O60942,E,234,A,3s24:A,234,No effect on GTase activity.,,,0.0,,,,,,,,,,,,,O60942_E_234_A
1658,O60942,K,294,A,3s24:A,294,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_K_294_A
1659,O60942,R,299,A,3s24:A,299,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_R_299_A
1660,O60942,E,345,A,3s24:A,345,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_E_345_A
1661,O60942,K,458,A,3s24:F,458,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_K_458_A
1662,O60942,K,460,A,3s24:F,460,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_K_460_A
1663,O60942,R,528,A,3s24:F,528,Strongly reduced GTase activity.,,,1.0,,,,,,,,,,,,,O60942_R_528_A
1664,O60942,R,530,A,3s24:F,530,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_R_530_A
1665,O60942,D,532,A,3s24:F,532,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_D_532_A
1666,O60942,K,533,A,3s24:F,533,Loss of GTase activity.,,,1.0,,,,,,,,,,,,,O60942_K_533_A
1667,O14745,F,355,R,2krg:A,355,Loss of MSX binding.,-1.0,,-999.0,,,,,,,,,,,,,O14745_F_355_R
1668,P51449,A,327,F,3l0l:B,327,Completely abolishes transcriptional activity.,,,1.0,,,,,,,,,,,,,P51449_A_327_F
1669,P51449,F,378,Q,3l0l:B,378,Completely abolishes transcriptional activity.,,,1.0,,,,,,,,,,,,,P51449_F_378_Q
1670,P51449,I,397,N,3l0l:B,397,Nearly abolishes transcriptional activity.,,,1.0,,,,,,,,,,,,,P51449_I_397_N
1671,Q8N5Y2,Y,31,A,3ob9:D,31,Diminishes interaction with histone H4 monomethylated at 'Lys-20'(H4K20Me1).,-1.0,,-999.0,,,,,,,,,,,,,Q8N5Y2_Y_31_A
1672,Q8N5Y2,H,55,A,3ob9:D,55,Diminishes DNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q8N5Y2_H_55_A
1673,Q8N5Y2,F,56,A,3ob9:D,56,Abolishes interaction with histone H4 monomethylated at 'Lys-20'(H4K20Me1).,-1.0,,-999.0,,,,,,,,,,,,,Q8N5Y2_F_56_A
1674,Q8N5Y2,W,59,G,3ob9:D,59,Diminishes DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8N5Y2_W_59_G
1675,Q8N5Y2,R,65,A,3ob9:D,65,Diminishes DNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q8N5Y2_R_65_A
1676,P16442,M,214,T,5bxc:A,214,Alters substrate specificity so that both UDP-N-acetyl-D-galactosamine and UDP-galactose are utilized.,,1.0,-999.0,,,,,,,,,,,,,P16442_M_214_T
1676,P16442,M,214,V,5bxc:A,214,Alters substrate specificity so that both UDP-N-acetyl-D-galactosamine and UDP-galactose are utilized.,,1.0,-999.0,,,,,,,,,,,,,P16442_M_214_V
1677,P16442,P,234,S,5bxc:A,234,Alters substrate specificity of group B transferase.,,-1.0,-999.0,,,,,,,,,,,,,P16442_P_234_S
1678,P16442,E,303,A,5bxc:A,303,Decreases specific activity of group B transferase almost to zero.,,,1.0,,,,,,,,,,,,,P16442_E_303_A
1679,Q9NZK5,C,137,G,3lgg:A,111,Abolishes secretion.,,,-999.0,,,,,,,,,1.0,,,,Q9NZK5_C_137_G
1680,Q9NZK5,W,362,G,3lgg:A,336,Reduces dimerization and enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,Q9NZK5_W_362_G
1681,Q8N5Y8,H,152,A,6hxs:A,152,Loss of ADP-ribosyltransferase activity,,,1.0,,,,,,,,,,,,,Q8N5Y8_H_152_A
1682,Q8N5Y8,H,152,Q,6hxs:A,152,ADP-ribosyltransferase activity is only 6% of wild-type,,,1.0,,,,,,,,,,,,,Q8N5Y8_H_152_Q
1683,Q8N5Y8,Y,182,A,6hxs:A,182,ADP-ribosyltransferase activity is only 6% of wild-type,,,1.0,,,,,,,,,,,,,Q8N5Y8_Y_182_A
1684,Q3MIT2,D,344,A,2v9k:A,344,Abolished tRNA pseudouridine synthase without affecting ability to promote miRNA processing.,,,1.0,,,,,,,,,,,,,Q3MIT2_D_344_A
1685,Q5TDH0,D,252,N,4rgh:A,220,Abolishes aspartic protease activity.,,,1.0,,,,,,,,,,,,,Q5TDH0_D_252_N
1686,Q96L73,R,1914,C,3ooi:A,63,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q96L73_R_1914_C
1687,Q96L73,R,1952,W,3ooi:A,101,Nearly abolished enzyme activity.,,,1.0,,,,,,,,,,,,,Q96L73_R_1952_W
1688,Q9BY11,I,125,E,3hai:A,125,Reduces membrane-binding. Abolishes membrane tubulation.,,-1.0,1.0,,,,,,,,,,,,,Q9BY11_I_125_E
1689,Q9BY11,M,126,E,3hai:A,126,Reduces membrane-binding. Abolishes membrane tubulation.,,-1.0,1.0,,,,,,,,,,,,,Q9BY11_M_126_E
1690,Q9UBN7,H,611,A,5edu:A,611,Reduces histone deacetylase activity.,,,1.0,,,,,,,,,,,,,Q9UBN7_H_611_A
1691,P10599,C,32,S,1cqh:A,32,"Loses its reducing activity, interaction with APEX1 and transcription activation",-1.0,,1.0,,,,,,,,,,,,,P10599_C_32_S
1692,P10599,C,35,S,1cqh:A,35,"Loses its reducing activity, interaction with APEX1 and transcription activation",-1.0,,1.0,,,,,,,,,,,,,P10599_C_35_S
1693,P10599,D,60,N,1cqh:A,60,Loss of pH-dependence of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P10599_D_60_N
1694,P10599,C,62,S,1cqh:A,62,Retains its reducing activity. Retains interaction with APEX1 and transcription activation,0.0,,0.0,,,,,,,,,,,,,P10599_C_62_S
1695,P10599,C,69,S,1cqh:A,69,"No effect on reducing activity, interaction with APEX1 and on S-nitrosylation of C-73. Retains interaction with APEX1 and transcription activation",0.0,,0.0,,,,,,,,,,,,,P10599_C_69_S
1696,P10599,E,70,A,1cqh:A,70,Strongly reduced interaction with CASP3,-1.0,,1.0,,,,,,,,,,,,,P10599_E_70_A
1697,P10599,K,72,A,1cqh:A,72,Strongly reduced interaction with CASP3,-1.0,,1.0,,,,,,,,,,,,,P10599_K_72_A
1698,P10599,C,73,D,1cqh:A,73,Strongly reduced S-nitrosylation of CASP3.,,,1.0,,,,,,,,,,,,,P10599_C_73_D
1699,P10599,C,73,S,1cqh:A,73,"Loss of nitrosylation, and loss of S-nitrosylating activity towards CASP3. Retains interaction with APEX1 and transcription activation",0.0,,1.0,,,,,,,,,,,,,P10599_C_73_S
1701,Q14565,R,230,A,7c99:A,230,Abolishes binding to ssDNA or dsDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q14565_R_230_A
1702,Q14565,F,233,A,7c99:A,233,Abolishes binding to ssDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q14565_F_233_A
1703,Q14565,R,236,A,7c99:A,236,Abolishes binding to ssDNA or dsDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q14565_R_236_A
1704,Q14565,R,242,A,7c99:A,242,Abolishes binding to ssDNA or dsDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q14565_R_242_A
1705,Q14565,E,258,A,7c99:A,258,Decreases octamer stability.,-1.0,,-999.0,,,,,,,,,,,,,Q14565_E_258_A
1705,Q14565,E,258,Q,7c99:A,258,Decreases octamer stability.,-1.0,,-999.0,,,,,,,,,,,,,Q14565_E_258_Q
1706,Q14565,R,311,A,6r3p:A,311,Abolishes binding to ssDNA.,,-1.0,-999.0,,,,,,,,,,,,,Q14565_R_311_A
1707,Q8N5K1,C,92,S,3fnv:B,92,Has the same optical signature of the native protein and improves yields of purified protein and a decreased tendency to aggregate.,,,-999.0,,,,,,,,,,,,,Q8N5K1_C_92_S
1708,Q8N5K1,C,99,S,3fnv:B,99,Impairs interaction with BCL2,-1.0,,-999.0,,,,,,,,,,,,,Q8N5K1_C_99_S
1709,Q8N5K1,C,101,S,3fnv:B,101,Impairs interaction with BCL2,-1.0,,-999.0,,,,,,,,,,,,,Q8N5K1_C_101_S
1710,Q8N5K1,C,110,S,3fnv:B,110,Impairs interaction with BCL2,-1.0,,-999.0,,,,,,,,,,,,,Q8N5K1_C_110_S
1711,Q8N5K1,H,114,Q,3fnv:B,114,Impairs interaction with BCL2,-1.0,,-999.0,,,,,,,,,,,,,Q8N5K1_H_114_Q
1712,Q15233,Y,267,A,5ifm:B,267,Abolishes interaction with PSPC1 and localization in nuclear paraspeckles,-1.0,,-999.0,,,,,,,,,1.0,,,,Q15233_Y_267_A
1713,Q15233,W,271,A,5ifm:B,271,Abolishes interaction with PSPC1 and localization in nuclear paraspeckles,-1.0,,-999.0,,,,,,,,,1.0,,,,Q15233_W_271_A
1714,P29218,K,36,Q,6giu:A,36,50-fold reduction in activity.,,,1.0,,,,,,,,,,,,,P29218_K_36_Q
1715,P29218,D,93,N,6giu:A,93,Loss of activity.,,,1.0,,,,,,,,,,,,,P29218_D_93_N
1716,P29218,S,165,A,6giu:A,165,Reduced enzyme activity with myo-inositol 1-phosphate.,,,1.0,,,,,,,,,,,,,P29218_S_165_A
1716,P29218,S,165,I,6giu:A,165,Reduced enzyme activity with myo-inositol 1-phosphate.,,,1.0,,,,,,,,,,,,,P29218_S_165_I
1717,P29218,E,213,Q,6giu:A,213,Strongly reduced affinity for myo-inositol 1-phosphate and strongly reduced enzyme activity with myo-inositol 1-phosphate.,,-1.0,1.0,,,,,,,,,,,,,P29218_E_213_Q
1718,O00187,Y,74,A,1szb:A,59,Strongly decreases affinity for MBL2. Decreases affinity for FCN2.,-1.0,,-999.0,,,,,,,,,,,,,O00187_Y_74_A
1719,O00187,Y,121,A,1szb:A,106,"Strongly decreases affinity for MBL2, but not for FCN2.",-1.0,,-999.0,,,,,,,,,,,,,O00187_Y_121_A
1720,O00187,E,124,A,1szb:A,109,Decreases affinity for MBL2. Slight decrease in affinity for FCN2.,-1.0,,-999.0,,,,,,,,,,,,,O00187_E_124_A
1721,O00187,R,444,Q,1zjk:A,444,Abolishes autocatalytic cleavage.,,,1.0,,,,,,,,,,,,,O00187_R_444_Q
1722,Q96C03,R,235,E,5wp9:B,235,Unable to associate with DNM1L into filaments forming the tubular structures that wrap around the scission site.,-1.0,,-999.0,,,,,,,,,,,,,Q96C03_R_235_E
1723,P13716,C,122,A,5hms:A,122,Reduces enzyme activity about 1000000-fold,,,1.0,,,,,,,,,,,,,P13716_C_122_A
1724,P13716,C,124,A,5hms:A,124,Reduces enzyme activity about 1000000-fold,,,1.0,,,,,,,,,,,,,P13716_C_124_A
1725,P13716,H,131,A,5hms:A,131,No effect on catalytic activity,,,0.0,,,,,,,,,,,,,P13716_H_131_A
1726,P13716,C,132,A,5hms:A,132,Reduces enzyme activity about 1000000-fold,,,1.0,,,,,,,,,,,,,P13716_C_132_A
1727,P13716,C,223,A,5hms:A,223,No effect on catalytic activity,,,0.0,,,,,,,,,,,,,P13716_C_223_A
1728,Q5VWG9,W,23,R,6mzl:C,50,Loss of interaction with TAF10.,-1.0,,-999.0,,,,,,,,,,,,,Q5VWG9_W_23_R
1729,A0AVK6,R,156,A,4yo2:A,156,Loss of DNA-binding and inhibition of E2F1-dependent activation. Impairs DNA-binding and dimerization,-1.0,-1.0,-999.0,,,,,,,,,,,,,A0AVK6_R_156_A
1730,A0AVK6,R,314,A,4yo2:A,314,Loss of DNA-binding and inhibition of E2F1-dependent activation. Impairs DNA-binding and dimerization,-1.0,-1.0,-999.0,,,,,,,,,,,,,A0AVK6_R_314_A
1731,Q07889,C,282,R,3ksy:A,282,Increases MAPK3 phosphorylation in response to EGF stimulation.,,,-999.0,,,,,,,,,,,,,Q07889_C_282_R
1732,Q8TEV9,T,796,A,6lt0:B,796,Impaired autophagosome maturation,,,-999.0,,,,,,,,,,,,,Q8TEV9_T_796_A
1733,Q8TEV9,T,796,D,6lt0:B,796,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,Q8TEV9_T_796_D
1734,Q12884,R,123,A,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_R_123_A
1734,Q12884,R,123,M,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_R_123_M
1734,Q12884,R,123,E,6y0f:C,123,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_R_123_E
1735,Q12884,E,203,A,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_203_A
1735,Q12884,E,203,D,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_203_D
1735,Q12884,E,203,Q,6y0f:C,203,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_203_Q
1736,Q12884,E,204,A,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_204_A
1736,Q12884,E,204,D,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_204_D
1736,Q12884,E,204,Q,6y0f:C,204,"Reduces dipeptidyl peptidase and endopeptidase activities. Does not inhibit cell adhesion, migration and invasion. Inhibits dipeptidyl peptidase and endopeptidase activities",,,1.0,,,,,,,,,,,,,Q12884_E_204_Q
1737,Q12884,S,624,A,6y0f:C,624,"Reduces dipeptidyl peptidase and gelatinolytic activities. Does not inhibit cell adhesion, migration and invasion.",,,1.0,,,,,,,,,,,,,Q12884_S_624_A
1738,Q12884,Y,656,F,6y0f:C,656,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_Y_656_F
1739,Q12884,A,657,D,6y0f:C,657,Inhibits endopeptidase activity. Increases dipeptidyl peptidase activity.,,,-999.0,,,,,,,,,,,,,Q12884_A_657_D
1739,Q12884,A,657,N,6y0f:C,657,Inhibits endopeptidase activity. Increases dipeptidyl peptidase activity.,,,-999.0,,,,,,,,,,,,,Q12884_A_657_N
1740,Q12884,A,657,F,6y0f:C,657,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_A_657_F
1740,Q12884,A,657,V,6y0f:C,657,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_A_657_V
1741,Q12884,A,657,Q,6y0f:C,657,Inhibits endopeptidase activity. No change in dipeptidyl peptidase activity.,,,1.0,,,,,,,,,,,,,Q12884_A_657_Q
1742,Q12884,A,657,S,6y0f:C,657,Reduces strongly endopeptidase activity. No change in dipeptidyl peptidase activity.,,,1.0,,,,,,,,,,,,,Q12884_A_657_S
1742,Q12884,A,657,T,6y0f:C,657,Reduces strongly endopeptidase activity. No change in dipeptidyl peptidase activity.,,,1.0,,,,,,,,,,,,,Q12884_A_657_T
1743,Q12884,N,704,A,6y0f:C,704,Reduces dipeptidyl peptidase and endopeptidase activities.,,,1.0,,,,,,,,,,,,,Q12884_N_704_A
1744,O00327,S,78,E,4h10:A,78,Phosphomimetic mutant which severely impairs DNA binding and CLOCK-ARNTL/BMAL1 transcriptional activity.,,-1.0,-999.0,,,,,,,,,,1.0,,,O00327_S_78_E
1745,O00327,M,88,F,4h10:A,88,No effect on CLOCK binding.,-1.0,,-999.0,,,,,,,,,,,,,O00327_M_88_F
1746,O00327,S,90,E,4h10:A,90,Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity.,,-1.0,-999.0,,,,,,,,,,1.0,,,O00327_S_90_E
1747,O00327,L,125,H,4h10:A,125,Impaired CLOCK binding.,-1.0,,-999.0,,,,,,,,,,,,,O00327_L_125_H
1748,Q92995,W,221,A,2l80:A,34,Does not abolish ability to stabilize SIAH2.,,,0.0,,,,,,,,,,,,,Q92995_W_221_A
1749,Q92995,K,233,A,2l80:A,46,Does not abolish ability to stabilize SIAH2.,,,0.0,,,,,,,,,,,,,Q92995_K_233_A
1750,Q92995,F,273,A,2l80:A,86,Impairs ability to stabilize SIAH2.,,,1.0,,,,,,,,,,,,,Q92995_F_273_A
1751,Q92995,M,664,E,2lbc:A,13,Impairs ability to stabilize SIAH2. Abolishes ability to stabilize SIAH2,,,1.0,,,,,,,,,,,,,Q92995_M_664_E
1752,Q92995,M,739,E,2lbc:A,88,Impairs ability to stabilize SIAH2. Abolishes ability to stabilize SIAH2,,,1.0,,,,,,,,,,,,,Q92995_M_739_E
1753,Q92990,P,219,A,4f52:E,219,Loss of interaction with FKBP4 and FKBP1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92990_P_219_A
1754,Q92990,K,425,A,4f52:E,425,Disrupts interaction with RBX1. Loss of inhibition of SCF (SKP1-Cullin-F-box protein) E3 ubiquitin-protein ligase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q92990_K_425_A
1755,Q92990,N,476,A,4f52:E,476,Disrupts interaction with RBX1. Loss of inhibition of SCF (SKP1-Cullin-F-box protein) E3 ubiquitin-protein ligase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q92990_N_476_A
1756,O00329,R,894,P,5vlr:A,894,Abolishes lipid and protein kinase activities.,,,1.0,,,,,,,,,,,,,O00329_R_894_P
1757,O75817,N,40,Q,6ahr:G,40,Strongly reduced interaction with RPP25.,-1.0,,-999.0,,,,,,,,,,,,,O75817_N_40_Q
1758,P07451,K,64,H,3uyq:A,64,Enhanced proton transfer in catalysis.,,,1.0,,,,,,,,,,,,,P07451_K_64_H
1759,P07451,R,67,H,3uyq:A,67,Enhanced proton transfer in catalysis.,,,1.0,,,,,,,,,,,,,P07451_R_67_H
1760,P07451,F,197,L,3uyq:A,197,Enhanced activity by at least 10-fold.,,,1.0,,,,,,,,,,,,,P07451_F_197_L
1761,Q96CB9,V,65,R,4fzv:A,65,Disrupts complex with MTERFD2,-1.0,,-999.0,,,,,,,,,,,,,Q96CB9_V_65_R
1762,Q96CB9,R,136,A,4fzv:A,136,Disrupts complex with MTERFD2,-1.0,,-999.0,,,,,,,,,,,,,Q96CB9_R_136_A
1763,Q96CB9,I,139,R,4fzv:A,139,Disrupts complex with MTERFD2,-1.0,,-999.0,,,,,,,,,,,,,Q96CB9_I_139_R
1764,Q96CB9,R,141,A,4fzv:A,141,Disrupts complex with MTERFD2,-1.0,,-999.0,,,,,,,,,,,,,Q96CB9_R_141_A
1765,O14593,D,121,V,3uxg:A,121,Loss of expression.,,,-999.0,,,,,,,,,,,,-1.0,O14593_D_121_V
1766,O14593,Y,224,A,3uxg:A,224,Loss of interaction with RFX5.,-1.0,,-999.0,,,,,,,,,,,,,O14593_Y_224_A
1767,P01732,G,111,R,1akj:D,90,Prevents CD8 expression.,,,-999.0,,,,,,,,,,,,-1.0,P01732_G_111_R
1768,Q86VW2,L,301,E,2rgn:B,301,Abolishes its exchange activity on RHOA.,,,1.0,,,,,,,,,,,,,Q86VW2_L_301_E
1769,Q86VW2,F,471,A,2rgn:B,471,Reduces exchange activity mediated by GNAQ activation,,,1.0,,,,,,,,,,,,,Q86VW2_F_471_A
1770,Q86VW2,L,472,A,2rgn:B,472,Reduces exchange activity mediated by GNAQ activation,,,1.0,,,,,,,,,,,,,Q86VW2_L_472_A
1771,Q86VW2,L,475,A,2rgn:B,475,Reduces exchange activity mediated by GNAQ activation,,,1.0,,,,,,,,,,,,,Q86VW2_L_475_A
1772,Q86VW2,P,478,A,2rgn:B,478,Reduces exchange activity mediated by GNAQ activation,,,1.0,,,,,,,,,,,,,Q86VW2_P_478_A
1773,Q86VW2,I,479,A,2rgn:B,479,Reduces exchange activity mediated by GNAQ activation,,,1.0,,,,,,,,,,,,,Q86VW2_I_479_A
1774,Q9BRS2,D,324,A,6zxg:z,324,Abolishes autophosphorylation activity,,,-999.0,-1.0,,,,,,,,,,,,Q9BRS2_D_324_A
1775,P29320,V,133,E,4l0p:A,133,Loss of EFNA5-binding ability and function.,-1.0,,1.0,,,,,,,,,,,,,P29320_V_133_E
1776,P29320,F,152,L,4l0p:A,152,Loss of EFNA5-binding ability and function.,-1.0,,1.0,,,,,,,,,,,,,P29320_F_152_L
1777,P29320,Y,742,F,3fxx:A,742,Full kinase activity,,,0.0,,,,,,,,,,,,,P29320_Y_742_F
1778,P29320,S,768,A,3fxx:A,768,Full kinase activity,,,0.0,,,,,,,,,,,,,P29320_S_768_A
1779,Q13976,L,281,A,4z07:A,296,Reduces cGMP binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q13976_L_281_A
1780,Q13976,R,282,A,4z07:A,297,Reduces cGMP binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q13976_R_282_A
1781,Q13976,T,302,A,4z07:A,317,Reduces cGMP binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q13976_T_302_A
1782,Q13976,Y,336,A,4ku8:A,351,Reduces cGMP binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q13976_Y_336_A
1783,P62837,K,63,A,2clw:A,63,Strongly reduced interaction with CNTO4.,-1.0,,-999.0,,,,,,,,,,,,,P62837_K_63_A
1783,P62837,K,63,E,2clw:A,63,Strongly reduced interaction with CNTO4.,-1.0,,-999.0,,,,,,,,,,,,,P62837_K_63_E
1784,P62837,C,85,A,2clw:A,85,Catalytically inactive. Loss of ability to promote FBXW2-mediated GCM1 ubiquitination. Inhibition of TNF-alpha-induced degradation of NFKBIA.,,,1.0,,,,,,,,,,,,,P62837_C_85_A
1785,P02649,R,79,T,2l7b:A,61,Changes the plasma lipoprotein distribution of ApoE4 to the HDL.,,,-999.0,,,,,,,,,,,,,P02649_R_79_T
1786,P02649,E,127,A,2l7b:A,109,No effect on plasma lipoprotein distribution.,,,-999.0,,,,,,,,,,,,,P02649_E_127_A
1787,P02649,S,157,R,2l7b:A,139,Increased binding to LDL receptor,1.0,,-999.0,,,,,,,,,,,,,P02649_S_157_R
1788,P02649,H,158,A,2l7b:A,140,Decreased binding to LDL receptor.,-1.0,,-999.0,,,,,,,,,,,,,P02649_H_158_A
1789,P02649,K,161,A,2l7b:A,143,Decreased binding to LDL receptor.,-1.0,,-999.0,,,,,,,,,,,,,P02649_K_161_A
1790,P02649,L,162,P,2l7b:A,144,Decreased binding to LDL receptor.,-1.0,,-999.0,,,,,,,,,,,,,P02649_L_162_P
1791,P02649,L,167,A,2l7b:A,149,Increased binding to LDL receptor,1.0,,-999.0,,,,,,,,,,,,,P02649_L_167_A
1792,P02649,R,168,A,2l7b:A,150,Decreased binding to LDL receptor.,-1.0,,-999.0,,,,,,,,,,,,,P02649_R_168_A
1793,P02649,D,172,A,2l7b:A,154,Restores the LDL receptor binding activity of ApoE2.,0.0,,-999.0,,,,,,,,,,,,,P02649_D_172_A
1794,P02649,T,212,A,2l7b:A,194,Loss of O-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,P02649_T_212_A
1795,Q9P246,D,80,A,2l5y:A,80,No effect on inhibitory activity,,,0.0,,,,,,,,,,,,,Q9P246_D_80_A
1796,Q9P246,E,91,A,2l5y:A,91,No effect on inhibitory activity,,,0.0,,,,,,,,,,,,,Q9P246_E_91_A
1797,Q01167,K,258,A,1jxs:A,3,Decreases DNA-binding to 40%.,,-1.0,-999.0,,,,,,,,,,,,,Q01167_K_258_A
1798,Q01167,K,300,A,1jxs:A,45,Decreases DNA-binding to 20%.,,-1.0,-999.0,,,,,,,,,,,,,Q01167_K_300_A
1799,Q01167,S,305,A,1jxs:A,50,Decreases DNA-binding to 70%.,,-1.0,-999.0,,,,,,,,,,,,,Q01167_S_305_A
1800,Q01167,R,307,A,1jxs:A,52,Abolishes DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q01167_R_307_A
1801,Q01167,H,308,A,1jxs:A,53,No effect on interaction with DVL2.,0.0,,-999.0,,,,,,,,,,,,,Q01167_H_308_A
1802,Q01167,K,328,A,1jxs:A,73,Decreases DNA-binding to 25%.,,-1.0,-999.0,,,,,,,,,,,,,Q01167_K_328_A
1803,Q9BXR0,D,279,N,6h42:A,279,Loss of transglycosylase activity.,,,1.0,,,,,,,,,,,,,Q9BXR0_D_279_N
1804,P20155,P,45,A,2jxd:A,23,No effect on inhibitory activity towards trypsin.,,,0.0,,,,,,,,,,,,,P20155_P_45_A
1805,P20155,R,46,A,2jxd:A,24,Loss of inhibitory activity towards trypsin.,,,1.0,,,,,,,,,,,,,P20155_R_46_A
1806,P20155,H,47,A,2jxd:A,25,Reduces inhibitory activity towards trypsin.,,,1.0,,,,,,,,,,,,,P20155_H_47_A
1807,P20155,F,48,A,2jxd:A,26,Reduces inhibitory activity towards trypsin.,,,1.0,,,,,,,,,,,,,P20155_F_48_A
1808,P09234,C,6,S,2vrd:A,6,Abolishes the binding to U1 snRNP.,-1.0,,-999.0,,,,,,,,,,,,,P09234_C_6_S
1809,P09234,C,9,S,2vrd:A,9,Abolishes the binding to U1 snRNP.,-1.0,,-999.0,,,,,,,,,,,,,P09234_C_9_S
1810,P09234,H,24,Q,2vrd:A,24,Abolishes the binding to U1 snRNP.,-1.0,,-999.0,,,,,,,,,,,,,P09234_H_24_Q
1811,P09234,C,25,S,2vrd:A,25,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,P09234_C_25_S
1812,P09234,H,30,Q,2vrd:A,30,Abolishes the binding to U1 snRNP.,-1.0,,-999.0,,,,,,,,,,,,,P09234_H_30_Q
1813,Q9H8Y8,L,59,A,4edj:A,59,Abolishes organelle clustering,,,-999.0,,,,,,,,,,,,,Q9H8Y8_L_59_A
1814,Q9H8Y8,I,100,S,4edj:A,100,Abolishes organelle clustering,,,-999.0,,,,,,,,,,,,,Q9H8Y8_I_100_S
1815,Q9H8Y8,D,148,N,4edj:A,148,Enhances homodimerization. Loss of ER stress-induced relocalization from Golgi to ER.,1.0,,-999.0,,,,,,,,,1.0,,,,Q9H8Y8_D_148_N
1816,Q9H8Y8,S,189,D,4edj:A,189,Phosphomimetic mutation that decreases the ability to promote organelle clustering.,,,-999.0,,,,,,,,,,1.0,,,Q9H8Y8_S_189_D
1817,Q9H1B7,C,715,A,2cs3:A,18,Loss of transcription activity.,,,1.0,,,,,,,,,,,,,Q9H1B7_C_715_A
1818,P17676,S,288,A,1h88:B,288,Loss of nuclear translocation.,,,-999.0,,,,,,,,,1.0,,,,P17676_S_288_A
1819,P09429,S,35,A,2yrq:A,42,"Greatly reduces phosphorylation, nuclear localization",,,-999.0,-1.0,,,,,,,,1.0,,,,P09429_S_35_A
1820,P09429,S,35,E,2yrq:A,42,Cytoplasmic localization (phosphorylation mimicking),,,-999.0,,,,,,,,,1.0,1.0,,,P09429_S_35_E
1821,P09429,S,39,A,2yrq:A,46,"Greatly reduces phosphorylation, nuclear localization",,,-999.0,-1.0,,,,,,,,1.0,,,,P09429_S_39_A
1822,P09429,S,39,E,2yrq:A,46,Cytoplasmic localization (phosphorylation mimicking),,,-999.0,,,,,,,,,1.0,1.0,,,P09429_S_39_E
1823,P09429,S,42,A,2yrq:A,49,"Greatly reduces phosphorylation, nuclear localization",,,-999.0,-1.0,,,,,,,,1.0,,,,P09429_S_42_A
1824,P09429,S,42,E,2yrq:A,49,Cytoplasmic localization (phosphorylation mimicking),,,-999.0,,,,,,,,,1.0,1.0,,,P09429_S_42_E
1825,P09429,S,46,A,2yrq:A,53,"Greatly reduces phosphorylation, nuclear localization",,,-999.0,-1.0,,,,,,,,1.0,,,,P09429_S_46_A
1826,P09429,S,46,E,2yrq:A,53,Cytoplasmic localization (phosphorylation mimicking),,,-999.0,,,,,,,,,1.0,1.0,,,P09429_S_46_E
1827,P09429,S,53,A,2yrq:A,60,"Greatly reduces phosphorylation, nuclear localization",,,-999.0,-1.0,,,,,,,,1.0,,,,P09429_S_53_A
1828,P09429,S,53,E,2yrq:A,60,Cytoplasmic localization (phosphorylation mimicking),,,-999.0,,,,,,,,,1.0,1.0,,,P09429_S_53_E
1829,P09429,D,67,A,2yrq:A,74,Abolishes cleavage by CASP1 and impairs ability to antagonize apoptosis-induced immune tolerance.,,,-999.0,,,,,,,,,,,,,P09429_D_67_A
1830,P09429,C,106,S,2yrq:A,113,Inhibits oxidation-dependent inactivation of immunostimmulatory activity in apoptotic cells.,,,-999.0,,,,,,,,,,,,,P09429_C_106_S
1831,Q9UKK6,I,114,R,1jkg:A,114,70% reduction in mRNA export activity.,,,1.0,,,,,,,,,,,,,Q9UKK6_I_114_R
1832,Q9UKK6,R,134,D,1jkg:A,134,57% reduction in mRNA export activity and loss of nuclear rim staining.,,,1.0,,,,,,,,,,,,,Q9UKK6_R_134_D
1833,Q9Y251,Y,156,A,5la7:A,156,Alteration of the correct processing of heparanase which results in the cleavage at an upstream site in the linker peptide and no activation of proheparanase.,,,-999.0,,,,,,,,,,,,,Q9Y251_Y_156_A
1833,Q9Y251,Y,156,E,5la7:A,156,Alteration of the correct processing of heparanase which results in the cleavage at an upstream site in the linker peptide and no activation of proheparanase.,,,-999.0,,,,,,,,,,,,,Q9Y251_Y_156_E
1834,Q9Y251,Y,156,V,5la7:A,156,Normal processing.,,,-999.0,0.0,,,,,,,,,,,,Q9Y251_Y_156_V
1835,Q9Y251,K,158,A,5la7:A,158,No association with GS-modified heparin,,-1.0,-999.0,,,,,,,,,,,,,Q9Y251_K_158_A
1836,Q9Y251,K,161,A,5la7:A,161,Two-fold increase in the level of secretion upon addition of GS-modified heparin. No association with GS-modified heparin,,-1.0,-999.0,,,,,,,,,1.0,,,,Q9Y251_K_161_A
1837,Q9Y251,N,162,Q,5la7:A,162,Faster electrophoretic migration typical of a size reduction and important decrease of secretion. Larger size reduction,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_162_Q
1838,Q9Y251,N,178,Q,5la7:A,178,Faster electrophoretic migration typical of a size reduction and important decrease of secretion. Larger size reduction,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_178_Q
1839,Q9Y251,N,200,Q,5la7:A,200,Faster electrophoretic migration typical of a size reduction and partial decrease in secretion. Larger size reduction,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_200_Q
1840,Q9Y251,N,217,Q,5la7:A,217,Faster electrophoretic migration typical of a size reduction and partial decrease in secretion. Larger size reduction,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_217_Q
1841,Q9Y251,E,225,A,5la7:A,225,Loss of heparanase activity. No effect on HPSE-mediated cell adhesion.,,,1.0,,,,,,,,,,,,,Q9Y251_E_225_A
1842,Q9Y251,N,238,Q,5la7:A,238,Faster electrophoretic migration typical of a size reduction. Larger size reduction and important decrease of secretion,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_238_Q
1843,Q9Y251,E,343,A,5la7:A,343,Loss of heparanase activity.,,,1.0,,,,,,,,,,,,,Q9Y251_E_343_A
1844,Q9Y251,D,367,A,5la7:A,367,Strong decrease in heparanase activity.,,,1.0,,,,,,,,,,,,,Q9Y251_D_367_A
1845,Q9Y251,E,378,A,5la7:A,378,No reduction in heparanase activity.,,,0.0,,,,,,,,,,,,,Q9Y251_E_378_A
1846,Q9Y251,E,396,A,5la7:A,396,No reduction in heparanase activity.,,,0.0,,,,,,,,,,,,,Q9Y251_E_396_A
1847,Q9Y251,V,414,K,5la7:A,414,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_V_414_K
1848,Q9Y251,K,417,E,5la7:A,417,No effect on processing nor secretion. No enzyme activity detected.,,,1.0,,,,,,,,,0.0,,,,Q9Y251_K_417_E
1849,Q9Y251,N,459,Q,5la7:A,459,Faster electrophoretic migration typical of a size reduction. Larger size reduction and important decrease of secretion,,,-999.0,,,,,,,,,1.0,,,,Q9Y251_N_459_Q
1850,Q9Y251,P,525,G,5la7:A,525,No effect on processing nor secretion. No enzyme activity detected.,,,1.0,,,,,,,,,0.0,,,,Q9Y251_P_525_G
1851,Q9Y251,F,527,R,5la7:A,527,No effect on processing nor secretion. No enzyme activity detected.,,,1.0,,,,,,,,,0.0,,,,Q9Y251_F_527_R
1852,Q9Y251,S,528,K,5la7:A,528,No effect on processing nor secretion. No enzyme activity detected.,,,1.0,,,,,,,,,0.0,,,,Q9Y251_S_528_K
1853,Q9Y251,Y,529,A,5la7:A,529,No effect on processing nor secretion. No enzyme activity detected.,,,1.0,,,,,,,,,0.0,,,,Q9Y251_Y_529_A
1854,Q9Y251,F,531,R,5la7:A,531,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_F_531_R
1855,Q9Y251,V,533,R,5la7:A,533,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_V_533_R
1856,Q9Y251,I,534,D,5la7:A,534,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_I_534_D
1857,Q9Y251,R,535,A,5la7:A,535,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_R_535_A
1858,Q9Y251,N,536,A,5la7:A,536,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_N_536_A
1859,Q9Y251,A,537,K,5la7:A,537,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_A_537_K
1860,Q9Y251,K,538,A,5la7:A,538,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_K_538_A
1861,Q9Y251,V,539,A,5la7:A,539,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_V_539_A
1862,Q9Y251,A,540,K,5la7:A,540,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_A_540_K
1863,Q9Y251,A,541,K,5la7:A,541,"No effect on processing, secretion nor enzyme activity.",,,0.0,,,,,,,,,0.0,,,,Q9Y251_A_541_K
1864,Q9Y251,C,542,A,5la7:A,542,"Abolishes processing, secretion and enzyme activity.",,,1.0,,,,,,,,,1.0,,,,Q9Y251_C_542_A
1865,P28039,T,61,A,5w78:A,61,Loss of glycosylation. No effect on enzyme activity or localization to cytoplasmic vesicles.,,,0.0,,,-1.0,,,,,,0.0,,,,P28039_T_61_A
1866,P28039,K,173,E,5w7c:C,173,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P28039_K_173_E
1867,P28039,S,263,A,5w7c:C,263,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P28039_S_263_A
1868,P28039,S,263,L,5w7c:C,263,Nearly abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,P28039_S_263_L
1869,P28039,R,345,E,5w7c:C,345,No effect on enzyme activity,,,0.0,,,,,,,,,,,,,P28039_R_345_E
1870,P28039,G,372,M,5w7c:C,372,"Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.",,,1.0,,,,,,,,,,,,,P28039_G_372_M
1871,P28039,K,379,E,5w7c:C,379,No effect on enzyme activity,,,0.0,,,,,,,,,,,,,P28039_K_379_E
1872,P28039,P,419,M,5w7c:C,419,"Loss of enzyme activity with lipopolysaccharide, due to steric hindrance. No effect on activity with small, synthetic substrate.",,,1.0,,,,,,,,,,,,,P28039_P_419_M
1873,Q13029,C,106,Y,2jv0:A,106,Reduced histone methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q13029_C_106_Y
1874,Q13029,A,159,V,2jv0:A,159,Reduced histone methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q13029_A_159_V
1875,O95970,N,192,Q,5y31:B,192,Affects glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O95970_N_192_Q
1876,O95970,N,277,Q,5y31:B,277,Affects glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O95970_N_277_Q
1877,O95970,N,422,Q,5y31:B,422,Affects glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O95970_N_422_Q
1878,Q9GZN7,F,261,A,5xqh:A,261,Decreased protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q9GZN7_F_261_A
1879,Q9GZN7,L,271,A,5xqh:A,271,Decreased protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q9GZN7_L_271_A
1880,Q99836,I,179,N,2js7:A,35,In Pococurante (Poc),,,-999.0,,,,,,,,,,,,,Q99836_I_179_N
1881,Q99836,R,196,A,2js7:A,52,"Reduced interaction with TIRAP, and strongly reduced activity. Strongly reduced interaction with TIRAP",-1.0,,1.0,,,,,,,,,,,,,Q99836_R_196_A
1882,Q99836,D,197,A,2js7:A,53,Slightly reduced activity.,,,1.0,,,,,,,,,,,,,Q99836_D_197_A
1883,Q99836,C,203,S,2js7:A,59,Abolished interaction with E.coli TcpC without affecting ability to promote Toll-like receptor (TLR)-mediated cytokine production,-1.0,,-999.0,,,,,,,,,,,,,Q99836_C_203_S
1884,Q99836,R,217,A,2js7:A,73,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,Q99836_R_217_A
1885,Q99836,C,280,S,2js7:A,136,Abolished interaction with E.coli TcpC without affecting ability to promote Toll-like receptor (TLR)-mediated cytokine production,-1.0,,-999.0,,,,,,,,,,,,,Q99836_C_280_S
1886,Q99836,K,282,A,2js7:A,138,Slightly reduced activity.,,,1.0,,,,,,,,,,,,,Q99836_K_282_A
1887,Q99836,R,288,A,2js7:A,144,"Slightly reduced activity, and reduced interaction with TIRAP. Strongly reduced interaction with TIRAP",-1.0,,1.0,,,,,,,,,,,,,Q99836_R_288_A
1888,Q9Y6H6,D,90,N,2ndj:A,90,Decreases current 4-fold in KCNH2/KCNE3 channel.,,,1.0,,,,,,,,,,,,,Q9Y6H6_D_90_N
1889,O60716,W,363,A,3l6y:A,363,Severely disrupts cadherin interaction.,-1.0,,-999.0,,,,,,,,,,,,,O60716_W_363_A
1890,O60716,K,401,M,3l6y:A,401,Complete loss of cadherin interaction.,-1.0,,-999.0,,,,,,,,,,,,,O60716_K_401_M
1891,O60716,K,444,M,3l6y:A,444,Severely disrupts cadherin interaction.,-1.0,,-999.0,,,,,,,,,,,,,O60716_K_444_M
1892,O60716,W,477,A,3l6y:A,477,Severely disrupts cadherin interaction.,-1.0,,-999.0,,,,,,,,,,,,,O60716_W_477_A
1893,O60716,N,478,A,3l6y:A,478,Complete loss of cadherin interaction.,-1.0,,-999.0,,,,,,,,,,,,,O60716_N_478_A
1894,P15529,N,83,Q,3o8e:B,49,No effect on cytoprotective function. No effect on Neisseria binding. No effect on Measles virus binding.,0.0,,-999.0,,,,,,,,,,,,,P15529_N_83_Q
1895,P15529,N,114,Q,3o8e:B,80,Strongly decreases cytoprotective function. Decreases Neisseria binding. Abolishes Measles virus binding.,-1.0,,-999.0,,,,,,,,,,,,,P15529_N_114_Q
1896,P15529,N,273,Q,3o8e:B,239,Strongly decreases cytoprotective function. Abolishes Neisseria binding. No effect on Measles virus binding.,-1.0,,-999.0,,,,,,,,,,,,,P15529_N_273_Q
1897,Q14332,Y,77,A,6c0b:B,77,Strongly reduced interaction with C.difficile toxin TcdB.,-1.0,,-999.0,,,,,,,,,,,,,Q14332_Y_77_A
1898,Q14332,K,127,A,6c0b:B,127,Strongly reduced interaction with C.difficile toxin TcdB.,-1.0,,-999.0,,,,,,,,,,,,,Q14332_K_127_A
1898,Q14332,K,127,E,6c0b:B,127,Strongly reduced interaction with C.difficile toxin TcdB.,-1.0,,-999.0,,,,,,,,,,,,,Q14332_K_127_E
1899,Q9NRW1,T,27,N,2ffq:A,27,Loss of APBA1-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW1_T_27_N
1900,Q9NRW1,Q,72,L,2ffq:A,72,Interacts with APBA1.,0.0,,-999.0,,,,,,,,,,,,,Q9NRW1_Q_72_L
1901,Q9NRW3,L,72,D,3vm8:A,72,Resistant to HIV-1 Vif and abolishes Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_L_72_D
1902,Q9NRW3,F,75,W,3vm8:A,75,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_F_75_W
1903,Q9NRW3,C,76,K,3vm8:A,76,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_C_76_K
1904,Q9NRW3,I,79,A,3vm8:A,79,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_I_79_A
1905,Q9NRW3,L,80,A,3vm8:A,80,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_L_80_A
1906,Q9NRW3,S,81,P,3vm8:A,81,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_S_81_P
1907,Q9NRW3,Y,86,A,3vm8:A,86,Resistant to HIV-1 Vif and abolishes Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_Y_86_A
1908,Q9NRW3,E,106,K,3vm8:A,106,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_E_106_K
1909,Q9NRW3,F,107,D,3vm8:A,107,Resistant to HIV-1 Vif and abolishes Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_F_107_D
1910,Q9NRW3,A,109,K,3vm8:A,109,Resistant to HIV-1 Vif.,,,-999.0,,,,,,,,,,,,,Q9NRW3_A_109_K
1911,Q9NRW3,H,111,D,3vm8:A,111,Resistant to HIV-1 Vif and reduces Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_H_111_D
1912,Q9NRW3,P,129,A,3vm8:A,129,No effect on Vif binding.,0.0,,-999.0,,,,,,,,,,,,,Q9NRW3_P_129_A
1913,Q9NRW3,E,141,K,3vm8:A,141,Remains sensitive to HIV-1 Vif but abolishes Vif binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9NRW3_E_141_K
1914,Q5TA50,F,42,A,4k80:A,42,Increases phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_F_42_A
1915,Q5TA50,L,43,R,4k80:A,43,Nearly abolishes phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_L_43_R
1916,Q5TA50,F,50,R,4k80:A,50,Slightly reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_F_50_R
1917,Q5TA50,I,53,N,4k80:A,53,Slightly decreases phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_I_53_N
1918,Q5TA50,D,56,V,4k80:A,56,Slightly decreases phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_D_56_V
1919,Q5TA50,K,60,A,4k80:A,60,Nearly abolishes phosphoceramide transfer. Induces autophagy in a dominant negatif manner.,,,1.0,,,,,,,,,,,,,Q5TA50_K_60_A
1920,Q5TA50,R,97,L,4k80:A,97,No effect.,,,1.0,,,,,,,,,,,,,Q5TA50_R_97_L
1921,Q5TA50,R,106,L,4k80:A,106,Nearly abolishes phosphoceramide transfer. Induces autophagy in a dominant negatif manner.,,,1.0,,,,,,,,,,,,,Q5TA50_R_106_L
1922,Q5TA50,R,110,L,4k80:A,110,Reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_R_110_L
1923,Q5TA50,R,113,E,4k80:A,113,Strongly reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_R_113_E
1923,Q5TA50,R,113,L,4k80:A,113,Strongly reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_R_113_L
1924,Q5TA50,W,117,A,4k80:A,117,Slightly reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_W_117_A
1925,Q5TA50,L,118,R,4k80:A,118,Abolishes phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_L_118_R
1926,Q5TA50,Y,149,A,4k80:A,149,Reduces phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_Y_149_A
1927,Q5TA50,V,158,N,4k80:A,158,Abolishes phosphoceramide transfer.,,,1.0,,,,,,,,,,,,,Q5TA50_V_158_N
1928,Q07869,D,304,A,3et1:B,304,Reduced heterodimerization with RXRA. Reduced DNA binding.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q07869_D_304_A
1929,Q07869,L,370,R,3et1:B,370,Abolishes heterodimerization with RXRA. No DNA binding.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q07869_L_370_R
1930,Q07869,L,391,R,3et1:B,391,Abolishes heterodimerization with RXRA. No DNA binding.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q07869_L_391_R
1931,Q07869,L,422,R,3et1:B,422,No effect on heterodimerization with RXRA nor on DNA binding and transactivation activity.,0.0,0.0,-999.0,,,,,,,,,,,,,Q07869_L_422_R
1932,Q07869,A,431,T,3et1:B,431,No effect on heterodimerization with RXRA nor on DNA binding.,0.0,0.0,-999.0,,,,,,,,,,,,,Q07869_A_431_T
1933,Q07869,L,433,R,3et1:B,433,"Abolishes heterodimerization with RXRA, DNA binding and transactivation activity.",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q07869_L_433_R
1934,P01111,S,89,A,6ziz:A,89,Abolished phosphorylation by STK19.,,,-999.0,,,,,,,,,,,,,P01111_S_89_A
1935,P01111,R,164,A,6ziz:A,164,Loss of GTP-binding activity.,,-1.0,-999.0,,,,,,,,,,,,,P01111_R_164_A
1936,Q92973,W,468,A,1qbk:B,460,Abolishes interaction with the ADAR nuclear localization signal. Abolishes ADAR nuclear import.,,,-999.0,,,,,,,,,,,,,Q92973_W_468_A
1937,Q92973,W,738,A,1qbk:B,730,Abolishes interaction with the ADAR nuclear localization signal. Abolishes ADAR nuclear import.,,,-999.0,,,,,,,,,,,,,Q92973_W_738_A
1938,P42575,C,320,S,2p2c:A,155,Loss of function.,,,1.0,,,,,,,,,,,,,P42575_C_320_S
1939,P42575,A,369,T,1pyo:D,222,Loss of function.,,,1.0,,,,,,,,,,,,,P42575_A_369_T
1940,Q9NPI8,F,251,R,2iqc:A,251,Reduced monoubiquitination of FANCD2.,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_F_251_R
1941,Q9NPI8,Y,287,A,2iqc:A,287,Strongly reduced monoubiquitination of FANCD2,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_Y_287_A
1942,Q9NPI8,L,289,A,2iqc:A,289,Strongly reduced monoubiquitination of FANCD2,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_L_289_A
1943,Q9NPI8,F,339,A,2iqc:A,339,Strongly reduced monoubiquitination of FANCD2,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_F_339_A
1944,Q9NPI8,V,341,A,2iqc:A,341,Strongly reduced monoubiquitination of FANCD2,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_V_341_A
1945,Q9NPI8,L,344,A,2iqc:A,344,Strongly reduced monoubiquitination of FANCD2,,,-999.0,,-1.0,,,,,,,,,,,Q9NPI8_L_344_A
1946,Q15822,W,115,A,5fjv:B,89,Changes ligand activation kinetics in a alpha-2(+),,-1.0,-999.0,,,,,,,,,,,,,Q15822_W_115_A
1947,Q15822,Y,225,F,5fjv:B,199,Decreases ligand activation in LS nAChR subtype,,-1.0,-999.0,,,,,,,,,,,,,Q15822_Y_225_F
1948,Q9NPI6,D,20,A,4b6h:A,20,Lowers decapping activity.,,,1.0,,,,,,,,,,,,,Q9NPI6_D_20_A
1949,Q9NPI6,R,59,A,4b6h:A,59,Lowers decapping activity.,,,1.0,,,,,,,,,,,,,Q9NPI6_R_59_A
1950,Q9UEU0,S,8,W,2v8s:V,8,Abolished binding to CLINT1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UEU0_S_8_W
1951,Q9UEU0,E,12,A,2v8s:V,12,Abolished binding to CLINT1. Abnormal subcellular localization restricted to late endosomes and lysosomes.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9UEU0_E_12_A
1952,Q9UEU0,I,17,S,2v8s:V,17,Normal binding to CLINT1.,0.0,,-999.0,,,,,,,,,,,,,Q9UEU0_I_17_S
1953,Q9UEU0,E,23,R,2v8s:V,23,Abolished binding to CLINT1. Rescued binding to CLINT1 E-146 mutant.,-1.0,,-999.0,,,,,,,,,,,,,Q9UEU0_E_23_R
1954,Q9UEU0,E,65,W,2v8s:V,65,Abolished binding to CLINT1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UEU0_E_65_W
1955,Q9UEU0,F,73,S,2v8s:V,73,Abolished binding to CLINT1. Abnormal subcellular localization restricted to late endosomes and lysosomes.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9UEU0_F_73_S
1956,Q9UEU0,P,76,S,2v8s:V,76,Reduced binding to CLINT1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UEU0_P_76_S
1957,Q9UEU0,M,77,S,2v8s:V,77,Normal binding to CLINT1.,0.0,,-999.0,,,,,,,,,,,,,Q9UEU0_M_77_S
1958,Q8N543,H,155,A,4nhy:A,155,Loss of function.,,,1.0,,,,,,,,,,,,,Q8N543_H_155_A
1959,Q8N543,D,157,A,4nhy:A,157,Loss of function.,,,1.0,,,,,,,,,,,,,Q8N543_D_157_A
1960,P35520,C,272,A,4l3v:A,272,Reduced heme content and cystathionine beta-synthase activity.,,,1.0,,,,,,,,,,,,,P35520_C_272_A
1961,P35520,C,275,S,4l3v:A,275,Reduced heme content and cystathionine beta-synthase activity.,,,1.0,,,,,,,,,,,,,P35520_C_275_S
1962,P35523,I,290,C,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_C
1962,P35523,I,290,E,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_E
1962,P35523,I,290,F,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_F
1962,P35523,I,290,G,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_G
1962,P35523,I,290,K,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_K
1962,P35523,I,290,L,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_L
1962,P35523,I,290,Q,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_Q
1962,P35523,I,290,T,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_T
1962,P35523,I,290,V,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_V
1962,P35523,I,290,Y,6qvu:A,290,Changed chloride channel activity,,,1.0,,,,,,,,,,,,,P35523_I_290_Y
1963,P35523,E,291,D,6qvu:A,291,No effect on calcium channel activity.,,,0.0,,,,,,,,,,,,,P35523_E_291_D
1964,P35523,E,291,L,6qvu:A,291,Loss of calcium channel activity.,,,0.0,,,,,,,,,,,,,P35523_E_291_L
1965,P35523,R,496,K,6qvu:A,496,Changed gating of the channel.,,,1.0,,,,,,,,,,,,,P35523_R_496_K
1966,P35523,G,499,K,6qvu:A,499,Changed gating of the channel.,,,1.0,,,,,,,,,,,,,P35523_G_499_K
1966,P35523,G,499,E,6qvu:A,499,Changed gating of the channel.,,,1.0,,,,,,,,,,,,,P35523_G_499_E
1967,P35523,G,499,Q,6qvu:A,499,No effect on gating of the channel.,,,0.0,,,,,,,,,,,,,P35523_G_499_Q
1968,P35523,E,500,Q,6qvu:A,500,No effect on channel function.,,,0.0,,,,,,,,,,,,,P35523_E_500_Q
1969,P04179,Y,58,A,5t30:A,34,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P04179_Y_58_A
1969,P04179,Y,58,H,5t30:A,34,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P04179_Y_58_H
1969,P04179,Y,58,N,5t30:A,34,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P04179_Y_58_N
1969,P04179,Y,58,V,5t30:A,34,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P04179_Y_58_V
1969,P04179,Y,58,F,5t30:A,34,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P04179_Y_58_F
1971,Q05397,V,928,G,1k05:B,928,Loss of interaction with TGFB1I1.,-1.0,,-999.0,,,,,,,,,,,,,Q05397_V_928_G
1972,Q05397,L,1034,S,1k05:B,1034,Loss of interaction with TGFB1I1.,-1.0,,-999.0,,,,,,,,,,,,,Q05397_L_1034_S
1973,Q05823,K,240,N,4oau:C,240,Reduced 2-5A binding activity,,-1.0,-999.0,,,,,,,,,,,,,Q05823_K_240_N
1974,Q05823,K,274,N,4oau:C,274,Reduced 2-5A binding activity,,-1.0,-999.0,,,,,,,,,,,,,Q05823_K_274_N
1975,Q05823,K,392,R,4oau:C,392,Complete loss of enzymatic activity and enzyme dimerization. No change in binding to 2-5A and RNA.,-1.0,0.0,1.0,,,,,,,,,,,,,Q05823_K_392_R
1976,Q05823,H,583,A,4oau:C,583,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_H_583_A
1977,Q05823,P,584,A,4oau:C,584,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_P_584_A
1978,Q05823,W,632,A,4oav:D,632,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,Q05823_W_632_A
1979,Q05823,D,661,A,4oav:D,661,Complete loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q05823_D_661_A
1980,Q05823,R,667,A,4oav:D,667,Complete loss of enzymatic activity. No change in 2-5A binding and enzyme dimerization.,0.0,0.0,1.0,,,,,,,,,,,,,Q05823_R_667_A
1981,Q05823,H,672,A,4oav:D,672,Complete loss of enzymatic activity. No change in 2-5A binding activity and enzyme dimerization.,0.0,0.0,1.0,,,,,,,,,,,,,Q05823_H_672_A
1982,P54753,K,665,R,5l6p:A,665,Kinase-dead. Loss of autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,P54753_K_665_R
1983,Q8WYN0,C,81,A,2p82:B,81,Reduces the redox sensitivity and retains activity in presence of H(2)O(2).,,,0.0,,,,,,,,,,,,,Q8WYN0_C_81_A
1984,O95425,L,2176,K,2k6n:A,38,Strongly increased affinity for F-actin.,1.0,,-999.0,,,,,,,,,,,,,O95425_L_2176_K
1985,Q9Y3R4,D,46,A,2f25:A,46,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y3R4_D_46_A
1986,Q9Y3R4,E,218,A,2f25:A,218,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y3R4_E_218_A
1986,Q9Y3R4,E,218,Q,2f25:A,218,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y3R4_E_218_Q
1987,Q9Y3R4,Q,270,E,2f25:A,270,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9Y3R4_Q_270_E
1988,P49336,D,173,A,5xs2:A,173,Abrogates kinase activity and TFIIH-dependent transcriptional repression.,,,1.0,,,,,,,,,,,,,P49336_D_173_A
1989,Q7RTN6,Y,185,F,3gni:B,185,Suppresses STK11/LKB1 activation without affecting complex assembly.,0.0,,-999.0,,,,,,,,,,,,,Q7RTN6_Y_185_F
1990,Q7RTN6,H,231,A,3gni:B,231,Inhibits interaction with STK11/LKB1,-1.0,,-999.0,,,,,,,,,,,,,Q7RTN6_H_231_A
1991,Q7RTN6,F,233,A,3gni:B,233,Inhibits interaction with STK11/LKB1,-1.0,,-999.0,,,,,,,,,,,,,Q7RTN6_F_233_A
1992,Q7RTN6,L,241,A,3gni:B,241,Inhibits interaction with STK11/LKB1.,-1.0,,-999.0,,,,,,,,,,,,,Q7RTN6_L_241_A
1993,Q7RTN6,Q,251,A,3gni:B,251,Inhibits interaction with STK11/LKB1.,-1.0,,-999.0,,,,,,,,,,,,,Q7RTN6_Q_251_A
1994,Q9H244,K,80,A,4pxz:A,80,Abolishes ADP binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_K_80_A
1995,Q9H244,S,83,A,4pxz:A,83,No effect on ADP binding.,,0.0,-999.0,,,,,,,,,,,,,Q9H244_S_83_A
1996,Q9H244,C,97,A,4pxz:A,97,Abolishes ADP binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_C_97_A
1997,Q9H244,S,156,A,4py0:A,156,Slightly decreases affinity for ADP.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_S_156_A
1998,Q9H244,N,159,A,4py0:A,159,Slightly decreases affinity for ADP.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_N_159_A
1999,Q9H244,C,175,A,4py0:A,175,Abolishes ADP binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_C_175_A
2000,Q9H244,R,256,A,4py0:A,256,Decreases affinity for ADP.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_R_256_A
2001,Q9H244,K,280,A,4py0:A,280,Abolishes ADP binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_K_280_A
2002,Q9H244,E,281,A,4py0:A,281,Abolishes ADP binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H244_E_281_A
2003,P23415,G,282,A,2m6i:A,254,"Increased single-channel conductance. No effect on glycine sensitivity, but decreased rate of activation.",,,-999.0,,,,,,,,,,,,,P23415_G_282_A
2004,P23415,K,304,C,2m6i:A,276,Decreases channel conductance,,,-999.0,,,,,,,,,,,,,P23415_K_304_C
2005,P63000,G,12,V,2rmk:A,12,Constitutively active. Interacts with PARD6 proteins. Increases nuclear localization and up-regulates transcriptional activity of NR3C2. Doesn't interact with CYRIB. Increases interaction with GARRE1.,,,1.0,,,,,,,,,1.0,,,,P63000_G_12_V
2006,P63000,T,17,N,2rmk:A,17,Constitutively inactivated. Abolishes interaction with PARD6 proteins. No effect on NR3C2 transcriptional activity. No interaction with PPP5C. Doesn't activate PPP5C phosphatase activity and translocate PPP5C to the plasma membrane. Doesn't interact with CYRIB.,,,1.0,,,,,,,,,,,,,P63000_T_17_N
2007,P63000,G,30,V,2rmk:A,30,No interaction with PPP5C,-1.0,,-999.0,,,,,,,,,,,,,P63000_G_30_V
2008,P63000,Y,32,F,2rmk:A,32,Abolishes AMPylation by Haemophilus IbpA.,,,-999.0,,,,,,,,,,,,,P63000_Y_32_F
2009,P63000,T,35,A,2rmk:A,35,Abolishes AMPylation by Vibrio VopS.,,,-999.0,,,,,,,,,,,,,P63000_T_35_A
2010,P63000,T,35,S,2rmk:A,35,No interaction with PPP5C,-1.0,,-999.0,,,,,,,,,,,,,P63000_T_35_S
2011,P63000,F,37,A,2rmk:A,37,Strongly reduced interaction with PLCB2.,-1.0,,-999.0,,,,,,,,,,,,,P63000_F_37_A
2012,P63000,W,56,A,2rmk:A,56,Strongly reduced interaction with PLCB2.,-1.0,,-999.0,,,,,,,,,,,,,P63000_W_56_A
2013,P63000,Q,61,L,2rmk:A,61,"Constitutively active. Interacts with PARD6 proteins. Interacts with PPP5C, activates its phosphatase activity and translocates PPP5C to the plasma membrane. No effect on interaction with RAPH1. Interacts with CYRIB. No interaction with PPP5C",,,1.0,,,,,,,,,,,,,P63000_Q_61_L
2014,P63000,L,67,A,2rmk:A,67,Strongly reduced interaction with PLCB2.,-1.0,,-999.0,,,,,,,,,,,,,P63000_L_67_A
2015,P63000,L,70,A,2rmk:A,70,Strongly reduced interaction with PLCB2.,-1.0,,-999.0,,,,,,,,,,,,,P63000_L_70_A
2016,Q8IVH4,K,290,A,2www:D,290,Abolishes binding to GTP and GTPase activity,,-1.0,1.0,,,,,,,,,,,,,Q8IVH4_K_290_A
2017,Q8IVH4,D,292,A,2www:D,292,Abolishes binding to GTP and GTPase activity,,-1.0,1.0,,,,,,,,,,,,,Q8IVH4_D_292_A
2018,Q14790,D,73,A,4zbw:A,73,Abolishes binding to FLASH. Induces NF-kappa-B activation.,-1.0,,-999.0,,,,,,,,,,,,,Q14790_D_73_A
2019,Q14790,C,360,S,2k7z:A,360,Abolishes interaction with UBR2.,-1.0,,-999.0,,,,,,,,,,,,,Q14790_C_360_S
2020,Q14790,S,387,A,2k7z:A,387,Impaired CDK1-mediated phosphorylation and enhanced apoptosis.,,,-999.0,-1.0,,,,,,,,,,,,Q14790_S_387_A
2021,Q15759,T,180,A,3gc8:A,180,Inactivation.,,,1.0,,,,,,,,,,,,,Q15759_T_180_A
2022,Q15759,Y,182,F,3gc8:A,182,Inactivation.,,,1.0,,,,,,,,,,,,,Q15759_Y_182_F
2023,P20809,H,182,V,6o4o:A,161,Increases affinity for IL11RA and stimulation of cell proliferation.,1.0,,-999.0,,,,,,,,,,,,,P20809_H_182_V
2024,P20809,D,186,A,6o4o:A,165,Strongly increases affinity for IL11RA and stimulation of cell proliferation.,1.0,,-999.0,,,,,,,,,,,,,P20809_D_186_A
2025,P20809,D,186,V,6o4o:A,165,Increases affinity for IL11RA and stimulation of cell proliferation.,1.0,,-999.0,,,,,,,,,,,,,P20809_D_186_V
2026,Q15750,D,213,A,5nzz:D,213,Loss of interaction with XIAP.,-1.0,,-999.0,,,,,,,,,,,,,Q15750_D_213_A
2027,Q15750,F,216,A,5nzz:D,216,Loss of interaction with XIAP.,-1.0,,-999.0,,,,,,,,,,,,,Q15750_F_216_A
2028,Q9NWB1,H,120,A,2n82:B,120,Reduces RNA-binding affinity 160-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_H_120_A
2029,Q9NWB1,F,126,A,2n82:B,126,Reduces RNA-binding affinity 1500-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_A
2029,Q9NWB1,F,126,I,2n82:B,126,Reduces RNA-binding affinity 1500-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_I
2029,Q9NWB1,F,126,R,2n82:B,126,Reduces RNA-binding affinity 1500-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_R
2030,Q9NWB1,F,126,H,2n82:B,126,Reduces RNA-binding affinity 15-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_H
2030,Q9NWB1,F,126,W,2n82:B,126,Reduces RNA-binding affinity 15-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_W
2031,Q9NWB1,F,126,Y,2n82:B,126,No effect on RNA-binding.,,0.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_126_Y
2032,Q9NWB1,F,158,A,2n82:B,158,Reduces RNA-binding affinity 700-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_158_A
2033,Q9NWB1,F,160,A,2n82:B,160,Reduces RNA-binding affinity 30'000-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9NWB1_F_160_A
2034,Q5JS13,L,148,A,3qxl:A,148,Loss of activity.,,,1.0,,,,,,,,,,,,,Q5JS13_L_148_A
2035,Q96DC9,G,47,P,4fjv:A,47,Affects its ability to cleave 'K63'-linked ubiquitin.,,,1.0,,,,,,,,,,,,,Q96DC9_G_47_P
2036,Q96DC9,C,51,S,4fjv:A,51,Loss of function in vitro.,,,1.0,,,,,,,,,,,,,Q96DC9_C_51_S
2037,Q96DC9,N,226,A,4fjv:A,226,Abolishes deubiquitinase activity.,,,1.0,,,,,,,,,,,,,Q96DC9_N_226_A
2038,P62280,C,60,S,6fec:G,60,Abolishes S-acylation.,,,-999.0,,,,,,-1.0,,,,,,,P62280_C_60_S
2039,P67809,W,65,A,6a6j:A,45,Abolished binding to C5-methylcytosine (m5C)-containing mRNAs.,,-1.0,-999.0,,,,,,,,,,,,,P67809_W_65_A
2040,P67809,W,65,F,6a6j:A,45,Decreased binding to C5-methylcytosine (m5C)-containing mRNAs. Decreased ability to discriminate between m5C-containing and unmethylated mRNAs.,,-1.0,-999.0,,,,,,,,,,,,,P67809_W_65_F
2041,P67809,S,102,A,6a6j:A,82,Loss of phosphorylation by PKB/AKT1. Inhibits translocation to the nucleus and tumor cell growth.,,,-999.0,-1.0,,,,,,,,1.0,,,,P67809_S_102_A
2042,Q99549,W,80,A,3lwe:A,25,Abolishes interaction with histone H3K9me3 and prevents recruitment of the HUSH complex to heterochromatin. Impaired ability to mediate silencing of unintegrated retroviral DNA.,-1.0,,-999.0,,,,,,,,,,,,,Q99549_W_80_A
2043,P49427,Y,70,R,4mdk:C,70,Loss of RBX1-binding.,-1.0,,-999.0,,,,,,,,,,,,,P49427_Y_70_R
2044,P49427,N,85,Q,4mdk:C,85,Inhibits both mono and polyubiquitination of NFKBIA.,,,1.0,,,,,,,,,,,,,P49427_N_85_Q
2045,P49427,Y,87,A,4mdk:C,87,Decreases polyubiquitination of NFKBIA.,,,1.0,,,,,,,,,,,,,P49427_Y_87_A
2046,P49427,C,93,S,4mdk:C,93,Loss of function.,,,1.0,,,,,,,,,,,,,P49427_C_93_S
2046,P49427,C,93,A,4mdk:C,93,Loss of function.,,,1.0,,,,,,,,,,,,,P49427_C_93_A
2047,P49427,S,95,D,4mdk:C,95,Inhibits both mono and polyubiquitination of NFKBIA.,,,1.0,,,,,,,,,,,,,P49427_S_95_D
2048,P49427,L,97,S,4mdk:C,97,Loss of function.,,,1.0,,,,,,,,,,,,,P49427_L_97_S
2049,P49427,E,112,A,4mdk:A,112,Inhibits both mono andpolyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_E_112_A
2050,P49427,T,117,E,4mdk:A,117,Loss of RBX1-binding.,-1.0,,-999.0,,,,,,,,,,,,,P49427_T_117_E
2051,P49427,S,129,L,4mdk:A,129,"No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,0.0,,,,,,,,,,,,,P49427_S_129_L
2052,P49427,S,129,R,4mdk:A,129,"Complete loss of activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,1.0,,,,,,,,,,,,,P49427_S_129_R
2053,P49427,E,133,R,4mdk:A,133,"No effect on activity, when assayed in a Sic1-SCF-cdc4 ubiquitination assay.",,,0.0,,,,,,,,,,,,,P49427_E_133_R
2054,P49427,S,138,A,4mdk:A,138,Decreases monoubiquitination of NFKBIA and inhibits polyubiquitination of NFKBIA.,,,1.0,,,,,,,,,,,,,P49427_S_138_A
2055,P49427,D,143,A,4mdk:A,143,Inhibits polyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_D_143_A
2056,P49427,M,147,A,4mdk:A,147,Inhibits polyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_M_147_A
2057,P49427,R,149,A,4mdk:A,149,Inhibits polyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_R_149_A
2058,P49427,K,150,A,4mdk:A,150,Inhibits polyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_K_150_A
2059,P49427,E,153,A,4mdk:A,153,Inhibits polyubiquitination of NFKBIA,,,1.0,,,,,,,,,,,,,P49427_E_153_A
2060,Q96QB1,F,475,G,2dky:A,45,Abolishes interaction with EF1A1.,-1.0,,-999.0,,,,,,,,,,,,,Q96QB1_F_475_G
2061,Q96QB1,L,476,G,2dky:A,46,Abolishes interaction with EF1A1.,-1.0,,-999.0,,,,,,,,,,,,,Q96QB1_L_476_G
2062,Q96QB1,R,1114,E,3kuq:A,1114,No catalytic activity.,,,1.0,,,,,,,,,,,,,Q96QB1_R_1114_E
2063,Q06520,M,137,I,1j99:A,137,Strongly reduces substrate inhibition when ADT or DHEA are used as substrates.,,,-999.0,,,,,,,,,,,,,Q06520_M_137_I
2064,Q06520,M,137,W,1j99:A,137,Substrate inhibition is completly eliminated for DHEA,,,-999.0,,,,,,,,,,,,,Q06520_M_137_W
2065,Q06520,Y,238,A,1j99:A,238,"Completely eliminates the substrate inhibition when ADT is used as substrate. Partially eliminates substrate inhibition when DHEA is used as substrate. Completely eliminates the substrate inhibition for DHEA, when associated with I-137.",,,-999.0,,,,,,,,,,,,,Q06520_Y_238_A
2066,Q06520,Y,238,F,1j99:A,238,Strongly reduces substrate inhibition when ADT or DHEA are used as substrates.,,,-999.0,,,,,,,,,,,,,Q06520_Y_238_F
2067,Q06520,Y,238,W,1j99:A,238,Strongly reduces substrate inhibition when ADT or DHEA are used as substrates.,,,-999.0,,,,,,,,,,,,,Q06520_Y_238_W
2068,P10746,S,63,A,1jr2:A,63,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_S_63_A
2069,P10746,R,65,A,1jr2:A,65,Slightly affects enzymatic activity.,,,1.0,,,,,,,,,,,,,P10746_R_65_A
2070,P10746,T,103,A,1jr2:A,103,Slightly affects enzymatic activity.,,,1.0,,,,,,,,,,,,,P10746_T_103_A
2071,P10746,E,127,A,1jr2:A,127,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_E_127_A
2072,P10746,Y,168,F,1jr2:A,168,Impairs enzymatic activity.,,,1.0,,,,,,,,,,,,,P10746_Y_168_F
2073,P10746,S,197,A,1jr2:A,197,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_S_197_A
2074,P10746,K,220,A,1jr2:A,220,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_K_220_A
2075,P10746,T,227,A,1jr2:A,227,Does not affect enzymatic activity.,,,0.0,,,,,,,,,,,,,P10746_T_227_A
2076,P10746,T,228,A,1jr2:A,228,Impairs enzymatic activity.,,,1.0,,,,,,,,,,,,,P10746_T_228_A
2077,Q9ULW5,T,77,N,2g6b:A,77,"Inactive, constitutively GDP-bound. Abolishes location at Golgi membranes. Impairs transport of ADRA2A and ADRA2B from the Golgi to the cell membrane.",,,1.0,,,,,,,,,1.0,,,,Q9ULW5_T_77_N
2078,Q9ULW5,N,177,I,2g6b:A,177,"Inactive, due to loss of GNP binding. Abolishes location at Golgi membranes. Impairs transport of ADRA2A and ADRA2B from the Golgi to the cell membrane.",,,1.0,,,,,,,,,1.0,,,,Q9ULW5_N_177_I
2079,Q9UQE7,K,105,A,6wg3:B,105,"20% loss of sister chromatid cohesion, no effect on cohesin complex assembly",0.0,-1.0,-999.0,,,,,,,,,,,,,Q9UQE7_K_105_A
2080,Q9UQE7,K,105,Q,6wg3:B,105,"No effect on sister chromatid cohesion, nor on cohesin complex assembly",0.0,0.0,-999.0,,,,,,,,,,,,,Q9UQE7_K_105_Q
2081,Q9UQE7,K,105,R,6wg3:B,105,Stabilizes interaction with PDS5A and WAPL,1.0,,-999.0,,,,,,,,,,,,,Q9UQE7_K_105_R
2082,Q9UQE7,K,106,A,6wg3:B,106,"20% loss of sister chromatid cohesion, no effect on cohesin complex assembly",0.0,-1.0,-999.0,,,,,,,,,,,,,Q9UQE7_K_106_A
2083,Q9UQE7,K,106,Q,6wg3:B,106,"No effect on sister chromatid cohesion, nor on cohesin complex assembly",0.0,0.0,-999.0,,,,,,,,,,,,,Q9UQE7_K_106_Q
2084,Q9UQE7,K,106,R,6wg3:B,106,Stabilizes interaction with PDS5A and WAPL,1.0,,-999.0,,,,,,,,,,,,,Q9UQE7_K_106_R
2085,P09913,R,184,E,4g1t:A,184,Abolishes RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09913_R_184_E
2086,P09913,K,255,E,4g1t:B,255,Significantly impairs RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P09913_K_255_E
2087,P09913,R,259,E,4g1t:B,259,Significantly impairs RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P09913_R_259_E
2088,P09913,R,292,E,4g1t:B,292,Abolishes RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09913_R_292_E
2089,P09913,K,410,E,4g1t:A,410,Abolishes RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09913_K_410_E
2090,Q9HCE7,K,28,A,3pyc:A,28,Fails to ubiquitinate RHOA,,,1.0,,,,,,,,,,,,,Q9HCE7_K_28_A
2091,Q9HCE7,K,85,A,3pyc:A,85,Fails to ubiquitinate RHOA,,,1.0,,,,,,,,,,,,,Q9HCE7_K_85_A
2092,P09917,W,76,A,3o8y:A,75,Impairs interaction with DICER1,-1.0,,-999.0,,,,,,,,,,,,,P09917_W_76_A
2093,P09917,W,103,A,3o8y:A,102,Abolishes binding to COTL1. Impairs interaction with DICER,-1.0,,-999.0,,,,,,,,,,,,,P09917_W_103_A
2094,P09917,S,272,A,3o8y:A,271,Loss of phosphorylation site. Permits export from the nucleus.,,,-999.0,-1.0,,,,,,,,1.0,,,,P09917_S_272_A
2095,P09917,D,359,N,3o8y:A,358,No loss of activity.,,,0.0,,,,,,,,,,,,,P09917_D_359_N
2096,P09917,F,360,W,3o8y:A,359,Loss of (5S)-lipoxygenase activity,,,1.0,,,,,,,,,,,,,P09917_F_360_W
2097,P09917,H,363,S,3o8y:A,362,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_363_S
2097,P09917,H,363,N,3o8y:A,362,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_363_N
2098,P09917,H,368,S,3o8y:A,367,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_368_S
2098,P09917,H,368,N,3o8y:A,367,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_368_N
2098,P09917,H,368,A,3o8y:A,367,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_368_A
2099,P09917,H,373,S,3o8y:A,372,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_373_S
2099,P09917,H,373,N,3o8y:A,372,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_373_N
2100,P09917,E,377,Q,3o8y:A,376,No activity.,,,1.0,,,,,,,,,,,,,P09917_E_377_Q
2101,P09917,H,391,A,3o8y:A,390,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_391_A
2102,P09917,H,391,S,3o8y:A,390,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_391_S
2102,P09917,H,391,N,3o8y:A,390,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_391_N
2103,P09917,H,400,A,3o8y:A,399,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_400_A
2104,P09917,H,400,S,3o8y:A,399,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_400_S
2104,P09917,H,400,N,3o8y:A,399,Still some substantial activity.,,,0.0,,,,,,,,,,,,,P09917_H_400_N
2105,P09917,A,425,I,3o8y:A,424,Loss of (5S)-lipoxygenase activity,,,1.0,,,,,,,,,,,,,P09917_A_425_I
2106,P09917,N,426,M,3o8y:A,425,Loss of (5S)-lipoxygenase activity,,,1.0,,,,,,,,,,,,,P09917_N_426_M
2107,P09917,H,433,N,3o8y:A,432,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P09917_H_433_N
2107,P09917,H,433,A,3o8y:A,432,Almost no loss of activity.,,,0.0,,,,,,,,,,,,,P09917_H_433_A
2108,P09917,S,524,A,3o8y:A,523,Prevents phosphorylation by PKA.,,,-999.0,-1.0,,,,,,,,,,,,P09917_S_524_A
2109,P09917,H,551,N,3o8y:A,550,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_551_N
2109,P09917,H,551,A,3o8y:A,550,No activity.,,,1.0,,,,,,,,,,,,,P09917_H_551_A
2110,P09917,A,604,I,3o8y:A,603,Loss of (5S)-lipoxygenase activity. Loss of (5S)-lipoxygenase activity,,,1.0,,,,,,,,,,,,,P09917_A_604_I
2111,P09917,S,664,A,3o8y:A,663,Does not affect arachidonate 5-lipoxygenase activity. Does not oxygenate arachidonate typical 15-lipoxygenase substrates such as dihomo-gamma-linolenic acid and N-arachidonyl glycine.,,,-999.0,,,,,,,,,,,,,P09917_S_664_A
2112,P09917,S,664,D,3o8y:A,663,Enhances affinity for arachidonic acid. Impairs arachidonate 5-lipoxygenase activity. Induces arachidonate 15-lipoxygenase activity. Oxygenates typical arachidonate 15-lipoxygenase substrates such as dihomo-gamma-linolenic acid and N-arachidonyl glycine. Synthesizes lipoxin A4 when incubated with a stable 5-lipoxygenase.,,1.0,-999.0,,,,,,,,,,,,,P09917_S_664_D
2113,O15519,Y,360,F,3h11:A,360,Decreases apoptosis-inducing activity. Reduces interaction with caspase-3 and proteolytic processing.,-1.0,,1.0,,,,,,,,,,,,,O15519_Y_360_F
2114,P09914,D,34,A,5udk:A,34,Abolishes PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_D_34_A
2115,P09914,R,38,M,5udk:A,38,Abolishes PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_R_38_M
2116,P09914,Q,42,E,5udk:A,42,Reduced PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_Q_42_E
2117,P09914,K,151,M,5udk:A,151,Abolishes PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_K_151_M
2118,P09914,Y,157,F,5udk:A,157,Reduced PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_Y_157_F
2119,P09914,R,187,H,5udk:A,187,Abolishes PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_R_187_H
2120,P09914,R,255,M,5udk:A,255,Abolishes PPP-RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P09914_R_255_M
2121,O15516,S,38,E,4h10:B,38,Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity.,,0.0,0.0,,,,,,,,,,1.0,,,O15516_S_38_E
2122,O15516,S,42,E,4h10:B,42,Phosphomimetic mutant with no effect on DNA binding or CLOCK-ARNTL/BMAL1 transcriptional activity.,,0.0,0.0,,,,,,,,,,1.0,,,O15516_S_42_E
2123,O15516,F,50,M,4h10:B,50,No effect on ARNTL/BMAL1 binding.,0.0,,-999.0,,,,,,,,,,,,,O15516_F_50_M
2124,O15516,H,84,L,4h10:B,84,Impaired ARNTL/BMAL1 binding.,-1.0,,-999.0,,,,,,,,,,,,,O15516_H_84_L
2125,O15516,E,116,K,6qpj:A,116,3-fold increase in PER1 reporter activity by CLOCK-ARNTL/BMAL1. Some reduction of CRY1 inhibition of CLOCK-ARNTL/BMAL1 transcriptional activity,,,1.0,,,,,,,,,,,,,O15516_E_116_K
2126,P11413,K,171,Q,2bh9:A,171,Inhibits catalytic activity. Does not impair dimerization.,0.0,,1.0,,,,,,,,,,,,,P11413_K_171_Q
2127,P11413,K,171,R,2bh9:A,171,Inhibits catalytic activity. Does not impair dimerization.,0.0,,1.0,,,,,,,,,,,,,P11413_K_171_R
2128,P11413,K,386,Q,2bh9:A,386,Impairs dimerization and reduces catalytic activity.,-1.0,,1.0,,,,,,,,,,,,,P11413_K_386_Q
2129,P11413,K,386,R,2bh9:A,386,Does not impair dimerization and catalytic activity.,0.0,,0.0,,,,,,,,,,,,,P11413_K_386_R
2130,P11413,K,403,Q,2bh9:A,403,Impairs dimerization and reduces catalytic activity in cells under oxidative stress.,-1.0,,1.0,,,,,,,,,,,,,P11413_K_403_Q
2131,P11413,K,403,R,2bh9:A,403,Does not impair dimerization and catalytic activity.,0.0,,0.0,,,,,,,,,,,,,P11413_K_403_R
2132,P11142,K,561,R,4kbq:C,561,Complete loss of in vitro methylation by METTL21A.,,,-999.0,,,,,,,,,,,,,P11142_K_561_R
2133,A1L3X0,H,150,A,6y7f:B,150,Loss of activity,,,1.0,,,,,,,,,,,,,A1L3X0_H_150_A
2134,A1L3X0,H,151,A,6y7f:B,151,Loss of activity,,,1.0,,,,,,,,,,,,,A1L3X0_H_151_A
2135,Q96G97,H,67,R,6ds5:A,67,Loss of oligomerization and function in lipid droplet formation,-1.0,,1.0,,,,,,,,,,,,,Q96G97_H_67_R
2136,Q96G97,Y,70,A,6ds5:A,70,Loss of oligomerization and function in lipid droplet formation,-1.0,,1.0,,,,,,,,,,,,,Q96G97_Y_70_A
2137,Q96G97,Y,151,A,6ds5:A,151,Loss of oligomerization and function in lipid droplet biogenesis,-1.0,,1.0,,,,,,,,,,,,,Q96G97_Y_151_A
2138,Q96G97,L,156,D,6ds5:A,156,Loss of oligomerization and function in lipid droplet formation,-1.0,,1.0,,,,,,,,,,,,,Q96G97_L_156_D
2139,Q96G97,L,169,D,6ds5:A,169,Loss of oligomerization and function in lipid droplet formation,-1.0,,1.0,,,,,,,,,,,,,Q96G97_L_169_D
2140,Q96G97,Q,175,A,6ds5:A,175,Loss of oligomerization and function in lipid droplet formation,-1.0,,1.0,,,,,,,,,,,,,Q96G97_Q_175_A
2141,Q96EK6,E,156,A,3cxp:A,156,Reduces affinity for glucosamine-6-phosphate 6-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q96EK6_E_156_A
2142,Q96EK6,E,156,D,3cxp:A,156,Slightly reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q96EK6_E_156_D
2143,P51580,R,152,E,2h11:A,152,Decreases affinity for 6-mercaptopurine. Slightly decreases catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,P51580_R_152_E
2144,Q03154,H,80,A,1q7l:A,80,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_H_80_A
2145,Q03154,D,113,A,1q7l:A,113,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_D_113_A
2146,Q03154,E,147,A,1q7l:A,147,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_E_147_A
2146,Q03154,E,147,Q,1q7l:A,147,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_E_147_Q
2147,Q03154,E,147,D,1q7l:A,147,Decreased protein stability. Loss of enzyme activity.,,,1.0,,,,,,,,,,,-1.0,,Q03154_E_147_D
2148,Q03154,E,148,A,1q7l:A,148,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_E_148_A
2149,Q03154,E,175,A,1q7l:A,175,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_E_175_A
2150,Q03154,H,373,A,1q7l:B,373,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q03154_H_373_A
2151,P10619,S,178,A,1ivy:A,150,Inactivates the enzyme.,,,1.0,,,,,,,,,,,,,P10619_S_178_A
2152,P10619,H,457,Q,1ivy:A,429,Inactivates the enzyme.,,,1.0,,,,,,,,,,,,,P10619_H_457_Q
2153,Q8NI60,K,276,R,4ped:A,276,Does not affect selectivity for binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.,-1.0,0.0,-999.0,,,,,,,,,,,,,Q8NI60_K_276_R
2153,Q8NI60,K,276,H,4ped:A,276,Does not affect selectivity for binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.,-1.0,0.0,-999.0,,,,,,,,,,,,,Q8NI60_K_276_H
2154,Q8NI60,Q,279,R,4ped:A,279,Does not affect selectivity for binding ADP or ATP.,,0.0,-999.0,,,,,,,,,,,,,Q8NI60_Q_279_R
2154,Q8NI60,Q,279,H,4ped:A,279,Does not affect selectivity for binding ADP or ATP.,,0.0,-999.0,,,,,,,,,,,,,Q8NI60_Q_279_H
2155,Q8NI60,A,339,G,4ped:A,339,Enables autophosphorylation but inhibits coenzyme Q biosynthesis in vivo.,,,1.0,1.0,,,,,,,,,,,,Q8NI60_A_339_G
2156,Q8NI60,K,358,R,4ped:A,358,Abolishes binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_K_358_R
2157,Q8NI60,E,405,A,4ped:A,405,Slightly affects selectivity for binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_E_405_A
2157,Q8NI60,E,405,Q,4ped:A,405,Slightly affects selectivity for binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_E_405_Q
2158,Q8NI60,E,411,Q,4ped:A,411,Impaired binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_E_411_Q
2159,Q8NI60,D,488,N,4ped:A,488,Impaired binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_D_488_N
2160,Q8NI60,N,493,A,4ped:A,493,Impaired binding ADP or ATP.,,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_N_493_A
2161,Q8NI60,D,507,N,4ped:A,507,Strongly impairs binding ADP or ATP. Impaired multi-subunit COQ enzyme complex.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q8NI60_D_507_N
2162,Q8NI60,R,611,A,4ped:A,611,Does not affect selectivity for binding ADP or ATP.,,0.0,-999.0,,,,,,,,,,,,,Q8NI60_R_611_A
2162,Q8NI60,R,611,Q,4ped:A,611,Does not affect selectivity for binding ADP or ATP.,,0.0,-999.0,,,,,,,,,,,,,Q8NI60_R_611_Q
2163,P01848,N,130,L,6jxr:m,263,Impairs TR-CD3 complex assembly.,-1.0,,-999.0,,,,,,,,,,,,,P01848_N_130_L
2163,P01848,N,130,F,6jxr:m,263,Impairs TR-CD3 complex assembly.,-1.0,,-999.0,,,,,,,,,,,,,P01848_N_130_F
2164,O14773,H,236,A,3edy:A,236,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,O14773_H_236_A
2165,O14773,D,360,A,3edy:A,360,Inactive. Impaired processing.,,,1.0,,,,,,,,,,,,,O14773_D_360_A
2166,O14773,S,475,A,3edy:A,475,Inactive. Impaired processing.,,,1.0,,,,,,,,,,,,,O14773_S_475_A
2167,O14773,D,517,A,3edy:A,517,Inactive. Impaired processing.,,,1.0,,,,,,,,,,,,,O14773_D_517_A
2168,P15260,V,61,Q,1fg9:D,44,Loss of function in the interferon-gamma-mediated signaling pathway.,,,1.0,,,,,,,,,,,,,P15260_V_61_Q
2169,Q13568,S,446,A,3dsh:A,436,Abolished nuclear translocation.,,,-999.0,,,,,,,,,1.0,,,,Q13568_S_446_A
2170,O14777,E,234,K,2ve7:B,234,Abrogates binding to RB1.,-1.0,,-999.0,,,,,,,,,,,,,O14777_E_234_K
2171,P61086,D,94,E,3e46:A,94,Decreased lysine reactivity and impaired formation of free polyubiquitin chains.,,-1.0,1.0,,,,,,,,,,,,,P61086_D_94_E
2172,Q13564,D,331,A,2nvu:A,331,Impairs the formation of the NEDD8-UBA3 thioester.,,-1.0,-999.0,,,,,,,,,,,,,Q13564_D_331_A
2173,P62068,C,44,S,5cvo:B,44,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P62068_C_44_S
2174,P61081,L,32,A,2nvu:C,32,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_L_32_A
2175,P61081,Q,35,A,2nvu:C,35,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_Q_35_A
2176,P61081,K,36,A,2nvu:C,36,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_K_36_A
2177,P61081,I,38,A,2nvu:C,38,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_I_38_A
2178,P61081,N,39,A,2nvu:C,39,No effect on thioester intermediate formation.,,0.0,-999.0,,,,,,,,,,,,,P61081_N_39_A
2179,P61081,L,41,A,2nvu:C,41,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_L_41_A
2180,P61081,F,51,A,2nvu:C,51,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_F_51_A
2181,P61081,D,55,A,2nvu:C,55,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_D_55_A
2182,P61081,L,57,A,2nvu:C,57,Strongly impairs thioester intermediate formation.,,-1.0,-999.0,,,,,,,,,,,,,P61081_L_57_A
2183,P61081,C,111,S,2nvu:C,111,"Forms a stable complex with NEDD8, which prevents subsequent NEDD8 conjugation to cullins.",1.0,,-999.0,,,,,,,,,,,,,P61081_C_111_S
2184,P61244,K,66,Q,1an2:A,66,Kept nuclear localization. Loss of nuclear localization,,,-999.0,,,,,,,,,,,,,P61244_K_66_Q
2185,P61244,K,66,R,1an2:A,66,"Loss of acetylation, kept nuclear localization",,,-999.0,,,,,,,,,0.0,,,,P61244_K_66_R
2186,P13569,K,464,M,1xmi:A,464,Impaired maturation of glycan chains indicating impaired trafficking from the endoplasmic reticulum to the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P13569_K_464_M
2187,P13569,F,508,R,1xmi:A,508,Impaired maturation of glycan chains indicating impaired trafficking from the endoplasmic reticulum to the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P13569_F_508_R
2188,P13569,I,539,T,1xmi:A,539,Enhances trafficking from the endoplasmic reticulum to the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P13569_I_539_T
2189,P13569,M,1137,R,6o1v:A,1137,"Abolishes channel activity. Impairs protein maturation, suggesting the protein is retained in the endoplasmic reticulum.",,,1.0,,,,,,,,,1.0,,,,P13569_M_1137_R
2190,P13569,I,1139,V,6o1v:A,1139,"Decreases channel activity, no visible effect on protein maturation.",,,1.0,,,,,,,,,,,,,P13569_I_1139_V
2191,P13569,D,1154,G,6o1v:A,1154,"Decreases channel activity, no visible effect on protein maturation.",,,1.0,,,,,,,,,,,,,P13569_D_1154_G
2192,P13569,K,1250,M,6o1v:A,1250,"No effect on maturation of glycans, suggesting that trafficking to the plasma membrane is not altered.",,,-999.0,,,,,,,,,0.0,,,,P13569_K_1250_M
2193,Q9UJW3,F,261,A,2pv0:A,261,Loss of binding to DNMT3A.,-1.0,,-999.0,,,,,,,,,,,,,Q9UJW3_F_261_A
2194,O60481,C,268,S,2rpc:A,31,Increases weakly its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_C_268_S
2195,O60481,H,281,R,2rpc:A,44,Increases its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_H_281_R
2196,O60481,R,304,M,2rpc:A,67,Increases its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_R_304_M
2197,O60481,K,307,M,2rpc:A,70,Increases its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_K_307_M
2198,O60481,K,310,M,2rpc:A,73,Increases its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_K_310_M
2199,O60481,K,312,M,2rpc:A,75,Increases its cytoplasmic localization.,,,-999.0,,,,,,,,,1.0,,,,O60481_K_312_M
2200,O60481,K,314,M,2rpc:A,77,Does not increase its cytoplasmic localization.,,,-999.0,,,,,,,,,0.0,,,,O60481_K_314_M
2201,O60481,R,320,A,2rpc:A,83,Increases its cytoplasmic localization. Does not interact with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_R_320_A
2202,O60481,K,326,M,2rpc:A,89,Does not increase its cytoplasmic localization.,,,-999.0,,,,,,,,,0.0,,,,O60481_K_326_M
2203,O60481,K,337,A,2rpc:A,100,Increases its cytoplasmic localization. Does not interact with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_K_337_A
2204,O60481,R,341,A,2rpc:A,104,Increases its cytoplasmic localization. Does not interact with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_R_341_A
2205,O60481,K,346,A,2rpc:A,109,Increases its cytoplasmic localization. Does not interact with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_K_346_A
2206,O60481,K,349,A,2rpc:A,112,Increases its cytoplasmic localization. Does not interacts with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_K_349_A
2207,O60481,R,350,A,2rpc:A,113,Increases its cytoplasmic localization. Does not interact with KPNA1 and KPNA6 and increases strongly its cytoplasmic localization,-1.0,,-999.0,,,,,,,,,1.0,,,,O60481_R_350_A
2208,O60481,K,356,A,2rpc:A,119,Does not increase its cytoplasmic localization.,,,-999.0,,,,,,,,,0.0,,,,O60481_K_356_A
2209,O95760,E,144,K,2kll:A,34,Decreases affinity for IL1RL1.,-1.0,,-999.0,,,,,,,,,,,,,O95760_E_144_K
2210,O95760,E,148,K,2kll:A,38,7-fold decrease in affinity for IL1RL1.,-1.0,,-999.0,,,,,,,,,,,,,O95760_E_148_K
2211,O95760,D,149,K,2kll:A,39,Almost abolishes binding to IL1RL1.,-1.0,,-999.0,,,,,,,,,,,,,O95760_D_149_K
2212,O95760,E,165,K,2kll:A,55,8-fold decrease in affinity for IL1RL1.,-1.0,,-999.0,,,,,,,,,,,,,O95760_E_165_K
2213,O95760,D,244,K,2kll:A,134,Decreases affinity for IL1RL1.,-1.0,,-999.0,,,,,,,,,,,,,O95760_D_244_K
2214,Q9BU89,H,56,A,4d50:A,56,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_H_56_A
2215,Q9BU89,E,57,A,4d50:A,57,Loss of deoxyhypusine monooxygenase activity. No effect on iron-binding.,,0.0,1.0,,,,,,,,,,,,,Q9BU89_E_57_A
2216,Q9BU89,M,86,A,4d50:A,86,Loss of iron-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BU89_M_86_A
2217,Q9BU89,M,86,L,4d50:A,86,No effect on iron-binding. Loss of iron-binding,,,-999.0,,,,,,,,,,,,,Q9BU89_M_86_L
2218,Q9BU89,H,89,A,4d50:A,89,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_H_89_A
2219,Q9BU89,E,90,A,4d50:A,90,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_E_90_A
2220,Q9BU89,H,207,A,4d50:A,207,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_H_207_A
2221,Q9BU89,E,208,A,4d50:A,208,Loss of deoxyhypusine monooxygenase activity. No effect on iron-binding.,,0.0,1.0,,,,,,,,,,,,,Q9BU89_E_208_A
2222,Q9BU89,M,237,L,4d50:A,237,Decreased iron-binding. Loss of iron-binding,,-1.0,-999.0,,,,,,,,,,,,,Q9BU89_M_237_L
2223,Q9BU89,H,240,A,4d50:A,240,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_H_240_A
2224,Q9BU89,E,241,A,4d50:A,241,Loss of deoxyhypusine monooxygenase activity. Loss of iron-binding.,,-1.0,1.0,,,,,,,,,,,,,Q9BU89_E_241_A
2225,Q9NUN7,D,19,G,6g7o:A,19,Mildly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NUN7_D_19_G
2226,Q9NUN7,E,22,G,6g7o:A,22,Strongly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NUN7_E_22_G
2227,Q9NUN7,N,24,G,6g7o:A,24,Strongly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NUN7_N_24_G
2228,Q9NUN7,S,99,A,6g7o:A,99,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9NUN7_S_99_A
2229,Q9NUN7,Y,149,A,6g7o:A,149,Decreased enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NUN7_Y_149_A
2230,Q9NUN7,S,228,A,6g7o:A,228,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9NUN7_S_228_A
2231,O00206,H,431,A,4g8a:B,431,Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+),,-1.0,-999.0,,,,,,,,,,,,,O00206_H_431_A
2232,O00206,H,456,A,4g8a:B,456,Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+),,-1.0,-999.0,,,,,,,,,,,,,O00206_H_456_A
2233,O00206,H,458,A,4g8a:B,458,Partially diminishes NF-kappa-B activation induced by Ni(2+). Strongly reduces NF-kappa-B activation induced by Ni(2+),,-1.0,-999.0,,,,,,,,,,,,,O00206_H_458_A
2234,O00206,N,526,A,4g8a:B,526,Abolishes LPS-response and prevents the cell surface expression.,,,-999.0,,,,,,,,,1.0,,,,O00206_N_526_A
2235,O00206,N,575,A,4g8a:B,575,Abolishes LPS-response and prevents the cell surface expression.,,,-999.0,,,,,,,,,1.0,,,,O00206_N_575_A
2236,Q9Y2G1,R,454,A,5yhu:A,445,Decreased affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y2G1_R_454_A
2237,Q9Y2G1,R,478,A,5yhu:A,469,Decreased affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y2G1_R_478_A
2238,Q9Y2G1,R,530,A,5yhu:A,521,Decreased affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y2G1_R_530_A
2239,Q8WTS6,E,220,A,1h3i:A,220,Increases near-attack conformations.,,,-999.0,,,,,,,,,,,,,Q8WTS6_E_220_A
2240,Q8WTS6,E,228,A,1h3i:A,228,Increases near-attack conformations.,,,-999.0,,,,,,,,,,,,,Q8WTS6_E_228_A
2241,Q8WTS6,Y,245,A,1h3i:A,245,Significantly reduces the monomethyltransferase activity but increases the dimethyltransferase activity.,,,-999.0,,,,,,,,,,,,,Q8WTS6_Y_245_A
2242,Q8WTS6,K,294,A,1h3i:A,294,Significantly reduces the catalytic activity.,,,1.0,,,,,,,,,,,,,Q8WTS6_K_294_A
2243,Q8WTS6,H,297,A,1h3i:A,297,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8WTS6_H_297_A
2243,Q8WTS6,H,297,G,1h3i:A,297,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8WTS6_H_297_G
2244,Q8WTS6,K,317,A,1h3i:A,317,Induces a reduction in methyltransferase activity toward TAF10 but an increased methyltransferase activity for H3 and p53/TP53.,,,-999.0,,,,,,,,,,,,,Q8WTS6_K_317_A
2245,Q9Y2G5,E,54,A,4ap6:A,54,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_E_54_A
2246,Q9Y2G5,W,92,A,4ap6:A,92,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_W_92_A
2247,Q9Y2G5,W,152,A,4ap6:A,152,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_W_152_A
2248,Q9Y2G5,W,273,A,4ap6:A,273,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_W_273_A
2249,Q9Y2G5,R,294,A,4ap6:A,294,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_R_294_A
2250,Q9Y2G5,D,297,A,4ap6:A,297,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y2G5_D_297_A
2251,Q9Y2G5,E,395,A,4ap6:A,395,No enhanced secretion of ADASMTS13,,,-999.0,,,,,,,,,0.0,,,,Q9Y2G5_E_395_A
2252,Q9Y2G5,E,396,A,4ap6:A,396,Reduces enzyme activity. No enhanced secretion of ADASMTS13,,,1.0,,,,,,,,,0.0,,,,Q9Y2G5_E_396_A
2253,Q15223,N,82,Y,3alp:B,82,Impairs interaction with herpes simplex glycoprotein D. Decreases susceptibility to infection by herpes simplex virus.,-1.0,,-999.0,,,,,,,,,,,,,Q15223_N_82_Y
2254,Q15223,S,84,Y,3alp:B,84,Impairs interaction with herpes simplex glycoprotein D. Decreases susceptibility to infection by herpes simplex virus.,-1.0,,-999.0,,,,,,,,,,,,,Q15223_S_84_Y
2255,Q15223,F,129,A,3alp:B,129,Impairs interaction with herpes simplex glycoprotein D. Decreases susceptibility to infection by herpes simplex virus.,-1.0,,-999.0,,,,,,,,,,,,,Q15223_F_129_A
2255,Q15223,F,129,S,3alp:B,129,Impairs interaction with herpes simplex glycoprotein D. Decreases susceptibility to infection by herpes simplex virus.,-1.0,,-999.0,,,,,,,,,,,,,Q15223_F_129_S
2256,O00194,T,23,N,2f7s:A,23,GDP-locked. Increases interaction with DENND10. Disrupts late endocytic pathway homeostasis.,1.0,,-999.0,,,,,,,,,,,,,O00194_T_23_N
2257,O00194,Q,78,L,2f7s:A,78,GTP-locked. decreases interaction with DENND10.,1.0,,-999.0,,,,,,,,,,,,,O00194_Q_78_L
2258,P07199,K,4,Q,1hlv:A,4,Abolishes N-terminal methylation.,,,-999.0,,,,,,,,,,,,,P07199_K_4_Q
2259,Q6NS38,D,173,A,3bu0:A,173,Loss of activity.,,,1.0,,,,,,,,,,,,,Q6NS38_D_173_A
2260,Q6NS38,H,236,A,3bu0:A,236,Reduced activity.,,,1.0,,,,,,,,,,,,,Q6NS38_H_236_A
2261,P13804,R,249,A,2a1u:A,249,Loss of electron transfer activity.,,,1.0,,,,,,,,,,,,,P13804_R_249_A
2262,Q03393,S,19,A,3i2b:A,19,Decrease in activity,,,1.0,,,,,,,,,,,,,Q03393_S_19_A
2263,P08172,N,58,A,5zkb:A,58,Nearly abolishes signaling via downstream effectors.,,,1.0,,,,,,,,,,,,,P08172_N_58_A
2264,P08172,D,103,E,5zkb:A,103,Reduced affinity for acetylcholine. Abolishes signaling via downstream effectors.,,-1.0,1.0,,,,,,,,,,,,,P08172_D_103_E
2265,P08172,Y,206,F,5zkb:A,206,Abolishes signaling via downstream effectors.,,,1.0,,,,,,,,,,,,,P08172_Y_206_F
2266,P08172,N,404,Q,5zkb:A,404,Reduced affinity for acetylcholine. Reduces signaling via downstream effectors.,,,1.0,,,,,,,,,,,,,P08172_N_404_Q
2267,Q9H9E3,R,729,A,3hr0:A,729,Severe defects in glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q9H9E3_R_729_A
2268,Q9H9E3,E,764,A,3hr0:A,764,Severe defects in glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q9H9E3_E_764_A
2269,O76064,R,42,A,2csw:A,42,"Abolishes interaction with ATM-phosphorylated MDC1. Abolishes interaction with human herpesvirus 1 ICP0. Abolishes recruitment to DNA damage sites after UV irradiation, ionizing radiation, or treatment with an alkylating agent.",-1.0,,-999.0,,,,,,,,,,,,,O76064_R_42_A
2270,O76064,C,403,S,4orh:G,403,Marked reduction of E2-dependent ubiquitination of histone H2A. Loss of UBE2E2- and UBE2N-binding. Loss of nuclear localization.,-1.0,,-999.0,,,,,,,,,1.0,,,,O76064_C_403_S
2271,O76064,I,405,A,4orh:G,405,"Impairs interaction with UBE2L6/UBCH8 and ability to mediate 'Lys-48'-linked ubiquitination E3 ligase activity, while it still catalyzes 'Lys-63'-linked ubiquitination and still interacts with UBE2N/UBC13.",-1.0,,-999.0,,,,,,,,,,,,,O76064_I_405_A
2272,O76064,C,406,S,4orh:G,406,Abolishes ubiquitin-ligase activity.,,,1.0,,,,,,,,,,,,,O76064_C_406_S
2273,O76064,D,443,R,4orh:G,443,Does not affect the monomeric structure but abolishes ability to monoubiquitinate H2A in nucleosomes.,,,-999.0,,,,,,,,,,,0.0,,O76064_D_443_R
2274,P16444,E,141,C,1itu:A,125,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P16444_E_141_C
2275,P16444,E,141,D,1itu:A,125,Abolished dipeptidase activity. Does not affect ability to bind neutrophils.,,0.0,1.0,,,,,,,,,,,,,P16444_E_141_D
2276,P16444,E,141,Q,1itu:A,125,Partial loss of activity.,,,1.0,,,,,,,,,,,,,P16444_E_141_Q
2277,P05109,C,42,A,5hlo:B,42,Loss of antifungal activity.,,,1.0,,,,,,,,,,,,,P05109_C_42_A
2278,O00330,R,183,A,2f60:K,130,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_R_183_A
2279,O00330,S,185,A,2f60:K,132,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_S_185_A
2280,O00330,P,186,A,2f60:K,133,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_P_186_A
2281,O00330,A,187,M,2f60:K,134,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_A_187_M
2282,O00330,R,189,A,2f60:K,136,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_R_189_A
2283,O00330,N,190,A,2f60:K,137,Decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_N_190_A
2284,O00330,N,190,K,2f60:K,137,Moderately decreased interaction with DLD.,-1.0,,-999.0,,,,,,,,,,,,,O00330_N_190_K
2285,O00330,E,193,A,2f60:K,140,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_E_193_A
2286,O00330,R,208,A,2f60:K,155,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_R_208_A
2287,O00330,R,208,D,2f60:K,155,Decreased interaction with DLD.,-1.0,,-999.0,,,,,,,,,,,,,O00330_R_208_D
2288,O00330,I,210,A,2f60:K,157,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_I_210_A
2289,O00330,I,210,R,2f60:K,157,Decreased interaction with DLD.,-1.0,,-999.0,,,,,,,,,,,,,O00330_I_210_R
2290,O00330,I,210,S,2f60:K,157,Decreased interaction with DLD.,-1.0,,-999.0,,,,,,,,,,,,,O00330_I_210_S
2291,O00330,K,213,A,2f60:K,160,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_K_213_A
2292,O00330,E,214,A,2f60:K,161,Strongly decreased DLD binding.,-1.0,,-999.0,,,,,,,,,,,,,O00330_E_214_A
2293,O00445,S,202,G,5h4z:A,202,Does not affect Ca(2+) affinity as measured by isothermal titration calorimetry of the mutant protein.,,0.0,-999.0,,,,,,,,,,,,,O00445_S_202_G
2294,P30038,S,352,A,3v9g:A,352,Reduced affinity for NAD. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P30038_S_352_A
2295,O95365,P,14,S,2nn2:A,14,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_P_14_S
2296,O95365,S,22,R,2nn2:A,22,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,,,,,O95365_S_22_R
2297,O95365,R,49,H,2nn2:A,49,Increased proteasomal degradation. No effect on nuclear localization.,,,-999.0,,,,,,,,,0.0,,,,O95365_R_49_H
2298,O95365,K,60,R,2nn2:A,60,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_K_60_R
2299,O95365,K,61,R,2nn2:A,61,Loss of sumoylation with SUMO1. May decrease interaction with transcriptional corepressors.,-1.0,,-999.0,,,,-1.0,,,,,,,,,O95365_K_61_R
2300,O95365,D,78,E,2if5:A,77,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_D_78_E
2301,O95365,R,112,C,2if5:A,111,No effect on transcription repressor activity. No effect on nuclear localization.,,,0.0,,,,,,,,,0.0,,,,O95365_R_112_C
2302,Q08499,D,503,N,3g58:A,367,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q08499_D_503_N
2303,Q08499,D,527,R,3g58:A,391,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q08499_D_527_R
2304,Q08499,R,563,D,3g58:A,427,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q08499_R_563_D
2305,P06865,N,115,Q,2gk1:I,115,No change of the catalytic activity associated with the alpha-chain. No catalytic activity associated with the alpha-chain,,,-999.0,,,,,,,,,,,,,P06865_N_115_Q
2306,P06865,N,157,Q,2gk1:I,157,No change of the catalytic activity associated with the alpha-chain. No catalytic activity associated with the alpha-chain,,,-999.0,,,,,,,,,,,,,P06865_N_157_Q
2307,P06865,N,295,Q,2gk1:I,295,No change of the catalytic activity associated with the alpha-chain. No catalytic activity associated with the alpha-chain,,,-999.0,,,,,,,,,,,,,P06865_N_295_Q
2308,P06132,D,86,E,3gw3:A,86,5-10% of wild-type activity.,,,1.0,,,,,,,,,,,,,P06132_D_86_E
2309,P06132,D,86,G,3gw3:A,86,Very low activity. Binds substrate with similar geometry as wild-type.,,0.0,1.0,,,,,,,,,,,,,P06132_D_86_G
2310,P06132,D,86,N,3gw3:A,86,No activity. Unable to bind substrate.,,0.0,1.0,,,,,,,,,,,,,P06132_D_86_N
2311,P06132,Y,164,F,3gw3:A,164,25-30% of wild-type activity.,,,1.0,,,,,,,,,,,,,P06132_Y_164_F
2312,Q9H0M0,E,614,A,5hpt:A,614,Reduces ubiquitin transfer.,,,1.0,,,,,,,,,,,,,Q9H0M0_E_614_A
2313,Q9H0M0,H,621,A,5hpt:A,621,Strongly reduces ubiquitin transfer.,,,1.0,,,,,,,,,,,,,Q9H0M0_H_621_A
2314,Q9H0M0,D,675,A,5hpt:A,675,Reduces ubiquitin transfer.,,,1.0,,,,,,,,,,,,,Q9H0M0_D_675_A
2315,Q9H0M0,E,798,A,5hpt:A,798,Reduces ubiquitin transfer. Strongly reduces ubiquitin transfer,,,1.0,,,,,,,,,,,,,Q9H0M0_E_798_A
2316,Q9H0M0,M,804,P,5hpt:A,804,Strongly reduces ubiquitin transfer,,,1.0,,,,,,,,,,,,,Q9H0M0_M_804_P
2317,Q9H0M0,E,806,P,5hpt:A,806,Strongly reduces ubiquitin transfer,,,1.0,,,,,,,,,,,,,Q9H0M0_E_806_P
2318,Q9H0M0,R,845,A,5hpt:A,845,No effect.,,,0.0,,,,,,,,,,,,,Q9H0M0_R_845_A
2319,Q9H0M0,Q,848,A,5hpt:A,848,Abolishes ubiquitin transfer,,,1.0,,,,,,,,,,,,,Q9H0M0_Q_848_A
2320,Q9H0M0,R,855,A,5hpt:A,855,Abolishes ubiquitin transfer,,,1.0,,,,,,,,,,,,,Q9H0M0_R_855_A
2321,Q9BV79,S,85,A,1zsy:A,69,Reduces catalytic activity by 68%.,,,1.0,,,,,,,,,,,,,Q9BV79_S_85_A
2322,Q9BV79,Y,94,F,1zsy:A,78,Reduces catalytic activity by 95%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,1.0,,,,,,,,,,,,,Q9BV79_Y_94_F
2323,Q9BV79,I,129,M,1zsy:A,113,Strongly increases activity with trans-oct-2-enoyl-CoA. No effect on activity with trans-tetradec-2-enoyl-CoA. Decreases activity with trans-hexadec-2-enoyl-CoA by 20%.,,,-999.0,,,,,,,,,,,,,Q9BV79_I_129_M
2324,Q9BV79,G,165,S,1zsy:A,149,Strongly increases activity with trans-oct-2-enoyl-CoA. Decreases activity with trans-tetradec-2-enoyl-CoA by 73%. Decreases activity with trans-hexadec-2-enoyl-CoA by 80%.,,,-999.0,,,,,,,,,,,,,Q9BV79_G_165_S
2325,Q9BV79,T,170,A,1zsy:A,154,Reduces catalytic activity by 69%.,,,1.0,,,,,,,,,,,,,Q9BV79_T_170_A
2326,Q9BV79,W,311,A,1zsy:A,295,Reduces catalytic activity by 98%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,1.0,,,,,,,,,,,,,Q9BV79_W_311_A
2327,Q9BV79,W,311,L,1zsy:A,295,Reduces catalytic activity by 87%. Strongly reduces affinity for trans-oct-2-enoyl-CoA.,,-1.0,1.0,,,,,,,,,,,,,Q9BV79_W_311_L
2328,Q9BV79,F,324,Y,1zsy:A,308,Strongly increases activity with trans-oct-2-enoyl-CoA. Decreases activity with trans-tetradec-2-enoyl-CoA by 25%. Decreases activity with trans-hexadec-2-enoyl-CoA by 68%.,,,-999.0,,,,,,,,,,,,,Q9BV79_F_324_Y
2329,O15296,D,39,A,4nre:A,39,Abolishes calcium-dependent association with membranes,,-1.0,-999.0,,,,,,,,,,,,,O15296_D_39_A
2330,O15296,E,44,A,4nre:A,44,Abolishes calcium-dependent association with membranes,,-1.0,-999.0,,,,,,,,,,,,,O15296_E_44_A
2331,O15296,D,85,A,4nre:A,85,Abolishes calcium-dependent association with membranes,,-1.0,-999.0,,,,,,,,,,,,,O15296_D_85_A
2332,O15296,D,602,Y,4nre:A,602,No effect on the stereoselectivity of the oxygenation reaction. Completely changes the stereoselectivity of the oxygenation reaction to produce (8S)-HPETE instead of (15S)-HPETE,,,-999.0,,,,,,,,,,,,,O15296_D_602_Y
2333,O15296,V,603,H,4nre:A,603,Changes the stereoselectivity of the oxygenation reaction. Completely changes the stereoselectivity of the oxygenation reaction to produce (8S)-HPETE instead of (15S)-HPETE,,,-999.0,,,,,,,,,,,,,O15296_V_603_H
2334,P07686,R,211,K,5bro:A,211,Does not affect the native conformation of the isozyme A. Does not affect hydrolysis of GM2 ganglioside by the isozyme A.,,,-999.0,,,,,,,,,,,0.0,,P07686_R_211_K
2335,P13639,S,595,A,4v6x:Az,595,Strongly reduced phosphorylation at Thr-57.,,,-999.0,-1.0,,,,,,,,,,,,P13639_S_595_A
2336,P13639,H,599,P,4v6x:Az,599,Strongly reduced phosphorylation at Thr-57.,,,1.0,,,,,,,,,,,,,P13639_H_599_P
2337,P13639,H,715,L,4v6x:Az,715,Confers resistance to diphtheria toxin.,,,-999.0,,,,,,,,,,,,,P13639_H_715_L
2337,P13639,H,715,M,4v6x:Az,715,Confers resistance to diphtheria toxin.,,,-999.0,,,,,,,,,,,,,P13639_H_715_M
2337,P13639,H,715,N,4v6x:Az,715,Confers resistance to diphtheria toxin.,,,-999.0,,,,,,,,,,,,,P13639_H_715_N
2337,P13639,H,715,Q,4v6x:Az,715,Confers resistance to diphtheria toxin.,,,-999.0,,,,,,,,,,,,,P13639_H_715_Q
2338,Q96EY1,H,121,Q,6iws:A,35,Loss of modulation of apoptosis.,,,1.0,,,,,,,,,,,,,Q96EY1_H_121_Q
2339,Q495A1,I,42,A,3q0h:A,42,"Abrogates interaction with PVR, cell clustering and PVR signaling.",-1.0,,-999.0,,,,,,,,,,,,,Q495A1_I_42_A
2340,Q495A1,I,42,D,3q0h:A,42,"Abrogates interaction with PVR, cell clustering and PVR signaling.",-1.0,,-999.0,,,,,,,,,,,,,Q495A1_I_42_D
2341,P00492,K,69,A,1bzy:A,68,"Reduced affinity for hypoxanthine, phosphoribosylpyrophosphate and IMP. Reduced catalytic activity.",,-1.0,1.0,,,,,,,,,,,,,P00492_K_69_A
2342,Q6IQ22,S,106,A,2il1:A,202,Loss of phosphorylation. No effect on GDI1 and GDI2 binding.,0.0,,-999.0,-1.0,,,,,,,,,,,,Q6IQ22_S_106_A
2343,Q6IQ22,S,106,E,2il1:A,202,"Phosphomimetic mutant. Loss of GDI1, GDI2, CHM and CHML binding.",-1.0,,-999.0,,,,,,,,,,1.0,,,Q6IQ22_S_106_E
2344,Q6IQ20,Q,158,S,4qn9:B,158,Impairs homodimerization resulting in loss of activity,-1.0,,1.0,,,,,,,,,,,,,Q6IQ20_Q_158_S
2345,Q6IQ20,Y,159,S,4qn9:B,159,Impairs homodimerization resulting in loss of activity,-1.0,,1.0,,,,,,,,,,,,,Q6IQ20_Y_159_S
2346,Q6IQ20,L,207,F,4qn9:B,207,Loss of activity.,,,1.0,,,,,,,,,,,,,Q6IQ20_L_207_F
2347,Q6IQ20,R,257,A,4qn9:B,257,Impairs binding to bile acids resulting in loss of activity.,,-1.0,1.0,,,,,,,,,,,,,Q6IQ20_R_257_A
2348,Q6IQ20,H,380,R,4qn9:B,380,Loss of activity.,,,1.0,,,,,,,,,,,,,Q6IQ20_H_380_R
2349,P04183,T,163,S,1w4r:A,163,140-fold lower K(m) for AZT.,,,1.0,,,,,,,,,,,,,P04183_T_163_S
2350,P78417,C,32,A,6mhd:A,32,Loss of activity.,,,1.0,,,,,,,,,,,,,P78417_C_32_A
2351,P04180,E,173,A,4x96:A,149,Increased activity towards PAPC. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_A
2352,P04180,E,173,D,4x96:A,149,Little change in enzyme specific activity nor in PAPC/POPC activity ratio.,,,0.0,,,,,,,,,,,,,P04180_E_173_D
2353,P04180,E,173,K,4x96:A,149,Decreased enzyme specific activity. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_K
2354,P04180,E,173,L,4x96:A,149,Increased activity towards PAPC. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_L
2355,P04180,E,173,Q,4x96:A,149,Decreased enzyme specific activity. Increased PAPC/POPC activity ratio.,,,1.0,,,,,,,,,,,,,P04180_E_173_Q
2356,P15880,K,58,R,4v6x:AC,58,Does not affect readthrough on the poly(A)-stall sequences,,,0.0,,,,,,,,,,,,,P15880_K_58_R
2357,P15880,K,275,R,4v6x:AC,275,Does not affect readthrough on the poly(A)-stall sequences,,,0.0,,,,,,,,,,,,,P15880_K_275_R
2358,Q9Y4U1,H,122,A,3sc0:A,122,Reduced affinity for cyanocobalamin.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y4U1_H_122_A
2359,Q9Y4U1,R,206,Q,3sc0:A,206,Impairs protein folding.,,,-999.0,,,,,,,,,,,-1.0,,Q9Y4U1_R_206_Q
2360,Q9Y4U1,R,230,Q,3sc0:A,230,Reduced activity in dealkylation of methylcobalamin.,,,1.0,,,,,,,,,,,,,Q9Y4U1_R_230_Q
2361,Q08345,R,105,A,4ag4:A,105,Inhibits collagen-induced phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q08345_R_105_A
2362,Q08345,N,211,A,4ag4:A,211,"Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.",,,-999.0,1.0,,,,,,,,,,,,Q08345_N_211_A
2363,Q08345,N,211,Q,4ag4:A,211,"Sustained phosphorylation regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation. Located intracellularly and at the cell surface. Displays a reduced rate of receptor internalization, which is not altered in the presence of collagen. Able to bind collagen as wild-type. Exhibits enhanced collagen-independent receptor dimerization. Complete loss of the collagen-independent constitutive activation",1.0,,1.0,,,,,,,,,,,,,Q08345_N_211_Q
2364,Q08345,S,213,A,4ag4:A,213,"Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.",,,1.0,,,,,,,,,,,,,Q08345_S_213_A
2365,Q08345,N,260,Q,4ag4:A,260,"Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.",,,1.0,,,,,,,,,,,,,Q08345_N_260_Q
2366,Q08345,K,655,A,6fio:A,655,Loss of kinase activity. Complete loss of the collagen-independent constitutive activation,,,1.0,,,,,,,,,,,,,Q08345_K_655_A
2367,Q08345,G,707,A,6fio:A,707,Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation.,,,1.0,,,,,,,,,,,,,Q08345_G_707_A
2368,Q08345,Y,740,F,3zos:A,740,Abolishes interaction with PTPN11.,-1.0,,-999.0,,,,,,,,,,,,,Q08345_Y_740_F
2369,P17643,Y,362,F,5m8o:A,362,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_Y_362_F
2370,P17643,R,374,S,5m8o:A,374,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_R_374_S
2371,P17643,T,391,V,5m8o:A,391,No effect,0.0,,0.0,,,,,,,,,,,,,P17643_T_391_V
2372,Q9Y6Y9,C,95,Y,2e59:A,95,Abolishes LPS-response.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6Y9_C_95_Y
2373,Q9UQQ1,E,416,A,4twe:A,416,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9UQQ1_E_416_A
2374,Q9BXW9,S,222,A,6vae:B,222,"Reduces phosphorylation by ATM. No effect on ubiquitination, foci formation or DNA repair ability, but impairs S-phase checkpoint activation.",,,0.0,-1.0,0.0,,,,,,,,,,,Q9BXW9_S_222_A
2375,Q9BXW9,K,561,R,6vae:B,561,Abolishes ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,Q9BXW9_K_561_R
2376,Q9BXW9,S,1257,A,6vae:B,1257,No effect on phosphorylation by ATM.,,,-999.0,0.0,,,,,,,,,,,,Q9BXW9_S_1257_A
2377,P08069,Y,980,F,1p4o:B,950,"Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10.",-1.0,,1.0,,,,,,,,,,,,,P08069_Y_980_F
2378,P08069,K,1033,A,1p4o:B,1003,"Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1.",-1.0,,1.0,,,,,,,,,,,,,P08069_K_1033_A
2379,P08069,Y,1280,F,1p4o:B,1250,No effect on GRB10-binding.,0.0,,-999.0,,,,,,,,,,,,,P08069_Y_1280_F
2380,P08069,Y,1281,F,1p4o:B,1251,No effect on GRB10-binding.,0.0,,-999.0,,,,,,,,,,,,,P08069_Y_1281_F
2381,Q9UKV8,L,140,W,6mdz:A,140,No effect.,0.0,,0.0,,,,,,,,,,,,,Q9UKV8_L_140_W
2382,Q9UKV8,F,470,V,4w5t:A,470,No effect on miRNA-binding or target mRNA cleavage. Abrogates binding to the 7-methylguanosine cap of mRNA and prevents inhibition of translation. Abolishes interaction with TNRC6C,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UKV8_F_470_V
2383,Q9UKV8,F,470,W,4w5t:A,470,No effect on binding to the 7-methylguanosine cap of mRNA or inhibition of translation.,,0.0,-999.0,,,,,,,,,,,,,Q9UKV8_F_470_W
2384,Q9UKV8,F,505,V,4w5t:A,505,No effect on miRNA-binding or target mRNA cleavage. Abrogates binding to the 7-methylguanosine cap of mRNA and prevents inhibition of translation and abolishes interaction with TNRC6C,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UKV8_F_505_V
2385,Q9UKV8,F,505,W,4w5t:A,505,No effect on binding to the 7-methylguanosine cap of mRNA or inhibition of translation.,,0.0,-999.0,,,,,,,,,,,,,Q9UKV8_F_505_W
2386,Q9UKV8,K,533,A,4w5t:A,533,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_K_533_A
2387,Q9UKV8,Q,545,A,4w5t:A,545,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_Q_545_A
2388,Q9UKV8,K,570,A,4w5t:A,570,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_K_570_A
2389,Q9UKV8,D,597,A,4w5t:A,597,Abrogates RNA cleavage but does not affect binding to siRNA or translational repression.,,0.0,1.0,,,,,,,,,,,,,Q9UKV8_D_597_A
2390,Q9UKV8,Q,633,A,4w5t:A,633,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_Q_633_A
2391,Q9UKV8,Q,633,R,4w5t:A,633,Abrogates RNA cleavage. Binds siRNA.,,0.0,1.0,,,,,,,,,,,,,Q9UKV8_Q_633_R
2392,Q9UKV8,H,634,P,4w5t:A,634,Abrogates RNA cleavage. Binds siRNA.,,0.0,1.0,,,,,,,,,,,,,Q9UKV8_H_634_P
2392,Q9UKV8,H,634,A,4w5t:A,634,Abrogates RNA cleavage. Binds siRNA.,,0.0,1.0,,,,,,,,,,,,,Q9UKV8_H_634_A
2393,Q9UKV8,D,669,A,4w5t:A,669,Abrogates RNA cleavage but does not affect binding to siRNA.,,0.0,1.0,,,,,,,,,,,,,Q9UKV8_D_669_A
2394,Q9UKV8,E,673,A,4w5t:A,673,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_E_673_A
2395,Q9UKV8,E,673,G,4w5t:A,673,No effect on RNA cleavage.,,,0.0,,,,,,,,,,,,,Q9UKV8_E_673_G
2396,Q9UKV8,F,676,A,4w5t:A,676,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_A
2396,Q9UKV8,F,676,I,4w5t:A,676,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_I
2396,Q9UKV8,F,676,M,4w5t:A,676,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_M
2396,Q9UKV8,F,676,R,4w5t:A,676,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_R
2396,Q9UKV8,F,676,Y,4w5t:A,676,Impairs RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_Y
2397,Q9UKV8,F,676,V,4w5t:A,676,Abrogates RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_F_676_V
2398,Q9UKV8,H,682,Y,4w5t:A,682,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_H_682_Y
2399,Q9UKV8,E,683,G,4w5t:A,683,No effect on RNA cleavage.,,,0.0,,,,,,,,,,,,,Q9UKV8_E_683_G
2400,Q9UKV8,P,700,A,4w5t:A,700,Reduced protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q9UKV8_P_700_A
2401,Q9UKV8,F,704,Y,4w5t:A,704,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_F_704_Y
2402,Q9UKV8,T,744,Y,4w5t:A,744,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9UKV8_T_744_Y
2403,Q9UKV8,H,807,A,4w5t:A,807,Abrogates RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_H_807_A
2403,Q9UKV8,H,807,R,4w5t:A,807,Abrogates RNA cleavage.,,,1.0,,,,,,,,,,,,,Q9UKV8_H_807_R
2404,O75509,N,82,Q,3u3q:A,82,Abolishes one glycosylation site and reduces total N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O75509_N_82_Q
2405,O75509,N,141,Q,3u3q:A,141,Abolishes one glycosylation site and reduces total N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O75509_N_141_Q
2406,Q9UKV3,D,1093,A,6g6s:A,1093,Abolishes cleavage by CASP3 and chromatin condensation activity.,,,1.0,,,,,,,,,,,,,Q9UKV3_D_1093_A
2407,Q9Y6K1,F,732,A,4u7p:A,732,Loss of activity du to the incapacity to bind the regulatory subunit DNMT3L.,-1.0,,1.0,,,,,,,,,,,,,Q9Y6K1_F_732_A
2408,P35354,Q,189,N,5ikq:B,204,Increases two-electron hydroperoxide reduction. Has no effect on cyclooxygenase activity.,,,1.0,,,,,,,,,,,,,P35354_Q_189_N
2409,P35354,Q,189,R,5ikq:B,204,Impairs two-electron hydroperoxide reduction and cyclooxygenase activity.,,,1.0,,,,,,,,,,,,,P35354_Q_189_R
2410,P35354,Q,189,V,5ikq:B,204,Impairs two-electron hydroperoxide reduction.,,,1.0,,,,,,,,,,,,,P35354_Q_189_V
2411,P35354,H,193,A,5ikq:B,208,Reduces two-electron hydroperoxide reduction and cyclooxygenase activity. Catalyzes predominantly one-electron hydroperoxide reduction.,,,1.0,,,,,,,,,,,,,P35354_H_193_A
2412,P35354,Y,371,A,5ikq:B,386,Decreased protein stability. Increased decrease of protein stability,,,-999.0,,,,,,,,,,,-1.0,,P35354_Y_371_A
2413,P35354,S,516,A,5ikq:B,531,No effect on protein stability. Increased decrease of protein stability,,,-999.0,,,,,,,,,,,,,P35354_S_516_A
2414,P35354,S,516,T,5ikq:B,531,Decreased enzyme activity with arachidonic acid. Loss of cyclooxygenase activity,,,1.0,,,,,,,,,,,,,P35354_S_516_T
2415,P35354,G,519,V,5ikq:B,534,Loss of cyclooxygenase activity. Loss of cyclooxygenase activity,,,1.0,,,,,,,,,,,,,P35354_G_519_V
2416,P35354,C,526,S,5ikq:B,541,Prevents activation by nitric oxid (NO).,,-1.0,-999.0,,,,,,,,,,,,,P35354_C_526_S
2417,P35354,C,555,S,5ikq:B,570,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P35354_C_555_S
2418,P35354,C,561,S,5ikq:B,576,Does not affect activation by nitric oxid (NO).,,0.0,-999.0,,,,,,,,,,,,,P35354_C_561_S
2419,Q9Y6K9,S,68,A,3brv:D,68,Increases formation of homodimers.,1.0,,-999.0,,,,,,,,,,,,,Q9Y6K9_S_68_A
2420,Q9Y6K9,S,68,E,3brv:D,68,Abolishes interaction with IKBKB,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6K9_S_68_E
2421,Q9Y6K9,S,85,A,3brv:D,85,Decreases ubiquitination and abolishes nuclear export.,,,-999.0,,-1.0,,,,,,,1.0,,,,Q9Y6K9_S_85_A
2422,Q9Y6K9,K,224,R,3cl3:D,224,No change in the ubiquitination level,,,-999.0,,0.0,,,,,,,,,,,Q9Y6K9_K_224_R
2423,Q9Y6K9,K,277,A,4bwn:A,277,Partial abolition of sumoylation. Abolishes sumoylation and IKK activation,-1.0,,-999.0,,,,-1.0,,,,,,,,,Q9Y6K9_K_277_A
2424,Q9Y6K9,K,285,R,4bwn:A,285,Important decrease in the ubiquitination level,,,-999.0,,,,-1.0,,,,,,,,,Q9Y6K9_K_285_R
2425,Q9Y6K9,E,296,A,4bwn:A,296,"No effet on oligomerization,impairs binding of 'Lys-63'-linked ubiuitin and linear tetra-ubiquitin, impairs TNF-induced NF-kappa-B activation.",0.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_E_296_A
2426,Q9Y6K9,V,300,D,4bwn:A,300,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_V_300_D
2427,Q9Y6K9,L,301,A,4bwn:A,301,Impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_L_301_A
2428,Q9Y6K9,Q,304,A,4bwn:A,304,Complete loss of cleavage by HAV protease 3c.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6K9_Q_304_A
2430,Q9Y6K9,I,307,N,4bwn:A,307,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_I_307_N
2431,Q9Y6K9,Y,308,A,4bwn:A,308,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_Y_308_A
2432,Q9Y6K9,K,309,A,4bwn:A,309,Partial abolition of sumoylation. Abolishes sumoylation and IKK activation,-1.0,,-999.0,,,,-1.0,,,,,,,,,Q9Y6K9_K_309_A
2433,Q9Y6K9,F,312,A,4bwn:A,312,"Greatly impairs tandem ubiquitin binding,impairs oligomerization, impairs TNF-induced NF-kappa-B activation.",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_F_312_A
2434,Q9Y6K9,F,312,W,4bwn:A,312,"MNo effet on oligomerization, preferentially binds tri-ubiquitin chains ('Lys-48' or 'Lys-63'-linked).",,,-999.0,,,,,,,,,,,,,Q9Y6K9_F_312_W
2435,Q9Y6K9,F,312,Y,4bwn:A,312,Impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_F_312_Y
2436,Q9Y6K9,Q,313,A,4bwn:A,313,Impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_Q_313_A
2437,Q9Y6K9,E,315,Q,4bwn:A,315,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_E_315_Q
2438,Q9Y6K9,Q,317,A,4bwn:A,317,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_Q_317_A
2438,Q9Y6K9,Q,317,W,4bwn:A,317,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_Q_317_W
2439,Q9Y6K9,A,323,D,4bwn:A,323,Greatly impairs tandem ubiquitin binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_A_323_D
2440,Q9Y6K9,L,329,A,4bwn:A,329,"Impairs oligomerization, impairs binding of 'Lys-63'-linked ubiuitin, impairs TNF-induced NF-kappa-B activation",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_L_329_A
2441,Q9Y6K9,L,329,P,4bwn:A,329,Abolishes binding to polyubiquitin.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_L_329_P
2442,Q9Y6K9,L,336,A,4bwn:A,336,"Impairs oligomerization, impairs binding of 'Lys-63'-linked ubiuitin, impairs TNF-induced NF-kappa-B activation",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y6K9_L_336_A
2443,P08263,Y,9,F,1pl1:A,9,Decreased isomerase activity.,,,1.0,,,,,,,,,,,,,P08263_Y_9_F
2444,P08263,I,71,A,1pl1:A,71,No significant effect on enzyme activity. Reduces protein stability.,,,0.0,,,,,,,,,,,-1.0,,P08263_I_71_A
2444,P08263,I,71,V,1pl1:A,71,No significant effect on enzyme activity. Reduces protein stability.,,,0.0,,,,,,,,,,,-1.0,,P08263_I_71_V
2445,P08263,A,216,H,1pl1:A,216,Confers ability to hydrolyze S-glutathionyl benzoate to glutathione and benzoic acid.,,,1.0,,,,,,,,,,,,,P08263_A_216_H
2446,P42566,V,154,E,1f8h:A,39,Loss of interaction with STON2 NPF motifs.,-1.0,,-999.0,,,,,,,,,,,,,P42566_V_154_E
2447,P42566,W,169,A,1f8h:A,54,Loss of interaction with STON2 NPF motifs.,-1.0,,-999.0,,,,,,,,,,,,,P42566_W_169_A
2448,P62993,P,49,L,1gri:A,49,Ineffective in DNA synthesis. Abolishes interaction with SHB,-1.0,,1.0,,,,,,,,,,,,,P62993_P_49_L
2449,P62993,E,89,K,1gri:A,89,No effect on the interaction with SOS1.,0.0,,-999.0,,,,,,,,,,,,,P62993_E_89_K
2450,P62993,S,90,N,1gri:A,90,No effect on the interaction with SOS1.,0.0,,-999.0,,,,,,,,,,,,,P62993_S_90_N
2451,P62993,G,203,R,1gri:A,203,Ineffective in DNA synthesis. Abolishes interaction with SOS1.,-1.0,,1.0,,,,,,,,,,,,,P62993_G_203_R
2452,P62993,P,206,L,1gri:A,206,Abolishes interaction with SHB,-1.0,,-999.0,,,,,,,,,,,,,P62993_P_206_L
2453,O76083,H,312,A,4gh6:A,252,Completely abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,O76083_H_312_A
2454,O76083,H,356,A,4gh6:A,296,"Reduces catalytic activity, but has no effect on substrate affinity.",,0.0,1.0,,,,,,,,,,,,,O76083_H_356_A
2455,O76083,M,425,A,4gh6:A,365,Induces a 2 fold change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_M_425_A
2456,O76083,I,463,A,4gh6:A,403,Induces a 6-9 fold change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_I_463_A
2457,O76083,E,466,A,4gh6:A,406,Decreased affinity and catalytic activity for cGMP and cAMP.,,,1.0,,,,,,,,,,,,,O76083_E_466_A
2458,O76083,L,480,A,4gh6:A,420,Induces a 6-9 fold change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_L_480_A
2459,O76083,Y,484,A,4gh6:A,424,Induces a 6-9 fold change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_Y_484_A
2460,O76083,F,501,A,4gh6:A,441,Induces a 2 fold change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_F_501_A
2461,O76083,Q,513,A,4gh6:A,453,Induces a dramatic change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_Q_513_A
2462,O76083,Q,513,E,4gh6:A,453,2 fold decreased affinity and catalytic activity for cGMP. 8 fold decreased catalytic activity for cAMP without affecting the affinity for cAMP.,,,-999.0,,,,,,,,,,,,,O76083_Q_513_E
2463,O76083,F,516,A,4gh6:A,456,Induces a dramatic change in inhibitory sensitivity by BAY-73-9961.,,,-999.0,,,,,,,,,,,,,O76083_F_516_A
2464,Q8NFU3,C,79,A,6bev:B,79,Leads to the loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q8NFU3_C_79_A
2464,Q8NFU3,C,79,S,6bev:B,79,Leads to the loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q8NFU3_C_79_S
2465,P0DJI8,R,33,A,4ip8:A,15,Reduces affinity for heparin,,-1.0,-999.0,,,,,,,,,,,,,P0DJI8_R_33_A
2466,P0DJI8,R,37,A,4ip8:A,19,Reduces affinity for heparin,,-1.0,-999.0,,,,,,,,,,,,,P0DJI8_R_37_A
2467,P0DJI8,R,65,A,4ip8:A,47,Reduces affinity for heparin,,-1.0,-999.0,,,,,,,,,,,,,P0DJI8_R_65_A
2468,P0DJI8,R,80,A,4ip8:A,62,Reduces affinity for heparin and nearly abolishes association with HDL,,-1.0,-999.0,,,,,,,,,,,,,P0DJI8_R_80_A
2469,P0DJI8,H,89,A,4ip8:A,71,Reduces affinity for heparin and nearly abolishes association with HDL,,-1.0,-999.0,,,,,,,,,,,,,P0DJI8_H_89_A
2470,Q92743,S,328,A,3nzi:A,328,Loss of activity.,,,1.0,,,,,,,,,,,,,Q92743_S_328_A
2471,Q92963,S,35,N,4klz:A,35,"Dominant negative. Loss of interaction with AFDN, RLF and RALGDS.",-1.0,,-999.0,,,,,,,,,,,,,Q92963_S_35_N
2472,Q92963,T,53,S,4klz:A,53,"Loss of interaction with AFDN, RLF and RALGDS",-1.0,,-999.0,,,,,,,,,,,,,Q92963_T_53_S
2473,Q92963,E,55,G,4klz:A,55,"Loss of interaction with AFDN, but not with RLF and RALGDS",-1.0,,-999.0,,,,,,,,,,,,,Q92963_E_55_G
2474,Q6NTF7,E,56,Q,6bbo:A,56,Reduces the ability to inhibit the retrotransposition of LINE-1 elements.,,,-999.0,,,,,,,,,,,,,Q6NTF7_E_56_Q
2475,O43809,K,23,R,3mdg:B,23,Abolishes acetylation.,,,-999.0,,,,,,,,,,,,,O43809_K_23_R
2476,O43809,K,29,R,3mdg:B,29,No effect on acetylation.,,,-999.0,,,,,,,,,,,,,O43809_K_29_R
2477,O43809,E,55,A,3mdg:B,55,Reduces affinity for UGUA RNA by 88%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_E_55_A
2478,O43809,R,63,S,3mdg:B,63,Reduces affinity for UGUA RNA by 99%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_R_63_S
2479,O43809,E,81,A,3mdg:B,81,Reduces affinity for UGUA RNA by 12%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_E_81_A
2480,O43809,F,103,A,3mdg:B,103,Reduces affinity for UGUA RNA by 99%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_F_103_A
2481,O43809,F,103,W,3mdg:B,103,Reduces affinity for UGUA RNA by over 90%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_F_103_W
2482,O43809,E,154,A,3mdg:B,154,Reduces affinity for UGUA RNA by 50%.,,-1.0,-999.0,,,,,,,,,,,,,O43809_E_154_A
2483,O43809,Y,158,A,3mdg:B,158,Abolishes interaction with CPSF6,-1.0,,-999.0,,,,,,,,,,,,,O43809_Y_158_A
2484,O43809,Y,160,A,3mdg:B,160,Abolishes interaction with CPSF6,-1.0,,-999.0,,,,,,,,,,,,,O43809_Y_160_A
2485,O43809,L,218,R,3mdg:B,218,Reduces interactions with CPSF6 and CPSF7 and decreases mRNA 3'-processing activity.,-1.0,,1.0,,,,,,,,,,,,,O43809_L_218_R
2486,Q8NFG4,F,118,D,6ulg:L,118,"Does not assemble into a stable folliculin complex (LFC), preventing localization to the lysosomal membrane upon amino acid starvation.",-1.0,,-999.0,,,,,,,,,,,,,Q8NFG4_F_118_D
2487,Q8NFG4,R,164,A,6ulg:L,164,Abolished GTPase activation (GAP) activity.,,-1.0,-999.0,,,,,,,,,,,,,Q8NFG4_R_164_A
2488,Q8NFG4,S,406,A,6ulg:L,406,Impaired ability to regulate autophagy,,,1.0,,,,,,,,,,,,,Q8NFG4_S_406_A
2489,Q8NFG4,S,537,A,6ulg:L,537,Impaired ability to regulate autophagy,,,1.0,,,,,,,,,,,,,Q8NFG4_S_537_A
2490,Q8NFG4,S,542,A,6ulg:L,542,Impaired ability to regulate autophagy,,,1.0,,,,,,,,,,,,,Q8NFG4_S_542_A
2491,Q9BSA9,R,35,A,6wc9:A,35,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_R_35_A
2492,Q9BSA9,F,39,V,6wc9:A,39,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_F_39_V
2493,Q9BSA9,S,40,A,6wc9:A,40,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_S_40_A
2494,Q9BSA9,D,41,A,6wc9:A,41,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_D_41_A
2494,Q9BSA9,D,41,E,6wc9:A,41,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_D_41_E
2494,Q9BSA9,D,41,N,6wc9:A,41,Impaired potassium channel activity.,,,1.0,,,,,,,,,,,,,Q9BSA9_D_41_N
2495,Q9BSA9,I,46,N,6wc9:A,46,Impaired selectivity,,,1.0,,,,,,,,,,,,,Q9BSA9_I_46_N
2496,Q9BSA9,V,50,A,6wc9:A,50,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_V_50_A
2497,Q9BSA9,L,53,A,6wc9:A,53,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_53_A
2498,Q9BSA9,I,271,N,6wc9:B,271,Impaired selectivity,,,1.0,,,,,,,,,,,,,Q9BSA9_I_271_N
2499,Q9BSA9,L,275,A,6wc9:B,275,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_275_A
2500,Q9BSA9,L,278,A,6wc9:B,278,Does not affect selectivity,,,0.0,,,,,,,,,,,,,Q9BSA9_L_278_A
2501,Q15814,R,262,A,2yuh:A,89,Inhibits stimulation of tubulin GTPase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q15814_R_262_A
2502,Q9NPJ3,N,50,A,3f5o:A,50,Reduced acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NPJ3_N_50_A
2503,Q9NPJ3,H,56,A,3f5o:A,56,Decreases affinity for substrate.,,-1.0,-999.0,,,,,,,,,,,,,Q9NPJ3_H_56_A
2504,Q9NPJ3,D,65,A,3f5o:A,65,Loss of acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NPJ3_D_65_A
2505,Q9NPJ3,D,65,E,3f5o:A,65,Reduced acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NPJ3_D_65_E
2505,Q9NPJ3,D,65,N,3f5o:A,65,Reduced acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NPJ3_D_65_N
2506,Q9NPJ3,S,83,A,3f5o:A,83,Reduced acyl-CoA hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NPJ3_S_83_A
2507,Q8WVQ1,D,112,A,1s1d:A,42,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_112_A
2508,Q8WVQ1,D,114,A,1s1d:A,44,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_114_A
2509,Q8WVQ1,S,139,C,1s1d:A,69,Reduces GDPase and ADPase activities 1.7-fold. Severe loss of dimer formation,-1.0,,1.0,,,,,,,,,,,,,Q8WVQ1_S_139_C
2510,Q8WVQ1,G,152,E,1s1d:A,82,Slightly reduced activity.,,,1.0,,,,,,,,,,,,,Q8WVQ1_G_152_E
2511,Q8WVQ1,E,160,Y,1s1d:A,90,Increases GDPase activity 2-fold and ADPase activity 5-fold. Forms dimer even at suboptimal Ca(2+) concentrations.,1.0,,1.0,,,,,,,,,,,,,Q8WVQ1_E_160_Y
2512,Q8WVQ1,R,163,A,1s1d:A,93,Reduces activity by 98%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_R_163_A
2513,Q8WVQ1,E,166,Q,1s1d:A,96,Reduces activity by 95%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_E_166_Q
2514,Q8WVQ1,S,168,A,1s1d:A,98,Reduces activity by over 99.9%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_S_168_A
2515,Q8WVQ1,D,169,N,1s1d:A,99,Reduces activity by 96%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_169_N
2516,Q8WVQ1,D,181,A,1s1d:A,111,Loss of activity.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_181_A
2517,Q8WVQ1,D,182,N,1s1d:A,112,Reduces activity by over 99.9%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_182_N
2518,Q8WVQ1,I,200,C,1s1d:A,130,Reduces GDPase activity 2-fold and ADPase activity 2.5-fold. No effect on dimer formation,0.0,,1.0,,,,,,,,,,,,,Q8WVQ1_I_200_C
2519,Q8WVQ1,S,202,C,1s1d:A,132,Reduces GDPase activity 1.7-fold and ADPase activity 1.5-fold. No effect on dimer formation,0.0,,1.0,,,,,,,,,,,,,Q8WVQ1_S_202_C
2520,Q8WVQ1,D,205,A,1s1d:A,135,Slightly reduced activity.,,,1.0,,,,,,,,,,,,,Q8WVQ1_D_205_A
2521,Q8WVQ1,E,215,Q,1s1d:A,145,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_E_215_Q
2522,Q8WVQ1,E,246,M,1s1d:A,176,Increases activity 5-fold.,,,1.0,,,,,,,,,,,,,Q8WVQ1_E_246_M
2523,Q8WVQ1,S,256,C,1s1d:A,186,No effect on GDPase and ADPase activities. No effect on dimer formation,0.0,,0.0,,,,,,,,,,,,,Q8WVQ1_S_256_C
2524,Q8WVQ1,C,287,S,1s1d:A,217,Reduces GDPase and ADPase activities 1.3-fold.,,,1.0,,,,,,,,,,,,,Q8WVQ1_C_287_S
2525,Q8WVQ1,R,301,A,1s1d:A,231,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q8WVQ1_R_301_A
2526,Q8WVQ1,S,308,C,1s1d:A,238,Reduces GDPase activity 1.3-fold and ADPase activity 2-fold. Severe loss of dimer formation,-1.0,,1.0,,,,,,,,,,,,,Q8WVQ1_S_308_C
2527,Q8WVQ1,A,317,C,1s1d:A,247,Reduces GDPase activity 1.7-fold and ADPase activity 1.5-fold. Severe loss of dimer formation,-1.0,,1.0,,,,,,,,,,,,,Q8WVQ1_A_317_C
2528,P61978,K,422,R,1khm:A,48,Loss of sumoylation. Loss of TP53 transcriptional stimulation.,,,-999.0,,,,-1.0,,,,,,,,,P61978_K_422_R
2529,P61978,D,424,A,1khm:A,50,Loss of sumoylation.,,,-999.0,,,,-1.0,,,,,,,,,P61978_D_424_A
2530,Q9UI30,L,8,D,6kmr:A,8,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,1.0,,,,,,,,,,,,,Q9UI30_L_8_D
2531,Q9UI30,L,9,D,6kmr:A,9,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,1.0,,,,,,,,,,,,,Q9UI30_L_9_D
2532,Q9UI30,I,113,D,6kmr:A,113,Strongly reduced ability to promote N5-methylation of ETF1 together with HEMK2/N6AMT1.,,,1.0,,,,,,,,,,,,,Q9UI30_I_113_D
2533,Q92564,D,250,A,5v89:A,250,Does not affect localization at nucleus,,,-999.0,,,,,,,,,0.0,,,,Q92564_D_250_A
2534,Q92564,A,274,R,5v89:A,274,Does not affect localization at nucleus,,,-999.0,,,,,,,,,0.0,,,,Q92564_A_274_R
2535,Q92564,D,280,A,5v89:A,280,Does not affect localization at nucleus,,,-999.0,,,,,,,,,0.0,,,,Q92564_D_280_A
2536,Q7L5D6,D,84,K,6au8:A,84,Reduces tail-anchored protein delivery.,,,1.0,,,,,,,,,,,,,Q7L5D6_D_84_K
2537,Q7L5D6,Y,182,A,6au8:A,182,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_Y_182_A
2538,Q7L5D6,F,188,A,6au8:A,188,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_F_188_A
2539,Q7L5D6,F,195,A,6au8:A,195,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_F_195_A
2540,Q7L5D6,W,241,A,6au8:A,241,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_W_241_A
2541,Q7L5D6,F,242,A,6au8:A,242,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_F_242_A
2542,Q7L5D6,V,257,A,6au8:A,257,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_V_257_A
2543,Q7L5D6,L,258,A,6au8:A,258,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_L_258_A
2544,Q7L5D6,C,259,A,6au8:A,259,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_C_259_A
2545,Q7L5D6,Y,262,A,6au8:A,262,Inhibits interaction with BAG6.,-1.0,,-999.0,,,,,,,,,,,,,Q7L5D6_Y_262_A
2546,Q7L5D6,L,266,A,6au8:A,266,No effect on interaction with BAG6.,0.0,,-999.0,,,,,,,,,,,,,Q7L5D6_L_266_A
2547,P52564,S,207,A,3vn9:A,207,Inactivation.,,,1.0,,,,,,,,,,,,,P52564_S_207_A
2548,P52564,S,207,E,3vn9:A,207,Constitutive activation according to PubMed,,,1.0,,,,,,,,,,,,,P52564_S_207_E
2549,P52564,T,211,A,3vn9:A,211,Inactivation.,,,1.0,,,,,,,,,,,,,P52564_T_211_A
2550,P52564,T,211,E,3vn9:A,211,Constitutive activation according to PubMed,,,1.0,,,,,,,,,,,,,P52564_T_211_E
2551,P52565,D,45,A,1cc0:E,45,Loss of RHOA interaction,-1.0,,-999.0,,,,,,,,,,,,,P52565_D_45_A
2552,P52565,K,99,A,1cc0:E,99,Loss of interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,P52565_K_99_A
2553,P52565,D,185,A,1cc0:E,185,Loss of RHOA interaction,-1.0,,-999.0,,,,,,,,,,,,,P52565_D_185_A
2554,P52565,K,199,A,1cc0:E,199,Loss of interaction with NGFR.,-1.0,,-999.0,,,,,,,,,,,,,P52565_K_199_A
2555,Q6PH85,D,211,A,4gao:A,211,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q6PH85_D_211_A
2556,Q6PH85,A,235,R,4gao:A,235,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q6PH85_A_235_R
2557,Q6PH85,D,241,A,4gao:A,241,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q6PH85_D_241_A
2558,Q9HAT8,R,106,A,3ega:A,106,Abolishes binding to IRAK1.,-1.0,,-999.0,,,,,,,,,,,,,Q9HAT8_R_106_A
2559,Q9HAT8,T,187,A,3ega:A,187,Abolishes binding to IRAK1,-1.0,,-999.0,,,,,,,,,,,,,Q9HAT8_T_187_A
2560,Q9HAT8,N,188,A,3ega:A,188,Abolishes binding to IRAK1,-1.0,,-999.0,,,,,,,,,,,,,Q9HAT8_N_188_A
2561,Q14203,K,68,A,2coy:A,75,Abolishes interaction with CLIP1.,-1.0,,-999.0,,,,,,,,,,,,,Q14203_K_68_A
2562,Q14203,R,90,E,2coy:A,97,Abolishes interaction with CLIP1.,-1.0,,-999.0,,,,,,,,,,,,,Q14203_R_90_E
2563,Q14258,K,21,R,5eya:G,21,No effect on ISGylation.,0.0,,-999.0,,,,,,,,,,,,,Q14258_K_21_R
2564,Q14258,K,65,R,5eya:G,65,No effect on ISGylation.,0.0,,-999.0,,,,,,,,,,,,,Q14258_K_65_R
2565,O75695,F,101,A,3bh7:B,101,Reduces affinity for mouse ARL3.,-1.0,,-999.0,,,,,,,,,,,,,O75695_F_101_A
2566,O75695,Q,115,A,3bh7:B,115,Reduces affinity for mouse ARL3.,-1.0,,-999.0,,,,,,,,,,,,,O75695_Q_115_A
2567,O75695,Q,116,A,3bh7:B,116,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,1.0,,,,,,,,,,,,,O75695_Q_116_A
2568,O75695,R,118,A,3bh7:B,118,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,1.0,,,,,,,,,,,,,O75695_R_118_A
2569,O75695,R,120,H,3bh7:B,120,Reduces affinity for mouse ARL3,-1.0,,-999.0,,,,,,,,,,,,,O75695_R_120_H
2570,O75695,D,121,S,3bh7:B,121,Reduces affinity for mouse ARL3,-1.0,,-999.0,,,,,,,,,,,,,O75695_D_121_S
2571,O75695,F,177,A,3bh7:B,177,Reduces affinity and GTP-hydrolysis rate for mouse ARL3.,-1.0,,1.0,,,,,,,,,,,,,O75695_F_177_A
2572,Q9UIV1,D,40,N,4gmj:B,40,Abolishes RNA deadenylase activity.,,,1.0,,,,,,,,,,,,,Q9UIV1_D_40_N
2573,Q9UIV1,E,42,Q,4gmj:B,42,Abolishes RNA deadenylase activity.,,,1.0,,,,,,,,,,,,,Q9UIV1_E_42_Q
2574,Q9UIV1,E,138,K,4gmj:B,138,Abolishes interaction with CNOT1,-1.0,,-999.0,,,,,,,,,,,,,Q9UIV1_E_138_K
2575,Q9UIV1,M,141,R,4gmj:B,141,Abolishes interaction with CNOT1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIV1_M_141_R
2576,Q9UIV1,T,142,Y,4gmj:B,142,Abolishes interaction with CNOT1,-1.0,,-999.0,,,,,,,,,,,,,Q9UIV1_T_142_Y
2577,Q9UIV1,E,149,K,4gmj:B,149,Abolishes interaction with CNOT1,-1.0,,-999.0,,,,,,,,,,,,,Q9UIV1_E_149_K
2578,Q9UIV1,D,161,N,4gmj:B,161,Abolishes RNA deadenylase activity. Drastically reduces the rate of deadenylation and decay of CBEP3-tethered mRNA.,,,1.0,,,,,,,,,,,,,Q9UIV1_D_161_N
2579,Q9UIV1,K,203,A,4gmj:B,203,Abolishes interaction with TOB1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIV1_K_203_A
2580,Q9UIV1,H,225,A,4gmj:B,225,Abolishes RNA deadenylase activity.,,,1.0,,,,,,,,,,,,,Q9UIV1_H_225_A
2581,Q9UIV1,D,230,N,4gmj:B,230,Abolishes RNA deadenylase activity.,,,1.0,,,,,,,,,,,,,Q9UIV1_D_230_N
2582,P27338,C,5,S,6yt2:A,5,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_5_S
2583,P27338,C,156,S,6yt2:A,156,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P27338_C_156_S
2584,P27338,T,158,A,6yt2:A,158,Dramatic loss of activity.,,,1.0,,,,,,,,,,,,,P27338_T_158_A
2585,P27338,C,172,S,6yt2:A,172,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_172_S
2586,P27338,C,192,S,6yt2:A,192,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_192_S
2587,P27338,I,199,F,6yt2:A,199,Alters specificity towards synthetic inhibitors.,,-1.0,-999.0,,,,,,,,,,,,,P27338_I_199_F
2588,P27338,C,297,S,6yt2:A,297,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_297_S
2589,P27338,C,312,S,6yt2:A,312,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_312_S
2590,P27338,C,365,S,6yt2:A,365,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P27338_C_365_S
2591,P27338,H,382,R,6yt2:A,382,Significant loss of activity.,,,1.0,,,,,,,,,,,,,P27338_H_382_R
2592,P27338,K,386,M,6yt2:A,386,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_K_386_M
2593,P27338,C,389,A,6yt2:A,389,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P27338_C_389_A
2594,P27338,C,389,S,6yt2:A,389,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_C_389_S
2595,P27338,S,394,A,6yt2:A,394,No loss of activity.,,,0.0,,,,,,,,,,,,,P27338_S_394_A
2596,P27338,C,397,S,6yt2:A,397,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P27338_C_397_S
2597,Q7Z2E3,R,43,A,3kt9:A,29,Impairs interaction with XRCC1 and XRCC4. Abolishes localization at sites of DNA double-strand breaks. Loss of interaction with MDC1.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q7Z2E3_R_43_A
2598,Q7Z2E3,K,52,A,3kt9:A,38,Impairs interaction with MDC1 and localization at sites of DNA double-strand breaks.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q7Z2E3_K_52_A
2599,Q7Z2E3,H,274,A,4ndg:A,260,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q7Z2E3_H_274_A
2600,Q7Z2E3,C,333,A,4ndg:A,319,Abolishes DNA-binding and enzyme activity,,-1.0,1.0,,,,,,,,,,,,,Q7Z2E3_C_333_A
2601,Q7Z2E3,C,336,A,4ndg:A,322,Abolishes DNA-binding and enzyme activity,,-1.0,1.0,,,,,,,,,,,,,Q7Z2E3_C_336_A
2602,Q8IU85,K,52,A,6t6f:A,52,Catalytically inactive form.,,,1.0,,,,,,,,,,,,,Q8IU85_K_52_A
2603,P30711,H,176,Q,2c3t:A,176,"Increases activity towards alkylhalogenides, but not hydroperoxides.",,,1.0,,,,,,,,,,,,,P30711_H_176_Q
2604,P30711,W,234,R,2c3t:A,234,Facilitates binding of substrates and increases catalytic activity.,,1.0,1.0,,,,,,,,,,,,,P30711_W_234_R
2605,Q53HL2,R,17,E,2qfa:B,17,Loss of localization to the central spindle and midbody in anaphase or cytokinesis,,,-999.0,,,,,,,,,1.0,,,,Q53HL2_R_17_E
2606,Q53HL2,R,19,E,2qfa:B,19,Loss of localization to the central spindle and midbody in anaphase or cytokinesis,,,-999.0,,,,,,,,,1.0,,,,Q53HL2_R_19_E
2607,Q53HL2,K,20,E,2qfa:B,20,Loss of localization to the central spindle and midbody in anaphase or cytokinesis,,,-999.0,,,,,,,,,1.0,,,,Q53HL2_K_20_E
2608,Q53HL2,K,26,R,2qfa:B,26,Fails to exhibit normal localization to the nucleolus in interphase depleted cells.,,,-999.0,,,,,,,,,1.0,,,,Q53HL2_K_26_R
2609,Q53HL2,R,35,E,2qfa:B,35,Loss of binding to INCENP,-1.0,,-999.0,,,,,,,,,,,,,Q53HL2_R_35_E
2610,Q53HL2,L,46,Y,2qfa:B,46,Loss of binding to INCENP,-1.0,,-999.0,,,,,,,,,,,,,Q53HL2_L_46_Y
2611,Q53HL2,W,70,E,2qfa:B,70,Loss of binding to BIRC5,-1.0,,-999.0,,,,,,,,,,,,,Q53HL2_W_70_E
2612,Q53HL2,F,74,E,2qfa:B,74,Loss of binding to BIRC5,-1.0,,-999.0,,,,,,,,,,,,,Q53HL2_F_74_E
2613,Q53HL2,T,230,A,2kdd:A,230,Decrease in AURKB activity and dimer disruption. Decrease in AURKB activity and almost no phosphorylation by TTK,,,1.0,-1.0,,,,,,,,,,,,Q53HL2_T_230_A
2614,Q53HL2,T,230,D,2kdd:A,230,Substantial loss of structure.,,,-999.0,,,,,,,,,,,-1.0,,Q53HL2_T_230_D
2614,Q53HL2,T,230,K,2kdd:A,230,Substantial loss of structure.,,,-999.0,,,,,,,,,,,-1.0,,Q53HL2_T_230_K
2615,Q53HL2,T,230,V,2kdd:A,230,Decrease in AURKB activity and no effect on the structure.,,,1.0,,,,,,,,,,,0.0,,Q53HL2_T_230_V
2616,Q96JY6,L,80,K,3pdv:A,80,Abolishes cell adhesion to collagen and ability to suppress anchorage independent growth.,,-1.0,-999.0,,,,,,,,,,,,,Q96JY6_L_80_K
2617,Q04724,V,486,S,2ce9:A,486,Abolishes HESX1 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q04724_V_486_S
2618,Q04724,Y,532,H,2ce9:A,532,Abolishes HESX1 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q04724_Y_532_H
2619,Q04724,L,702,S,2ce9:A,702,Abolishes HESX1 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q04724_L_702_S
2620,Q04724,S,715,P,2ce9:A,715,Abolishes HESX1 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q04724_S_715_P
2621,Q9H3U1,K,33,E,2dba:A,40,Abolishes interaction with HSP90AB1,-1.0,,-999.0,,,,,,,,,,,,,Q9H3U1_K_33_E
2622,Q9H3U1,A,40,D,2dba:A,47,Abolishes interaction with HSP90AB1,-1.0,,-999.0,,,,,,,,,,,,,Q9H3U1_A_40_D
2623,Q9H3U1,K,70,E,2dba:A,77,Abolishes interaction with HSP90AB1,-1.0,,-999.0,,,,,,,,,,,,,Q9H3U1_K_70_E
2624,Q9H3U1,A,77,D,2dba:A,84,Abolishes interaction with HSP90AB1,-1.0,,-999.0,,,,,,,,,,,,,Q9H3U1_A_77_D
2625,Q14781,I,17,F,2d9u:A,16,Reduced interaction with H3C15 and H3C1.,-1.0,,-999.0,,,,,,,,,,,,,Q14781_I_17_F
2626,O75326,R,267,K,3nvq:A,267,Abolishes ITGB1-dependent enhancement of axon growth,,,-999.0,,,,,,,,,,,,,O75326_R_267_K
2627,O75326,D,269,E,3nvq:A,269,Abolishes ITGB1-dependent enhancement of axon growth,,,-999.0,,,,,,,,,,,,,O75326_D_269_E
2628,Q86YC2,T,1030,I,2w18:A,1030,Unstable and promotes protein degradation,,,-999.0,,,,,,,,,,,-1.0,,Q86YC2_T_1030_I
2629,O00214,R,69,H,6z6y:A,69,Abolishes localization to cytoplasmic vesicles in case of infection by S.typhimurium.,,,-999.0,,,,,,,,,1.0,,,,O00214_R_69_H
2630,O00214,R,190,H,2yro:A,22,Does not affect localization to cytoplasmic vesicles in case of infection by S.typhimurium.,,,-999.0,,,,,,,,,0.0,,,,O00214_R_190_H
2631,Q9H1Y0,K,130,R,5npw:C,130,"Loss of conjugaction with ATG12. Does affect interaction with DHX58, nor with MAVS.",-1.0,,-999.0,,,,,,,,,,,,,Q9H1Y0_K_130_R
2632,P07996,N,1067,K,1ux6:A,1049,Loss of N-glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,P07996_N_1067_K
2633,O14907,K,20,A,2l4s:A,20,Abolishes interaction with KCNJ4.,-1.0,,-999.0,,,,,,,,,,,,,O14907_K_20_A
2634,O14907,H,90,A,2l4s:A,90,Abolishes interaction with KCNJ4.,-1.0,,-999.0,,,,,,,,,,,,,O14907_H_90_A
2635,P82251,P,482,A,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_A
2635,P82251,P,482,G,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_G
2635,P82251,P,482,S,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_S
2635,P82251,P,482,V,6li9:B,482,No effect on amino acid transport activity.,,,0.0,,,,,,,,,,,,,P82251_P_482_V
2636,P82251,P,482,F,6li9:B,482,Decreased amino acid transport activity.,,,1.0,,,,,,,,,,,,,P82251_P_482_F
2636,P82251,P,482,I,6li9:B,482,Decreased amino acid transport activity.,,,1.0,,,,,,,,,,,,,P82251_P_482_I
2636,P82251,P,482,M,6li9:B,482,Decreased amino acid transport activity.,,,1.0,,,,,,,,,,,,,P82251_P_482_M
2636,P82251,P,482,W,6li9:B,482,Decreased amino acid transport activity.,,,1.0,,,,,,,,,,,,,P82251_P_482_W
2637,O43813,R,4,A,3e73:A,4,Loss of glutathione binding.,,-1.0,-999.0,,,,,,,,,,,,,O43813_R_4_A
2638,O43813,K,317,A,3e73:A,317,Loss of glutathione binding.,,-1.0,-999.0,,,,,,,,,,,,,O43813_K_317_A
2639,O43813,C,322,A,3e73:A,322,Loss of glutathione binding.,,-1.0,-999.0,,,,,,,,,,,,,O43813_C_322_A
2640,O43813,R,364,A,3e73:A,364,Loss of glutathione binding.,,-1.0,-999.0,,,,,,,,,,,,,O43813_R_364_A
2640,O43813,R,364,E,3e73:A,364,Loss of glutathione binding.,,-1.0,-999.0,,,,,,,,,,,,,O43813_R_364_E
2641,P41180,R,69,E,5fbk:A,69,Abolishes G-protein coupled receptor signaling pathway.,,,1.0,,,,,,,,,,,,,P41180_R_69_E
2642,P41180,N,102,I,5fbk:A,102,Abolishes G-protein coupled receptor activity.,,,1.0,,,,,,,,,,,,,P41180_N_102_I
2643,P41180,T,145,A,5k5t:A,145,Abolishes G-protein coupled receptor activity.,,,1.0,,,,,,,,,,,,,P41180_T_145_A
2644,P41180,S,147,A,5k5t:A,147,Nearly abolished G-protein coupled receptor activity.,,,1.0,,,,,,,,,,,,,P41180_S_147_A
2645,P41180,S,170,A,5k5t:A,170,Abolishes G-protein coupled receptor activity.,,,1.0,,,,,,,,,,,,,P41180_S_170_A
2646,P41180,Y,218,S,5k5t:A,218,Abolishes G-protein coupled receptor activity.,,,1.0,,,,,,,,,,,,,P41180_Y_218_S
2647,P41180,E,297,I,5k5t:A,297,Abolishes ability to sense calcium or magnesium levels.,,,1.0,,,,,,,,,,,,,P41180_E_297_I
2648,P41180,S,417,L,5k5t:A,417,Abolishes G-protein coupled receptor signaling pathway.,,,1.0,,,,,,,,,,,,,P41180_S_417_L
2649,P41180,W,458,A,5k5t:A,458,Decreased G-protein coupled receptor signaling pathway.,,,1.0,,,,,,,,,,,,,P41180_W_458_A
2650,P41180,C,482,S,5k5t:A,482,Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.,,-1.0,1.0,,,,,,,,,,,,,P41180_C_482_S
2650,P41180,C,482,Y,5k5t:A,482,Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.,,-1.0,1.0,,,,,,,,,,,,,P41180_C_482_Y
2651,P41181,S,148,A,4oj2:X,148,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_S_148_A
2652,P41181,S,148,D,4oj2:X,148,Retained in the endoplasmic reticulum.,,,-999.0,,,,,,,,,1.0,,,,P41181_S_148_D
2653,P41181,S,229,A,4oj2:X,229,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_S_229_A
2654,P41181,S,229,D,4oj2:X,229,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_S_229_D
2655,P41181,S,231,A,4oj2:X,231,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_S_231_A
2656,P41181,S,231,D,4oj2:X,231,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_S_231_D
2657,P41181,T,244,A,4oj2:X,244,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_T_244_A
2658,P41181,T,244,E,4oj2:X,244,"No effect on sorting from the ER to the vesicles, redistribution to apical membrane, or endocytosis.",,,-999.0,,,,,,,,,0.0,,,,P41181_T_244_E
2659,P41181,S,256,A,4oj2:X,256,Retained in vesicles.,,,-999.0,,,,,,,,,1.0,,,,P41181_S_256_A
2660,P41181,S,256,D,4oj2:X,256,Expressed in the apical membrane.,,,-999.0,,,,,,,,,,,,,P41181_S_256_D
2661,P16284,N,52,Q,5c14:A,25,Probable loss of N-glycosylation. No effect on homophilic cell adhesion,,0.0,-999.0,,,-1.0,,,,,,,,,,P16284_N_52_Q
2662,P16284,L,74,E,5c14:A,47,Reduced homophilic cell adhesion,,-1.0,-999.0,,,,,,,,,,,,,P16284_L_74_E
2663,P16284,N,84,Q,5c14:A,57,Probable loss of N-glycosylation. No effect on homophilic cell adhesion,,0.0,-999.0,,,-1.0,,,,,,,,,,P16284_N_84_Q
2664,P16284,K,89,A,5c14:A,62,Lacks homophilic binding ability and is distributed over the entire plasma membrane.,,-1.0,-999.0,,,,,,,,,,,,,P16284_K_89_A
2665,P16284,I,112,E,5c14:A,85,Reduced homophilic cell adhesion,,-1.0,-999.0,,,,,,,,,,,,,P16284_I_112_E
2666,P16284,N,151,Q,5c14:A,124,Probable loss of N-glycosylation. No effect on homophilic cell adhesion,,0.0,-999.0,,,-1.0,,,,,,,,,,P16284_N_151_Q
2667,P16284,F,188,E,5c14:A,161,Reduced homophilic cell adhesion,,-1.0,-999.0,,,,,,,,,,,,,P16284_F_188_E
2668,P16284,I,190,E,5c14:A,163,Reduced homophilic cell adhesion,,-1.0,-999.0,,,,,,,,,,,,,P16284_I_190_E
2669,O00189,F,255,A,3l81:A,255,Abolishes interaction with APP.,-1.0,,-999.0,,,,,,,,,,,,,O00189_F_255_A
2670,O00189,R,283,D,3l81:A,283,Strongly reduced interaction with APP.,-1.0,,-999.0,,,,,,,,,,,,,O00189_R_283_D
2671,P19099,I,112,P,6xz8:B,112,Increases 11-beta- and 18-hydroxylase activities toward 11-deoxycorticosterone,,,1.0,,,,,,,,,,,,,P19099_I_112_P
2672,P19099,D,147,E,6xz8:B,147,Increases 11-beta-hydroxylase activity toward 11-deoxycorticosterone and 11-deoxycortisol.,,,1.0,,,,,,,,,,,,,P19099_D_147_E
2673,P19099,K,152,N,6xz8:B,152,No significant effect on hydroxylase activities toward 11-deoxycorticosterone and 11-deoxycortisol.,,,0.0,,,,,,,,,,,,,P19099_K_152_N
2674,Q2MKA7,R,66,A,4cdk:E,66,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_R_66_A
2675,Q2MKA7,R,66,W,4cdk:E,66,Reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_R_66_W
2676,Q2MKA7,R,70,C,4cdk:E,70,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_R_70_C
2676,Q2MKA7,R,70,E,4cdk:E,70,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_R_70_E
2677,Q2MKA7,Q,71,E,4cdk:E,71,No effect on activation of Wnt signaling.,,,0.0,,,,,,,,,,,,,Q2MKA7_Q_71_E
2678,Q2MKA7,Q,71,R,4cdk:E,71,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_Q_71_R
2679,Q2MKA7,G,73,E,4cdk:E,73,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_G_73_E
2679,Q2MKA7,G,73,R,4cdk:E,73,Strongly reduces activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_G_73_R
2680,Q2MKA7,R,87,A,4cdk:E,87,Nearly abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_R_87_A
2681,Q2MKA7,F,106,A,4cdk:E,106,Abolishes activation of Wnt signaling. Abolishes LGR4 binding.,-1.0,,1.0,,,,,,,,,,,,,Q2MKA7_F_106_A
2682,Q2MKA7,F,106,E,4cdk:E,106,Abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_F_106_E
2683,Q2MKA7,F,110,A,4cdk:E,110,Nearly abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_F_110_A
2684,Q2MKA7,F,110,E,4cdk:E,110,Abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,Q2MKA7_F_110_E
2685,Q2MKA7,K,122,A,4cdk:E,122,Strongly reduces affinity for LGR4.,-1.0,,-999.0,,,,,,,,,,,,,Q2MKA7_K_122_A
2686,Q2MKA7,R,124,A,4cdk:E,124,Strongly reduces affinity for LGR4.,-1.0,,-999.0,,,,,,,,,,,,,Q2MKA7_R_124_A
2687,Q02763,C,224,S,4k0v:A,224,Reduces protein abundance.,,,-999.0,,,,,,,,,,,,,Q02763_C_224_S
2688,Q02763,Y,1102,F,6mwe:A,1102,Abolishes interaction with SHC1.,-1.0,,-999.0,,,,,,,,,,,,,Q02763_Y_1102_F
2689,Q99551,R,162,A,3n6s:A,162,Reduces affinity for cognate DNA,,-1.0,-999.0,,,,,,,,,,,,,Q99551_R_162_A
2690,Q99551,R,169,A,3n6s:A,169,Strongly reduces affinity for DNA. Strongly reduces transcription termination.,,-1.0,-999.0,,,,,,,,,,,,,Q99551_R_169_A
2691,Q99551,R,202,A,3n6s:A,202,Strongly reduces affinity for DNA. Strongly reduces transcription termination.,,-1.0,-999.0,,,,,,,,,,,,,Q99551_R_202_A
2692,Q99551,F,243,A,3n6s:A,243,Reduces affinity for cognate DNA,,-1.0,-999.0,,,,,,,,,,,,,Q99551_F_243_A
2693,Q99551,R,251,A,3n6s:A,251,Strongly reduces transcription termination.,,,-999.0,,,,,,,,,,,,,Q99551_R_251_A
2694,Q99551,Y,288,A,3n6s:A,288,Reduces affinity for cognate DNA,,-1.0,-999.0,,,,,,,,,,,,,Q99551_Y_288_A
2695,Q99551,R,350,A,3n6s:A,350,Reduces transcription termination.,,,-999.0,,,,,,,,,,,,,Q99551_R_350_A
2696,Q99551,R,387,A,3n6s:A,387,Strongly reduces affinity for cognate DNA. Strongly reduces transcription termination.,,-1.0,-999.0,,,,,,,,,,,,,Q99551_R_387_A
2697,Q13303,Y,90,F,1zsx:A,76,No effect on its activity in promoting KCNA4 channel closure.,,,0.0,,,,,,,,,,,,,Q13303_Y_90_F
2698,Q96PM5,M,176,E,2jrj:A,48,Abolishes E3 ubiquitin-protein ligase activity.,,,1.0,,,,,,,,,,,,,Q96PM5_M_176_E
2699,Q96PM5,C,186,A,2jrj:A,58,Abolishes E3 ubiquitin-protein ligase activity.,,,1.0,,,,,,,,,,,,,Q96PM5_C_186_A
2700,O95398,L,315,W,6h7e:B,273,Abolishes activation of RAP1A.,-1.0,,-999.0,,,,,,,,,,,,,O95398_L_315_W
2701,O95398,R,321,K,6h7e:B,279,Reduces activation of RAP1A.,-1.0,,-999.0,,,,,,,,,,,,,O95398_R_321_K
2702,O95398,F,342,A,6h7e:B,300,Diminishes GEF activity dependence on cAMP concentration.,,,-999.0,,,,,,,,,,,,,O95398_F_342_A
2702,O95398,F,342,T,6h7e:B,300,Diminishes GEF activity dependence on cAMP concentration.,,,-999.0,,,,,,,,,,,,,O95398_F_342_T
2703,Q14676,R,58,A,3uot:A,58,Abrogates binding to the MRE11 complex and to CHEK2.,-1.0,,-999.0,,,,,,,,,,,,,Q14676_R_58_A
2704,Q14676,S,72,A,3uot:A,72,Abrogates binding to CHEK2.,-1.0,,-999.0,,,,,,,,,,,,,Q14676_S_72_A
2705,Q14676,N,96,A,3uot:A,96,Abrogates binding to CHEK2,-1.0,,-999.0,,,,,,,,,,,,,Q14676_N_96_A
2706,Q14676,G,97,A,3uot:A,97,Abrogates binding to CHEK2,-1.0,,-999.0,,,,,,,,,,,,,Q14676_G_97_A
2707,Q14676,T,98,A,3uot:A,98,Abrogates binding to CHEK2,-1.0,,-999.0,,,,,,,,,,,,,Q14676_T_98_A
2708,O60218,K,125,L,4ga8:A,125,Increased affinity and reduced catalytic activity towards all-trans-retinaldehyde.,,1.0,1.0,,,,,,,,,,,,,O60218_K_125_L
2709,O60218,C,299,S,4ga8:A,299,Decreased affinity and reduced catalytic activity towards 4-hydroxynonenal.,,-1.0,1.0,,,,,,,,,,,,,O60218_C_299_S
2710,O60218,V,301,L,4ga8:A,301,Reduced catalytic activity towards all-trans-retinaldehyde.,,,1.0,,,,,,,,,,,,,O60218_V_301_L
2711,Q9ULV1,S,233,A,6bd4:A,233,Increased signaling activity in presence of NDP/norrin but not in presence of WNT3A.,,,-999.0,,,,,,,,,,,,,Q9ULV1_S_233_A
2712,Q9ULV1,S,233,F,6bd4:A,233,Slightly increased signaling activity in presence of NDP/norrin and reduced signaling in presence of WNT3A.,,,-999.0,,,,,,,,,,,,,Q9ULV1_S_233_F
2713,Q9ULV1,Y,250,F,6bd4:A,250,Reduced signaling activity in presence of NDP/norrin.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_250_F
2715,Q9ULV1,R,253,C,6bd4:A,253,Reduced signaling activity in presence of NDP/norrin.,,,1.0,,,,,,,,,,,,,Q9ULV1_R_253_C
2716,Q9ULV1,Y,265,A,6bd4:A,265,Slight increase in signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_265_A
2717,Q9ULV1,Y,269,A,6bd4:A,269,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_269_A
2718,Q9ULV1,E,341,A,6bd4:A,341,Reduced signaling activity in presence of NDP/norrin.,,,1.0,,,,,,,,,,,,,Q9ULV1_E_341_A
2719,Q9ULV1,D,371,A,6bd4:A,371,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_D_371_A
2720,Q9ULV1,Y,378,A,6bd4:A,378,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_378_A
2721,Q9ULV1,N,381,A,6bd4:A,381,Slight increase in signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_N_381_A
2722,Q9ULV1,L,399,F,6bd4:A,399,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_L_399_F
2723,Q9ULV1,S,418,N,6bd4:A,418,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_S_418_N
2724,Q9ULV1,Y,444,A,6bd4:A,444,Reduced signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_444_A
2724,Q9ULV1,Y,444,F,6bd4:A,444,Reduced signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_Y_444_F
2725,Q9ULV1,Y,455,A,6bd4:A,455,Increased signaling activity in presence of WNT3A but not in presence of NDP/norrin.,,,-999.0,,,,,,,,,,,,,Q9ULV1_Y_455_A
2726,Q9ULV1,E,458,A,6bd4:A,458,No effect on signaling activity.,,,0.0,,,,,,,,,,,,,Q9ULV1_E_458_A
2727,Q9ULV1,E,477,A,6bd4:A,477,Increased signaling activity in presence of WNT3A but not in presence of NDP/norrin.,,,-999.0,,,,,,,,,,,,,Q9ULV1_E_477_A
2728,Q9ULV1,K,480,A,6bd4:A,480,Increased signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_K_480_A
2729,Q9ULV1,W,494,L,6bd4:A,494,Reduced signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_W_494_L
2730,Q9ULV1,W,496,A,6bd4:A,496,Reduced signaling activity.,,,1.0,,,,,,,,,,,,,Q9ULV1_W_496_A
2731,O94762,D,157,A,5lb3:B,157,Abolishes helicase activity.,,,1.0,,,,,,,,,,,,,O94762_D_157_A
2732,O94762,R,550,A,4bk0:B,550,Impairs protein folding and abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,-1.0,,O94762_R_550_A
2733,O94762,H,552,A,4bk0:B,552,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_H_552_A
2734,O94762,L,556,E,4bk0:B,556,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_L_556_E
2735,O94762,E,584,A,4bk0:B,584,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_E_584_A
2735,O94762,E,584,D,4bk0:B,584,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_E_584_D
2736,O94762,Y,597,A,4bk0:B,597,Reduces interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_Y_597_A
2737,O94762,K,598,E,4bk0:B,598,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_K_598_E
2738,O94762,L,602,D,4bk0:B,602,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_L_602_D
2738,O94762,L,602,E,4bk0:B,602,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_L_602_E
2739,O94762,K,603,E,4bk0:B,603,Abolishes interaction with POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,O94762_K_603_E
2740,O94760,L,30,A,6szq:D,30,Reduces enzyme activity and affinity for asymmetric dimethylarginine about 12-fold.,,-1.0,1.0,,,,,,,,,,,,,O94760_L_30_A
2741,O94760,E,78,A,6szq:D,78,"Reduces enzyme activity about 1000-fold, and affinity for asymmetric dimethylarginine about 100-fold.",,-1.0,1.0,,,,,,,,,,,,,O94760_E_78_A
2742,O94760,L,271,G,6szq:D,271,"Reduces enzyme activity about 10-fold, and affinity for asymmetric dimethylarginine about 7-fold.",,-1.0,1.0,,,,,,,,,,,,,O94760_L_271_G
2743,O15554,T,250,S,6cnn:A,250,Loss of sensitivity to triarylmethanes.,,-1.0,-999.0,,,,,,,,,,,,,O15554_T_250_S
2744,O15554,V,275,A,6cnn:A,275,Loss of sensitivity to triarylmethanes.,,-1.0,-999.0,,,,,,,,,,,,,O15554_V_275_A
2745,Q9ULV8,Y,244,A,3op0:A,244,Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination.,-1.0,,1.0,,,,,,,,,,,,,Q9ULV8_Y_244_A
2746,Q9ULV8,Y,244,F,3op0:A,244,No effect on interaction with EGFR and SRC as well as on SRC ubiquitination.,0.0,,0.0,,,,,,,,,,,,,Q9ULV8_Y_244_F
2747,Q9ULV8,R,264,A,3op0:A,264,Abolishes interaction with EGFR. Decreases interaction with SRC and abolishes SRC ubiquitination.,-1.0,,1.0,,,,,,,,,,,,,Q9ULV8_R_264_A
2748,Q9ULV8,P,265,L,3op0:A,265,Enhances interaction with EGFR and SRC as well as SRC ubiquitination.,1.0,,1.0,,,,,,,,,,,,,Q9ULV8_P_265_L
2749,Q9ULV8,S,266,A,3op0:A,266,Decreases interactions with EGFR and SRC as well as SRC ubiquitination.,-1.0,,1.0,,,,,,,,,,,,,Q9ULV8_S_266_A
2750,Q9ULV8,T,268,A,3op0:A,268,Abolishes interaction with EGFR. Decreases interaction with and ubiquitination of SRC.,-1.0,,1.0,,,,,,,,,,,,,Q9ULV8_T_268_A
2751,Q9ULV8,G,276,E,3op0:A,276,"No effect on interaction with RET. Binds slightly to SRC, this interaction is independent of SRC phosphorylation. Strongly decreases SRC ubiquitination. Abolishes interaction with EGFR.",-1.0,,1.0,,,,,,,,,,,,,Q9ULV8_G_276_E
2752,O94768,K,62,A,6y6h:A,62,Loss of activity and of apoptotic function.,,,1.0,,,,,,,,,,,,,O94768_K_62_A
2753,P19544,H,343,A,6blw:A,343,Reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P19544_H_343_A
2754,P19544,R,366,A,6blw:A,366,Strongly reduced binding of DNA and RNA.,,-1.0,-999.0,,,,,,,,,,,,,P19544_R_366_A
2755,P19544,R,372,A,6blw:A,372,Strongly reduced binding of DNA and RNA.,,-1.0,-999.0,,,,,,,,,,,,,P19544_R_372_A
2756,P19544,R,394,A,6blw:A,394,Strongly reduced binding of DNA and RNA.,,-1.0,-999.0,,,,,,,,,,,,,P19544_R_394_A
2756,P19544,R,394,S,6blw:A,394,Strongly reduced binding of DNA and RNA.,,-1.0,-999.0,,,,,,,,,,,,,P19544_R_394_S
2757,Q13415,R,720,Q,7jpo:A,720,Abolished ATPase activity.,,,1.0,,,,,,,,,,,,,Q13415_R_720_Q
2758,Q8IU60,E,147,Q,5qon:A,147,Loss of decapping activity,,,1.0,,,,,,,,,,,,,Q8IU60_E_147_Q
2759,Q8IU60,E,148,Q,5qon:A,148,Strongly reduced decapping activity.,,,1.0,,,,,,,,,,,,,Q8IU60_E_148_Q
2760,P07333,L,301,S,4liq:E,301,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,P07333_L_301_S
2761,P07333,D,802,V,2ogv:A,802,Constitutive kinase activity. Loss of inhibition by imatinib.,,,1.0,,,,,,,,,,,,,P07333_D_802_V
2762,P07333,Y,809,F,2ogv:A,809,"Reduced kinase activity. Reduced interaction with SRC, FYN and YES1.",-1.0,,1.0,,,,,,,,,,,,,P07333_Y_809_F
2763,Q7Z2W4,H,810,N,2x5y:A,810,No effect on the structural inability to bind NAD(+),,0.0,-999.0,,,,,,,,,,,,,Q7Z2W4_H_810_N
2764,Q7Z2W4,N,830,Y,2x5y:A,830,No effect on the structural inability to bind NAD(+),,0.0,-999.0,,,,,,,,,,,,,Q7Z2W4_N_830_Y
2765,P04406,M,46,L,6m61:O,46,Drastic reduction of the extent and significant prolongation of the lag phase of free radical-induced aggregation.,,,-999.0,,,,,,,,,,,,,P04406_M_46_L
2766,P04406,M,105,L,6m61:O,105,Increased resistance to free radical-induced aggregation.,,,-999.0,,,,,,,,,,,,,P04406_M_105_L
2767,P04406,C,152,S,6m61:O,152,Markedly reduced glycolytic activity,,,1.0,,,,,,,,,,,,,P04406_C_152_S
2768,P04406,C,156,S,6m61:O,156,Markedly reduced glycolytic activity,,,1.0,,,,,,,,,,,,,P04406_C_156_S
2769,P04406,W,196,F,6m61:O,196,Increased free radical-induced aggregation.,,,-999.0,,,,,,,,,,,,,P04406_W_196_F
2770,P04406,L,245,M,6m61:O,245,Inhibits S-nitrosylation of Cys-247,,,-999.0,,,,,,-1.0,,,,,,,P04406_L_245_M
2771,P04406,C,247,S,6m61:O,247,Markedly reduced glycolytic activity,,,1.0,,,,,,,,,,,,,P04406_C_247_S
2772,P04406,E,250,M,6m61:O,250,Inhibits S-nitrosylation of Cys-247,,,-999.0,,,,,,-1.0,,,,,,,P04406_E_250_M
2773,P04406,Y,320,F,6m61:O,320,No effect on free radical-induced aggregation.,,,-999.0,,,,,,,,,,,,,P04406_Y_320_F
2774,Q8TF76,E,492,A,6z5a:A,492,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,1.0,,,,,,,,,,,,,Q8TF76_E_492_A
2775,Q8TF76,K,511,A,6z5a:A,511,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q8TF76_K_511_A
2776,Q8TF76,H,651,A,6z5a:A,651,"Strongly reduced enzyme activity, markedly reduced affinity for histone H3.",-1.0,,1.0,,,,,,,,,,,,,Q8TF76_H_651_A
2777,Q8TF76,D,707,L,6z5a:A,707,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,1.0,,,,,,,,,,,,,Q8TF76_D_707_L
2778,Q8TF76,D,709,N,6z5a:A,709,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,1.0,,,,,,,,,,,,,Q8TF76_D_709_N
2779,Q8TF76,G,713,F,6z5a:A,713,Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.,-1.0,,1.0,,,,,,,,,,,,,Q8TF76_G_713_F
2780,Q8TF76,D,716,L,6z5a:A,716,Markedly reduced histone H3 phosphorylation.,,,1.0,,,,,,,,,,,,,Q8TF76_D_716_L
2781,Q8IWE5,G,828,D,3hw2:B,829,Loss of interaction with sifA.,-1.0,,-999.0,,,,,,,,,,,,,Q8IWE5_G_828_D
2782,Q8IWE5,R,830,D,3hw2:B,831,Loss of interaction with sifA.,-1.0,,-999.0,,,,,,,,,,,,,Q8IWE5_R_830_D
2783,Q8IWE5,R,831,A,3hw2:B,832,Alters interaction with sifA.,-1.0,,-999.0,,,,,,,,,,,,,Q8IWE5_R_831_A
2784,Q8IWE5,C,869,D,3hw2:B,870,Loss of interaction with sifA.,-1.0,,-999.0,,,,,,,,,,,,,Q8IWE5_C_869_D
2785,Q13418,H,99,D,2kbx:A,99,Alters interaction with LIMS1.,-1.0,,-999.0,,,,,,,,,,,,,Q13418_H_99_D
2786,Q13418,E,359,K,6mib:A,359,Inactivation of ILK.,,,1.0,,,,,,,,,,,,,Q13418_E_359_K
2787,P11172,D,312,N,3mw7:A,123,Loss of OMPdecase activity.,,,1.0,,,,,,,,,,,,,P11172_D_312_N
2788,P04439,N,110,Q,6o9c:A,86,Impairs the recruitment of HLA-A*02 in the peptide-loading complex.,-1.0,,-999.0,,,,,,,,,,,,,P04439_N_110_Q
2789,P04439,S,156,C,6o9c:A,132,Impairs the maturation of a peptide-receptive HLA-A*02-B2M complex.,,,-999.0,,,,,,,,,,,,,P04439_S_156_C
2790,P04439,T,158,K,6o9c:A,134,"Impairs binding to TAP1-TAP2 transporter, resulting in impaired presentation of intracellular peptides.",-1.0,,1.0,,,,,,,,,,,,,P04439_T_158_K
2791,P14416,C,126,S,7jvr:R,126,No effect on palmitoylation,,,-999.0,,,,,,0.0,,,,,,,P14416_C_126_S
2792,P11177,E,259,A,3exi:B,229,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_259_A
2792,P11177,E,259,Q,3exi:B,229,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_259_Q
2793,P11177,E,262,A,3exi:B,232,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_262_A
2793,P11177,E,262,Q,3exi:B,232,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_262_Q
2794,P11177,E,264,A,3exi:B,234,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_264_A
2794,P11177,E,264,Q,3exi:B,234,Does not affect interaction with DLAT.,0.0,,-999.0,,,,,,,,,,,,,P11177_E_264_Q
2795,P11177,D,319,A,3exi:B,289,Inhibits interaction with DLAT. Does not affect pyruvate decarboxylase activity. Loss of multienzyme pyruvate dehydrogenase complex activity.,-1.0,,0.0,,,,,,,,,,,,,P11177_D_319_A
2796,P11177,D,319,N,3exi:B,289,Reduces interaction with DLAT. Reduces multienzyme pyruvate dehydrogenase complex activity. Does not affect pyruvate decarboxylase activity.,-1.0,,0.0,,,,,,,,,,,,,P11177_D_319_N
2797,P61769,D,79,P,6o9b:B,79,Increases tendency towards amyloid formation.,1.0,,-999.0,,,,,,,,,,,,,P61769_D_79_P
2798,P61769,W,80,G,6o9b:B,80,Decreases tendency towards amyloid formation.,-1.0,,-999.0,,,,,,,,,,,,,P61769_W_80_G
2799,P61769,W,80,V,6o9b:B,80,Increases tendency towards amyloid formation.,1.0,,-999.0,,,,,,,,,,,,,P61769_W_80_V
2800,Q6P988,S,232,A,4uz9:A,232,Abolishes enzyme activity. Unable to mediate serine depalmitoleoylation of WNT proteins.,,,1.0,,,,,,,,,,,,,Q6P988_S_232_A
2801,Q155Q3,D,648,A,3pz7:A,437,Loss of interaction with DVL2. Abolishes activation of Wnt signaling.,-1.0,,-999.0,,,,,,,,,,,,,Q155Q3_D_648_A
2802,Q155Q3,F,651,A,3pz7:A,440,Loss of interaction with DVL2. Abolishes activation of Wnt signaling.,-1.0,,-999.0,,,,,,,,,,,,,Q155Q3_F_651_A
2803,Q155Q3,K,655,A,3pz7:A,444,Loss of interaction with DVL2. Abolishes activation of Wnt signaling.,-1.0,,-999.0,,,,,,,,,,,,,Q155Q3_K_655_A
2804,P47900,L,44,A,4xnw:A,44,Loss of ADP analog binding.,,-1.0,-999.0,,,,,,,,,,,,,P47900_L_44_A
2805,P47900,Y,110,F,4xnw:A,110,Loss of ADP analog binding.,,-1.0,-999.0,,,,,,,,,,,,,P47900_Y_110_F
2806,P47900,Y,203,A,4xnw:A,203,Loss of ADP analog binding.,,-1.0,-999.0,,,,,,,,,,,,,P47900_Y_203_A
2807,P47900,T,205,A,4xnw:A,205,Loss of ADP analog binding.,,-1.0,-999.0,,,,,,,,,,,,,P47900_T_205_A
2808,P47900,N,283,A,4xnw:C,283,Loss of ADP analog binding.,,-1.0,-999.0,,,,,,,,,,,,,P47900_N_283_A
2809,P47900,Y,306,F,4xnw:C,306,Strongly decreased affinity for ADP analog.,,-1.0,-999.0,,,,,,,,,,,,,P47900_Y_306_F
2810,Q9NZI5,L,378,A,5mpf:B,378,Decreases affinity for target DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZI5_L_378_A
2811,Q9NZI5,T,380,A,5mpf:B,380,Decreases affinity for target DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZI5_T_380_A
2812,Q9NZI5,Q,385,A,5mpf:B,385,Decreases affinity for target DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZI5_Q_385_A
2813,Q9NZI5,C,421,A,5mpf:B,421,No effect on affinity for target DNA.,,0.0,-999.0,,,,,,,,,,,,,Q9NZI5_C_421_A
2814,Q9NZI5,R,427,A,5mpf:B,427,Loss of activity as transcriptional activator. Strongly decreases affinity for target DNA.,,-1.0,1.0,,,,,,,,,,,,,Q9NZI5_R_427_A
2815,Q9NZI5,R,427,Q,5mpf:B,427,Loss of activity as transcriptional activator. Nearly abolishes affinity for target DNA. Causes steric hindrance that impedes DNA-binding by neighboring residues.,,-1.0,1.0,,,,,,,,,,,,,Q9NZI5_R_427_Q
2816,Q9NZI5,K,428,A,5mpf:B,428,Decreases affinity for target DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZI5_K_428_A
2817,Q9NZI5,R,430,A,5mpf:B,430,Decreases affinity for target DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZI5_R_430_A
2818,Q15782,S,143,D,4p8u:A,143,Confers chitinase activity,,,1.0,,,,,,,,,,,,,Q15782_S_143_D
2819,Q15782,I,145,E,4p8u:A,145,Confers chitinase activity,,,1.0,,,,,,,,,,,,,Q15782_I_145_E
2820,Q7L2H7,L,350,P,6fec:8,350,Reduces HSV binding and entry.,-1.0,,-999.0,,,,,,,,,,,,,Q7L2H7_L_350_P
2821,Q7L2H7,L,354,P,6fec:8,354,Reduces HSV binding and entry.,-1.0,,-999.0,,,,,,,,,,,,,Q7L2H7_L_354_P
2822,Q7L2H7,L,361,P,6fec:8,361,Reduces HSV binding and entry.,-1.0,,-999.0,,,,,,,,,,,,,Q7L2H7_L_361_P
2823,Q7L2H7,V,364,P,6fec:8,364,Reduces HSV binding and entry.,-1.0,,-999.0,,,,,,,,,,,,,Q7L2H7_V_364_P
2824,Q13573,E,66,A,6qdv:K,66,Abolishes interaction with PPIL1.,-1.0,,-999.0,,,,,,,,,,,,,Q13573_E_66_A
2824,Q13573,E,66,R,6qdv:K,66,Abolishes interaction with PPIL1.,-1.0,,-999.0,,,,,,,,,,,,,Q13573_E_66_R
2825,Q13573,M,76,A,6qdv:K,76,Abolishes interaction with PPIL1.,-1.0,,-999.0,,,,,,,,,,,,,Q13573_M_76_A
2826,Q13572,K,18,A,2odt:X,18,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_K_18_A
2827,Q13572,H,58,A,2odt:X,58,No effect.,,,0.0,,,,,,,,,,,,,Q13572_H_58_A
2828,Q13572,K,59,A,2odt:X,59,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_K_59_A
2829,Q13572,R,106,A,2odt:X,106,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_R_106_A
2830,Q13572,K,157,A,2odt:X,157,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_K_157_A
2831,Q13572,H,162,Q,2odt:X,162,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_H_162_Q
2832,Q13572,G,163,A,2odt:X,163,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_G_163_A
2832,Q13572,G,163,P,2odt:X,163,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_G_163_P
2834,Q13572,H,167,A,2odt:X,167,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_H_167_A
2834,Q13572,H,167,Q,2odt:X,167,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_H_167_Q
2835,Q13572,Q,188,A,2odt:X,188,No effect.,,,0.0,,,,,,,,,,,,,Q13572_Q_188_A
2836,Q13572,H,193,A,2odt:X,193,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_H_193_A
2837,Q13572,K,199,A,2odt:X,199,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_K_199_A
2838,Q13572,R,212,A,2odt:X,212,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_R_212_A
2839,Q13572,S,214,A,2odt:X,214,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_S_214_A
2840,Q13572,L,215,A,2odt:X,215,No effect.,,,0.0,,,,,,,,,,,,,Q13572_L_215_A
2841,Q13572,D,281,A,2q7d:B,281,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_D_281_A
2842,Q13572,D,295,A,2q7d:B,295,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_D_295_A
2843,Q13572,N,297,A,2q7d:B,297,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_N_297_A
2843,Q13572,N,297,L,2q7d:B,297,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_N_297_L
2844,Q13572,N,297,D,2q7d:B,297,Induces a strong reduction in kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_N_297_D
2845,Q13572,G,301,A,2q7d:B,301,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q13572_G_301_A
2846,P47871,W,36,A,6lml:R,36,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_W_36_A
2847,P47871,D,63,A,6lml:R,63,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_D_63_A
2848,P47871,Y,65,A,6lml:R,65,Strongly reduced affinity for glucagon. Increased constitutive signaling via G-proteins.,,-1.0,-999.0,,,,,,,,,,,,,P47871_Y_65_A
2849,P47871,Q,113,A,6lml:R,113,No effect on affinity for glucagon.,,0.0,-999.0,,,,,,,,,,,,,P47871_Q_113_A
2849,P47871,Q,113,N,6lml:R,113,No effect on affinity for glucagon.,,0.0,-999.0,,,,,,,,,,,,,P47871_Q_113_N
2850,P47871,Q,113,C,6lml:R,113,Causes the formation of an artifactual disulfide bond that abolishes glucagon binding,,-1.0,-999.0,,,,,,1.0,,,,,,,P47871_Q_113_C
2851,P47871,Q,113,E,6lml:R,113,Strongly reduced affinity for glucagon.,,-1.0,-999.0,,,,,,,,,,,,,P47871_Q_113_E
2852,P47871,V,130,C,6lml:R,130,Causes the formation of an artifactual disulfide bond that interferes with glucagon binding,,-1.0,-999.0,,,,,,1.0,,,,,,,P47871_V_130_C
2853,P47871,A,135,P,6lml:R,135,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_A_135_P
2854,P47871,Y,145,A,6lml:R,145,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_Y_145_A
2855,P47871,Y,149,A,6lml:R,149,Abolishes expression at cell surface and glucagon binding.,,-1.0,-999.0,,,,,,,,,1.0,,,,P47871_Y_149_A
2856,P47871,L,198,A,6lml:R,198,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_L_198_A
2857,P47871,R,201,D,6lml:R,201,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_R_201_D
2858,P47871,Y,202,A,6lml:R,202,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_Y_202_A
2859,P47871,D,208,Q,6lml:R,208,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_D_208_Q
2860,P47871,D,209,C,6lml:R,209,Causes the formation of an artifactual disulfide bond that abolishes glucagon binding,,-1.0,-999.0,,,,,,1.0,,,,,,,P47871_D_209_C
2861,P47871,L,210,C,6lml:R,210,Causes the formation of an artifactual disulfide bond that interferes with glucagon binding,,-1.0,-999.0,,,,,,1.0,,,,,,,P47871_L_210_C
2862,P47871,W,215,L,6lml:R,215,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_W_215_L
2863,P47871,Q,232,L,6lml:R,232,Abolishes expression at cell surface and glucagon binding.,,-1.0,-999.0,,,,,,,,,1.0,,,,P47871_Q_232_L
2864,P47871,Y,233,A,6lml:R,233,Abolishes glucagon binding. Strongly reduces expression at the cell surface.,,-1.0,-999.0,,,,,,,,,1.0,,,,P47871_Y_233_A
2865,P47871,K,286,L,6lml:R,286,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_K_286_L
2866,P47871,E,290,A,6lml:R,290,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_E_290_A
2867,P47871,C,294,A,6lml:R,294,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_C_294_A
2867,P47871,C,294,S,6lml:R,294,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_C_294_S
2868,P47871,W,295,A,6lml:R,295,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_W_295_A
2868,P47871,W,295,H,6lml:R,295,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_W_295_H
2869,P47871,W,304,Q,6lml:R,304,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_W_304_Q
2870,P47871,S,350,A,6lml:R,350,Strongly decreases affinity for synthetic antagonist.,,-1.0,-999.0,,,,,,,,,,,,,P47871_S_350_A
2871,P47871,T,353,A,6lml:R,353,Loss of synthetic antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_T_353_A
2872,P47871,L,382,A,6lml:R,382,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_L_382_A
2873,P47871,L,386,F,6lml:R,386,Abolishes glucagon binding.,,-1.0,-999.0,,,,,,,,,,,,,P47871_L_386_F
2874,Q8NE71,K,342,M,5zxd:B,44,Does not inhibit ribosome binding. Reduces ATP-binding. Inhibits ATP-binding and reduces protein synthesis,,-1.0,-999.0,,,,,,,,,,,,,Q8NE71_K_342_M
2875,Q8NE71,Q,367,E,5zxd:B,69,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_Q_367_E
2876,Q8NE71,G,454,D,5zxd:B,156,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_G_454_D
2877,Q8NE71,E,477,Q,5zxd:B,179,Does not inhibit ribosome binding. Reduces protein synthesis,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_E_477_Q
2878,Q8NE71,H,506,L,5zxd:B,208,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_H_506_L
2879,Q8NE71,K,664,M,5zxd:A,366,Does not inhibit ribosome binding. Reduces ATP-binding. Inhibits ATP-binding and reduces protein synthesis,,-1.0,-999.0,,,,,,,,,,,,,Q8NE71_K_664_M
2880,Q8NE71,Q,695,E,5zxd:A,397,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_Q_695_E
2881,Q8NE71,G,745,D,5zxd:A,447,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_G_745_D
2882,Q8NE71,E,768,Q,5zxd:A,470,Does not inhibit ribosome binding. Reduces protein synthesis,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_E_768_Q
2883,Q8NE71,H,797,L,5zxd:A,499,Does not inhibit ribosome binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE71_H_797_L
2884,Q92793,D,1116,R,5i8g:A,1116,Impairs binding to acetylated histones.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_D_1116_R
2885,Q92793,F,1126,A,5i8g:A,1126,Impairs binding to acetylated histones.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_F_1126_A
2886,Q92793,N,1162,E,5i8g:A,1162,Abolishes interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_N_1162_E
2886,Q92793,N,1162,R,5i8g:A,1162,Abolishes interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_N_1162_R
2887,Q92793,W,1165,A,5i8g:A,1165,Abolishes interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_W_1165_A
2888,Q92793,K,1170,E,5i8g:A,1170,Impairs binding to acetylated histones.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_K_1170_E
2889,Q92793,S,1179,I,5i8g:A,1179,Impairs interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_S_1179_I
2890,Q92793,K,1180,E,5i8g:A,1180,Abolishes interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_K_1180_E
2891,Q92793,E,1183,R,5i8g:A,1183,Abolishes interaction with ASF1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92793_E_1183_R
2892,O00231,S,14,A,5ln3:Q,14,Does not affect phosphorylation by AMPK,,,-999.0,0.0,,,,,,,,,,,,O00231_S_14_A
2893,O00231,S,79,A,5ln3:Q,79,Does not affect phosphorylation by AMPK,,,-999.0,0.0,,,,,,,,,,,,O00231_S_79_A
2894,O00231,S,272,A,5ln3:Q,272,Does not affect phosphorylation by AMPK,,,-999.0,0.0,,,,,,,,,,,,O00231_S_272_A
2895,Q6PJP8,D,838,N,5q32:A,838,"Impaired nuclear focus formation, reduced interaction with PIAS and increased sensitivity to cisplatin.",-1.0,,-999.0,,,,,,,,,,,,,Q6PJP8_D_838_N
2896,Q6PJP8,H,994,A,5q32:A,994,"Impaired nuclear focus formation, reduced interaction with PIAS and increased sensitivity to cisplatin.",-1.0,,-999.0,,,,,,,,,,,,,Q6PJP8_H_994_A
2897,O95484,N,38,S,6ov2:A,38,Mildly decrease HCV infection susceptibility in cell culture.,,,-999.0,,,,,,,,,,,,,O95484_N_38_S
2898,O95484,A,43,S,6ov2:A,43,No effect on HCV infection susceptibility in cell culture.,,,-999.0,,,,,,,,,,,,,O95484_A_43_S
2899,O95484,V,45,N,6ov2:A,45,Abolishes HCV infection susceptibility in cell culture.,,,-999.0,,,,,,,,,,,,,O95484_V_45_N
2900,O95484,S,53,N,6ov2:A,53,No effect on HCV infection susceptibility in cell culture.,,,-999.0,,,,,,,,,,,,,O95484_S_53_N
2901,P01911,D,181,N,1seb:B,152,Reduces the interaction with HLA-DM complex that results in impaired dissociation of CLIP from MHCII.,-1.0,,-999.0,,,,,,,,,,,,,P01911_D_181_N
2902,P01911,L,213,H,1seb:B,184,Reduces the interaction with HLA-DM complex that results in impaired dissociation of CLIP from MHCII.,-1.0,,-999.0,,,,,,,,,,,,,P01911_L_213_H
2903,P01911,E,216,K,1seb:B,187,Reduces the interaction with HLA-DM complex that results in impaired dissociation of CLIP from MHCII.,-1.0,,-999.0,,,,,,,,,,,,,P01911_E_216_K
2904,Q9HCI7,H,64,Y,4b7y:C,64,Great reduction in H2B ubiquitination. No effect on MSL1-binding.,0.0,,1.0,,,,,,,,,,,,,Q9HCI7_H_64_Y
2905,P17028,K,286,A,1x6e:A,22,Partial cytoplasmic accumulation.,,,-999.0,,,,,,,,,1.0,,,,P17028_K_286_A
2906,P17028,R,290,A,1x6e:A,26,Partial cytoplasmic accumulation.,,,-999.0,,,,,,,,,1.0,,,,P17028_R_290_A
2907,P45983,K,55,D,6zr5:B,55,Abolished protein kinase activity.,,,1.0,,,,,,,,,,,,,P45983_K_55_D
2908,P45983,T,183,A,6zr5:B,183,Phosphorylation blocked.,,,1.0,,,,,,,,,,,,,P45983_T_183_A
2909,P45983,Y,185,F,6zr5:B,185,Phosphorylation blocked.,,,1.0,,,,,,,,,,,,,P45983_Y_185_F
2910,Q15257,D,185,A,2hv7:A,150,Impairs ATPase activity of the PP2A(D),,,-999.0,,,,,,,,,,,,,Q15257_D_185_A
2911,Q15257,A,239,D,2hv7:A,204,Impairs ATPase activity of the PP2A(D),,,-999.0,,,,,,,,,,,,,Q15257_A_239_D
2912,Q15257,G,240,D,2hv7:A,205,Impairs ATPase activity of the PP2A(D),,,-999.0,,,,,,,,,,,,,Q15257_G_240_D
2913,Q15257,V,244,D,2hv7:A,209,Impairs interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_V_244_D
2914,Q15257,E,305,A,2hv7:A,270,Abolishes interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_E_305_A
2915,Q15257,V,316,D,2hv7:A,281,Impairs interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_V_316_D
2916,Q15257,G,325,D,2hv7:A,290,Abolishes interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_G_325_D
2917,Q15257,M,329,D,2hv7:A,294,Abolishes interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_M_329_D
2918,Q15257,K,337,G,2hv7:A,302,Impairs interaction with the PP2A(D) complex.,-1.0,,-999.0,,,,,,,,,,,,,Q15257_K_337_G
2919,Q7KZI7,T,208,A,3iec:A,208,Prevents phosphorylation and activation by STK11/LKB1 complex.,,,1.0,,,,,,,,,,,,,Q7KZI7_T_208_A
2920,Q9BYJ9,Y,397,A,4rcj:A,397,Strongly reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_Y_397_A
2921,Q9BYJ9,D,401,N,4rcj:A,401,Increased binding to N6-methyladenosine (m6A)-containing RNAs.,,1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_D_401_N
2922,Q9BYJ9,W,411,A,4rcj:A,411,Abolished binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_W_411_A
2923,Q9BYJ9,W,465,A,4rcj:A,465,Abolished binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_W_465_A
2924,Q9BYJ9,W,470,A,4rcj:A,470,Abolished binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_W_470_A
2925,Q9BYJ9,R,506,A,4rcj:A,506,Reduced binding to N6-methyladenosine (m6A)-containing RNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q9BYJ9_R_506_A
2926,P34925,K,364,A,6tua:A,364,No induction of the MAPK pathway.,,,-999.0,,,,,,,,,,,,,P34925_K_364_A
2927,P34925,N,484,F,6tua:A,484,Gain of an autophosphorylation activity. Gain of an autophosphorylation activity,,,1.0,,,,,,,,,,,,,P34925_N_484_F
2928,P34925,A,485,G,6tua:A,485,Gain of an autophosphorylation activity. Gain of an autophosphorylation activity,,,1.0,,,,,,,,,,,,,P34925_A_485_G
2929,Q96C23,H,107,A,1so0:A,107,Decreased activity by 5-fold.,,,1.0,,,,,,,,,,,,,Q96C23_H_107_A
2930,Q96C23,H,176,A,1so0:A,176,Decreased activity by 300-fold.,,,1.0,,,,,,,,,,,,,Q96C23_H_176_A
2931,Q96C23,E,307,A,1so0:A,307,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96C23_E_307_A
2932,Q9H9Z2,W,46,A,5udz:A,46,Does not affect localization to P-bodies,,,-999.0,,,,,,,,,0.0,,,,Q9H9Z2_W_46_A
2933,Q9H9Z2,F,55,A,5udz:A,55,Does not affect localization to P-bodies,,,-999.0,,,,,,,,,0.0,,,,Q9H9Z2_F_55_A
2934,Q9H9Z2,F,73,A,5udz:A,73,Does not affect localization to P-bodies,,,-999.0,,,,,,,,,0.0,,,,Q9H9Z2_F_73_A
2935,Q9H9Z2,H,147,A,2li8:A,147,Abolishes ability to suppress pre-let-7 biogenesis and localization to P-bodies without affecting pre-let-7 binding,,,1.0,,,,,,,,,1.0,,,,Q9H9Z2_H_147_A
2936,Q9H9Z2,H,169,A,2li8:A,169,Abolishes ability to suppress pre-let-7 biogenesis and localization to P-bodies without affecting pre-let-7 binding,,,1.0,,,,,,,,,1.0,,,,Q9H9Z2_H_169_A
2937,Q96AP4,S,351,A,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_A
2937,Q96AP4,S,351,Q,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_Q
2937,Q96AP4,S,351,Y,6fge:A,351,No effect.,,,0.0,,,,,,,,,,,,,Q96AP4_S_351_Y
2938,Q96AP4,C,360,A,6fge:A,360,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_C_360_A
2939,Q96AP4,D,406,A,6fge:A,406,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_D_406_A
2940,Q96AP4,E,428,A,6fge:A,428,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_E_428_A
2941,Q96AP4,Q,487,A,6fge:A,487,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_Q_487_A
2942,Q96AP4,H,491,A,6fge:A,491,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_H_491_A
2943,Q96AP4,D,512,A,6fge:A,512,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96AP4_D_512_A
2944,P18440,R,64,A,2pqt:A,64,Reduced enzymatic activity.,,,1.0,,,,,,,,,,,,,P18440_R_64_A
2944,P18440,R,64,M,2pqt:A,64,Reduced enzymatic activity.,,,1.0,,,,,,,,,,,,,P18440_R_64_M
2944,P18440,R,64,Q,2pqt:A,64,Reduced enzymatic activity.,,,1.0,,,,,,,,,,,,,P18440_R_64_Q
2944,P18440,R,64,K,2pqt:A,64,Reduced enzymatic activity.,,,1.0,,,,,,,,,,,,,P18440_R_64_K
2945,Q96I25,D,319,A,2peh:A,319,Impairs interaction with SF1,-1.0,,-999.0,,,,,,,,,,,,,Q96I25_D_319_A
2946,Q96I25,D,319,K,2peh:A,319,"Abolishes interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,1.0,,,,,,,,,,,,,Q96I25_D_319_K
2947,Q96I25,R,375,A,2peh:A,375,"Impairs interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,1.0,,,,,,,,,,,,,Q96I25_R_375_A
2948,Q96I25,Y,376,A,2peh:A,376,"Impairs interaction with SF3B1, SF1 and U2AF2. Abolishes regulation of alternative splicing.",-1.0,,1.0,,,,,,,,,,,,,Q96I25_Y_376_A
2949,Q96I25,F,377,A,2peh:A,377,Impairs interaction with SF1 and U2AF2 and abolishes interaction with SF3B1. Abolishes regulation of alternative splicing.,-1.0,,1.0,,,,,,,,,,,,,Q96I25_F_377_A
2950,O00308,K,498,R,5tj7:B,498,Does not affect FBXL15-mediated ubiquitination.,,,0.0,,,,,,,,,,,,,O00308_K_498_R
2951,O00308,H,500,K,5tj7:B,500,Does not affect FBXL15-mediated ubiquitination.,,,0.0,,,,,,,,,,,,,O00308_H_500_K
2952,O00308,C,838,A,5tj7:B,838,Abolishes ubiquitination of POU5F1.,,,1.0,,,,,,,,,,,,,O00308_C_838_A
2953,O95372,S,122,A,5syn:A,122,Abolishes ability to mediate depalmitoylation of ZDHHC6.,,,1.0,,,,,,,,,,,,,O95372_S_122_A
2954,Q9BVI0,C,96,S,3p8d:A,96,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVI0_C_96_S
2955,Q9BVI0,W,97,A,3p8d:A,97,Abolishes interaction with methylated p53.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVI0_W_97_A
2956,Q9BVI0,C,100,S,3p8d:A,100,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVI0_C_100_S
2957,Q9BVI0,Y,103,A,3p8d:A,103,Abolishes interaction with methylated p53.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVI0_Y_103_A
2958,P21796,E,73,Q,5xdo:A,73,Abolishes ceramide and phosphatidylcholine binding.,,-1.0,-999.0,,,,,,,,,,,,,P21796_E_73_Q
2959,P21796,S,193,A,5xdo:A,193,Conformation remains open and constitutively allows cytochrome c efflux.,,,1.0,,,,,,,,,,,,,P21796_S_193_A
2960,P21796,S,193,E,5xdo:A,193,Conformation remains closed and prevents cytochrome c leakage.,,,1.0,,,,,,,,,,,,,P21796_S_193_E
2961,Q9Y657,W,72,A,7bqz:A,72,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_W_72_A
2961,Q9Y657,W,72,R,7bqz:A,72,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_W_72_R
2962,Q9Y657,Y,98,R,7bqz:A,98,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_Y_98_R
2963,Q9Y657,S,109,A,7bqz:A,109,Impaired phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q9Y657_S_109_A
2964,Q9Y657,S,124,A,7bqz:A,124,Impaired phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q9Y657_S_124_A
2965,Q9Y657,F,141,A,7bqz:A,141,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway. Impaired ability to activate expression of pre-rRNA.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_F_141_A
2966,Q9Y657,E,142,A,7bqz:A,142,Impaired binding to histone H3K4me3 and H3R8me2a.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_E_142_A
2967,Q9Y657,Y,170,A,7bqz:A,170,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway. Impaired ability to activate expression of pre-rRNA.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_Y_170_A
2968,Q9Y657,Y,177,A,7bqz:A,177,Impaired binding to histone H3K4me3 and H3R8me2a.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_Y_177_A
2969,Q9Y657,D,184,A,7bqz:A,184,Impaired binding to histone H3K4me3 and H3R8me2a.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_D_184_A
2969,Q9Y657,D,184,R,7bqz:A,184,Impaired binding to histone H3K4me3 and H3R8me2a.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_D_184_R
2970,Q9Y657,D,189,A,7bqz:A,189,Impaired binding to histone H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_D_189_A
2970,Q9Y657,D,189,R,7bqz:A,189,Impaired binding to histone H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y657_D_189_R
2971,Q9Y657,F,251,R,7cna:D,251,Impaired binding to histone H3K4me3 and H3R8me2a and impaired ability to activate the Wnt signaling pathway.,-1.0,,1.0,,,,,,,,,,,,,Q9Y657_F_251_R
2972,Q9UL25,T,33,N,1z08:C,33,Defects in GTP-binding. Abolishes the interaction with VAMP8 in response to starvation. Abolishes the interaction with TMED10.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UL25_T_33_N
2973,Q9UL25,Q,78,L,1z08:C,78,Defects in GTP hydrolysis. Does not affect the interaction with VAMP8 in response to starvation. Does not affect the interaction with TMED10.,0.0,,1.0,,,,,,,,,,,,,Q9UL25_Q_78_L
2974,P18848,K,311,R,1ci6:A,311,Decreased acetylation without affecting ubiquitination by SCF(BTRC).,,,-999.0,,0.0,,,,,,,,,,,P18848_K_311_R
2975,P49841,R,96,A,1j1b:B,596,Prevents the phosphorylation of phosphate-primed glycogen synthase.,,,1.0,,,,,,,,,,,,,P49841_R_96_A
2976,P49841,L,128,A,1j1b:B,628,Abolishes activity toward AXIN1.,-1.0,,-999.0,,,,,,,,,,,,,P49841_L_128_A
2977,Q687X5,S,138,Q,6hcy:A,138,Strongly reduced enzyme activity. No effect on trimerization and on heme binding.,0.0,0.0,1.0,,,,,,,,,,,,,Q687X5_S_138_Q
2978,P56696,E,123,G,7byl:A,123,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_E_123_G
2979,P56696,H,124,G,7byl:A,124,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_H_124_G
2980,P56696,Q,125,G,7byl:A,125,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_Q_125_G
2981,P56696,E,126,G,7byl:A,126,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_E_126_G
2982,P56696,S,205,G,7byl:A,205,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_S_205_G
2983,P56696,Q,210,G,7byl:A,210,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_Q_210_G
2984,P56696,R,213,G,7byl:A,213,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_R_213_G
2985,P56696,R,216,G,7byl:A,216,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_R_216_G
2986,P56696,K,261,G,7byl:A,261,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_K_261_G
2987,P56696,D,262,G,7byl:A,262,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_D_262_G
2988,P56696,D,266,G,7byl:A,266,Resistant to inhibition by potassium channel toxin SsTX. Normal voltage activation.,,-1.0,0.0,,,,,,,,,,,,,P56696_D_266_G
2989,P56696,S,268,G,7byl:A,268,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_S_268_G
2990,P56696,D,272,G,7byl:A,272,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_D_272_G
2991,P56696,D,288,G,7byl:A,288,Resistant to inhibition by potassium channel toxin SsTX. Normal voltage activation.,,-1.0,-999.0,,,,,,,,,,,,,P56696_D_288_G
2992,P56696,T,290,V,7byl:A,290,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_T_290_V
2993,P56696,H,292,G,7byl:A,292,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_H_292_G
2994,P56696,L,295,V,7byl:A,295,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_L_295_V
2995,P56696,V,298,T,7byl:A,298,No effect on inhibition by potassium channel toxin SsTX.,,0.0,-999.0,,,,,,,,,,,,,P56696_V_298_T
2996,Q9BRQ3,H,156,A,5lor:A,156,Abolishes enzyme activity with UDP-galactose.,,,1.0,,,,,,,,,,,,,Q9BRQ3_H_156_A
2997,Q9BRQ3,E,189,A,5lor:A,189,Abolishes enzyme activity with UDP-galactose.,,,1.0,,,,,,,,,,,,,Q9BRQ3_E_189_A
2998,Q9BRQ3,E,193,A,5lor:A,193,Abolishes enzyme activity with UDP-galactose.,,,1.0,,,,,,,,,,,,,Q9BRQ3_E_193_A
2999,P0DMV9,K,561,R,4po2:A,561,Complete loss of in vitro methylation by METTL21A.,,,-999.0,,,,,,,,,,,,,P0DMV9_K_561_R
3000,P0DMV8,D,10,A,3a8y:A,10,Reduces affinity for ADP.,,-1.0,-999.0,,,,,,,,,,,,,P0DMV8_D_10_A
3001,P0DMV8,K,77,Q,3a8y:A,77,No loss of acetylation and ATPase activity. Exhibits normal protein refolding activity during the early phase but exhibits defects in ubiquitin-mediated protein degradation during the later phase.,,,0.0,,-1.0,,,,,,,,,0.0,,P0DMV8_K_77_Q
3002,P0DMV8,K,77,R,3a8y:A,77,Significant loss of acetylation and ATPase activity. Decreased binding to HOPX and HSP90 and increased binding to STUB1 and NAA10. Impaired capacity for protein refolding during the early phase after stress but shows normal protein degradation activity in the late phase.,,,1.0,,,,,,,,,,,-1.0,,P0DMV8_K_77_R
3003,P0DMV8,D,199,A,3a8y:A,199,Reduces affinity for ADP.,,-1.0,-999.0,,,,,,,,,,,,,P0DMV8_D_199_A
3004,P0DMV8,K,561,R,5gjj:A,177,Complete loss of in vitro methylation by METTL21A.,,,-999.0,,,,,,,,,,,,,P0DMV8_K_561_R
3005,Q00722,Q,52,A,2fju:B,52,Strongly reduces interaction with RAC1.,-1.0,,-999.0,,,,,,,,,,,,,Q00722_Q_52_A
3006,Q6IQ55,K,50,E,6u0k:B,50,Leads to inactivation/destabilization of the protein.,,,1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_50_E
3006,Q6IQ55,K,50,A,6u0k:B,50,Leads to inactivation/destabilization of the protein.,,,1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_50_A
3007,Q6IQ55,K,143,E,6u0k:B,143,Leads to inactivation/destabilization of the protein.,,,1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_143_E
3007,Q6IQ55,K,143,A,6u0k:B,143,Leads to inactivation/destabilization of the protein.,,,1.0,,,,,,,,,,,-1.0,,Q6IQ55_K_143_A
3008,Q6IQ55,D,163,A,6u0k:B,163,Abolishes serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q6IQ55_D_163_A
3009,Q6IQ55,R,181,E,6u0k:B,181,Impaired serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q6IQ55_R_181_E
3009,Q6IQ55,R,181,A,6u0k:B,181,Impaired serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q6IQ55_R_181_A
3010,Q6IQ55,A,184,E,6u0k:B,184,Impaired serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q6IQ55_A_184_E
3010,Q6IQ55,A,184,G,6u0k:B,184,Impaired serine/threonine-protein kinase activity.,,,1.0,,,,,,,,,,,,,Q6IQ55_A_184_G
3011,P52597,W,20,A,2kfy:A,20,Loss of RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52597_W_20_A
3012,P52597,E,84,A,2kfy:A,84,Loss of RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52597_E_84_A
3013,P52597,R,116,A,2hgm:A,116,Decreases affinity for RNA oligonucleotide 100-fold.,,-1.0,-999.0,,,,,,,,,,,,,P52597_R_116_A
3014,P52597,F,120,A,2hgm:A,120,Little disruption of binding RNA. Decreases affinity for RNA oligonucleotide 100-fold. Abrogates RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P52597_F_120_A
3015,P52597,K,150,A,2hgm:A,150,No effect on affinity for RNA oligonucleotide.,,0.0,-999.0,,,,,,,,,,,,,P52597_K_150_A
3016,P52597,F,156,A,2hgm:A,156,Drastically effects folding of RRM2.,,,-999.0,,,,,,,,,,,,,P52597_F_156_A
3017,P52597,K,173,A,2hgm:A,173,Minimal effect on affinity for RNA oligonucleotide.,,0.0,-999.0,,,,,,,,,,,,,P52597_K_173_A
3018,P52597,H,178,A,2hgm:A,178,Little disruption of binding RNA.,,-1.0,-999.0,,,,,,,,,,,,,P52597_H_178_A
3019,P52597,R,179,A,2hgm:A,179,Decreases affinity for RNA oligonucleotide 100-fold.,,-1.0,-999.0,,,,,,,,,,,,,P52597_R_179_A
3020,P52597,Y,180,A,2hgm:A,180,Decreases affinity for RNA oligonucleotide 10-fold. Abrogates RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P52597_Y_180_A
3021,P52597,E,182,A,2hgm:A,182,Decreases affinity for RNA oligonucleotide 100-fold.,,-1.0,-999.0,,,,,,,,,,,,,P52597_E_182_A
3022,P52597,F,184,A,2hgm:A,184,Minimal effect on affinity for RNA oligonucleotide.,,0.0,-999.0,,,,,,,,,,,,,P52597_F_184_A
3023,Q9NQC7,C,601,A,2vhf:B,601,Loss of deubiquitinating activity.,,,1.0,,,,,,,,,,,,,Q9NQC7_C_601_A
3023,Q9NQC7,C,601,S,2vhf:B,601,Loss of deubiquitinating activity.,,,1.0,,,,,,,,,,,,,Q9NQC7_C_601_S
3024,Q9NQC7,L,622,D,2vhf:B,622,Impaired interaction with SPATA2.,-1.0,,-999.0,,,,,,,,,,,,,Q9NQC7_L_622_D
3025,Q9NQC7,H,871,N,2vhf:B,871,Loss of deubiquitinating activity.,,,1.0,,,,,,,,,,,,,Q9NQC7_H_871_N
3026,Q86WV5,Y,115,A,4joi:C,115,2.5-fold reduction in binding affinity for STN1.,-1.0,,-999.0,,,,,,,,,,,,,Q86WV5_Y_115_A
3027,P09211,Y,8,F,5dal:A,7,Reduces catalytic activity about 50-fold.,,,1.0,,,,,,,,,,,,,P09211_Y_8_F
3028,P09211,D,99,A,5dal:A,98,Reduces affinity for glutathione. Slightly reduced catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,P09211_D_99_A
3029,Q92888,Y,487,F,3odo:A,487,No effect.,,0.0,0.0,,,,,,,,,,,,,Q92888_Y_487_F
3030,Q92888,Y,738,F,3odo:A,738,Lowers the exchange activity.,,,1.0,,,,,,,,,,,,,Q92888_Y_738_F
3031,P14384,E,277,A,1uwy:A,260,5-fold decrease in substrate affinity. 22-fold decrease in specific affinity. 104-fold decrease in catalytic efficiency. Greatly reduced heat stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,P14384_E_277_A
3032,P14384,E,277,Q,1uwy:A,260,2-fold decrease in substrate affinity. Small increase in specific affinity. Reduced heat stability by 50%.,,-1.0,-999.0,,,,,,,,,,,-1.0,,P14384_E_277_Q
3033,P14384,E,281,Q,1uwy:A,264,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P14384_E_281_Q
3034,Q6ZW76,D,450,K,4nj8:A,31,Decreased homooligomerization. No effect on interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_D_450_K
3035,Q6ZW76,I,455,E,4nj8:A,36,Decreased homooligomerization. No effect on interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_I_455_E
3036,Q6ZW76,E,466,K,4nj8:A,47,Decreased homooligomerization. No effect on interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_E_466_K
3037,Q6ZW76,L,471,E,4nj8:A,52,Decreased homooligomerization. Decreased interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_L_471_E
3038,Q6ZW76,F,472,E,4nj8:A,53,Decreased homooligomerization. Decreased interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_F_472_E
3039,Q6ZW76,K,477,E,4nj8:A,58,Decreased homooligomerization. Decreased interaction with ANKS6.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZW76_K_477_E
3040,Q9H1D0,R,510,E,6e2f:C,470,"Decreases channel opening, and thereby decreases channel activity.",,,1.0,,,,,,,,,,,,,Q9H1D0_R_510_E
3041,Q9H1D0,Q,523,A,6e2f:C,483,Decreases channel activity.,,,1.0,,,,,,,,,,,,,Q9H1D0_Q_523_A
3042,Q9H1D0,D,582,A,6e2f:C,542,Abolishes channel activity.,,,1.0,,,,,,,,,,,,,Q9H1D0_D_582_A
3043,Q9H1D0,A,606,T,6e2f:C,566,"Decreases channel opening, and thereby strongly decreases channel activity.",,,1.0,,,,,,,,,,,,,Q9H1D0_A_606_T
3044,P60033,K,116,E,5tcx:A,116,Reduces binding to integrin.,-1.0,,-999.0,,,,,,,,,,,,,P60033_K_116_E
3045,P60033,I,119,A,5tcx:A,119,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_I_119_A
3046,P60033,K,121,E,5tcx:A,121,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_K_121_E
3047,P60033,K,124,E,5tcx:A,124,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_K_124_E
3048,P60033,F,126,A,5tcx:A,126,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_F_126_A
3049,P60033,K,144,E,5tcx:A,144,Reduces binding to integrin,-1.0,,-999.0,,,,,,,,,,,,,P60033_K_144_E
3050,P60033,K,148,E,5tcx:A,148,Reduces binding to integrin,-1.0,,-999.0,,,,,,,,,,,,,P60033_K_148_E
3051,P60033,F,186,A,5tcx:A,186,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_F_186_A
3052,P60033,K,187,E,5tcx:A,187,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P60033_K_187_E
3053,P60033,E,188,K,5tcx:A,188,Strongly reduced affinity for HCV protein E2,-1.0,,-999.0,,,,,,,,,,,,,P60033_E_188_K
3053,P60033,E,188,Q,5tcx:A,188,Strongly reduced affinity for HCV protein E2,-1.0,,-999.0,,,,,,,,,,,,,P60033_E_188_Q
3055,P60033,D,196,E,5tcx:A,196,Strongly reduced affinity for HCV protein E2,-1.0,,-999.0,,,,,,,,,,,,,P60033_D_196_E
3056,P60033,D,196,K,5tcx:A,196,Strongly reduced affinity for HCV protein E2.,-1.0,,-999.0,,,,,,,,,,,,,P60033_D_196_K
3056,P60033,D,196,Q,5tcx:A,196,Strongly reduced affinity for HCV protein E2.,-1.0,,-999.0,,,,,,,,,,,,,P60033_D_196_Q
3056,P60033,D,196,R,5tcx:A,196,Strongly reduced affinity for HCV protein E2.,-1.0,,-999.0,,,,,,,,,,,,,P60033_D_196_R
3057,P60033,E,219,A,5tcx:A,219,Reduced affinity for cholesterol binding.,,-1.0,-999.0,,,,,,,,,,,,,P60033_E_219_A
3057,P60033,E,219,Q,5tcx:A,219,Reduced affinity for cholesterol binding.,,-1.0,-999.0,,,,,,,,,,,,,P60033_E_219_Q
3058,Q15027,S,14,A,4ckh:A,14,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_S_14_A
3059,Q15027,S,29,A,4ckh:A,29,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_S_29_A
3060,Q15027,K,274,N,4ckh:A,274,Loss of binding to PIP2 and PIP3. Loss of association with endosomal tubules when coexpressed with PIP5K1C.,-1.0,,-999.0,,,,,,,,,,,,,Q15027_K_274_N
3061,Q15027,S,277,A,4ckh:A,277,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_S_277_A
3062,Q15027,F,280,A,4ckh:A,280,Reduced membrane binding and ability to induce liposome tubulation.,,-1.0,1.0,,,,,,,,,,,,,Q15027_F_280_A
3063,Q15027,F,280,E,4ckh:A,280,Almost abolishes membrane binding.,,-1.0,-999.0,,,,,,,,,,,,,Q15027_F_280_E
3064,Q15027,F,280,W,4ckh:A,280,Preserves membrane binding and ability to tubulate liposomes.,,0.0,0.0,,,,,,,,,,,,,Q15027_F_280_W
3065,Q15027,T,289,A,4ckh:A,289,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_T_289_A
3066,Q15027,S,358,A,4ckh:A,358,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_S_358_A
3067,Q15027,R,448,Q,3t9k:A,448,Loss of GAP activity. No effect on GULP1 binding or association with endosomal tubules when coexpressed with PIP5K1C.,,,1.0,,,,,,,,,,,,,Q15027_R_448_Q
3068,Q15027,T,461,A,3t9k:A,461,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_T_461_A
3069,Q15027,S,568,A,3t9k:B,568,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_S_568_A
3070,Q15027,T,711,A,3t9k:A,711,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_T_711_A
3071,Q15027,Y,712,F,3t9k:A,712,No effect on interaction with ITGB1.,0.0,,-999.0,,,,,,,,,,,,,Q15027_Y_712_F
3072,O00541,F,327,R,2ep8:A,327,Reduces incorporation into the PeBoW complex and nucleolar localization and impairs maturation of 28S ribosomal RNA.,,,-999.0,,,,,,,,,1.0,,,,O00541_F_327_R
3073,O00541,I,347,R,2ep8:A,347,Reduces incorporation into the PeBoW complex and nucleolar localization and impairs maturation of 28S ribosomal RNA.,,,-999.0,,,,,,,,,1.0,,,,O00541_I_347_R
3074,O00541,R,380,W,2ep8:A,380,Slightly impairs nucleolar localization.,,,-999.0,,,,,,,,,1.0,,,,O00541_R_380_W
3075,O00541,W,397,R,2ep8:A,397,Reduces incorporation into the PeBoW complex and nucleolar localization and impairs maturation of 28S ribosomal RNA.,,,-999.0,,,,,,,,,1.0,,,,O00541_W_397_R
3076,Q9Y6X9,Y,18,A,5of9:B,18,Abolishes homodimerization. No effect on ATPase activity. Loss of HUSH-dependent gene silencing.,-1.0,,0.0,,,,,,,,,,,,,Q9Y6X9_Y_18_A
3077,Q9Y6X9,N,39,A,5of9:B,39,Loss of ATP-binding and ATPase activity. Does not homodimerizes. Seems to abolish chromatin compaction.,-1.0,-1.0,1.0,,,,,,,,,,,,,Q9Y6X9_N_39_A
3078,Q9Y6X9,D,68,A,5of9:B,68,Loss of ATP-binding and ATPase activity. Loss of binding to ATP and ATPase activity,,-1.0,1.0,,,,,,,,,,,,,Q9Y6X9_D_68_A
3079,Q9Y6X9,D,69,A,5of9:B,69,No effect on binding to ATP and ATPase activity,,0.0,0.0,,,,,,,,,,,,,Q9Y6X9_D_69_A
3080,Q9Y6X9,R,266,A,5of9:B,266,Increases HUSH-dependent gene silencing.,,,1.0,,,,,,,,,,,,,Q9Y6X9_R_266_A
3081,Q9Y6X9,R,319,E,5of9:B,319,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_319_E
3082,Q9Y6X9,R,326,E,5of9:B,326,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,1.0,,,,,,,,,,,,,Q9Y6X9_R_326_E
3083,Q9Y6X9,R,329,E,5of9:B,329,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,1.0,,,,,,,,,,,,,Q9Y6X9_R_329_E
3084,Q9Y6X9,R,333,E,5of9:B,333,Loss of HUSH-dependent gene silencing. Decreases dsDNA-binding affinity,,-1.0,1.0,,,,,,,,,,,,,Q9Y6X9_R_333_E
3085,Q9Y6X9,R,344,E,5of9:B,344,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_344_E
3086,Q9Y6X9,R,351,E,5of9:B,351,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_351_E
3087,Q9Y6X9,R,358,E,5of9:B,358,No effect on HUSH-dependent gene silencing.,,,0.0,,,,,,,,,,,,,Q9Y6X9_R_358_E
3088,Q9Y2V2,H,76,Q,3aqq:B,76,Reduced affinity for single-stranded DNA.,,,0.0,,,,,,,,,,,,,Q9Y2V2_H_76_Q
3089,P78318,R,155,E,4iyp:A,155,Abolishes interaction with PPP2CA.,-1.0,,-999.0,,,,,,,,,,,,,P78318_R_155_E
3090,P78318,K,158,D,4iyp:A,158,Abolishes interaction with PPP2CA.,-1.0,,-999.0,,,,,,,,,,,,,P78318_K_158_D
3091,P78318,Y,162,D,4iyp:A,162,Abolishes interaction with PPP2CA.,-1.0,,-999.0,,,,,,,,,,,,,P78318_Y_162_D
3092,P78318,E,214,R,4iyp:A,214,Abolishes interaction with PPP2CA.,-1.0,,-999.0,,,,,,,,,,,,,P78318_E_214_R
3093,Q92993,L,254,A,2ou2:A,202,Does not affect phosphorylation,,,-999.0,0.0,,,,,,,,,,,,Q92993_L_254_A
3094,Q92993,L,257,A,2ou2:A,205,Does not affect phosphorylation,,,-999.0,0.0,,,,,,,,,,,,Q92993_L_257_A
3095,Q92993,G,380,A,2ou2:A,328,Loss of function. Does not affect phosphorylation.,,,1.0,0.0,,,,,,,,,,,,Q92993_G_380_A
3096,P22301,R,42,A,2ilk:A,24,About 80% loss of IL10RA binding.,-1.0,,-999.0,,,,,,,,,,,,,P22301_R_42_A
3097,P04083,S,34,A,1ain:A,7,No effect on secretion and modulation of exocytosis.,,,-999.0,,,,,,,,,0.0,,,,P04083_S_34_A
3098,P04083,S,45,A,1ain:A,18,Abolishes secretion and nearly abolishes modulation of exocytosis.,,,-999.0,,,,,,,,,1.0,,,,P04083_S_45_A
3099,P22303,D,206,N,4bdt:A,175,"Misfolding, absence of secretion.",,,-999.0,,,,,,,,,1.0,,-1.0,,P22303_D_206_N
3100,P22303,S,234,A,4bdt:A,203,Loss of activity.,,,1.0,,,,,,,,,,,,,P22303_S_234_A
3101,P22303,E,365,A,4bdt:A,334,Loss of activity.,,,1.0,,,,,,,,,,,,,P22303_E_365_A
3102,P22303,D,435,N,4bdt:A,404,"Misfolding, absence of secretion.",,,1.0,,,,,,,,,,,,,P22303_D_435_N
3103,P22303,H,478,A,4bdt:A,447,Loss of activity.,,,1.0,,,,,,,,,,,,,P22303_H_478_A
3104,P53778,D,179,A,1cm8:A,179,Emulation of the active state.,,,0.0,,,,,,,,,,,,,P53778_D_179_A
3105,P53778,Y,185,F,1cm8:A,185,Loss of activity.,,,1.0,,,,,,,,,,,,,P53778_Y_185_F
3106,P53778,F,330,S,6una:B,330,No effect.,,,0.0,,,,,,,,,,,,,P53778_F_330_S
3107,P22307,N,528,D,1qnd:A,104,Strongly reduces sterol carrier and phosphatidylcholine transfer activity,,,1.0,,,,,,,,,,,,,P22307_N_528_D
3108,P22307,N,528,I,1qnd:A,104,Strongly reduces sterol carrier and phosphatidylcholine transfer activity.,,,1.0,,,,,,,,,,,,,P22307_N_528_I
3109,P22307,G,530,D,1qnd:A,106,Strongly reduces sterol carrier and phosphatidylcholine transfer activity,,,1.0,,,,,,,,,,,,,P22307_G_530_D
3110,Q6IMN6,I,1048,R,4oum:A,1048,Impaired homotrimer formation. No effect on LRP6 binding although LRP6 phosphorylation is significantly reduced.,-1.0,,1.0,,,,,,,,,,,,,Q6IMN6_I_1048_R
3111,Q6IMN6,D,1078,A,4oum:A,1078,Loss of calcium binding and increased homotrimer stability,1.0,-1.0,-999.0,,,,,,,,,,,,,Q6IMN6_D_1078_A
3112,Q6IMN6,E,1084,A,4oum:A,1084,Loss of calcium binding and increased homotrimer stability,1.0,-1.0,-999.0,,,,,,,,,,,,,Q6IMN6_E_1084_A
3113,Q6IMN6,I,1091,S,4oum:A,1091,Impaired homotrimer formation. No effect on LRP6 binding although LRP6 phosphorylation is significantly reduced.,-1.0,,1.0,,,,,,,,,,,,,Q6IMN6_I_1091_S
3114,Q6IMN6,W,1114,S,4oum:A,1114,No effect on homotrimer formation.,0.0,,-999.0,,,,,,,,,,,,,Q6IMN6_W_1114_S
3115,Q6IMN6,Y,1122,S,4oum:A,1122,No effect on homotrimer formation.,0.0,,-999.0,,,,,,,,,,,,,Q6IMN6_Y_1122_S
3116,Q5SQI0,Q,58,A,4if5:A,58,Loss of acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_Q_58_A
3117,Q5SQI0,S,61,A,4if5:A,61,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q5SQI0_S_61_A
3118,Q5SQI0,I,64,A,4if5:A,64,Strong reduction in acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_I_64_A
3119,Q5SQI0,R,69,A,4if5:A,69,Strong reduction in acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_R_69_A
3120,Q5SQI0,K,102,A,4if5:A,102,Strong reduction in acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_K_102_A
3121,Q5SQI0,F,105,A,4if5:A,105,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_F_105_A
3122,Q5SQI0,V,106,A,4if5:A,106,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_V_106_A
3123,Q5SQI0,L,107,A,4if5:A,107,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_L_107_A
3124,Q5SQI0,D,108,A,4if5:A,108,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_108_A
3125,Q5SQI0,D,109,A,4if5:A,109,Slight increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_109_A
3126,Q5SQI0,D,109,R,4if5:A,109,Marginal increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_109_R
3127,Q5SQI0,E,111,A,4if5:A,111,2-fold increase in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_E_111_A
3128,Q5SQI0,E,111,R,4if5:A,111,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q5SQI0_E_111_R
3129,Q5SQI0,E,115,A,4if5:A,115,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_E_115_A
3130,Q5SQI0,E,117,A,4if5:A,117,Reduced activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_E_117_A
3131,Q5SQI0,C,120,A,4if5:A,120,Strong reduction in microtubule acetylation.,,,1.0,,,,,,,,,,,,,Q5SQI0_C_120_A
3131,Q5SQI0,C,120,S,4if5:A,120,Strong reduction in microtubule acetylation.,,,1.0,,,,,,,,,,,,,Q5SQI0_C_120_S
3132,Q5SQI0,D,157,E,4if5:A,157,Strong reduction in microtubule acetylation.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_157_E
3132,Q5SQI0,D,157,N,4if5:A,157,Strong reduction in microtubule acetylation.,,,1.0,,,,,,,,,,,,,Q5SQI0_D_157_N
3133,Q5SQI0,R,158,A,4if5:A,158,20% of wild-type acetyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_R_158_A
3134,Q5SQI0,N,182,A,4if5:A,182,Strong reduction in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_N_182_A
3135,Q5SQI0,F,183,A,4if5:A,183,Strong reduction in activity.,,,1.0,,,,,,,,,,,,,Q5SQI0_F_183_A
3136,Q9GZL7,S,76,L,6p0q:A,76,Reduces interaction with MDN1.,-1.0,,-999.0,,,,,,,,,,,,,Q9GZL7_S_76_L
3137,Q9GZL7,E,78,A,6p0q:A,78,Abolishes interaction with MDN1.,-1.0,,-999.0,,,,,,,,,,,,,Q9GZL7_E_78_A
3138,Q8TCG1,N,230,E,5ufl:B,230,Reduces binding to PPP2R5C.,-1.0,,-999.0,,,,,,,,,,,,,Q8TCG1_N_230_E
3139,Q8TCG1,R,522,D,5ufl:A,522,Decreases homodimerization. Reduces binding to PPP2R5C. Decreases protein level.,-1.0,,-999.0,,,,,,,,,,,,,Q8TCG1_R_522_D
3140,Q8TCG1,L,533,E,5ufl:A,533,Decreases homodimerization. Reduces binding to PPP2R5C. Decreases protein level.,-1.0,,-999.0,,,,,,,,,,,,,Q8TCG1_L_533_E
3148,Q9Y6J6,K,75,H,2m0q:A,75,Increases tail current in KCNH2/KCNE2 channel.,,,-999.0,,,,,,,,,,,,,Q9Y6J6_K_75_H
3149,P0C870,C,47,A,5nfo:A,47,Impairs homodimer formation.,-1.0,,-999.0,,,,,,,,,,,,,P0C870_C_47_A
3150,P0C870,H,178,A,5nfo:A,178,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,1.0,,,,,,,,,,,,,P0C870_H_178_A
3151,P0C870,D,180,A,5nfo:A,180,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,1.0,,,,,,,,,,,,,P0C870_D_180_A
3152,P0C870,H,277,A,5nfo:A,277,Loss of peptidase activity toward methylated histones and reduced anchorage-independent growth of transformed cells,,,1.0,,,,,,,,,,,,,P0C870_H_277_A
3153,P17812,E,161,K,5u03:A,161,Localizes to cystolic filament structures.,,,-999.0,,,,,,,,,1.0,,,,P17812_E_161_K
3154,Q14318,D,149,N,5mgx:G,149,Abolishes calcium-binding and reduces affinity for BCL2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q14318_D_149_N
3155,Q14318,D,151,N,5mgx:G,151,Abolishes calcium-binding and reduces affinity for BCL2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q14318_D_151_N
3156,P62987,K,48,R,5hpl:C,48,No effect on HLTF-mediated polyubiquitination of PCNA.,,,0.0,,,,,,,,,,,,,P62987_K_48_R
3157,P62987,K,63,R,5hpl:C,63,Abolishes HLTF-mediated polyubiquitination of PCNA.,,,1.0,,,,,,,,,,,,,P62987_K_63_R
3158,P62987,S,65,A,5hpl:C,65,Prevents phosphorylation in case of mitophagy.,,,-999.0,-1.0,,,,,,,,,,,,P62987_S_65_A
3159,P62987,S,65,D,5hpl:C,65,Phosphomimetic mutant that binds and activates PRKN.,,,-999.0,,,,,,,,,,1.0,,,P62987_S_65_D
3160,P62987,H,68,G,5hpl:C,68,Loss of DTX3L-mediated polyubiquitination of histone H3 and H4.,,,1.0,,,,,,,,,,,,,P62987_H_68_G
3161,P62987,R,72,G,5hpl:C,72,No effect on ADP-ribosylation.,,,0.0,,,,,,,,,,,,,P62987_R_72_G
3162,P62987,R,72,K,5hpl:C,72,"No effect on ADP-ribosylation, when associated with K-74.",,,-999.0,,,,,,,,,,,,,P62987_R_72_K
3163,P62987,R,74,G,5hpl:C,74,No effect on ADP-ribosylation.,,,0.0,,,,,,,,,,,,,P62987_R_74_G
3164,P62987,R,74,K,5hpl:C,74,"No effect on ADP-ribosylation, when associated with K-72.",,,-999.0,,,,,,,,,,,,,P62987_R_74_K
3165,P62987,G,76,A,5hpl:C,76,Loss of ADP-ribosylation.,,,1.0,,,,,,,,,,,,,P62987_G_76_A
3166,O95396,C,365,A,3i2v:A,31,Does not affect sulfurtransferase activity.,,,0.0,,,,,,,,,,,,,O95396_C_365_A
3167,O95396,C,412,A,3i2v:A,78,Abolishes sulfurtransferase activity.,,,1.0,,,,,,,,,,,,,O95396_C_412_A
3168,O95396,K,413,R,3i2v:A,79,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_K_413_R
3169,O95396,L,414,K,3i2v:A,80,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_L_414_K
3170,O95396,G,415,A,3i2v:A,81,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_G_415_A
3171,O95396,N,416,V,3i2v:A,82,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_N_416_V
3172,O95396,D,417,R,3i2v:A,83,Results in 470-fold increased activity.,,,1.0,,,,,,,,,,,,,O95396_D_417_R
3173,O95396,D,417,T,3i2v:A,83,Results in 90-fold increased activity.,,,1.0,,,,,,,,,,,,,O95396_D_417_T
3174,O95396,P,458,G,3i2v:A,124,Does not affect sulfurtransferase specificity and activity.,,,0.0,,,,,,,,,,,,,O95396_P_458_G
3175,Q92956,Y,61,A,4rsu:D,61,Abolishes cis interactions with BTLA.,-1.0,,-999.0,,,,,,,,,,,,,Q92956_Y_61_A
3176,Q92956,Y,61,F,4rsu:D,61,Does not affect cis interactions with BTLA.,0.0,,-999.0,,,,,,,,,,,,,Q92956_Y_61_F
3177,O94925,Y,249,A,5uqe:D,249,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_Y_249_A
3178,O94925,S,286,A,5uqe:D,286,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_S_286_A
3179,O94925,K,289,A,5uqe:D,289,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_K_289_A
3180,O94925,F,318,Y,5uqe:D,318,No effect on catalytic activity. Loss of inhibition by BPTES,-1.0,,0.0,,,,,,,,,,,,,O94925_F_318_Y
3181,O94925,L,321,A,5uqe:D,321,Decreased enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_L_321_A
3182,O94925,F,322,S,5uqe:D,322,No effect on catalytic activity. Loss of inhibition by BPTES,-1.0,,0.0,,,,,,,,,,,,,O94925_F_322_S
3183,O94925,L,323,A,5uqe:D,323,Decreased enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_L_323_A
3184,O94925,Y,394,A,5uqe:D,394,Decreased enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_Y_394_A
3185,O94925,Y,394,L,5uqe:D,394,No effect on catalytic activity. Loss of inhibition by BPTES.,-1.0,,0.0,,,,,,,,,,,,,O94925_Y_394_L
3186,O94925,Y,466,A,5uqe:D,466,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94925_Y_466_A
3187,Q99962,A,63,S,2d4c:B,63,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,1.0,,,,,,,,,,,,,Q99962_A_63_S
3188,Q99962,A,66,D,2d4c:B,66,"Loss of tubulation of liposomes, no effect on liposome binding.",,0.0,1.0,,,,,,,,,,,,,Q99962_A_66_D
3189,Q99962,A,66,S,2d4c:B,66,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,1.0,,,,,,,,,,,,,Q99962_A_66_S
3190,Q99962,A,66,W,2d4c:B,66,"Vesiculation of liposomes, no effect on liposome binding, indol ring located in hydrophobic core of the membrane.",,0.0,-999.0,,,,,,,,,,,,,Q99962_A_66_W
3191,Q99962,M,70,Q,2d4c:B,70,"Reduced tubulation of liposomes, 3-fold increase in tubule diameter, no effect on liposome binding",,0.0,1.0,,,,,,,,,,,,,Q99962_M_70_Q
3192,Q99962,F,202,W,1x03:A,202,No effect. Indol ring not associated with the membrane.,,,0.0,,,,,,,,,,,,,Q99962_F_202_W
3193,P43220,L,32,A,5nx2:A,32,No effect on stimulation of cAMP accumulation and on GLP-1 binding.,0.0,0.0,0.0,,,,,,,,,,,,,P43220_L_32_A
3194,P43220,Y,69,A,5nx2:A,69,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_Y_69_A
3195,P43220,Y,88,A,5nx2:A,88,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_Y_88_A
3196,P43220,L,89,A,5nx2:A,89,Abolishes stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_L_89_A
3197,P43220,P,90,A,5nx2:A,90,Strongly decreased stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_P_90_A
3198,P43220,R,121,A,5nx2:A,121,Strongly decreased stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_R_121_A
3199,P43220,E,127,A,5nx2:A,127,No effect on stimulation of cAMP accumulation in response to GLP-1.,0.0,,0.0,,,,,,,,,,,,,P43220_E_127_A
3200,P43220,E,128,A,5nx2:A,128,Slightly decreases stimulation of cAMP accumulation in response to GLP-1.,-1.0,,1.0,,,,,,,,,,,,,P43220_E_128_A
3201,P43220,E,128,Q,5nx2:A,128,No effect on stimulation of cAMP accumulation in response to GLP-1.,0.0,,0.0,,,,,,,,,,,,,P43220_E_128_Q
3202,P43220,R,176,Q,5nx2:A,176,Decreases sensitivity to GLP-1.,-1.0,,-999.0,,,,,,,,,,,,,P43220_R_176_Q
3203,P43220,I,317,C,5nx2:A,317,Causes the formation of an artifactual disulfide bond that abolishes signaling in response to GLP-1 binding,-1.0,,-999.0,,,,,,1.0,,,,,,,P43220_I_317_C
3204,P43220,S,352,A,5nx2:A,352,Abolishes inhibition by negative allosteric modulators.,,-1.0,-999.0,,,,,,,,,,,,,P43220_S_352_A
3205,P43220,T,355,A,5nx2:A,355,"Abolishes inhibition by the negative allosteric modulators NNC0640 and PF-06372222, but does not abolish inhibition by MK-0893.",,-1.0,-999.0,,,,,,,,,,,,,P43220_T_355_A
3206,P43220,G,361,C,5nx2:A,361,Causes the formation of an artifactual disulfide bond that abolishes signaling in response to GLP-1 binding,-1.0,,-999.0,,,,,,1.0,,,,,,,P43220_G_361_C
3207,O14732,D,104,N,2ddk:A,104,Loss of activity.,,,1.0,,,,,,,,,,,,,O14732_D_104_N
3208,O43741,H,235,A,4rer:B,235,Results in an AMPK enzyme that is activable by phosphorylation but has significantly increased rate of dephosphorylation in phosphatase assays.,,,-999.0,-1.0,,,,,,,,,,,,O43741_H_235_A
3209,Q92797,K,185,A,3ods:A,185,Abolishes stimulation of SSU72 phosphatase activity.,,,-999.0,,,,,,,,,,,,,Q92797_K_185_A
3210,Q92794,C,543,G,2rc4:A,543,Abrogates HAT activity.,,,-999.0,,,,,,,,,,,,,Q92794_C_543_G
3211,Q92794,K,545,A,2rc4:A,545,Reduced affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92794_K_545_A
3212,Q92794,G,657,E,2rc4:A,657,Abrogates HAT activity.,,,-999.0,,,,,,,,,,,,,Q92794_G_657_E
3213,Q92794,I,727,E,2rc4:A,727,Slightly reduced affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92794_I_727_E
3214,Q92794,H,732,D,2rc4:A,732,Reduced affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92794_H_732_D
3215,O75208,L,190,E,6awl:A,190,Impairs interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_L_190_E
3216,O75208,M,227,E,6awl:A,227,Impairs interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_M_227_E
3217,O75208,D,237,K,6awl:A,237,Impairs interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_D_237_K
3218,O75208,W,240,D,6awl:A,240,Abolishes interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_W_240_D
3218,O75208,W,240,K,6awl:A,240,Abolishes interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_W_240_K
3219,O75208,Y,241,D,6awl:A,241,Abolishes interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_Y_241_D
3219,O75208,Y,241,K,6awl:A,241,Abolishes interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_Y_241_K
3220,O75208,L,256,K,6awl:A,256,Impairs interaction with COQ7.,-1.0,,-999.0,,,,,,,,,,,,,O75208_L_256_K
3221,P22234,H,303,Y,6yb9:A,303,Loss of AIR carboxylase activity.,,,1.0,,,,,,,,,,,,,P22234_H_303_Y
3222,P22234,S,332,A,6yb9:A,332,Loss of AIR carboxylase activity.,,,1.0,,,,,,,,,,,,,P22234_S_332_A
3223,P22234,G,334,A,6yb9:A,334,Loss of AIR carboxylase activity.,,,1.0,,,,,,,,,,,,,P22234_G_334_A
3224,P22234,S,400,A,6yb9:A,400,No change of AIR carboxylase activity.,,,0.0,,,,,,,,,,,,,P22234_S_400_A
3225,P04792,S,15,D,6dv5:A,15,"Mimicks phosphorylation state, leading to dreased ability to act as molecular chaperones",,,1.0,,,,,,,,,,1.0,,,P04792_S_15_D
3226,P04792,S,82,D,2n3j:A,82,"Mimicks phosphorylation state, leading to dreased ability to act as molecular chaperones",,,1.0,,,,,,,,,,1.0,,,P04792_S_82_D
3227,Q9NZD2,I,45,N,4gxg:A,45,18% decrease in activity.,,,1.0,,,,,,,,,,,,,Q9NZD2_I_45_N
3228,Q9NZD2,D,48,V,4gxg:A,48,Significant inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_D_48_V
3229,Q9NZD2,N,52,I,4gxg:A,52,Significant inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_N_52_I
3230,Q9NZD2,K,55,I,4gxg:A,55,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_K_55_I
3231,Q9NZD2,W,96,A,4gxg:A,96,Almost complete inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_W_96_A
3232,Q9NZD2,W,96,F,4gxg:A,96,Partial inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_W_96_F
3233,Q9NZD2,F,103,S,4gxg:A,103,About 25% decrease in activity.,,,1.0,,,,,,,,,,,,,Q9NZD2_F_103_S
3234,Q9NZD2,L,136,R,4gxg:A,136,Significant inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_L_136_R
3235,Q9NZD2,H,140,L,4gxg:A,140,Almost complete inactivation,,,1.0,,,,,,,,,,,,,Q9NZD2_H_140_L
3236,Q9NZD2,F,148,S,4gxg:A,148,About 50% decrease in activity.,,,1.0,,,,,,,,,,,,,Q9NZD2_F_148_S
3237,Q9NZD2,L,165,R,4gxg:A,165,46% decrease in activity.,,,1.0,,,,,,,,,,,,,Q9NZD2_L_165_R
3238,Q9NZD2,F,183,S,4gxg:A,183,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_F_183_S
3239,Q9NZD2,Y,207,L,4gxg:A,207,No loss of activity,,,0.0,,,,,,,,,,,,,Q9NZD2_Y_207_L
3240,P30838,C,244,S,3sza:B,243,Abolishes activity.,,,1.0,,,,,,,,,,,,,P30838_C_244_S
3241,Q9UK80,C,221,A,3mtn:A,221,Abolishes ubiquitin thioesterase activity.,,,1.0,,,,,,,,,,,,,Q9UK80_C_221_A
3242,P04155,C,82,S,1ps2:A,58,Abolishes inhibition of gastric cancer cell growth.,,,1.0,,,,,,,,,,,,,P04155_C_82_S
3243,Q9HAW0,R,110,A,5n9g:A,110,Decreases affinity for DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q9HAW0_R_110_A
3244,Q9HAW0,C,361,A,4roe:A,361,Abolishes response to oxidative stress. Abolishes the decrease in the formation of a ternary complex with DNA and TBP in response to oxidative stress.,,,-999.0,,,,,,,,,,,,,Q9HAW0_C_361_A
3245,Q9HAW0,C,361,D,4roe:A,361,Impairs formation of a ternary complex with DNA and TBP.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9HAW0_C_361_D
3246,Q9Y3B8,D,168,A,6n6j:A,136,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q9Y3B8_D_168_A
3247,P28161,T,210,C,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_C
3247,P28161,T,210,F,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_F
3247,P28161,T,210,H,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_H
3247,P28161,T,210,I,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_I
3247,P28161,T,210,K,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_K
3247,P28161,T,210,L,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_L
3247,P28161,T,210,R,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_R
3247,P28161,T,210,Y,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_Y
3247,P28161,T,210,W,1hna:A,209,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P28161_T_210_W
3248,Q96LD8,D,10,A,2bkr:A,10,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_D_10_A
3249,Q96LD8,W,26,A,2bkr:A,26,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,Q96LD8_W_26_A
3250,Q96LD8,D,29,A,2bkr:A,29,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_D_29_A
3250,Q96LD8,D,29,N,2bkr:A,29,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_D_29_N
3251,Q96LD8,V,58,A,2bkr:A,58,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_V_58_A
3252,Q96LD8,F,74,A,2bkr:A,74,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_F_74_A
3253,Q96LD8,P,77,A,2bkr:A,77,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_P_77_A
3254,Q96LD8,N,91,A,2bkr:A,91,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_N_91_A
3255,Q96LD8,H,102,N,2bkr:A,102,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_H_102_N
3256,Q96LD8,W,103,A,2bkr:A,103,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,Q96LD8_W_103_A
3256,Q96LD8,W,103,H,2bkr:A,103,Strongly reduces activity.,,,1.0,,,,,,,,,,,,,Q96LD8_W_103_H
3257,Q96LD8,D,119,A,2bkr:A,119,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_D_119_A
3257,Q96LD8,D,119,N,2bkr:A,119,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_D_119_N
3258,Q96LD8,Q,157,A,2bkr:A,157,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96LD8_Q_157_A
3259,Q96LD8,C,163,A,2bkr:A,163,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q96LD8_C_163_A
3260,O75689,C,21,A,3feh:A,21,Loss of GTPase-activating activity.,,,1.0,,,,,,,,,,,,,O75689_C_21_A
3261,O75689,C,24,A,3feh:A,24,Loss of GTPase-activating activity.,,,1.0,,,,,,,,,,,,,O75689_C_24_A
3262,O75689,R,149,C,3feh:A,149,40-45% reduction in PtdInsP2 3-kinase dependent membrane localization. Almost complete loss of PtdInsP2 3-kinase dependent membrane localization,,,-999.0,,,,,,,,,1.0,,,,O75689_R_149_C
3263,O75689,R,273,C,3lju:X,273,70% reduction in PtdInsP2 3-kinase dependent membrane localization. Almost complete loss of PtdInsP2 3-kinase dependent membrane localization,,,-999.0,,,,,,,,,1.0,,,,O75689_R_273_C
3264,Q14449,K,140,A,4k81:A,140,Partial loss of INSR-binding. Loss of inhibition of AKT1 activation. Loss of inhibition of MAPK3 phosphorylation. Loss of NRAS-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q14449_K_140_A
3265,Q14449,E,245,G,4k81:A,245,"4-fold increase in PI(3,4,5)P3-binding affinity",,1.0,-999.0,,,,,,,,,,,,,Q14449_E_245_G
3266,Q14449,Q,246,S,4k81:A,246,"4-fold increase in PI(3,4,5)P3-binding affinity",,1.0,-999.0,,,,,,,,,,,,,Q14449_Q_246_S
3267,Q14449,K,252,A,4k81:A,252,"Partial loss of INSR-binding. Loss of inhibition of AKT1 activation. Loss of inhibition of MAPK3 phosphorylation. Loss of translocation to the plasma membrane upon insulin-stimulation. More than 3-fold decrease in PI(3,4,5)P3-binding affinity.",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q14449_K_252_A
3268,Q14449,G,299,N,4k81:A,299,"No effect on PI(3,4,5)P3-binding.",,0.0,-999.0,,,,,,,,,,,,,Q14449_G_299_N
3269,Q14449,Q,348,A,4k81:A,348,Loss of inhibition of AKT1 activation,,,-999.0,,,,,,,,,,,,,Q14449_Q_348_A
3270,Q14449,N,349,A,4k81:A,349,Loss of inhibition of AKT1 activation,,,-999.0,,,,,,,,,,,,,Q14449_N_349_A
3271,Q9H269,A,669,D,4bx9:C,669,"Disrupts interaction with VPS33A, no effect on interaction with VPS18 and impairs endosome-lysosome fusion",-1.0,,-999.0,,,,,,,,,,,,,Q9H269_A_669_D
3272,Q9H269,R,725,E,4bx9:C,725,"Disrupts interaction with VPS33A, no effect on interaction with VPS18 and impairs endosome-lysosome fusion",-1.0,,-999.0,,,,,,,,,,,,,Q9H269_R_725_E
3273,P35670,H,1069,A,2arf:A,1069,Loss of ATPase activity. Cannot form an acylphosphate intermediate during catalysis. Does not alter folding of the nucleotide-binding domain.,,,1.0,,,,,,,,,,,0.0,,P35670_H_1069_A
3273,P35670,H,1069,C,2arf:A,1069,Loss of ATPase activity. Cannot form an acylphosphate intermediate during catalysis. Does not alter folding of the nucleotide-binding domain.,,,1.0,,,,,,,,,,,0.0,,P35670_H_1069_C
3274,P46527,Y,74,F,1jsu:C,74,No change in binding CDK4 and no inhibition of CDK4 activity. Translocates to nucleus. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7.,0.0,,-999.0,,,,,,,,,0.0,,,,P46527_Y_74_F
3275,P46527,Y,88,F,1jsu:C,88,"Abolishes LYN-mediated phosphorylation, reduces CDK2-mediated phosphorylation on T-187, has greater cell cycle arrest into S-phase, no effect on binding CDK2 complexes, reduced CDK4 binding and inhibits CDK4 enzyme activity. No nuclear translocation. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding",-1.0,,1.0,,,,,,,,,1.0,,,,P46527_Y_88_F
3276,P46527,Y,89,F,1jsu:C,89,"No effect on binding CDK2 complexes, reduced CDK4 binding and greatly inhibits CDK4 enzyme activity. No nuclear translocation. Inhibits in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding",-1.0,,-999.0,,,,,,,,,1.0,,,,P46527_Y_89_F
3277,Q8IW75,N,221,A,5ei0:A,221,Reduced N-glycosylation. Loss of N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,Q8IW75_N_221_A
3278,Q8IW75,N,233,A,5ei0:A,233,Reduced N-glycosylation. Loss of N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,Q8IW75_N_233_A
3279,Q8IW75,N,267,A,5ei0:A,267,Reduced N-glycosylation. Loss of N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,Q8IW75_N_267_A
3280,Q8IW75,R,302,A,5ei0:A,302,Significantly impairs KLK7 inhibition activity. Slightly enhances KLK7 inhibition activity,,,1.0,,,,,,,,,,,,,Q8IW75_R_302_A
3280,Q8IW75,R,302,E,5ei0:A,302,Significantly impairs KLK7 inhibition activity. Slightly enhances KLK7 inhibition activity,,,1.0,,,,,,,,,,,,,Q8IW75_R_302_E
3281,Q8IW75,D,305,C,5ei0:A,305,Results in formation of an artificial disulfide bond which stabilizes the reactive center loop and enhances KLK7 inhibition activity,,,-999.0,,,,,,1.0,,,,,,,Q8IW75_D_305_C
3282,Q8IW75,T,365,R,5ei0:A,365,Fails to inhibit KLK7 activity. Increased protein stability in cleaved form and conformational changes which may allow escape of the substrate.,,-1.0,1.0,,,,,,,,,,,1.0,,Q8IW75_T_365_R
3283,Q8IW75,A,369,P,5ei0:A,369,Fails to inhibit KLK7 activity. Increased protein stability in cleaved form and conformational changes which may allow escape of the substrate.,,-1.0,1.0,,,,,,,,,,,1.0,,Q8IW75_A_369_P
3284,Q99497,L,10,P,4zgg:A,10,Abolishes detoxification acivity on methylglyocal-adducted CoA.,,,1.0,,,,,,,,,,,,,Q99497_L_10_P
3285,Q99497,E,18,A,4zgg:A,18,Strongly decreases enzymatic activity. Almost abolishes detoxification acivity on methylglyocal-adducted CoA.,,,1.0,,,,,,,,,,,,,Q99497_E_18_A
3286,Q99497,E,18,D,4zgg:A,18,Strongly decreases enzymatic activity.,,,1.0,,,,,,,,,,,,,Q99497_E_18_D
3287,Q99497,E,18,N,4zgg:A,18,Strongly decreases enzymatic activity.,,,1.0,,,,,,,,,,,,,Q99497_E_18_N
3288,Q99497,E,18,Q,4zgg:A,18,Strongly decreases enzymatic activity.,,,1.0,,,,,,,,,,,,,Q99497_E_18_Q
3289,Q99497,C,46,A,4zgg:A,46,Reduces protein stability. No effect on oxidation.,,,-999.0,,,,,,0.0,,,,,-1.0,,Q99497_C_46_A
3291,Q99497,C,46,S,4zgg:A,46,No effect on mitochondrial translocation neither on deglycase activity.,,,1.0,,,,,,,,,0.0,,,,Q99497_C_46_S
3292,Q99497,V,51,A,4zgg:A,51,Disrupts dimer formation and strongly reduces ability to eliminate hydrogen peroxide.,-1.0,,1.0,,,,,,,,,,,,,Q99497_V_51_A
3293,Q99497,C,53,A,4zgg:A,53,Strongly reduces chaperone activity and ability to eliminate hydrogen peroxide.,,,1.0,,,,,,,,,,,,,Q99497_C_53_A
3294,Q99497,C,53,S,4zgg:A,53,No effect on mitochondrial translocation neither on deglycase activity.,,,0.0,,,,,,,,,0.0,,,,Q99497_C_53_S
3295,Q99497,C,106,A,4zgg:A,106,"Abolishes enzymatic activity. Abolishes oxidation, association with mitochondria and protease activity. No effect on chaperone activity. Reduces binding to OTUD7B.",-1.0,,1.0,,,,,,0.0,,,,,,,Q99497_C_106_A
3297,Q99497,C,106,D,4zgg:A,106,Abolishes oxidation and association with mitochondria. No effect on chaperone activity.,,,-999.0,,,,,,-1.0,,,1.0,,,,Q99497_C_106_D
3298,Q99497,C,106,S,4zgg:A,106,Loss of protein and nucleic acid deglycase activity. No effect on mitochondrial translocation. Reduced protease activity. No effect on protection against metal cytotoxicity. No effect on methylglyoxal-adducted glutathione or CoA.,,,1.0,,,,,,,,,0.0,,,,Q99497_C_106_S
3299,Q99497,H,126,A,4zgg:A,126,Strongly decreases enzymatic activity.,,,1.0,,,,,,,,,,,,,Q99497_H_126_A
3300,Q99497,K,130,R,4zgg:A,130,Partially compensates for loss of stability,,,-999.0,,,,,,,,,,,0.0,,Q99497_K_130_R
3301,Q99497,A,179,T,4zgg:A,179,No effect on detoxification acivity on methylglyocal-adducted CoA.,,,0.0,,,,,,,,,,,,,Q99497_A_179_T
3302,P23435,Y,122,A,5kc5:A,122,Abolishes GRID2 interaction.,-1.0,,-999.0,,,,,,,,,,,,,P23435_Y_122_A
3303,P23435,R,124,A,5kc5:A,124,Abolishes GRID2 interaction.,-1.0,,-999.0,,,,,,,,,,,,,P23435_R_124_A
3304,P23435,D,147,A,5kc5:A,147,Abolishes GRID2 interaction.,-1.0,,-999.0,,,,,,,,,,,,,P23435_D_147_A
3305,Q8WY64,Y,265,A,6qly:A,265,Unable to clear LDLR from the plasma membrane.,,,1.0,,,,,,,,,,,,,Q8WY64_Y_265_A
3306,Q8WY64,T,269,R,6qly:A,269,Unable to clear LDLR from the plasma membrane.,,,1.0,,,,,,,,,,,,,Q8WY64_T_269_R
3307,Q8WY64,C,387,A,2yho:E,387,Abolishes autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,Q8WY64_C_387_A
3309,Q8WY64,V,389,R,2yho:E,389,Inhibits LDLR degradation.,,,1.0,,,,,,,,,,,,,Q8WY64_V_389_R
3310,Q8WY64,L,415,E,2yho:E,415,Inhibits LDLR degradation.,,,1.0,,,,,,,,,,,,,Q8WY64_L_415_E
3311,Q96RI1,K,289,R,3hc6:A,275,Abrogates SUMO1-mediated inhibition of ligand-induced transcactivation at ABCB11/BSEP and NR0B2/SHP promoters,,,-999.0,,,,,,,,,,,,,Q96RI1_K_289_R
3312,Q96RI1,E,291,A,3hc6:A,277,Abrogates SUMO1-mediated inhibition of ligand-induced transcactivation at ABCB11/BSEP and NR0B2/SHP promoters,,,-999.0,,,,,,,,,,,,,Q96RI1_E_291_A
3313,Q96RI1,K,353,R,3hc6:A,339,"Decreases transcriptional activation SLC51A/OSTA, SLC51B/OSTB and ABCB11/BSEP, no effect on interaction with RXRA and SETD7, decreases association with ABCB11/BSEP promoter.",,,-999.0,,,,,,,,,,,,,Q96RI1_K_353_R
3314,Q96RI1,R,455,S,3hc6:A,441,"As a heterodimer with RXRA, impaired transcriptional activity.",,,-999.0,,,,,,,,,,,,,Q96RI1_R_455_S
3315,Q96RI1,T,456,A,3hc6:A,442,Impairs transcriptional activation of ABCB11/BSEP.,,,1.0,,,,,,,,,,,,,Q96RI1_T_456_A
3316,Q96RI1,K,474,R,3hc6:A,460,"Decreases transcriptional activation SLC51A/OSTA, SLC51B/OSTB and ABCB11/BSEP, no effect on interaction with RXRA and impairs interaction with SETD7.",,,1.0,,,,,,,,,,,,,Q96RI1_K_474_R
3317,P46937,W,199,A,5ydx:A,42,Loss of interaction with ERBB4 and loss of transcriptional coactivation function toward CTF,-1.0,,-999.0,,,,,,,,,,,,,P46937_W_199_A
3318,P46937,P,202,A,5ydx:A,45,Loss of interaction with ERBB4 and loss of transcriptional coactivation function toward CTF,-1.0,,-999.0,,,,,,,,,,,,,P46937_P_202_A
3319,Q02083,V,116,F,6dxw:A,116,Decreased autoproteolytic cleavage and strongly reduced enzyme activity with liposome-bound substrate. Loss of enzyme activity with Triton-solubilized substrate.,,,1.0,,,,,,,,,,,,,Q02083_V_116_F
3320,Q02083,C,126,A,6dxw:A,126,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q02083_C_126_A
3321,Q02083,C,126,S,6dxw:A,126,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q02083_C_126_S
3322,Q02083,R,142,G,6dxw:A,142,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q02083_R_142_G
3323,Q02083,D,145,A,6dxw:A,145,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q02083_D_145_A
3324,Q02083,L,152,F,6dxw:A,152,Strongly reduced enzyme activity both with liposome-bound and Triton-solubilized substrate.,,,1.0,,,,,,,,,,,,,Q02083_L_152_F
3325,Q02083,E,195,A,6dxw:A,195,Abolishes decrease of enzyme activity at pH 6 and pH 7.,,,1.0,,,,,,,,,,,,,Q02083_E_195_A
3325,Q02083,E,195,Q,6dxw:A,195,Abolishes decrease of enzyme activity at pH 6 and pH 7.,,,1.0,,,,,,,,,,,,,Q02083_E_195_Q
3326,Q02083,N,287,D,6dxw:A,287,Loss of autoproteolytic cleavage and loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q02083_N_287_D
3327,Q02083,N,309,Q,6dxw:A,309,Loss of one glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,Q02083_N_309_Q
3328,Q02083,N,333,Q,6dxw:A,333,Loss of one glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,Q02083_N_333_Q
3329,Q96PN6,K,95,A,4oyz:A,95,Nearly abolishes bicarbonate-mediated increase of enzyme activity. Abolishes bicarbonate-mediated increase of enzyme activity,,-1.0,-999.0,,,,,,,,,,,,,Q96PN6_K_95_A
3330,Q96PN6,R,176,A,4oyz:A,176,Reduces bicarbonate-mediated increase of enzyme activity. Abolishes bicarbonate-mediated increase of enzyme activity,,-1.0,-999.0,,,,,,,,,,,,,Q96PN6_R_176_A
3331,P07948,K,275,A,3a4o:X,44,Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus,,,1.0,,,,,,,,,1.0,,,,P07948_K_275_A
3332,P07948,K,275,L,3a4o:X,44,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P07948_K_275_L
3332,P07948,K,275,R,3a4o:X,44,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P07948_K_275_R
3333,P07948,D,346,A,3a4o:X,115,Impedes the trafficking from the Golgi apparatus toward the cell membrane,,,-999.0,,,,,,,,,1.0,,,,P07948_D_346_A
3334,P07948,E,353,A,3a4o:X,122,Impedes the trafficking from the Golgi apparatus toward the cell membrane,,,-999.0,,,,,,,,,1.0,,,,P07948_E_353_A
3335,P07948,D,498,A,3a4o:X,267,Impedes the trafficking from the Golgi apparatus toward the cell membrane,,,-999.0,,,,,,,,,1.0,,,,P07948_D_498_A
3336,P07948,D,499,A,3a4o:X,268,Impedes the trafficking from the Golgi apparatus toward the cell membrane,,,-999.0,,,,,,,,,1.0,,,,P07948_D_499_A
3337,Q8N3J5,D,298,A,2iq1:A,298,Loss of activity.,,,1.0,,,,,,,,,,,,,Q8N3J5_D_298_A
3338,Q96FI4,E,3,Q,5itq:A,3,Loss of glycosylase and AP lyase activity.,,,1.0,,,,,,,,,,,,,Q96FI4_E_3_Q
3339,Q96FI4,K,54,L,5itq:A,54,Loss of glycosylase activity.,,,1.0,,,,,,,,,,,,,Q96FI4_K_54_L
3340,Q96FI4,R,277,A,5itq:A,277,Strongly reduced glycosylase activity. Has little effect on AP lyase activity.,,,1.0,,,,,,,,,,,,,Q96FI4_R_277_A
3358,P11387,K,532,A,1sc7:A,532,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P11387_K_532_A
3359,P11387,K,532,R,1sc7:A,532,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P11387_K_532_R
3360,P11387,Y,723,F,1sc7:A,723,No change in CPT-induced clearing from nuclei.,,,-999.0,,,,,,,,,0.0,,,,P11387_Y_723_F
3361,Q16774,S,2,L,6nui:A,2,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_S_2_L
3362,Q16774,G,3,A,6nui:A,3,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_G_3_A
3363,Q16774,L,25,P,6nui:A,25,Leads to aggregation. Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_L_25_P
3364,Q16774,V,91,M,6nui:A,91,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_V_91_M
3365,Q16774,R,96,H,6nui:A,96,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_R_96_H
3366,Q16774,R,116,Q,6nui:A,116,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_R_116_Q
3367,Q16774,S,121,F,6nui:A,121,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_S_121_F
3368,Q16774,S,186,Y,6nui:A,186,Increases in Kcat with GMP as substrate.,,,-999.0,,,,,,,,,,,,,Q16774_S_186_Y
3369,Q02880,E,482,Q,5zad:A,477,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q02880_E_482_Q
3370,Q02880,S,485,A,5zad:A,480,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q02880_S_485_A
3371,Q02880,R,508,E,5zad:A,503,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q02880_R_508_E
3372,Q02880,K,510,E,5zad:A,505,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q02880_K_510_E
3373,Q02880,R,515,Q,5zad:A,510,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q02880_R_515_Q
3374,P51159,L,70,P,6huf:A,60,Abolishes interaction with SYTL2.,-1.0,,-999.0,,,,,,,,,,,,,P51159_L_70_P
3375,P51159,A,76,V,6huf:A,66,Abolishes interaction with SYTL2.,-1.0,,-999.0,,,,,,,,,,,,,P51159_A_76_V
3376,P51159,Q,78,L,6huf:A,68,GTP-locked. decreases interaction with DENND10.,-1.0,,-999.0,,,,,,,,,,,,,P51159_Q_78_L
3377,A8MW95,E,173,L,5k7b:B,173,Decreases homodimerization. Decreases interaction with ATG14.,-1.0,,-999.0,,,,,,,,,,,,,A8MW95_E_173_L
3378,A8MW95,N,187,L,5k7b:B,187,Increases strongly homodimerization. Decreases interaction with ATG14.,,,-999.0,,,,,,,,,,,,,A8MW95_N_187_L
3379,A8MW95,A,190,L,5k7b:B,190,Decreases interaction with ATG14. Increases slightly homodimerization,,,-999.0,,,,,,,,,,,,,A8MW95_A_190_L
3380,A8MW95,A,197,L,5k7b:B,197,Decreases interaction with ATG14. Probably strongly increases homodimerization,,,-999.0,,,,,,,,,,,,,A8MW95_A_197_L
3381,A8MW95,E,208,L,5k7b:B,208,Decreases interaction with ATG14. Probably strongly increases homodimerization,,,-999.0,,,,,,,,,,,,,A8MW95_E_208_L
3382,A8MW95,H,211,L,5k7b:B,211,Increases homodimerization. Decreases interaction with ATG14.,,,-999.0,,,,,,,,,,,,,A8MW95_H_211_L
3383,A8MW95,Y,215,L,5k7b:B,215,Decreases interaction with ATG14. Increases slightly homodimerization,,,-999.0,,,,,,,,,,,,,A8MW95_Y_215_L
3384,A8MW95,Q,222,L,5k7b:B,222,Decreases homodimerization. Decreases interaction with ATG14.,-1.0,,-999.0,,,,,,,,,,,,,A8MW95_Q_222_L
3385,A8MW95,R,243,L,5k7b:B,243,Decreases homodimerization. Decreases interaction with ATG14.,-1.0,,-999.0,,,,,,,,,,,,,A8MW95_R_243_L
3386,P33764,C,30,A,3nsi:B,30,Abolishes calcium binding,,-1.0,-999.0,,,,,,,,,,,,,P33764_C_30_A
3387,P33764,C,68,A,3nsi:B,68,Abolishes calcium binding,,-1.0,-999.0,,,,,,,,,,,,,P33764_C_68_A
3388,P33764,C,81,A,3nsi:B,81,Increases affinity for calcium,,1.0,-999.0,,,,,,,,,,,,,P33764_C_81_A
3389,Q8IXH7,R,291,Q,6gml:W,291,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_R_291_Q
3390,Q8IXH7,K,315,M,6gml:W,315,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_315_M
3391,Q8IXH7,K,371,M,6gml:W,371,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_371_M
3392,Q8IXH7,K,372,M,6gml:W,372,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_372_M
3393,Q8IXH7,K,374,M,6gml:W,374,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_374_M
3394,Q8IXH7,K,384,M,6gml:W,384,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_384_M
3395,Q8IXH7,K,388,M,6gml:W,388,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_K_388_M
3396,Q8IXH7,R,419,Q,6gml:W,419,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_R_419_Q
3397,Q8IXH7,R,506,Q,6gml:W,506,Reduces RNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q8IXH7_R_506_Q
3398,P11766,R,115,A,2fze:A,114,Loss of FDH activity and loss of activation by fatty acids.,,-1.0,1.0,,,,,,,,,,,,,P11766_R_115_A
3398,P11766,R,115,D,2fze:A,114,Loss of FDH activity and loss of activation by fatty acids.,,-1.0,1.0,,,,,,,,,,,,,P11766_R_115_D
3399,Q9H9S0,F,102,A,2kt0:A,29,No effect on POU5F1 promoter DNA-binding.,,0.0,-999.0,,,,,,,,,,,,,Q9H9S0_F_102_A
3400,Q9H9S0,L,122,A,2kt0:A,49,Increased POU5F1 promoter DNA-binding and protein stability.,,1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_L_122_A
3401,Q9H9S0,Q,124,A,2kt0:A,51,Decreased POU5F1 promoter DNA-binding and protein stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_Q_124_A
3402,Q9H9S0,M,125,A,2kt0:A,52,Decreased POU5F1 promoter DNA-binding and protein stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_M_125_A
3403,Q9H9S0,Y,136,A,2kt0:A,63,Decreased POU5F1 promoter DNA-binding and protein stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_Y_136_A
3404,Q9H9S0,K,137,A,2kt0:A,64,Inhibits POU5F1 promoter DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H9S0_K_137_A
3405,Q9H9S0,K,140,A,2kt0:A,67,Decreased POU5F1 promoter DNA-binding and protein stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_K_140_A
3406,Q9H9S0,T,141,A,2kt0:A,68,Inhibits POU5F1 promoter DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H9S0_T_141_A
3407,Q9H9S0,Q,144,A,2kt0:A,71,No effect on POU5F1 promoter DNA-binding. Decreased protein stability.,,0.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_Q_144_A
3408,Q9H9S0,N,145,A,2kt0:A,72,Inhibits POU5F1 promoter DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H9S0_N_145_A
3409,Q9H9S0,R,147,A,2kt0:A,74,Inhibits POU5F1 promoter DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9H9S0_R_147_A
3410,Q9H9S0,M,148,A,2kt0:A,75,No effect on POU5F1 promoter DNA-binding. Increased protein stability.,,0.0,-999.0,,,,,,,,,,,1.0,,Q9H9S0_M_148_A
3411,Q9H9S0,K,151,A,2kt0:A,78,Decreased POU5F1 promoter DNA-binding and protein stability.,,-1.0,-999.0,,,,,,,,,,,-1.0,,Q9H9S0_K_151_A
3412,Q9UNA0,E,411,A,2rjq:A,411,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UNA0_E_411_A
3413,Q9H9S5,D,362,A,6kam:A,362,Decrease in ribitol-5-phosphate transferase activity.,,,1.0,,,,,,,,,,,,,Q9H9S5_D_362_A
3414,Q8N6P7,K,58,A,3dlq:R,58,Strongly reduced response to IL22.,-1.0,,-999.0,,,,,,,,,,,,,Q8N6P7_K_58_A
3415,Q8N6P7,Y,60,A,3dlq:R,60,Loss of response to IL22.,-1.0,,-999.0,,,,,,,,,,,,,Q8N6P7_Y_60_A
3415,Q8N6P7,Y,60,R,3dlq:R,60,Loss of response to IL22.,-1.0,,-999.0,,,,,,,,,,,,,Q8N6P7_Y_60_R
3416,P36888,Y,589,F,6il3:A,589,Reduced phosphorylation of the wild-type kinase in response to ligand binding. No effect on the phosphorylation of the constitutively activated mutant kinase variants. Abolishes activation of STAT5A.,-1.0,,-999.0,,,,,,,,,,,,,P36888_Y_589_F
3417,P36888,Y,591,F,6il3:A,591,No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A.,-1.0,,0.0,,,,,,,,,,,,,P36888_Y_591_F
3418,P36888,Y,599,F,6il3:A,599,Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2.,-1.0,,1.0,,,,,,,,,,,,,P36888_Y_599_F
3419,P36888,K,644,A,6il3:A,644,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,P36888_K_644_A
3420,Q8IUH5,Y,67,A,3eu9:A,67,Decreased binding affinity for SNAP25.,-1.0,,-999.0,,,,,,,,,,,,,Q8IUH5_Y_67_A
3421,Q8IUH5,E,89,A,3eu9:A,89,No effect on SNAP25 binding.,0.0,,-999.0,,,,,,,,,,,,,Q8IUH5_E_89_A
3422,Q8IUH5,N,100,A,3eu9:A,100,Abolishes SNAP25 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q8IUH5_N_100_A
3423,Q8IUH5,D,122,A,3eu9:A,122,Mildly decreased binding affinity for SNAP25.,-1.0,,-999.0,,,,,,,,,,,,,Q8IUH5_D_122_A
3424,Q8IUH5,W,130,A,3eu9:A,130,Abolishes SNAP25 and HTT binding.,-1.0,,-999.0,,,,,,,,,,,,,Q8IUH5_W_130_A
3425,P50213,E,152,A,6kdf:E,125,No significant effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,,-999.0,,,,,,,,,,,,,P50213_E_152_A
3426,P50213,Y,153,F,6kdf:E,126,"Complete loss of activity of the heterotetramer, heterodimer composed of IDH3A and IDH3B subunits and the heterodimer composed of IDH3A and IDH3G subunits with no effect on their oligomeric states.",,,1.0,,,,,,,,,,,,,P50213_Y_153_F
3427,P50213,K,169,A,6kdf:E,142,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,1.0,,,,,,,,,,,,,P50213_K_169_A
3428,P50213,K,200,A,6kdf:E,173,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,1.0,,,,,,,,,,,,,P50213_K_200_A
3429,P50213,N,202,A,6kdf:E,175,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,1.0,,,,,,,,,,,,,P50213_N_202_A
3430,P50213,D,208,A,6kdf:E,181,Complete loss of the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,1.0,,,,,,,,,,,,,P50213_D_208_A
3431,P50213,Y,255,A,6kdf:E,228,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,1.0,,,,,,,,,,,,,P50213_Y_255_A
3432,P36406,C,34,A,5vzv:A,34,Loss of E3 ubiquitin-protein ligase activity.,,,1.0,,,,,,,,,,,,,P36406_C_34_A
3433,P36406,H,53,A,5vzv:A,53,Loss of E3 ubiquitin-protein ligase activity.,,,1.0,,,,,,,,,,,,,P36406_H_53_A
3434,P36404,L,3,A,3doe:A,3,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_L_3_A
3435,P36404,L,3,D,3doe:A,3,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_L_3_D
3436,P36404,L,4,A,3doe:A,4,Does not reduce interaction with ARL2BP.,0.0,,-999.0,,,,,,,,,,,,,P36404_L_4_A
3437,P36404,L,4,D,3doe:A,4,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_L_4_D
3438,P36404,I,6,R,3doe:A,6,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_I_6_R
3439,P36404,L,7,A,3doe:A,7,Does not reduce interaction with ARL2BP.,0.0,,-999.0,,,,,,,,,,,,,P36404_L_7_A
3440,P36404,L,7,D,3doe:A,7,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_L_7_D
3441,P36404,T,30,N,3doe:A,30,Does not inhibit the interaction with TBCD and rescues the TBCD-induced microtubule destruction. Reduces interaction with ARL2BP. Inhibits accumulation of STAT3 in the nucleus.,-1.0,,-999.0,,,,,,,,,,,,,P36404_T_30_N
3442,P36404,T,47,A,3doe:A,47,Does not inhibit the interaction with TBCD and rescues the TBCD-induced microtubule destruction.,0.0,,-999.0,,,,,,,,,,,,,P36404_T_47_A
3443,P36404,F,50,A,3doe:A,50,Reduces interaction with ARL2BP. Inhibits the interaction with TBCD and rescues the TBCD-induced microtubule destruction.,-1.0,,-999.0,,,,,,,,,,,,,P36404_F_50_A
3444,P36404,Q,70,L,3doe:A,70,"Induces cell cycle arrest, reduces ability to form microtubules and centrosome fragmentation. Inhibits the interaction with TBCD and does not rescue the TBCD-induced microtubule destruction. Interacts with ARL2BP and PDE6D.",-1.0,,1.0,,,,,,,,,,,,,P36404_Q_70_L
3445,P36404,Y,76,A,3doe:A,76,Does not reduce interaction with ARL2BP.,0.0,,-999.0,,,,,,,,,,,,,P36404_Y_76_A
3446,P36404,Y,80,A,3doe:A,80,Reduces interaction with ARL2BP.,-1.0,,-999.0,,,,,,,,,,,,,P36404_Y_80_A
3447,P49356,W,102,T,1jcq:B,102,Removes the steric hindrance that normally precludes geranylgeranyl diphosphate binding. Reduces farnesyltransferase activity and confers geranylgeranyltransferase activity.,,,-999.0,,,,,,,,,,,,,P49356_W_102_T
3448,P49356,D,200,N,1jcq:B,200,Reduced catalytic efficiency.,,,1.0,,,,,,,,,,,,,P49356_D_200_N
3449,P49356,G,249,V,1jcq:B,249,Reduced catalytic efficiency.,,,1.0,,,,,,,,,,,,,P49356_G_249_V
3450,P49356,G,349,S,1jcq:B,349,Reduced catalytic efficiency.,,,1.0,,,,,,,,,,,,,P49356_G_349_S
3451,P11166,N,45,T,6tha:A,45,Loss of glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,P11166_N_45_T
3452,P11166,I,192,C,6tha:A,192,Strongly decreases glucose transport.,,,1.0,,,,,,,,,,,,,P11166_I_192_C
3453,P11166,L,204,C,6tha:A,204,Abolishes glucose transport.,,,1.0,,,,,,,,,,,,,P11166_L_204_C
3454,P11166,P,205,C,6tha:A,205,Abolishes glucose transport.,,,1.0,,,,,,,,,,,,,P11166_P_205_C
3455,P11166,S,226,A,6tha:A,226,"Abolishes phosphorylation by PKA, leading to impaired response to TPA.",,,-999.0,-1.0,,,,,,,,,,,,P11166_S_226_A
3456,P11166,G,340,C,6tha:A,340,Strongly decreases glucose transport.,,,1.0,,,,,,,,,,,,,P11166_G_340_C
3457,Q06418,I,99,R,1rhf:A,59,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q06418_I_99_R
3458,Q14865,K,336,A,2oeh:A,19,Abolishes methylation and FSK-dependent DNA-binding of the PHF2-ARID5B complex to promoters.,,-1.0,-999.0,,,,,,,,,,,,,Q14865_K_336_A
3458,Q14865,K,336,R,2oeh:A,19,Abolishes methylation and FSK-dependent DNA-binding of the PHF2-ARID5B complex to promoters.,,-1.0,-999.0,,,,,,,,,,,,,Q14865_K_336_R
3459,O60939,C,55,A,6vrr:A,55,Does not bind alpha subunit. Loss of ability to protect alpha subunit from inhibition by the spider protoxin-II.,-1.0,,-999.0,,,,,,,,,,,,,O60939_C_55_A
3459,O60939,C,55,S,6vrr:A,55,Does not bind alpha subunit. Loss of ability to protect alpha subunit from inhibition by the spider protoxin-II.,-1.0,,-999.0,,,,,,,,,,,,,O60939_C_55_S
3460,Q8WXI8,E,173,Q,3whd:A,173,"No effect on already low affinity binding to trehalose-6,6'-dimycolate.",,0.0,-999.0,,,,,,,,,,,,,Q8WXI8_E_173_Q
3461,Q8WXI8,D,175,N,3whd:A,175,"No effect on already low affinity binding to trehalose-6,6'-dimycolate.",,0.0,-999.0,,,,,,,,,,,,,Q8WXI8_D_175_N
3462,Q9UBQ0,D,8,A,5osi:A,8,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_D_8_A
3463,Q9UBQ0,N,39,A,5osi:A,39,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_N_39_A
3464,Q9UBQ0,N,39,D,5osi:A,39,No effect on in vitro protein phosphatase activity.,,,0.0,,,,,,,,,,,,,Q9UBQ0_N_39_D
3465,Q9UBQ0,D,62,A,5osi:A,62,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_D_62_A
3465,Q9UBQ0,D,62,N,5osi:A,62,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_D_62_N
3466,Q9UBQ0,H,86,A,5osi:A,86,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_H_86_A
3467,Q9UBQ0,V,90,D,5osi:A,90,Decreases interaction with VPS35.,-1.0,,-999.0,,,,,,,,,,,,,Q9UBQ0_V_90_D
3468,Q9UBQ0,I,91,D,5osi:A,91,Disrupts interaction with VPS35.,-1.0,,-999.0,,,,,,,,,,,,,Q9UBQ0_I_91_D
3469,Q9UBQ0,H,117,A,5osi:A,117,Loss of in vitro protein phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9UBQ0_H_117_A
3470,Q9UBQ0,L,152,E,5osi:A,152,Disrupts interaction with TBC1D5.,-1.0,,-999.0,,,,,,,,,,,,,Q9UBQ0_L_152_E
3471,O95718,Y,185,A,1lo1:A,185,6-fold decrease in DNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,O95718_Y_185_A
3472,Q8IYT8,K,39,R,6qau:A,39,Decreased kinase activity and decreased autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,Q8IYT8_K_39_R
3473,P22681,S,80,D,5j3x:B,80,Abolishes interaction with ZAP70.,-1.0,,-999.0,,,,,,,,,,,,,P22681_S_80_D
3474,P22681,P,82,A,5j3x:B,82,Abolishes interaction with ZAP70.,-1.0,,-999.0,,,,,,,,,,,,,P22681_P_82_A
3475,P22681,D,229,Q,5j3x:B,229,Abolishes interaction with ZAP70.,-1.0,,-999.0,,,,,,,,,,,,,P22681_D_229_Q
3476,P22681,E,240,S,5j3x:B,240,Abolishes interaction with ZAP70.,-1.0,,-999.0,,,,,,,,,,,,,P22681_E_240_S
3477,P22681,R,294,K,5j3x:B,294,Abolishes interaction with ZAP70.,-1.0,,-999.0,,,,,,,,,,,,,P22681_R_294_K
3478,P22681,G,306,E,5j3x:B,306,"Abolishes interaction with ZAP70 and EPHB1, but does not affect interaction with SLA. Reduces ubiquitination and therefore proteasomal degradation of SPRED2.",-1.0,,1.0,,,,,,,,,,,,,P22681_G_306_E
3479,P22681,Y,371,F,5j3x:B,371,Strongly reduces tyrosine phosphorylation by INSR,,,-999.0,-1.0,,,,,,,,,,,,P22681_Y_371_F
3480,P22681,C,381,A,5j3x:B,381,Loss of ubiquitin ligase activity.,,,1.0,,,,,,,,,,,,,P22681_C_381_A
3483,Q13546,S,25,D,4itj:B,25,Phophomimetic mutant. Significant loss of kinase activity.,,,1.0,,,,,,,,,,1.0,,,Q13546_S_25_D
3484,Q13546,K,45,A,4itj:B,45,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q13546_K_45_A
3485,Q13546,S,161,A,4itj:B,161,Decreases RIPK1 kinase activity.,,,1.0,,,,,,,,,,,,,Q13546_S_161_A
3486,Q13546,S,161,E,4itj:B,161,No effect on RIPK1 autophosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q13546_S_161_E
3487,Q13546,K,599,R,6ac5:A,599,"Blocks homodimerization, necroptosis and apoptosis.",-1.0,,-999.0,,,,,,,,,,,,,Q13546_K_599_R
3488,O95716,T,86,A,2gf9:A,86,Loss of phosphorylation. Reduced binding of CHM and CHML binding.,-1.0,,-999.0,-1.0,,,,,,,,,,,,O95716_T_86_A
3489,O95716,T,86,E,2gf9:A,86,Phosphomimetic mutant. Loss of CHM and CHML binding.,-1.0,,-999.0,,,,,,,,,,1.0,,,O95716_T_86_E
3490,Q96F86,E,306,A,3d3k:A,306,Abolishes homodimerization and RNA binding,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q96F86_E_306_A
3491,Q96F86,V,310,A,3d3k:A,310,Abolishes homodimerization and RNA binding,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q96F86_V_310_A
3492,Q6ZSG1,R,309,A,5d0k:C,309,Reduced binding to free ubiquitin.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZSG1_R_309_A
3493,Q6ZSG1,M,313,A,5d0k:C,313,Reduced binding to free ubiquitin and reduced E3 ubiquitin-protein ligase activity.,-1.0,,1.0,,,,,,,,,,,,,Q6ZSG1_M_313_A
3494,Q6ZSG1,R,335,A,5d0k:C,335,Reduced ubiquitin discharge.,,,1.0,,,,,,,,,,,,,Q6ZSG1_R_335_A
3495,Q9UKK9,W,28,A,2dsb:A,28,Reduces affinity for substrate about 8-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate,,-1.0,1.0,,,,,,,,,,,,,Q9UKK9_W_28_A
3496,Q9UKK9,T,45,A,2dsb:A,45,Impaired phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,Q9UKK9_T_45_A
3497,Q9UKK9,T,45,D,2dsb:A,45,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,Q9UKK9_T_45_D
3498,Q9UKK9,W,46,A,2dsb:A,46,Reduces affinity for substrate about 6-fold. Strongly reduced catalytic activity and strongly reduced affinity for substrate,,-1.0,1.0,,,,,,,,,,,,,Q9UKK9_W_46_A
3499,Q9UKK9,R,51,Q,2dsb:A,51,Reduces affinity for substrate about 15-fold and reduces catalytic rate about 17-fold.,,-1.0,1.0,,,,,,,,,,,,,Q9UKK9_R_51_Q
3500,Q9UKK9,R,84,Q,2dsb:A,84,Reduces affinity for substrate about 5-fold and reduces catalytic rate 67-fold.,,-1.0,1.0,,,,,,,,,,,,,Q9UKK9_R_84_Q
3501,Q9UKK9,L,98,A,2dsb:A,98,Reduces affinity for substrate about 6-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q9UKK9_L_98_A
3502,Q9UKK9,E,112,Q,2dsb:A,112,Catalytic inactive mutant for both ADP-sugar pyrophosphatase and nuclear ATP-synthesis activities. Reduces catalytic rate 6300-fold.,,-1.0,1.0,,,,,,,,,,,,,Q9UKK9_E_112_Q
3503,Q9UKK9,E,116,Q,2dsb:A,116,Reduces catalytic rate 2000-fold.,,,1.0,,,,,,,,,,,,,Q9UKK9_E_116_Q
3504,Q9UKK9,E,166,Q,2dsb:A,166,Reduces catalytic rate 120-fold.,,,1.0,,,,,,,,,,,,,Q9UKK9_E_166_Q
3505,Q96J02,C,871,A,5c7m:A,871,Loss of ubiquitin protein ligase activity. Results in altered endosomal sorting and reduced degradation of CXCR4. Unable to inhibit MAVS-induced activation of INFB.,-1.0,,1.0,,,,,,,,,1.0,,,,Q96J02_C_871_A
3506,Q07075,T,356,V,4kx7:A,356,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q07075_T_356_V
3507,Q07075,R,887,A,4kx7:A,887,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q07075_R_887_A
3508,Q9UH99,L,536,D,4dxr:A,536,Disrupts interaction with SYNE2.,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_L_536_D
3509,Q9UH99,D,542,N,4dxr:A,542,Disrupts interaction with SYNE2.,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_D_542_N
3510,Q9UH99,C,563,A,4dxr:A,563,Decreases stability of the SUN2,,,-999.0,,,,,,,,,,,-1.0,,Q9UH99_C_563_A
3511,Q9UH99,A,603,E,4dxr:A,603,Decreases interaction with SYNE2. Disrupts interaction with SYNE2,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_A_603_E
3512,Q9UH99,G,609,D,4dxr:A,609,Decreases interaction with SYNE2.,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_G_609_D
3513,Q9UH99,H,628,A,4dxr:A,628,Disrupts interaction with SYNE2.,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_H_628_A
3514,Q9UH99,S,641,E,4dxr:A,641,Decreases interaction with SYNE2. Disrupts interaction with SYNE2,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_S_641_E
3515,Q9UH99,Y,703,E,4dxr:A,703,Decreases interaction with SYNE2. Disrupts interaction with SYNE2,-1.0,,-999.0,,,,,,,,,,,,,Q9UH99_Y_703_E
3516,Q9UH99,Y,707,F,4dxr:A,707,"Disrupts interaction with SYNE2, impairs localization to the nuclear envelope.",-1.0,,-999.0,,,,,,,,,1.0,,,,Q9UH99_Y_707_F
3517,P13725,C,74,S,1evs:A,49,Inactive.,,,1.0,,,,,,,,,,,,,P13725_C_74_S
3518,Q504Y3,W,30,A,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_A
3518,Q504Y3,W,30,V,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_V
3518,Q504Y3,W,30,L,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_L
3518,Q504Y3,W,30,M,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_M
3518,Q504Y3,W,30,G,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_G
3518,Q504Y3,W,30,S,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_S
3518,Q504Y3,W,30,T,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_T
3518,Q504Y3,W,30,N,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_N
3518,Q504Y3,W,30,Q,4z0r:A,30,Reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_Q
3519,Q504Y3,W,30,C,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_C
3519,Q504Y3,W,30,D,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_D
3519,Q504Y3,W,30,E,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_E
3519,Q504Y3,W,30,H,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_H
3519,Q504Y3,W,30,K,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_K
3519,Q504Y3,W,30,R,4z0r:A,30,Significantly reduced histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_R
3522,Q504Y3,W,30,P,4z0r:A,30,Loss of histone H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_30_P
3523,Q504Y3,W,41,F,4z0r:A,41,Significantly reduced histone H3K4me3 binding. Loss of histone H3K4me3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q504Y3_W_41_F
3524,Q9NQ94,Y,234,A,2cpd:A,234,Slightly reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NQ94_Y_234_A
3525,Q9NQ94,F,270,A,2cpd:A,270,Slightly reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NQ94_F_270_A
3526,Q8IUF8,H,179,Y,4bxf:A,179,Abolishes demethylase activity.,,,1.0,,,,,,,,,,,,,Q8IUF8_H_179_Y
3527,Q9ULC4,T,81,A,3r90:A,81,No phosphorylation by MAPK1,,,-999.0,-1.0,,,,,,,,,,,,Q9ULC4_T_81_A
3528,Q9ULC4,S,118,A,3r90:A,118,No phosphorylation by CDK1,,,-999.0,-1.0,,,,,,,,,,,,Q9ULC4_S_118_A
3529,P51149,L,8,A,1yhn:A,8,Abolishes interaction with RILP and reduces its localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,P51149_L_8_A
3530,P51149,K,10,A,1yhn:A,10,Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,P51149_K_10_A
3531,P51149,T,22,N,1yhn:A,22,"Abolishes localization on late endosomes, lysosomes and phagosomes and reduces phagosomal fusions. Abolishes association of RILP with the phagosomes. No loss of interaction with CLN5. No loss of interaction with PRPH. Reduced interaction with VPS13A.",-1.0,,-999.0,,,,,,,,,1.0,,,,P51149_T_22_N
3532,P51149,Q,67,L,1yhn:A,67,"Does not abolish localization on late endosomes, lysosomes and phagosomes and does not reduce phagosomal fusions. No loss of interaction with CLN5 and VPS13A. Increases interaction with PRPH.",1.0,,-999.0,,,,,,,,,0.0,,,,P51149_Q_67_L
3533,P51149,V,180,A,1yhn:A,180,Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,P51149_V_180_A
3534,P51149,L,182,A,1yhn:A,182,Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments,0.0,,-999.0,,,,,,,,,0.0,,,,P51149_L_182_A
3535,P51149,Y,183,A,1yhn:A,183,Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments,0.0,,-999.0,,,,,,,,,0.0,,,,P51149_Y_183_A
3536,P51148,S,85,A,4kyi:B,85,"Loss of phosphorylation. No effect on GDI1, GDI2, CHML and CHM binding.",0.0,,-999.0,-1.0,,,,,,,,,,,,P51148_S_85_A
3537,P51148,S,85,E,4kyi:B,85,"Phosphomimetic mutant. Loss of GDI1, GDI2, CHML and CHM binding.",-1.0,,-999.0,,,,,,,,,,1.0,,,P51148_S_85_E
3538,P05161,R,44,A,6bi8:C,44,"Does not affect ISG15 signaling, interaction with ITGAL or activation of SRC family tyrosine kinases.",0.0,,-999.0,,,,,,,,,,,,,P05161_R_44_A
3539,P05161,S,83,A,6bi8:C,83,"Does not affect ISG15 signaling, interaction with ITGAL or activation of SRC family tyrosine kinases.",0.0,,-999.0,,,,,,,,,,,,,P05161_S_83_A
3540,P05161,Y,96,L,6bi8:C,96,Reduces ISG15 signaling. Strongly reduces ISG15 signaling and abolishes interaction with ITGAL and activation of SRC family tyrosine kinases,-1.0,,-999.0,,,,,,,,,,,,,P05161_Y_96_L
3541,P05161,R,99,A,6bi8:C,99,Strongly reduces ISG15 signaling and abolishes interaction with ITGAL.,-1.0,,-999.0,,,,,,,,,,,,,P05161_R_99_A
3542,P05161,T,101,A,6bi8:C,101,Strongly reduces ISG15 signaling and abolishes interaction with ITGAL and activation of SRC family tyrosine kinases.,-1.0,,-999.0,,,,,,,,,,,,,P05161_T_101_A
3543,P05161,Q,102,D,6bi8:C,102,Reduces ISG15 signaling. Strongly reduces ISG15 signaling and abolishes interaction with ITGAL and activation of SRC family tyrosine kinases,-1.0,,-999.0,,,,,,,,,,,,,P05161_Q_102_D
3544,P05161,T,103,A,6bi8:C,103,Strongly reduces ISG15 signaling and abolishes interaction with ITGAL.,-1.0,,-999.0,,,,,,,,,,,,,P05161_T_103_A
3545,P13051,D,154,E,1yuo:A,145,Loss of activity.,,,1.0,,,,,,,,,,,,,P13051_D_154_E
3545,P13051,D,154,N,1yuo:A,145,Loss of activity.,,,1.0,,,,,,,,,,,,,P13051_D_154_N
3546,P13051,Y,156,A,1yuo:A,147,Thymine-DNA glycosylase activity.,,,-999.0,,,,,,,,,,,,,P13051_Y_156_A
3546,P13051,Y,156,C,1yuo:A,147,Thymine-DNA glycosylase activity.,,,-999.0,,,,,,,,,,,,,P13051_Y_156_C
3546,P13051,Y,156,S,1yuo:A,147,Thymine-DNA glycosylase activity.,,,-999.0,,,,,,,,,,,,,P13051_Y_156_S
3547,P13051,N,213,D,1yuo:A,204,Cytosine-DNA glycosylase activity.,,,-999.0,,,,,,,,,,,,,P13051_N_213_D
3548,P47736,F,100,E,3brw:B,100,Impaired dimerization,-1.0,,-999.0,,,,,,,,,,,,,P47736_F_100_E
3549,P47736,L,173,E,3brw:B,173,Impaired dimerization,-1.0,,-999.0,,,,,,,,,,,,,P47736_L_173_E
3550,P47736,E,207,A,3brw:B,207,Reduces GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_E_207_A
3551,P47736,H,267,A,3brw:B,267,Abolishes GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_H_267_A
3552,P47736,R,286,A,3brw:B,286,Reduces GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_R_286_A
3553,P47736,H,287,A,3brw:B,287,Abolishes GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_H_287_A
3554,P47736,N,290,A,3brw:B,290,Abolishes GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_N_290_A
3554,P47736,N,290,K,3brw:B,290,Abolishes GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_N_290_K
3555,P47736,D,291,A,3brw:B,291,Abolishes GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_D_291_A
3556,P47736,R,388,A,3brw:B,388,Reduces GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_R_388_A
3556,P47736,R,388,P,3brw:B,388,Reduces GTPase activation.,,,1.0,,,,,,,,,,,,,P47736_R_388_P
3557,P10644,Y,373,A,5kjz:A,373,Impairs response of PKA to c-AMP.,,-1.0,-999.0,,,,,,,,,,,,,P10644_Y_373_A
3558,O95994,E,60,A,2lns:A,60,"Monomer only, and reduced cell adhesion efficiency.",-1.0,,-999.0,,,,,,,,,1.0,,,,O95994_E_60_A
3559,O95994,Y,63,A,2lns:A,63,Disrupted dimerization.,-1.0,,-999.0,,,,,,,,,,,,,O95994_Y_63_A
3560,O95994,K,64,A,2lns:A,64,Disrupted dimerization.,-1.0,,-999.0,,,,,,,,,,,,,O95994_K_64_A
3561,O95994,C,81,S,2lns:A,81,Loss of interaction with MUC2.,-1.0,,-999.0,,,,,,,,,,,,,O95994_C_81_S
3562,Q9UL18,P,670,S,4kxt:A,670,Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_P_670_S
3563,Q9UL18,L,674,F,4kxt:A,674,Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_L_674_F
3564,Q9UL18,P,675,Q,4kxt:A,675,Does not confer enzyme activity by itself. Confers low RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_P_675_Q
3565,Q9UL18,R,805,H,4kxt:A,805,Does not confer enzyme activity by itself. Confers modest RNA cleavage activity,,,1.0,,,,,,,,,,,,,Q9UL18_R_805_H
3566,P29317,R,103,E,3mbw:A,103,Significantly reduced response to EFNA1.,-1.0,,-999.0,,,,,,,,,,,,,P29317_R_103_E
3567,P29317,K,646,M,5nkh:A,646,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P29317_K_646_M
3568,P29317,D,739,N,5nkh:A,739,Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration.,,,-999.0,,,,,,,,,,,,,P29317_D_739_N
3569,P29317,S,897,A,7kjb:A,897,Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.,,,-999.0,-1.0,,,,,,,,,,,,P29317_S_897_A
3569,P29317,S,897,D,7kjb:A,897,Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.,,,-999.0,-1.0,,,,,,,,,,,,P29317_S_897_D
3570,Q86UE8,D,613,A,5o0y:A,613,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q86UE8_D_613_A
3571,Q9BV57,E,94,A,4qgn:A,94,Loss of aci-reductone dioxygenase activity.,,,1.0,,,,,,,,,,,,,Q9BV57_E_94_A
3572,Q5T0W9,K,230,A,5qhj:A,230,Loss of the ability to interact with and activate EGFR.,-1.0,,-999.0,,,,,,,,,,,,,Q5T0W9_K_230_A
3573,P51151,I,40,L,1wms:A,40,Loss of interaction with HPS4,-1.0,,-999.0,,,,,,,,,,,,,P51151_I_40_L
3574,P51151,F,44,L,1wms:A,44,Loss of interaction with HPS4,-1.0,,-999.0,,,,,,,,,,,,,P51151_F_44_L
3575,P51151,W,61,L,1wms:A,61,Loss of interaction with HPS4,-1.0,,-999.0,,,,,,,,,,,,,P51151_W_61_L
3576,P51151,Q,66,L,1wms:A,66,Loss of interaction with HPS4,-1.0,,-999.0,,,,,,,,,,,,,P51151_Q_66_L
3577,Q9NQL2,S,76,L,2q3f:A,57,Increased RPTOR-binding.,1.0,,-999.0,,,,,,,,,,,,,Q9NQL2_S_76_L
3578,Q9NQL2,Q,121,L,2q3f:A,102,Decreased RPTOR-binding.,1.0,,-999.0,,,,,,,,,,,,,Q9NQL2_Q_121_L
3579,P13612,T,222,A,3v4p:A,189,Blocks binding to PLA2G2A.,-1.0,,-999.0,,,,,,,,,,,,,P13612_T_222_A
3580,P13612,G,223,A,3v4p:A,190,Blocks binding to PLA2G2A.,-1.0,,-999.0,,,,,,,,,,,,,P13612_G_223_A
3581,Q9Y468,D,316,N,1oz2:A,248,Does not affect binding to monomethylated and dimethylated peptides.,,0.0,-999.0,,,,,,,,,,,,,Q9Y468_D_316_N
3582,Q9Y468,F,340,A,1oz2:A,272,Does not affect binding to monomethylated and dimethylated peptides.,,0.0,-999.0,,,,,,,,,,,,,Q9Y468_F_340_A
3583,Q9Y468,D,423,A,1oz2:A,355,Abolishes binding to monomethylated and dimethylated peptides.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_D_423_A
3584,Q9Y468,D,423,N,1oz2:A,355,Strongly impairs binding to monomethylated and dimethylated peptides. Abolishes binding to p53/TP53 monomethylated at 'Lys-382'.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_D_423_N
3585,Q9Y468,N,426,A,1oz2:A,358,Abolishes binding to monomethylated and dimethylated peptides.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_N_426_A
3586,Q9Y468,N,426,Q,1oz2:A,358,Strongly impairs binding to monomethylated and dimethylated peptides. Abolishes binding to p53/TP53 monomethylated at 'Lys-382'.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_N_426_Q
3587,Q9Y468,C,431,F,1oz2:A,363,Strongly impairs binding to monomethylated and dimethylated peptides.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_C_431_F
3587,Q9Y468,C,431,R,1oz2:A,363,Strongly impairs binding to monomethylated and dimethylated peptides.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_C_431_R
3588,Q9Y468,F,447,A,1oz2:A,379,Abolishes binding to monomethylated and dimethylated peptides. Abolishes binding to p53/TP53 monomethylated at 'Lys-382'.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9Y468_F_447_A
3589,Q9Y468,W,450,L,1oz2:A,382,Abolishes binding to p53/TP53 monomethylated at 'Lys-382'.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y468_W_450_L
3590,Q9Y468,Y,454,L,1oz2:A,386,Abolishes binding to p53/TP53 monomethylated at 'Lys-382'.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y468_Y_454_L
3591,Q9Y468,D,527,N,1oz2:A,459,Does not affect binding to monomethylated and dimethylated peptides.,,0.0,-999.0,,,,,,,,,,,,,Q9Y468_D_527_N
3592,Q9Y468,F,551,A,1oz2:A,483,Does not affect binding to monomethylated and dimethylated peptides.,,0.0,-999.0,,,,,,,,,,,,,Q9Y468_F_551_A
3593,Q9UIF7,D,233,N,3n5n:Y,222,Loss of DNA glycosylase activity.,,,1.0,,,,,,,,,,,,,Q9UIF7_D_233_N
3594,P51813,Y,566,F,3sxs:A,566,Abolishes almost completely the SRC-induced phosphorylation of BMX.,,,1.0,,,,,,,,,,,,,P51813_Y_566_F
3595,Q9HBB8,R,109,G,6oae:A,84,Loss of binding to CDHR2.,-1.0,,-999.0,,,,,,,,,,,,,Q9HBB8_R_109_G
3596,P34913,D,9,A,4j03:A,9,Loss of phosphatase activity.,,,1.0,,,,,,,,,,,,,P34913_D_9_A
3597,P34913,C,522,S,4j03:A,522,"Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of epoxide hydrolase activity.",,,1.0,,,,,,,,,,,,,P34913_C_522_S
3598,P20160,C,52,S,1fy1:A,26,Loss of antibiotic activity.,,,1.0,,,,,,,,,,,,,P20160_C_52_S
3599,P20160,C,68,S,1fy1:A,42,Loss of antibiotic activity.,,,1.0,,,,,,,,,,,,,P20160_C_68_S
3600,Q15019,F,156,D,6upq:A,156,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q15019_F_156_D
3601,Q15019,S,218,A,6upq:A,218,Loss of phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q15019_S_218_A
3602,Q15019,W,260,A,6upq:A,260,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q15019_W_260_A
3603,Q15019,H,270,D,6upq:A,270,Loss of dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q15019_H_270_D
3604,Q15013,F,191,A,6f0x:P,191,Loss of interaction with MAD2L1 and disruption of ability to overcome spindle checkpoint-dependent mitotic arrest,-1.0,,-999.0,,,,,,,,,,,,,Q15013_F_191_A
3605,O15382,C,342,A,1ekp:A,315,Reduces activity about 6-fold.,,,1.0,,,,,,,,,,,,,O15382_C_342_A
3606,O15382,C,345,A,1ekp:A,318,Slight reduction of activity.,,,1.0,,,,,,,,,,,,,O15382_C_345_A
3607,Q7L0Y3,D,314,N,5nfj:A,314,Abolished mitochondrial tRNA methylation. Does not affect mitochondrial tRNA 5'-end processing.,,,1.0,,,,,,,,,,,,,Q7L0Y3_D_314_N
3608,Q9Y265,D,302,N,6hts:E,302,Abolishes ATPase activity,,,1.0,,,,,,,,,,,,,Q9Y265_D_302_N
3609,P78504,F,207,A,4cc1:A,207,Strongly reduced NOTCH1 binding.,-1.0,,-999.0,,,,,,,,,,,,,P78504_F_207_A
3610,Q08211,K,5,A,3vyy:A,5,Reduces siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_5_A
3611,Q08211,N,6,A,3vyy:A,6,Reduces siRNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q08211_N_6_A
3612,Q08211,Y,9,A,3vyy:A,9,Inhibits siRNA-binding and interaction with AGO2.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_Y_9_A
3613,Q08211,N,30,A,3vyy:A,30,Does not reduce siRNA-binding and interaction with AGO2.,0.0,0.0,-999.0,,,,,,,,,,,,,Q08211_N_30_A
3614,Q08211,N,53,A,3vyy:A,53,Inhibits siRNA-binding and decreases interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_N_53_A
3615,Q08211,K,54,A,3vyy:A,54,Inhibits siRNA-binding and decreases interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_54_A
3616,Q08211,K,55,A,3vyy:A,55,Inhibits siRNA-binding and decreases interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_55_A
3617,Q08211,K,182,A,3vyx:A,182,Reduces siRNA-binding and interaction with AGO2.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_182_A
3618,Q08211,N,186,A,3vyx:A,186,Reduces siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_N_186_A
3619,Q08211,Q,187,A,3vyx:A,187,Reduces siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_Q_187_A
3620,Q08211,H,207,A,3vyx:A,207,Reduces siRNA-binding and interaction with AGO2.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_H_207_A
3621,Q08211,N,234,A,3vyx:A,234,Inhibits siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_N_234_A
3622,Q08211,K,235,A,3vyx:A,235,Inhibits siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_235_A
3623,Q08211,K,236,A,3vyx:A,236,Inhibits siRNA-binding and interaction with AGO2,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q08211_K_236_A
3624,Q08211,W,332,A,3llm:A,332,Abrogates transcriptional activation by the MTAD region. No change in RNA polymerase II holoenzyme binding.,-1.0,,-999.0,,,,,,,,,,,,,Q08211_W_332_A
3625,Q08211,W,339,A,3llm:A,339,Abrogates transcriptional activation and RNA polymerase II binding by the MTAD region. No change in ATP binding and ATPase activities.,-1.0,0.0,-999.0,,,,,,,,,,,,,Q08211_W_339_A
3626,Q08211,W,342,A,3llm:A,342,Abrogates transcriptional activation by the MTAD region. No change in RNA polymerase II holoenzyme binding.,-1.0,,-999.0,,,,,,,,,,,,,Q08211_W_342_A
3627,Q08211,I,347,A,3llm:A,347,Reduces NUP98-induced mRNA transcription and alternative splicing activities.,,,1.0,,,,,,,,,,,,,Q08211_I_347_A
3628,Q08211,K,417,R,3llm:A,417,"Inhibits interaction with AGO2, DICER1 and TARBP2. Abrogates helicase activity and transcriptional activation. Does not inhibit binding to origins of DNA replication.",-1.0,0.0,1.0,,,,,,,,,,,,,Q08211_K_417_R
3628,Q08211,K,417,N,3llm:A,417,"Inhibits interaction with AGO2, DICER1 and TARBP2. Abrogates helicase activity and transcriptional activation. Does not inhibit binding to origins of DNA replication.",-1.0,0.0,1.0,,,,,,,,,,,,,Q08211_K_417_N
3630,Q08211,D,511,A,3llm:A,511,Does not inhibit binding to origins of DNA replication,,-1.0,-999.0,,,,,,,,,,,,,Q08211_D_511_A
3631,Q08211,E,512,A,3llm:A,512,Does not inhibit binding to origins of DNA replication,,-1.0,-999.0,,,,,,,,,,,,,Q08211_E_512_A
3632,Q08211,S,543,L,3llm:A,543,Does not inhibit binding to origins of DNA replication.,,-1.0,-999.0,,,,,,,,,,,,,Q08211_S_543_L
3633,O75832,E,182,A,1tr4:A,182,Abolishes interaction with RB1.,-1.0,,-999.0,,,,,,,,,,,,,O75832_E_182_A
3634,Q9UKT5,C,341,W,3l2o:B,341,Abolishes interaction with TERF1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UKT5_C_341_W
3635,Q9UKT5,A,345,R,3l2o:B,345,Abolishes interaction with TERF1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UKT5_A_345_R
3636,Q9UKT7,C,358,A,4i6j:B,358,Loss of binding with CRY1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UKT7_C_358_A
3637,Q9UKT7,C,358,S,4i6j:B,358,"Decrease in binding efficiency with CRY2 and of CRY2 ubiquitination efficiency, loss of binding with CRY1.",-1.0,,1.0,,,,,,,,,,,,,Q9UKT7_C_358_S
3638,P09661,Y,15,D,1a9n:C,15,Results in defective spliceosome assembly.,-1.0,,1.0,,,,,,,,,,,,,P09661_Y_15_D
3639,P09661,R,27,Q,1a9n:C,27,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_R_27_Q
3640,P09661,T,68,K,1a9n:C,68,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_T_68_K
3641,P09661,N,72,K,1a9n:C,72,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_N_72_K
3642,P09661,N,73,K,1a9n:C,73,No change in spliceosome assembly.,0.0,,0.0,,,,,,,,,,,,,P09661_N_73_K
3643,P09661,E,92,V,1a9n:C,92,Results in defective spliceosome assembly.,-1.0,,1.0,,,,,,,,,,,,,P09661_E_92_V
3644,P09661,Q,148,R,1a9n:C,148,Results in defective spliceosome assembly.,-1.0,,1.0,,,,,,,,,,,,,P09661_Q_148_R
3645,Q86TI0,M,930,A,3qye:A,930,Substantially reduced RabGAP GTPase hydrolysis activity.,,,1.0,,,,,,,,,,,,,Q86TI0_M_930_A
3646,Q86TI0,L,1019,A,3qye:A,1019,Substantially reduced RabGAP GTPase hydrolysis activity.,,,1.0,,,,,,,,,,,,,Q86TI0_L_1019_A
3647,Q8NE35,R,441,A,2dnl:A,427,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_R_441_A
3648,Q8NE35,F,444,A,2dnl:A,430,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8NE35_F_444_A
3648,Q8NE35,F,444,N,2dnl:A,430,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8NE35_F_444_N
3649,Q8NE35,F,444,Y,2dnl:A,430,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_F_444_Y
3650,Q8NE35,G,446,A,2dnl:A,432,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_G_446_A
3651,Q8NE35,R,463,A,2dnl:A,449,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_R_463_A
3652,Q8NE35,D,470,A,2dnl:A,456,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_D_470_A
3653,Q8NE35,K,474,A,2dnl:A,460,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_K_474_A
3654,Q8NE35,S,479,A,2dnl:A,465,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_S_479_A
3655,Q8NE35,F,488,A,2dnl:A,474,Reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8NE35_F_488_A
3656,Q8NE35,F,488,Y,2dnl:A,474,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_F_488_Y
3657,Q8NE35,R,528,A,2dnl:A,514,Does not impair RNA binding.,,0.0,-999.0,,,,,,,,,,,,,Q8NE35_R_528_A
3658,Q7Z5Q5,D,623,A,4xvl:A,623,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q7Z5Q5_D_623_A
3659,Q7Z5Q5,E,675,R,4xvl:A,675,Reduces polymerase activity. No effect on accuracy.,,,1.0,,,,,,,,,,,,,Q7Z5Q5_E_675_R
3660,Q7Z5Q5,K,679,A,4xvl:A,679,No effect on polymerase activity. Increases accuracy by ten-fold.,,,0.0,,,,,,,,,,,,,Q7Z5Q5_K_679_A
3661,Q92947,E,414,D,2r0m:A,370,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q92947_E_414_D
3662,Q92541,R,401,E,6ted:R,401,Loss of binding to single-stranded DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92541_R_401_E
3663,Q92541,E,410,K,6ted:R,410,Reduced binding to single-stranded DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92541_E_410_K
3664,Q92541,R,429,E,6ted:R,429,Loss of binding to single-stranded DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92541_R_429_E
3665,Q92541,Q,434,A,6ted:R,434,Reduced binding to single-stranded DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92541_Q_434_A
3666,Q92541,R,435,E,6ted:R,435,Loss of binding to single-stranded DNA.,,-1.0,-999.0,,,,,,,,,,,,,Q92541_R_435_E
3667,Q92540,K,66,E,1ya0:B,66,Abolishes interaction with UPF1,-1.0,,-999.0,,,,,,,,,,,,,Q92540_K_66_E
3668,Q92540,R,163,E,1ya0:B,163,Abolishes interaction with UPF1,-1.0,,-999.0,,,,,,,,,,,,,Q92540_R_163_E
3669,Q92785,F,275,A,5b79:A,16,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,1.0,,,,,,,,,,,,,Q92785_F_275_A
3670,Q92785,R,300,A,5b79:A,41,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,1.0,,,,,,,,,,,,,Q92785_R_300_A
3671,Q92785,D,346,A,5b79:A,87,Strongly decreased interaction with histones H3 and H4 and loss of function,-1.0,,1.0,,,,,,,,,,,,,Q92785_D_346_A
3672,Q92784,W,358,E,5szb:A,358,Abolishes binding to acetylated histones H3 and H4.,-1.0,,-999.0,,,,,,,,,,,,,Q92784_W_358_E
3673,Q92784,C,360,R,5szb:A,360,Abolishes binding to acetylated histones H3 and H4,-1.0,,-999.0,,,,,,,,,,,,,Q92784_C_360_R
3674,Q92784,C,363,R,5szb:A,363,Abolishes binding to acetylated histones H3 and H4,-1.0,,-999.0,,,,,,,,,,,,,Q92784_C_363_R
3675,Q96RN5,E,42,A,2gut:A,42,Abrogates interaction with SREBF1.,-1.0,,-999.0,,,,,,,,,,,,,Q96RN5_E_42_A
3676,Q96RN5,L,58,D,2gut:A,58,Abrogates interaction with SREBF1.,-1.0,,-999.0,,,,,,,,,,,,,Q96RN5_L_58_D
3677,Q96RN5,A,60,D,2gut:A,60,Abrogates interaction with SREBF1.,-1.0,,-999.0,,,,,,,,,,,,,Q96RN5_A_60_D
3678,P52788,D,201,A,3c6m:C,201,"100,000-fold decrease in catalytic efficiency.",,,1.0,,,,,,,,,,,,,P52788_D_201_A
3678,P52788,D,201,N,3c6m:C,201,"100,000-fold decrease in catalytic efficiency.",,,1.0,,,,,,,,,,,,,P52788_D_201_N
3679,P52788,D,276,N,3c6m:C,276,"200,000-fold decrease in catalytic efficiency.",,,1.0,,,,,,,,,,,,,P52788_D_276_N
3680,P52788,E,353,Q,3c6m:C,353,800-fold decrease in catalytic efficiency.,,,1.0,,,,,,,,,,,,,P52788_E_353_Q
3681,P52789,D,209,A,5hfu:B,209,Decreased hexokinase activity.,,,1.0,,,,,,,,,,,,,P52789_D_209_A
3682,P52789,R,468,A,5hfu:B,468,Induces a rapid dissociation of D-glucose.,,,-999.0,,,,,,,,,,,,,P52789_R_468_A
3683,P52789,D,657,A,5hfu:B,657,Decreased hexokinase activity.,,,1.0,,,,,,,,,,,,,P52789_D_657_A
3684,Q01469,K,24,A,4lkt:A,24,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,Q01469_K_24_A
3685,Q01469,R,33,A,4lkt:A,33,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,Q01469_R_33_A
3686,Q01469,K,34,A,4lkt:A,34,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,Q01469_K_34_A
3687,P20340,T,27,N,5lef:A,27,Loss of APBA1-binding. No loss of RIC1- and RGP1-binding.,-1.0,,-999.0,,,,,,,,,,,,,P20340_T_27_N
3688,P20340,I,46,E,5lef:A,46,Loss of RAB6IP1-binding.,-1.0,,-999.0,,,,,,,,,,,,,P20340_I_46_E
3689,P20340,Q,72,L,5lef:A,72,Loss of GTPase activity. Interacts with APBA1.,1.0,,1.0,,,,,,,,,,,,,P20340_Q_72_L
3690,P05412,R,272,V,1t2k:C,272,Abolishes the synergistic activity with SMAD3 to activate TGF-beta-mediated transcription.,-1.0,,-999.0,,,,,,,,,,,,,P05412_R_272_V
3691,P05412,T,286,A,1t2k:C,286,Complete loss of PAK2-mediated phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,P05412_T_286_A
3692,Q9Y3C8,Q,30,A,2k07:A,30,Does not affect neither UBA5-binding nor thioester formation with UFM1.,0.0,,-999.0,,,,,,,,,,,,,Q9Y3C8_Q_30_A
3693,Q9Y3C8,K,33,A,2k07:A,33,Impairs binding to UBA5 and thioester formation with UFM1.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3C8_K_33_A
3694,Q9Y3C8,C,116,S,2k07:A,116,"Instead of the formation of an intermediate complex with a thiol ester bond between UFC1 (E2-like enzyme) and UFM1 (substrate), a stable complex with an O-ester bond is formed.",-1.0,1.0,-999.0,,,,,,,,,,,,,Q9Y3C8_C_116_S
3695,Q96SB4,S,222,A,5mxx:A,222,No effect on protein phosphorylation.,,,0.0,,,,,,,,,,,,,Q96SB4_S_222_A
3696,Q96SB4,S,555,A,3beg:A,555,Protein phosphorylation impaired at this position.,,,1.0,,,,,,,,,,,,,Q96SB4_S_555_A
3697,Q96SB4,S,619,A,3beg:A,619,No effect on protein phosphorylation.,,,0.0,,,,,,,,,,,,,Q96SB4_S_619_A
3698,Q8N807,C,135,A,5xf7:A,135,Does not affect homodimerization,0.0,,-999.0,,,,,,,,,,,,,Q8N807_C_135_A
3699,Q8N807,C,420,A,5xf7:A,420,Does not affect homodimerization,0.0,,-999.0,,,,,,,,,,,,,Q8N807_C_420_A
3700,O43172,R,192,E,5o9z:F,191,Decreases PRPF3 binding.,-1.0,,-999.0,,,,,,,,,,,,,O43172_R_192_E
3701,O43172,R,192,K,5o9z:F,191,Decreases PRPF3 binding.,-1.0,,-999.0,,,,,,,,,,,,,O43172_R_192_K
3702,O43172,R,192,W,5o9z:F,191,Decreases PRPF3 binding.,-1.0,,-999.0,,,,,,,,,,,,,O43172_R_192_W
3703,O43173,H,354,A,5cxy:A,354,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O43173_H_354_A
3704,Q8N4A0,D,459,H,6h0b:B,459,"Affects the glycopeptide specificity and abolishes ability to glycosylate Muc1, Muc2 and Muc5AC.",,,1.0,,,,,,,,,,,,,Q8N4A0_D_459_H
3705,Q5VZV1,D,141,A,4mtl:B,141,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q5VZV1_D_141_A
3706,Q14451,R,458,L,1mw4:A,46,Impairs phosphotyrosine binding by SH2 domain.,,-1.0,-999.0,,,,,,,,,,,,,Q14451_R_458_L
3707,Q14451,Y,480,F,1mw4:A,68,Global loss of tyrosine phosphorylation. Abolishes interaction with FHL2 and HAX1.,-1.0,,1.0,,,,,,,,,,,,,Q14451_Y_480_F
3708,Q14451,Y,492,F,1mw4:A,80,Global loss of tyrosine phosphorylation. Abolishes interaction with FHL2 and HAX1.,-1.0,,1.0,,,,,,,,,,,,,Q14451_Y_492_F
3709,Q14451,F,511,R,1mw4:A,99,Abolishes dimerization. Abolishes activation of HRAS.,-1.0,,1.0,,,,,,,,,,,,,Q14451_F_511_R
3710,Q96LW7,L,17,A,4dwn:A,17,Abolishes the NF-kappa-B inhibitory activity.,,,1.0,,,,,,,,,,,,,Q96LW7_L_17_A
3711,Q96LW7,L,65,A,4dwn:A,65,Abolishes the NF-kappa-B inhibitory activity.,,,1.0,,,,,,,,,,,,,Q96LW7_L_65_A
3712,Q9BWS9,Y,84,S,3bxw:A,62,Significantly decreased carbohydrate binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BWS9_Y_84_S
3713,Q9BWS9,W,88,A,3bxw:A,66,Significantly decreased carbohydrate binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BWS9_W_88_A
3714,Q9BWS9,W,110,A,3bxw:A,88,Significantly decreased carbohydrate binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BWS9_W_110_A
3715,Q9BWS9,Y,261,S,3bxw:B,239,Significantly decreased carbohydrate binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BWS9_Y_261_S
3716,Q9BWS9,W,277,A,3bxw:B,255,No noticeable effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q9BWS9_W_277_A
3717,Q9BWS9,Y,302,S,3bxw:B,280,Significantly decreased carbohydrate binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9BWS9_Y_302_S
3718,Q13093,S,108,A,3f98:A,108,Activity is higher than wild-type.,,,1.0,,,,,,,,,,,,,Q13093_S_108_A
3719,Q13093,H,114,A,3f98:A,114,Impairs the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_H_114_A
3719,Q13093,H,114,Q,3f98:A,114,Impairs the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_H_114_Q
3719,Q13093,H,114,E,3f98:A,114,Impairs the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_H_114_E
3720,Q13093,W,115,A,3f98:A,115,Impairs the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_W_115_A
3721,Q13093,L,116,A,3f98:A,116,Reduces the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_L_116_A
3722,Q13093,M,117,A,3f98:A,117,Reduces the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_M_117_A
3723,Q13093,Y,205,A,3f98:A,205,Impairs the association with LDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_Y_205_A
3724,Q13093,S,273,A,3f98:A,273,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13093_S_273_A
3725,Q13093,D,286,A,3f98:A,286,Almost no activity.,,,1.0,,,,,,,,,,,,,Q13093_D_286_A
3726,Q13093,D,286,N,3f98:A,286,Diminishes activity.,,,1.0,,,,,,,,,,,,,Q13093_D_286_N
3727,Q13093,D,296,A,3f98:A,296,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13093_D_296_A
3728,Q13093,D,296,N,3f98:A,296,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13093_D_296_N
3729,Q13093,D,304,A,3f98:A,304,No change in activity.,,,0.0,,,,,,,,,,,,,Q13093_D_304_A
3730,Q13093,D,338,A,3f98:A,338,Activity is higher than wild-type.,,,1.0,,,,,,,,,,,,,Q13093_D_338_A
3731,Q13093,H,351,A,3f98:A,351,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13093_H_351_A
3732,Q13093,H,367,N,3f98:A,367,Reduces the association with HDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_H_367_N
3733,Q13093,M,368,K,3f98:A,368,Impairs the association with HDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_M_368_K
3734,Q13093,L,369,A,3f98:A,369,Impairs the association with HDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_L_369_A
3735,Q13093,K,370,T,3f98:A,370,Reduces the association with HDL particles.,,-1.0,-999.0,,,,,,,,,,,,,Q13093_K_370_T
3736,P26358,C,653,G,3swr:A,653,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_653_G
3737,P26358,C,656,G,3swr:A,656,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_656_G
3738,P26358,C,659,G,3swr:A,659,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_659_G
3739,P26358,C,664,F,3swr:A,664,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_664_F
3740,P26358,C,667,G,3swr:A,667,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_667_G
3741,P26358,C,670,G,3swr:A,670,Reduces activity about 10-fold,,,1.0,,,,,,,,,,,,,P26358_C_670_G
3742,P26358,C,1226,A,3swr:A,1226,Loss of activity.,,,1.0,,,,,,,,,,,,,P26358_C_1226_A
3743,Q4G0W2,Y,102,H,5y15:A,102,Decreases the already low catalytic activity.,,,1.0,,,,,,,,,,,,,Q4G0W2_Y_102_H
3744,Q4G0W2,C,103,S,5y15:A,103,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q4G0W2_C_103_S
3745,Q4G0W2,N,105,A,5y15:A,105,Increases activity with phosphotyrosine,,,1.0,,,,,,,,,,,,,Q4G0W2_N_105_A
3746,Q4G0W2,R,107,V,5y15:A,107,Increases activity with phosphotyrosine,,,1.0,,,,,,,,,,,,,Q4G0W2_R_107_V
3747,Q9UQ84,D,78,A,5v0d:Z,78,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. Also reduces DNA-binding to 5'-overhanging flap structures.,,-1.0,1.0,,,,,,,,,,,,,Q9UQ84_D_78_A
3748,Q9UQ84,D,173,A,5v0d:Z,173,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. No effect on DNA-binding to 5'-overhanging flap structures.,,0.0,1.0,,,,,,,,,,,,,Q9UQ84_D_173_A
3749,Q9UQ84,D,225,A,5v0d:Z,225,Abrogates double-stranded DNA exonuclease activity and endonuclease activity against 5'-overhanging flap structures. Also enhances DNA-binding to 5'-overhanging flap structures.,,1.0,1.0,,,,,,,,,,,,,Q9UQ84_D_225_A
3750,O14960,Y,104,H,5b0h:A,86,No metalloendopeptidase activity.,,,1.0,,,,,,,,,,,,,O14960_Y_104_H
3751,O14965,K,162,R,4dee:A,162,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O14965_K_162_R
3752,O14965,F,165,A,4dee:A,165,Decreases the interaction with phosphatase type 1 isoforms.,-1.0,,-999.0,,,,,,,,,,,,,O14965_F_165_A
3753,O14965,G,198,N,4dee:A,198,Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA.,,,1.0,,,,,,,,,,,,,O14965_G_198_N
3754,O14965,R,205,A,4dee:A,205,Reduces ubiquitination and proteasomal degradation.,,,-999.0,,-1.0,,,,,,,,,,,O14965_R_205_A
3755,O14965,D,274,N,4dee:A,274,Abolishes autophosphorylation.,,,1.0,,,,,,,,,,,,,O14965_D_274_N
3756,O14965,T,287,A,4dee:A,287,No direct effect on catalytic activity.,,,0.0,,,,,,,,,,,,,O14965_T_287_A
3757,O14965,T,287,E,4dee:A,287,Enhances interaction with TPX2.,1.0,,-999.0,,,,,,,,,,,,,O14965_T_287_E
3758,O14965,T,288,D,4dee:A,288,Mimics phosphorylation state and increases kinase activity.,,,1.0,,,,,,,,,,1.0,,,O14965_T_288_D
3759,O14965,C,290,A,4dee:A,290,Enhances stability,,,-999.0,,,,,,,,,,,1.0,,O14965_C_290_A
3760,O14965,Y,334,A,4dee:A,334,Reduces binding to MYCN.,-1.0,,-999.0,,,,,,,,,,,,,O14965_Y_334_A
3761,O14965,Q,335,A,4dee:A,335,Reduces binding to MYCN.,-1.0,,-999.0,,,,,,,,,,,,,O14965_Q_335_A
3762,O14965,F,346,A,4dee:A,346,Decreases the interaction with phosphatase type 1 isoforms.,-1.0,,-999.0,,,,,,,,,,,,,O14965_F_346_A
3763,O14965,C,393,A,4dee:A,393,Enhances stability,,,-999.0,,,,,,,,,,,1.0,,O14965_C_393_A
3764,O14966,T,71,A,6hh2:A,71,Loss of phosphorylation by LRRK2.,,,-999.0,-1.0,,,,,,,,,,,,O14966_T_71_A
3765,O14966,T,71,E,6hh2:A,71,Loss of phosphorylation by LRRK2. Does not stimulate LRRK2 kinase activity,,,-999.0,-1.0,,,,,,,,,,,,O14966_T_71_E
3766,O14966,S,72,A,6hh2:A,72,Loss of phosphorylation by LRRK2.,,,-999.0,-1.0,,,,,,,,,,,,O14966_S_72_A
3767,O14966,S,72,E,6hh2:A,72,Loss of phosphorylation by LRRK2. Does not stimulate LRRK2 kinase activity,,,-999.0,-1.0,,,,,,,,,,,,O14966_S_72_E
3768,O14966,M,73,S,6hh2:A,73,Loss of LRRK2 binding. Does not stimulate LRRK2 kinase activity. Localized to the cytosol.,-1.0,,-999.0,,,,,,,,,1.0,,,,O14966_M_73_S
3769,O14966,R,75,S,6hh2:A,75,Loss of LRRK2 binding. Does not stimulate LRRK2 kinase activity. Localized to the cytosol.,-1.0,,-999.0,,,,,,,,,1.0,,,,O14966_R_75_S
3770,P12956,K,160,A,6erg:D,160,Abolishes adduct formation,,,-999.0,,,,,,,,,,,,,P12956_K_160_A
3771,P12956,K,164,A,6erg:D,164,Abolishes adduct formation,,,-999.0,,,,,,,,,,,,,P12956_K_164_A
3772,Q99574,N,161,G,3fgq:A,161,Increases protein stability and abolishes tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_N_161_G
3773,Q99574,L,162,K,3fgq:A,162,Increases protein stability and abolishes tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_L_162_K
3774,Q99574,V,163,I,3fgq:A,163,Increases protein stability and decreases tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,,,Q99574_V_163_I
3775,Q99574,E,289,A,3fgq:A,289,Slightly decreases inhibitory activity. No effect on thermal stability.,,,1.0,,,,,,,,,,,0.0,,Q99574_E_289_A
3776,Q99574,S,340,A,3fgq:A,340,Increases protein stability and decreases tendency to form polymers. No effect on inhibitory activity.,-1.0,,0.0,,,,,,,,,,,1.0,,Q99574_S_340_A
3777,Q96DN0,M,168,W,4f9z:A,168,Decreases somatostatin-14 binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96DN0_M_168_W
3778,Q96DN0,I,196,A,4f9z:A,196,Decreases somatostatin-14 binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96DN0_I_196_A
3778,Q96DN0,I,196,L,4f9z:A,196,Decreases somatostatin-14 binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96DN0_I_196_L
3778,Q96DN0,I,196,W,4f9z:A,196,Decreases somatostatin-14 binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96DN0_I_196_W
3780,Q96DN0,E,231,K,4f9z:A,231,Greatly reduces PDIA3 binding in vivo and in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96DN0_E_231_K
3780,Q96DN0,E,231,A,4f9z:A,231,Greatly reduces PDIA3 binding in vivo and in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96DN0_E_231_A
3781,Q96DN0,W,232,A,4f9z:A,232,Greatly reduces PDIA3 binding in vivo and in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96DN0_W_232_A
3782,Q96DN0,D,233,G,4f9z:A,233,Greatly reduces PDIA3 binding in vivo and in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96DN0_D_233_G
3783,Q8N608,N,257,Q,4wjl:B,257,Abolishes sorting to the cell surface and dimerization.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q8N608_N_257_Q
3784,Q9GZU7,D,96,E,1t9z:A,96,No effect. Completely abolishes phosphatase activity,,,-999.0,,,,,,,,,,,,,Q9GZU7_D_96_E
3785,Q9GZU7,D,98,N,1t9z:A,98,Completely abolishes phosphatase activity,,,1.0,,,,,,,,,,,,,Q9GZU7_D_98_N
3786,P40818,C,786,S,3n3k:A,786,Impairs deubiquitination activity and leads to endosome membrane accumulation.,,,1.0,,,,,,,,,1.0,,,,P40818_C_786_S
3787,Q9UIL1,E,93,V,4bwd:A,93,Causes trimerization and impairs interaction with FEZ1 coiled coil but does not impair interaction with full-length FEZ1,,,-999.0,,,,,,,,,,,,,Q9UIL1_E_93_V
3788,Q9UIL1,K,97,L,4bwd:A,97,Causes trimerization and impairs interaction with FEZ1 coiled coil but does not impair interaction with full-length FEZ1,,,-999.0,,,,,,,,,,,,,Q9UIL1_K_97_L
3789,Q9UIL1,R,117,E,4bwd:A,117,Impairs interaction with FEZ1 coiled coil but does not impair interaction with full-length FEZ1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UIL1_R_117_E
3790,Q9UIL1,N,125,L,4bwd:A,125,Causes tetramerization and loss of interaction with FEZ1,,,-999.0,,,,,,,,,,,,,Q9UIL1_N_125_L
3791,Q9UIL1,N,132,V,4bwd:A,132,Causes tetramerization and loss of interaction with FEZ1,,,-999.0,,,,,,,,,,,,,Q9UIL1_N_132_V
3792,Q15493,E,18,A,4gnc:A,18,Reduces enzyme activity by about 90%.,,,1.0,,,,,,,,,,,,,Q15493_E_18_A
3793,Q15493,N,103,A,4gnc:A,103,Reduces enzyme activity by about 95%.,,,1.0,,,,,,,,,,,,,Q15493_N_103_A
3794,Q15493,N,154,A,4gnc:A,154,Reduces enzyme activity by about 95%.,,,1.0,,,,,,,,,,,,,Q15493_N_154_A
3795,Q15493,D,204,A,4gnc:A,204,Reduces enzyme activity by over 98%.,,,1.0,,,,,,,,,,,,,Q15493_D_204_A
3796,Q16696,L,110,V,2pg6:A,110,Decreases phenacetin O-deethylation activity 8 fold.,,,1.0,,,,,,,,,,,,,Q16696_L_110_V
3797,Q16696,A,117,V,2pg6:A,117,Increases phenacetin O-deethylation activity 5 fold.,,,1.0,,,,,,,,,,,,,Q16696_A_117_V
3798,Q16696,S,208,I,2pg6:A,208,Decreases phenacetin O-deethylation activity 10 fold.,,,1.0,,,,,,,,,,,,,Q16696_S_208_I
3799,Q16696,A,213,S,2pg6:A,213,Decreases phenacetin O-deethylation activity 2 fold.,,,1.0,,,,,,,,,,,,,Q16696_A_213_S
3800,Q16696,F,300,I,2pg6:A,300,Decreases phenacetin O-deethylation activity 40 fold.,,,1.0,,,,,,,,,,,,,Q16696_F_300_I
3801,Q16696,A,301,G,2pg6:A,301,Decreases phenacetin O-deethylation activity 20 fold.,,,1.0,,,,,,,,,,,,,Q16696_A_301_G
3802,Q16696,M,365,V,2pg6:A,365,Decreases phenacetin O-deethylation activity 7 fold.,,,1.0,,,,,,,,,,,,,Q16696_M_365_V
3803,Q16696,L,366,I,2pg6:A,366,Increases phenacetin O-deethylation activity 3 fold.,,,1.0,,,,,,,,,,,,,Q16696_L_366_I
3804,Q16696,G,369,S,2pg6:A,369,Decreases phenacetin O-deethylation activity 9 fold.,,,1.0,,,,,,,,,,,,,Q16696_G_369_S
3805,Q16696,H,372,R,2pg6:A,372,Decreases phenacetin O-deethylation activity 3 fold.,,,1.0,,,,,,,,,,,,,Q16696_H_372_R
3806,O14818,Y,153,F,5ln3:D,153,Displays impaired G1/S transition and S/G2 progression.,,,1.0,,,,,,,,,,,,,O14818_Y_153_F
3807,P36873,H,125,A,4ut3:A,125,Loss of activity.,,,1.0,,,,,,,,,,,,,P36873_H_125_A
3808,P36873,C,273,A,4ut3:A,273,Abolishes interaction with microcystin toxin.,,-1.0,-999.0,,,,,,,,,,,,,P36873_C_273_A
3808,P36873,C,273,S,4ut3:A,273,Abolishes interaction with microcystin toxin.,,-1.0,-999.0,,,,,,,,,,,,,P36873_C_273_S
3808,P36873,C,273,L,4ut3:A,273,Abolishes interaction with microcystin toxin.,,-1.0,-999.0,,,,,,,,,,,,,P36873_C_273_L
3809,Q16698,N,148,A,1w73:D,148,Reduces enzyme activity by 97%.,,,1.0,,,,,,,,,,,,,Q16698_N_148_A
3810,Q16698,Y,199,A,1w73:D,199,Reduces enzyme activity by 99%. Strongly reduced affinity for substrate and for NADP.,,-1.0,1.0,,,,,,,,,,,,,Q16698_Y_199_A
3811,Q16698,S,210,A,1w73:D,210,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q16698_S_210_A
3812,Q16698,K,214,A,1w73:D,214,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q16698_K_214_A
3813,Q13435,R,471,K,6qx9:B2,471,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_471_K
3814,Q13435,R,495,K,6qx9:B2,495,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_495_K
3815,Q13435,R,502,K,6qx9:B2,502,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_502_K
3816,Q13435,F,506,A,6qx9:B2,506,Does not affect methylation by PRMT9,,,-999.0,,,,,,,,,,,,,Q13435_F_506_A
3817,Q13435,K,507,A,6qx9:B2,507,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,1.0,,,,,,,,,,,,,Q13435_K_507_A
3818,Q13435,K,507,R,6qx9:B2,507,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,1.0,,,,,,,,,,,,,Q13435_K_507_R
3819,Q13435,R,508,K,6qx9:B2,508,Abolishes interaction with SMN1,-1.0,,-999.0,,,,,,,,,,,,,Q13435_R_508_K
3820,Q13435,K,509,A,6qx9:B2,509,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,1.0,,,,,,,,,,,,,Q13435_K_509_A
3821,Q13435,K,509,R,6qx9:B2,509,Moderately diminished formation of omega-N monomethylarginine but greatly reduced formation of symmetrical dimethylarginine,,,1.0,,,,,,,,,,,,,Q13435_K_509_R
3822,Q13435,Y,510,A,6qx9:B2,510,Does not affect methylation by PRMT9,,,-999.0,,,,,,,,,,,,,Q13435_Y_510_A
3823,Q13435,R,515,K,6qx9:B2,515,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_515_K
3824,Q13435,R,530,K,6qx9:B2,530,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_530_K
3825,Q13435,R,537,K,6qx9:B2,537,Does not affect methylation by PRMT9.,,,-999.0,,,,,,,,,,,,,Q13435_R_537_K
3826,Q13438,R,188,A,3aih:A,188,Loss of glycan-binding activity and partial inhibition of ERAD of the misfolded glycoprotein NHK (PubMed,,-1.0,-999.0,,,,,,,,,,,,,Q13438_R_188_A
3827,Q13439,Y,2177,A,1upt:D,2177,Loss of localization at the Golgi apparatus. Loss of ARL1-binding.,,,-999.0,,,,,,,,,1.0,,,,Q13439_Y_2177_A
3828,Q13439,Y,2177,F,1upt:D,2177,No effect on localization at the Golgi apparatus.,,,-999.0,,,,,,,,,0.0,,,,Q13439_Y_2177_F
3829,Q13439,V,2181,A,1upt:D,2181,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_V_2181_A
3830,Q13439,F,2183,A,1upt:D,2183,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_F_2183_A
3831,Q13439,Y,2185,A,1upt:D,2185,Loss of localization at the Golgi apparatus.,,,-999.0,,,,,,,,,1.0,,,,Q13439_Y_2185_A
3832,Q13439,M,2186,A,1upt:D,2186,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_M_2186_A
3833,Q13439,T,2193,A,1upt:D,2193,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_T_2193_A
3834,Q13439,M,2194,A,1upt:D,2194,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_M_2194_A
3835,Q13439,V,2197,A,1upt:D,2197,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_V_2197_A
3836,Q13439,I,2198,A,1upt:D,2198,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_I_2198_A
3837,Q13439,L,2202,A,1upt:D,2202,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_L_2202_A
3838,Q13439,F,2204,A,1upt:D,2204,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_F_2204_A
3839,Q13439,I,2212,A,1upt:D,2212,Abolishes Golgi localization.,,,-999.0,,,,,,,,,1.0,,,,Q13439_I_2212_A
3840,P04424,K,51,N,1k62:B,51,2-fold reduction in activity.,,,1.0,,,,,,,,,,,,,P04424_K_51_N
3841,P04424,H,89,Q,1k62:B,89,10-fold reduction in activity.,,,1.0,,,,,,,,,,,,,P04424_H_89_Q
3842,P04424,K,288,R,1k62:B,288,Refractory to inhibition by TSA and NAM and by addition of extra amino acids. No effect on protein structure.,,,-999.0,,,,,,,,,,,0.0,,P04424_K_288_R
3843,O95497,E,79,A,4cyg:A,79,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O95497_E_79_A
3844,O95497,K,178,A,4cyg:A,178,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O95497_K_178_A
3845,Q6NW40,A,186,R,4ui2:D,186,Severely impairs interaction with NEO1.,-1.0,,-999.0,,,,,,,,,,,,,Q6NW40_A_186_R
3846,Q6NW40,P,206,N,4ui2:D,206,Introduces a N-linked glycan,,,-999.0,,,1.0,,,,,,,,,,Q6NW40_P_206_N
3847,O60306,K,829,A,7abi:U,829,Decreased affinity for ATP and ADP. Loss of RNA helicase activity. Disrupts spliceosomal pre-mRNA splicing and leads to the accumulation of spliceosomal B complexes.,,-1.0,1.0,,,,,,,,,,,,,O60306_K_829_A
3848,O60306,Y,1196,A,7abi:U,1196,Strongly reduced RNA helicase activity. No effect on ATPase activity. No effect on spliceosomal pre-mRNA splicing.,,,1.0,,,,,,,,,,,,,O60306_Y_1196_A
3849,P81274,R,228,A,6hc2:A,221,Abolishes location at mitotic spindle poles,,,-999.0,,,,,,,,,1.0,,,,P81274_R_228_A
3850,P81274,R,228,E,6hc2:A,221,Strongly reduces interaction with INSC. Abolishes interaction with INSC,-1.0,,-999.0,,,,,,,,,,,,,P81274_R_228_E
3851,P81274,R,243,A,6hc2:A,236,Abolishes location at mitotic spindle poles,,,-999.0,,,,,,,,,1.0,,,,P81274_R_243_A
3852,P81274,N,290,R,6hc2:A,283,Abolishes interaction with INSC,-1.0,,-999.0,,,,,,,,,,,,,P81274_N_290_R
3853,Q6DD88,K,73,A,5vgr:A,73,Alters endoplasmic reticulum morphogenesis.,,,1.0,,,,,,,,,,,,,Q6DD88_K_73_A
3854,Q6DD88,R,213,Q,5vgr:A,213,Alters endoplasmic reticulum morphogenesis.,,,1.0,,,,,,,,,,,,,Q6DD88_R_213_Q
3855,Q96QP1,Q,67,A,5z2c:A,67,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_Q_67_A
3856,Q96QP1,R,116,A,5z2c:A,116,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_R_116_A
3857,Q96QP1,R,150,A,5z2c:A,150,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_R_150_A
3858,Q96QP1,R,153,A,5z2c:A,153,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_R_153_A
3859,Q96QP1,D,231,A,5z2c:A,231,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_D_231_A
3860,Q96QP1,K,233,A,5z2c:A,233,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity.,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_K_233_A
3861,Q96QP1,T,237,E,5z2c:A,237,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_T_237_E
3862,Q96QP1,F,295,K,5z2c:A,295,Impaired ADP-D-glycero-beta-D-manno-heptose-binding and ability to activate the serine/threonine-protein kinase activity,,-1.0,1.0,,,,,,,,,,,,,Q96QP1_F_295_K
3863,Q8WXF7,R,77,A,4idp:D,77,Abolishes GTPase activity and impairs homodimerization.,-1.0,,1.0,,,,,,,,,,,,,Q8WXF7_R_77_A
3864,Q8WXF7,R,77,E,4idp:D,77,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q8WXF7_R_77_E
3865,Q8WXF7,K,80,A,4idp:D,80,Alters endoplasmic reticulum morphogenesis.,,,1.0,,,,,,,,,,,,,Q8WXF7_K_80_A
3866,Q8WXF7,F,151,S,4idp:D,151,Affects endoplasmic reticulum and Golgi morphology.,,,1.0,,,,,,,,,,,,,Q8WXF7_F_151_S
3867,Q8WXF7,T,162,P,4idp:D,162,Affects endoplasmic reticulum and Golgi morphology.,,,1.0,,,,,,,,,,,,,Q8WXF7_T_162_P
3868,Q8WXF7,Q,191,R,4idp:D,191,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q8WXF7_Q_191_R
3869,Q8WXF7,H,247,R,4idp:D,247,Impairs homodimerization and GTPase activity.,-1.0,,1.0,,,,,,,,,,,,,Q8WXF7_H_247_R
3870,Q8WXF7,S,398,Y,4idp:D,398,Affects endoplasmic reticulum and Golgi morphology.,,,1.0,,,,,,,,,,,,,Q8WXF7_S_398_Y
3871,O60907,F,77,A,2xtc:A,26,"Abolished homotetramerization, leading to a homodimer.",-1.0,,-999.0,,,,,,,,,,,,,O60907_F_77_A
3872,O60907,I,90,A,2xtc:A,39,Reduced interaction with NCOR2 and GPS2.,-1.0,,-999.0,,,,,,,,,,,,,O60907_I_90_A
3873,O60907,L,94,A,2xtc:A,43,Does not affect interaction with NCOR2 and GPS2.,0.0,,-999.0,,,,,,,,,,,,,O60907_L_94_A
3873,O60907,L,94,E,2xtc:A,43,Does not affect interaction with NCOR2 and GPS2.,0.0,,-999.0,,,,,,,,,,,,,O60907_L_94_E
3874,O60907,P,96,G,2xtc:A,45,Does not affect interaction with NCOR2 and GPS2.,0.0,,-999.0,,,,,,,,,,,,,O60907_P_96_G
3875,O60907,L,108,A,2xtc:A,57,Reduced interaction with NCOR2 and GPS2.,-1.0,,-999.0,,,,,,,,,,,,,O60907_L_108_A
3875,O60907,L,108,Q,2xtc:A,57,Reduced interaction with NCOR2 and GPS2.,-1.0,,-999.0,,,,,,,,,,,,,O60907_L_108_Q
3876,O60907,V,111,N,2xtc:A,60,Reduced interaction with NCOR2 and GPS2. Abolished ability to repress transcription.,-1.0,,1.0,,,,,,,,,,,,,O60907_V_111_N
3876,O60907,V,111,Q,2xtc:A,60,Reduced interaction with NCOR2 and GPS2. Abolished ability to repress transcription.,-1.0,,1.0,,,,,,,,,,,,,O60907_V_111_Q
3877,O60907,I,117,A,2xtc:A,66,Does not affect interaction with NCOR2 and GPS2.,0.0,,-999.0,,,,,,,,,,,,,O60907_I_117_A
3878,P29373,K,21,A,5hzq:A,20,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,P29373_K_21_A
3879,P29373,R,30,A,5hzq:A,29,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,P29373_R_30_A
3880,P29373,K,31,A,5hzq:A,30,Loss of ligand-induced nuclear import,,-1.0,-999.0,,,,,,,,,1.0,,,,P29373_K_31_A
3881,Q8WXF1,F,119,A,5ifn:A,119,"Abolishes accumulation in paraspeckles, but not in perinucleolar caps",,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_F_119_A
3882,Q8WXF1,F,121,A,5ifn:A,121,"Abolishes accumulation in paraspeckles, but not in perinucleolar caps",,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_F_121_A
3883,Q8WXF1,K,198,A,5ifn:A,198,"Abolishes accumulation in paraspeckles, but not in perinucleolar caps",,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_K_198_A
3884,Q8WXF1,F,200,A,5ifn:A,200,"Abolishes accumulation in paraspeckles, but not in perinucleolar caps",,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_F_200_A
3885,Q8WXF1,Y,275,A,5ifn:A,275,Abolishes interaction with NONO and localization in nuclear paraspeckles,-1.0,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_Y_275_A
3886,Q8WXF1,W,279,A,5ifn:A,279,Abolishes interaction with NONO and localization in nuclear paraspeckles,-1.0,,-999.0,,,,,,,,,1.0,,,,Q8WXF1_W_279_A
3887,O95727,F,56,A,3rbg:C,56,Reduced binding to CADM1. Severely impairs interaction with CADM1,-1.0,,-999.0,,,,,,,,,,,,,O95727_F_56_A
3888,O95727,T,57,A,3rbg:C,57,Reduced binding to CADM1. Severely impairs interaction with CADM1,-1.0,,-999.0,,,,,,,,,,,,,O95727_T_57_A
3889,O95727,K,67,A,3rbg:C,67,Reduced binding to CADM1. Severely impairs interaction with CADM1,-1.0,,-999.0,,,,,,,,,,,,,O95727_K_67_A
3890,O95727,Y,101,A,3rbg:C,101,Reduced binding to CADM1. Severely impairs interaction with CADM1,-1.0,,-999.0,,,,,,,,,,,,,O95727_Y_101_A
3891,Q96GD4,K,106,R,4af3:A,106,Leads to loss of kinase activity and severely impairs mitotic progression.,,,1.0,,,,,,,,,,,,,Q96GD4_K_106_R
3892,Q96GD0,D,25,N,5gyn:A,25,Abolishes phosphatase activity.,,,1.0,,,,,,,,,,,,,Q96GD0_D_25_N
3893,Q13825,K,105,N,2zqr:A,105,Abolishes RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q13825_K_105_N
3894,Q13825,K,109,E,2zqr:A,109,Abolishes RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q13825_K_109_E
3895,Q13825,K,113,Q,2zqr:A,113,Abolishes RNA-binding,,-1.0,-999.0,,,,,,,,,,,,,Q13825_K_113_Q
3896,P49773,V,97,D,6g9z:A,97,Loss of dimerization. Strongly reduced enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,P49773_V_97_D
3896,P49773,V,97,E,6g9z:A,97,Loss of dimerization. Strongly reduced enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,P49773_V_97_E
3897,P49773,G,105,A,6g9z:A,105,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,P49773_G_105_A
3898,P49773,S,107,A,6g9z:A,107,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,P49773_S_107_A
3899,P49773,H,114,A,6g9z:A,114,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P49773_H_114_A
3900,P49773,W,123,A,6g9z:A,123,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P49773_W_123_A
3901,P15291,Y,282,G,6fwt:A,282,Reduction in N-acetylglucosamine binding.,,-1.0,-999.0,,,,,,,,,,,,,P15291_Y_282_G
3902,P15291,Y,285,F,6fwt:A,285,No change in enzymatic activity.,,,1.0,,,,,,,,,,,,,P15291_Y_285_F
3903,P15291,Y,307,G,6fwt:A,307,Reduction in N-acetylglucosamine and UDP-galactose binding.,,-1.0,-999.0,,,,,,,,,,,,,P15291_Y_307_G
3904,P15291,W,308,G,6fwt:A,308,Reduction in N-acetylglucosamine binding.,,-1.0,-999.0,,,,,,,,,,,,,P15291_W_308_G
3905,P15291,W,310,G,6fwt:A,310,Reduction in N-acetylglucosamine binding.,,-1.0,-999.0,,,,,,,,,,,,,P15291_W_310_G
3906,P15291,M,340,H,6fwt:A,340,Favors the closed conformation of the enzyme.,,,-999.0,,,,,,,,,,,1.0,,P15291_M_340_H
3907,P50336,R,59,G,3nks:A,59,Decreases enzyme activity by 75%.,,,1.0,,,,,,,,,,,,,P50336_R_59_G
3908,P50336,R,59,Q,3nks:A,59,Decreases enzyme activity by 90%. Strongly decreases affinity for protoporphyrinogen-IX.,,-1.0,1.0,,,,,,,,,,,,,P50336_R_59_Q
3909,P50336,L,74,P,3nks:A,74,Abolishes enzyme activity. Impairs protein folding and/or stability.,,,1.0,,,,,,,,,,,-1.0,,P50336_L_74_P
3910,P50336,R,97,D,3nks:A,97,Decreases enzyme activity by 89%. Impairs protein folding and/or stability.,,,1.0,,,,,,,,,,,-1.0,,P50336_R_97_D
3911,P50336,L,166,N,4ivo:B,166,Decreases enzyme activity by 95%.,,,1.0,,,,,,,,,,,,,P50336_L_166_N
3912,P50336,G,169,A,4ivo:B,169,Decreases enzyme activity by 64%.,,,1.0,,,,,,,,,,,,,P50336_G_169_A
3913,P50336,S,284,I,4ivo:B,284,Decreases enzyme activity by 87%. Impairs protein folding and/or stability.,,,1.0,,,,,,,,,,,-1.0,,P50336_S_284_I
3914,P50336,V,290,L,4ivo:B,290,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P50336_V_290_L
3915,P50336,F,331,A,4ivo:B,331,Decreases enzyme activity by 50%.,,,1.0,,,,,,,,,,,,,P50336_F_331_A
3916,P50336,L,334,A,4ivo:B,334,Decreases enzyme activity by 86%.,,,1.0,,,,,,,,,,,,,P50336_L_334_A
3917,P50336,V,347,A,4ivo:B,347,Decreases enzyme activity by 45%.,,,1.0,,,,,,,,,,,,,P50336_V_347_A
3918,P50336,M,368,A,4ivo:B,368,Decreases enzyme activity by 52%.,,,1.0,,,,,,,,,,,,,P50336_M_368_A
3919,P11021,T,229,A,6asy:A,229,Impaired ATPase activity.,,,1.0,,,,,,,,,,,,,P11021_T_229_A
3920,P11021,K,585,R,5e85:A,585,Complete loss of in vitro methylation by METTL21A.,,,-999.0,,,,,,,,,,,,,P11021_K_585_R
3921,Q9UJX5,D,33,K,6tm5:I,33,"Impairs UBE2S-mediated polyubiquitination, decreasing substrate affinity. Does not affect UBE2C-mediated multiubiquitination.",,-1.0,-999.0,,,,,,,,,,,,,Q9UJX5_D_33_K
3922,P15056,M,53,D,5vyk:C,1053,Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.,-1.0,,1.0,,,,,,,,,,,,,P15056_M_53_D
3923,P15056,K,88,E,5vyk:C,1088,Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.,-1.0,,1.0,,,,,,,,,,,,,P15056_K_88_E
3924,P15056,K,483,S,6nyb:A,483,Reduces kinase activity with MAP2K1.,-1.0,,1.0,,,,,,,,,,,,,P15056_K_483_S
3925,P15056,R,509,H,6nyb:A,509,Loss of MAP2K1-mediated-BRAF-KSR1 dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P15056_R_509_H
3926,P15056,K,578,R,6nyb:A,578,Blocks EGF-induced ubiquitination and ERK activation.,,,-999.0,,-1.0,,,,,,,,,,,P15056_K_578_R
3927,P15056,I,666,R,6nyb:A,666,"No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1.",0.0,,1.0,,,,,,,,,,,,,P15056_I_666_R
3928,P15056,R,671,K,6nyb:A,671,Increased kinase activity and stability in response to EGF treatment.,,,1.0,,,,,,,,,,,1.0,,P15056_R_671_K
3929,P08603,H,337,A,3gav:A,337,About 10% loss of heparin-binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_H_337_A
3930,P08603,R,341,A,3gav:A,341,About 20% loss of heparin-binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_R_341_A
3931,P08603,R,1182,A,3gav:A,1182,About 50% loss of C3b binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_R_1182_A
3932,P08603,W,1183,L,3gav:A,1183,About 40% loss of C3b binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_W_1183_L
3933,P08603,K,1186,A,3gav:A,1186,About 20% loss of C3b binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_K_1186_A
3934,P08603,K,1188,A,3gav:A,1188,About 50% loss of C3b binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_K_1188_A
3935,P08603,E,1198,A,3gav:A,1198,About 30% loss of C3b binding.,,-1.0,-999.0,,,,,,,,,,,,,P08603_E_1198_A
3936,P50440,D,170,N,3jdw:A,170,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P50440_D_170_N
3937,P50440,E,233,K,3jdw:A,233,Complete loss of activity,,,1.0,,,,,,,,,,,,,P50440_E_233_K
3938,P50440,D,254,N,3jdw:A,254,Significantly reduced activity.,,,1.0,,,,,,,,,,,,,P50440_D_254_N
3939,P50440,H,303,V,3jdw:A,303,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P50440_H_303_V
3940,P50440,D,305,A,3jdw:A,305,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P50440_D_305_A
3941,P50440,R,322,E,3jdw:A,322,Significantly reduced activity.,,,1.0,,,,,,,,,,,,,P50440_R_322_E
3942,P50440,S,355,A,3jdw:A,355,Significantly reduced activity.,,,1.0,,,,,,,,,,,,,P50440_S_355_A
3943,P50440,C,407,S,3jdw:A,407,Complete loss of activity,,,1.0,,,,,,,,,,,,,P50440_C_407_S
3944,P50440,C,410,A,3jdw:A,410,No effect on activity.,,,0.0,,,,,,,,,,,,,P50440_C_410_A
3945,Q9NR71,G,124,R,4wgk:B,124,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_G_124_R
3946,Q9NR71,H,194,A,4wgk:B,194,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_H_194_A
3947,Q9NR71,H,196,A,4wgk:B,196,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_H_196_A
3948,Q9NR71,A,211,R,4wgk:B,211,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_A_211_R
3949,Q9NR71,R,257,A,4wgk:B,257,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_R_257_A
3950,Q9NR71,S,258,A,4wgk:B,258,Decreased ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_S_258_A
3951,Q9NR71,H,303,A,4wgk:B,303,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_H_303_A
3952,Q9NR71,D,352,S,4wgk:B,352,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_D_352_S
3953,Q9NR71,S,354,A,4wgk:B,354,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_S_354_A
3954,Q9NR71,C,362,A,4wgk:B,362,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_C_362_A
3955,Q9NR71,S,374,A,4wgk:B,374,Decreased ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_S_374_A
3956,Q9NR71,S,396,A,4wgk:B,396,No effect on ceramide hydrolase activity.,,,0.0,,,,,,,,,,,,,Q9NR71_S_396_A
3957,Q9NR71,G,465,R,4wgk:B,465,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_G_465_R
3958,Q9NR71,E,540,A,4wgk:B,540,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_E_540_A
3959,Q9NR71,Y,579,F,4wgk:B,579,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_Y_579_F
3960,Q9NR71,Y,591,F,4wgk:B,591,Loss of ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_Y_591_F
3961,Q9NR71,S,595,A,4wgk:B,595,Decreased ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_S_595_A
3962,Q9NR71,S,729,A,4wgk:B,729,Decreased ceramide hydrolase activity.,,,1.0,,,,,,,,,,,,,Q9NR71_S_729_A
3963,Q9UQB8,K,142,E,1y2o:A,142,Abolishes actin-bundling and filopodia formation,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_K_142_E
3964,Q9UQB8,K,143,E,1y2o:A,143,Abolishes actin-bundling and filopodia formation,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_K_143_E
3965,Q9UQB8,K,146,E,1y2o:A,146,Abolishes actin-bundling and filopodia formation,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_K_146_E
3966,Q9UQB8,K,147,E,1y2o:A,147,Abolishes actin-bundling and filopodia formation,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_K_147_E
3967,Q9UQB8,W,413,G,3rnj:A,413,Impairs the SH3 domain and abolishes the interaction with EPS8.,-1.0,,1.0,,,,,,,,,,,-1.0,,Q9UQB8_W_413_G
3968,Q9UQB8,F,427,A,3rnj:A,427,Loss of interaction with ENAH and no induction of filopodia,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_F_427_A
3969,Q9UQB8,P,428,A,3rnj:A,428,Loss of interaction with ENAH and no induction of filopodia,-1.0,,1.0,,,,,,,,,,,,,Q9UQB8_P_428_A
3970,Q9UQB9,K,72,R,6gr9:A,72,Impairs kinase activity.,,,1.0,,,,,,,,,,,,,Q9UQB9_K_72_R
3971,Q9UQB9,D,166,Y,6gr9:A,166,"Impairs kinase activity, and keeps AURKC with the chromosomes until the end of mitosis.",,,1.0,,,,,,,,,,,,,Q9UQB9_D_166_Y
3972,Q9UQB9,T,198,A,6gr9:A,198,Impairs kinase activity.,,,1.0,,,,,,,,,,,,,Q9UQB9_T_198_A
3973,Q15276,D,812,K,1tu3:J,812,No effect on RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_D_812_K
3974,Q15276,E,815,K,1tu3:J,815,No effect on RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_E_815_K
3975,Q15276,Q,818,W,1tu3:J,818,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_Q_818_W
3976,Q15276,D,820,K,1tu3:J,820,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_D_820_K
3977,Q15276,F,821,R,1tu3:J,821,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_F_821_R
3978,Q15276,V,822,D,1tu3:J,822,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_V_822_D
3979,Q15276,Q,826,A,1tu3:J,826,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_Q_826_A
3980,Q15276,Q,829,A,1tu3:J,829,Strongly decreases RAB5A binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,Q15276_Q_829_A
3981,Q13882,W,44,A,2kgt:A,44,Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region.,-1.0,,1.0,,,,,,,,,,,,,Q13882_W_44_A
3982,Q13882,Y,66,A,2kgt:A,66,Decrease in STAP2 phosphorylation.,,,1.0,,,,,,,,,,,,,Q13882_Y_66_A
3983,Q13882,R,105,L,1rja:A,31,Decrease in STAP2 phosphorylation.,,,1.0,,,,,,,,,,,,,Q13882_R_105_L
3984,Q13882,W,184,A,6cz3:A,184,Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1.,-1.0,,1.0,,,,,,,,,,,,,Q13882_W_184_A
3985,Q13882,K,219,M,5d7v:A,219,"Abolishes kinase activity and cell transformation, and phosphorylation of STAP2.",,,1.0,,,,,,,,,,,,,Q13882_K_219_M
3986,Q13882,K,219,R,5d7v:A,219,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q13882_K_219_R
3987,Q13882,Y,342,A,5d7v:A,342,"3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation",,,1.0,,,,,,,,,,,,,Q13882_Y_342_A
3988,Q9HB75,L,801,A,2of5:H,801,No effect on complex assembly with CRADD.,0.0,,-999.0,,,,,,,,,,,,,Q9HB75_L_801_A
3989,Q9HB75,Y,814,A,2of5:H,814,Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_Y_814_A
3990,Q9HB75,R,815,A,2of5:H,815,Partial loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_R_815_A
3991,Q9HB75,R,815,E,2of5:H,815,Loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_R_815_E
3992,Q9HB75,R,825,A,2of5:H,825,Partial loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_R_825_A
3993,Q9HB75,R,825,E,2of5:H,825,Partial loss of complex assembly with CRADD. Decreased PIDDosome assembly. Decreased CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_R_825_E
3994,Q9HB75,D,826,K,2of5:H,826,Partial loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_D_826_K
3995,Q9HB75,L,828,E,2of5:H,828,Loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_L_828_E
3996,Q9HB75,E,830,K,2of5:H,830,No effect on complex assembly with CRADD.,0.0,,-999.0,,,,,,,,,,,,,Q9HB75_E_830_K
3997,Q9HB75,F,837,D,2of5:H,837,Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_F_837_D
3998,Q9HB75,R,862,A,2of5:H,862,Loss of complex assembly with CRADD. Loss of PIDDosome assembly. Loss of CASP2 activation.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_R_862_A
3999,Q9HB75,Q,863,A,2of5:H,863,Partial loss of complex assembly with CRADD.,-1.0,,-999.0,,,,,,,,,,,,,Q9HB75_Q_863_A
4000,Q13888,C,291,A,6o9l:6,291,Reconstituted TFIIH complex lacks p62 and has no transcriptional activity.,,,1.0,,,,,,,,,,,,,Q13888_C_291_A
4001,Q13888,C,308,A,6o9l:6,308,Reconstituted TFIIH complex lacks p62 and has no transcriptional activity.,,,1.0,,,,,,,,,,,,,Q13888_C_308_A
4002,Q13888,C,345,A,6o9l:6,345,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_345_A
4003,Q13888,C,360,A,6o9l:6,360,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_360_A
4004,Q13888,C,363,A,6o9l:6,363,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_363_A
4005,Q13888,H,376,A,6o9l:6,376,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_H_376_A
4006,Q13888,H,380,A,6o9l:6,380,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_H_380_A
4007,Q13888,C,382,A,6o9l:6,382,No effect on the transcriptional activity of the reconstituted TFIIH complex.,,,0.0,,,,,,,,,,,,,Q13888_C_382_A
4008,O00141,K,127,M,3hdm:A,127,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,O00141_K_127_M
4009,O00141,T,256,A,2r5t:A,256,Low activity.,,,1.0,,,,,,,,,,,,,O00141_T_256_A
4010,O00141,T,256,D,2r5t:A,256,Low activity.,,,1.0,,,,,,,,,,,,,O00141_T_256_D
4011,O00141,T,256,E,2r5t:A,256,Low activity.,,,1.0,,,,,,,,,,,,,O00141_T_256_E
4012,O00141,Y,298,A,2r5t:A,298,Abolishes interaction with NEDD4 and NEDD4L.,-1.0,,-999.0,,,,,,,,,,,,,O00141_Y_298_A
4013,Q9P2T1,C,186,A,2a7r:A,186,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9P2T1_C_186_A
4014,Q9P2T1,T,188,A,2a7r:A,188,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9P2T1_T_188_A
4015,Q9P2T1,E,289,Q,2a7r:A,289,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9P2T1_E_289_Q
4016,P51795,Y,687,A,2ja3:D,617,"Strongly decreased affinity for ATP, but no effect on chloride transport.",,-1.0,0.0,,,,,,,,,,,,,P51795_Y_687_A
4017,P51795,S,688,A,2ja3:D,618,No effect ATP binding or chloride transport.,,0.0,0.0,,,,,,,,,,,,,P51795_S_688_A
4018,P51795,Y,742,A,2ja3:D,672,Abolishes interaction with NEDD4 and NEDD4L.,-1.0,,-999.0,,,,,,,,,,,,,P51795_Y_742_A
4019,P51795,D,797,A,2ja3:D,727,"Strongly decreased affinity for ATP, but no effect on chloride transport.",,-1.0,0.0,,,,,,,,,,,,,P51795_D_797_A
4020,O14638,T,179,C,6c01:A,179,Causes the formation of covalently linked homodimers in solution,1.0,,-999.0,,,,,,,,,,,,,O14638_T_179_C
4021,O14638,K,204,A,6c01:A,204,Strongly decreases affinity for nucleotides and slows their hydrolysis.,,-1.0,1.0,,,,,,,,,,,,,O14638_K_204_A
4022,O14638,N,227,A,6c01:A,227,No effect on affinity for nucleotides and enzyme activity.,,0.0,0.0,,,,,,,,,,,,,O14638_N_227_A
4023,O14638,E,275,A,6c01:A,275,No effect on substrate specificity. Increases affinity for nucleotides and slows their hydrolysis.,,1.0,1.0,,,,,,,,,,,,,O14638_E_275_A
4024,O14638,A,336,C,6c01:A,336,Causes the formation of covalently linked homodimers in solution,1.0,,-999.0,,,,,,,,,,,,,O14638_A_336_C
4025,P13995,D,168,A,6jid:A,168,Significant loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_D_168_A
4026,P13995,D,168,E,6jid:A,168,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_D_168_E
4027,P13995,D,168,N,6jid:A,168,80% decrease in NAD-dependent dehydrogenase specific activity. 18% decrease in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,1.0,,,,,,,,,,,,,P13995_D_168_N
4028,P13995,D,168,S,6jid:A,168,82% decrease in NAD-dependent dehydrogenase specific activity. 65% decrease in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,1.0,,,,,,,,,,,,,P13995_D_168_S
4029,P13995,R,201,A,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_R_201_A
4029,P13995,R,201,S,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_R_201_S
4029,P13995,R,201,K,6jid:A,201,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_R_201_K
4030,P13995,D,225,A,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_D_225_A
4030,P13995,D,225,S,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_D_225_S
4030,P13995,D,225,E,6jid:A,225,Complete loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_D_225_E
4031,P13995,D,225,N,6jid:A,225,84% decrease in NAD-dependent dehydrogenase specific activity. 36% increase in NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,-1.0,1.0,,,,,,,,,,,,,P13995_D_225_N
4032,P13995,R,233,A,6jid:A,233,Significant loss of NAD and NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_R_233_A
4033,P13995,R,233,K,6jid:A,233,50% decrease in NAD and NADP-dependent dehydrogenase specific activity. Reduced affinity for magnesium.,,,1.0,,,,,,,,,,,,,P13995_R_233_K
4034,P13995,R,233,S,6jid:A,233,Almost complete loss of NAD-dependent dehydrogenase specific activity. 50% decrease in NADP-dependent dehydrogenase specific activity.,,,1.0,,,,,,,,,,,,,P13995_R_233_S
4035,P55011,R,294,A,6pzt:A,294,Severely impairs transporter activity.,,,1.0,,,,,,,,,,,,,P55011_R_294_A
4036,P51553,N,117,A,5gri:B,78,No effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,0.0,-999.0,,,,,,,,,,,,,P51553_N_117_A
4037,P51553,T,120,A,5gri:B,81,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_T_120_A
4038,P51553,S,130,A,5gri:B,91,No significant effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,0.0,-999.0,,,,,,,,,,,,,P51553_S_130_A
4039,P51553,N,133,A,5gri:B,94,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_N_133_A
4040,P51553,R,136,A,5gri:B,97,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_R_136_A
4041,P51553,R,167,A,5gri:B,128,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_R_167_A
4042,P51553,E,173,A,5gri:B,134,No effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,0.0,-999.0,,,,,,,,,,,,,P51553_E_173_A
4043,P51553,Y,174,F,5gri:B,135,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_Y_174_F
4044,P51553,K,190,A,5gri:B,151,Complete loss of the activation of the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_K_190_A
4045,P51553,D,229,A,5gri:B,190,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_D_229_A
4046,P51553,Y,276,F,5gri:B,237,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate and ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_Y_276_F
4047,P51553,R,311,A,5gri:B,272,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by citrate.,,-1.0,-999.0,,,,,,,,,,,,,P51553_R_311_A
4048,P51553,N,312,A,5gri:B,273,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_N_312_A
4049,P51553,T,313,A,5gri:B,274,Significantly impairs the activation of the heterodimer composed of IDH3A and IDH3G subunits by ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_T_313_A
4050,P51553,K,315,A,5gri:B,276,No significant effect on the activation of the heterodimer composed of IDH3A and IDH3G subunits by ADP.,,0.0,-999.0,,,,,,,,,,,,,P51553_K_315_A
4051,P51553,N,324,A,5gri:B,285,Complete loss of the activation of the heterodimer composed of IDH3A and IDH3G subunits by ADP.,,-1.0,-999.0,,,,,,,,,,,,,P51553_N_324_A
4052,Q9Y2R2,S,35,E,3h2x:A,35,Loss of phosphorylation by PKC/PRKCD.,,,-999.0,-1.0,,,,,,,,,,,,Q9Y2R2_S_35_E
4053,Q9Y2R2,T,36,E,3h2x:A,36,No effect on phosphorylation by PKC/PRKCD.,,,-999.0,0.0,,,,,,,,,,,,Q9Y2R2_T_36_E
4054,Q9Y2R2,C,129,S,3h2x:A,129,Decreases activity 2 fold.,,,1.0,,,,,,,,,,,,,Q9Y2R2_C_129_S
4055,Q9Y2R2,C,231,S,3h2x:A,231,Decreases activity 7 fold.,,,1.0,,,,,,,,,,,,,Q9Y2R2_C_231_S
4056,O60870,K,135,R,2v1n:A,86,Almost complete loss of in vitro methylation by METTL22.,,,-999.0,,,,,,,,,,,,,O60870_K_135_R
4057,O60870,K,302,E,7abi:7,302,Significant reduction of RNA-binding activity.,,-1.0,-999.0,,,,,,,,,,,,,O60870_K_302_E
4058,O60870,K,391,E,7abi:7,391,Significant reduction of RNA-binding activity.,,-1.0,-999.0,,,,,,,,,,,,,O60870_K_391_E
4059,P51955,K,37,R,5m51:A,37,Loss of kinase activity and of ability to activate NEK11.,-1.0,,1.0,,,,,,,,,,,,,P51955_K_37_R
4060,P51955,D,141,A,5m51:A,141,Loss of autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P51955_D_141_A
4061,P51955,T,170,A,2w5b:A,170,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,P51955_T_170_A
4062,P51955,T,170,E,2w5b:A,170,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_T_170_E
4063,P51955,S,171,A,2w5b:A,171,No effect on kinase activity.,,,0.0,,,,,,,,,,,,,P51955_S_171_A
4064,P51955,S,171,D,2w5b:A,171,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_S_171_D
4065,P51955,T,175,A,2w5b:A,175,Kinase activity decreased by two fold.,,,1.0,,,,,,,,,,,,,P51955_T_175_A
4066,P51955,T,175,E,2w5b:A,175,Kinase activity increased by two fold.,,,1.0,,,,,,,,,,,,,P51955_T_175_E
4067,P51955,T,179,A,2w5b:A,179,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51955_T_179_A
4068,P51955,T,179,E,2w5b:A,179,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51955_T_179_E
4069,P51955,S,241,A,2w5b:A,241,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51955_S_241_A
4070,P51955,S,241,D,2w5b:A,241,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P51955_S_241_D
4071,P30041,S,32,A,5b6m:F,32,"Loss of phospholipase activity, but no effect on peroxidase activity.",,,1.0,,,,,,,,,,,,,P30041_S_32_A
4072,P30041,C,47,S,5b6m:F,47,"Loss of peroxidase activity, but no effect on phospholipase activity.",,,1.0,,,,,,,,,,,,,P30041_C_47_S
4073,P30043,H,153,A,5ooh:A,153,Reduced affinity for biliverdin.,,-1.0,-999.0,,,,,,,,,,,,,P30043_H_153_A
4074,P30044,C,100,S,1urm:A,47,Loss of antioxidant activity. Loss of S-palmitoylation.,,,1.0,,,,,,-1.0,,,,,,,P30044_C_100_S
4075,P30044,C,125,S,1urm:A,72,No change in antioxidant activity. No change in S-palmitoylation levels.,,,0.0,,,,,,0.0,,,,,,,P30044_C_125_S
4076,P30044,C,204,S,1urm:A,151,Loss of antioxidant activity. No change in S-palmitoylation levels.,,,1.0,,,,,,0.0,,,,,,,P30044_C_204_S
4077,O14558,V,67,G,4jut:C,67,No effect on homodimer-based self-association properties,0.0,,-999.0,,,,,,,,,,,,,O14558_V_67_G
4078,O14558,S,134,Q,4jut:C,134,Decreases heteromer formation with CRYAB.,-1.0,,-999.0,,,,,,,,,,,,,O14558_S_134_Q
4079,Q12933,K,31,R,3knv:A,31,Abolishes 'Lys-63'-linked polyubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,Q12933_K_31_R
4080,Q12933,T,117,A,3knv:A,117,Loss of phosphorylation site. Abolishes activation of NF-kappa-B.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q12933_T_117_A
4081,Q12933,I,285,A,3m0d:A,285,Strongly reduced interaction with BIRC3.,-1.0,,-999.0,,,,,,,,,,,,,Q12933_I_285_A
4082,Q12933,V,288,A,3m0d:A,288,Strongly reduced interaction with BIRC3.,-1.0,,-999.0,,,,,,,,,,,,,Q12933_V_288_A
4083,Q12933,E,292,A,3m0d:A,292,Strongly reduced interaction with BIRC3.,-1.0,,-999.0,,,,,,,,,,,,,Q12933_E_292_A
4084,Q9Y678,W,776,S,1r4x:A,776,Loss of interaction with ZNF289/ARFGAP2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y678_W_776_S
4085,Q96EF0,A,253,K,4y7i:A,253,Increases catalytic activity.,,,1.0,,,,,,,,,,,,,Q96EF0_A_253_K
4086,Q96EF0,K,255,A,4y7i:A,255,Decreases catalytic activity.,,,1.0,,,,,,,,,,,,,Q96EF0_K_255_A
4087,Q9BV20,C,168,S,4ldr:B,168,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9BV20_C_168_S
4088,Q9BV20,D,248,A,4ldr:B,248,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9BV20_D_248_A
4089,Q9NZU7,D,238,A,3ox5:A,35,Loss of magnesium-binding. Loss of binding to ITPRs,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9NZU7_D_238_A
4090,Q9NZU7,D,240,A,3ox5:A,37,Loss of magnesium-binding. Loss of binding to ITPRs,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9NZU7_D_240_A
4091,Q9NZU7,D,242,A,3ox5:A,39,Loss of magnesium-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NZU7_D_242_A
4092,Q9NZU7,D,249,A,3ox5:A,46,No effect on magnesium-binding.,,0.0,-999.0,,,,,,,,,,,,,Q9NZU7_D_249_A
4093,Q9NZU7,D,315,A,3ox5:A,112,Loss of binding to ITPRs,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU7_D_315_A
4094,Q9NZU7,N,317,A,3ox5:A,114,Loss of binding to ITPRs,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU7_N_317_A
4095,Q9NZU7,S,323,A,3ox5:A,120,Loss of phosphorylation and loss of calcium release by InsP(3).,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q9NZU7_S_323_A
4096,Q9NZU7,D,352,A,3ox5:A,149,Loss of binding to ITPRs,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU7_D_352_A
4097,Q9NZU7,N,354,A,3ox5:A,151,Loss of binding to ITPRs,-1.0,,-999.0,,,,,,,,,,,,,Q9NZU7_N_354_A
4098,Q9NP72,S,22,N,1x3s:A,22,Loss of localization to lipid droplets and interaction with ZFYVE1.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9NP72_S_22_N
4099,Q9NP72,Q,67,L,1x3s:A,67,No loss of localization to lipid droplets and interaction with ZFYVE1.,0.0,,-999.0,,,,,,,,,0.0,,,,Q9NP72_Q_67_L
4100,Q9NP77,C,12,S,3o2q:E,12,Abolishes phosphatase activity.,,,1.0,,,,,,,,,,,,,Q9NP77_C_12_S
4101,Q8TDI0,L,518,A,6guu:B,518,Reduced affinity for trimethylated histone H3K27me3.,-1.0,,-999.0,,,,,,,,,,,,,Q8TDI0_L_518_A
4102,Q8TDI0,Y,619,E,6guu:B,619,Reduced affinity for trimethylated histone H3K27me3.,-1.0,,-999.0,,,,,,,,,,,,,Q8TDI0_Y_619_E
4103,P08922,K,1980,M,4uxl:A,1980,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P08922_K_1980_M
4104,P49862,H,54,F,3bsq:A,40,No effect on zinc inhibition.,,0.0,-999.0,,,,,,,,,,,,,P49862_H_54_F
4105,P49862,H,109,A,3bsq:A,95,No zinc inhibition.,,-1.0,-999.0,,,,,,,,,,,,,P49862_H_109_A
4106,P62877,C,53,A,2lgv:A,53,Strong reduction in ligase activity,,,1.0,,,,,,,,,,,,,P62877_C_53_A
4107,P62877,C,56,A,2lgv:A,56,Strong reduction in ligase activity,,,1.0,,,,,,,,,,,,,P62877_C_56_A
4108,P62877,C,75,A,2lgv:A,75,Strong reduction in ligase activity,,,1.0,,,,,,,,,,,,,P62877_C_75_A
4109,P62877,H,77,A,2lgv:A,77,Strong reduction in ligase activity,,,1.0,,,,,,,,,,,,,P62877_H_77_A
4110,P35968,K,868,M,4ase:A,868,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P35968_K_868_M
4111,P35968,Y,996,F,3u6j:A,996,Strongly reduced autophosphorylation. Reduces phosphorylation of PLCG1.,,,1.0,-1.0,,,,,,,,,,,,P35968_Y_996_F
4112,P35968,C,1045,A,3u6j:A,1045,Significantly higher kinase activity.,,,1.0,,,,,,,,,,,,,P35968_C_1045_A
4113,P35968,Y,1054,F,3u6j:A,1054,Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins,,,1.0,-1.0,,,,,,,,,,,,P35968_Y_1054_F
4114,P35968,Y,1059,F,3u6j:A,1059,Strongly reduced autophosphorylation. Abolishes phosphorylation of downstream signaling proteins,,,1.0,-1.0,,,,,,,,,,,,P35968_Y_1059_F
4115,O00560,K,214,A,4z33:A,214,"Disruption of the cooperative binding of C-terminal peptides from FZD7 and phosphatidylinositol-4,5-bisphosphate. Impaired interaction with FZD7 and disruption of the cooperative binding of C-terminal peptides from FZD7 and phosphatidylinositol-4,5-bisphosphate",-1.0,-1.0,-999.0,,,,,,,,,,,,,O00560_K_214_A
4116,O00560,N,215,D,4z33:A,215,"Disruption of the cooperative binding of C-terminal peptides from FZD7 and phosphatidylinositol-4,5-bisphosphate.",,-1.0,-999.0,,,,,,,,,,,,,O00560_N_215_D
4117,O00560,K,250,A,4z33:A,250,"Disruption of the cooperative binding of C-terminal peptides from FZD7 and phosphatidylinositol-4,5-bisphosphate. Impaired interaction with FZD7 and disruption of the cooperative binding of C-terminal peptides from FZD7 and phosphatidylinositol-4,5-bisphosphate",-1.0,-1.0,-999.0,,,,,,,,,,,,,O00560_K_250_A
4118,Q86WT6,C,61,A,6yxe:A,61,Loss of E3 ubiquitin-protein ligase activity,,,1.0,,,,,,,,,,,,,Q86WT6_C_61_A
4119,Q86WT6,C,64,A,6yxe:A,64,Loss of E3 ubiquitin-protein ligase activity,,,1.0,,,,,,,,,,,,,Q86WT6_C_64_A
4120,Q07912,L,120,Q,4ewh:A,120,No effect on autophosphorylation at Y-284.,,,0.0,0.0,,,,,,,,,,,,Q07912_L_120_Q
4121,Q07912,K,158,R,4ewh:A,158,Loss of autophosphorylation at Y-284.,,,1.0,-1.0,,,,,,,,,,,,Q07912_K_158_R
4122,Q07912,L,197,Q,4ewh:A,197,No effect on autophosphorylation at Y-284.,,,0.0,0.0,,,,,,,,,,,,Q07912_L_197_Q
4123,Q07912,V,365,R,4ewh:A,365,Increased autophosphorylation at Y-284.,,,1.0,1.0,,,,,,,,,,,,Q07912_V_365_R
4124,P29965,Y,170,E,1aly:A,170,Decreases ITGA5,,,-999.0,,,,,,,,,,,,,P29965_Y_170_E
4125,P29965,H,224,E,1aly:A,224,Decreases ITGA5,,,-999.0,,,,,,,,,,,,,P29965_H_224_E
4126,P29965,G,226,E,1aly:A,226,Decreases ITGA5,,,-999.0,,,,,,,,,,,,,P29965_G_226_E
4127,P29965,G,252,E,1aly:A,252,Decreases ITGA5,,,-999.0,,,,,,,,,,,,,P29965_G_252_E
4128,O00764,D,235,A,2f7k:A,235,"15-fold decrease in pyridoxal kinase activity, and a 7-fold decrease in affinity for pyridoxal.",,-1.0,1.0,,,,,,,,,,,,,O00764_D_235_A
4129,O00764,D,235,N,2f7k:A,235,2-fold decrease in pyridoxal kinase activity and pyridoxal affinity.,,-1.0,1.0,,,,,,,,,,,,,O00764_D_235_N
4130,O00762,C,114,S,1i7k:A,114,Loss of function,,,1.0,,,,,,,,,,,,,O00762_C_114_S
4131,P28562,C,258,S,6d66:A,458,Loss of phosphatase activity.,,,1.0,,,,,,,,,,,,,P28562_C_258_S
4132,P43351,R,55,A,5jrb:K,55,Abolishes ssDNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P43351_R_55_A
4133,P43351,Y,65,A,5jrb:K,65,Moderately defective in both ss and dsDNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P43351_Y_65_A
4134,P43351,K,152,A,5jrb:K,152,Abolishes ssDNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P43351_K_152_A
4135,P43351,R,153,A,5jrb:K,153,Moderately defective in both ss and dsDNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P43351_R_153_A
4136,P43351,R,156,A,5jrb:K,156,Moderately defective in both ss and dsDNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P43351_R_156_A
4137,P43357,D,170,A,4v0p:A,170,Abolishes HLA-A1 binding.,-1.0,,-999.0,,,,,,,,,,,,,P43357_D_170_A
4138,P43357,Y,176,A,4v0p:A,176,Abolishes HLA-A1 binding.,-1.0,,-999.0,,,,,,,,,,,,,P43357_Y_176_A
4139,Q8NHM5,V,1069,A,5jh5:A,1069,Decreased ininteraction with UBB.,-1.0,,-999.0,,,,,,,,,,,,,Q8NHM5_V_1069_A
4140,Q8NHM5,A,1072,Y,5jh5:A,1072,Increased interaction with UBB.,-1.0,,-999.0,,,,,,,,,,,,,Q8NHM5_A_1072_Y
4141,Q12849,Q,155,A,2lmi:A,17,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_Q_155_A
4142,Q12849,W,159,A,2lmi:A,21,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_W_159_A
4143,Q12849,E,223,A,2lmi:A,85,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_E_223_A
4144,Q12849,R,406,A,4qu7:A,406,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_R_406_A
4145,Q12849,F,410,A,4qu7:A,410,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_F_410_A
4146,Q12849,E,470,A,4qu7:A,470,Impairs RNA-binding and melting of G-quadruplex RNA structures,,-1.0,-999.0,,,,,,,,,,,,,Q12849_E_470_A
4147,P78330,S,23,A,1l8o:A,23,Reduces activity by about 50%.,,,1.0,,,,,,,,,,,,,P78330_S_23_A
4148,P78330,S,23,T,1l8o:A,23,Reduces activity by about 80%.,,,1.0,,,,,,,,,,,,,P78330_S_23_T
4149,P78330,E,29,D,1l8o:A,29,Reduces activity by about 95%.,,,1.0,,,,,,,,,,,,,P78330_E_29_D
4150,P78330,E,29,Q,1l8o:A,29,Loss of activity.,,,1.0,,,,,,,,,,,,,P78330_E_29_Q
4151,P78330,R,65,A,1l8o:A,65,Loss of activity.,,,1.0,,,,,,,,,,,,,P78330_R_65_A
4151,P78330,R,65,K,1l8o:A,65,Loss of activity.,,,1.0,,,,,,,,,,,,,P78330_R_65_K
4152,P78330,N,133,A,1l8o:A,133,Reduces activity by about 75%.,,,1.0,,,,,,,,,,,,,P78330_N_133_A
4153,P78330,T,182,S,1l8o:A,182,Reduces activity by about 99%.,,,1.0,,,,,,,,,,,,,P78330_T_182_S
4154,P78330,T,182,V,1l8o:A,182,Reduces activity by about 25%.,,,1.0,,,,,,,,,,,,,P78330_T_182_V
4155,P78330,R,202,A,1l8o:A,202,Reduces activity by about 99%.,,,1.0,,,,,,,,,,,,,P78330_R_202_A
4156,P78330,R,202,K,1l8o:A,202,Reduces activity by about 95%.,,,1.0,,,,,,,,,,,,,P78330_R_202_K
4157,Q12840,R,280,S,4uy0:C,280,Strongly reduces microtubule affinity,-1.0,,-999.0,,,,,,,,,,,,,Q12840_R_280_S
4158,Q9H668,D,78,A,6w6w:C,78,Defective of TEN1 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H668_D_78_A
4159,Q9H668,I,164,A,6w6w:C,164,Defective of TEN1 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H668_I_164_A
4160,Q9H668,M,167,A,6w6w:C,167,Defective of TEN1 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H668_M_167_A
4161,O75533,W,218,A,5z56:1,218,Abolishes interaction with RBM39,-1.0,,-999.0,,,,,,,,,,,,,O75533_W_218_A
4162,O75533,T,223,A,5z56:1,223,No effect on interaction with PPP1R8.,0.0,,-999.0,,,,,,,,,,,,,O75533_T_223_A
4163,O75533,T,227,A,5z56:1,227,No effect on interaction with PPP1R8.,0.0,,-999.0,,,,,,,,,,,,,O75533_T_227_A
4164,O75533,W,232,A,5z56:1,232,Abolishes interaction with RBM39,-1.0,,-999.0,,,,,,,,,,,,,O75533_W_232_A
4165,O75533,T,235,A,5z56:1,235,No effect on interaction with PPP1R8.,0.0,,-999.0,,,,,,,,,,,,,O75533_T_235_A
4166,O75533,T,244,A,5z56:1,244,Slight inhibition of interaction with PPP1R8.,-1.0,,-999.0,,,,,,,,,,,,,O75533_T_244_A
4167,O75533,T,248,A,5z56:1,248,Slight inhibition of interaction with PPP1R8.,-1.0,,-999.0,,,,,,,,,,,,,O75533_T_248_A
4168,O75533,W,254,A,5z56:1,254,Abolishes interaction with RBM39,-1.0,,-999.0,,,,,,,,,,,,,O75533_W_254_A
4169,O75533,T,257,A,5z56:1,257,No effect on interaction with PPP1R8.,0.0,,-999.0,,,,,,,,,,,,,O75533_T_257_A
4170,O75533,K,700,E,6ff7:u,700,Does not affect the stability of the SF3B complex interaction with U2AF65. Does not decrease the affinity to RNA.,0.0,0.0,-999.0,,,,,,,,,,,,,O75533_K_700_E
4171,P61970,E,42,K,1gy5:B,42,No effect on localization to the nucleoplasm.,,,-999.0,,,,,,,,,0.0,,,,P61970_E_42_K
4172,P10147,R,40,A,5cor:A,18,Slightly reduces heparin binding.,,-1.0,-999.0,,,,,,,,,,,,,P10147_R_40_A
4173,P10147,D,49,A,5cor:A,27,Reduces self-association,-1.0,,-999.0,,,,,,,,,,,,,P10147_D_49_A
4174,P10147,R,68,A,5cor:A,46,Strongly reduces heparin binding.,,-1.0,-999.0,,,,,,,,,,,,,P10147_R_68_A
4175,P10147,R,70,A,5cor:A,48,Reduces heparin binding.,,-1.0,-999.0,,,,,,,,,,,,,P10147_R_70_A
4176,P10147,E,89,A,5cor:A,67,Reduces self-association.,-1.0,,-999.0,,,,,,,,,,,,,P10147_E_89_A
4177,P68104,K,36,R,6zmo:CD,36,No effect on methylation by EEF1AKMT2. Abolishes EEF1AKMT4-mediated methylation.,,,-999.0,,,,,,,,,,,,,P68104_K_36_R
4178,P68104,K,55,R,6zmo:CD,55,No effect on methylation by EEF1AKMT2. Abolishes methylation by EEF1AKNMT.,,,-999.0,,,,,,,,,,,,,P68104_K_55_R
4179,P68104,K,79,R,6zmo:CD,79,No effect on methylation by EEF1AKMT2.,,,-999.0,,,,,,,,,,,,,P68104_K_79_R
4180,P68104,K,165,A,6zmo:CD,165,Abolishes methylation by EEF1AKMT3.,,,-999.0,,,,,,,,,,,,,P68104_K_165_A
4181,P68104,K,165,R,6zmo:CD,165,No effect on methylation by EEF1AKMT2.,,,-999.0,,,,,,,,,,,,,P68104_K_165_R
4182,P68104,K,318,R,6zmo:CD,318,Abolishes methylation by EEF1AKMT2.,,,-999.0,,,,,,,,,,,,,P68104_K_318_R
4183,P68104,T,432,A,6zmo:CD,432,Abolishes phosphorylation by PASK.,,,-999.0,-1.0,,,,,,,,,,,,P68104_T_432_A
4184,Q07820,K,194,R,2kbw:A,194,Reduced ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,Q07820_K_194_R
4185,Q07820,K,197,R,2kbw:A,197,Reduced ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,Q07820_K_197_R
4186,Q07820,K,208,R,2kbw:A,208,No effect on ubiquitination.,,,-999.0,,0.0,,,,,,,,,,,Q07820_K_208_R
4187,Q07820,K,234,R,2kbw:A,234,No effect on ubiquitination.,,,-999.0,,0.0,,,,,,,,,,,Q07820_K_234_R
4188,P18031,S,50,A,2cni:A,50,No phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P18031_S_50_A
4188,P18031,S,50,D,2cni:A,50,No phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P18031_S_50_D
4189,P18031,D,181,A,2cni:A,181,Substrate-trapping mutant.,,1.0,-999.0,,,,,,,,,,,,,P18031_D_181_A
4190,P18031,C,215,S,2cni:A,215,Catalytically inactive mutant,,,1.0,,,,,,,,,,,,,P18031_C_215_S
4191,P22392,R,88,A,3bbc:A,88,Decreased single-stranded DNA-binding and nucleotide-binding activity. No effect on 3D-structure.,,-1.0,-999.0,,,,,,,,,,,0.0,,P22392_R_88_A
4192,P78423,K,60,A,1b2t:A,36,Reduced binding to integrin ITGAV,-1.0,,-999.0,,,,,,,,,,,,,P78423_K_60_A
4193,P78423,K,60,E,1b2t:A,36,"Dominant-negative mutant, reduced binding to integrins ITGAV",-1.0,,-999.0,,,,,,,,,,,,,P78423_K_60_E
4194,P78423,R,61,A,1b2t:A,37,Reduced binding to integrin ITGAV,-1.0,,-999.0,,,,,,,,,,,,,P78423_R_61_A
4195,P78423,R,61,E,1b2t:A,37,"Dominant-negative mutant, reduced binding to integrins ITGAV",-1.0,,-999.0,,,,,,,,,,,,,P78423_R_61_E
4196,P78423,R,71,A,1b2t:A,47,Loss of binding to CX3CR1 and ability to induce chemotaxis but no effect on binding to integrins.,-1.0,,1.0,,,,,,,,,,,,,P78423_R_71_A
4197,P78423,K,78,A,1b2t:A,54,Little or no effect on binding to integrin ITGAV,0.0,,-999.0,,,,,,,,,,,,,P78423_K_78_A
4199,P78423,K,83,A,1b2t:A,59,Little or no effect on binding to integrin ITGAV,0.0,,-999.0,,,,,,,,,,,,,P78423_K_83_A
4200,Q9Y320,C,170,G,2dj0:A,41,Increased homodimerization even in absence of oxidative stress.,1.0,,-999.0,,,,,,,,,,,,,Q9Y320_C_170_G
4201,Q92932,C,945,A,2qep:A,945,"No effect to increase invasion, migration, and metastatic lung colonization in mice breast cancer model.",,,-999.0,,,,,,,,,,,,,Q92932_C_945_A
4202,Q92932,C,945,S,2qep:A,945,Loss of activity.,,,1.0,,,,,,,,,,,,,Q92932_C_945_S
4203,Q9H867,E,73,Q,4lg1:A,73,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H867_E_73_Q
4204,Q9H867,D,96,A,4lg1:A,96,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H867_D_96_A
4204,Q9H867,D,96,V,4lg1:A,96,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H867_D_96_V
4205,Q9H867,D,144,V,4lg1:A,144,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H867_D_144_V
4206,Q96P16,D,65,A,4jxt:A,65,Partial loss of binding to POLR2A CTD in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96P16_D_65_A
4207,Q96P16,R,106,A,4jxt:A,106,Partial loss of binding to POLR2A CTD phosphorylated at 'Ser-2' in the heptad repeats in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96P16_R_106_A
4208,Q96P16,R,114,A,4jxt:A,114,Partial loss of binding to POLR2A CTD in vitro.,-1.0,,-999.0,,,,,,,,,,,,,Q96P16_R_114_A
4209,O75223,G,23,A,2i5t:A,23,Marked decrease in catalytic efficiency.,,,1.0,,,,,,,,,,,,,O75223_G_23_A
4210,O75223,E,98,A,2i5t:A,98,Abolishes activity without altering structure.,,,1.0,,,,,,,,,,,0.0,,O75223_E_98_A
4210,O75223,E,98,Q,2i5t:A,98,Abolishes activity without altering structure.,,,1.0,,,,,,,,,,,0.0,,O75223_E_98_Q
4211,O75223,Y,105,F,2i5t:A,105,Marked decrease in catalytic efficiency and specific activity.,,,1.0,,,,,,,,,,,,,O75223_Y_105_F
4212,O75223,Y,125,F,2i5t:A,125,Little or no change in reaction kinetics.,,,0.0,,,,,,,,,,,,,O75223_Y_125_F
4213,Q13153,H,83,L,1f3m:A,83,"Abolishes interaction with CDC42, leading to strongly decreased activity",-1.0,,1.0,,,,,,,,,,,,,Q13153_H_83_L
4214,Q13153,H,86,L,1f3m:A,86,"Abolishes interaction with CDC42, leading to strongly decreased activity",-1.0,,1.0,,,,,,,,,,,,,Q13153_H_86_L
4215,Q13153,L,107,F,1f3m:A,107,"Abolishes autoinhibition, leading to constitutive kinase activity.",,,1.0,,,,,,,,,,,,,Q13153_L_107_F
4216,Q13153,K,299,R,5dey:A,299,Strongly decreases activity. Abolishes kinase activity,,,1.0,,,,,,,,,,,,,Q13153_K_299_R
4217,Q13153,D,389,N,5dey:A,389,Abolishes kinase activity,,,1.0,,,,,,,,,,,,,Q13153_D_389_N
4218,Q13153,D,393,A,5dey:A,393,Abolishes autophosphorylation at Thr-423.,,,1.0,-1.0,,,,,,,,,,,,Q13153_D_393_A
4219,Q13153,T,423,A,5dey:A,423,Decreases CDC42-stimulated activity and autophosphorylation.,-1.0,,1.0,-1.0,,,,,,,,,,,,Q13153_T_423_A
4220,Q13153,T,423,E,5dey:A,423,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,Q13153_T_423_E
4221,Q14191,E,84,A,2fbx:A,84,Abolishes exonuclease activity.,,,1.0,,,,,,,,,,,,,Q14191_E_84_A
4222,Q14191,L,88,A,2fbx:A,88,No effect on exonuclease activity.,,,0.0,,,,,,,,,,,,,Q14191_L_88_A
4223,Q14191,W,145,A,2fbx:A,145,Reduces exonuclease activity.,,,1.0,,,,,,,,,,,,,Q14191_W_145_A
4224,Q14191,Y,212,F,2fbx:A,212,Strongly reduces exonuclease activity.,,,1.0,,,,,,,,,,,,,Q14191_Y_212_F
4225,Q14191,R,987,A,2axl:A,39,Reduces affinity for DNA about 8-fold. Loss of DNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q14191_R_987_A
4226,Q14191,S,989,A,2axl:A,41,Reduces affinity for DNA about 4-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q14191_S_989_A
4227,Q14191,R,993,A,2axl:A,45,Reduces affinity for DNA about 20-fold. Loss of DNA binding,,-1.0,-999.0,,,,,,,,,,,,,Q14191_R_993_A
4228,Q14191,R,993,E,2axl:A,45,Loss of DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q14191_R_993_E
4229,Q14191,F,1037,A,2axl:A,89,Reduces affinity for DNA about 8-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q14191_F_1037_A
4230,Q14191,M,1038,A,2axl:A,90,Reduces affinity for DNA about 4-fold.,,-1.0,-999.0,,,,,,,,,,,,,Q14191_M_1038_A
4231,Q05193,K,44,A,6dlu:P,44,Inhibits receptor-mediated endocytosis.,,,1.0,,,,,,,,,,,,,Q05193_K_44_A
4232,Q9NTM9,C,31,A,3iwp:A,31,Reduces copper binding. Reduces copper binding by 75%,,-1.0,-999.0,,,,,,,,,,,,,Q9NTM9_C_31_A
4233,Q9NTM9,C,52,A,3iwp:A,52,Reduces copper binding. Reduces copper binding by 75%,,-1.0,-999.0,,,,,,,,,,,,,Q9NTM9_C_52_A
4234,O60936,K,17,R,4uz0:A,17,Abolished ubiquitination in response to an apoptotic stimulus,,,-999.0,,-1.0,,,,,,,,,,,O60936_K_17_R
4235,O60936,L,31,F,4uz0:A,31,Did not reduce creatine kinase release or infarct size after myocardial ischemia/reperfusion. Causes loss of mitochondrial membrane potential and nuclear condensation. Failes to prevent the increase in Bax. Interacts with BAX.,0.0,,-999.0,,,,,,,,,,,,,O60936_L_31_F
4236,O60936,K,68,R,4uz0:A,68,Abolished ubiquitination in response to an apoptotic stimulus,,,-999.0,,-1.0,,,,,,,,,,,O60936_K_68_R
4238,Q96NA2,F,248,A,1yhn:B,248,Strongly reduces dimerization and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_F_248_A
4239,Q96NA2,I,251,A,1yhn:B,251,"Abolishes dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments.",-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_I_251_A
4240,Q96NA2,L,252,A,1yhn:B,252,Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_L_252_A
4241,Q96NA2,R,255,A,1yhn:B,255,"Abolishes dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments.",-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_R_255_A
4242,Q96NA2,L,258,A,1yhn:B,258,"Reduces dimerization, interaction with RAB7A and localization to late endosomal/lysosomal compartments.",-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_L_258_A
4243,Q96NA2,K,304,A,1yhn:B,304,Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_K_304_A
4244,Q96NA2,M,305,A,1yhn:B,305,Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_M_305_A
4245,Q96NA2,L,306,A,1yhn:B,306,Abolishes interaction with RAB7A and localization to late endosomal/lysosomal compartments.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q96NA2_L_306_A
4246,Q96QV1,E,380,A,3ho3:A,380,Abolishes SHH binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96QV1_E_380_A
4247,Q96QV1,M,382,A,3ho3:A,382,Abolishes SHH binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96QV1_M_382_A
4248,Q96QV1,D,383,A,3ho3:A,383,Abolishes SHH binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96QV1_D_383_A
4248,Q96QV1,D,383,R,3ho3:A,383,Abolishes SHH binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96QV1_D_383_R
4249,Q96QV1,D,387,A,3ho3:A,387,Abolishes SHH binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96QV1_D_387_A
4250,Q6PHR2,K,44,R,6fdy:U,44,Decreased kinase activity.,,,1.0,,,,,,,,,,,,,Q6PHR2_K_44_R
4251,Q6PHR2,K,139,R,6fdy:U,139,Loss of kinase activity. Does not promote GLI1 nuclear localization.,,,1.0,,,,,,,,,,,,,Q6PHR2_K_139_R
4252,P68036,K,9,E,4q5h:C,9,Marked decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P68036_K_9_E
4253,P68036,F,63,A,4q5h:C,63,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P68036_F_63_A
4254,P68036,C,86,S,4q5h:C,86,Loss of catalytic activity. Prevents ubiquitin-dependent proteasomal degradation of UBE2L3.,,,1.0,,,,,,,,,,,,,P68036_C_86_S
4255,P68036,P,88,D,4q5h:C,88,Does not convert into a lysine reactive E2,,,-999.0,,,,,,,,,,,,,P68036_P_88_D
4256,P68036,E,93,R,4q5h:C,93,Decrease in autoubiquitination.,,,1.0,,,,,,,,,,,,,P68036_E_93_R
4257,P68036,K,96,E,4q5h:C,96,Decrease in autoubiquitination.,,,1.0,,,,,,,,,,,,,P68036_K_96_E
4258,P68036,K,100,E,4q5h:C,100,Decrease in autoubiquitination.,,,1.0,,,,,,,,,,,,,P68036_K_100_E
4259,P68036,H,119,D,4q5h:C,119,Does not convert into a lysine reactive E2,,,-999.0,,,,,,,,,,,,,P68036_H_119_D
4260,Q9UN36,L,186,D,2xmr:A,172,Decreased interaction with CTNNB1. Abolishes down-regulation of Wnt signaling.,-1.0,,-999.0,,,,,,,,,,,,,Q9UN36_L_186_D
4261,P07814,F,1097,A,4k88:A,97,Almost complete loss of prolyl-tRNA ligase activity.,,,1.0,,,,,,,,,,,,,P07814_F_1097_A
4262,P07814,F,1097,W,4k88:A,97,No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone.,,-1.0,0.0,,,,,,,,,,,,,P07814_F_1097_W
4263,P07814,R,1152,K,4k88:A,152,No effect on prolyl-tRNA ligase activity. Decreases inhibition by halofuginone.,,-1.0,0.0,,,,,,,,,,,,,P07814_R_1152_K
4264,P07814,R,1152,L,4k88:A,152,Almost complete loss of prolyl-tRNA ligase activity.,,,1.0,,,,,,,,,,,,,P07814_R_1152_L
4265,Q15910,S,21,A,5ls6:A,21,Enhances methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1.,,,1.0,-1.0,,,,,,,,,,,,Q15910_S_21_A
4266,Q15910,S,21,D,5ls6:A,21,Reduces methyltransferase activity towards 'Lys-27' of histone H3 and abrogates phosphorylation by PKB/AKT1.,,,1.0,-1.0,,,,,,,,,,,,Q15910_S_21_D
4267,Q15910,S,75,A,5ls6:A,75,Reduced protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q15910_S_75_A
4268,Q15910,C,588,Y,6wkr:C,588,Strongly impairs methyltransferase activity towards 'Lys-27' of histone H3.,,,1.0,,,,,,,,,,,,,Q15910_C_588_Y
4269,Q15910,F,667,I,6wkr:C,667,Strongly decreases histone methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q15910_F_667_I
4270,Q15910,H,689,A,6wkr:C,689,Abrogates methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q15910_H_689_A
4271,Q8IW19,R,376,A,2kuo:A,376,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,,,-1.0,,,,,Q8IW19_R_376_A
4272,Q8IW19,C,379,A,2kuo:A,379,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,,,-1.0,,,,,Q8IW19_C_379_A
4273,Q8IW19,C,385,A,2kuo:A,385,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,,,-1.0,,,,,Q8IW19_C_385_A
4274,Q8IW19,C,421,A,2kuo:A,421,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,,,-1.0,,,,,Q8IW19_C_421_A
4275,Q8IW19,C,427,A,2kuo:A,427,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,,,-1.0,,,,,Q8IW19_C_427_A
4278,O75643,R,603,A,6s8q:B,603,Strongly decreased ATP-dependent RNA helicase activity.,,,1.0,,,,,,,,,,,,,O75643_R_603_A
4279,O75643,R,637,A,6s8q:B,637,Strongly decreased ATP-dependent RNA helicase activity.,,,1.0,,,,,,,,,,,,,O75643_R_637_A
4280,O75643,K,1544,A,6s8q:B,1544,Decreased ATP-dependent RNA helicase activity.,,,1.0,,,,,,,,,,,,,O75643_K_1544_A
4281,O75643,H,1548,A,6s8q:B,1548,Strongly decreased ATP-dependent RNA helicase activity.,,,1.0,,,,,,,,,,,,,O75643_H_1548_A
4282,O75643,T,1578,A,6s8q:B,1578,Decreased ATP-dependent RNA helicase activity.,,,1.0,,,,,,,,,,,,,O75643_T_1578_A
4283,Q93096,T,13,F,5bx1:A,13,Reduces trimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q93096_T_13_F
4284,Q93096,D,71,A,5bx1:A,71,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q93096_D_71_A
4285,Q93096,D,72,A,5bx1:A,72,80% loss of catalytic activity,,,1.0,,,,,,,,,,,,,Q93096_D_72_A
4286,Q93096,C,104,S,5bx1:A,104,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q93096_C_104_S
4287,Q93096,Q,131,A,5bx1:A,131,Reduces trimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q93096_Q_131_A
4288,O75319,H,166,G,4jmj:A,92,No effect on phosphatase activity with ATP and ADP.,,,0.0,,,,,,,,,,,,,O75319_H_166_G
4289,O75319,C,199,S,4jmj:A,125,Loss of activity. No effect in RNA-binding.,,0.0,1.0,,,,,,,,,,,,,O75319_C_199_S
4290,O75319,H,201,A,4jmj:A,127,Strongly decreases phosphatase activity with ATP and ADP.,,,1.0,,,,,,,,,,,,,O75319_H_201_A
4291,O75319,N,204,A,4jmj:A,130,Strongly decreases phosphatase activity with ATP and ADP.,,,1.0,,,,,,,,,,,,,O75319_N_204_A
4292,O75319,R,239,K,4jmj:A,165,Slightly decreases phosphatase activity with ATP. Strongly decreases phosphatase activity with ADP.,,,1.0,,,,,,,,,,,,,O75319_R_239_K
4293,Q8WV92,M,69,D,2ymb:D,69,"Abolishes interaction with CHMP1A, CHMP1B and CHMP2A.",-1.0,,-999.0,,,,,,,,,,,,,Q8WV92_M_69_D
4294,Q8WV92,E,73,A,2ymb:D,73,"Abolishes interaction with CHMP1A, CHMP1B and CHMP2A. Abolishes location at the midbody.",-1.0,,-999.0,,,,,,,,,1.0,,,,Q8WV92_E_73_A
4295,Q8WV92,Y,132,A,2ymb:D,132,Abolishes homodimerization,-1.0,,-999.0,,,,,,,,,,,,,Q8WV92_Y_132_A
4296,Q8WV92,R,168,E,2ymb:A,168,Strongly reduces binding to membranes,,-1.0,-999.0,,,,,,,,,1.0,,,,Q8WV92_R_168_E
4297,Q8WV92,R,220,E,2ymb:A,220,Strongly reduces binding to membranes,,-1.0,-999.0,,,,,,,,,1.0,,,,Q8WV92_R_220_E
4298,Q8WV92,F,221,A,2ymb:A,221,Abolishes homodimerization,-1.0,,-999.0,,,,,,,,,,,,,Q8WV92_F_221_A
4299,Q8WV92,Y,225,A,2ymb:A,225,Abolishes homodimerization,-1.0,,-999.0,,,,,,,,,,,,,Q8WV92_Y_225_A
4300,Q8WV92,R,231,E,2ymb:A,231,Strongly reduces binding to membranes,,-1.0,-999.0,,,,,,,,,1.0,,,,Q8WV92_R_231_E
4301,Q5XUX0,S,278,A,5vzu:B,278,Fails to accumulate following gamma-irradiation.,,,-999.0,,,,,,,,,,,,,Q5XUX0_S_278_A
4302,Q8N6T7,H,133,Y,5y2f:A,131,Loss of enzyme activity. Abolishes RBBP8 deacetylation and promotion of DNA end resection after DNA damage.,,,1.0,,,,,,,,,,,,,Q8N6T7_H_133_Y
4303,Q04759,Y,90,F,2enj:A,90,Loss of function in T-cells proliferation. No effect on kinase activity.,,,0.0,,,,,,,,,,,,,Q04759_Y_90_F
4304,Q04759,A,148,E,2enn:A,148,Constitutively active form.,,,1.0,,,,,,,,,,,,,Q04759_A_148_E
4305,Q04759,K,409,A,5f9e:A,409,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q04759_K_409_A
4305,Q04759,K,409,E,5f9e:A,409,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q04759_K_409_E
4306,Q04759,T,538,A,5f9e:A,538,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q04759_T_538_A
4307,Q04759,S,676,A,5f9e:A,676,Reduction in kinase activity.,,,1.0,,,,,,,,,,,,,Q04759_S_676_A
4308,Q04759,S,695,A,5f9e:A,695,Reduction in kinase activity.,,,1.0,,,,,,,,,,,,,Q04759_S_695_A
4309,Q8N122,S,722,A,5h64:B,722,Abolishes AMPK-mediated phosphorylation,,,-999.0,,,,,,,,,,,,,Q8N122_S_722_A
4310,Q8N122,S,792,A,6u62:A,792,Abolishes AMPK-mediated phosphorylation,,,-999.0,,,,,,,,,,,,,Q8N122_S_792_A
4311,P32322,E,221,A,2ger:A,221,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P32322_E_221_A
4312,Q13085,S,344,A,6g2d:C,344,No effect on interaction with BRCA1.,0.0,,-999.0,,,,,,,,,,,,,Q13085_S_344_A
4313,Q13085,S,432,A,6g2d:C,432,No effect on interaction with BRCA1.,0.0,,-999.0,,,,,,,,,,,,,Q13085_S_432_A
4314,Q13085,S,1585,A,6g2d:C,1585,No effect on interaction with BRCA1.,0.0,,-999.0,,,,,,,,,,,,,Q13085_S_1585_A
4315,Q13085,S,1952,A,6g2d:C,1952,No effect on interaction with BRCA1.,0.0,,-999.0,,,,,,,,,,,,,Q13085_S_1952_A
4316,Q13085,S,2211,A,6g2d:C,2211,No effect on interaction with BRCA1.,0.0,,-999.0,,,,,,,,,,,,,Q13085_S_2211_A
4317,P05546,R,122,L,1jmo:A,103,Normal thrombin inhibition and glycosaminoglycan affinity.,,0.0,0.0,,,,,,,,,,,,,P05546_R_122_L
4318,P05546,R,122,Q,1jmo:A,103,Greatly reduced thrombin inhibition. Normal glycosaminoglycan affinity.,,0.0,1.0,,,,,,,,,,,,,P05546_R_122_Q
4319,P05546,R,122,W,1jmo:A,103,Greatly reduced thrombin inhibition. Normal glycosaminoglycan affinity.,,0.0,1.0,,,,,,,,,,,,,P05546_R_122_W
4320,P05546,K,204,M,1jmo:A,185,Reduced heparin- and no dermatan sulfate-activated inhibition.,,-1.0,-999.0,,,,,,,,,,,,,P05546_K_204_M
4321,P05546,K,204,N,1jmo:A,185,Reduced heparin- and no dermatan sulfate-activated inhibition.,,-1.0,-999.0,,,,,,,,,,,,,P05546_K_204_N
4322,P05546,K,204,T,1jmo:A,185,Reduced heparin- and no dermatan sulfate-activated inhibition.,,-1.0,-999.0,,,,,,,,,,,,,P05546_K_204_T
4323,O43765,C,38,A,4cpg:A,52,Reduces tail-anchored proteins transfer.,,,1.0,,,,,,,,,,,,,O43765_C_38_A
4324,O75792,D,67,A,3puf:D,67,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_D_67_A
4325,O75792,K,69,A,3puf:D,69,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_K_69_A
4326,O75792,N,112,A,3puf:D,112,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_N_112_A
4327,O75792,Y,210,A,3puf:D,210,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_Y_210_A
4328,O75792,Y,210,F,3puf:D,210,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_Y_210_F
4329,O75792,T,240,A,3puf:D,240,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,O75792_T_240_A
4330,Q9BSB4,H,31,S,5xv1:D,31,Impairs interaction with ATG13,-1.0,,-999.0,,,,,,,,,,,,,Q9BSB4_H_31_S
4331,Q9BSB4,D,54,R,5xv1:D,54,Impairs interaction with ATG13,-1.0,,-999.0,,,,,,,,,,,,,Q9BSB4_D_54_R
4332,Q9BSB4,I,152,D,5xv1:D,152,Abolishes interaction with ATG13,-1.0,,-999.0,,,,,,,,,,,,,Q9BSB4_I_152_D
4333,Q9BSB4,I,153,D,5xv1:D,153,Abolishes interaction with ATG13,-1.0,,-999.0,,,,,,,,,,,,,Q9BSB4_I_153_D
4334,Q9BSB4,V,156,D,5xv1:D,156,Abolishes interaction with ATG13,-1.0,,-999.0,,,,,,,,,,,,,Q9BSB4_V_156_D
4335,Q02750,K,97,A,3w8q:A,97,Loss of catalytic activity. Strongly reduces phosphorylation upon UV irradiation.,,,1.0,-1.0,,,,,,,,,,,,Q02750_K_97_A
4336,Q02750,K,97,R,3w8q:A,97,Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization.,0.0,,1.0,,,,,,,,,,,,,Q02750_K_97_R
4337,Q02750,S,150,A,3w8q:A,150,No loss of activity.,,,1.0,,,,,,,,,,,,,Q02750_S_150_A
4338,Q02750,S,212,A,3w8q:A,212,No loss of activity.,,,1.0,,,,,,,,,,,,,Q02750_S_212_A
4339,Q02750,S,218,A,3w8q:A,218,Loss of catalytic activity. No effect on BRAF-KSR1 dimerization,0.0,,1.0,,,,,,,,,,,,,Q02750_S_218_A
4340,Q02750,S,218,D,3w8q:A,218,No effect on BRAF-KSR1 dimerization,0.0,,-999.0,,,,,,,,,,,,,Q02750_S_218_D
4341,Q02750,M,219,V,3w8q:A,219,Increases interaction with KSR1 and BRAF.,1.0,,-999.0,,,,,,,,,,,,,Q02750_M_219_V
4342,Q02750,M,219,W,3w8q:A,219,Increases interaction with KSR1 and BRAF,1.0,,-999.0,,,,,,,,,,,,,Q02750_M_219_W
4343,Q02750,A,220,L,3w8q:A,220,Increases interaction with KSR1 and BRAF,1.0,,-999.0,,,,,,,,,,,,,Q02750_A_220_L
4344,Q02750,N,221,Y,3w8q:A,221,Increases interaction with KSR1 and BRAF.,1.0,,-999.0,,,,,,,,,,,,,Q02750_N_221_Y
4345,Q02750,S,222,A,3w8q:A,222,Loss of catalytic activity. No effect on BRAF-KSR1 dimerization,0.0,,1.0,,,,,,,,,,,,,Q02750_S_222_A
4346,Q02750,S,222,D,3w8q:A,222,No effect on BRAF-KSR1 dimerization,0.0,,-999.0,,,,,,,,,,,,,Q02750_S_222_D
4347,Q02750,F,311,S,6v2x:B,311,Loss of interaction with BRAF and KSR1. Loss of BRAF-KSR1 dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q02750_F_311_S
4348,O95551,N,120,A,5ino:A,120,Strongly reduced phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_N_120_A
4349,O95551,E,152,A,5ino:A,152,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_E_152_A
4350,O95551,Y,178,F,5ino:A,178,Strongly decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_Y_178_F
4350,O95551,Y,178,W,5ino:A,178,Strongly decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_Y_178_W
4351,O95551,R,206,A,5ino:A,206,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_R_206_A
4351,O95551,R,206,K,5ino:A,206,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_R_206_K
4352,O95551,D,262,A,5ino:A,262,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_D_262_A
4353,O95551,D,262,H,5ino:A,262,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_D_262_H
4353,O95551,D,262,L,5ino:A,262,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_D_262_L
4353,O95551,D,262,M,5ino:A,262,Loss of phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_D_262_M
4354,O95551,L,305,A,5ino:A,305,Decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_L_305_A
4354,O95551,L,305,F,5ino:A,305,Decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_L_305_F
4354,O95551,L,305,W,5ino:A,305,Decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_L_305_W
4355,O95551,D,316,N,5ino:A,316,Strongly decreased phosphodiesterase activity.,,,1.0,,,,,,,,,,,,,O95551_D_316_N
4356,P54646,T,172,D,5iso:A,172,Phosphomimetic mutant.,,,-999.0,,,,,,,,,,1.0,,,P54646_T_172_D
4357,P54317,N,353,Q,2pvs:B,334,Loss of N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,P54317_N_353_Q
4358,Q9UNQ0,M,71,V,6hbu:A,71,Decreased protein abundance. No effect on substrate transmembrane transport.,,,0.0,,,,,,,,,,,,,Q9UNQ0_M_71_V
4359,Q9UNQ0,K,86,M,6hbu:A,86,Decreased protein abundance. Decreased localization to the plasma membrane and retained intracellularly. Loss of ATPase-coupled transmembrane transporter activity.,,,1.0,,,,,,,,,1.0,,,,Q9UNQ0_K_86_M
4360,Q9UNQ0,E,211,Q,6hbu:A,211,Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,1.0,,,,,,,,,,,,,Q9UNQ0_E_211_Q
4361,Q9UNQ0,R,383,C,6hbu:A,383,Loss of protein expression.,,,-999.0,,,,,,,,,,,,-1.0,Q9UNQ0_R_383_C
4362,Q9UNQ0,N,418,Q,6hbu:A,418,No effect.,,,0.0,,,,,,,,,,,,,Q9UNQ0_N_418_Q
4363,Q9UNQ0,T,435,A,6hbu:A,435,No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased substrate-induced ATP hydrolysis. Increased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_T_435_A
4364,Q9UNQ0,T,435,F,6hbu:A,435,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_T_435_F
4365,Q9UNQ0,N,436,A,6hbu:A,436,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_N_436_A
4366,Q9UNQ0,F,439,A,6hbu:A,439,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Decreased substrate-induced ATP hydrolysis. Decreased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_F_439_A
4367,Q9UNQ0,R,482,D,6hbu:A,482,Decreases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_D
4368,Q9UNQ0,R,482,G,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_G
4368,Q9UNQ0,R,482,N,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_N
4368,Q9UNQ0,R,482,S,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_S
4368,Q9UNQ0,R,482,T,6hbu:A,482,Increases ATPase activity.,,,1.0,,,,,,,,,,,,,Q9UNQ0_R_482_T
4369,Q9UNQ0,R,482,K,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_K
4369,Q9UNQ0,R,482,I,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_I
4369,Q9UNQ0,R,482,M,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_M
4369,Q9UNQ0,R,482,Y,6hbu:A,482,No change in ATPase activity.,,,0.0,,,,,,,,,,,,,Q9UNQ0_R_482_Y
4371,Q9UNQ0,V,546,A,6hbu:A,546,No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport.,,,0.0,,,,,,,,,,,0.0,,Q9UNQ0_V_546_A
4372,Q9UNQ0,V,546,F,6hbu:A,546,No effect on stability. Decreased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Decreased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_V_546_F
4373,Q9UNQ0,M,549,A,6hbu:A,549,No effect on stability. No effect on estrone-3 sulfate ATPase-coupled transmembrane transporter activity. No effect on substrate-induced ATP hydrolysis. No effect on substrate transport.,,,0.0,,,,,,,,,,,0.0,,Q9UNQ0_M_549_A
4374,Q9UNQ0,L,554,A,6hbu:A,554,No effect on stability. Increased estrone-3 sulfate ATPase-coupled transmembrane transporter activity. Increased basal and substrate-induced ATP hydrolysis. Increased substrate transport.,,,1.0,,,,,,,,,,,0.0,,Q9UNQ0_L_554_A
4375,Q9UNQ0,L,555,A,6hbu:A,555,Loss of protein expression.,,,-999.0,,,,,,,,,,,,-1.0,Q9UNQ0_L_555_A
4376,Q9UNQ0,N,557,Q,6hbu:A,557,No effect.,,,0.0,,,,,,,,,,,,,Q9UNQ0_N_557_Q
4377,Q9UNQ0,H,583,A,6hbu:A,583,Strongly reduced binding to hemin but not to PPIX.,0.0,-1.0,-999.0,,,,,,,,,,,,,Q9UNQ0_H_583_A
4378,Q9UNQ0,N,596,Q,6hbu:A,596,Loss of glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q9UNQ0_N_596_Q
4379,Q9UNQ0,C,603,A,6hbu:A,603,Strongly reduced binding to hemin but not to PPIX.,0.0,-1.0,-999.0,,,,,,,,,,,,,Q9UNQ0_C_603_A
4380,Q9UNQ0,Y,605,A,6hbu:A,605,No effect on hemin binding.,,0.0,-999.0,,,,,,,,,,,,,Q9UNQ0_Y_605_A
4381,Q8IZT8,R,99,A,3bd9:A,99,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q8IZT8_R_99_A
4382,Q8IZT8,R,104,A,3bd9:A,104,"Reduces enzyme activity by 93%,.",,,1.0,,,,,,,,,,,,,Q8IZT8_R_104_A
4383,Q8IZT8,K,155,A,3bd9:A,155,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q8IZT8_K_155_A
4384,Q8IZT8,Q,195,A,3bd9:A,195,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q8IZT8_Q_195_A
4385,O60260,S,65,E,5c1z:A,65,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,O60260_S_65_E
4386,O60260,C,332,S,6n13:B,332,Impairs folding of IBR domain.,,,-999.0,,,,,,,,,,,-1.0,,O60260_C_332_S
4387,O60260,C,337,A,6n13:B,337,Impairs the ability to ubiquitinate SNCAIP.,,,1.0,,,,,,,,,,,,,O60260_C_337_A
4388,O60260,C,365,S,6n13:B,365,Impairs protein folding.,,,-999.0,,,,,,,,,,,-1.0,,O60260_C_365_S
4389,O60260,W,403,A,6n13:B,403,Decreased autoinhibition and increased E3 activity.,,,1.0,,,,,,,,,,,,,O60260_W_403_A
4390,O60260,C,421,A,6n13:B,421,Impairs the ability of self-ubiquitination and to ubiquitinate SNCAIP.,,,1.0,,-1.0,,,,,,,,,,,O60260_C_421_A
4391,O60260,C,431,S,6n13:B,431,Impairs the ability to ubiquitinate target proteins.,,,1.0,,,,,,,,,,,,,O60260_C_431_S
4392,O60260,H,433,N,6n13:B,433,Impaired activity.,,,1.0,,,,,,,,,,,,,O60260_H_433_N
4392,O60260,H,433,A,6n13:B,433,Impaired activity.,,,1.0,,,,,,,,,,,,,O60260_H_433_A
4393,O60260,E,444,Q,6n13:B,444,Impaired activity.,,,1.0,,,,,,,,,,,,,O60260_E_444_Q
4393,O60260,E,444,A,6n13:B,444,Impaired activity.,,,1.0,,,,,,,,,,,,,O60260_E_444_A
4394,Q8IWT6,T,44,A,6djb:A,44,Altered anion selectivity.,,-1.0,-999.0,,,,,,,,,,,,,Q8IWT6_T_44_A
4394,Q8IWT6,T,44,C,6djb:A,44,Altered anion selectivity.,,-1.0,-999.0,,,,,,,,,,,,,Q8IWT6_T_44_C
4395,Q8IWT6,N,66,A,6djb:A,66,Abolishes N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,Q8IWT6_N_66_A
4396,Q8IWT1,C,58,A,4mz3:A,58,Abolishes regulation of channel activity.,,,1.0,,,,,,,,,,,,,Q8IWT1_C_58_A
4397,Q8IWT1,C,131,A,4mz3:A,131,Decreases protein stability. Causes conformation changes that impair interaction with the alpha subunit.,-1.0,,-999.0,,,,,,,,,,,-1.0,,Q8IWT1_C_131_A
4397,Q8IWT1,C,131,W,4mz3:A,131,Decreases protein stability. Causes conformation changes that impair interaction with the alpha subunit.,-1.0,,-999.0,,,,,,,,,,,-1.0,,Q8IWT1_C_131_W
4398,O60264,K,211,R,6ne3:W,211,Loss of ATP hydrolysis and no association of the SMARCA5/cohesin/NuRD complex with chromatin.,-1.0,,1.0,,,,,,,,,,,,,O60264_K_211_R
4399,P11362,K,514,A,4rwk:A,514,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P11362_K_514_A
4400,P11362,R,577,E,4rwk:A,577,Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.,,,0.0,-1.0,,,,,,,,,,,,P11362_R_577_E
4401,P11362,R,609,V,4rwk:A,609,Abolishes interaction with PLCG1.,-1.0,,-999.0,,,,,,,,,,,,,P11362_R_609_V
4402,P11362,D,623,A,4rwk:A,623,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P11362_D_623_A
4403,P11362,Y,653,F,4rwk:A,653,No effect on kinase activity. Loss of autophosphorylation and kinase activity,,,-999.0,,,,,,,,,,,,,P11362_Y_653_F
4404,P11362,Y,654,F,4rwk:A,654,Reduced kinase activity. Loss of autophosphorylation and kinase activity,,,1.0,-1.0,,,,,,,,,,,,P11362_Y_654_F
4405,P11362,D,755,V,4rwk:A,755,Abolishes interaction with PLCG1.,-1.0,,-999.0,,,,,,,,,,,,,P11362_D_755_V
4406,P11362,Y,766,F,3gqi:A,766,"Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation.",-1.0,,1.0,,,,,,,,,,,,,P11362_Y_766_F
4407,P11586,S,49,A,1dig:B,1049,No effect on dehydrogenase and cyclohydrolase activity. Strong increase of Km for NADP.,,-1.0,1.0,,,,,,,,,,,,,P11586_S_49_A
4408,P11586,S,49,Q,1dig:B,1049,"Reduces dehydrogenase by 75% and cyclohydrolase activity by 99%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,1.0,,,,,,,,,,,,,P11586_S_49_Q
4409,P11586,Y,52,A,1dig:B,1052,"Reduces dehydrogenase activity by 99%. Reduces cyclohydrolase activity by 70%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,1.0,,,,,,,,,,,,,P11586_Y_52_A
4409,P11586,Y,52,S,1dig:B,1052,"Reduces dehydrogenase activity by 99%. Reduces cyclohydrolase activity by 70%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,1.0,,,,,,,,,,,,,P11586_Y_52_S
4410,P11586,Y,52,F,1dig:B,1052,"Slightly reduces dehydrogenase and cyclohydrolase activity. Increase of Km for NADP and for 5,10-methenyltetrahydrofolate.",,-1.0,1.0,,,,,,,,,,,,,P11586_Y_52_F
4411,P11586,K,56,A,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,1.0,,,,,,,,,,,,,P11586_K_56_A
4411,P11586,K,56,I,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,1.0,,,,,,,,,,,,,P11586_K_56_I
4411,P11586,K,56,S,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,1.0,,,,,,,,,,,,,P11586_K_56_S
4411,P11586,K,56,T,1dig:B,1056,Decreases dehydrogenase activity over 90%. Loss of cyclohydrolase activity.,,,1.0,,,,,,,,,,,,,P11586_K_56_T
4412,P11586,K,56,E,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,1.0,,,,,,,,,,,,,P11586_K_56_E
4412,P11586,K,56,M,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,1.0,,,,,,,,,,,,,P11586_K_56_M
4412,P11586,K,56,Q,1dig:B,1056,"Moderate decrease of dehydrogenase activity. Loss of cyclohydrolase activity. Strong increase of Km for NADP. Decrease of Km for 5,10-methenyltetrahydrofolate.",,,1.0,,,,,,,,,,,,,P11586_K_56_Q
4413,P11586,K,56,R,1dig:B,1056,"Reduces dehydrogenase and cyclohydrolase activity by 99%. No effect on Km for NADP and for 5,10-methenyltetrahydrofolate.",,0.0,1.0,,,,,,,,,,,,,P11586_K_56_R
4414,P11586,C,147,Q,1dig:B,1147,Reduces dehydrogenase activity by 50% and cyclohydrolase activity by 87%.,,,1.0,,,,,,,,,,,,,P11586_C_147_Q
4415,P26010,D,159,A,3v4p:B,140,Loss of integrin alpha-E/beta-7 binding to E-cadherin and of integrin alpha-4/beta-7 binding to MADCAM1.,-1.0,,-999.0,,,,,,,,,,,,,P26010_D_159_A
4416,P19971,Y,199,A,2wk5:A,199,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,P19971_Y_199_A
4417,P19971,Y,199,F,2wk5:A,199,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,P19971_Y_199_F
4418,P19971,Y,199,L,2wk5:A,199,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,P19971_Y_199_L
4419,Q8IXJ6,S,53,A,4x3o:A,53,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_S_53_A
4420,Q8IXJ6,R,97,A,1j8f:C,97,No effect on deacetylase activity.,,,0.0,,,,,,,,,,,,,Q8IXJ6_R_97_A
4421,Q8IXJ6,S,98,A,1j8f:C,98,Inhibits deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_S_98_A
4422,Q8IXJ6,S,100,A,1j8f:C,100,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_S_100_A
4423,Q8IXJ6,E,116,A,1j8f:C,116,Reduces binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_E_116_A
4424,Q8IXJ6,E,120,A,1j8f:C,120,Reduces binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_E_120_A
4425,Q8IXJ6,Q,167,A,1j8f:C,167,Reduces deacetylase activity. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress,,,1.0,,,,,,,,,,,,,Q8IXJ6_Q_167_A
4426,Q8IXJ6,N,168,A,1j8f:C,168,Abolishes deacetylation of alpha-tubulin. Inhibits deacetylation of histone H3 at 'Lys-18'. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress,,,1.0,,,,,,,,,,,,,Q8IXJ6_N_168_A
4427,Q8IXJ6,D,170,A,1j8f:C,170,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_D_170_A
4427,Q8IXJ6,D,170,N,1j8f:C,170,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_D_170_N
4428,Q8IXJ6,H,187,Y,1j8f:C,187,"Inhibits deacetylase activity toward histone, alpha-tubulin, FZR1 and CDC20. No effect on CDK2-dependent phosphorylation. Does not inhibit interaction with alpha-tubulin, HDAC6, HIF1A and the cyclin E-CDK2 complex. Inhibits interaction with BEX4 and KMT5A. Abolishes deacetylation, dimeric formation and enzymatic activity increase of G6PD. Prevents histone H4 methylation at 'Lys-20'(H4K20me1) in metaphase chromosomes. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress",-1.0,,1.0,,,,,,,,,,,,,Q8IXJ6_H_187_Y
4428,Q8IXJ6,H,187,A,1j8f:C,187,"Inhibits deacetylase activity toward histone, alpha-tubulin, FZR1 and CDC20. No effect on CDK2-dependent phosphorylation. Does not inhibit interaction with alpha-tubulin, HDAC6, HIF1A and the cyclin E-CDK2 complex. Inhibits interaction with BEX4 and KMT5A. Abolishes deacetylation, dimeric formation and enzymatic activity increase of G6PD. Prevents histone H4 methylation at 'Lys-20'(H4K20me1) in metaphase chromosomes. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress",-1.0,,1.0,,,,,,,,,,,,,Q8IXJ6_H_187_A
4429,Q8IXJ6,F,244,A,1j8f:C,244,Reduces strongly binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_F_244_A
4430,Q8IXJ6,Q,265,A,1j8f:C,265,Reduces binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_Q_265_A
4431,Q8IXJ6,S,271,A,1j8f:C,271,Reduces binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_S_271_A
4432,Q8IXJ6,S,279,A,1j8f:C,279,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_S_279_A
4433,Q8IXJ6,T,280,A,1j8f:C,280,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_T_280_A
4434,Q8IXJ6,D,294,A,1j8f:C,294,Reduces binding for the peptide inhibitor S2iL5.,-1.0,,-999.0,,,,,,,,,,,,,Q8IXJ6_D_294_A
4435,Q8IXJ6,S,311,A,1j8f:C,311,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_S_311_A
4436,Q8IXJ6,Y,315,A,1j8f:C,315,Reduces deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8IXJ6_Y_315_A
4437,O15550,H,1146,A,6g8f:A,1146,Abolishes histone demethylase activity.,,,1.0,,,,,,,,,,,,,O15550_H_1146_A
4438,P48023,P,206,D,5l19:A,206,Lowers binding to TNFRSF6 and reduces cytotoxicity more than 100-fold.,-1.0,,-999.0,,,,,,,,,,,,,P48023_P_206_D
4438,P48023,P,206,F,5l19:A,206,Lowers binding to TNFRSF6 and reduces cytotoxicity more than 100-fold.,-1.0,,-999.0,,,,,,,,,,,,,P48023_P_206_F
4438,P48023,P,206,R,5l19:A,206,Lowers binding to TNFRSF6 and reduces cytotoxicity more than 100-fold.,-1.0,,-999.0,,,,,,,,,,,,,P48023_P_206_R
4439,P48023,Y,218,F,5l19:A,218,Lowers binding to TNFRSF6 and abolishes cytotoxicity.,-1.0,,-999.0,,,,,,,,,,,,,P48023_Y_218_F
4439,P48023,Y,218,R,5l19:A,218,Lowers binding to TNFRSF6 and abolishes cytotoxicity.,-1.0,,-999.0,,,,,,,,,,,,,P48023_Y_218_R
4440,P48023,F,275,L,5l19:A,275,Abolishes binding to TNRFSF6 and cytotoxicity.,-1.0,,-999.0,,,,,,,,,,,,,P48023_F_275_L
4441,P21917,V,382,Y,5wiv:A,430,Increased basal level of G protein-mediated signaling.,,,-999.0,,,,,,,,,,,,,P21917_V_382_Y
4442,Q15642,I,454,S,2ke4:A,398,Abrogates interaction with CDC42.,-1.0,,-999.0,,,,,,,,,,,,,Q15642_I_454_S
4443,Q15642,L,468,S,2ke4:A,412,Impairs interaction with CDC42.,-1.0,,-999.0,,,,,,,,,,,,,Q15642_L_468_S
4444,P45381,R,71,K,4mri:B,71,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P45381_R_71_K
4445,P45381,Y,164,F,4mri:B,164,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P45381_Y_164_F
4446,P45381,R,168,K,4mri:B,168,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P45381_R_168_K
4447,P45381,E,178,A,4mri:B,178,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P45381_E_178_A
4448,P45381,E,178,D,4mri:B,178,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P45381_E_178_D
4449,P45381,E,178,Q,4mri:B,178,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,P45381_E_178_Q
4450,P45381,E,285,D,4mri:B,285,5-fold decrease in activity.,,,1.0,,,,,,,,,,,,,P45381_E_285_D
4451,P45381,Y,288,F,4mri:B,288,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P45381_Y_288_F
4452,P12724,I,40,A,1h1h:A,13,Loss of in vitro formation of amyloid-like aggregates.,-1.0,,-999.0,,,,,,,,,,,,,P12724_I_40_A
4453,Q13426,K,140,R,6abo:A,140,No change in sumoylation.,,,-999.0,,,,0.0,,,,,,,,,Q13426_K_140_R
4454,Q13426,K,210,R,6abo:A,210,Abolishes sumoylation. No nuclear location. 5-fold decrease in recombination efficiency.,,,1.0,,,,-1.0,,,,,1.0,,,,Q13426_K_210_R
4455,P62314,L,58,K,3jcr:p,58,Loss of interaction with CLNS1A.,-1.0,,-999.0,,,,,,,,,,,,,P62314_L_58_K
4456,P62314,I,60,R,3jcr:p,60,Loss of interaction with CLNS1A.,-1.0,,-999.0,,,,,,,,,,,,,P62314_I_60_R
4457,O95487,R,715,A,3eh1:A,715,Decreased ability to package the SNARE SEC22B cargo into COPII vesicles. Has no effect on other cargos packaging.,,,1.0,,,,,,,,,,,,,O95487_R_715_A
4458,O95486,R,541,A,3egd:B,541,Decreased ability to interact with and package the SNARE SEC22B cargo into COPII vesicles. Has no effect on other cargos packaging.,,,1.0,,,,,,,,,,,,,O95486_R_541_A
4459,Q712K3,C,93,S,6nyo:A,93,Loss of function.,,,1.0,,,,,,,,,,,,,Q712K3_C_93_S
4460,Q712K3,L,97,S,6nyo:A,97,Loss of function.,,,1.0,,,,,,,,,,,,,Q712K3_L_97_S
4461,Q96J94,P,379,H,2l5c:A,379,Impairs binding to 2'-O-methylated 3'-end of piRNAs,,-1.0,-999.0,,,,,,,,,,,,,Q96J94_P_379_H
4462,Q96J94,M,381,Y,2l5c:A,381,Impairs binding to 2'-O-methylated 3'-end of piRNAs,,-1.0,-999.0,,,,,,,,,,,,,Q96J94_M_381_Y
4463,Q7Z2Z2,T,33,A,5anc:K,33,Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,,,1.0,,,,,,,,,,,,,Q7Z2Z2_T_33_A
4464,Q7Z2Z2,H,96,A,5anc:K,96,Loss of GTPase activity. Abolishes dissociation of EIF6 from 60S pre-ribosome subunits.,,,1.0,,,,,,,,,,,,,Q7Z2Z2_H_96_A
4465,Q9HD47,D,27,K,5yfg:A,27,Decreased binding to RAN.,-1.0,,-999.0,,,,,,,,,,,,,Q9HD47_D_27_K
4466,Q9HD47,E,50,K,5yfg:A,50,Strongly decreased binding to RAN. Abolishes binding to RAN,-1.0,,-999.0,,,,,,,,,,,,,Q9HD47_E_50_K
4467,Q9HD47,E,53,K,5yfg:A,53,Decreased binding to RAN. Abolishes binding to RAN,-1.0,,-999.0,,,,,,,,,,,,,Q9HD47_E_53_K
4468,Q9HD47,D,70,K,5yfg:A,70,Decreased binding to RAN.,-1.0,,-999.0,,,,,,,,,,,,,Q9HD47_D_70_K
4469,Q9HD40,R,75,A,4zdo:B,75,Inactive in vivo.,,,1.0,,,,,,,,,,,,,Q9HD40_R_75_A
4470,Q9HD40,R,97,A,4zdo:B,97,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_R_97_A
4471,Q9HD40,R,97,Q,4zdo:B,97,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_R_97_Q
4472,Q9HD40,Q,105,A,4zdo:B,105,Inactive in vivo.,,,1.0,,,,,,,,,,,,,Q9HD40_Q_105_A
4473,Q9HD40,K,173,A,4zdo:B,173,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_K_173_A
4474,Q9HD40,K,173,M,4zdo:B,173,Indistinguishable from wild-type.,,,0.0,,,,,,,,,,,,,Q9HD40_K_173_M
4475,Q9HD40,K,284,A,4zdo:B,284,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9HD40_K_284_A
4476,Q9HD40,R,313,A,4zdo:B,313,Inactive in vivo.,,,1.0,,,,,,,,,,,,,Q9HD40_R_313_A
4477,P30101,C,57,A,3f8u:A,57,No loss of activity. No loss of activity,,,0.0,,,,,,,,,,,,,P30101_C_57_A
4478,P30101,C,57,S,3f8u:A,57,Activity changed to serine protease.,,,1.0,,,,,,,,,,,,,P30101_C_57_S
4479,P30101,C,60,S,3f8u:A,60,Activity changed to serine protease,,,1.0,,,,,,,,,,,,,P30101_C_60_S
4480,P30101,C,406,A,3f8u:A,406,No loss of activity. No loss of activity,,,1.0,,,,,,,,,,,,,P30101_C_406_A
4481,P30101,C,406,S,3f8u:A,406,Activity changed to serine protease.,,,1.0,,,,,,,,,,,,,P30101_C_406_S
4482,P30101,C,409,S,3f8u:A,409,Activity changed to serine protease,,,1.0,,,,,,,,,,,,,P30101_C_409_S
4483,Q96GG9,C,115,A,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_A
4483,Q96GG9,C,115,G,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_G
4483,Q96GG9,C,115,I,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_I
4483,Q96GG9,C,115,L,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_L
4483,Q96GG9,C,115,T,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_T
4483,Q96GG9,C,115,V,4p5o:E,115,Loss of ability to stimulate cullin neddylation.,,,1.0,,,,,,,,,,,,,Q96GG9_C_115_V
4484,Q96GG9,D,211,A,4p5o:E,211,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q96GG9_D_211_A
4485,Q96GG9,A,235,R,4p5o:E,235,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q96GG9_A_235_R
4486,Q96GG9,D,241,A,4p5o:E,241,"Loss of interaction with CUL1, CUL2, CUL3, CULA4, CULA5 CAND1 and RBX1",-1.0,,-999.0,,,,,,,,,,,,,Q96GG9_D_241_A
4487,Q96GG9,D,241,N,4p5o:E,241,Loss of binding to CAND1 and CUL-RBX1 complex but retains binding to UBE2M.,-1.0,,-999.0,,,,,,,,,,,,,Q96GG9_D_241_N
4488,Q13526,Y,23,A,1nmv:A,23,Reduced affinity for KIF20B.,-1.0,,-999.0,,,,,,,,,,,,,Q13526_Y_23_A
4489,Q13526,W,34,A,1nmv:A,34,"Loss of binding to phosphorylated target proteins, including to phosphorylated RBBP8/CtIP",-1.0,,-999.0,,,,,,,,,,,,,Q13526_W_34_A
4490,Q13526,K,63,A,1nmv:A,63,Loss of peptidyl-prolyl cis/trans isomerase activity.,,,1.0,,,,,,,,,,,,,Q13526_K_63_A
4491,Q13526,S,71,D,1nmv:A,71,"Loss of peptidyl-prolyl cis/trans isomerase activity, nuclear localization and cellular function.",,,1.0,,,,,,,,,1.0,,,,Q13526_S_71_D
4491,Q13526,S,71,E,1nmv:A,71,"Loss of peptidyl-prolyl cis/trans isomerase activity, nuclear localization and cellular function.",,,1.0,,,,,,,,,1.0,,,,Q13526_S_71_E
4492,Q13526,C,113,A,1nmv:A,113,Loss of peptidyl-prolyl cis/trans isomerase activity,,,1.0,,,,,,,,,,,,,Q13526_C_113_A
4493,P49674,K,38,R,4hok:M,38,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P49674_K_38_R
4498,Q9UBS5,W,182,A,7c7s:A,182,Abolishes signaling via G-proteins. Abolishes antagonist binding.,,-1.0,1.0,,,,,,,,,,,,,Q9UBS5_W_182_A
4499,Q9UBS5,Y,230,A,7c7s:A,230,Slightly decreases signaling via G-proteins.,,,1.0,,,,,,,,,,,,,Q9UBS5_Y_230_A
4500,Q9UBS5,Y,234,A,7c7s:A,234,Decreases signaling via G-proteins.,,,1.0,,,,,,,,,,,,,Q9UBS5_Y_234_A
4501,Q9UBS5,H,287,A,7c7s:A,287,Strongly reduces signaling via G-proteins. Abolishes antagonist binding.,,-1.0,1.0,,,,,,,,,,,,,Q9UBS5_H_287_A
4502,Q9UBS5,Y,367,A,7c7s:A,367,Strongly reduces signaling via G-proteins. No effect on antagonist binding.,,0.0,1.0,,,,,,,,,,,,,Q9UBS5_Y_367_A
4503,Q9UBS5,W,395,A,7c7s:A,395,Strongly reduces signaling via G-proteins. Strongly reduces antagonist binding.,,-1.0,1.0,,,,,,,,,,,,,Q9UBS5_W_395_A
4504,P48730,K,38,M,6gzm:B,38,Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.,,,1.0,,,,,,,,,1.0,,,,P48730_K_38_M
4505,P48730,T,176,I,6gzm:B,176,Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.,,,1.0,,,,,,,,,1.0,,,,P48730_T_176_I
4506,P48735,K,413,A,6adi:A,413,44-fold loss in activity.,,,1.0,,,,,,,,,,,,,P48735_K_413_A
4507,P48735,K,413,Q,6adi:A,413,20-fold decrease in Vmax.,,,1.0,,,,,,,,,,,,,P48735_K_413_Q
4508,P48735,K,413,R,6adi:A,413,No appreciable difference in Km for isocitrate and NADP.,,0.0,0.0,,,,,,,,,,,,,P48735_K_413_R
4509,P48736,K,833,R,5g55:A,833,Reduced inflammatory reactions but no alterations in cardiac contractility.,,,-999.0,,,,,,,,,,,,,P48736_K_833_R
4510,P48736,R,947,P,5g55:A,947,Abolishes protein and lipid kinase activity. Does not abolishes interaction with GRK2.,0.0,,1.0,,,,,,,,,,,,,P48736_R_947_P
4511,P16234,Y,572,F,5k5x:A,572,Abolishes interaction with SRC-family members and impairs internalization of the activated receptor,-1.0,,-999.0,,,,,,,,,,,,,P16234_Y_572_F
4512,P16234,Y,574,F,5k5x:A,574,Abolishes interaction with SRC-family members and impairs internalization of the activated receptor,-1.0,,-999.0,,,,,,,,,,,,,P16234_Y_574_F
4513,Q06278,C,44,W,4uhw:A,44,Disrupts protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q06278_C_44_W
4514,Q06278,G,1269,R,4uhw:A,1269,No effect on dimerization. Loss of oxidase activity.,0.0,,1.0,,,,,,,,,,,,,Q06278_G_1269_R
4515,Q96KN2,H,132,A,3dlj:A,106,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96KN2_H_132_A
4516,Q96KN2,D,165,A,3dlj:A,139,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96KN2_D_165_A
4517,Q96KN2,E,200,A,3dlj:A,174,Loss of activity.,,,1.0,,,,,,,,,,,,,Q96KN2_E_200_A
4518,Q96KN7,E,1121,A,4qam:B,1121,Nearly abolishes interaction with RPGR,-1.0,,-999.0,,,,,,,,,,,,,Q96KN7_E_1121_A
4519,Q96KN7,E,1121,K,4qam:B,1121,Decreases interaction with RPGR.,-1.0,,-999.0,,,,,,,,,,,,,Q96KN7_E_1121_K
4520,Q96KN7,H,1174,A,4qam:B,1174,Nearly abolishes interaction with RPGR,-1.0,,-999.0,,,,,,,,,,,,,Q96KN7_H_1174_A
4521,Q96KN7,H,1174,D,4qam:B,1174,Abolishes interaction with RPGR.,-1.0,,-999.0,,,,,,,,,,,,,Q96KN7_H_1174_D
4522,Q96KN7,E,1245,A,4qam:B,1245,Nearly abolishes interaction with RPGR,-1.0,,-999.0,,,,,,,,,,,,,Q96KN7_E_1245_A
4523,Q96KN7,E,1245,K,4qam:B,1245,No effect on interaction with RPGR.,0.0,,-999.0,,,,,,,,,,,,,Q96KN7_E_1245_K
4524,Q9NWX6,D,58,A,3otc:A,29,Reduces activity by 99.5%.,,,1.0,,,,,,,,,,,,,Q9NWX6_D_58_A
4525,Q9NWX6,H,63,A,3otc:A,34,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NWX6_H_63_A
4526,Q9NWX6,S,104,A,3otc:A,75,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NWX6_S_104_A
4527,Q9NWX6,D,105,A,3otc:A,76,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NWX6_D_105_A
4528,Q9NWX6,E,106,A,3otc:A,77,Reduces activity by 95%.,,,1.0,,,,,,,,,,,,,Q9NWX6_E_106_A
4529,Q9NWX6,T,127,A,3otc:A,98,Abolishes oligomerization. Loss of enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,Q9NWX6_T_127_A
4530,Q9NWX6,H,181,A,3otc:A,152,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NWX6_H_181_A
4531,Q9NWX6,K,216,A,3otc:A,187,Reduces activity by 98.5%.,,,1.0,,,,,,,,,,,,,Q9NWX6_K_216_A
4532,Q9NWX6,N,227,A,3otc:A,198,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NWX6_N_227_A
4533,P30405,C,203,S,5a0e:A,161,Blocks Ca(2+)-induced mPTP opening and reduces hydrogen peroxide-induced cell death.,-1.0,,-999.0,,,,,,,,,,,,,P30405_C_203_S
4534,P10768,L,54,A,3fcx:B,54,83% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_L_54_A
4535,P10768,S,149,A,3fcx:B,149,Loss of activity.,,,1.0,,,,,,,,,,,,,P10768_S_149_A
4536,P10768,S,149,T,3fcx:B,149,1.3% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_S_149_T
4537,P10768,M,150,A,3fcx:B,150,62% increase in activity.,,,1.0,,,,,,,,,,,,,P10768_M_150_A
4538,P10768,D,226,A,3fcx:B,226,4.3% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_D_226_A
4539,P10768,D,226,N,3fcx:B,226,9% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_D_226_N
4540,P10768,H,260,A,3fcx:B,260,3% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_H_260_A
4541,P10768,H,260,Q,3fcx:B,260,1.3% of wild-type activity.,,,1.0,,,,,,,,,,,,,P10768_H_260_Q
4542,Q9Y2C4,S,137,D,5zki:B,137,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q9Y2C4_S_137_D
4543,Q9Y2C4,H,140,A,5zki:B,140,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9Y2C4_H_140_A
4544,Q6IA69,C,175,S,6ofb:A,175,Eliminates glutamine-dependent NAD synthetase activity with the ammonia-dependent activity intact.,,,1.0,,,,,,,,,,,,,Q6IA69_C_175_S
4545,O00159,S,736,A,4byf:A,701,Abolishes interaction with YWHAB.,-1.0,,-999.0,,,,,,,,,,,,,O00159_S_736_A
4546,O00159,S,736,E,4byf:A,701,Increases affinity for YWHAB.,1.0,,-999.0,,,,,,,,,,,,,O00159_S_736_E
4547,P61224,G,12,V,4dxa:A,12,Constitutively activated.,,,1.0,,,,,,,,,,,,,P61224_G_12_V
4548,P61224,Q,25,A,4dxa:A,25,Impairs interaction with KRIT1.,-1.0,,-999.0,,,,,,,,,,,,,P61224_Q_25_A
4549,P61224,Y,32,A,4dxa:A,32,25-fold reduction in RAP1GAP-stimulated GTPase activity.,,,1.0,,,,,,,,,,,,,P61224_Y_32_A
4550,P61224,Y,32,F,4dxa:A,32,2-fold reduction in RAP1GAP-stimulated GTPase activity.,,,1.0,,,,,,,,,,,,,P61224_Y_32_F
4551,P61224,E,37,A,4dxa:A,37,Strong reduction in nucleotide exchange with EPAC2.,,,-999.0,,,,,,,,,,,,,P61224_E_37_A
4552,P61224,D,38,A,4dxa:A,38,Impairs interaction with KRIT1.,-1.0,,-999.0,,,,,,,,,,,,,P61224_D_38_A
4553,P61224,Q,63,E,4dxa:A,63,Abolishes complex formation with RAP1GAP. Loss GTPase activity.,-1.0,,1.0,,,,,,,,,,,,,P61224_Q_63_E
4554,P61224,F,64,A,4dxa:A,64,Abolishes complex formation with RAP1GAP. Loss GTPase activity.,-1.0,,1.0,,,,,,,,,,,,,P61224_F_64_A
4555,Q9Y2C9,F,678,A,4om7:A,678,Does not inhibit homodimer formation.,0.0,,-999.0,,,,,,,,,,,,,Q9Y2C9_F_678_A
4556,Q9Y2C9,C,712,R,4om7:A,712,Inhibits homodimer formation.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2C9_C_712_R
4557,Q9Y2C9,L,716,R,4om7:A,716,Inhibits homodimer formation.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2C9_L_716_R
4558,Q15465,C,24,S,3m1n:B,24,Abolishes palmitoylation.,,,-999.0,,,,,,-1.0,,,,,,,Q15465_C_24_S
4559,Q9H0M4,W,256,I,2rr4:A,256,Loss of histone H3K4me3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_W_256_I
4560,Q9H0M4,E,300,A,2rr4:A,300,Reduced histone H3K4me3 binding but complete loss of non-methylated histone H3K4 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_E_300_A
4561,Q9H0M4,E,301,R,2rr4:A,301,Loss of histone H3K4me3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_E_301_R
4562,Q9H0M4,T,302,L,2rr4:A,302,Loss of histone H3K4me3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_T_302_L
4563,Q9H0M4,W,303,A,2rr4:A,303,Reduced histone H3K4me3 binding but no effect on non-methylated histone H3K4 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_W_303_A
4564,Q9H0M4,W,303,E,2rr4:A,303,Silghtly reduced histone H3K4me3 and non-methylated histone H3K4 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_W_303_E
4565,Q9H0M4,W,303,P,2rr4:A,303,Loss of histone H3K4me3 binding,-1.0,,-999.0,,,,,,,,,,,,,Q9H0M4_W_303_P
4566,Q9BYW2,F,1589,A,5jlb:A,1589,Strongly reduced methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_F_1589_A
4567,Q9BYW2,Y,1604,A,5jlb:A,1604,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_Y_1604_A
4568,Q9BYW2,R,1625,H,5jlb:A,1625,Loss of methyltransferase activity. Abolishes ability to monomethylate STAT1.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1625_H
4568,Q9BYW2,R,1625,G,5jlb:A,1625,Loss of methyltransferase activity. Abolishes ability to monomethylate STAT1.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1625_G
4569,Q9BYW2,C,1631,A,5jlb:A,1631,Does not affect methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q9BYW2_C_1631_A
4570,Q9BYW2,E,1636,A,5jlb:A,1636,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_E_1636_A
4571,Q9BYW2,T,1637,A,5jlb:A,1637,Increased methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_T_1637_A
4572,Q9BYW2,F,1668,A,5jlb:A,1668,Strongly reduced methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_F_1668_A
4573,Q9BYW2,Q,1669,A,5jlb:A,1669,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_Q_1669_A
4574,Q9BYW2,R,1670,A,5jlb:A,1670,Impaired methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_A
4574,Q9BYW2,R,1670,V,5jlb:A,1670,Impaired methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_V
4574,Q9BYW2,R,1670,L,5jlb:A,1670,Impaired methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_L
4574,Q9BYW2,R,1670,I,5jlb:A,1670,Impaired methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_I
4574,Q9BYW2,R,1670,F,5jlb:A,1670,Impaired methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_F
4575,Q9BYW2,R,1670,P,5jlb:A,1670,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_P
4575,Q9BYW2,R,1670,W,5jlb:A,1670,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_W
4575,Q9BYW2,R,1670,K,5jlb:A,1670,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_K
4575,Q9BYW2,R,1670,Q,5jlb:A,1670,Loss of methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_R_1670_Q
4576,Q9BYW2,Y,1671,A,5jlb:A,1671,Strongly reduced methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9BYW2_Y_1671_A
4577,Q9BYW2,R,2475,A,2a7o:A,23,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_R_2475_A
4578,Q9BYW2,K,2476,A,2a7o:A,24,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_K_2476_A
4579,Q9BYW2,Q,2480,A,2a7o:A,28,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_Q_2480_A
4580,Q9BYW2,F,2481,A,2a7o:A,29,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_F_2481_A
4581,Q9BYW2,V,2483,A,2a7o:A,31,Impairs interaction with hyperphosphorylated POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_V_2483_A
4582,Q9BYW2,K,2506,A,2a7o:A,54,Impairs interaction with hyperphosphorylated POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_K_2506_A
4583,Q9BYW2,R,2510,A,2a7o:A,58,Impairs interaction with hyperphosphorylated POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_R_2510_A
4584,Q9BYW2,H,2514,A,2a7o:A,62,Impairs interaction with hyperphosphorylated POLR2A.,-1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_H_2514_A
4585,Q9BYW2,G,2515,A,2a7o:A,63,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_G_2515_A
4585,Q9BYW2,G,2515,T,2a7o:A,63,Does not affect interaction with hyperphosphorylated POLR2A.,0.0,,-999.0,,,,,,,,,,,,,Q9BYW2_G_2515_T
4586,Q9BYW2,E,2528,A,2a7o:A,76,Increases interaction with hyperphosphorylated POLR2A,1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_E_2528_A
4587,Q9BYW2,E,2531,A,2a7o:A,79,Increases interaction with hyperphosphorylated POLR2A,1.0,,-999.0,,,,,,,,,,,,,Q9BYW2_E_2531_A
4588,O14607,H,1093,A,5fy7:A,1014,Abolishes lysine demethylase activity.,,,1.0,,,,,,,,,,,,,O14607_H_1093_A
4589,O14607,S,1138,G,5fy7:A,1059,No effect on lysine demethylase activity.,,,0.0,,,,,,,,,,,,,O14607_S_1138_G
4590,O14607,P,1214,I,5fy7:A,1135,Significantly higher lysine demethylase activity.,,,1.0,,,,,,,,,,,,,O14607_P_1214_I
4591,Q13636,Q,64,L,2fg5:A,64,No change in GTPase activity.,,,1.0,,,,,,,,,,,,,Q13636_Q_64_L
4592,Q13637,T,39,N,4cz2:B,39,Decreased GTP-binding activity.,,-1.0,-999.0,,,,,,,,,,,,,Q13637_T_39_N
4593,Q13637,Q,85,L,4cz2:B,85,No change in GTPase activity.,,,0.0,,,,,,,,,,,,,Q13637_Q_85_L
4594,Q13637,G,89,T,4cz2:B,89,Impairs interaction with ANKRD27,-1.0,,-999.0,,,,,,,,,,,,,Q13637_G_89_T
4595,Q13637,N,90,S,4cz2:B,90,Impairs interaction with ANKRD27,-1.0,,-999.0,,,,,,,,,,,,,Q13637_N_90_S
4596,Q13637,M,91,S,4cz2:B,91,Impairs interaction with ANKRD27,-1.0,,-999.0,,,,,,,,,,,,,Q13637_M_91_S
4597,Q13637,R,93,S,4cz2:B,93,Impairs interaction with ANKRD27,-1.0,,-999.0,,,,,,,,,,,,,Q13637_R_93_S
4598,Q13637,V,94,L,4cz2:B,94,Impairs interaction with ANKRD27,-1.0,,-999.0,,,,,,,,,,,,,Q13637_V_94_L
4599,Q13637,A,185,F,4cz2:B,185,Abolishes binding to protein kinase A type II regulatory subunit.,-1.0,,-999.0,,,,,,,,,,,,,Q13637_A_185_F
4600,Q13637,L,188,P,4cz2:B,188,Abolishes binding to protein kinase A type II regulatory subunit.,-1.0,,-999.0,,,,,,,,,,,,,Q13637_L_188_P
4601,P51787,V,324,L,6v00:A,324,Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.,,,0.0,,,,,,,,,,,,,P51787_V_324_L
4602,P51787,K,326,R,6v00:A,326,Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.,-1.0,,0.0,,,,,,,,,,,,,P51787_K_326_R
4603,P51787,T,327,V,6v00:A,327,Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.,-1.0,,0.0,,,,,,,,,,,,,P51787_T_327_V
4604,P51787,I,328,L,6v00:A,328,Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.,-1.0,,0.0,,,,,,,,,,,,,P51787_I_328_L
4605,P51787,S,338,C,6v00:A,338,Inhibits voltage-gated potassium channel activity.,,,1.0,,,,,,,,,,,,,P51787_S_338_C
4606,P51787,F,340,C,6v00:A,340,Inhibits voltage-gated potassium channel activity.,,,1.0,,,,,,,,,,,,,P51787_F_340_C
4607,P51787,I,375,D,6v00:A,375,"Reduced protein expression, probably due to misfolding and proteasomal degradation. No detectable electrophysiological activity. Reduced electrophysiological activity in the presence of KCNE1.",,,1.0,,,,,,,,,,,-1.0,-1.0,P51787_I_375_D
4608,P51787,V,516,D,6v00:A,516,"Reduced protein expression, probably due to misfolding and proteasomal degradation. Significantly reduced electrophysiological activity. Reduced electrophysiological activity in the presence of KCNE1.",,,1.0,,,,,,,,,,,-1.0,-1.0,P51787_V_516_D
4609,P55064,S,156,A,5dye:D,156,No effect on location at the cell membrane.,,,-999.0,,,,,,,,,0.0,,,,P55064_S_156_A
4610,P55064,S,156,E,5dye:D,156,Increased location at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P55064_S_156_E
4611,P13987,Y,29,R,5imt:D,4,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_Y_29_R
4612,P13987,N,33,R,5imt:D,8,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_33_R
4612,P13987,N,33,Q,5imt:D,8,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_33_Q
4613,P13987,D,37,R,5imt:D,12,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_D_37_R
4614,P13987,F,48,R,5imt:D,23,Some loss of function. Some lysis.,,,1.0,,,,,,,,,,,,,P13987_F_48_R
4615,P13987,D,49,R,5imt:D,24,Loss of function. Lysis.,,,1.0,,,,,,,,,,,,,P13987_D_49_R
4616,P13987,L,58,E,5imt:D,33,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_L_58_E
4617,P13987,K,63,E,5imt:D,38,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_K_63_E
4618,P13987,W,65,E,5imt:D,40,Complete loss of function. Lysis.,,,1.0,,,,,,,,,,,,,P13987_W_65_E
4619,P13987,K,66,D,5imt:D,41,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_K_66_D
4620,P13987,K,66,Q,5imt:D,41,Loss of glycation mediated inactivation.,,-1.0,-999.0,,,,,,,,,,,,,P13987_K_66_Q
4621,P13987,F,67,K,5imt:D,42,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_F_67_K
4622,P13987,H,69,Q,5imt:D,44,Loss of glycation mediated inactivation.,,-1.0,-999.0,,,,,,,,,,,,,P13987_H_69_Q
4623,P13987,F,72,E,5imt:D,47,Almost complete loss of function. Lysis.,,,1.0,,,,,,,,,,,,,P13987_F_72_E
4624,P13987,R,78,E,5imt:D,53,Loss of function. Lysis.,,,1.0,,,,,,,,,,,,,P13987_R_78_E
4625,P13987,L,79,D,5imt:D,54,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_L_79_D
4626,P13987,E,81,R,5imt:D,56,Almost complete loss of function. Lysis.,,,1.0,,,,,,,,,,,,,P13987_E_81_R
4627,P13987,N,82,K,5imt:D,57,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_N_82_K
4628,P13987,Y,87,R,5imt:D,62,No loss of function.,,,0.0,,,,,,,,,,,,,P13987_Y_87_R
4629,O60869,T,40,D,6zvh:i,40,Loss of interaction with CALM,-1.0,,-999.0,,,,,,,,,,,,,O60869_T_40_D
4630,O60869,T,58,D,6zvh:i,58,Loss of interaction with CALM,-1.0,,-999.0,,,,,,,,,,,,,O60869_T_58_D
4631,O60869,T,65,D,6zvh:i,65,No effect on CALM-binding. No effect,0.0,,0.0,,,,,,,,,,,,,O60869_T_65_D
4632,O60869,T,74,D,6zvh:i,74,No effect on CALM-binding. No effect,0.0,,0.0,,,,,,,,,,,,,O60869_T_74_D
4633,O60869,S,87,A,6zvh:i,87,No effect on CALM-binding.,0.0,,-999.0,,,,,,,,,,,,,O60869_S_87_A
4634,O60869,S,87,D,6zvh:i,87,Loss of interaction with CALM and higher affinity for TBP. Same effect,-1.0,,-999.0,,,,,,,,,,,,,O60869_S_87_D
4635,O60869,T,91,A,6zvh:i,91,No effect on CALM-binding.,0.0,,-999.0,,,,,,,,,,,,,O60869_T_91_A
4636,O60869,T,91,D,6zvh:i,91,Partial loss of interaction with CALM. Complete loss of interaction,-1.0,,-999.0,,,,,,,,,,,,,O60869_T_91_D
4637,O60869,S,111,D,6zvh:i,111,Loss of interaction with CALM,-1.0,,-999.0,,,,,,,,,,,,,O60869_S_111_D
4638,P52895,Y,24,A,2hdj:A,24,Strongly decreases affinity for androstenedione. Decreases androstenedione reductase activity about 60-fold.,,-1.0,1.0,,,,,,,,,,,,,P52895_Y_24_A
4639,P52895,K,31,A,2hdj:A,31,Increases the low androstenedione reductase activity.,,,1.0,,,,,,,,,,,,,P52895_K_31_A
4639,P52895,K,31,M,2hdj:A,31,Increases the low androstenedione reductase activity.,,,1.0,,,,,,,,,,,,,P52895_K_31_M
4640,P52895,R,301,A,2hdj:A,301,Decreases 3-alpha-hydroxysteroid reductase activity about 50-fold.,,,1.0,,,,,,,,,,,,,P52895_R_301_A
4641,P52895,R,304,A,2hdj:A,304,Decreases 3-alpha-hydroxysteroid reductase activity about 500-fold.,,,1.0,,,,,,,,,,,,,P52895_R_304_A
4642,O00370,N,14,A,1vyb:A,14,Loss of endonuclease activity and reduced transposition efficiency.,,,1.0,,,,,,,,,,,,,O00370_N_14_A
4643,O00370,E,43,A,1vyb:A,43,Loss of endonuclease activity.,,,1.0,,,,,,,,,,,,,O00370_E_43_A
4644,O00370,D,145,A,1vyb:A,145,Loss of endonuclease activity and reduced transposition efficiency.,,,1.0,,,,,,,,,,,,,O00370_D_145_A
4645,O00370,D,205,G,1vyb:A,205,Loss of endonuclease activity and reduced transposition efficiency.,,,1.0,,,,,,,,,,,,,O00370_D_205_G
4646,O00370,H,230,A,1vyb:A,230,Loss of endonuclease activity and reduced transposition efficiency.,,,1.0,,,,,,,,,,,,,O00370_H_230_A
4647,Q12923,R,2205,W,1wch:A,2205,No effect on substrate affinity.,,0.0,-999.0,,,,,,,,,,,,,Q12923_R_2205_W
4648,Q12923,Q,2221,M,1wch:A,2221,Reduces substrate affinity 2 fold.,,-1.0,-999.0,,,,,,,,,,,,,Q12923_Q_2221_M
4649,Q12923,M,2307,T,1wch:A,2307,Reduces substrate affinity 7 fold.,,-1.0,-999.0,,,,,,,,,,,,,Q12923_M_2307_T
4650,Q12923,C,2408,S,1wch:A,2408,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q12923_C_2408_S
4651,Q12923,R,2444,E,1wch:A,2444,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q12923_R_2444_E
4652,Q12923,R,2444,K,1wch:A,2444,Reduces substrate affinity 7 fold.,,,1.0,,,,,,,,,,,,,Q12923_R_2444_K
4653,Q12923,R,2444,Q,1wch:A,2444,Strongly decreases catalytic activity.,,,1.0,,,,,,,,,,,,,Q12923_R_2444_Q
4654,Q12923,H,2448,A,1wch:A,2448,Reduces substrate affinity 2 fold.,,-1.0,-999.0,,,,,,,,,,,,,Q12923_H_2448_A
4655,Q12923,G,2449,V,1wch:A,2449,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q12923_G_2449_V
4656,Q12923,E,2474,D,1wch:A,2474,No effect on substrate affinity.,,0.0,-999.0,,,,,,,,,,,,,Q12923_E_2474_D
4657,P29374,Y,583,A,2lcc:A,16,No effect on binding to trimethylated lysines.,,0.0,-999.0,,,,,,,,,,,,,P29374_Y_583_A
4658,P29374,Y,592,A,2lcc:A,25,Significantly reduces affinity for trimethylated lysines.,,-1.0,-999.0,,,,,,,,,,,,,P29374_Y_592_A
4659,P29374,Y,612,A,2lcc:A,45,Abolishes binding to trimethylated lysines.,,-1.0,-999.0,,,,,,,,,,,,,P29374_Y_612_A
4660,P29374,W,615,A,2lcc:A,48,Abolishes binding to trimethylated lysines.,,-1.0,-999.0,,,,,,,,,,,,,P29374_W_615_A
4661,P29374,Y,619,A,2lcc:A,52,Abolishes binding to trimethylated lysines.,,-1.0,-999.0,,,,,,,,,,,,,P29374_Y_619_A
4662,Q9Y663,K,161,A,1t8u:B,161,99.6% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_161_A
4663,Q9Y663,K,162,A,1t8u:B,162,99.6% loss of enzymatic activity,,,1.0,,,,,,,,,,,,,Q9Y663_K_162_A
4664,Q9Y663,R,166,E,1t8u:B,166,99.8% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_R_166_E
4665,Q9Y663,E,170,Q,1t8u:B,170,17% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_E_170_Q
4666,Q9Y663,R,173,S,1t8u:B,173,44.1% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_R_173_S
4667,Q9Y663,G,182,A,1t8u:B,182,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9Y663_G_182_A
4668,Q9Y663,E,184,Q,1t8u:B,184,99.9% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_E_184_Q
4669,Q9Y663,H,186,F,1t8u:B,186,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_H_186_F
4670,Q9Y663,D,189,N,1t8u:B,189,99.1% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_D_189_N
4671,Q9Y663,R,190,E,1t8u:B,190,32% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_R_190_E
4672,Q9Y663,K,194,A,1t8u:B,194,99.5% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_194_A
4673,Q9Y663,K,215,A,1t8u:B,215,99.9% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_215_A
4674,Q9Y663,S,218,A,1t8u:B,218,23.3% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_S_218_A
4675,Q9Y663,E,224,Q,1t8u:B,224,47.6% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_E_224_Q
4676,Q9Y663,Q,255,A,1t8u:B,255,99.6% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_Q_255_A
4677,Q9Y663,K,259,A,1t8u:B,259,48.3% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_259_A
4678,Q9Y663,I,288,A,1t8u:B,288,65% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_I_288_A
4679,Q9Y663,K,293,A,1t8u:B,293,33.6% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_293_A
4680,Q9Y663,H,362,A,1t8u:B,362,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9Y663_H_362_A
4681,Q9Y663,G,365,A,1t8u:B,365,43% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_G_365_A
4682,Q9Y663,K,366,A,1t8u:B,366,99.8% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_366_A
4683,Q9Y663,K,368,A,1t8u:B,368,99.9% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_K_368_A
4684,Q9Y663,R,370,E,1t8u:B,370,99.2% loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y663_R_370_E
4685,P08913,D,94,N,6kux:A,79,No change in binding affinity. eliminates guanine nucleotide-sensitive agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P08913_D_94_N
4686,P08913,D,128,N,6kux:A,113,No binding to yohimbine. Increase in adenylate cyclase activity.,,-1.0,1.0,,,,,,,,,,,,,P08913_D_128_N
4687,P08913,D,145,N,6kux:A,130,Lower affinity for agonists. Eliminates guanine nucleotide-sensitive agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P08913_D_145_N
4688,P13674,Y,210,A,4bt9:B,193,Strongly reduced affinity for peptide substrate.,,-1.0,-999.0,,,,,,,,,,,,,P13674_Y_210_A
4689,P13674,Y,213,A,4bt9:B,196,Strongly reduced affinity for peptide substrate.,,-1.0,-999.0,,,,,,,,,,,,,P13674_Y_213_A
4690,P13674,Y,247,A,4bt9:B,230,Strongly reduced affinity for peptide substrate.,,-1.0,-999.0,,,,,,,,,,,,,P13674_Y_247_A
4691,O00506,K,49,R,4nzw:B,49,Loss of kinase activity and autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,O00506_K_49_R
4692,O00506,D,158,A,2xik:A,158,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O00506_D_158_A
4693,Q8IVH8,K,48,E,5j5t:A,48,Loss of kinase activity and ability to activate JNK family.,,,1.0,,,,,,,,,,,,,Q8IVH8_K_48_E
4694,P14867,Q,269,L,6i53:A,242,Reduced potentiation and activation by the agonist alphaxalone.,,-1.0,-999.0,,,,,,,,,,,,,P14867_Q_269_L
4695,P14867,W,273,L,6i53:A,246,Completely abolishes potentiation and activation by the agonist alphaxalone.,,-1.0,-999.0,,,,,,,,,,,,,P14867_W_273_L
4696,P14867,T,333,A,6i53:A,306,Reduced potentiation and activation by the agonist alphaxalone.,,-1.0,-999.0,,,,,,,,,,,,,P14867_T_333_A
4697,P14866,H,105,A,3r27:A,105,6-fold decrease in RNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,P14866_H_105_A
4698,P14866,V,132,A,3r27:A,132,4-fold increase in RNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,P14866_V_132_A
4699,P14866,L,141,A,3r27:A,141,15-fold decrease in RNA-binding affinity,,-1.0,-999.0,,,,,,,,,,,,,P14866_L_141_A
4700,P14866,N,172,A,3r27:A,172,1-fold increase in RNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,P14866_N_172_A
4701,P14866,S,174,A,3r27:A,174,15-fold decrease in RNA-binding affinity,,-1.0,-999.0,,,,,,,,,,,,,P14866_S_174_A
4702,P14866,H,504,A,3to8:A,504,Significant decrease in RNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,P14866_H_504_A
4703,P14866,F,506,A,3to8:A,506,Significant decrease in RNA-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,P14866_F_506_A
4704,Q68DC2,E,798,K,4nl9:D,29,Loss of interaction with ANKS3.,-1.0,,-999.0,,,,,,,,,,,,,Q68DC2_E_798_K
4705,Q68DC2,D,811,K,4nl9:D,42,Loss of interaction with ANKS3.,-1.0,,-999.0,,,,,,,,,,,,,Q68DC2_D_811_K
4706,Q68DC2,R,823,W,4nl9:D,54,Loss of interaction with ANKS3.,-1.0,,-999.0,,,,,,,,,,,,,Q68DC2_R_823_W
4707,Q96ES7,W,175,A,3mev:B,175,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_W_175_A
4708,Q96ES7,E,179,A,3mev:B,179,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_E_179_A
4709,Q96ES7,D,194,A,3mev:B,194,Abolishes H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_194_A
4709,Q96ES7,D,194,R,3mev:B,194,Abolishes H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_194_R
4710,Q96ES7,D,196,R,3mev:B,196,Abolishes H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_196_R
4711,Q96ES7,P,214,A,3mev:B,214,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_P_214_A
4712,Q96ES7,Q,232,A,3mev:B,232,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_Q_232_A
4713,Q96ES7,Y,238,A,3mev:B,238,Strongly reduced H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_Y_238_A
4714,Q96ES7,Y,238,F,3mev:B,238,Does not affect binding to H3K4me3.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_Y_238_F
4715,Q96ES7,Q,240,A,3mev:B,240,Slightly reduced H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_Q_240_A
4716,Q96ES7,T,242,A,3mev:B,242,Almost abolished H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_T_242_A
4717,Q96ES7,Y,245,A,3mev:B,245,Abolishes H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_Y_245_A
4718,Q96ES7,Y,245,F,3mev:B,245,Reduced H3K4me3 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_Y_245_F
4719,Q96ES7,P,256,A,3mev:B,256,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_P_256_A
4720,Q96ES7,F,264,A,3mev:B,264,Strongly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_F_264_A
4721,Q96ES7,D,266,A,3mev:B,266,Strongly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_A
4721,Q96ES7,D,266,F,3mev:B,266,Strongly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_F
4721,Q96ES7,D,266,Y,3mev:B,266,Strongly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_Y
4721,Q96ES7,D,266,W,3mev:B,266,Strongly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_W
4722,Q96ES7,D,266,E,3mev:B,266,Does not affect binding to H3K4me3.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_E
4723,Q96ES7,D,266,N,3mev:B,266,Slightly reduced binding to H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,Q96ES7_D_266_N
4724,Q96ES7,R,282,A,3mev:B,282,Does not strongly affect binding to H3K4me.,0.0,,-999.0,,,,,,,,,,,,,Q96ES7_R_282_A
4725,Q13569,N,140,A,1wyw:A,140,Loss of DNA glycosylase activity but still able to bind DNA.,,0.0,1.0,,,,,,,,,,,,,Q13569_N_140_A
4726,Q13569,A,145,G,1wyw:A,145,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_A_145_G
4727,Q13569,H,151,A,1wyw:A,151,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_H_151_A
4727,Q13569,H,151,Q,1wyw:A,151,Increased DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_H_151_Q
4728,Q13569,N,191,A,1wyw:A,191,Reduced DNA glycosylase activity on G/T and G/U mispairs.,,,1.0,,,,,,,,,,,,,Q13569_N_191_A
4729,Q13569,T,197,A,1wyw:A,197,Reduced DNA glycosylase activity on G/T mispairs.,,,1.0,,,,,,,,,,,,,Q13569_T_197_A
4730,Q13569,R,281,A,1wyw:A,281,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_R_281_A
4731,Q13569,E,310,Q,1wyw:A,310,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_E_310_Q
4732,Q13569,F,315,A,1wyw:A,315,Restores the DNA-binding ability of the sumoylated form.,,,1.0,,,,,,,,,,,,,Q13569_F_315_A
4733,Q93091,I,36,A,5oab:A,13,"Strongly impairs bactericidal activity, bacterial agglutination activity and binding to bacterial lipopolysaccharide (LPS).",,,1.0,,,,,,,,,,,,,Q93091_I_36_A
4734,Q93091,H,38,A,5oab:A,15,Significantly reduced activity towards dinucleotides UpA and CpA. Slightly reduced activity towards polymeric substrates poly(U) and poly(U),,-1.0,-999.0,,,,,,,,,,,,,Q93091_H_38_A
4735,Q93091,H,59,R,5oab:A,36,No significant effect on activity towards dinucleotides UpA and CpA. Reduced activity towards polymeric substrates poly(U) and poly(U),,-1.0,-999.0,,,,,,,,,,,,,Q93091_H_59_R
4736,P05093,A,105,L,6ciz:C,105,"Increases the affinity for progesterone, resulting in preferential hydroxylation of progesterone at C17 over C16",,1.0,-999.0,,,,,,,,,,,,,P05093_A_105_L
4737,Q9UM00,D,191,A,6w6l:6,140,Abolishes the calcium channel activity.,,,1.0,,,,,,,,,,,,,Q9UM00_D_191_A
4738,Q9UM00,D,191,E,6w6l:6,140,Retains some of the calcium channel activity.,,,0.0,,,,,,,,,,,,,Q9UM00_D_191_E
4739,Q9UM07,Q,346,A,5n0y:A,346,Impaired binding of TDFA Inhibitor.,,-1.0,-999.0,,,,,,,,,,,,,Q9UM07_Q_346_A
4740,Q9UM07,R,374,A,5n0y:A,374,Strongly reduces enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9UM07_R_374_A
4741,Q9UM07,R,374,Q,5n0y:A,374,Impaired binding of TDFA Inhibitor.,,-1.0,-999.0,,,,,,,,,,,,,Q9UM07_R_374_Q
4742,Q9UM07,R,639,Q,5n0y:A,639,Impaired binding of TDFA Inhibitor.,,-1.0,-999.0,,,,,,,,,,,,,Q9UM07_R_639_Q
4743,Q9UM07,C,645,A,5n0y:A,645,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9UM07_C_645_A
4744,P45954,V,137,L,2jif:A,137,Decreased acyl-CoA dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P45954_V_137_L
4745,P45954,F,138,L,2jif:A,138,Increased acyl-CoA dehydrogenase activity. No effect on substrate specificity.,,0.0,1.0,,,,,,,,,,,,,P45954_F_138_L
4746,P45954,S,210,N,2jif:A,210,Increased acyl-CoA dehydrogenase activity. Changed substrate specificity.,,-1.0,1.0,,,,,,,,,,,,,P45954_S_210_N
4747,P45954,A,416,T,2jif:A,416,Increased acyl-CoA dehydrogenase activity. No effect on substrate specificity.,,0.0,1.0,,,,,,,,,,,,,P45954_A_416_T
4748,Q08495,S,403,A,1qzp:A,74,Inhibits phosphorylation and interaction with plasmodium berghei 14-3-3 protein,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q08495_S_403_A
4749,Q08495,S,403,E,1qzp:A,74,Reduces F-actin bundling but not F-actin binding activity.,,,0.0,,,,,,,,,,,,,Q08495_S_403_E
4750,P28222,L,126,A,5v54:A,126,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P28222_L_126_A
4751,P28222,D,129,A,5v54:A,129,Abolishes agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P28222_D_129_A
4752,P28222,I,130,A,5v54:A,130,Abolishes agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P28222_I_130_A
4753,P28222,C,133,A,5v54:A,133,Abolishes agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P28222_C_133_A
4754,P28222,T,134,A,5v54:A,134,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P28222_T_134_A
4755,P28223,L,229,A,6a94:A,229,"Strongly increases dissociation of bound lysergic acid diethylamine, without affecting binding affinity. Reduces signaling via arrestins, but has no effect on signaling via the phosphatidylinositol-calcium second messenger system.",,0.0,1.0,,,,,,,,,,,,,P28223_L_229_A
4756,O75815,L,744,E,3t6a:A,744,Weakens interaction with BCAR1.,-1.0,,-999.0,,,,,,,,,,,,,O75815_L_744_E
4757,O75815,R,748,A,3t6a:A,748,Abolishes interaction with BCAR1 and SRC.,-1.0,,-999.0,,,,,,,,,,,,,O75815_R_748_A
4758,Q9Y530,H,32,A,2lgr:A,32,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y530_H_32_A
4759,Q9Y530,C,33,S,2lgr:A,33,No effect.,,0.0,0.0,,,,,,,,,,,,,Q9Y530_C_33_S
4760,Q9Y530,S,35,A,2lgr:A,35,Reduced catalytic activity. No effect on affinity towards substrate.,,0.0,1.0,,,,,,,,,,,,,Q9Y530_S_35_A
4761,Q9Y530,T,83,A,2lgr:A,83,Reduced catalytic activity. No effect on affinity towards substrate.,,0.0,1.0,,,,,,,,,,,,,Q9Y530_T_83_A
4762,Q9Y530,K,84,A,2lgr:A,84,Abolishes enzyme activity and ability to form a stable covalent adduct with the ADP-ribosylated substrate.,,-1.0,1.0,,,,,,,,,,,,,Q9Y530_K_84_A
4763,Q9Y530,G,123,E,2lgr:A,123,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q9Y530_G_123_E
4764,Q9Y530,D,125,A,2lgr:A,125,Abolishes enzyme activity without affecting ability to form a stable covalent adduct with the ADP-ribosylated substrate.,,0.0,1.0,,,,,,,,,,,,,Q9Y530_D_125_A
4765,P00439,I,283,C,2pah:A,283,Loss of positive cooperativity and reduction of fold-activation by L-Phe preincubation.,,-1.0,-999.0,,,,,,,,,,,,,P00439_I_283_C
4766,P09455,R,22,A,5ljk:A,21,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,1.0,,,,,,,,,,,,,P09455_R_22_A
4767,P09455,L,30,A,5ljk:A,29,Decreases cellular retinol uptake and impairs retinol storage.,,,1.0,,,,,,,,,,,,,P09455_L_30_A
4768,P09455,R,31,A,5ljk:A,30,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,1.0,,,,,,,,,,,,,P09455_R_31_A
4769,P09455,K,32,A,5ljk:A,31,No effect on retinol binding. Abolishes interaction with STA6 and the ability to enhance STA6-mediated vitamin A uptake.,-1.0,0.0,1.0,,,,,,,,,,,,,P09455_K_32_A
4770,P09455,K,41,L,5ljk:A,40,Strongly decreased affinity for retinol. Further decrease in affinity for retinol,,-1.0,-999.0,,,,,,,,,,,,,P09455_K_41_L
4771,P09455,R,59,E,5ljk:A,58,Decreases cellular retinol uptake and impairs retinol storage.,,,1.0,,,,,,,,,,,,,P09455_R_59_E
4772,P09455,Q,109,L,5ljk:A,108,Strongly decreased affinity for retinol. Further decrease in for retinol,,-1.0,-999.0,,,,,,,,,,,,,P09455_Q_109_L
4773,Q9P2I0,H,67,A,6v4x:I,67,Inhibits histone 3'-end processing.,,,1.0,,,,,,,,,,,,,Q9P2I0_H_67_A
4774,Q9P2I0,D,289,A,6v4x:I,289,Does not inhibit histone 3'-end processing.,,,0.0,,,,,,,,,,,,,Q9P2I0_D_289_A
4775,Q9P2I0,R,543,A,6v4x:I,543,Inhibits histone 3'-end processing.,,,1.0,,,,,,,,,,,,,Q9P2I0_R_543_A
4776,P24530,C,402,S,6igk:A,402,Abolishes palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P24530_C_402_S
4777,P24530,C,403,S,5x93:A,403,Abolishes palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P24530_C_403_S
4778,P01009,M,382,V,1hp7:A,358,Oxidation-resistant inhibitor of therapeutic importance.,,,-999.0,,,,,,,,,,,,,P01009_M_382_V
4779,P02751,Y,641,A,2ha1:A,33,Severely compromised ability to form fibronectin aggregates,-1.0,,-999.0,,,,,,,,,,,,,P02751_Y_641_A
4780,P02751,I,642,A,2ha1:A,34,Little effect on ability to form fibronectin aggregates,0.0,,-999.0,,,,,,,,,,,,,P02751_I_642_A
4781,P02751,L,663,A,2ha1:A,55,No effect on secondary structure nor on fibronectin binding nor on activation of p38 K but abolishes polymerization activity,,,-999.0,,,,,,,,,,,,,P02751_L_663_A
4782,P02751,Y,666,A,2ha1:A,58,No effect on secondary structure nor on fibronectin binding nor on activation of p38 kinase but abolishes polymerization activity,,,-999.0,,,,,,,,,,,,,P02751_Y_666_A
4783,P02751,L,681,A,2ha1:A,73,Severely compromised ability to form fibronectin aggregates,-1.0,,-999.0,,,,,,,,,,,,,P02751_L_681_A
4784,P02751,I,682,A,2ha1:A,74,Little effect on ability to form fibronectin aggregates,0.0,,-999.0,,,,,,,,,,,,,P02751_I_682_A
4785,P02751,S,683,A,2ha1:A,75,Severely compromised ability to form fibronectin aggregates,-1.0,,-999.0,,,,,,,,,,,,,P02751_S_683_A
4786,P02751,I,684,A,2ha1:A,76,Little effect on ability to form fibronectin aggregates,0.0,,-999.0,,,,,,,,,,,,,P02751_I_684_A
4787,P02751,E,691,A,2ha1:A,83,Slightly enhanced ability to form fibronectin aggregates,1.0,,-999.0,,,,,,,,,,,,,P02751_E_691_A
4788,P02751,V,692,A,2ha1:A,84,Little effect on ability to form fibronectin aggregates,0.0,,-999.0,,,,,,,,,,,,,P02751_V_692_A
4789,P02751,R,694,A,2ha1:A,86,Slightly enhanced ability to form fibronectin aggregates,1.0,,-999.0,,,,,,,,,,,,,P02751_R_694_A
4790,P02751,F,695,A,2ha1:A,87,Loss of ability to form fibronectin aggregates,-1.0,,-999.0,,,,,,,,,,,,,P02751_F_695_A
4791,P02751,D,696,A,2ha1:A,88,Slightly enhanced ability to form fibronectin aggregates,1.0,,-999.0,,,,,,,,,,,,,P02751_D_696_A
4792,P02751,F,697,A,2ha1:A,89,Loss of ability to form fibronectin aggregates,-1.0,,-999.0,,,,,,,,,,,,,P02751_F_697_A
4793,P20807,C,129,S,6bdt:C,129,Loss of activity. No effect on CMYA5-binding.,-1.0,,1.0,,,,,,,,,,,,,P20807_C_129_S
4794,Q8WVM0,G,65,A,6ajk:A,65,"Abolishes methyltransferase activity, DNA-binding and SAM-binding. Does not abolish transcription activator function.",,-1.0,1.0,,,,,,,,,,,,,Q8WVM0_G_65_A
4795,Q8WVM0,N,141,A,6ajk:A,141,"Does not affect SAM-binding, DNA-binding nor transcription activator function.",,0.0,0.0,,,,,,,,,,,,,Q8WVM0_N_141_A
4796,Q8WVM0,K,220,A,6ajk:A,220,"Abolishes methyltransferase activity. Does not affect SAM-binding, DNA-binding nor transcription activator function.",,0.0,1.0,,,,,,,,,,,,,Q8WVM0_K_220_A
4797,Q15561,D,266,A,6ge6:A,266,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_D_266_A
4798,Q15561,K,297,A,6ge6:A,297,Important loss of interaction with YAP1 and complete loss of transforming ability.,-1.0,,1.0,,,,,,,,,,,,,Q15561_K_297_A
4799,Q15561,W,299,A,6ge6:A,299,Important loss of interaction with YAP1 and complete loss of transforming ability.,-1.0,,1.0,,,,,,,,,,,,,Q15561_W_299_A
4800,Q15561,F,337,A,5oaq:A,337,Reduced interaction with YAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q15561_F_337_A
4801,Q15561,F,373,A,5oaq:A,373,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_F_373_A
4802,Q15561,L,380,A,5oaq:A,380,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_L_380_A
4803,Q15561,E,391,A,5oaq:A,391,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_E_391_A
4804,Q15561,F,393,A,5oaq:A,393,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_F_393_A
4805,Q15561,H,427,A,5oaq:A,427,Reduced transforming ability.,,,1.0,,,,,,,,,,,,,Q15561_H_427_A
4806,Q15561,Y,429,A,5oaq:A,429,Loss of interaction with YAP1 and also activation by YAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q15561_Y_429_A
4806,Q15561,Y,429,H,5oaq:A,429,Loss of interaction with YAP1 and also activation by YAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q15561_Y_429_H
4808,Q9NRN7,R,47,A,2cg5:A,57,"Reduces affinity for magnesium 7-fold, and enzyme activity 2-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_R_47_A
4809,Q9NRN7,R,86,A,2cg5:A,96,"Reduces affinity for magnesium and coenzyme A, and reduces enzyme activity 7-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_R_86_A
4810,Q9NRN7,H,111,A,2cg5:A,121,"Reduces affinity for magnesium 75-fold, and enzyme activity 150-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_H_111_A
4811,Q9NRN7,Q,112,E,2cg5:A,122,Reduces affinity for magnesium 200-fold and abolishes enzyme activity,,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_Q_112_E
4812,Q9NRN7,D,129,A,2cg5:A,139,"Reduces affinity for magnesium 10-fold, and enzyme activity 30000-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_D_129_A
4813,Q9NRN7,E,181,A,2cg5:A,191,"Reduces affinity for magnesium 40-fold, and enzyme activity 32000-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_E_181_A
4814,Q9NRN7,E,181,Q,2cg5:A,191,"Reduces affinity for magnesium 20-fold, and enzyme activity 6500-fold.",,-1.0,1.0,,,,,,,,,,,,,Q9NRN7_E_181_Q
4815,Q9NRN7,K,185,A,2cg5:A,195,"Reduces enzyme activity 2000-fold, with only minor change in the affinity for magnesium and coenzyme A.",,0.0,1.0,,,,,,,,,,,,,Q9NRN7_K_185_A
4816,P01344,R,48,E,2l29:B,24,Does not affect integrin binding. Defective integrin binding and IGF2 signaling,,,-999.0,,,,,,,,,,,,,P01344_R_48_E
4817,P01344,R,58,E,2l29:B,34,Does not affect integrin binding. Defective integrin binding and IGF2 signaling,,,-999.0,,,,,,,,,,,,,P01344_R_58_E
4818,P01344,R,61,E,2l29:B,37,Does not affect integrin binding. Defective integrin binding and IGF2 signaling,,,-999.0,,,,,,,,,,,,,P01344_R_61_E
4819,P01344,R,62,E,2l29:B,38,Does not affect integrin binding. Defective integrin binding and IGF2 signaling,,,-999.0,,,,,,,,,,,,,P01344_R_62_E
4820,P01344,R,64,E,2l29:B,40,Slight but significant increase in integrin binding.,1.0,,-999.0,,,,,,,,,,,,,P01344_R_64_E
4821,P35226,K,62,A,4r8p:K,62,Strongly decreases histone H2A ubiquitination,,,1.0,,,,,,,,,,,,,P35226_K_62_A
4822,P35226,R,64,A,4r8p:K,64,Mildly decreases histone H2A ubiquitination. Strongly decreases histone H2A ubiquitination,,,1.0,,,,,,,,,,,,,P35226_R_64_A
4823,P35226,K,73,N,4r8p:K,73,Increases stimulation of RNF2 ubiquitin ligase activity,,,1.0,,,,,,,,,,,,,P35226_K_73_N
4824,P35226,D,77,E,4r8p:K,77,Increases stimulation of RNF2 ubiquitin ligase activity,,,1.0,,,,,,,,,,,,,P35226_D_77_E
4825,P35226,R,165,E,2na1:A,165,Decreases affinity for PHC2. Abolishes interaction with PHC2,-1.0,,-999.0,,,,,,,,,,,,,P35226_R_165_E
4826,P35226,M,170,E,2na1:A,170,Strongly decreases affinity for PHC2.,-1.0,,-999.0,,,,,,,,,,,,,P35226_M_170_E
4827,P35226,H,174,E,2na1:A,174,Strongly decreases affinity for PHC2. Abolishes interaction with PHC2,-1.0,,-999.0,,,,,,,,,,,,,P35226_H_174_E
4828,P35557,S,64,P,3qic:A,64,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_S_64_P
4829,P35557,E,177,K,3qic:A,177,Small change in glucokinase activity.,,,1.0,,,,,,,,,,,,,P35557_E_177_K
4830,P35557,M,197,V,3qic:A,197,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_M_197_V
4831,P35557,I,211,F,3qic:A,211,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_I_211_F
4832,P35557,Y,214,A,3qic:A,214,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose. No effect on affinity for ATP.,,1.0,1.0,,,,,,,,,,,,,P35557_Y_214_A
4833,P35557,Y,215,A,3qic:A,215,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose. Loss of inhibition by GCKR. No effect on affinity for ATP.,-1.0,1.0,-999.0,,,,,,,,,,,,,P35557_Y_215_A
4834,P35557,E,256,A,3qic:A,256,Inactive enzyme with no glucokinase activity.,,,1.0,,,,,,,,,,,,,P35557_E_256_A
4835,P35557,K,414,A,3qic:A,414,Small change in glucokinase activity.,,,1.0,,,,,,,,,,,,,P35557_K_414_A
4836,P35557,S,453,A,3qic:A,453,Increased glucokinase activity based on measure of catalytic efficiency. Increased affinity for glucose.,,1.0,1.0,,,,,,,,,,,,,P35557_S_453_A
4837,P35222,Y,142,E,1g3j:A,142,No effect on interaction with BCL9 and BCL9L.,0.0,,-999.0,,,,,,,,,,,,,P35222_Y_142_E
4838,P35222,L,156,A,1qz7:A,156,Abolishes interaction with BCL9 but no effect on interaction with CDH3,-1.0,,-999.0,,,,,,,,,,,,,P35222_L_156_A
4839,P35222,L,159,A,1qz7:A,159,No effect on interaction with BCL9 and CDH3. Abolishes interaction with BCL9 but no effect on interaction with CDH3,0.0,,-999.0,,,,,,,,,,,,,P35222_L_159_A
4840,P35222,L,178,A,1qz7:A,178,No effect on interaction with BCL9 and CDH3.,0.0,,-999.0,,,,,,,,,,,,,P35222_L_178_A
4841,P35222,F,253,A,1qz7:A,253,Abolishes or strongly reduces AXIN2 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_F_253_A
4842,P35222,H,260,A,1qz7:A,260,Abolishes or strongly reduces AXIN1 and AXIN2 binding. Strongly reduces phosphorylation and degradation,-1.0,,-999.0,-1.0,,,,,,,,,,,,P35222_H_260_A
4843,P35222,K,292,A,1qz7:A,292,Abolishes or strongly reduces AXIN1 and AXIN2 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_K_292_A
4844,P35222,K,312,E,1qz7:A,312,Abolishes TCF7L2 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_K_312_E
4845,P35222,K,345,A,1qz7:A,345,Abolishes APC binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_K_345_A
4846,P35222,W,383,A,1qz7:A,383,Abolishes APC binding. Strongly reduces phosphorylation and degradation,-1.0,,-999.0,-1.0,,,,,,,,,,,,P35222_W_383_A
4847,P35222,R,386,A,1qz7:A,386,Strongly reduces APC binding. Strongly reduces phosphorylation and degradation,-1.0,,-999.0,-1.0,,,,,,,,,,,,P35222_R_386_A
4848,P35222,N,426,A,1qz7:A,426,Abolishes TCF7L2 and LEF1 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_N_426_A
4849,P35222,K,435,A,1qz7:A,435,Strongly reduces or abolishes LEF1 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_K_435_A
4850,P35222,K,435,E,1qz7:A,435,Abolishes TCF7L2 binding.,-1.0,,-999.0,,,,,,,,,,,,,P35222_K_435_E
4851,P35222,R,469,A,1qz7:A,469,"Abolishes TCF7L2 binding, and strongly reduces or abolishes LEF1 binding.",-1.0,,-999.0,,,,,,,,,,,,,P35222_R_469_A
4852,P35222,H,470,A,1qz7:A,470,"Abolishes TCF7L2 binding, and strongly reduces or abolishes LEF1 binding.",-1.0,,-999.0,,,,,,,,,,,,,P35222_H_470_A
4853,P35222,K,508,A,1qz7:A,508,Abolishes TCF7L2 and LEF1 binding.,1.0,,-999.0,,,,,,,,,,,,,P35222_K_508_A
4854,P35222,Y,654,E,1qz7:A,654,Enhances TBP binding and transactivation of target genes.,1.0,,-999.0,,,,,,,,,,,,,P35222_Y_654_E
4855,P35222,Y,654,F,1qz7:A,654,Abolishes increase of TBP binding after phosphorylation by CSK.,,,-999.0,,,,,,,,,,,,,P35222_Y_654_F
4856,P35222,F,660,A,1qz7:A,660,Abolishes CTNNBIP1 binding,-1.0,,-999.0,,,,,,,,,,,,,P35222_F_660_A
4857,P35222,R,661,A,1qz7:A,661,Abolishes CTNNBIP1 binding,-1.0,,-999.0,,,,,,,,,,,,,P35222_R_661_A
4858,P08138,K,343,A,2n97:A,343,Decreased interaction with ARHGDIA.,-1.0,,-999.0,,,,,,,,,,,,,P08138_K_343_A
4859,P08138,D,412,A,2n97:A,412,Decreased interaction with ARHGDIA.,-1.0,,-999.0,,,,,,,,,,,,,P08138_D_412_A
4860,P08138,E,420,A,2n97:A,420,Decreased interaction with ARHGDIA.,-1.0,,-999.0,,,,,,,,,,,,,P08138_E_420_A
4861,Q9P126,K,150,A,2c6u:A,150,Substantial reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_K_150_A
4862,Q9P126,K,171,A,2c6u:A,171,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_K_171_A
4863,Q9P126,E,184,A,2c6u:A,184,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_E_184_A
4864,Q9P126,E,187,A,2c6u:A,187,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_E_187_A
4865,Q9P126,D,188,A,2c6u:A,188,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_D_188_A
4866,Q9P126,K,190,A,2c6u:A,190,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_K_190_A
4867,Q9P126,N,192,A,2c6u:A,192,Significant reduction in rhodocytin binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9P126_N_192_A
4868,P35558,K,70,R,1nhx:A,70,Abolishes acetylation and increases protein stability,,,-999.0,,,,,,,,,,,1.0,,P35558_K_70_R
4869,P35558,K,71,R,1nhx:A,71,Abolishes acetylation and increases protein stability,,,-999.0,,,,,,,,,,,1.0,,P35558_K_71_R
4870,P35558,S,90,A,1nhx:A,90,"Abolished phosphorylation by AKT1, interaction with INSIG proteins (INSIG1 and INSIG2) and ability to regulate lipogenesis.",-1.0,,1.0,-1.0,,,,,,,,,,,,P35558_S_90_A
4871,P35558,S,90,E,1nhx:A,90,"Phosphomimetic mutant, promotes the serine protein kinase activity by reducing the binding affinity to oxaloacetate.",,-1.0,1.0,,,,,,,,,,1.0,,,P35558_S_90_E
4872,P35558,C,288,S,1nhx:A,288,Abolished both phosphoenolpyruvate carboxykinase and protein kinase activities.,,,1.0,,,,,,,,,,,,,P35558_C_288_S
4873,P35558,K,594,R,1nhx:A,594,Abolishes acetylation and increases protein stability,,,-999.0,,,,,,,,,,,1.0,,P35558_K_594_R
4874,Q5U5Q3,G,343,D,5wwx:A,343,Prevents RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q5U5Q3_G_343_D
4875,Q9Y3A5,K,151,N,5an9:J,151,Strongly reduced release of EIF6 from pre-60S ribosome subunits.,,,-999.0,,,,,,,,,,,,,Q9Y3A5_K_151_N
4876,P54725,K,8,A,1oqy:A,8,No effect on interaction with EEF1A1.,0.0,,-999.0,,,,,,,,,,,,,P54725_K_8_A
4877,P54725,T,9,A,1oqy:A,9,Abolishes interaction with PSMD4,-1.0,,-999.0,,,,,,,,,,,,,P54725_T_9_A
4878,P54725,L,10,E,1oqy:A,10,Impairs UBL-UBA domain interaction and enhances ubiquitin-binding,-1.0,1.0,-999.0,,,,,,,,,,,,,P54725_L_10_E
4879,P54725,K,47,A,1oqy:A,47,No effect on UBL-UBA domain interaction.,0.0,,-999.0,,,,,,,,,,,,,P54725_K_47_A
4880,P54725,K,47,E,1oqy:A,47,Impairs UBL-UBA domain interaction and enhances ubiquitin-binding,-1.0,1.0,-999.0,,,,,,,,,,,,,P54725_K_47_E
4882,P54725,I,49,A,1oqy:A,49,Impairs interaction with PSMD4.,-1.0,,-999.0,,,,,,,,,,,,,P54725_I_49_A
4883,P54725,I,49,T,1oqy:A,49,Abolishes interaction with PSMD4,-1.0,,-999.0,,,,,,,,,,,,,P54725_I_49_T
4884,P54725,I,54,A,1oqy:A,54,Impairs interaction with PSMD4.,-1.0,,-999.0,,,,,,,,,,,,,P54725_I_54_A
4885,P54725,F,71,A,1oqy:A,71,Impairs interaction with PSMD4.,-1.0,,-999.0,,,,,,,,,,,,,P54725_F_71_A
4886,P54725,T,77,E,1oqy:A,77,Impairs UBL-UBA domain interaction and enhances ubiquitin-binding,-1.0,1.0,-999.0,,,,,,,,,,,,,P54725_T_77_E
4887,P54725,T,77,S,1oqy:A,77,No effect on interaction with PSMD4.,0.0,,-999.0,,,,,,,,,,,,,P54725_T_77_S
4888,P54725,T,79,P,1oqy:A,79,Increases interaction with PSMD1 and PSMC1.,-1.0,,-999.0,,,,,,,,,,,,,P54725_T_79_P
4889,P54725,P,333,E,1oqy:A,333,Abolishes interaction with HIV-1 vpr.,-1.0,,-999.0,,,,,,,,,,,,,P54725_P_333_E
4890,O75582,D,195,A,1vzo:A,195,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O75582_D_195_A
4891,O75582,S,212,A,1vzo:A,212,Inactivates the N-terminal kinase domain.,,,1.0,,,,,,,,,,,,,O75582_S_212_A
4892,O75582,T,700,A,3kn5:B,700,Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.,,,-999.0,-1.0,,,,,,,,,,,,O75582_T_700_A
4892,O75582,T,700,D,3kn5:B,700,Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.,,,-999.0,-1.0,,,,,,,,,,,,O75582_T_700_D
4893,Q96SD1,D,17,N,7afs:A,17,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_17_N
4893,Q96SD1,D,17,A,7afs:A,17,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_17_A
4894,Q96SD1,H,33,A,7afs:A,33,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_H_33_A
4895,Q96SD1,H,35,A,7afs:A,35,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_H_35_A
4896,Q96SD1,D,37,N,7afs:A,37,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_37_N
4896,Q96SD1,D,37,A,7afs:A,37,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_37_A
4897,Q96SD1,H,38,A,7afs:A,38,"Reduces PRKDC-dependent endonuclease activity, although V(D)J recombination is largely normal.",,,1.0,,,,,,,,,,,,,Q96SD1_H_38_A
4898,Q96SD1,H,115,A,7afs:A,115,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_H_115_A
4899,Q96SD1,D,136,N,7afs:A,136,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_136_N
4899,Q96SD1,D,136,A,7afs:A,136,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_136_A
4900,Q96SD1,D,165,N,7afs:A,165,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_165_N
4900,Q96SD1,D,165,A,7afs:A,165,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_D_165_A
4901,Q96SD1,H,319,A,7afs:A,319,Abolishes PRKDC-dependent endonuclease activity and V(D)J recombination.,,,1.0,,,,,,,,,,,,,Q96SD1_H_319_A
4902,Q8IYM1,G,56,N,6mqb:A,56,"Abolishes binding to GTP and to SEPTIN11, and also abolishes the ability of SEPTIN12 to form filamentous structures.",-1.0,-1.0,-999.0,,,,,,,,,,,,,Q8IYM1_G_56_N
4903,P21439,K,435,M,6s7p:A,435,"Inhibits efflux activity for PC and cholesterol, but does not alter glycosylation and surface expression in the presence of taurocholate.",,,-999.0,,,0.0,,,,,,0.0,,,,P21439_K_435_M
4904,P21439,A,953,D,6s7p:A,953,Accumulates predominantly in intracellular compartments with only a small fraction at the plasma membrane and inhibits partially the efflux activity for PC.,,,-999.0,,,,,,,,,1.0,,,,P21439_A_953_D
4905,P21439,K,1075,M,6s7p:A,1075,"Inhibits efflux activity for PC and cholesterol, but does not alter glycosylation and surface expression in the presence of taurocholate.",,,-999.0,,,0.0,,,,,,0.0,,,,P21439_K_1075_M
4906,P54252,C,14,A,2aga:A,19,Loss of deubiquitination activity.,,,1.0,,,,,,,,,,,,,P54252_C_14_A
4907,P01225,T,78,E,4mqw:B,60,Increased activation of the follicle-stimulating hormone signaling pathway.,,,1.0,,,,,,,,,,,,,P01225_T_78_E
4908,P15121,D,44,N,1z89:A,43,Reduced glyceraldehyde oxidoreductase activity.,,,1.0,,,,,,,,,,,,,P15121_D_44_N
4909,P15121,Y,49,F,1z89:A,48,Complete loss of glyceraldehyde oxidoreductase activity.,,,1.0,,,,,,,,,,,,,P15121_Y_49_F
4910,P15121,K,78,M,1z89:A,77,Reduced glyceraldehyde oxidoreductase activity.,,,1.0,,,,,,,,,,,,,P15121_K_78_M
4911,P15121,H,111,N,1z89:A,110,Reduced glyceraldehyde oxidoreductase activity.,,,1.0,,,,,,,,,,,,,P15121_H_111_N
4912,Q9NZK7,N,40,G,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_N_40_G
4912,Q9NZK7,N,40,M,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_N_40_M
4912,Q9NZK7,N,40,W,5wzv:A,21,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_N_40_W
4913,Q9NZK7,D,41,A,5wzv:A,22,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_D_41_A
4913,Q9NZK7,D,41,K,5wzv:A,22,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_D_41_K
4914,Q9NZK7,H,65,A,5wzv:A,46,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9NZK7_H_65_A
4915,Q9NZK7,D,66,A,5wzv:A,47,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9NZK7_D_66_A
4916,Q9NZK7,N,132,A,5wzv:A,113,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_N_132_A
4916,Q9NZK7,N,132,K,5wzv:A,113,Significantly decreases the catalytic efficiency.,,,1.0,,,,,,,,,,,,,Q9NZK7_N_132_K
4917,P98170,Y,75,G,2pop:D,3075,Loss of interaction with TAB1/MAP3K7IP1,-1.0,,-999.0,,,,,,,,,,,,,P98170_Y_75_G
4918,P98170,V,80,A,2pop:D,3080,Strongly reduced interaction with TAB1/MAP3K7IP1. Reduced activation of MAP3K7/TAK1. Reduced activation of NF-kappa-B.,-1.0,,-999.0,,,,,,,,,,,,,P98170_V_80_A
4919,P98170,V,80,D,2pop:D,3080,Loss of interaction with TAB1/MAP3K7IP1. Reduced activation of MAP3K7/TAK1. Strongly reduced activation of NF-kappa-B.,-1.0,,-999.0,,,,,,,,,,,,,P98170_V_80_D
4920,P98170,V,86,E,2pop:D,3086,Loss of dimerization. Reduces activation of NF-kappa-B.,-1.0,,-999.0,,,,,,,,,,,,,P98170_V_86_E
4921,P98170,S,87,A,2pop:D,3087,No effect on dimerization.,0.0,,-999.0,,,,,,,,,,,,,P98170_S_87_A
4922,P98170,S,87,D,2pop:D,3087,Abolishes dimerization. Interferes with ubiquitination.,-1.0,,1.0,,,,,,,,,,,,,P98170_S_87_D
4922,P98170,S,87,E,2pop:D,3087,Abolishes dimerization. Interferes with ubiquitination.,-1.0,,1.0,,,,,,,,,,,,,P98170_S_87_E
4923,P98170,L,98,G,2qra:A,98,Loss of interaction with TAB1/MAP3K7IP1,-1.0,,-999.0,,,,,,,,,,,,,P98170_L_98_G
4924,P98170,L,141,A,1c9q:A,18,Reduced inhibition of caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_L_141_A
4925,P98170,V,147,A,1c9q:A,24,Reduced inhibition of caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_V_147_A
4926,P98170,D,148,A,1c9q:A,25,Abolishes inhibition of caspase-3. Reduced interaction with PRSS25,-1.0,,-999.0,,,,,,,,,,,,,P98170_D_148_A
4927,P98170,I,149,A,1c9q:A,26,Reduced inhibition of caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_I_149_A
4928,P98170,D,151,A,1c9q:A,28,Reduced inhibition of caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_D_151_A
4929,P98170,L,167,A,1c9q:A,44,Reduced inhibition of caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_L_167_A
4930,P98170,D,196,A,1c9q:A,73,Reduced inhibition of caspase-3. May affect protein folding and stability.,-1.0,,-999.0,,,,,,,,,,,-1.0,,P98170_D_196_A
4931,P98170,D,214,S,1c9q:A,91,Reduced interaction with PRSS25. Reduced interaction with PRSS25,-1.0,,-999.0,,,,,,,,,,,,,P98170_D_214_S
4932,P98170,N,259,D,1f9x:A,259,Reduced interaction with PRSS25,-1.0,,-999.0,,,,,,,,,,,,,P98170_N_259_D
4933,P98170,W,310,R,1f9x:A,310,Reduced interaction with PRSS25,-1.0,,-999.0,,,,,,,,,,,,,P98170_W_310_R
4934,P98170,E,314,S,1f9x:A,314,Decreased interaction with DIABLO/SMAC and with PRSS25. Decreases interaction with PRSS25,-1.0,,-999.0,,,,,,,,,,,,,P98170_E_314_S
4935,P98170,C,450,A,2ecg:A,28,Inhibits degradation of active caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_C_450_A
4935,P98170,C,450,S,2ecg:A,28,Inhibits degradation of active caspase-3.,-1.0,,-999.0,,,,,,,,,,,,,P98170_C_450_S
4936,P98170,H,467,A,2ecg:A,45,Loss of E3 ubiquitin-protein ligase activity.,,,1.0,,,,,,,,,,,,,P98170_H_467_A
4937,Q9HAZ1,K,189,R,6fyv:A,191,Loss of function.,,,1.0,,,,,,,,,,,,,Q9HAZ1_K_189_R
4938,Q04760,C,19,A,1qip:B,18,No effect on NO-mediated modification. Impaired NO-mediated modification,,,-999.0,,,,,,,,,,,,,Q04760_C_19_A
4939,Q04760,C,20,A,1qip:B,19,No effect on NO-mediated modification. Impaired NO-mediated modification,,,-999.0,,,,,,,,,,,,,Q04760_C_20_A
4940,Q04760,Q,34,E,1qip:B,33,Reduces enzyme activity by 99%.,,,1.0,,,,,,,,,,,,,Q04760_Q_34_E
4941,Q04760,S,45,A,1qip:B,44,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q04760_S_45_A
4942,Q04760,C,61,A,1qip:B,60,No effect on NO-mediated modification.,,,-999.0,,,,,,,,,,,,,Q04760_C_61_A
4943,Q04760,S,69,A,1qip:B,68,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q04760_S_69_A
4944,Q04760,S,94,A,1qip:B,93,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q04760_S_94_A
4945,Q04760,T,98,A,1qip:B,97,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q04760_T_98_A
4946,Q04760,E,100,Q,1qip:B,99,Reduces enzyme activity by over 99%.,,,1.0,,,,,,,,,,,,,Q04760_E_100_Q
4947,Q04760,T,102,A,1qip:B,101,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q04760_T_102_A
4948,Q04760,T,107,A,1qip:B,106,Loss of phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q04760_T_107_A
4949,Q04760,C,139,A,1qip:B,138,Impaired NO-mediated modification. Loss of NO-mediated modification,,,-999.0,,,,,,,,,,,,,Q04760_C_139_A
4950,Q04760,E,173,Q,1qip:B,172,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q04760_E_173_Q
4951,P52630,R,374,A,6wcz:A,374,Prevents the nuclear import,,,-999.0,,,,,,,,,1.0,,,,P52630_R_374_A
4952,P52630,K,375,A,6wcz:A,375,Prevents the nuclear import,,,-999.0,,,,,,,,,1.0,,,,P52630_K_375_A
4953,P52630,R,409,A,6wcz:A,409,Prevents the nuclear import,,,-999.0,,,,,,,,,1.0,,,,P52630_R_409_A
4954,Q01081,W,134,A,1jmt:A,134,Decreases affinity for UAF2 by 3 orders of magnitude.,-1.0,,-999.0,,,,,,,,,,,,,Q01081_W_134_A
4955,P23443,K,167,N,4l3l:A,144,Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252.,,,1.0,-1.0,,,,,,,,,,,,P23443_K_167_N
4956,P00747,S,741,A,4duu:A,722,"Proteolytically cleaved, but abolishes plasmin activity and cell detachment.",,,-999.0,,,,,,,,,,,,,P00747_S_741_A
4957,P00740,Y,305,F,6x5j:A,94,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_Y_305_F
4958,P00740,K,311,T,6x5j:A,100,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_K_311_T
4959,P00740,Y,312,A,6x5j:A,101,Strongly decreases enzyme activity with a synthetic peptide substrate.,,,1.0,,,,,,,,,,,,,P00740_Y_312_A
4960,P00740,Y,391,T,6x5j:A,180,Strongly increases enzyme activity with a synthetic peptide substrate,,,1.0,,,,,,,,,,,,,P00740_Y_391_T
4961,O43715,F,27,A,6i3y:A,40,Impairs interaction with PRELID3A.,-1.0,,-999.0,,,,,,,,,,,,,O43715_F_27_A
4962,O43719,Y,136,D,6y50:q,136,Loss of interaction with U snRNPs.,,-1.0,-999.0,,,,,,,,,,,,,O43719_Y_136_D
4963,P00749,S,323,E,2vnt:A,154,"Abolishes phosphorylation, proadhesive function and ability to induce chemotactic response",,,-999.0,-1.0,,,,,,,,,,,,P00749_S_323_E
4964,Q9BSM1,Y,191,A,4hpl:B,191,Abolishes interaction with BCOR and BCORL1.,-1.0,,-999.0,,,,,,,,,,,,,Q9BSM1_Y_191_A
4965,Q9BSM1,R,193,A,4hpl:B,193,Abolishes interaction with BCOR and BCORL1.,-1.0,,-999.0,,,,,,,,,,,,,Q9BSM1_R_193_A
4966,Q9BSM1,S,195,F,4hpl:B,195,Abolishes repressor activity. May be a PKC phosphorylation site.,,,1.0,-1.0,,,,,,,,,,,,Q9BSM1_S_195_F
4967,Q9BSM1,V,206,D,4hpl:B,206,Abolishes interaction with BCOR and BCORL1.,-1.0,,-999.0,,,,,,,,,,,,,Q9BSM1_V_206_D
4968,O15492,Y,168,F,2bt2:A,168,30% decrease in GAP activity.,,,1.0,,,,,,,,,,,,,O15492_Y_168_F
4969,O15492,Y,177,F,2bt2:A,177,No effect on GAP activity.,,,0.0,,,,,,,,,,,,,O15492_Y_177_F
4970,O15496,H,88,Q,5g3m:A,46,Loss of PLA2 activity toward PAF. Impairs anti-adenoviral activity.,-1.0,,1.0,,,,,,,,,,,,,O15496_H_88_Q
4971,O15498,F,42,E,6j7f:C,42,Increases palmitoylation. Targeted to Golgi membranes. Targeted to Golgi and cytosol,,,1.0,,,,,,,,,,,,,O15498_F_42_E
4972,O15498,C,194,S,6j7f:C,194,Decreases palmitoylation by 55%. Prevents palmitoylation,,,1.0,,,,,,,,,,,,,O15498_C_194_S
4973,P12931,K,298,M,1y57:A,295,Kinase inactive. Abolishes ubiquitination promoted by CBLC.,,,1.0,,-1.0,,,,,,,,,,,P12931_K_298_M
4974,P12931,P,302,E,1y57:A,299,Kinase active. Interacts with PDLIM4,0.0,,1.0,,,,,,,,,,,,,P12931_P_302_E
4975,P12931,P,307,E,1y57:A,304,Kinase active. Interacts with PDLIM4,0.0,,1.0,,,,,,,,,,,,,P12931_P_307_E
4976,P12931,Y,419,F,1y57:A,416,Loss of kinase activity. Loss of interaction with PDLIM4.,-1.0,,1.0,,,,,,,,,,,,,P12931_Y_419_F
4977,P41279,T,290,A,5iu2:A,290,Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding.,0.0,,1.0,-1.0,,,,,,,,,,,,P41279_T_290_A
4978,P41279,T,290,D,5iu2:A,290,Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding.,0.0,,1.0,-1.0,,,,,,,,,,,,P41279_T_290_D
4979,P41279,T,290,E,5iu2:A,290,Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding.,0.0,,1.0,-1.0,,,,,,,,,,,,P41279_T_290_E
4980,P61088,C,87,A,7bbd:C,87,Loss of polyubiquitination of PCNA. Impairs interaction with SHPRH.,-1.0,,1.0,,,,,,,,,,,,,P61088_C_87_A
4981,P61088,K,92,R,7bbd:C,92,No ISGylation.,,,-999.0,,,,,,0.0,,,,,,,P61088_K_92_R
4982,P61088,K,94,R,7bbd:C,94,No effect on ISGylation.,,,-999.0,,,,,,0.0,,,,,,,P61088_K_94_R
4983,P46976,Y,195,F,3u2u:A,195,Loss of glucosylation.,,,-999.0,,,,,,0.0,,,,,,,P46976_Y_195_F
4985,Q13188,K,56,R,4lgd:B,56,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13188_K_56_R
4986,Q9H9B1,E,905,A,6by9:A,905,Abolishes binding to histone H3K9me.,-1.0,,-999.0,,,,,,,,,,,,,Q9H9B1_E_905_A
4987,Q9UI95,Y,63,A,6bcd:A,63,Alters interaction with REV3L. Loss of interaction with REV3L,-1.0,,-999.0,,,,,,,,,,,,,Q9UI95_Y_63_A
4988,Q9UI95,R,124,A,6bcd:A,124,Induces structural changes that increase affinity for REV3L and REV1. No effect on interaction with REV1,1.0,,-999.0,,,,,,,,,,,1.0,,Q9UI95_R_124_A
4989,Q9UI95,W,171,A,6bcd:A,171,Alters interaction with REV3L and REV1. Loss of interaction with REV3L,-1.0,,-999.0,,,,,,,,,,,,,Q9UI95_W_171_A
4990,Q9UI95,L,186,A,6bcd:A,186,Significantly prevents interaction with REV1,-1.0,,-999.0,,,,,,,,,,,,,Q9UI95_L_186_A
4991,Q9UI95,Q,200,A,6bcd:A,200,Significantly prevents interaction with REV1,-1.0,,-999.0,,,,,,,,,,,,,Q9UI95_Q_200_A
4992,Q9UI95,Y,202,A,6bcd:A,202,Significantly prevents interaction with REV1,-1.0,,-999.0,,,,,,,,,,,,,Q9UI95_Y_202_A
4993,Q6ZMT1,Q,306,L,6b27:A,306,Mildly decreased affinity for CACNA1S.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZMT1_Q_306_L
4994,Q6ZMT1,W,329,S,6b27:A,329,Loss of interaction with CACNA1S.,-1.0,,-999.0,,,,,,,,,,,,,Q6ZMT1_W_329_S
4995,Q6ZMT1,Q,347,I,6b27:A,347,No effect on the structure of the two SH3 domains.,,,-999.0,,,,,,,,,,,0.0,,Q6ZMT1_Q_347_I
4996,Q6ZMT4,H,282,A,3kv6:D,282,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q6ZMT4_H_282_A
4997,Q9UH77,S,433,E,5nkp:B,433,Phosphomimetic mutant that shows decreased interaction with WNK4.,-1.0,,-999.0,,,,,,,,,,1.0,,,Q9UH77_S_433_E
4997,Q9UH77,S,433,D,5nkp:B,433,Phosphomimetic mutant that shows decreased interaction with WNK4.,-1.0,,-999.0,,,,,,,,,,1.0,,,Q9UH77_S_433_D
4998,P21926,C,9,A,6k4j:A,9,Loss of palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P21926_C_9_A
4999,P21926,C,78,A,6k4j:A,78,Loss of palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P21926_C_78_A
5000,P21926,C,79,A,6k4j:A,79,Loss of palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P21926_C_79_A
5001,P21926,C,87,A,6k4j:A,87,Loss of palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P21926_C_87_A
5002,P08686,V,281,I,4y8w:A,282,Normal KM but 50% reduced Vmax.,,,1.0,,,,,,,,,,,,,P08686_V_281_I
5003,P08686,V,281,T,4y8w:A,282,Normal KM but 10% reduced Vmax.,,,1.0,,,,,,,,,,,,,P08686_V_281_T
5004,P08686,C,428,M,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,1.0,,,,,,,,,,,,,P08686_C_428_M
5004,P08686,C,428,S,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,1.0,,,,,,,,,,,,,P08686_C_428_S
5004,P08686,C,428,T,4y8w:C,429,Loss of activity and loss of P450 absorption.,,,1.0,,,,,,,,,,,,,P08686_C_428_T
5005,P18433,Y,798,F,6uzt:A,789,"Abolishes integrin-mediated interaction with BCAR1 and BCAR3 and reduces interaction between BCAR1 and CRK and, BCAR1 and SRC. Abolishes integrin-induced SRC-mediated tyrosine phosphorylation of BCAR1. Abolishes integrin-mediated recruitment of BCAR1, BCAR3, CRK and PTPRA to focal adhesions. Reduces integrin-mediated activation and membrane recruitment of RAC1 and CDC42.",-1.0,,1.0,,,,,,,,,,,,,P18433_Y_798_F
5006,A6ND01,E,45,A,5f4e:B,45,Nearly abolishes interaction with IZUMO1.,-1.0,,-999.0,,,,,,,,,,,,,A6ND01_E_45_A
5007,A6ND01,E,45,K,5f4e:B,45,Abolishes interaction with IZUMO1.,-1.0,,-999.0,,,,,,,,,,,,,A6ND01_E_45_K
5008,A6ND01,W,62,A,5f4e:B,62,Nearly abolishes interaction with IZUMO1.,-1.0,,-999.0,,,,,,,,,,,,,A6ND01_W_62_A
5009,A6ND01,L,81,A,5f4e:B,81,Abolishes interaction with IZUMO1.,-1.0,,-999.0,,,,,,,,,,,,,A6ND01_L_81_A
5010,A6ND01,K,163,E,5jkd:B,163,Mildly decreases interaction with IZUMO1.,-1.0,,-999.0,,,,,,,,,,,,,A6ND01_K_163_E
5011,P61328,R,114,A,4jq0:A,57,"Gain of function, affects voltage dependence of SCN8A fast inactivation.",,,1.0,,,,,,,,,,,,,P61328_R_114_A
5012,P61328,R,114,G,4jq0:A,57,"Gain of function, affects voltage dependence of SCN8A fast inactivation.",,,1.0,,,,,,,,,,,,,P61328_R_114_G
5013,Q13454,C,99,S,4m90:A,58,Reduces N-glycosylation of cysteine-proximal acceptor sites,,,1.0,,,,,,,,,,,,,Q13454_C_99_S
5014,Q13454,C,102,S,4m90:A,61,Reduces N-glycosylation of cysteine-proximal acceptor sites,,,1.0,,,,,,,,,,,,,Q13454_C_102_S
5015,Q9BYX4,S,828,A,7jl0:A,828,Promotes multimerization after polyI,1.0,,-999.0,,,,,,,,,,,,,Q9BYX4_S_828_A
5016,Q9BYX4,S,828,D,7jl0:A,828,Inhibits multimerization after polyI,-1.0,,-999.0,,,,,,,,,,,,,Q9BYX4_S_828_D
5017,Q9BYX4,T,829,A,7jl0:A,829,Moderately increases signaling.,,,1.0,,,,,,,,,,,,,Q9BYX4_T_829_A
5018,O43447,W,133,F,1qoi:A,133,Abolishes inhibition by cyclosporin A.,,,1.0,,,,,,,,,,,,,O43447_W_133_F
5019,Q8IWA4,K,15,A,5go4:A,15,Decreases GTPase activity. Impairs mitochondrial fusion.,,,1.0,,,,,,,,,,,,,Q8IWA4_K_15_A
5020,Q8IWA4,R,74,P,5go4:A,74,Mildly decreases GTPase activity and impairs mitochondrial fusion.,,,1.0,,,,,,,,,,,,,Q8IWA4_R_74_P
5021,Q8IWA4,K,88,A,5go4:A,88,Abolishes GTPase activity. Abolishes dimerization.,-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_K_88_A
5022,Q8IWA4,K,88,T,5go4:A,88,Induces a strong decrease in mitochondrial clustering.,,,-999.0,,,,,,,,,,,,,Q8IWA4_K_88_T
5023,Q8IWA4,K,99,A,5go4:A,99,Mildly decreases GTPase activity.,,,1.0,,,,,,,,,,,,,Q8IWA4_K_99_A
5024,Q8IWA4,P,102,L,5go4:A,102,Impairs protein folding. Decreases GTPase activity.,,,1.0,,,,,,,,,,,-1.0,,Q8IWA4_P_102_L
5025,Q8IWA4,H,107,A,5go4:A,107,"Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",,0.0,1.0,,,,,,,,,,,,,Q8IWA4_H_107_A
5026,Q8IWA4,T,109,A,5go4:A,109,Acts as a dominant negative mutant,,,1.0,,,,,,,,,,,,,Q8IWA4_T_109_A
5027,Q8IWA4,H,144,A,5go4:A,144,Abolishes GTPase activity. Abolishes dimerization.,-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_H_144_A
5028,Q8IWA4,D,173,A,5go4:A,173,Decreases GTPase activity.,,,1.0,,,,,,,,,,,,,Q8IWA4_D_173_A
5029,Q8IWA4,D,189,A,5go4:A,189,Causes mitochondrial clumping.,,,-999.0,,,,,,,,,,,,,Q8IWA4_D_189_A
5030,Q8IWA4,E,209,A,5go4:A,209,"Abolishes dimerization. Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_E_209_A
5031,Q8IWA4,R,238,A,5go4:A,238,"Abolishes dimerization. Loss of function in mitochondrial fusion. Abolishes GTPase activity, but has no effect on GTP binding.",-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_R_238_A
5032,Q8IWA4,W,239,A,5go4:A,239,Abolishes GTP binding and GTPase activity. Loss of function in mitochondrial fusion.,,-1.0,1.0,,,,,,,,,,,,,Q8IWA4_W_239_A
5033,Q8IWA4,E,245,A,5go4:A,245,Decreases GTPase activity. Abolishes dimerization. Impairs mitochondrial fusion.,-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_E_245_A
5034,Q8IWA4,G,309,P,5go4:A,309,Mildly decreases GTPase activity and impairs mitochondrial fusion.,,,1.0,,,,,,,,,,,,,Q8IWA4_G_309_P
5035,Q8IWA4,I,328,A,5go4:A,328,Slightly decreases GTPase activity.,,,1.0,,,,,,,,,,,,,Q8IWA4_I_328_A
5036,Q8IWA4,K,336,N,5go4:A,336,Loss of function in mitochondrial fusion. Abolishes dimerization. Decreases GTPase activity.,-1.0,,1.0,,,,,,,,,,,,,Q8IWA4_K_336_N
5037,Q8IWA4,K,336,P,5go4:A,336,Decreases GTPase activity and impairs mitochondrial fusion.,,,1.0,,,,,,,,,,,,,Q8IWA4_K_336_P
5038,Q13459,A,1739,E,5c5s:A,158,Decreases interaction with RHOA. Strongly decreases stimulation of RHOA GTPase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q13459_A_1739_E
5038,Q13459,A,1739,N,5c5s:A,158,Decreases interaction with RHOA. Strongly decreases stimulation of RHOA GTPase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q13459_A_1739_N
5039,Q13459,N,1741,E,5c5s:A,160,Decreases interaction with RHOA. Decreases stimulation of RHOA GTPase activity.,-1.0,,-999.0,,,,,,,,,,,,,Q13459_N_1741_E
5040,Q13459,R,1742,E,5c5s:A,161,Strongly decreases interaction with RHOA. Strongly decreases stimulation of RHOA GTPase activity.,,,-999.0,,,,,,,,,,,,,Q13459_R_1742_E
5041,P15104,C,209,A,2qc8:A,209,Reduced ability to mediate autopalmitoylation.,,,1.0,,,,,,-1.0,,,,,,,P15104_C_209_A
5042,P15104,R,324,A,2qc8:A,324,Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.,,,1.0,,,,,,,,,1.0,,,,P15104_R_324_A
5042,P15104,R,324,C,2qc8:A,324,Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.,,,1.0,,,,,,,,,1.0,,,,P15104_R_324_C
5043,P25445,R,250,E,1ddf:A,234,Strongly decreased interaction with FADD.,-1.0,,-999.0,,,,,,,,,,,,,P25445_R_250_E
5044,P25445,E,261,K,1ddf:A,245,Loss of interaction with FADD.,-1.0,,-999.0,,,,,,,,,,,,,P25445_E_261_K
5045,P25445,Q,283,K,1ddf:A,267,Loss of interaction with FADD.,-1.0,,-999.0,,,,,,,,,,,,,P25445_Q_283_K
5046,P25445,K,287,D,1ddf:A,271,Strongly decreased interaction with FADD.,-1.0,,-999.0,,,,,,,,,,,,,P25445_K_287_D
5047,P25445,Y,291,D,1ddf:A,275,Decreased interaction with FADD.,-1.0,,-999.0,,,,,,,,,,,,,P25445_Y_291_D
5048,P25445,I,313,D,1ddf:A,297,"Constitutive activation. Promotes apoptosis, both in the presence and in the absence of stimulation by a ligand.",,,1.0,,,,,,,,,,,,,P25445_I_313_D
5049,Q13451,K,28,Q,5njx:A,28,Mimics acetylation,,,-999.0,,,,,,,,,,1.0,,,Q13451_K_28_Q
5050,Q13451,K,28,R,5njx:A,28,Decreased acetylation,,,-999.0,,,,,,,,,,,,,Q13451_K_28_R
5051,Q13451,K,155,Q,5njx:A,155,Mimics acetylation,,,-999.0,,,,,,,,,,1.0,,,Q13451_K_155_Q
5052,Q13451,K,155,R,5njx:A,155,Decreased acetylation,,,-999.0,,,,,,,,,,,,,Q13451_K_155_R
5053,P50225,C,70,S,1z28:A,70,Increased sensitivity of enzyme activity to heat inactivation.,,,1.0,,,,,,,,,,,,,P50225_C_70_S
5054,P50225,D,249,G,1z28:A,249,Increased activity towards p-nitrophenol.,,,1.0,,,,,,,,,,,,,P50225_D_249_G
5055,P63096,G,42,R,6ot0:A,42,Abolishes switch to an activated conformation and dissociation from beta and gamma subunits upon GTP binding. Abolishes interaction with RGS family members.,,,-999.0,,,,,,,,,,,,,P63096_G_42_R
5056,P63096,E,116,L,6ot0:A,116,Enhances interaction (inactive GDP-bound) with RGS14.,1.0,,-999.0,,,,,,,,,,,,,P63096_E_116_L
5057,P63096,Q,147,L,6ot0:A,147,Enhances interaction (inactive GDP-bound) with RGS14.,1.0,,-999.0,,,,,,,,,,,,,P63096_Q_147_L
5058,P63096,E,245,L,6ot0:A,245,Enhances interaction (inactive GDP-bound) with RGS14.,1.0,,-999.0,,,,,,,,,,,,,P63096_E_245_L
5059,P63092,Q,170,A,6au6:A,170,Increases GDP release but does not affect receptor-mediated activation.,0.0,-1.0,0.0,,,,,,,,,,,,,P63092_Q_170_A
5060,P63092,Q,227,L,6au6:A,227,Increases binding to GAS2L2,1.0,,-999.0,,,,,,,,,,,,,P63092_Q_227_L
5061,P63092,R,258,A,6au6:A,258,Increases GDP release and impairs receptor-mediated activation,-1.0,-1.0,1.0,,,,,,,,,,,,,P63092_R_258_A
5062,P63092,D,295,N,6au6:A,295,Increases binding to GAS2L2,1.0,,-999.0,,,,,,,,,,,,,P63092_D_295_N
5063,P10997,F,48,A,6uck:A,26,Promotes formation of fibrillar aggregates.,1.0,,-999.0,,,,,,,,,,,,,P10997_F_48_A
5063,P10997,F,48,D,6uck:A,26,Promotes formation of fibrillar aggregates.,1.0,,-999.0,,,,,,,,,,,,,P10997_F_48_D
5063,P10997,F,48,S,6uck:A,26,Promotes formation of fibrillar aggregates.,1.0,,-999.0,,,,,,,,,,,,,P10997_F_48_S
5064,Q9UBR1,R,130,I,6ftq:A,130,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UBR1_R_130_I
5065,Q9UBR1,K,132,L,6ftq:A,132,"Loss of catalytic activity. Forms dimers, but no higher oligomers.",-1.0,,1.0,,,,,,,,,,,,,Q9UBR1_K_132_L
5066,Q9UBR1,C,233,A,6ftq:A,233,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UBR1_C_233_A
5067,Q9UBR1,T,299,C,6ftq:A,299,"Loss of catalytic activity. Forms dimers, but no higher oligomers.",-1.0,,1.0,,,,,,,,,,,,,Q9UBR1_T_299_C
5068,Q8ND25,C,184,A,5ywr:B,184,Loss of E3 activity.,,,1.0,,,,,,,,,,,,,Q8ND25_C_184_A
5069,Q8NI35,L,19,W,1vf6:B,19,Reduces L27 domain binding affinity to MPP5 L27 domain.,-1.0,,-999.0,,,,,,,,,,,,,Q8NI35_L_19_W
5070,Q8NI35,F,38,W,1vf6:B,38,Reduces L27 domain binding affinity to MPP5 L27 domain.,-1.0,,-999.0,,,,,,,,,,,,,Q8NI35_F_38_W
5071,P49662,C,258,A,6kmz:A,258,Loss of enzymatic activity. Loss of LPS-induced pyroptosis. No effect on the interaction with LPS. Decrease in cell death induced by TMEM214 overexpression. Does not support IL1B and IL18 secretion following UVB irradiation.,0.0,,1.0,,,,,,,,,,,,,P49662_C_258_A
5072,P49662,C,258,S,6kmz:A,258,Loss of autocatalysis.,,,1.0,,,,,,,,,,,,,P49662_C_258_S
5073,P49662,W,267,L,6kmz:A,267,Abolished interaction with Gasdermin-D (GSDMD) and ability to mediate its cleavage.,-1.0,,-999.0,,,,,,,,,,,,,P49662_W_267_L
5073,P49662,W,267,N,6kmz:A,267,Abolished interaction with Gasdermin-D (GSDMD) and ability to mediate its cleavage.,-1.0,,-999.0,,,,,,,,,,,,,P49662_W_267_N
5074,P49662,V,291,N,6nry:A,291,Abolished interaction with Gasdermin-D (GSDMD) and ability to mediate its cleavage.,-1.0,,-999.0,,,,,,,,,,,,,P49662_V_291_N
5075,O14727,K,160,R,3jbt:A,160,No association with APAF-1. No binding to pro-caspase-9.,-1.0,,-999.0,,,,,,,,,,,,,O14727_K_160_R
5076,O14727,M,368,L,3jbt:A,368,Activation of pro-caspase-9 independent of cytochrome c. Increased ability to induce apoptosis.,,,1.0,,,,,,,,,,,,,O14727_M_368_L
5077,P03956,Y,360,F,4auo:A,341,Partial reduction of tyrosine phosphorylation in the presence of PKDCC/VLK.,,,1.0,,,,,,,,,,,,,P03956_Y_360_F
5078,Q96BZ9,R,105,A,4hlq:C,105,1000-fold decrease in GAP activity.,,,1.0,,,,,,,,,,,,,Q96BZ9_R_105_A
5079,Q96BZ9,Q,144,L,4hlq:C,144,1000-fold decrease in GAP activity.,,,1.0,,,,,,,,,,,,,Q96BZ9_Q_144_L
5080,P48728,D,129,A,1wsv:A,101,Loss of aminomethyltransferase activity.,,,1.0,,,,,,,,,,,,,P48728_D_129_A
5080,P48728,D,129,N,1wsv:A,101,Loss of aminomethyltransferase activity.,,,1.0,,,,,,,,,,,,,P48728_D_129_N
5081,P16220,K,290,R,5zk1:A,304,"Decreased sumoylation, in vivo and in vitro. Loss of nuclear localization.",,,-999.0,,,,-1.0,,,,,1.0,,,,P16220_K_290_R
5082,Q9H999,E,138,V,2i7p:D,138,Prevents acetyl-CoA production.,,,1.0,,,,,,,,,,,,,Q9H999_E_138_V
5083,Q9H999,R,207,W,2i7p:D,207,Increases affinity for ATP and decreases affinity for acetyl-CoA. Increases acetyl-CoA production.,,1.0,1.0,,,,,,,,,,,,,Q9H999_R_207_W
5084,Q53H47,N,223,S,3bo5:A,209,Reduces activity in double-strand break repair.,,,1.0,,,,,,,,,,,,,Q53H47_N_223_S
5085,Q53H47,D,261,S,3bo5:A,247,Reduces activity in double-strand break repair.,,,1.0,,,,,,,,,,,,,Q53H47_D_261_S
5086,Q53H47,F,473,K,3k9k:B,460,Abolishes homodimerization and DNA-binding and reduces cleavage of single-stranded DNA.,-1.0,-1.0,1.0,,,,,,,,,,,,,Q53H47_F_473_K
5087,Q53H47,D,496,A,3k9k:B,483,Abolishes DNA cleavage.,,,1.0,,,,,,,,,,,,,Q53H47_D_496_A
5088,Q53H47,D,503,S,3k9k:B,490,Reduces activity in double-strand break repair.,,,1.0,,,,,,,,,,,,,Q53H47_D_503_S
5089,Q53H47,N,623,D,3k9j:A,610,Loss of function in DNA repair. Altered DNA-binding properties.,,-1.0,1.0,,,,,,,,,,,,,Q53H47_N_623_D
5089,Q53H47,N,623,E,3k9j:A,610,Loss of function in DNA repair. Altered DNA-binding properties.,,-1.0,1.0,,,,,,,,,,,,,Q53H47_N_623_E
5090,P16662,T,373,V,2o6l:A,373,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,1.0,,,,,,,,,,,,,P16662_T_373_V
5091,P16662,H,374,A,2o6l:A,374,Abolished androsterone glucuronosyltransferase activity,,,1.0,,,,,,,,,,,,,P16662_H_374_A
5091,P16662,H,374,E,2o6l:A,374,Abolished androsterone glucuronosyltransferase activity,,,1.0,,,,,,,,,,,,,P16662_H_374_E
5092,P16662,N,378,A,2o6l:A,378,Abolished androsterone glucuronosyltransferase activity,,,1.0,,,,,,,,,,,,,P16662_N_378_A
5093,P16662,G,379,D,2o6l:A,379,Abolished androsterone glucuronosyltransferase activity,,,1.0,,,,,,,,,,,,,P16662_G_379_D
5094,P16662,G,379,S,2o6l:A,379,Abolished androsterone glucuronosyltransferase activity,,,1.0,,,,,,,,,,,,,P16662_G_379_S
5095,P16662,D,398,A,2o6l:A,398,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,1.0,,,,,,,,,,,,,P16662_D_398_A
5095,P16662,D,398,N,2o6l:A,398,"Reduced androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,1.0,,,,,,,,,,,,,P16662_D_398_N
5096,P16662,Q,399,A,2o6l:A,399,"Abolished androsterone, hyodeoxycholic acid and tetrachlorocatechol glucuronosyltransferase activities.",,,1.0,,,,,,,,,,,,,P16662_Q_399_A
5097,Q16769,K,144,A,6gbx:A,144,Lowers activity by approximately 40%.,,,1.0,,,,,,,,,,,,,Q16769_K_144_A
5098,Q16769,F,146,A,6gbx:A,146,Lowers activity by approximately 30%.,,,1.0,,,,,,,,,,,,,Q16769_F_146_A
5099,Q16769,S,160,A,6gbx:A,160,Reduces activity by about 50%.,,,1.0,,,,,,,,,,,,,Q16769_S_160_A
5100,Q16769,S,160,G,6gbx:A,160,Reduces activity by 96%.,,,1.0,,,,,,,,,,,,,Q16769_S_160_G
5101,Q16769,E,201,D,6gbx:A,201,Reduces activity by about 98%.,,,1.0,,,,,,,,,,,,,Q16769_E_201_D
5102,Q16769,E,201,L,6gbx:A,201,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_E_201_L
5102,Q16769,E,201,Q,6gbx:A,201,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_E_201_Q
5103,Q16769,W,207,L,6gbx:A,207,Greatly lowers activity.,,,1.0,,,,,,,,,,,,,Q16769_W_207_L
5104,Q16769,D,248,A,6gbx:A,248,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q16769_D_248_A
5105,Q16769,D,248,Q,6gbx:A,248,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_D_248_Q
5106,Q16769,Q,304,L,6gbx:A,304,Lowers activity by approximately 35%.,,,1.0,,,,,,,,,,,,,Q16769_Q_304_L
5107,Q16769,D,305,A,6gbx:A,305,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_D_305_A
5107,Q16769,D,305,E,6gbx:A,305,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_D_305_E
5107,Q16769,D,305,L,6gbx:A,305,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_D_305_L
5108,Q16769,D,305,N,6gbx:A,305,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,Q16769_D_305_N
5109,Q16769,H,319,L,6gbx:A,319,Reduces activity by 87%.,,,1.0,,,,,,,,,,,,,Q16769_H_319_L
5110,Q16769,F,325,A,6gbx:A,325,Greatly lowers activity.,,,1.0,,,,,,,,,,,,,Q16769_F_325_A
5111,Q16769,W,329,A,6gbx:A,329,Abolishes activity.,,,1.0,,,,,,,,,,,,,Q16769_W_329_A
5112,Q16763,C,95,S,1zdn:A,95,Loss of function.,,,1.0,,,,,,,,,,,,,Q16763_C_95_S
5113,Q16763,K,117,A,1zdn:A,117,Reduced ubiquitination activity.,,,1.0,,,,,,,,,,,,,Q16763_K_117_A
5114,Q16760,W,1145,G,3bq7:C,5,Loss of homooligomerization.,-1.0,,-999.0,,,,,,,,,,,,,Q16760_W_1145_G
5115,P30203,D,291,A,5a2e:A,291,Strongly reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_D_291_A
5116,P30203,E,293,A,5a2e:A,293,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_E_293_A
5117,P30203,Y,295,A,5a2e:A,295,Abolishes interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_Y_295_A
5118,P30203,E,298,A,5a2e:A,298,Nearly abolishes interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_E_298_A
5119,P30203,R,314,A,5a2e:A,314,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_R_314_A
5120,P30203,Y,327,A,5a2e:A,327,Nearly abolishes interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_Y_327_A
5121,P30203,S,329,A,5a2e:A,329,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_S_329_A
5122,P30203,N,346,A,5a2e:A,346,Strongly reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_N_346_A
5123,P30203,L,349,A,5a2e:A,349,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_L_349_A
5124,P30203,Q,352,A,5a2e:A,352,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_Q_352_A
5125,P30203,S,353,A,5a2e:A,353,Reduces interaction with ALCAM.,-1.0,,-999.0,,,,,,,,,,,,,P30203_S_353_A
5126,O00168,C,60,S,2jo1:A,40,Significantly reduced half-life,,,-999.0,,,,,,,,,,,-1.0,,O00168_C_60_S
5127,O00168,C,62,S,2jo1:A,42,Significantly reduced half-life,,,-999.0,,,,,,,,,,,-1.0,,O00168_C_62_S
5128,Q9UBT2,N,56,A,1y8q:D,56,Abolishes ATP-dependent activation of SUMO proteins.,,,1.0,,,,,,,,,,,,,Q9UBT2_N_56_A
5129,Q9UBT2,L,57,A,1y8q:D,57,Strongly reduces ATP-dependent activation of SUMO proteins.,,,1.0,,,,,,,,,,,,,Q9UBT2_L_57_A
5130,Q9UBT2,R,59,A,1y8q:D,59,Strongly reduces ATP-dependent activation of SUMO proteins.,,,1.0,,,,,,,,,,,,,Q9UBT2_R_59_A
5131,Q9UBT2,K,72,A,1y8q:D,72,Abolishes ATP-dependent activation of SUMO proteins.,,,1.0,,,,,,,,,,,,,Q9UBT2_K_72_A
5132,Q9UBT2,D,117,A,1y8q:D,117,Abolishes ATP-dependent activation of SUMO proteins.,,,1.0,,,,,,,,,,,,,Q9UBT2_D_117_A
5133,Q9UBT2,C,173,A,2px9:A,173,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9UBT2_C_173_A
5134,Q9UBT2,T,174,A,2px9:A,174,Slightly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9UBT2_T_174_A
5135,Q9UBT2,H,184,Q,2px9:A,184,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9UBT2_H_184_Q
5136,Q9UBT2,I,235,A,2px9:A,235,Strongly reduced interaction with UBE2I,-1.0,,-999.0,,,,,,,,,,,,,Q9UBT2_I_235_A
5137,Q9UBT2,I,238,A,2px9:A,238,Strongly reduced interaction with UBE2I,-1.0,,-999.0,,,,,,,,,,,,,Q9UBT2_I_238_A
5138,Q8WTT0,S,139,A,4zes:A,139,Significantly impairs carbohydrate binding for the trisaccharide Gal(beta1-3/4)GlcNAc(beta1-2)Man.,,-1.0,-999.0,,,,,,,,,,,,,Q8WTT0_S_139_A
5139,Q8WTT0,N,184,A,4zes:A,184,Abolishes carbohydrate binding for the trisaccharide Gal(beta1-3/4)GlcNAc(beta1-2)Man.,,-1.0,-999.0,,,,,,,,,,,,,Q8WTT0_N_184_A
5140,Q8WTT0,R,186,A,4zes:A,186,Significantly impairs carbohydrate binding for the trisaccharide Gal(beta1-3/4)GlcNAc(beta1-2)Man.,,-1.0,-999.0,,,,,,,,,,,,,Q8WTT0_R_186_A
5141,Q8WTT0,V,200,A,4zes:A,200,Significantly impairs carbohydrate binding for the trisaccharide Gal(beta1-3/4)GlcNAc(beta1-2)Man.,,-1.0,-999.0,,,,,,,,,,,,,Q8WTT0_V_200_A
5142,Q8WTT0,Q,202,A,4zes:A,202,Significantly impairs carbohydrate binding for the trisaccharide Gal(beta1-3/4)GlcNAc(beta1-2)Man.,,-1.0,-999.0,,,,,,,,,,,,,Q8WTT0_Q_202_A
5143,P47897,H,175,A,4ye9:A,175,Decreases catalytic efficiency about 60-fold.,,,1.0,,,,,,,,,,,,,P47897_H_175_A
5146,Q9HB96,T,346,A,2ilr:A,346,"Non-phosphorylatable by CHEK1, not polyubiquitinated and unable to complement the mitomycin C hypersensitivity of cells lacking FANCE",,,-999.0,-1.0,-1.0,,,,,,,,,,,Q9HB96_T_346_A
5147,Q9HB96,S,374,A,2ilr:A,374,"Non-phosphorylatable by CHEK1, not polyubiquitinated and unable to complement the mitomycin C hypersensitivity of cells lacking FANCE",,,-999.0,-1.0,-1.0,,,,,,,,,,,Q9HB96_S_374_A
5148,Q9HB90,S,75,L,6ulg:G,75,Increased RPTOR-binding.,1.0,,-999.0,,,,,,,,,,,,,Q9HB90_S_75_L
5149,Q9HB90,S,75,N,6ulg:G,75,"Reduced affinity for all nucleotides, but with preferential binding of GDP over GTP, leading to activate mTORC1.",,-1.0,-999.0,,,,,,,,,,,,,Q9HB90_S_75_N
5150,Q9HB90,Q,120,L,6ulg:G,120,"Maintains GTP-bound state, leading to inactivate mTORC1. Decreased RPTOR-binding.",-1.0,1.0,-999.0,,,,,,,,,,,,,Q9HB90_Q_120_L
5151,P19835,H,455,Q,1f6w:A,435,Abolishes lipase activity. Decreases Vmax for esterase activity by 2.5-fold.,,,1.0,,,,,,,,,,,,,P19835_H_455_Q
5152,O14618,C,22,S,6fon:A,22,Reduces copper binding by half,,-1.0,-999.0,,,,,,,,,,,,,O14618_C_22_S
5153,O14618,C,25,S,6fon:A,25,Reduces copper binding by half,,-1.0,-999.0,,,,,,,,,,,,,O14618_C_25_S
5154,O14618,C,244,S,6fon:A,244,Reduces copper binding by half,,-1.0,-999.0,,,,,,,,,,,,,O14618_C_244_S
5155,O14618,C,246,S,6fon:A,246,Reduces copper binding by half,,-1.0,-999.0,,,,,,,,,,,,,O14618_C_246_S
5156,Q13625,W,1098,K,6ghm:D,1098,Loss of interaction with APC2.,-1.0,,-999.0,,,,,,,,,,,,,Q13625_W_1098_K
5157,Q15459,E,48,F,7abi:p,48,SLURP 1 motif acquires binding to SF3A3,1.0,,-999.0,,,,,,,,,,,,,Q15459_E_48_F
5158,Q15459,K,55,L,7abi:p,55,SLURP 1 motif acquires binding to SF3A3,1.0,,-999.0,,,,,,,,,,,,,Q15459_K_55_L
5159,Q15459,F,162,E,6y5q:6,162,No effect on binding to SF3A3.,0.0,,-999.0,,,,,,,,,,,,,Q15459_F_162_E
5160,Q15459,L,169,K,6y5q:6,169,Abolishes binding to SF3A3.,-1.0,,-999.0,,,,,,,,,,,,,Q15459_L_169_K
5161,Q13627,K,188,R,4aze:A,188,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q13627_K_188_R
5162,Q13627,Y,321,F,4aze:A,321,Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues.,,,1.0,0.0,,,,,,,,,,,,Q13627_Y_321_F
5163,P19838,C,61,S,2o61:B,59,"Suppresses S-nitrosylation-induced inhibition of DNA-binding activity. Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of DNA-binding activity.",,-1.0,-999.0,,,,,,,,,,,,,P19838_C_61_S
5164,P15328,Y,82,A,4lrh:D,60,Slightly reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_Y_82_A
5165,P15328,D,103,A,4lrh:D,81,Strongly reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_D_103_A
5166,P15328,Y,107,A,4lrh:D,85,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_Y_107_A
5167,P15328,W,124,A,4lrh:D,102,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_W_124_A
5168,P15328,R,125,A,4lrh:D,103,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_R_125_A
5169,P15328,R,128,A,4lrh:D,106,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_R_128_A
5170,P15328,H,157,A,4lrh:D,135,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_H_157_A
5171,P15328,W,162,A,4lrh:D,140,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_W_162_A
5172,P15328,S,196,A,4lrh:D,174,Moderately reduced affinity for folate.,,-1.0,-999.0,,,,,,,,,,,,,P15328_S_196_A
5173,Q96AT9,S,10,A,3qc3:A,10,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q96AT9_S_10_A
5174,Q96AT9,L,12,A,3qc3:A,12,Reduces enzyme activity by half.,,,1.0,,,,,,,,,,,,,Q96AT9_L_12_A
5175,Q96AT9,H,35,A,3qc3:A,35,Alters protein structure. Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,-1.0,,Q96AT9_H_35_A
5176,Q96AT9,D,37,A,3qc3:A,37,Alters protein structure. Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,-1.0,,Q96AT9_D_37_A
5177,Q96AT9,M,39,A,3qc3:A,39,Lowers enzyme activity by 10%.,,,1.0,,,,,,,,,,,,,Q96AT9_M_39_A
5178,Q96AT9,H,70,A,3qc3:A,70,Alters protein structure.,,,-999.0,,,,,,,,,,,-1.0,,Q96AT9_H_70_A
5179,Q96AT9,M,72,A,3qc3:A,72,Reduces enzyme activity by half.,,,1.0,,,,,,,,,,,,,Q96AT9_M_72_A
5180,Q96AT9,M,141,A,3qc3:A,141,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q96AT9_M_141_A
5181,Q96AT9,D,175,A,3qc3:A,175,Alters protein structure.,,,-999.0,,,,,,,,,,,-1.0,,Q96AT9_D_175_A
5182,P56524,H,803,L,2vqj:A,159,Abolishes histone deacetylase activity.,,,1.0,,,,,,,,,,,,,P56524_H_803_L
5183,P05154,R,248,E,2ol2:A,229,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Strongly reduces the rate of thrombin inhibition in the presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_R_248_E
5184,P05154,R,253,E,2ol2:A,234,Inhibits strongly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_R_253_E
5185,P05154,E,272,K,2ol2:A,253,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,0.0,,,,,,,,,,,,,P05154_E_272_K
5186,P05154,K,274,E,2ol2:A,255,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_K_274_E
5187,P05154,K,285,E,2ol2:A,266,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_K_285_E
5188,P05154,R,288,E,2ol2:A,269,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_R_288_E
5189,P05154,K,289,E,2ol2:A,270,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Inhibits weakly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_K_289_E
5190,P05154,K,292,E,2ol2:A,273,Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_K_292_E
5191,P05154,T,360,R,2ol2:A,341,Inhibits heterodimer formation with TMPRSS11E.,-1.0,,-999.0,,,,,,,,,,,,,P05154_T_360_R
5192,P05154,T,371,R,2ol2:A,352,Increases inhibition of activated protein C/F5 and factor XI/F11 activities. Decreases inhibition of thrombin activity.,,,1.0,,,,,,,,,,,,,P05154_T_371_R
5193,P05154,F,372,P,2ol2:A,353,Increases inhibition of thrombin activity.,,,1.0,,,,,,,,,,,,,P05154_F_372_P
5193,P05154,F,372,G,2ol2:A,353,Increases inhibition of thrombin activity.,,,1.0,,,,,,,,,,,,,P05154_F_372_G
5194,P05154,R,373,P,2ol2:A,354,Increases inhibition of thrombin activity. Inhibits heterodimer formation with TMPRSS11E.,-1.0,,1.0,,,,,,,,,,,,,P05154_R_373_P
5195,P05154,R,376,P,2ol2:A,357,"Does not change inhibition of thrombin, activated protein C/F5 and factor XI/F11 activities.",,,0.0,,,,,,,,,,,,,P05154_R_376_P
5196,P05154,R,381,E,2ol2:A,362,Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin.,,,1.0,,,,,,,,,,,,,P05154_R_381_E
5197,Q6V1X1,E,275,K,6hp8:A,275,13-fold reduction in affinity for Ala-Pro-AFC,,-1.0,-999.0,,,,,,,,,,,,,Q6V1X1_E_275_K
5198,Q6V1X1,D,451,F,6hp8:A,451,Reduced dimerization and reduced enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,Q6V1X1_D_451_F
5199,Q6V1X1,S,755,A,6hp8:A,755,Abolishes activity,,,1.0,,,,,,,,,,,,,Q6V1X1_S_755_A
5200,Q6V1X1,D,788,A,6hp8:A,788,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q6V1X1_D_788_A
5200,Q6V1X1,D,788,S,6hp8:A,788,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q6V1X1_D_788_S
5200,Q6V1X1,D,788,V,6hp8:A,788,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q6V1X1_D_788_V
5201,Q6V1X1,D,788,E,6hp8:A,788,Loss of enzyme activity. Loss of dimerization.,-1.0,,1.0,,,,,,,,,,,,,Q6V1X1_D_788_E
5202,Q6V1X1,D,833,A,6hp8:A,833,Abolishes activity,,,1.0,,,,,,,,,,,,,Q6V1X1_D_833_A
5203,Q6V1X1,H,865,A,6hp8:A,865,Abolishes activity,,,1.0,,,,,,,,,,,,,Q6V1X1_H_865_A
5204,P55211,Y,153,F,2ar9:B,153,"Inhibits tyrosine phosphorylation. Reduces caspase-9 subunit p35 formation in response to genotoxic stress. Attenuates ABL1/c-Abl-mediated caspase-3 activation, DNA fragmentation and UV irradiation-induced apoptosis.",,,-999.0,-1.0,,,,,,,,,,,,P55211_Y_153_F
5205,P55210,C,186,A,4fdl:B,186,No apoptotic activity. Loss of autocatalytic cleavage.,,,1.0,,,,,,,,,,,,,P55210_C_186_A
5206,P55212,C,163,A,4nbl:A,163,Catalytically inactive active-site mutant.,,,1.0,,,,,,,,,,,,,P55212_C_163_A
5207,P55212,S,257,A,4n5d:A,257,Suppression of caspase-6 activation.,,,1.0,,,,,,,,,,,,,P55212_S_257_A
5208,P55212,S,257,D,4n5d:A,257,Prevents caspase-6 autoactivation.,,,1.0,,,,,,,,,,,,,P55212_S_257_D
5209,P55212,S,257,E,4n5d:A,257,Loss of self-activation.,,,1.0,,,,,,,,,,,,,P55212_S_257_E
5210,Q9C035,C,15,A,2ecv:A,22,Abolishes E3 ligase activity.,,,1.0,,,,,,,,,,,,,Q9C035_C_15_A
5211,Q04828,E,127,D,1mrq:A,127,30-fold decrease in k(cat)/K(m) value for progesterone reduction,,,-999.0,,,,,,,,,,,,,Q04828_E_127_D
5212,Q04828,H,222,I,1mrq:A,222,Marked decrease in k(cat)/K(m) value for progesterone,,,-999.0,,,,,,,,,,,,,Q04828_H_222_I
5213,Q04828,H,222,S,1mrq:A,222,Marked decrease in k(cat)/K(m) value for progesterone,,,-999.0,,,,,,,,,,,,,Q04828_H_222_S
5214,Q04828,R,304,L,1mrq:A,304,70-fold decrease in progesterone reduction. No effect on DHT reduction.,,,1.0,,,,,,,,,,,,,Q04828_R_304_L
5215,Q04828,Y,305,F,1mrq:A,305,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_Y_305_F
5216,Q04828,T,307,V,1mrq:A,307,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_T_307_V
5217,Q04828,D,309,V,1mrq:A,309,No effect on progesterone reduction.,,,0.0,,,,,,,,,,,,,Q04828_D_309_V
5218,P51684,C,36,A,6wwz:R,36,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_36_A
5219,P51684,C,36,D,6wwz:R,36,Loss of calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_36_D
5219,P51684,C,36,G,6wwz:R,36,Loss of calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_36_G
5220,P51684,C,36,S,6wwz:R,36,"No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and no effect on cell surface expression",-1.0,,1.0,,,,,,,,,0.0,,,,P51684_C_36_S
5221,P51684,C,57,S,6wwz:R,57,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_57_S
5222,P51684,C,118,S,6wwz:R,118,"Loss of calcium flux and chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and significant reduction in cell surface expression",-1.0,,1.0,,,,,,,,,1.0,,,,P51684_C_118_S
5223,P51684,C,131,S,6wwz:R,131,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_131_S
5224,P51684,C,138,S,6wwz:R,138,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_138_S
5225,P51684,C,168,S,6wwz:R,168,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_168_S
5226,P51684,C,197,S,6wwz:R,197,"Loss of calcium flux and chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and significant reduction in cell surface expression",-1.0,,1.0,,,,,,,,,1.0,,,,P51684_C_197_S
5227,P51684,C,233,S,6wwz:R,233,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_233_S
5228,P51684,C,266,S,6wwz:R,266,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_266_S
5229,P51684,C,288,A,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_288_A
5229,P51684,C,288,G,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_288_G
5229,P51684,C,288,R,6wwz:R,288,No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,1.0,,,,,,,,,0.0,,,,P51684_C_288_R
5230,P51684,C,288,S,6wwz:R,288,"No loss of calcium flux but loss of chemotaxis in response to CCL20 stimulation, impaired CCL20-binding and no effect on cell surface expression",-1.0,,1.0,,,,,,,,,0.0,,,,P51684_C_288_S
5231,P51684,C,309,S,6wwz:R,309,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_309_S
5232,P51684,C,310,S,6wwz:R,310,No effect on calcium flux and chemotaxis in response to CCL20 stimulation. No effect on cell surface expression.,,,0.0,,,,,,,,,0.0,,,,P51684_C_310_S
5233,Q12913,D,1205,A,2nz6:A,1205,Substrate trapping with much higher affinity for substrate.,,1.0,-999.0,,,,,,,,,,,,,Q12913_D_1205_A
5234,Q12913,C,1239,S,2nz6:A,1239,Catalytically inactive and substrate trapping with higher affinity for substrate.,,1.0,1.0,,,,,,,,,,,,,Q12913_C_1239_S
5235,Q07021,G,107,D,1p32:A,107,Impairs HIV RNA splicing in mouse cells.,,,-999.0,,,,,,,,,,,,,Q07021_G_107_D
5236,Q9UBD6,F,74,L,3hd6:A,74,Reduction of ammonia transport.,,,1.0,,,,,,,,,,,,,Q9UBD6_F_74_L
5237,Q9UBD6,V,137,I,3hd6:A,137,Reduction of ammonia transport.,,,1.0,,,,,,,,,,,,,Q9UBD6_V_137_I
5238,Q9UBD6,D,177,N,3hd6:A,177,Loss of function.,,,1.0,,,,,,,,,,,,,Q9UBD6_D_177_N
5239,Q9UBD6,F,235,V,3hd6:A,235,Reduction of ammonia transport.,,,1.0,,,,,,,,,,,,,Q9UBD6_F_235_V
5240,P31645,S,611,A,5i6z:A,611,Loss of 10 % of serotonin uptake activity. Loss of 5 % of serotonin uptake activity,,,1.0,,,,,,,,,,,,,P31645_S_611_A
5241,P31645,S,611,D,5i6z:A,611,Loss of 61 % of serotonin uptake activity. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,1.0,,,,,,,,,,,,,P31645_S_611_D
5242,P31645,T,613,A,5i6z:A,613,Loss of 26 % of serotonin uptake activity. Loss of 5 % of serotonin uptake activity,,,1.0,,,,,,,,,,,,,P31645_T_613_A
5243,P31645,T,613,D,5i6z:A,613,Loss of 26 % of serotonin uptake activity. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,1.0,,,,,,,,,,,,,P31645_T_613_D
5244,P31645,T,616,A,5i6z:A,616,No change. Loss of 5 % of serotonin uptake activity,,,1.0,,,,,,,,,,,,,P31645_T_616_A
5245,P31645,T,616,D,5i6z:A,616,No change. Loss of 95 % of serotonin uptake activity and lack of association between VIM and the plasma membrane,,,1.0,,,,,,,,,,,,,P31645_T_616_D
5246,P54253,K,589,R,1oa8:D,590,Sumoylation reduced to 53% of wild-type.,,,-999.0,,-1.0,,,,,,,,,,,P54253_K_589_R
5247,P54253,K,594,R,1oa8:D,595,Sumoylation reduced to 68% of wild-type.,,,-999.0,,-1.0,,,,,,,,,,,P54253_K_594_R
5248,P54253,K,609,R,1oa8:D,610,Sumoylation reduced to 43% of wild-type.,,,-999.0,,-1.0,,,,,,,,,,,P54253_K_609_R
5249,P54253,K,691,R,1oa8:D,692,No effect on sumoylation.,,,-999.0,,0.0,,,,,,,,,,,P54253_K_691_R
5250,P55854,K,11,R,2mp2:B,11,Abolishes the formation of poly(SUMO) chains.,-1.0,,-999.0,,,,,,,,,,,,,P55854_K_11_R
5251,P55854,I,33,A,2mp2:B,33,Impaired interaction with USP25,-1.0,,-999.0,,,,,,,,,,,,,P55854_I_33_A
5252,P55854,K,34,A,2mp2:B,34,Impaired interaction with USP25,-1.0,,-999.0,,,,,,,,,,,,,P55854_K_34_A
5253,P14859,S,385,A,1gt0:C,107,Loss of inhibition of DNA binding.,,,1.0,,,,,,,,,,,,,P14859_S_385_A
5254,O00584,H,65,Y,3t0o:A,65,Abolishes the effect on degradation of mitochondrion-associated cytosolic rRNAs.,,,1.0,,,,,,,,,,,,,O00584_H_65_Y
5255,O00584,H,118,Y,3t0o:A,118,Abolishes the effect on degradation of mitochondrion-associated cytosolic rRNAs.,,,1.0,,,,,,,,,,,,,O00584_H_118_Y
5256,Q9NQG5,R,114,A,4q96:A,114,Complete loss of binding to POLR2A CTD in vivo.,-1.0,,-999.0,,,,,,,,,,,,,Q9NQG5_R_114_A
5257,Q9Y230,D,299,N,6hts:D,299,Abolishes ATPase activity.,,,1.0,,,,,,,,,,,,,Q9Y230_D_299_N
5258,P16581,E,109,D,4csy:A,88,Decreased adhesion to cells expressing SELPLG.,,,-999.0,,,,,,,,,1.0,,,,P16581_E_109_D
5259,O00746,R,90,D,1ehw:A,57,Abolishes cardiolipin-containing membrane binding,,-1.0,-999.0,,,,,,,,,,,,,O00746_R_90_D
5260,Q9Y233,D,554,A,4lm1:A,564,Loss of activity and of zinc binding.,,-1.0,1.0,,,,,,,,,,,,,Q9Y233_D_554_A
5261,Q9Y233,D,554,N,4lm1:A,564,Reduces activity 1000-fold.,,,1.0,,,,,,,,,,,,,Q9Y233_D_554_N
5262,Q9Y239,V,41,A,2nz7:B,41,Abolishes interaction with RIPK2/RICK.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y239_V_41_A
5263,Q9Y239,V,41,Q,2nz7:B,41,Abolishes caspase-9 activation.,,,1.0,,,,,,,,,,,,,Q9Y239_V_41_Q
5264,Q9Y239,L,44,A,2nz7:B,44,Abolishes activation of NF-kappa-B. No effect on interaction with RIPK2.,0.0,,1.0,,,,,,,,,,,,,Q9Y239_L_44_A
5265,Q9Y239,D,48,K,2nz7:B,48,Abolishes activation of NF-kappa-B. No effect on interaction with RIPK2.,0.0,,1.0,,,,,,,,,,,,,Q9Y239_D_48_K
5266,Q9Y239,E,53,K,2nz7:B,53,No effect on activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,0.0,,,,,,,,,,,,,Q9Y239_E_53_K
5267,Q9Y239,D,54,K,2nz7:B,54,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,1.0,,,,,,,,,,,,,Q9Y239_D_54_K
5268,Q9Y239,E,56,K,2nz7:B,56,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,1.0,,,,,,,,,,,,,Q9Y239_E_56_K
5269,Q9Y239,R,69,E,2nz7:B,69,Abolishes activation of NF-kappa-B. Abolishes interaction with RIPK2.,-1.0,,1.0,,,,,,,,,,,,,Q9Y239_R_69_E
5270,A7KAX9,R,407,A,3iug:A,407,Mild effect on GAP activity and neurite-promotion upon nerve growth factor stimulation.,,,1.0,,,,,,,,,,,,,A7KAX9_R_407_A
5271,A7KAX9,R,407,I,3iug:A,407,Loss of GAP activity.,,,1.0,,,,,,,,,,,,,A7KAX9_R_407_I
5272,A7KAX9,R,407,M,3iug:A,407,"Loss of GAP activity. In isoform 1, no inhibitory effect on neurite extension.",,,1.0,,,,,,,,,,,,,A7KAX9_R_407_M
5273,A7KAX9,K,447,A,3iug:A,447,Loss of GAP activity.,,,1.0,,,,,,,,,,,,,A7KAX9_K_447_A
5274,P08235,S,767,N,3wff:A,767,Loss of transcription transactivation.,,,1.0,,,,,,,,,,,,,P08235_S_767_N
5275,P08235,S,767,Q,3wff:A,767,Strong decrease of transcription transactivation.,,,1.0,,,,,,,,,,,,,P08235_S_767_Q
5276,P08235,N,770,A,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_A
5276,P08235,N,770,D,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_D
5276,P08235,N,770,H,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_H
5276,P08235,N,770,Q,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_Q
5276,P08235,N,770,S,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_S
5276,P08235,N,770,T,3wff:A,770,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_N_770_T
5277,P08235,Q,776,A,3wff:A,776,Reduces aldosterone binding and transcription transactivation.,,,1.0,,,,,,,,,,,,,P08235_Q_776_A
5278,P08235,K,782,E,3wff:A,782,Decreased coactivator binding.,,-1.0,-999.0,,,,,,,,,,,,,P08235_K_782_E
5279,P08235,K,785,E,3wff:A,785,Loss of coactivator binding.,,-1.0,-999.0,,,,,,,,,,,,,P08235_K_785_E
5280,P08235,E,796,R,3wff:A,796,Decreased coactivator binding.,,-1.0,-999.0,,,,,,,,,,,,,P08235_E_796_R
5281,P08235,C,808,S,3wff:A,808,Increases aldosterone-binding.,,1.0,-999.0,,,,,,,,,,,,,P08235_C_808_S
5282,P08235,S,810,M,3wff:A,810,Alters receptor specificity.,,-1.0,-999.0,,,,,,,,,,,,,P08235_S_810_M
5283,P08235,R,817,A,3wff:A,817,Reduces aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_R_817_A
5284,P08235,C,849,S,3wff:A,849,Strongly decreases affinity for aldosterone and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_C_849_S
5285,P08235,C,942,S,3wff:A,942,Abolishes steroid binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_C_942_S
5286,P08235,T,945,A,3wff:A,945,Decreases aldosterone-binding and cortisol-binding.,,-1.0,-999.0,,,,,,,,,,,,,P08235_T_945_A
5287,P08235,L,952,A,3wff:A,952,Reduces transcription transactivation.,,,1.0,,,,,,,,,,,,,P08235_L_952_A
5288,P08235,K,953,A,3wff:A,953,Slightly reduces aldosterone binding and abolishes transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_K_953_A
5289,P08235,V,954,A,3wff:A,954,Reduces aldosterone binding and abolishes transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_V_954_A
5290,P08235,F,956,A,3wff:A,956,Abolishes aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_F_956_A
5291,P08235,P,957,A,3wff:A,957,Slightly reduces aldosterone binding and transcription transactivation.,,-1.0,1.0,,,,,,,,,,,,,P08235_P_957_A
5292,P02730,E,85,A,1hyn:Q,85,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_E_85_A
5292,P02730,E,85,R,1hyn:Q,85,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_E_85_R
5293,P02730,R,283,A,1hyn:Q,283,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_R_283_A
5293,P02730,R,283,E,1hyn:Q,283,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_R_283_E
5293,P02730,R,283,S,1hyn:Q,283,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_R_283_S
5294,P02730,E,681,Q,4yzf:A,681,Impairs expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,P02730_E_681_Q
5295,P18754,K,4,Q,5tbk:I,4,Abolishes N-terminal methylation.,,,-999.0,,,,,,,,,,,,,P18754_K_4_Q
5296,P18754,K,4,R,5tbk:I,4,Strongly impairs N-terminal methylation and subcellular localization.,,,-999.0,,,,,,,,,1.0,,,,P18754_K_4_R
5297,P18754,R,9,A,5tbk:I,9,Decreases KPNA4 binding. Strongly decreases KPNA4 binding,-1.0,,-999.0,,,,,,,,,,,,,P18754_R_9_A
5298,P18754,S,11,E,5tbk:I,11,Phosphomimetic mutant. Decreases KPNA4 binding by about 10%.,-1.0,,-999.0,,,,,,,,,,1.0,,,P18754_S_11_E
5299,P18754,K,21,A,5tbk:I,21,Decreases KPNA4 binding. Strongly decreases KPNA4 binding,-1.0,,-999.0,,,,,,,,,,,,,P18754_K_21_A
5300,P18754,D,182,A,5tbk:I,182,Abolishes interaction with Ran and impairs chromosome localization.,-1.0,,-999.0,,,,,,,,,1.0,,,,P18754_D_182_A
5301,P08238,E,42,A,6n8w:C,42,"Strong ATP-binding. Strong interaction with HSF1, HIF1A, ERBB2, MET, KEAP1 and RHOBTB2.",1.0,1.0,-999.0,,,,,,,,,,,,,P08238_E_42_A
5302,P08238,D,88,A,6n8w:C,88,"Impaired ATP-binding. Strong interaction with HIF1A, MET, KEAP1 and RHOBTB2. Loss of interaction with HSF1 and ERBB2.",,-1.0,-999.0,,,,,,,,,,,,,P08238_D_88_A
5303,P08238,Y,301,F,5fwk:A,301,Decreases interaction with NOS3 and SRC. impairs resists LPS-induced tyrosine phosphorylation. Does not block LPS-induced pp60src phosphorylation.,-1.0,,-999.0,,,,,,,,,,,,,P08238_Y_301_F
5304,P08238,K,531,A,5fwk:A,531,Highly decreases the signal of SMYD2-dependent HSP90AB1 methylation,,,-999.0,,,,,,,,,,,,,P08238_K_531_A
5305,P08238,K,574,A,5fwk:A,574,Decreases the signal of SMYD2-dependent HSP90AB1 methylation. Highly decreases the signal of SMYD2-dependent HSP90AB1 methylation,,,-999.0,,,,,,,,,,,,,P08238_K_574_A
5306,P08238,C,590,A,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,1.0,,,,,,,,,,,,,P08238_C_590_A
5306,P08238,C,590,N,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,1.0,,,,,,,,,,,,,P08238_C_590_N
5306,P08238,C,590,D,5fwk:A,590,Reduced ATPase activity and client protein activation.,-1.0,,1.0,,,,,,,,,,,,,P08238_C_590_D
5307,Q9Y6N9,R,103,H,3k1r:A,103,Strongly reduced affinity for USH1G.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6N9_R_103_H
5308,Q86VN1,L,10,D,2hth:B,10,No effect on interaction with ubiquitin.,0.0,,-999.0,,,,,,,,,,,,,Q86VN1_L_10_D
5309,Q86VN1,V,67,A,2hth:B,67,Reduces affinity for ubiquitin up to 10-fold.,-1.0,,-999.0,,,,,,,,,,,,,Q86VN1_V_67_A
5310,Q86VN1,F,68,A,2hth:B,68,Reduces affinity for ubiquitin up to 10-fold.,-1.0,,-999.0,,,,,,,,,,,,,Q86VN1_F_68_A
5311,Q86VN1,E,70,A,2hth:B,70,Reduces affinity for ubiquitin up to 10-fold.,-1.0,,-999.0,,,,,,,,,,,,,Q86VN1_E_70_A
5312,P00918,W,5,A,6qeb:A,5,"Impaired activity, not rescued by 4-methylimidazole (4-MI)",,-1.0,1.0,,,,,,,,,,,,,P00918_W_5_A
5313,P00918,Y,7,F,6qeb:A,7,Enhanced activity.,,,1.0,,,,,,,,,,,,,P00918_Y_7_F
5314,P00918,Y,7,H,6qeb:A,7,Reduced proton transfer rate.,,,1.0,,,,,,,,,,,,,P00918_Y_7_H
5315,P00918,N,62,A,6qeb:A,62,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_62_A
5316,P00918,N,62,D,6qeb:A,62,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_62_D
5317,P00918,N,62,H,6qeb:A,62,Reduced proton transfer,,,1.0,,,,,,,,,,,,,P00918_N_62_H
5318,P00918,N,62,L,6qeb:A,62,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_62_L
5319,P00918,N,62,T,6qeb:A,62,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_62_T
5320,P00918,N,62,V,6qeb:A,62,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_62_V
5321,P00918,H,64,A,6qeb:A,64,"Reduced CO(2) hydrase activity, rescued by 4-methylimidazole (4-MI). Reduced proton transfer",,,1.0,,,,,,,,,,,,,P00918_H_64_A
5322,P00918,H,64,G,6qeb:A,64,"Impaired activity, not rescued by 4-methylimidazole (4-MI).",,-1.0,1.0,,,,,,,,,,,,,P00918_H_64_G
5323,P00918,H,64,W,6qeb:A,64,"Impaired activity, rescued by 4-methylimidazole (4-MI). Impaired activity, not rescued by 4-methylimidazole (4-MI)",,,1.0,,,,,,,,,,,,,P00918_H_64_W
5324,P00918,A,65,F,6qeb:A,65,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_A_65_F
5325,P00918,A,65,S,6qeb:A,65,"2-fold decrease in enzyme efficiency, as determined by kcat/KM ratio, and efficiently inhibited by chlorzolamide",,,1.0,,,,,,,,,,,,,P00918_A_65_S
5326,P00918,N,67,H,6qeb:A,67,Enhanced proton transfer,,,1.0,,,,,,,,,,,,,P00918_N_67_H
5327,P00918,N,67,L,6qeb:A,67,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_N_67_L
5328,P00918,N,67,Q,6qeb:A,67,"2-fold decrease in enzyme efficiency, as determined by kcat/KM ratio, and efficiently inhibited by chlorzolamide",,,1.0,,,,,,,,,,,,,P00918_N_67_Q
5329,P00918,H,94,C,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,1.0,,,,,,,,,,,,,P00918_H_94_C
5329,P00918,H,94,D,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,1.0,,,,,,,,,,,,,P00918_H_94_D
5329,P00918,H,94,E,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,1.0,,,,,,,,,,,,,P00918_H_94_E
5329,P00918,H,94,N,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,1.0,,,,,,,,,,,,,P00918_H_94_N
5329,P00918,H,94,Q,6qeb:A,94,"Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities, impaired stability of zinc binding.",,,1.0,,,,,,,,,,,,,P00918_H_94_Q
5330,P00918,E,106,A,6qeb:A,106,Strongly reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_E_106_A
5330,P00918,E,106,Q,6qeb:A,106,Strongly reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_E_106_Q
5331,P00918,E,106,D,6qeb:A,106,Normal CO(2) hydrase activity.,,,0.0,,,,,,,,,,,,,P00918_E_106_D
5332,P00918,E,117,Q,6qeb:A,117,Strongly reduced activity and sulfonamide affinity.,,-1.0,1.0,,,,,,,,,,,,,P00918_E_117_Q
5333,P00918,H,119,D,6qeb:A,119,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_H_119_D
5333,P00918,H,119,N,6qeb:A,119,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_H_119_N
5333,P00918,H,119,Q,6qeb:A,119,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_H_119_Q
5334,P00918,H,119,E,6qeb:A,119,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_H_119_E
5335,P00918,V,121,A,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_A
5335,P00918,V,121,G,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_G
5335,P00918,V,121,I,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_I
5335,P00918,V,121,L,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_L
5335,P00918,V,121,S,6qeb:A,121,Reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_S
5336,P00918,V,121,K,6qeb:A,121,Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_K
5336,P00918,V,121,R,6qeb:A,121,Strongly reduced CO(2) hydrase and p-nitrophenyl acetate esterase activities.,,,1.0,,,,,,,,,,,,,P00918_V_121_R
5337,P00918,V,142,F,6qeb:A,142,Strongly impaired activity.,,,1.0,,,,,,,,,,,,,P00918_V_142_F
5337,P00918,V,142,Y,6qeb:A,142,Strongly impaired activity.,,,1.0,,,,,,,,,,,,,P00918_V_142_Y
5338,P00918,V,142,G,6qeb:A,142,Weakly impaired activity.,,,1.0,,,,,,,,,,,,,P00918_V_142_G
5339,P00918,V,142,H,6qeb:A,142,Impaired activity.,,,1.0,,,,,,,,,,,,,P00918_V_142_H
5340,P00918,L,197,A,6qeb:A,197,Reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_L_197_A
5341,P00918,L,197,E,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_L_197_E
5341,P00918,L,197,H,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_L_197_H
5341,P00918,L,197,R,6qeb:A,197,Strongly reduced CO(2) hydrase activity.,,,1.0,,,,,,,,,,,,,P00918_L_197_R
5342,P00918,L,197,F,6qeb:A,197,Normal activity.,,,0.0,,,,,,,,,,,,,P00918_L_197_F
5343,P00918,T,198,A,6qeb:A,198,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_A
5343,P00918,T,198,C,6qeb:A,198,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_C
5343,P00918,T,198,H,6qeb:A,198,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_H
5343,P00918,T,198,P,6qeb:A,198,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_P
5344,P00918,T,198,D,6qeb:A,198,"Strongly reduced activity, but enhanced zinc affinity.",,1.0,1.0,,,,,,,,,,,,,P00918_T_198_D
5344,P00918,T,198,E,6qeb:A,198,"Strongly reduced activity, but enhanced zinc affinity.",,1.0,1.0,,,,,,,,,,,,,P00918_T_198_E
5345,P00918,T,198,S,6qeb:A,198,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_S
5345,P00918,T,198,V,6qeb:A,198,Reduced activity.,,,1.0,,,,,,,,,,,,,P00918_T_198_V
5346,P00918,T,199,H,6qeb:A,199,Higher affinity for bicarbonate. Enhanced proton transfer capacity,,1.0,1.0,,,,,,,,,,,,,P00918_T_199_H
5347,P00918,T,199,S,6qeb:A,199,"Enhanced p-nitrophenyl acetate esterase activity, but normal CO(2) hydrase activity.",,,1.0,,,,,,,,,,,,,P00918_T_199_S
5348,P00918,P,201,A,6qeb:A,201,"Normal CO(2) hydrase activity, but impaired stability.",,,0.0,,,,,,,,,,,-1.0,,P00918_P_201_A
5349,Q6VAB6,R,718,H,2y4i:B,718,"Impairs formation of heterotetramers with MAP2K1, but not the formation of heterodimers.",-1.0,,-999.0,,,,,,,,,,,,,Q6VAB6_R_718_H
5350,Q6VAB6,D,786,A,2y4i:B,786,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q6VAB6_D_786_A
5351,Q6VAB6,A,879,L,7jur:B,879,Impairs MAP2K1 binding.,-1.0,,-999.0,,,,,,,,,,,,,Q6VAB6_A_879_L
5352,P24522,L,77,E,2kg4:A,77,Abolishes dimerization.,-1.0,,-999.0,,,,,,,,,,,,,P24522_L_77_E
5353,Q92913,P,207,Q,3hbw:A,207,Loss of interaction with SCN1A.,-1.0,,-999.0,,,,,,,,,,,,,Q92913_P_207_Q
5354,Q15116,N,49,A,6jjp:F,49,Decreased N-glycosylation without affecting binding to binding to nivolumab drug.,,0.0,-999.0,,,-1.0,,,,,,,,,,Q15116_N_49_A
5355,Q15116,N,58,A,6jjp:F,58,Decreased N-glycosylation without affecting binding to binding to nivolumab drug.,,0.0,-999.0,,,-1.0,,,,,,,,,,Q15116_N_58_A
5356,Q15116,N,74,A,6jjp:F,74,Decreased N-glycosylation without affecting binding to binding to nivolumab drug.,,0.0,-999.0,,,-1.0,,,,,,,,,,Q15116_N_74_A
5357,Q15116,N,116,A,6jjp:F,116,Decreased N-glycosylation without affecting binding to binding to nivolumab drug.,,0.0,-999.0,,,-1.0,,,,,,,,,,Q15116_N_116_A
5358,P53355,K,42,A,2x0g:A,42,"Loss of activity, apoptotic function and of autophosphorylation.",,,1.0,-1.0,,,,,,,,,,,,P53355_K_42_A
5359,P53355,S,289,A,2x0g:A,289,Loss of phosphorylation and significant increase in proapoptotic activity.,,,1.0,-1.0,,,,,,,,,,,,P53355_S_289_A
5360,P53355,S,289,E,2x0g:A,289,Reduction in proapoptotic activity.,,,1.0,,,,,,,,,,,,,P53355_S_289_E
5361,P53355,S,308,A,2x0g:A,308,Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity.,,1.0,1.0,,,,,,,,,,,,,P53355_S_308_A
5362,P53355,S,308,D,2x0g:A,308,Reduced Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Decreases apoptotic activity.,,-1.0,1.0,,,,,,,,,,,,,P53355_S_308_D
5363,P53355,S,313,A,2x0g:A,313,Minimal effect on activity.,,,0.0,,,,,,,,,,,,,P53355_S_313_A
5364,P21731,L,291,R,6iiu:A,291,Suppresses antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P21731_L_291_R
5365,P21731,R,295,Q,6iiu:A,295,Reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P21731_R_295_Q
5366,P21731,W,299,L,6iiu:A,299,Reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P21731_W_299_L
5367,P21731,W,299,R,6iiu:A,299,Reduces antagonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P21731_W_299_R
5368,P28340,D,402,A,6s1m:A,402,Loss of exonuclease activity. No effect on DNA polymerase activity.,,,1.0,,,,,,,,,,,,,P28340_D_402_A
5369,P28347,Y,421,A,6im5:A,421,Important loss of interaction with YAP1.,-1.0,,-999.0,,,,,,,,,,,,,P28347_Y_421_A
5370,Q9BVC4,S,72,D,6zwo:D,72,Impairs interaction with MTOR.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVC4_S_72_D
5371,Q9BVC4,G,192,D,6zwo:D,192,Abolishes interaction with MTOR.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVC4_G_192_D
5372,Q9BVC4,F,320,S,6zwo:D,320,Impairs interaction with MTOR.,-1.0,,-999.0,,,,,,,,,,,,,Q9BVC4_F_320_S
5373,Q9H4Y5,Y,34,A,3qag:A,34,Abolishes DHAR activity.,-1.0,,-999.0,,,,,,,,,,,,,Q9H4Y5_Y_34_A
5374,Q8N4P3,R,24,A,5vxa:A,24,Abrogates ppGpp hydrolase activity.,,,1.0,,,,,,,,,,,,,Q8N4P3_R_24_A
5375,Q8N4P3,E,65,A,5vxa:A,65,Abrogates ppGpp hydrolase activity.,,,1.0,,,,,,,,,,,,,Q8N4P3_E_65_A
5376,Q8N4P3,D,66,A,5vxa:A,66,Reduces ppGpp hydrolase activity.,,,1.0,,,,,,,,,,,,,Q8N4P3_D_66_A
5377,P53350,C,67,V,5ta8:A,67,In analog-sensitive mutant,,,-999.0,,,,,,,,,,,,,P53350_C_67_V
5378,P53350,K,82,M,5ta8:A,82,Loss of kinase activity. No effect on S-phase progression.,,,1.0,,,,,,,,,,,,,P53350_K_82_M
5379,P53350,K,82,R,5ta8:A,82,Loss of kinase activity. No effect on RIOK2-binding.,0.0,,1.0,,,,,,,,,,,,,P53350_K_82_R
5380,P53350,L,130,G,5ta8:A,130,In analog-sensitive mutant,,,-999.0,,,,,,,,,,,,,P53350_L_130_G
5381,P53350,S,137,A,5ta8:A,137,No change in activity. Increases activity and restores recovery after DNA damage checkpoint,,,1.0,,,,,,,,,,,,,P53350_S_137_A
5382,P53350,S,137,D,5ta8:A,137,Increases activity. Results in a block in G1/S.,,,1.0,,,,,,,,,,,,,P53350_S_137_D
5383,P53350,D,176,N,5ta8:A,176,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,P53350_D_176_N
5384,P53350,D,194,A,5ta8:A,194,Does not interfere with FRY-binding.,0.0,,-999.0,,,,,,,,,,,,,P53350_D_194_A
5385,P53350,T,210,A,5ta8:A,210,Abolishes activity. Abolishes checkpoint recovery.,,,1.0,,,,,,,,,,,,,P53350_T_210_A
5386,P53350,T,210,D,5ta8:A,210,Increases activity and restores recovery after DNA damage checkpoint.,,,1.0,,,,,,,,,,,,,P53350_T_210_D
5387,P53350,T,210,V,5ta8:A,210,"Reduced catalytic activity, but no effect on affinity for ATP.",,0.0,1.0,,,,,,,,,,,,,P53350_T_210_V
5388,P53350,W,414,F,4o56:A,414,Abolishes interaction with CDC25C and reduces centrosomal localization.,-1.0,,-999.0,,,,,,,,,1.0,,,,P53350_W_414_F
5390,P53350,V,415,A,4o56:A,415,Loss of centrosomal localization and of S-phase progression,,,-999.0,,,,,,,,,1.0,,,,P53350_V_415_A
5391,P53350,L,427,A,4o56:A,427,"No effect on centrosomal localization, nor on S-phase progression",,,-999.0,,,,,,,,,0.0,,,,P53350_L_427_A
5392,P53350,K,492,R,4o56:A,492,Severe mitotic defects leading to prometaphase delay. Increased localization at kinetochores leading to increased levels of phosphorylated BUBR1.,,,-999.0,,,,,,,,,1.0,,,,P53350_K_492_R
5393,P53350,H,538,A,4o56:A,538,In pincer mutant,,,-999.0,,,,,,,,,,,,,P53350_H_538_A
5394,P53350,K,540,M,4o56:A,540,In pincer mutant,,,-999.0,,,,,,,,,,,,,P53350_K_540_M
5395,Q86VP1,Q,771,A,2m7q:A,51,Normal affinity for ubiquitin.,0.0,,-999.0,,,,,,,,,,,,,Q86VP1_Q_771_A
5396,Q86VP1,E,774,A,2m7q:A,54,Reduced affinity for ubiquitin.,-1.0,,-999.0,,,,,,,,,,,,,Q86VP1_E_774_A
5397,Q86VP1,R,775,A,2m7q:A,55,Normal affinity for ubiquitin.,0.0,,-999.0,,,,,,,,,,,,,Q86VP1_R_775_A
5398,Q86VP1,V,777,S,2m7q:A,57,Reduced affinity for ubiquitin.,-1.0,,-999.0,,,,,,,,,,,,,Q86VP1_V_777_S
5399,Q86VP1,Q,778,A,2m7q:A,58,Reduced affinity for ubiquitin.,-1.0,,-999.0,,,,,,,,,,,,,Q86VP1_Q_778_A
5400,Q86VP1,F,781,A,2m7q:A,61,Reduced affinity for ubiquitin.,-1.0,,-999.0,,,,,,,,,,,,,Q86VP1_F_781_A
5401,P35236,T,66,A,3o4s:A,45,Prevents dissociation of bound MAP kinase and enhances their dephosphorylation,1.0,,-999.0,,,,,,,,,,,,,P35236_T_66_A
5402,P35236,S,93,A,3o4s:A,72,Prevents dissociation of bound MAP kinase and enhances their dephosphorylation,1.0,,-999.0,,,,,,,,,,,,,P35236_S_93_A
5403,P35236,Y,125,A,3o4s:A,104,Strongly reduced catalytic activity.,,,1.0,,,,,,,,,,,,,P35236_Y_125_A
5404,P35236,D,257,A,3o4s:A,236,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P35236_D_257_A
5405,P35236,C,291,S,3o4s:A,270,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P35236_C_291_S
5406,P35236,Q,335,A,3o4s:A,314,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,P35236_Q_335_A
5407,O75489,T,145,I,5xti:BP,145,Results in increased protein instability and aggregation,1.0,,-999.0,,,,,,,,,,,-1.0,,O75489_T_145_I
5408,O75489,R,199,W,5xti:BP,199,Results in increased protein instability and aggregation,1.0,,-999.0,,,,,,,,,,,-1.0,,O75489_R_199_W
5409,P53041,K,32,A,1a17:A,32,"Loss of interaction with HSP90AA1. No effect on interaction with S100A1, S100A2 and S100A6.",-1.0,,-999.0,,,,,,,,,,,,,P53041_K_32_A
5410,P53041,R,74,A,1a17:A,74,"Loss of interaction with HSP90AA1. No effect on interaction with S100A1, S100A2 and S100A6.",-1.0,,-999.0,,,,,,,,,,,,,P53041_R_74_A
5411,P53041,G,83,N,1a17:A,83,No effect on interaction with HSP90AA1.,0.0,,-999.0,,,,,,,,,,,,,P53041_G_83_N
5412,P53041,K,93,E,1a17:A,93,Decreases interaction with RAC1 and translocation to the membrane in presence of active RAC1.,-1.0,,-999.0,,,,,,,,,1.0,,,,P53041_K_93_E
5413,P53041,K,97,A,1a17:A,97,"Loss of interaction with HSP90AA1. No effect on interaction with S100A1, S100A2 and S100A6. Loss of interaction with RAF1.",-1.0,,-999.0,,,,,,,,,,,,,P53041_K_97_A
5414,P53041,R,101,A,1a17:A,101,"Loss of interaction with HSP90AA1. No effect on interaction with S100A1, S100A2 and S100A6.",-1.0,,-999.0,,,,,,,,,,,,,P53041_R_101_A
5415,P53041,H,304,Q,1wao:1,304,Catalytically inactive,,,1.0,,,,,,,,,,,,,P53041_H_304_Q
5416,P00352,C,302,A,5l2o:A,302,Does not prevent inhibition by duocarmycin analogs.,,0.0,-999.0,,,,,,,,,,,,,P00352_C_302_A
5416,P00352,C,302,S,5l2o:A,302,Does not prevent inhibition by duocarmycin analogs.,,0.0,-999.0,,,,,,,,,,,,,P00352_C_302_S
5417,P00352,G,458,N,5l2o:A,458,No significant effect on aldehyde dehydrogenase activity. Prevents the inhibition by ALDH1A1-specific inhibitors.,,-1.0,0.0,,,,,,,,,,,,,P00352_G_458_N
5418,P56589,L,125,P,3ajb:A,125,Abolishes binding to PEX19 without affecting targeting to peroxisomes,-1.0,,-999.0,,,,,,,,,0.0,,,,P56589_L_125_P
5419,P56589,N,134,D,3ajb:A,134,Abolishes binding to PEX19 without affecting targeting to peroxisomes,,,-999.0,,,,,,,,,0.0,,,,P56589_N_134_D
5420,Q9BXJ9,Y,834,F,6c95:A,834,Reduced NatA complex stability and reduced catalytic activity.,1.0,,1.0,,,,,,,,,,,,,Q9BXJ9_Y_834_F
5420,Q9BXJ9,Y,834,A,6c95:A,834,Reduced NatA complex stability and reduced catalytic activity.,1.0,,1.0,,,,,,,,,,,,,Q9BXJ9_Y_834_A
5421,P06239,S,59,E,1h92:A,2,Allows interaction with SQSTM1.,0.0,,-999.0,,,,,,,,,,,,,P06239_S_59_E
5422,P06239,R,154,K,1lck:A,154,No effect on interaction with SQSTM1.,0.0,,-999.0,,,,,,,,,,,,,P06239_R_154_K
5423,Q96PU5,C,942,S,3jvz:C,922,Abolishes activity. No effect on USP36 protein levels.,,,1.0,,,,,,,,,,,,,Q96PU5_C_942_S
5424,Q9BXJ7,N,35,Q,6gje:A,35,Loss of expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,Q9BXJ7_N_35_Q
5425,Q9BXJ7,S,37,A,6gje:A,37,No effect.,0.0,,-999.0,,,,,,,,,0.0,,,,Q9BXJ7_S_37_A
5426,Q9BXJ7,L,59,P,6gje:A,59,Loss of interaction with CUBN and strongly reduced CUBN expression at the cell surface.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9BXJ7_L_59_P
5427,Q9BXJ7,G,254,E,6gje:A,254,Loss of interaction with CUBN and strongly reduced CUBN expression at the cell surface.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9BXJ7_G_254_E
5428,Q8N0X4,D,320,A,5vxs:F,320,Abolishes citramalyl-CoA lyase activity.,,,1.0,,,,,,,,,,,,,Q8N0X4_D_320_A
5428,Q8N0X4,D,320,N,5vxs:F,320,Abolishes citramalyl-CoA lyase activity.,,,1.0,,,,,,,,,,,,,Q8N0X4_D_320_N
5429,O43639,W,148,K,4e6r:A,148,Abolishes interaction with DOCK1.,-1.0,,-999.0,,,,,,,,,,,,,O43639_W_148_K
5430,O43639,W,234,K,1wx6:A,54,Abolishes interaction with DOCK1.,-1.0,,-999.0,,,,,,,,,,,,,O43639_W_234_K
5431,P67775,D,85,N,2npp:C,85,Loss of phosphatase activity.,,,1.0,,,,,,,,,,,,,P67775_D_85_N
5432,P23470,R,958,E,2nlk:A,958,Loss of dimerization,-1.0,,-999.0,,,,,,,,,,,,,P23470_R_958_E
5433,P23470,K,960,E,2nlk:A,960,Loss of dimerization,-1.0,,-999.0,,,,,,,,,,,,,P23470_K_960_E
5434,P23470,D,1305,K,2nlk:A,1305,Loss of dimerization,-1.0,,-999.0,,,,,,,,,,,,,P23470_D_1305_K
5435,P23470,D,1306,K,2nlk:A,1306,Loss of dimerization,-1.0,,-999.0,,,,,,,,,,,,,P23470_D_1306_K
5436,Q8TEA1,R,126,A,5wws:A,126,Decreases substantially tRNA methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8TEA1_R_126_A
5437,Q8TEA1,Y,131,A,5wws:A,131,Abolishes methylation of tRNA (Cys).,,,1.0,,,,,,,,,,,,,Q8TEA1_Y_131_A
5438,Q8TEA1,K,159,A,5wws:A,159,Decreases tRNA methyltransferase activiry. Abolishes tRNA methyltransferase activiry,,,1.0,,,,,,,,,,,,,Q8TEA1_K_159_A
5439,Q8TEA1,K,160,A,5wws:A,160,Decreases tRNA methyltransferase activiry. Abolishes tRNA methyltransferase activiry,,,1.0,,,,,,,,,,,,,Q8TEA1_K_160_A
5440,Q8TEA1,R,181,A,5wws:A,181,Decreases subtantially tRNA methyltransferase activiry.,,,1.0,,,,,,,,,,,,,Q8TEA1_R_181_A
5441,Q8TEA1,L,218,A,5wws:A,218,Decreases substantially tRNA methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8TEA1_L_218_A
5442,Q8TEA1,N,220,A,5wws:A,220,Decreases substantially tRNA methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8TEA1_N_220_A
5443,Q8TEA1,S,223,A,5wws:A,223,Dose not affect tRNA methyltransferase activity.,,,0.0,,,,,,,,,,,,,Q8TEA1_S_223_A
5444,Q8TEA1,K,248,A,5wws:A,248,Abolishes tRNA methyltransferase activity. Does not affect S-Adenosylmethionine binding.,,0.0,1.0,,,,,,,,,,,,,Q8TEA1_K_248_A
5445,Q8TEA1,D,266,A,5wws:A,266,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,1.0,,,,,,,,,,,,,Q8TEA1_D_266_A
5446,Q8TEA1,K,271,A,5wws:A,271,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,1.0,,,,,,,,,,,,,Q8TEA1_K_271_A
5447,Q8TEA1,D,293,A,5wws:A,293,Loss of S-Adenosylmethionine binding. Loss of tRNA methyltransferase activity.,,-1.0,1.0,,,,,,,,,,,,,Q8TEA1_D_293_A
5448,Q8TEA1,D,323,A,5wws:B,323,Abolishes tRNA methyltransferase activity. Abolishes S-Adenosylmethionine binding.,,-1.0,1.0,,,,,,,,,,,,,Q8TEA1_D_323_A
5449,Q8TEA1,C,373,A,5wws:B,373,Does not impair target RNA binding. Abolishes tRNA (cytosine-5-)-methyltransferase activity.,,0.0,1.0,,,,,,,,,,,,,Q8TEA1_C_373_A
5450,Q8TEA1,F,458,A,5wws:B,458,Abolishes tRNA methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8TEA1_F_458_A
5451,O75663,D,71,L,5d9g:A,71,"Abolishes interaction with PPP2CA, PPP2CB and PPP4C.",-1.0,,-999.0,,,,,,,,,,,,,O75663_D_71_L
5452,O75663,Y,79,H,5d9g:A,79,Diminishes interaction with PPP2CA.,-1.0,,-999.0,,,,,,,,,,,,,O75663_Y_79_H
5453,O75663,I,136,T,5d9g:A,136,"Abolishes interaction with PPP2CA, PPP2CB and PPP4C.",-1.0,,-999.0,,,,,,,,,,,,,O75663_I_136_T
5454,O75663,M,196,V,5d9g:A,196,"Abolishes interaction with PPP2CA, PPP2CB and PPP4C.",-1.0,,-999.0,,,,,,,,,,,,,O75663_M_196_V
5455,O75663,D,198,N,5d9g:A,198,"Abolishes interaction with PPP2CA, PPP2CB and PPP4C.",-1.0,,-999.0,,,,,,,,,,,,,O75663_D_198_N
5456,P04062,C,43,S,2j25:A,4,Loss of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,P04062_C_43_S
5457,P04062,C,57,S,2j25:A,18,Loss of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,P04062_C_57_S
5458,P04062,C,62,S,2j25:A,23,Loss of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,P04062_C_62_S
5459,P04062,E,379,G,2j25:A,340,1000-fold decreases of glucosylceramidase activity.,,,1.0,,,,,,,,,,,,,P04062_E_379_G
5460,P27540,R,91,A,5v0l:A,91,Diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_R_91_A
5461,P27540,N,93,A,5v0l:A,93,Diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_N_93_A
5462,P27540,H,94,A,5v0l:A,94,Severely diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_H_94_A
5463,P27540,E,98,A,5v0l:A,98,Severely diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_E_98_A
5464,P27540,R,99,A,5v0l:A,99,Diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_R_99_A
5465,P27540,R,101,A,5v0l:A,101,Severely diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_R_101_A
5466,P27540,R,102,A,5v0l:A,102,Severely diminishes DNA interaction.,,-1.0,-999.0,,,,,,,,,,,,,P27540_R_102_A
5467,Q496J9,N,559,A,5moy:B,559,"No change in interaction with C.botulinum neurotoxin type A heavy chain (botA, BoNT/A HC). Decreased molecular weight probably due to glycosylation loss, decreased interaction with BoNT/A HC.",,0.0,-999.0,,,-1.0,,,,,,,,,,Q496J9_N_559_A
5468,Q496J9,N,559,Q,5moy:B,559,"Decreased molecular weight probably due to glycosylation loss, decreased binding to BoNT/A HC. Greater reduction in weight",-1.0,,-999.0,,,-1.0,,,,,,,,,,Q496J9_N_559_Q
5469,Q496J9,S,561,A,5moy:B,561,"Decreased molecular weight probably due to glycosylation loss, decreased binding to BoNT/A HC.",-1.0,,-999.0,,,-1.0,,,,,,,,,,Q496J9_S_561_A
5470,Q496J9,F,563,A,5moy:B,563,No longer interacts with BoNT/A HC.,-1.0,,-999.0,,,,,,,,,,,,,Q496J9_F_563_A
5471,Q496J9,N,565,Q,5moy:B,565,"Decreased molecular weight probably due to glycosylation loss, no change in binding to BoNT/A heavy chain. Greater reduction in weight",-1.0,,-999.0,,,-1.0,,,,,,,,,,Q496J9_N_565_Q
5472,Q9BQP7,D,251,A,5zyw:A,251,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9BQP7_D_251_A
5473,Q9BQP7,K,253,A,5zyw:A,253,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9BQP7_K_253_A
5475,Q15843,A,72,R,1xt9:B,72,Prevents adenylation by UBE1C.,,,-999.0,,,,,,-1.0,,,,,,,Q15843_A_72_R
5476,P06748,T,95,A,5ehd:C,95,Does not affect phosphorylation by PLK2.,,,-999.0,0.0,,,,,,,,,,,,P06748_T_95_A
5477,P06748,T,234,A,2llh:A,10,Partial loss of phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,P06748_T_234_A
5478,P06748,T,237,A,2llh:A,13,Partial loss of phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P06748_T_237_A
5479,P06748,K,248,A,2llh:A,24,Partial destabilization of the structure.,,,-999.0,,,,,,,,,,,-1.0,,P06748_K_248_A
5480,P06748,K,250,A,2llh:A,26,Increase in the stabilization of the structure.,,,-999.0,,,,,,,,,,,1.0,,P06748_K_250_A
5481,P06748,K,263,A,2llh:A,39,Increase in the stabilization of the structure and partial delocalization to the nucleoplasm. Complete delocalization to the nucleoplasm,,,-999.0,,,,,,,,,1.0,,1.0,,P06748_K_263_A
5482,P06748,K,263,R,2llh:A,39,No change in the sumoylation level.,,,-999.0,,,,0.0,,,,,,,,,P06748_K_263_R
5483,P06748,K,267,A,2llh:A,43,Increase in the stabilization of the structure and complete delocalization to the nucleoplasm. Complete delocalization to the nucleoplasm,,,-999.0,,,,,,,,,1.0,,1.0,,P06748_K_267_A
5484,P06748,F,268,A,2llh:A,44,Complete destabilization of the structure and loss of nucleolus localization,,,-999.0,,,,,,,,,1.0,,-1.0,,P06748_F_268_A
5485,P06748,F,276,A,2llh:A,52,Complete destabilization of the structure and loss of nucleolus localization,,,-999.0,,,,,,,,,1.0,,-1.0,,P06748_F_276_A
5486,P06748,W,288,A,2llh:A,64,Complete destabilization of the structure,,,-999.0,,,,,,,,,,,-1.0,,P06748_W_288_A
5487,P06748,W,290,A,2llh:A,66,Partial destabilization of the structure. Complete destabilization of the structure,,,-999.0,,,,,,,,,,,-1.0,,P06748_W_290_A
5488,O43709,K,180,R,6g4w:q,180,"Resistant to down-regulation in response to TNF and IFNG combined treatment and effective coactivator for NR3C1, even in the presence of TNF and IFNG",,,-999.0,,,,,,,,,,,,,O43709_K_180_R
5489,O43709,K,196,R,6g4w:q,196,"Resistant to down-regulation in response to TNF and IFNG combined treatment and effective coactivator for NR3C1, even in the presence of TNF and IFNG",,,-999.0,,,,,,,,,,,,,O43709_K_196_R
5490,O15488,Y,228,F,4ueg:B,197,Loss of autoglucosylation.,,,1.0,,,-1.0,,,,,,,,,,O15488_Y_228_F
5491,O15488,Y,230,F,4ueg:B,199,No loss of activity.,,,0.0,,,,,,,,,,,,,O15488_Y_230_F
5492,Q9GZT9,C,201,A,3hqr:A,201,Little change in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_201_A
5493,Q9GZT9,C,208,A,3hqr:A,208,Little change in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_208_A
5494,Q9GZT9,R,252,A,3hqr:A,252,Reduced C-terminal ODD domain (CODD) hydroxylation of HIF1A.,,,1.0,,,,,,,,,,,,,Q9GZT9_R_252_A
5495,Q9GZT9,D,254,A,3hqr:A,254,Reduced C-terminal ODD domain (CODD) hxdroxylation of HIF1A.,,,1.0,,,,,,,,,,,,,Q9GZT9_D_254_A
5495,Q9GZT9,D,254,K,3hqr:A,254,Reduced C-terminal ODD domain (CODD) hxdroxylation of HIF1A.,,,1.0,,,,,,,,,,,,,Q9GZT9_D_254_K
5496,Q9GZT9,C,266,A,3hqr:A,266,Little change in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_266_A
5497,Q9GZT9,C,283,A,3hqr:A,283,Little change in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_283_A
5498,Q9GZT9,C,302,A,3hqr:A,302,Slight increase in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_302_A
5499,Q9GZT9,Y,303,F,3hqr:A,303,No effect.,,,0.0,,,,,,,,,,,,,Q9GZT9_Y_303_F
5500,Q9GZT9,C,323,A,3hqr:A,323,Little change in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_323_A
5501,Q9GZT9,C,326,A,3hqr:A,326,Slight increase in enzyme activity.,,,1.0,,,,,,,,,,,,,Q9GZT9_C_326_A
5502,Q9GZT9,R,383,A,3hqr:A,383,Reduces enzyme activity by 95%.,,,1.0,,,,,,,,,,,,,Q9GZT9_R_383_A
5503,Q9NYL2,K,45,M,6jut:A,45,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9NYL2_K_45_M
5504,Q9NYL2,T,161,A,6jut:A,161,Loss of autophosphorylation activity.,,,1.0,-1.0,,,,,,,,,,,,Q9NYL2_T_161_A
5505,Q9NYL2,T,162,A,6jut:A,162,Slight loss of autophosphorylation activity.,,,1.0,-1.0,,,,,,,,,,,,Q9NYL2_T_162_A
5506,Q9NYL2,S,165,A,6jut:A,165,Loss of autophosphorylation activity.,,,1.0,-1.0,,,,,,,,,,,,Q9NYL2_S_165_A
5507,P17081,T,23,N,2atx:A,31,Loss of interaction with GOPC.,-1.0,,-999.0,,,,,,,,,,,,,P17081_T_23_N
5508,P17081,D,44,A,2atx:A,52,Loss of interaction with GOPC.,-1.0,,-999.0,,,,,,,,,,,,,P17081_D_44_A
5509,P17081,Q,67,L,2atx:A,75,Constitutively active. Interacts with PARD6 proteins and GOPC.,1.0,,1.0,,,,,,,,,,,,,P17081_Q_67_L
5510,O96028,Y,1092,A,5lsu:A,1092,Loss of methyltransferase activity. Reduces levels of H3K36me2 in preadipocytes,,,1.0,,,,,,,,,,,,,O96028_Y_1092_A
5511,O96028,H,1142,G,5lsu:A,1142,Reduces levels of H3K36me2 in preadipocytes,,,-999.0,,,,,,,,,,,,,O96028_H_1142_G
5512,O96028,Y,1179,A,5lsu:A,1179,Loss of methyltransferase activity. Reduces levels of H3K36me2 in preadipocytes,,,1.0,,,,,,,,,,,,,O96028_Y_1179_A
5513,Q9Y5X4,L,372,R,4log:B,1372,Reduces transcription repressor activity.,,,1.0,,,,,,,,,,,,,Q9Y5X4_L_372_R
5514,Q9Y5X4,L,375,R,4log:B,1375,Reduces transcription repressor activity.,,,1.0,,,,,,,,,,,,,Q9Y5X4_L_375_R
5515,Q9Y5X0,R,53,A,4pzg:A,53,Abolishes vacuolization induced by overexpression.,,,-999.0,,,,,,,,,,,,,Q9Y5X0_R_53_A
5516,Q9Y5X0,K,79,A,4pzg:A,79,Slightly reduced vacuolization induced by overexpression.,,,-999.0,,,,,,,,,,,,,Q9Y5X0_K_79_A
5517,Q9Y5X0,R,94,A,4pzg:A,94,Reduced vacuolization induced by overexpression.,,,-999.0,,,,,,,,,,,,,Q9Y5X0_R_94_A
5518,O43526,T,217,A,7cr7:A,217,No effect on current or expression.,,,0.0,,,,,,,,,,,,0.0,O43526_T_217_A
5519,O43526,T,217,D,7cr7:A,217,Abolishes currents without reducing channel protein expression.,,,1.0,,,,,,,,,,,,,O43526_T_217_D
5520,O43526,G,279,S,7cr7:A,279,More than 50% reduction of wt heteromeric current. Ratio of 1,,,1.0,,,,,,,,,,,,,O43526_G_279_S
5521,Q99720,E,123,G,6dk1:C,123,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_123_G
5522,Q99720,D,126,G,6dk1:C,126,Reduces ligand-binding. No effect on subcellular localization.,,-1.0,-999.0,,,,,,,,,0.0,,,,Q99720_D_126_G
5523,Q99720,E,138,G,6dk1:C,138,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_138_G
5524,Q99720,E,144,G,6dk1:C,144,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_144_G
5525,Q99720,E,150,G,6dk1:C,150,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_150_G
5526,Q99720,E,158,G,6dk1:C,158,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_158_G
5527,Q99720,E,163,G,6dk1:C,163,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_163_G
5528,Q99720,E,172,G,6dk1:C,172,Reduces ligand-binding. No effect on subcellular localization.,,-1.0,-999.0,,,,,,,,,0.0,,,,Q99720_E_172_G
5529,Q99720,D,188,G,6dk1:C,188,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_D_188_G
5530,Q99720,D,195,G,6dk1:C,195,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_D_195_G
5531,Q99720,E,213,G,6dk1:C,213,No effect on ligand-binding.,,0.0,-999.0,,,,,,,,,,,,,Q99720_E_213_G
5532,Q9H9E1,W,188,A,4qqi:A,188,Loss of interaction with CCDC8. Decreased affinity for HDAC4.,-1.0,,-999.0,,,,,,,,,,,,,Q9H9E1_W_188_A
5533,Q9H9E1,Y,254,A,4qqi:A,254,Decreased affinity for HDAC4.,-1.0,,-999.0,,,,,,,,,,,,,Q9H9E1_Y_254_A
5534,Q9UNS1,R,1081,G,4xht:A,1081,Abolishes interaction with PARP1.,-1.0,,1.0,,,,,,,,,,,,,Q9UNS1_R_1081_G
5535,P19113,K,305,G,4e1o:A,305,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P19113_K_305_G
5536,P19113,Y,334,F,4e1o:A,334,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P19113_Y_334_F
5537,P19113,S,354,G,4e1o:A,354,Strongly decreases affinity for histidine. Strongly increases affinity for L-DOPA and confers enzyme activity toward L-DOPA.,,,-999.0,,,,,,,,,,,,,P19113_S_354_G
5538,O94888,P,459,G,1wj4:A,90,Abolishes interaction with VCP/p97.,-1.0,,-999.0,,,,,,,,,,,,,O94888_P_459_G
5539,O14842,Y,12,A,5tzy:A,12,Reduces cell surface expression and response to linolenic acid and synthetic agonists.,,-1.0,-999.0,,,,,,,,,1.0,,,,O14842_Y_12_A
5540,O14842,Y,44,F,5tzy:A,44,Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_Y_44_F
5541,O14842,Y,91,A,5tzy:A,91,Reduces response to linolenic acid. Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_Y_91_A
5542,O14842,Y,114,F,5tzy:A,114,Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_Y_114_F
5543,O14842,S,123,A,5tzy:A,123,Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_S_123_A
5544,O14842,H,137,A,5tzy:A,137,Reduces response to linolenic acid. Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_H_137_A
5545,O14842,E,145,A,5tzy:A,145,Constitutive receptor signaling.,,,1.0,,,,,,,,,,,,,O14842_E_145_A
5546,O14842,E,172,A,4phu:A,172,Constitutive receptor signaling.,,,1.0,,,,,,,,,,,,,O14842_E_172_A
5547,O14842,R,183,A,4phu:A,183,Reduces response to linolenic acid. Strongly reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_R_183_A
5548,O14842,Y,240,A,5tzr:A,2240,Reduces response to linolenic acid. Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_Y_240_A
5549,O14842,N,244,A,5tzr:A,2244,Reduces response to linolenic acid. Reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_N_244_A
5550,O14842,R,258,A,5tzr:A,2258,Strongly reduces response to linolenic acid. Strongly reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_R_258_A
5551,O14842,R,258,K,5tzr:A,2258,Reduces response to linolenic acid. Strongly reduces response to synthetic agonists.,,-1.0,-999.0,,,,,,,,,,,,,O14842_R_258_K
5552,Q9UN19,K,173,L,1fb8:A,173,No interaction with 3-phosphoinositides.,,-1.0,-999.0,,,,,,,,,,,,,Q9UN19_K_173_L
5553,Q9UN19,R,184,C,1fb8:A,184,No membrane association.,,,-999.0,,,,,,,,,1.0,,,,Q9UN19_R_184_C
5554,Q9UN19,K,197,E,1fb8:A,197,No membrane association.,,,-999.0,,,,,,,,,1.0,,,,Q9UN19_K_197_E
5555,Q9UN19,W,250,L,1fb8:A,250,No interaction with 3-phosphoinositides.,,-1.0,-999.0,,,,,,,,,,,,,Q9UN19_W_250_L
5556,P26038,I,115,M,1e5w:A,115,Inhibits S-nitrosylation of Cys-117,,,-999.0,,,,,,-1.0,,,,,,,P26038_I_115_M
5557,P26038,E,120,M,1e5w:A,120,Inhibits S-nitrosylation of Cys-117,,,-999.0,,,,,,-1.0,,,,,,,P26038_E_120_M
5558,P26038,Y,556,R,1ef1:C,556,Impairs phosphorylation by STK10.,,,-999.0,-1.0,,,,,,,,,,,,P26038_Y_556_R
5559,P26038,T,558,A,1ef1:C,558,Abolishes phosphorylation by STK10.,,,-999.0,-1.0,,,,,,,,,,,,P26038_T_558_A
5560,P26038,T,558,D,1ef1:C,558,Completely abolishes the interaction between N- and C-terminal domains.,,,-999.0,,,,,,,,,,,,,P26038_T_558_D
5562,P16109,E,129,D,1g1r:A,88,Impairs interaction with SELPLG. Abolishes cell rolling on glycan ligands.,-1.0,-1.0,-999.0,,,,,,,,,,,,,P16109_E_129_D
5563,Q6W2J9,L,1706,D,2n1l:A,76,Slightly inhibits interaction with PCGF1.,-1.0,,-999.0,,,,,,,,,,,,,Q6W2J9_L_1706_D
5563,Q6W2J9,L,1706,R,2n1l:A,76,Slightly inhibits interaction with PCGF1.,-1.0,,-999.0,,,,,,,,,,,,,Q6W2J9_L_1706_R
5564,P63241,K,47,A,5dlq:F,47,Abolishes acetylation.,,,-999.0,,,,,,,,,,,,,P63241_K_47_A
5564,P63241,K,47,R,5dlq:F,47,Abolishes acetylation.,,,-999.0,,,,,,,,,,,,,P63241_K_47_R
5565,P63241,K,47,D,5dlq:F,47,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_47_D
5566,P63241,G,49,A,5dlq:F,49,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_G_49_A
5567,P63241,K,50,A,5dlq:F,50,Decreases significantly the acetylation at position K-47 and causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_50_A
5568,P63241,K,50,I,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_50_I
5568,P63241,K,50,D,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_50_D
5568,P63241,K,50,R,5dlq:F,50,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_50_R
5569,P63241,G,52,A,5dlq:F,52,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_G_52_A
5570,P63241,K,55,A,5dlq:F,55,Causes total inactivation of eIF5A in supporting yeast growth.,,,1.0,,,,,,,,,,,,,P63241_K_55_A
5571,P63241,V,81,G,5dlq:F,81,Leads to temperature sensitivity when expressed in yeast cells.,,,-999.0,,,,,,,,,,,,,P63241_V_81_G
5572,P49736,S,108,A,5bnv:F,108,Reduces phosphorylation by ATR.,,,-999.0,-1.0,,,,,,,,,,,,P49736_S_108_A
5573,P62330,T,27,N,1e0s:A,27,Fails to associate with membranes. Does not inhibit filopodia formation.,,,-999.0,,,,,,,,,1.0,,,,P62330_T_27_N
5574,P62330,Q,67,L,1e0s:A,67,Inhibits filopodia formation and dendritic branching.,,,-999.0,,,,,,,,,,,,,P62330_Q_67_L
5575,Q9NZ42,E,10,S,6idf:D,10,Induces a N-linked glycosylation on N-8.,,,-999.0,,,1.0,,,,,,,,,,Q9NZ42_E_10_S
5576,Q9NZ42,C,15,A,6idf:D,15,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_C_15_A
5577,Q9NZ42,C,15,S,6idf:D,15,No effect on APP processing by the gamma-secretase complex.,,,0.0,,,,,,,,,,,,,Q9NZ42_C_15_S
5578,Q9NZ42,F,25,A,6idf:D,25,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_F_25_A
5579,Q9NZ42,L,26,A,6idf:D,26,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_L_26_A
5580,Q9NZ42,W,30,A,6idf:D,30,"Decreased expression levels, and decreased stimulation of presenilin endoproteolysis.",,,1.0,,,,,,,,,,,,-1.0,Q9NZ42_W_30_A
5581,Q9NZ42,N,33,A,6idf:D,33,Increased expression at the cell membrane.,,,-999.0,,,,,,,,,1.0,,,,Q9NZ42_N_33_A
5582,Q9NZ42,W,36,A,6idf:D,36,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_W_36_A
5583,Q9NZ42,A,46,N,6idf:D,46,No effect.,,,0.0,,,0.0,,,,,,,,,,Q9NZ42_A_46_N
5584,Q9NZ42,K,54,A,6idf:D,54,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_K_54_A
5585,Q9NZ42,S,93,N,6idf:D,93,Induces a N-linked glycosylation.,,,-999.0,,,1.0,,,,,,,,,,Q9NZ42_S_93_N
5586,Q9NZ42,F,94,A,6idf:D,94,Decreased APP processing by the gamma-secretase complex.,,,1.0,,,,,,,,,,,,,Q9NZ42_F_94_A
5587,Q9UPY3,F,960,A,5zal:A,960,2-fold decrease in activity.,,,1.0,,,,,,,,,,,,,Q9UPY3_F_960_A
5588,Q9UPY3,Y,971,A,5zal:A,971,10-fold decrease in activity,,,1.0,,,,,,,,,,,,,Q9UPY3_Y_971_A
5589,Q9UPY3,Y,972,A,5zal:A,972,10-fold decrease in activity,,,1.0,,,,,,,,,,,,,Q9UPY3_Y_972_A
5590,Q9UPY3,E,1036,A,5zal:A,1036,5-fold decrease in activity.,,,1.0,,,,,,,,,,,,,Q9UPY3_E_1036_A
5591,Q9UPY3,E,1313,A,5zal:A,1313,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_E_1313_A
5592,Q9UPY3,D,1320,A,5zal:A,1320,Decreased activity. Loss of activity,,,1.0,,,,,,,,,,,,,Q9UPY3_D_1320_A
5593,Q9UPY3,E,1340,A,5zal:A,1340,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_E_1340_A
5594,Q9UPY3,Q,1702,A,5zal:A,1702,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_Q_1702_A
5595,Q9UPY3,D,1709,A,5zal:A,1709,Decreased activity. Loss of activity,,,1.0,,,,,,,,,,,,,Q9UPY3_D_1709_A
5596,Q9UPY3,P,1729,E,5zal:A,1729,No effect on activity.,,,0.0,,,,,,,,,,,,,Q9UPY3_P_1729_E
5597,Q9UPY3,E,1813,A,5zal:A,1813,Decreased activity. Loss of activity,,,1.0,,,,,,,,,,,,,Q9UPY3_E_1813_A
5598,Q96G74,S,177,D,3tmp:C,177,Loss of deubiquitinase activity. Abolishes activation by protein kinases.,-1.0,,1.0,,,,,,,,,,,,,Q96G74_S_177_D
5598,Q96G74,S,177,E,3tmp:C,177,Loss of deubiquitinase activity. Abolishes activation by protein kinases.,-1.0,,1.0,,,,,,,,,,,,,Q96G74_S_177_E
5599,Q96G74,C,224,S,3tmp:A,224,Loss of deubiquitinase activity. Loss of suppression of IFN production.,,,1.0,,,,,,,,,,,,,Q96G74_C_224_S
5600,Q9NZ45,C,72,S,4ezf:A,72,Abolishes absorption in the 300-500 nm range.,,,-999.0,,,,,,,,,,,,,Q9NZ45_C_72_S
5601,Q9NZ45,C,74,S,4ezf:A,74,Abolishes absorption in the 300-500 nm range.,,,-999.0,,,,,,,,,,,,,Q9NZ45_C_74_S
5602,Q9NZ45,C,83,S,4ezf:A,83,Abolishes absorption in the 300-500 nm range.,,,-999.0,,,,,,,,,,,,,Q9NZ45_C_83_S
5603,Q9NZ45,D,84,N,4ezf:A,84,Does not affect absorption in the 300-500 nm range.,,,-999.0,,,,,,,,,,,,,Q9NZ45_D_84_N
5604,Q9NZ45,H,87,C,4ezf:A,87,Affects absorption in the 300-500 nm range but it is not reduced. Increased stability of the 2Fe-2S cluster at low pH.,,1.0,-999.0,,,,,,,,,,,,,Q9NZ45_H_87_C
5605,Q9NZ45,H,87,Q,4ezf:A,87,Abolishes absorption in the 300-500 nm range.,,,-999.0,,,,,,,,,,,,,Q9NZ45_H_87_Q
5606,Q9UJ41,A,58,G,2c7m:A,59,Reduces affinity for ubiquitin 3-fold.,-1.0,,-999.0,,,,,,,,,,,,,Q9UJ41_A_58_G
5607,Q9UJ41,D,313,A,1txu:A,313,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,Q9UJ41_D_313_A
5608,Q9UJ41,P,317,A,1txu:A,317,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,Q9UJ41_P_317_A
5609,Q9UJ41,Y,354,A,1txu:A,354,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,Q9UJ41_Y_354_A
5610,Q9UJ41,T,357,A,1txu:A,357,Strongly reduced activity.,,,1.0,,,,,,,,,,,,,Q9UJ41_T_357_A
5611,Q8WUI4,H,843,A,3c0y:A,843,Enhanced deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_A
5612,Q8WUI4,H,843,F,3c0y:A,843,Enhanced deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_F
5613,Q8WUI4,H,843,Y,3c0y:A,843,6000 fold increase in deacetylase activity.,,,1.0,,,,,,,,,,,,,Q8WUI4_H_843_Y
5614,P26639,Y,392,E,4hwt:B,425,Partially restores in vitro translation.,,,-999.0,,,,,,,,,,,,,P26639_Y_392_E
5615,P26639,F,458,A,4hwt:B,491,Partially restores in vitro translation.,,,-999.0,,,,,,,,,,,,,P26639_F_458_A
5616,P26639,D,462,L,4hwt:B,495,"Does not restore in vitro translation, probably does not bind BN.",-1.0,,-999.0,,,,,,,,,,,,,P26639_D_462_L
5617,P26639,L,567,R,4hwt:B,600,"Does not restore in vitro translation, does not replace endogenous yeast enzyme.",,,-999.0,,,,,,,,,,,,,P26639_L_567_R
5617,P26639,L,567,W,4hwt:B,600,"Does not restore in vitro translation, does not replace endogenous yeast enzyme.",,,-999.0,,,,,,,,,,,,,P26639_L_567_W
5618,P26639,L,567,V,4hwt:B,600,Replaces endogenous yeast enzyme.,,,-999.0,,,,,,,,,,,,,P26639_L_567_V
5619,P40616,T,31,N,1upt:A,31,Loss of interaction with ARFIP1 and ARFIP2.,-1.0,,-999.0,,,,,,,,,,,,,P40616_T_31_N
5620,P40616,Q,71,L,1upt:A,71,"Altered Golgi structure with an engorged lumen. Interacts with ARFIP2, GOLGA4, RGPD8, SCOC and UNC119.",1.0,,1.0,,,,,,,,,,,,,P40616_Q_71_L
5621,Q96GA7,G,72,A,2rkb:A,72,Strongly increased enzyme activity towards threonine.,,,1.0,,,,,,,,,,,,,Q96GA7_G_72_A
5622,Q96GA7,C,309,A,2rkb:A,309,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q96GA7_C_309_A
5623,Q9UBU8,V,208,E,2lkm:B,169,Abolishes binding to MRFAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UBU8_V_208_E
5624,Q9UBU8,E,234,R,2lkm:B,195,No effect on MRFAP1 binding.,0.0,,-999.0,,,,,,,,,,,,,Q9UBU8_E_234_R
5625,Q9UBU8,Y,251,A,2lkm:B,212,No effect on MRFAP1 binding.,0.0,,-999.0,,,,,,,,,,,,,Q9UBU8_Y_251_A
5626,Q9UBU8,N,254,C,2lkm:B,215,Reduces binding to MRFAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q9UBU8_N_254_C
5627,Q9BUL8,K,132,D,3l8i:C,132,Loss of interaction with CCM2 and PXN,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_K_132_D
5628,Q9BUL8,A,135,D,3l8i:C,135,Loss of interaction with CCM2.,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_A_135_D
5629,Q9BUL8,K,139,D,3l8i:C,139,Loss of interaction with CCM2 and PXN,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_K_139_D
5630,Q9BUL8,K,172,D,3l8i:C,172,Loss of interaction with CCM2 and PXN,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_K_172_D
5631,Q9BUL8,S,175,D,3l8i:C,175,Loss of interaction with CCM2.,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_S_175_D
5632,Q9BUL8,K,179,D,3l8i:C,179,Loss of interaction with CCM2 and PXN,-1.0,,-999.0,,,,,,,,,,,,,Q9BUL8_K_179_D
5633,P61026,T,23,N,5szj:A,23,Probable dominant negative mutant locked in the inactive GDP-bound form,,1.0,1.0,,,,,,,,,,,,,P61026_T_23_N
5634,P61026,Q,68,L,5szj:A,68,Probable constitutively active mutant unable to hydrolyze GTP,,,-999.0,,,,,,,,,,,,,P61026_Q_68_L
5635,P61026,T,73,A,5szj:A,73,Loss of phosphorylation. No effect on GDI1 and GDI2 binding. Increases localization to the cytosol.,0.0,,-999.0,-1.0,,,,,,,,1.0,,,,P61026_T_73_A
5636,P61026,T,73,E,5szj:A,73,Phosphomimetic mutant. Loss of GDI1 and GDI2 binding. Increases localization to the Golgi complex.,-1.0,,-999.0,,,,,,,,,1.0,1.0,,,P61026_T_73_E
5637,Q9UDY8,C,464,A,4i1p:C,464,Slight decrease in NF-kappa-B activation.,,,1.0,,,,,,,,,,,,,Q9UDY8_C_464_A
5638,Q9UDY8,E,653,A,4i1p:C,653,Abolishes binding to TRAF6.,-1.0,,-999.0,,,,,,,,,,,,,Q9UDY8_E_653_A
5639,P61020,Q,79,L,2hei:B,79,Constitutively active.,,,1.0,,,,,,,,,,,,,P61020_Q_79_L
5640,P61020,S,84,A,2hei:B,84,"Loss of phosphorylation. No effect on GDI1, GDI2, CHML and CHM binding.",0.0,,-999.0,-1.0,,,,,,,,,,,,P61020_S_84_A
5641,P61020,S,84,E,2hei:B,84,"Phosphomimetic mutant. Loss of GDI1, GDI2, CHML and CHM binding.",-1.0,,-999.0,,,,,,,,,,1.0,,,P61020_S_84_E
5642,Q8IXL7,H,141,G,6q9v:A,109,30-fold reduction in activity.,,,1.0,,,,,,,,,,,,,Q8IXL7_H_141_G
5643,Q8IXL7,N,160,F,6q9v:A,128,7000-fold reduction in activity.,,,1.0,,,,,,,,,,,,,Q8IXL7_N_160_F
5644,Q8IXL7,N,160,Y,6q9v:A,128,500-fold reduction in activity.,,,1.0,,,,,,,,,,,,,Q8IXL7_N_160_Y
5645,Q9NWZ3,K,213,A,6lxy:B,213,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q9NWZ3_K_213_A
5646,Q96BI3,H,171,A,6idf:C,171,Impaired gamma-secretease assembly and reduced proteolytic activity of the gamma-secretase complex.,-1.0,,1.0,,,,,,,,,,,,,Q96BI3_H_171_A
5647,Q96BI3,H,197,A,6idf:C,197,Impaired gamma-secretease assembly and reduced proteolytic activity of the gamma-secretase complex.,-1.0,,1.0,,,,,,,,,,,,,Q96BI3_H_197_A
5648,Q6XZF7,V,1521,R,1uhc:A,19,Decreased interaction of SH3 domain 6 with L.monocytogenes InlC.,-1.0,,-999.0,,,,,,,,,,,,,Q6XZF7_V_1521_R
5649,Q6XZF7,P,1529,A,1uhc:A,27,Wild-type interaction of SH3 domain 6 with L.monocytogenes InlC.,0.0,,-999.0,,,,,,,,,,,,,Q6XZF7_P_1529_A
5650,Q6XZF7,N,1569,R,1uhc:A,67,Decreased interaction of SH3 domain 6 with L.monocytogenes InlC.,-1.0,,-999.0,,,,,,,,,,,,,Q6XZF7_N_1569_R
5651,Q9NR21,Y,38,A,2dk6:A,24,No effect on subcellular location at the nuclear envelope.,,,-999.0,,,,,,,,,0.0,,,,Q9NR21_Y_38_A
5652,Q9NR21,F,48,A,2dk6:A,34,No effect on subcellular location at the nuclear envelope.,,,-999.0,,,,,,,,,0.0,,,,Q9NR21_F_48_A
5653,Q9NR21,Y,84,A,2dk6:A,70,Loss of subcellular location at the nuclear envelope.,,,-999.0,,,,,,,,,1.0,,,,Q9NR21_Y_84_A
5654,Q9NR21,Q,93,A,2dk6:A,79,Loss of subcellular location at the nuclear envelope.,,,-999.0,,,,,,,,,1.0,,,,Q9NR21_Q_93_A
5655,Q9NR21,R,102,A,2dk6:A,88,Loss of subcellular location at the nuclear envelope.,,,-999.0,,,,,,,,,1.0,,,,Q9NR21_R_102_A
5656,P12277,C,283,S,3dre:A,283,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P12277_C_283_S
5656,P12277,C,283,Y,3dre:A,283,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P12277_C_283_Y
5657,P12277,R,292,H,3dre:A,292,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P12277_R_292_H
5657,P12277,R,292,L,3dre:A,292,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P12277_R_292_L
5657,P12277,R,292,Q,3dre:A,292,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P12277_R_292_Q
5658,P12277,R,292,K,3dre:A,292,42% of wild-type activity.,,,1.0,,,,,,,,,,,,,P12277_R_292_K
5659,P12277,D,340,E,3dre:A,340,No change in activity.,,,0.0,,,,,,,,,,,,,P12277_D_340_E
5660,Q8NCC3,D,46,A,4x93:B,13,Decreases phospholipase and transacetylase activity. Has no effect on association with membranes.,,,1.0,,,,,,,,,0.0,,,,Q8NCC3_D_46_A
5661,Q8NCC3,L,83,S,4x93:B,50,No effect on phospholipase activity. Strongly decreases transacetylase activity and association with membranes.,,,1.0,,,,,,,,,1.0,,,,Q8NCC3_L_83_S
5662,Q8NCC3,V,85,S,4x93:B,52,No effect on phospholipase activity. Strongly decreases transacetylase activity and association with membranes.,,,1.0,,,,,,,,,1.0,,,,Q8NCC3_V_85_S
5663,Q8NCC3,N,99,A,4x93:B,66,"Loss of glycosylation site. Leads to retention in the endoplasmic reticulum and nearly abolishes the production of the mature, active enzyme.",,,1.0,,,-1.0,,,,,,1.0,,,-1.0,Q8NCC3_N_99_A
5664,Q8NCC3,S,198,A,4x93:B,165,Abolishes phospholipase and transacetylase activity. Abolishes association with membranes.,,,1.0,,,,,,,,,1.0,,,,Q8NCC3_S_198_A
5665,Q8NCC3,K,235,A,4x93:B,202,No effect on phospholipase activity. Abolishes transacetylase activity. Has no effect on association with membranes.,,,1.0,,,,,,,,,0.0,,,,Q8NCC3_K_235_A
5666,Q8NCC3,N,273,A,4x93:B,240,"Loss of glycosylation site. Mildly reduces production of the mature, active enzyme.",,,1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_273_A
5667,Q8NCC3,N,289,A,4x93:B,256,"Loss of glycosylation site. Mildly reduces production of the mature, active enzyme.",,,1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_289_A
5668,Q8NCC3,T,362,A,4x93:B,329,No effect on phospholipase activity. Strongly decreases transacetylase activity and abolishes association with membranes.,,,1.0,,,,,,,,,1.0,,,,Q8NCC3_T_362_A
5669,Q8NCC3,N,398,A,4x93:B,365,"Loss of glycosylation site. Slightly reduces production of the mature, active enzyme.",,,1.0,,,-1.0,,,,,,,,,-1.0,Q8NCC3_N_398_A
5670,Q9NWT6,H,199,A,2yde:A,199,Prevents suppression of HIF CAD activity. Strongly stimulates 2-oxoglutarate turnover. No stimulation of 2-oxoglutarate turnover,,,-999.0,,,,,,,,,,,,,Q9NWT6_H_199_A
5671,Q9NWT6,D,201,A,2yde:A,201,Prevents suppression of HIF CAD activity.,,,1.0,,,,,,,,,,,,,Q9NWT6_D_201_A
5672,Q9NWT6,D,201,E,2yde:A,201,Loss of HIF1A Asn hydroxylation activity. Slightly stimulates 2-oxoglutarate turnover.,,,1.0,,,,,,,,,,,,,Q9NWT6_D_201_E
5673,Q9NWT6,D,201,G,2yde:A,201,No impact on HIF1A Asn hydroxylation activity. Loss of Asp hydroxylation ability. Strongly stimulates 2-oxoglutarate turnover. Loss of HIF1A Asn hydroxylation activity and slight stimulation of 2-oxoglutarate turnover,,,-999.0,,,,,,,,,,,,,Q9NWT6_D_201_G
5674,Q9NWT6,Q,239,H,2yde:A,239,No effect on Asp hydroxylation ability.,,,0.0,,,,,,,,,,,,,Q9NWT6_Q_239_H
5675,Q9NWT6,W,296,R,2yde:A,296,Loss of HIF1A Asn hydroxylation activity and slight stimulation of 2-oxoglutarate turnover,,,1.0,,,,,,,,,,,,,Q9NWT6_W_296_R
5676,Q9NWT6,L,340,R,2yde:A,340,"Impairs dimer formation, leading to loss of HIF1A Asn hydroxylation activity. No stimulation of 2-oxoglutarate turnover",-1.0,,1.0,,,,,,,,,,,,,Q9NWT6_L_340_R
5677,Q9NWT6,I,344,R,2yde:A,344,No effect on dimer formation and HIF1A Asn hydroxylation activity.,0.0,,0.0,,,,,,,,,,,,,Q9NWT6_I_344_R
5678,Q96DU3,R,108,A,2if7:D,86,Inhibits dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96DU3_R_108_A
5679,Q96DU3,Q,110,A,2if7:D,88,Inhibits dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96DU3_Q_110_A
5680,Q96DU3,S,112,A,2if7:D,90,Inhibits dimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96DU3_S_112_A
5681,Q15287,N,171,R,4a8x:A,171,Impairs interaction with SAP18.,-1.0,,-999.0,,,,,,,,,,,,,Q15287_N_171_R
5682,Q15287,Y,205,A,4a8x:A,205,Abolishes exon-skipping.,,,-999.0,,,,,,,,,,,,,Q15287_Y_205_A
5683,Q15287,Y,207,A,4a8x:A,207,Abolishes exon-skipping.,,,-999.0,,,,,,,,,,,,,Q15287_Y_207_A
5684,Q15286,S,22,N,6if2:B,22,Destabilization of the intercellular bridge during cytokinesis. Strong reduction in fast recycling.,,,1.0,,,,,,,,,,,,,Q15286_S_22_N
5685,Q15286,Q,67,L,6if2:B,67,Loss of GTPase activity. Increased fast recycling.,,,1.0,,,,,,,,,,,,,Q15286_Q_67_L
5686,Q15286,T,72,A,6if2:B,72,Loss of phosphorylation. No effect on binding to GDI1 and GDI2.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q15286_T_72_A
5687,Q15286,T,72,E,6if2:B,72,"Phosphomimetic mutant. Loss of binding to GDI1, GDI2, CHM and CHML.",-1.0,,-999.0,,,,,,,,,,1.0,,,Q15286_T_72_E
5688,P55197,I,22,A,5dah:A,22,Does not affect interaction with histone H3.,0.0,,-999.0,,,,,,,,,,,,,P55197_I_22_A
5689,P55197,V,80,A,5dah:A,80,Does not affect interaction with histone H3.,0.0,,-999.0,,,,,,,,,,,,,P55197_V_80_A
5690,P55197,A,106,V,5dah:A,106,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_A_106_V
5691,P55197,L,107,A,5dah:A,107,Impairs interaction with histone H3. Reduces association to chromatin. Does not rescued histone H3 'Lys-79' dimethylation (H3K79me2) levels in MLLT10-depleted cells. Does not rescued DOT1L-target genes in MLLT10-depleted cells.,-1.0,,-999.0,,,,,,,,,,,,,P55197_L_107_A
5692,P55197,I,109,A,5dah:A,109,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_I_109_A
5693,P55197,F,114,A,5dah:A,114,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_F_114_A
5694,P55197,M,120,A,5dah:A,120,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_M_120_A
5695,P55197,E,179,A,5dah:A,179,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_E_179_A
5696,P55197,Y,190,A,5dah:A,190,Impairs interaction with histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P55197_Y_190_A
5697,P34972,K,109,A,6pt0:R,109,No effect on agonist binding. Affects cannabinoid agonist binding,,-1.0,-999.0,,,,,,,,,,,,,P34972_K_109_A
5698,P34972,K,109,R,6pt0:R,109,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P34972_K_109_R
5699,P34972,S,112,G,6pt0:R,112,Affects cannabinoid agonist binding,,-1.0,-999.0,,,,,,,,,,,,,P34972_S_112_G
5700,P34972,D,130,A,6pt0:R,130,Loss of ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,1.0,,,,,,,,,,,,,P34972_D_130_A
5701,P34972,R,131,A,6pt0:R,131,No effect on ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,1.0,,,,,,,,,,,,,P34972_R_131_A
5702,P34972,L,201,P,6pt0:R,201,Abolishes ligand binding and agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,1.0,,,,,,,,,,,,,P34972_L_201_P
5703,P34972,Y,207,A,6pt0:R,207,Abolishes agonist-induced inhibitory effect on adenylate cyclase. No effect on ligand binding.,,0.0,1.0,,,,,,,,,,,,,P34972_Y_207_A
5704,P34972,A,244,E,6pt0:R,244,Loss of ligand binding. Alters agonist-induced inhibitory effect on adenylate cyclase.,,-1.0,1.0,,,,,,,,,,,,,P34972_A_244_E
5705,Q5D1E8,D,141,N,3v33:A,141,Abolishes RNase activity.,,,1.0,,,,,,,,,,,,,Q5D1E8_D_141_N
5707,Q5D1E8,N,144,A,3v33:A,144,No change in RNase activity.,,,0.0,,,,,,,,,,,,,Q5D1E8_N_144_A
5708,Q5D1E8,C,157,A,3v33:A,157,Does not inhibit antiviral effects.,,,0.0,,,,,,,,,,,,,Q5D1E8_C_157_A
5709,Q5D1E8,R,214,A,3v33:A,214,Abolishes RNase activity.,,,1.0,,,,,,,,,,,,,Q5D1E8_R_214_A
5710,Q5D1E8,D,225,A,3v33:A,225,"Loss of pre-miRNA RNase activity, IL17A mRNA instability and antiviral effects",,,1.0,,,,,,,,,,,,,Q5D1E8_D_225_A
5711,Q5D1E8,D,226,A,3v33:A,226,"Loss of pre-miRNA RNase activity, IL17A mRNA instability and antiviral effects",,,1.0,,,,,,,,,,,,,Q5D1E8_D_226_A
5712,Q13613,C,438,S,5c16:A,438,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q13613_C_438_S
5713,Q13613,D,443,A,5c16:A,443,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q13613_D_443_A
5714,Q13613,R,444,A,5c16:A,444,"Abolishes enzyme activity with phosphatidylinositol 3-phosphate. Reduces activity with phosphatidylinositol (3,5)-bisphosphate.",,,1.0,,,,,,,,,,,,,Q13613_R_444_A
5715,Q13613,R,484,A,5c16:A,484,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q13613_R_484_A
5716,Q13617,K,621,R,6r6h:O,621,No effect on conjugation with NEDD8.,0.0,,-999.0,,,,,,,,,,,,,Q13617_K_621_R
5717,Q13617,K,689,R,6r6h:O,689,Loss of conjugation with NEDD8.,-1.0,,-999.0,,,,,,,,,,,,,Q13617_K_689_R
5718,Q13617,K,719,R,6r6h:O,719,No effect on conjugation with NEDD8.,0.0,,-999.0,,,,,,,,,,,,,Q13617_K_719_R
5719,Q9NS18,C,68,S,2cq9:A,28,Abolishes absorption at 320 nm and 420 nm suggesting the loss of 2Fe-2S-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NS18_C_68_S
5720,Q9NS18,S,78,P,2cq9:A,38,Specifically increases the specific activity but decreases affinity for glutathionylated substrates.,,-1.0,1.0,,,,,,,,,,,,,Q9NS18_S_78_P
5721,Q9NS18,C,80,S,2cq9:A,40,Strongly impairs enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9NS18_C_80_S
5722,Q9NS18,C,153,S,2cq9:A,113,Abolishes absorption at 320 nm and 420 nm suggesting the loss of 2Fe-2S-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NS18_C_153_S
5723,Q6MZP7,C,525,Y,5fd3:A,525,Abolishes DNA-binding to the CDK1 promoter,,-1.0,-999.0,,,,,,,,,,,,,Q6MZP7_C_525_Y
5724,Q6MZP7,C,527,Y,5fd3:A,527,Abolishes DNA-binding to the CDK1 promoter,,-1.0,-999.0,,,,,,,,,,,,,Q6MZP7_C_527_Y
5725,Q6MZP7,Y,536,A,5fd3:A,536,Loss of DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q6MZP7_Y_536_A
5725,Q6MZP7,Y,536,F,5fd3:A,536,Loss of DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q6MZP7_Y_536_F
5725,Q6MZP7,Y,536,R,5fd3:A,536,Loss of DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q6MZP7_Y_536_R
5726,P50616,Y,45,A,2z15:A,54,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P50616_Y_45_A
5727,P50616,F,55,A,2z15:A,64,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P50616_F_55_A
5728,P50616,D,65,A,2z15:A,74,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P50616_D_65_A
5729,P50616,W,93,A,2z15:A,102,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P50616_W_93_A
5730,P50616,D,95,A,2z15:A,104,Impairs interaction with CNOT7 and CNOT8.,-1.0,,-999.0,,,,,,,,,,,,,P50616_D_95_A
5731,P34947,K,215,R,6pjx:A,215,Failed to phosphorylate p53/TP53.,,,1.0,,,,,,,,,,,,,P34947_K_215_R
5732,P34947,R,388,A,6pjx:A,388,Nuclear exclusion,,,-999.0,,,,,,,,,1.0,,,,P34947_R_388_A
5733,P34947,K,389,A,6pjx:A,389,Nuclear exclusion,,,-999.0,,,,,,,,,1.0,,,,P34947_K_389_A
5734,P34947,K,391,A,6pjx:A,391,Nuclear exclusion,,,-999.0,,,,,,,,,1.0,,,,P34947_K_391_A
5735,P34947,K,393,A,6pjx:A,393,Nuclear exclusion,,,-999.0,,,,,,,,,1.0,,,,P34947_K_393_A
5736,P34947,R,394,A,6pjx:A,394,Nuclear exclusion,,,-999.0,,,,,,,,,1.0,,,,P34947_R_394_A
5737,P34947,S,484,A,6pjx:A,484,15-20 fold defects in kinase activity,,,1.0,,,,,,,,,,,,,P34947_S_484_A
5738,P34947,T,485,A,6pjx:A,485,15-20 fold defects in kinase activity,,,1.0,,,,,,,,,,,,,P34947_T_485_A
5739,P50613,K,41,A,6o9l:8,41,Total loss of activity.,,,1.0,,,,,,,,,,,,,P50613_K_41_A
5740,P50613,F,91,G,6o9l:8,91,Enhanced capacity to bind ATP analogs.,,1.0,-999.0,,,,,,,,,,,,,P50613_F_91_G
5741,P50613,S,164,A,6o9l:8,164,No mitotic repression of transcriptional activity of the reconstituted TFIIH complex.,,,1.0,,,,,,,,,,,,,P50613_S_164_A
5742,P50613,T,170,A,6o9l:8,170,Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex.,,,1.0,,,,,,,,,,,,,P50613_T_170_A
5743,Q06141,E,114,Q,4mth:A,114,Reduces peptidoglycan binding and antibacterial activity.,,-1.0,1.0,,,,,,,,,,,,,Q06141_E_114_Q
5744,Q06141,E,118,Q,4mth:A,118,Reduces antibacterial activity but no effect on peptidoglycan binding.,,0.0,1.0,,,,,,,,,,,,,Q06141_E_118_Q
5745,Q8WWA0,C,48,S,4wmq:A,48,Forms mainly dimers. Forms mainly monomers,1.0,,-999.0,,,,,,,,,,,,,Q8WWA0_C_48_S
5746,O60880,R,32,Q,1ka6:A,32,Strongly reduced affinity for SLAMF1.,-1.0,,-999.0,,,,,,,,,,,,,O60880_R_32_Q
5747,O60880,R,78,E,1ka6:A,78,Disrupts interaction with FYN.,-1.0,,-999.0,,,,,,,,,,,,,O60880_R_78_E
5748,Q8TBZ3,F,262,A,5k1c:C,262,Impaired binding to USP12.,-1.0,,-999.0,,,,,,,,,,,,,Q8TBZ3_F_262_A
5749,Q8TBZ3,W,306,A,5k1c:C,306,Impaired binding to USP12.,-1.0,,-999.0,,,,,,,,,,,,,Q8TBZ3_W_306_A
5750,P30307,E,352,K,3op3:A,352,Partial loss of HIV-1 Vpr binding.,-1.0,,-999.0,,,,,,,,,,,,,P30307_E_352_K
5751,P30307,K,359,E,3op3:A,359,No effect on HIV-1 Vpr binding.,-1.0,,-999.0,,,,,,,,,,,,,P30307_K_359_E
5752,Q9BYC5,R,365,A,6vld:B,365,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_R_365_A
5752,Q9BYC5,R,365,K,6vld:B,365,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_R_365_K
5753,Q9BYC5,R,366,A,6vld:B,366,Decreases activity to 3%.,,,1.0,,,,,,,,,,,,,Q9BYC5_R_366_A
5753,Q9BYC5,R,366,K,6vld:B,366,Decreases activity to 3%.,,,1.0,,,,,,,,,,,,,Q9BYC5_R_366_K
5754,Q9BYC5,D,368,A,6vld:B,368,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_D_368_A
5755,Q9BYC5,K,369,A,6vld:B,369,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_K_369_A
5756,Q9BYC5,E,373,A,6vld:B,373,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_E_373_A
5757,Q9BYC5,Y,382,A,6vld:B,382,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_Y_382_A
5758,Q9BYC5,D,409,A,6vld:B,409,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_D_409_A
5759,Q9BYC5,D,410,A,6vld:B,410,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9BYC5_D_410_A
5760,Q9BYC5,D,453,A,6vld:B,453,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_D_453_A
5761,Q9BYC5,S,469,A,6vld:B,469,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BYC5_S_469_A
5762,P51693,H,426,A,3q7g:A,426,Reduced affinity for heparin. Reduces homodimerization.,-1.0,-1.0,-999.0,,,,,,,,,,,,,P51693_H_426_A
5763,P51693,R,429,A,3q7g:A,429,Strongly reduced affinity for heparin. Strongly reduced homodimerization.,-1.0,-1.0,-999.0,,,,,,,,,,,,,P51693_R_429_A
5764,P51693,H,433,A,3q7g:A,433,Reduced affinity for heparin. Reduces homodimerization.,-1.0,-1.0,-999.0,,,,,,,,,,,,,P51693_H_433_A
5765,P51692,T,684,A,6mbw:B,684,Abolishes interaction with INSR.,-1.0,,-999.0,,,,,,,,,,,,,P51692_T_684_A
5766,O15033,C,790,A,6jx5:A,790,Failure to form ubiquitin thioester complex and does not inhibit apoptosis.,,,1.0,,,,,,,,,,,,,O15033_C_790_A
5767,Q9BRZ2,C,21,A,5jw7:B,21,"Complete loss of autoubiquitination. Complete loss of autoubiquitination, loss of antiviral activity against yellow fever virus and human coronavirus virus OC43, but normal induction of interferon-beta following Sendai virus infection",,,1.0,,-1.0,,,,,,,,,,,Q9BRZ2_C_21_A
5768,Q9BRZ2,C,24,A,5jw7:B,24,"Complete loss of autoubiquitination, loss of antiviral activity against yellow fever virus and human coronavirus virus OC43, but normal induction of interferon-beta following Sendia virus infection",,,1.0,,-1.0,,,,,,,,,,,Q9BRZ2_C_24_A
5769,Q9BUB5,K,78,M,2hw6:A,78,Loss of kinase activity,,,1.0,,,,,,,,,,,,,Q9BUB5_K_78_M
5770,P37173,K,277,R,5e92:A,277,"Abolishes kinase activity, TGF-beta signaling and interaction with DAXX.",,,1.0,,,,,,,,,,,,,P37173_K_277_R
5771,P19447,K,346,R,6o9m:7,346,No transcriptional activity of the reconstituted TFIIH complex.,,,1.0,,,,,,,,,,,,,P19447_K_346_R
5772,P58753,P,125,H,2ndh:A,125,Abolishes NF-kappa-B activation.,,,1.0,,,,,,,,,,,,,P58753_P_125_H
5773,P09960,Q,135,A,3b7r:L,134,Srongly increased epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_Q_135_A
5773,P09960,Q,135,L,3b7r:L,134,Srongly increased epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_Q_135_L
5775,P09960,Q,137,A,3b7r:L,136,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_Q_137_A
5776,P09960,Q,137,L,3b7r:L,136,"Aminopeptidase activity strongly impaired, but keeps LTA4 activity.",,,1.0,,,,,,,,,,,,,P09960_Q_137_L
5777,P09960,Q,137,N,3b7r:L,136,"Aminopeptidase activity almost absent, but keeps LTA4 activity.",,,1.0,,,,,,,,,,,,,P09960_Q_137_N
5778,P09960,H,140,Q,3b7r:L,139,"Aminopeptidase activity almost absent, but keeps LTA4 activity.",,,1.0,,,,,,,,,,,,,P09960_H_140_Q
5779,P09960,G,269,A,3b7r:L,268,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_G_269_A
5780,P09960,G,270,A,3b7r:L,269,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_G_270_A
5781,P09960,M,271,L,3b7r:L,270,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_M_271_L
5782,P09960,E,272,A,3b7r:L,271,Complete loss of epoxide hydrolase activity and aminopeptidase activity.,,,1.0,,,,,,,,,,,,,P09960_E_272_A
5782,P09960,E,272,D,3b7r:L,271,Complete loss of epoxide hydrolase activity and aminopeptidase activity.,,,1.0,,,,,,,,,,,,,P09960_E_272_D
5783,P09960,E,272,Q,3b7r:L,271,"Loss of LTA4 hydrolase activity, and aminopeptidase activity strongly impaired.",,,1.0,,,,,,,,,,,,,P09960_E_272_Q
5784,P09960,N,273,A,3b7r:L,272,No loss of epoxide hydrolase activity and aminopeptidase activity.,,,0.0,,,,,,,,,,,,,P09960_N_273_A
5785,P09960,H,296,Y,3b7r:L,295,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,1.0,,,,,,,,,,,,,P09960_H_296_Y
5786,P09960,E,297,A,3b7r:L,296,Loss of epoxide hydrolase and aminopeptidase activities.,,,1.0,,,,,,,,,,,,,P09960_E_297_A
5787,P09960,E,297,K,3b7r:L,296,Loss of epoxide hydrolase and aminopeptidase activities.,,,1.0,,,,,,,,,,,,,P09960_E_297_K
5788,P09960,E,297,Q,3b7r:L,296,"Loss of aminopeptidase activity, but keeps LTA4 hydrolase activity.",,,1.0,,,,,,,,,,,,,P09960_E_297_Q
5789,P09960,H,300,L,3b7r:L,299,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,1.0,,,,,,,,,,,,,P09960_H_300_L
5790,P09960,E,319,A,3b7r:L,318,Complete loss of LTA4 hydrolase and peptidase enzyme activities.,,,1.0,,,,,,,,,,,,,P09960_E_319_A
5791,P09960,D,372,N,3b7r:L,371,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_D_372_N
5792,P09960,D,374,N,3b7r:L,373,No loss of activity.,,,0.0,,,,,,,,,,,,,P09960_D_374_N
5793,P09960,D,376,A,3b7r:L,375,Strongly reduced hydrolysis of peptides starting with Arg. Small effect on hydrolysis of peptides starting with Ala. Abolishes epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_D_376_A
5794,P09960,D,376,E,3b7r:L,375,Strongly reduced aminopeptidase activity. Abolishes epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_D_376_E
5795,P09960,D,376,N,3b7r:L,375,Abolishes aminopeptidase activity. Decreased epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_D_376_N
5796,P09960,E,385,Q,3b7r:L,384,Reduced aminopeptidase activity. Minor effect on epoxide hydrolase activity.,,,1.0,,,,,,,,,,,,,P09960_E_385_Q
5797,P09960,R,564,A,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,1.0,,,,,,,,,,,,,P09960_R_564_A
5797,P09960,R,564,K,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,1.0,,,,,,,,,,,,,P09960_R_564_K
5797,P09960,R,564,M,3b7r:L,563,Abolishes epoxide hydrolase activity. Reduced aminopeptidase activity.,,,1.0,,,,,,,,,,,,,P09960_R_564_M
5798,P09960,K,566,A,3b7r:L,565,Strongly reduced affinity for peptide substrates. Reduced epoxide hydrolase and aminopeptidase activity.,,-1.0,1.0,,,,,,,,,,,,,P09960_K_566_A
5798,P09960,K,566,M,3b7r:L,565,Strongly reduced affinity for peptide substrates. Reduced epoxide hydrolase and aminopeptidase activity.,,-1.0,1.0,,,,,,,,,,,,,P09960_K_566_M
5799,P09960,K,566,R,3b7r:L,565,No effect on epoxide hydrolase and aminopeptidase activity.,,,0.0,,,,,,,,,,,,,P09960_K_566_R
5800,Q96H22,R,11,A,6c0w:K,11,Decreases the binding to centromeres.,,-1.0,-999.0,,,,,,,,,,,,,Q96H22_R_11_A
5801,Q96H22,R,196,A,6eqt:A,196,Decreases the binding to centromeres.,,-1.0,-999.0,,,,,,,,,,,,,Q96H22_R_196_A
5802,P11836,T,159,K,6y92:A,159,Abrogates recognition by some antibodies,,-1.0,-999.0,,,,,,,,,,,,,P11836_T_159_K
5803,P11836,N,163,D,6y92:A,163,Decreased binding of some antibodies. No effect on rituximab binding.,,-1.0,-999.0,,,,,,,,,,,,,P11836_N_163_D
5804,P11836,N,166,D,6y92:A,166,Decreased binding of some antibodies. No effect on rituximab binding.,,-1.0,-999.0,,,,,,,,,,,,,P11836_N_166_D
5805,P11836,A,170,S,6y92:A,170,"Abrogates recognition by therapeutic antibodies, including rituximab",,-1.0,-999.0,,,,,,,,,,,,,P11836_A_170_S
5806,P11836,P,172,S,6y92:A,172,"Marked reduction in rituximab binding. Abrogates recognition by antibodies, including rituximab",,-1.0,-999.0,,,,,,,,,,,,,P11836_P_172_S
5807,P16591,R,483,Q,2kk6:A,42,Abolishes kinase activity. Abolishes location at microtubules.,,,1.0,,,,,,,,,1.0,,,,P16591_R_483_Q
5808,Q9HBI1,V,256,Q,4edm:B,256,Abolishes interaction with PXN.,-1.0,,-999.0,,,,,,,,,,,,,Q9HBI1_V_256_Q
5809,Q9HBI1,F,299,D,4edm:B,299,Abolishes interaction with ILK. Abolishes location at focal adhesion sites.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9HBI1_F_299_D
5810,Q9BU02,K,11,A,3bhd:B,11,Mildly decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BU02_K_11_A
5811,Q9BU02,D,37,A,3bhd:B,37,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q9BU02_D_37_A
5812,Q9BU02,Y,39,A,3bhd:B,39,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q9BU02_Y_39_A
5813,Q9BU02,W,53,A,3bhd:B,53,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q9BU02_W_53_A
5814,Q9BU02,K,65,A,3bhd:B,65,Strongly decreases enzyme activity. No effect on affinity for thiamine triphosphate.,,0.0,1.0,,,,,,,,,,,,,Q9BU02_K_65_A
5815,Q9BU02,Y,79,A,3bhd:B,79,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BU02_Y_79_A
5816,Q9BU02,E,81,A,3bhd:B,81,Mildly decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BU02_E_81_A
5817,Q9BU02,D,147,A,3bhd:B,147,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q9BU02_D_147_A
5818,Q9BU02,K,193,A,3bhd:B,193,Strongly decreases affinity for thiamine triphosphate and enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,Q9BU02_K_193_A
5819,P49903,T,85,A,3fd5:B,85,Strongly reduced ADP hydrolysis.,,,1.0,,,,,,,,,,,,,P49903_T_85_A
5820,P49903,G,268,C,3fd5:B,268,No change in ATP-binding.,,0.0,-999.0,,,,,,,,,,,,,P49903_G_268_C
5821,P49903,G,270,R,3fd5:B,270,No change in ATP-binding.,,0.0,-999.0,,,,,,,,,,,,,P49903_G_270_R
5822,P49903,G,273,A,3fd5:B,273,Loss of ATP-binding.,,-1.0,-999.0,,,,,,,,,,,,,P49903_G_273_A
5822,P49903,G,273,D,3fd5:B,273,Loss of ATP-binding.,,-1.0,-999.0,,,,,,,,,,,,,P49903_G_273_D
5822,P49903,G,273,V,3fd5:B,273,Loss of ATP-binding.,,-1.0,-999.0,,,,,,,,,,,,,P49903_G_273_V
5823,P49903,H,274,N,3fd5:B,274,Reduced ATP-binding.,,-1.0,-999.0,,,,,,,,,,,,,P49903_H_274_N
5824,P49903,H,274,Y,3fd5:B,274,Increased ATP-binding.,,1.0,-999.0,,,,,,,,,,,,,P49903_H_274_Y
5825,P08754,K,35,A,4g5o:D,35,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_K_35_A
5826,P08754,L,36,A,4g5o:D,36,Increased affinity for PLCD4.,1.0,,-999.0,,,,,,,,,,,,,P08754_L_36_A
5827,P08754,L,37,A,4g5o:D,37,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_L_37_A
5828,P08754,L,39,A,4g5o:D,39,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_L_39_A
5829,P08754,G,42,R,4g5o:D,42,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_G_42_R
5830,P08754,I,184,A,4g5o:D,184,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_I_184_A
5831,P08754,W,211,A,4g5o:D,211,Decreased affinity for CCDC88C and PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_W_211_A
5832,P08754,F,215,A,4g5o:D,215,Decreased affinity for CCDC88C and PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_F_215_A
5833,P08754,V,218,A,4g5o:D,218,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_V_218_A
5834,P08754,K,248,M,4g5o:D,248,No effect on binding to CCDC88C.,0.0,,-999.0,,,,,,,,,,,,,P08754_K_248_M
5835,P08754,L,249,H,4g5o:D,249,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_L_249_H
5836,P08754,L,249,V,4g5o:D,249,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_L_249_V
5837,P08754,S,252,A,4g5o:D,252,Increased affinity for PLCD4.,1.0,,-999.0,,,,,,,,,,,,,P08754_S_252_A
5838,P08754,S,252,D,4g5o:D,252,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_S_252_D
5839,P08754,N,256,A,4g5o:D,256,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_N_256_A
5840,P08754,N,256,E,4g5o:D,256,Decreased affinity for PLCD4.,-1.0,,-999.0,,,,,,,,,,,,,P08754_N_256_E
5841,P08754,K,257,A,4g5o:D,257,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_K_257_A
5842,P08754,W,258,F,4g5o:D,258,Increased affinity for PLCD4. No effect on binding to CCDC88C.,1.0,,-999.0,,,,,,,,,,,,,P08754_W_258_F
5843,P08754,F,259,A,4g5o:D,259,No effect on binding to PLCD4.,0.0,,-999.0,,,,,,,,,,,,,P08754_F_259_A
5844,P23284,K,129,A,3ich:A,97,Impairs interaction with CLGN and CANX.,-1.0,,-999.0,,,,,,,,,,,,,P23284_K_129_A
5845,Q07812,K,21,E,1f16:A,21,"Reduces interaction with BCL2L11, homooligomerization and triggering of apoptosis.",-1.0,,-999.0,,,,,,,,,,,,,Q07812_K_21_E
5846,Q07812,M,74,D,1f16:A,74,"Strongly reduced interaction with MCL1, BCL2, BCL2L1 and BCL2L2. No effect on cytochrome c release and subsequent apoptosis triggered by etoposide.",-1.0,,-999.0,,,,,,,,,,,,,Q07812_M_74_D
5846,Q07812,M,74,E,1f16:A,74,"Strongly reduced interaction with MCL1, BCL2, BCL2L1 and BCL2L2. No effect on cytochrome c release and subsequent apoptosis triggered by etoposide.",-1.0,,-999.0,,,,,,,,,,,,,Q07812_M_74_E
5847,Q07812,S,184,D,1f16:A,184,Constitutive cytoplasmic location.,,,-999.0,,,,,,,,,1.0,,,,Q07812_S_184_D
5847,Q07812,S,184,E,1f16:A,184,Constitutive cytoplasmic location.,,,-999.0,,,,,,,,,1.0,,,,Q07812_S_184_E
5847,Q07812,S,184,H,1f16:A,184,Constitutive cytoplasmic location.,,,-999.0,,,,,,,,,1.0,,,,Q07812_S_184_H
5847,Q07812,S,184,K,1f16:A,184,Constitutive cytoplasmic location.,,,-999.0,,,,,,,,,1.0,,,,Q07812_S_184_K
5848,Q07812,S,184,V,1f16:A,184,Constitutive mitochondrial location.,,,-999.0,,,,,,,,,1.0,,,,Q07812_S_184_V
5849,P62937,R,55,A,1cwh:A,55,Loss of peptidyl-prolyl cis-trans isomerase activity. No loss of its interaction with BSG/CD147 or its ability to induce leukocyte chemotaxis. No effect on its interaction with MAP3K5/ASK1. Loss of its ability to negatively regulate oxidative stress-induced apoptosis mediated by MAP3K5/ASK1. Reduced interaction with TARDBP. No loss of interaction with influenza A virus matrix protein 1 or its ability to inhibit viral replication.,,,1.0,,,,,,,,,,,,,P62937_R_55_A
5850,P62937,F,60,A,1cwh:A,60,Loss of ability to stimulate MAPK/ERK phosphorylation.,,,1.0,,,,,,,,,,,,,P62937_F_60_A
5851,P62937,R,69,A,1cwh:A,69,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,1.0,,,,,,,,,,,,,P62937_R_69_A
5852,P62937,H,70,A,1cwh:A,70,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,1.0,,,,,,,,,,,,,P62937_H_70_A
5853,P62937,T,107,A,1cwh:A,107,No effect on peptidyl-prolyl cis-trans isomerase activity. Reduced interaction with BSG/CD147 and ability to induce leukocyte chemotaxis.,-1.0,,1.0,,,,,,,,,,,,,P62937_T_107_A
5854,P62937,F,113,A,1cwh:A,113,Reduced ability to stimulate MAPK/ERK phosphorylation.,,,1.0,,,,,,,,,,,,,P62937_F_113_A
5855,P62937,W,121,A,1cwh:A,121,200-fold decrease of sensitivity to CsA. Reduced ability to stimulate MAPK/ERK phosphorylation.,,-1.0,1.0,,,,,,,,,,,,,P62937_W_121_A
5856,P62937,W,121,E,1cwh:A,121,Loss of peptidyl-prolyl cis-trans isomerase activity.,,,1.0,,,,,,,,,,,,,P62937_W_121_E
5857,P62937,W,121,F,1cwh:A,121,75-fold decrease of sensitivity to CsA.,,-1.0,-999.0,,,,,,,,,,,,,P62937_W_121_F
5858,P62937,W,121,H,1cwh:A,121,No effect on peptidyl-prolyl cis-trans isomerase activity.,,,1.0,,,,,,,,,,,,,P62937_W_121_H
5859,P62937,K,125,Q,1cwh:A,125,Acetylation-mimetic mutant,,,-999.0,,,,,,,,,,1.0,,,P62937_K_125_Q
5860,P62937,K,125,R,1cwh:A,125,Loss of acetylation and interaction with TARDBP.,-1.0,,-999.0,,,,,,,,,,,,,P62937_K_125_R
5861,P62937,H,126,A,1cwh:A,126,Loss of peptidyl-prolyl cis-trans isomerase activity and interaction with HCV NS5A. Loss of ability to stimulate MAPK/ERK phosphorylation.,-1.0,,1.0,,,,,,,,,,,,,P62937_H_126_A
5862,P09622,K,89,E,1zmc:D,54,Abolishes dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,1.0,,,,,,,,,,,,,P09622_K_89_E
5863,P09622,H,383,A,1zmc:D,348,Reduces dihydrolipoyl dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P09622_H_383_A
5864,P09622,H,383,L,1zmc:D,348,Reduces dihydrolipoyl dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P09622_H_383_L
5865,P09622,D,448,A,1zmc:D,413,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_D_448_A
5866,P09622,D,448,N,1zmc:D,413,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_D_448_N
5867,P09622,E,466,A,1zmc:D,431,Decreases dehydrogenase activity. Loss of proteolytic activity.,,,1.0,,,,,,,,,,,,,P09622_E_466_A
5868,P09622,Y,473,A,1zmc:D,438,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_Y_473_A
5869,P09622,Y,473,F,1zmc:D,438,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_Y_473_F
5870,P09622,Y,473,H,1zmc:D,438,Reduces interaction with PDHX. Inhibits multienzyme pyruvate dehydrogenase complex activity. Does not affect dihydrolipoyl dehydrogenase activity.,-1.0,,0.0,,,,,,,,,,,,,P09622_Y_473_H
5871,P09622,R,482,A,1zmc:D,447,Does not affect dihydrolipoyl dehydrogenase activity.,,,0.0,,,,,,,,,,,,,P09622_R_482_A
5872,P09622,R,482,M,1zmc:D,447,Does not affect interaction with PDHX.,0.0,,-999.0,,,,,,,,,,,,,P09622_R_482_M
5873,P09622,H,485,A,1zmc:D,450,Loss of dehydrogenase activity. Increases proteolytic activity.,,,-999.0,,,,,,,,,,,,,P09622_H_485_A
5874,P09622,S,491,A,1zmc:D,456,Loss of proteolytic activity. Does not affect dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P09622_S_491_A
5875,P09622,E,492,Q,1zmc:D,457,Reduces dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,1.0,,,,,,,,,,,,,P09622_E_492_Q
5876,P09622,K,505,M,1zmc:D,470,Reduces dihydrolipoyl dehydrogenase activity. Does not affect interaction with PDHX.,0.0,,1.0,,,,,,,,,,,,,P09622_K_505_M
5877,Q9NVI1,K,523,R,6vae:A,523,Abolishes monoubiquitination by FANCL and UBE2T.,,,-999.0,,-1.0,,,,,,,,,,,Q9NVI1_K_523_R
5878,Q92905,H,138,Q,6r7h:E,138,"Abolishes ability to deneddylate cullins, without affecting the 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex.",,,1.0,,,,,,,,,,,,,Q92905_H_138_Q
5879,Q15120,N,120,H,1y8p:A,120,No effect on kinase activity,,,0.0,,,,,,,,,,,,,Q15120_N_120_H
5880,Q15120,D,121,N,1y8p:A,121,No effect on kinase activity,,,0.0,,,,,,,,,,,,,Q15120_D_121_N
5881,Q15125,W,68,A,6ohu:A,68,Reduces catalytic activity to less than 35% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_W_68_A
5882,Q15125,I,75,A,6ohu:A,75,Reduces catalytic activity to less than 35% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_I_75_A
5883,Q15125,H,76,A,6ohu:A,76,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_H_76_A
5884,Q15125,E,80,A,6ohu:A,80,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_E_80_A
5885,Q15125,Y,111,W,6ohu:A,111,Reduces catalytic activity to less than 2% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_Y_111_W
5886,Q15125,M,121,A,6ohu:A,121,Reduces catalytic activity to less than 35% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_M_121_A
5887,Q15125,M,121,V,6ohu:A,121,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q15125_M_121_V
5888,Q15125,E,122,A,6ohu:A,122,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_E_122_A
5889,Q15125,T,125,A,6ohu:A,125,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_T_125_A
5890,Q15125,Y,188,A,6ohu:A,188,Reduces catalytic activity to less than 35% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_Y_188_A
5891,Q15125,F,189,A,6ohu:A,189,Reduces catalytic activity to less than 35% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_F_189_A
5892,Q15125,F,189,L,6ohu:A,189,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q15125_F_189_L
5893,Q15125,N,193,A,6ohu:A,193,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_N_193_A
5894,Q15125,W,196,A,6ohu:A,196,Reduces catalytic activity to less than 10% of wild-type.,,,1.0,,,,,,,,,,,,,Q15125_W_196_A
5895,Q15126,K,17,M,3ch4:B,17,Approximately 8-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_K_17_M
5896,Q15126,R,18,Q,3ch4:B,18,Approximately 85-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_18_Q
5897,Q15126,K,19,M,3ch4:B,19,Approximately 9-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_K_19_M
5898,Q15126,K,22,M,3ch4:B,22,Approximately 100000-fold decrease in Vmax for MgATP.,,,1.0,,,,,,,,,,,,,Q15126_K_22_M
5899,Q15126,D,23,N,3ch4:B,23,Approximately 7-fold decrease in Vmax for MgATP and R-MVP. Approximately 10-fold increase in KM for MgATP and 5-fold increase in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_D_23_N
5900,Q15126,K,48,M,3ch4:B,48,Approximately 1400-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_K_48_M
5901,Q15126,K,69,M,3ch4:B,69,Approximately 500-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_K_69_M
5902,Q15126,R,73,M,3ch4:B,73,Approximately 3000-fold decrease in Vmax for MgATP and R-MVP. No change in KM for MgATP and approximately 3-fold increase in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_73_M
5903,Q15126,R,84,M,3ch4:B,84,Approximately 10-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and 50-fold increase in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_84_M
5904,Q15126,R,93,M,3ch4:B,93,Almost no change in KM and Vmax for MgATP and R-MVP.,,0.0,0.0,,,,,,,,,,,,,Q15126_R_93_M
5905,Q15126,R,110,M,3ch4:B,110,Approximately 20000-fold decrease in Vmax for MgATP.,,,1.0,,,,,,,,,,,,,Q15126_R_110_M
5906,Q15126,R,111,M,3ch4:B,111,Approximately 65-fold decrease in Vmax for MgATP and R-MVP. Approximately 8-fold increase in KM for MgATP and 60-fold increase in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_111_M
5907,Q15126,R,130,M,3ch4:B,130,Approximately 4-fold decrease in Vmax for MgATP and R-MVP. Approximately 3-fold increase in KM for MgATP and R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_130_M
5908,Q15126,R,138,M,3ch4:B,138,Approximately 3-fold decrease in Vmax for MgATP and R-MVP. Approximately 5-fold increase in KM for MgATP and no change in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_138_M
5909,Q15126,R,141,M,3ch4:B,141,Approximately 15-fold decrease in Vmax for MgATP and R-MVP. Approximately 50-fold increase in KM for MgATP and approximately 7-fold in KM for R-MVP.,,-1.0,1.0,,,,,,,,,,,,,Q15126_R_141_M
5910,Q86W47,T,11,A,6v22:E,2011,Suppresses the effect of okadaic acid and increases activation time constant,,,-999.0,,,,,,,,,,,,,Q86W47_T_11_A
5911,Q86W47,T,11,D,6v22:E,2011,Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics,,,1.0,,,,,,,,,,,,,Q86W47_T_11_D
5912,Q86W47,S,17,A,6v22:E,2017,Suppresses the effect of okadaic acid and increases activation time constant,,,-999.0,,,,,,,,,,,,,Q86W47_S_17_A
5913,Q86W47,S,17,E,6v22:E,2017,Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics,,,1.0,,,,,,,,,,,,,Q86W47_S_17_E
5914,Q86W47,N,53,A,6v22:E,2053,Loss of N-glycosylation and reduced protection against charybdotoxin,,,-999.0,,,-1.0,,,,,,,,,,Q86W47_N_53_A
5915,Q86W47,N,90,A,6v22:E,2090,Loss of N-glycosylation and reduced protection against charybdotoxin,,,-999.0,,,-1.0,,,,,,,,,,Q86W47_N_90_A
5916,Q9Y316,W,16,A,3bcz:A,16,Abolishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_W_16_A
5917,Q9Y316,H,49,A,3bcz:A,49,Abolishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_H_49_A
5918,Q9Y316,Y,54,A,3bcz:A,54,Diminishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_Y_54_A
5919,Q9Y316,H,81,A,3bcz:A,81,Abolishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_H_81_A
5920,Q9Y316,H,192,A,3bcz:A,192,Abolishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_H_192_A
5921,Q9Y316,C,244,A,3bcz:A,244,Abolishes interaction with ERBB2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y316_C_244_A
5922,P09467,Q,70,E,5q0b:A,69,Increased affinity towards Ca(2+) and Mg(2+).,,1.0,-999.0,,,,,,,,,,,,,P09467_Q_70_E
5923,P09467,D,119,A,5q0b:A,118,Reduced activity.,,,1.0,,,,,,,,,,,,,P09467_D_119_A
5924,P09467,D,122,A,5q0b:A,121,Reduced activity.,,,1.0,,,,,,,,,,,,,P09467_D_122_A
5925,P43250,I,6,A,3nyo:A,6,12-13 fold defects in kinase activity,,,1.0,,,,,,,,,,,,,P43250_I_6_A
5926,P43250,V,7,A,3nyo:A,7,12-13 fold defects in kinase activity,,,1.0,,,,,,,,,,,,,P43250_V_7_A
5927,P43250,N,9,A,3nyo:A,9,140-fold defects in kinase activity.,,,1.0,,,,,,,,,,,,,P43250_N_9_A
5928,P43250,L,12,A,3nyo:A,12,1100-fold defects in kinase activity.,,,1.0,,,,,,,,,,,,,P43250_L_12_A
5929,P0DPD7,D,88,A,2pxx:A,88,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_D_88_A
5930,P0DPD7,E,129,A,2pxx:A,129,Abolishes protein-lysine N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_E_129_A
5931,P0DPD7,K,130,A,2pxx:A,130,Abolishes protein-lysine N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_K_130_A
5932,P0DPD7,T,132,A,2pxx:A,132,Reduces protein-lysine N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_T_132_A
5933,P0DPD7,L,133,A,2pxx:A,133,Reduces protein-lysine N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_L_133_A
5934,P0DPD7,D,134,A,2pxx:A,134,Abolishes protein-lysine N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,P0DPD7_D_134_A
5935,O75907,L,346,W,6vz1:A,346,Strongly reduced diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_L_346_W
5936,O75907,T,371,A,6vz1:A,371,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_T_371_A
5937,O75907,Q,375,A,6vz1:A,375,Slightly decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_Q_375_A
5938,O75907,W,377,F,6vz1:A,377,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_W_377_F
5939,O75907,N,378,A,6vz1:A,378,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_N_378_A
5939,O75907,N,378,L,6vz1:A,378,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_N_378_L
5940,O75907,V,381,A,6vz1:A,381,Does not affect diacylglycerol O-acyltransferase activity.,,,0.0,,,,,,,,,,,,,O75907_V_381_A
5941,O75907,V,381,W,6vz1:A,381,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_V_381_W
5942,O75907,H,382,A,6vz1:A,382,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_H_382_A
5943,O75907,C,385,W,6vz1:A,385,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_C_385_W
5944,O75907,I,386,A,6vz1:A,386,Slightly decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_I_386_A
5945,O75907,Y,390,A,6vz1:A,390,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_Y_390_A
5946,O75907,K,391,A,6vz1:A,391,Slightly decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_K_391_A
5947,O75907,K,400,L,6vz1:A,400,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_K_400_L
5948,O75907,R,404,A,6vz1:A,404,Does not affect diacylglycerol O-acyltransferase activity.,,,0.0,,,,,,,,,,,,,O75907_R_404_A
5949,O75907,R,404,L,6vz1:A,404,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_R_404_L
5950,O75907,V,407,F,6vz1:A,407,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_V_407_F
5951,O75907,S,411,A,6vz1:A,411,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_S_411_A
5951,O75907,S,411,W,6vz1:A,411,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_S_411_W
5952,O75907,S,411,I,6vz1:A,411,Decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_S_411_I
5953,O75907,H,415,A,6vz1:A,415,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_H_415_A
5954,O75907,E,416,A,6vz1:A,416,Abolished diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_E_416_A
5955,O75907,M,434,A,6vz1:A,434,Reduced diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_M_434_A
5955,O75907,M,434,I,6vz1:A,434,Reduced diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_M_434_I
5956,O75907,Q,437,A,6vz1:A,437,Reduced diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_Q_437_A
5957,O75907,Q,465,A,6vz1:A,465,Reduced diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_Q_465_A
5958,O75907,V,469,A,6vz1:A,469,Slightly decreased diacylglycerol O-acyltransferase activity.,,,1.0,,,,,,,,,,,,,O75907_V_469_A
5959,Q9UK55,Y,408,A,3f1s:A,387,Loss of inhibitory activity.,,,1.0,,,,,,,,,,,,,Q9UK55_Y_408_A
5960,Q9UK53,W,378,A,2qic:A,235,Unable to stimulate DNA repair after UV irradiation or promote DNA-damage-induced apoptosis.,,,1.0,,,,,,,,,,,,,Q9UK53_W_378_A
5961,Q5T5U3,Y,1000,A,2dhj:A,77,Altered interaction with ARF1 and loss of association to membranes.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q5T5U3_Y_1000_A
5962,Q5T5U3,I,1054,A,2j59:N,1053,Altered interaction with ARF1 and loss of association to membranes.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q5T5U3_I_1054_A
5963,O75475,K,360,A,6tvm:A,360,"Reduced interaction with POGZ, CDCA7L and human HIV-1 integrase.",-1.0,,-999.0,,,,,,,,,,,,,O75475_K_360_A
5964,O75475,I,365,A,6tvm:A,365,Loss of interaction with human HIV-1 integrase,-1.0,,-999.0,,,,,,,,,,,,,O75475_I_365_A
5965,O75475,D,366,A,6tvm:A,366,Loss of interaction with human HIV-1 integrase,-1.0,,-999.0,,,,,,,,,,,,,O75475_D_366_A
5966,O75475,D,366,N,6tvm:A,366,Loss of interaction with human HIV-1 integrase,-1.0,,-999.0,,,,,,,,,,,,,O75475_D_366_N
5967,O75475,L,368,A,6tvm:A,368,Reduced interaction with KMT2A. Significant loss of interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O75475_L_368_A
5968,O75475,V,370,A,6tvm:A,370,"Reduced interaction with POGZ, CDCA7L and human HIV-1 integrase.",-1.0,,-999.0,,,,,,,,,,,,,O75475_V_370_A
5969,O75475,R,404,D,6tvm:A,404,Significant loss of interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O75475_R_404_D
5970,O75475,R,405,D,6tvm:A,405,Significant loss of interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O75475_R_405_D
5971,O75475,F,406,A,6tvm:A,406,Loss of interaction with human HIV-1 integrase and POGZ,-1.0,,-999.0,,,,,,,,,,,,,O75475_F_406_A
5972,O75475,K,407,D,6tvm:A,407,Reduced interaction with KMT2A. Significant loss of interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O75475_K_407_D
5973,O75475,V,408,A,6tvm:A,408,Reduced interaction with human HIV-1 integrase,-1.0,,-999.0,,,,,,,,,,,,,O75475_V_408_A
5974,O75473,D,146,F,4bsr:A,146,Abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,O75473_D_146_F
5975,O75473,D,170,F,4bsr:A,170,Abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,O75473_D_170_F
5976,O75473,A,190,D,4bsr:A,190,Abolishes activation of Wnt signaling.,,,1.0,,,,,,,,,,,,,O75473_A_190_D
5977,Q8TEP8,P,2313,A,6fvi:A,1717,"Increased presence on interphasic centrosomes, and decreased presence on mitotic centrosomes",,,-999.0,,,,,,,,,1.0,,,,Q8TEP8_P_2313_A
5978,Q96QK1,L,108,P,7bln:A,108,Disrupts interaction with VPS26,-1.0,,-999.0,,,,,,,,,,,,,Q96QK1_L_108_P
5979,Q96QK1,H,675,R,7bln:A,675,Disrupts interaction with VPS29. Does not effect interaction with VPS26.,,,-999.0,,,,,,,,,,,,,Q96QK1_H_675_R
5980,Q13158,S,12,R,2gf5:A,12,Loss of interaction with CASP8.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_S_12_R
5981,Q13158,F,25,R,2gf5:A,25,Loss of interaction with FAS. Loss of self-association. Abolishes induction of apoptosis.,-1.0,,1.0,,,,,,,,,,,,,Q13158_F_25_R
5982,Q13158,K,33,E,2gf5:A,33,Loss of self-association.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_K_33_E
5983,Q13158,R,38,A,2gf5:A,38,Loss of interaction with CASP8.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_R_38_A
5984,Q13158,D,44,R,2gf5:A,44,Loss of interaction with CASP8. Abolishes induction of apoptosis. Decreased interaction with FAS.,-1.0,,1.0,,,,,,,,,,,,,Q13158_D_44_R
5985,Q13158,E,51,R,2gf5:A,51,Loss of interaction with CASP8.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_E_51_R
5986,Q13158,R,117,E,2gf5:A,117,Loss of interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_R_117_E
5987,Q13158,V,121,N,2gf5:A,121,Loss of interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_V_121_N
5988,Q13158,D,123,R,2gf5:A,123,Strongly decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_D_123_R
5989,Q13158,R,135,E,2gf5:A,135,Strongly decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_R_135_E
5990,Q13158,R,142,E,2gf5:A,142,Decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_R_142_E
5991,Q13158,L,172,A,2gf5:A,172,Loss of interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_L_172_A
5991,Q13158,L,172,E,2gf5:A,172,Loss of interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_L_172_E
5992,Q13158,L,172,K,2gf5:A,172,Strongly decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_L_172_K
5993,Q13158,D,175,K,2gf5:A,175,Strongly decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_D_175_K
5994,Q13158,L,176,E,2gf5:A,176,Decreased interaction with FAS.,-1.0,,-999.0,,,,,,,,,,,,,Q13158_L_176_E
5995,Q6P2Q9,V,1788,D,5mqf:A,1788,Strongly reduced interaction with RNA.,,-1.0,-999.0,,,,,,,,,,,,,Q6P2Q9_V_1788_D
5996,Q6P2Q9,T,1789,P,5mqf:A,1789,Strongly reduced interaction with RNA.,,-1.0,-999.0,,,,,,,,,,,,,Q6P2Q9_T_1789_P
5997,Q9H611,K,234,A,6hph:A,234,Loss of ATPase activity. Lower activity for single-stranded DNA.,,,1.0,,,,,,,,,,,,,Q9H611_K_234_A
5998,Q92879,F,63,L,2dhs:A,63,Does not reduce RNA-binding,,0.0,-999.0,,,,,,,,,,,,,Q92879_F_63_L
5999,Q92879,L,472,F,2rqc:A,472,Does not reduce RNA-binding,,0.0,-999.0,,,,,,,,,,,,,Q92879_L_472_F
6000,Q92692,N,81,A,3r0n:A,81,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q92692_N_81_A
6001,Q92692,M,89,F,3r0n:A,89,Loss of entry of HHV-1/Rid1 and HSV-2. No effect on PRV entry.,,,-999.0,,,,,,,,,,,,,Q92692_M_89_F
6002,Q92692,M,89,I,3r0n:A,89,Increased entry of HHV-1/Rid1 and HSV-2.,,,-999.0,,,,,,,,,,,,,Q92692_M_89_I
6003,Q969G6,E,79,Q,1q9s:A,86,Loss of kinase activity. No effect on TNFRSF1A- and CYBA-binding.,,0.0,1.0,,,,,,,,,,,,,Q969G6_E_79_Q
6004,Q13535,K,2327,R,5yz0:A,2327,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q13535_K_2327_R
6005,Q13535,D,2475,A,5yz0:A,2475,Abolishes kinase activity,,,1.0,,,,,,,,,,,,,Q13535_D_2475_A
6006,Q13535,D,2494,E,5yz0:A,2494,Abolishes kinase activity,,,1.0,,,,,,,,,,,,,Q13535_D_2494_E
6007,P54278,E,41,A,1ea6:A,41,Decreased DNA mismatch repair activity.,,,1.0,,,,,,,,,,,,,P54278_E_41_A
6008,P54278,D,70,N,1ea6:A,70,"No effect on protein abundance, no effect on subcellular localization and loss of DNA mismatch repair activity.",,,1.0,,,,,,,,,0.0,,,0.0,P54278_D_70_N
6009,P54274,A,74,D,5wir:A,74,Abolishes dimerization and telomere binding,-1.0,-1.0,-999.0,,,,,,,,,,,,,P54274_A_74_D
6010,P54274,A,75,P,5wir:A,75,Abolishes dimerization and telomere binding,-1.0,-1.0,-999.0,,,,,,,,,,,,,P54274_A_75_P
6011,P54274,W,77,P,5wir:A,77,Abolishes telomere binding.,,-1.0,-999.0,,,,,,,,,,,,,P54274_W_77_P
6012,P54274,F,81,P,5wir:A,81,Abolishes telomere binding.,,-1.0,-999.0,,,,,,,,,,,,,P54274_F_81_P
6013,P54274,F,90,P,5wir:A,90,Diminishes telomere binding.,,-1.0,-999.0,,,,,,,,,,,,,P54274_F_90_P
6014,P54274,L,115,R,5wir:A,115,Loss of interaction with FBXO4.,-1.0,,-999.0,,,,,,,,,,,,,P54274_L_115_R
6015,P54274,L,120,R,5wir:A,120,Loss of interaction with FBXO4.,-1.0,,-999.0,,,,,,,,,,,,,P54274_L_120_R
6016,P54274,S,219,A,5wir:A,219,Loss of phosphorylation,,,-999.0,-1.0,,,,,,,,,,,,P54274_S_219_A
6017,P54274,S,219,D,5wir:A,219,Fails to induce apoptosis and decreases radiation hypersensitivity of ataxia-telangiectasia cells (phospho-mimicking mutants).,,,-999.0,,,,,,,,,,1.0,,,P54274_S_219_D
6017,P54274,S,219,E,5wir:A,219,Fails to induce apoptosis and decreases radiation hypersensitivity of ataxia-telangiectasia cells (phospho-mimicking mutants).,,,-999.0,,,,,,,,,,1.0,,,P54274_S_219_E
6018,P46597,L,11,F,4a6e:A,11,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P46597_L_11_F
6019,P46597,L,31,H,4a6e:A,31,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P46597_L_31_H
6020,P46597,T,296,M,4a6e:A,296,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P46597_T_296_M
6021,P46597,H,318,D,4a6e:A,318,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P46597_H_318_D
6022,P18054,H,355,Q,3d3l:A,355,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P18054_H_355_Q
6023,P18054,H,360,Q,3d3l:A,360,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P18054_H_360_Q
6023,P18054,H,360,Y,3d3l:A,360,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P18054_H_360_Y
6024,P18054,H,365,Q,3d3l:A,365,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P18054_H_365_Q
6025,P18054,H,383,Q,3d3l:A,383,Altered catalytic activity and protein expression.,,,1.0,,,,,,,,,,,,-1.0,P18054_H_383_Q
6026,P18054,H,392,Q,3d3l:A,392,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,P18054_H_392_Q
6027,P18054,H,540,Q,3d3l:B,540,Complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,P18054_H_540_Q
6028,P08575,C,853,S,1ygu:B,828,Loss of activity. Abolishes interaction with SKAP1.,-1.0,,1.0,,,,,,,,,,,,,P08575_C_853_S
6031,P46100,H,189,N,2jm1:A,189,Impairs interaction with histone H3 peptides and reduces localization to pericentromeric heterochromatin foci.,-1.0,,-999.0,,,,,,,,,1.0,,,,P46100_H_189_N
6032,P46100,Y,203,A,2jm1:A,203,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3),-1.0,,-999.0,,,,,,,,,,,,,P46100_Y_203_A
6032,P46100,Y,203,K,2jm1:A,203,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3),-1.0,,-999.0,,,,,,,,,,,,,P46100_Y_203_K
6033,P46100,Y,204,A,2jm1:A,204,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3) and reduces localization to pericentromeric heterochromatin foci.,-1.0,,-999.0,,,,,,,,,1.0,,,,P46100_Y_204_A
6034,P46100,D,207,A,2jm1:A,207,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3) and reduces localization to pericentromeric heterochromatin foci.,-1.0,,-999.0,,,,,,,,,1.0,,,,P46100_D_207_A
6035,P46100,I,209,A,2jm1:A,209,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3).,-1.0,,-999.0,,,,,,,,,,,,,P46100_I_209_A
6036,P46100,D,214,A,2jm1:A,214,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3).,-1.0,,-999.0,,,,,,,,,,,,,P46100_D_214_A
6037,P46100,D,217,A,2jm1:A,217,Impairs interaction with histone H3 peptides trimethylated at 'Lys-10' (H3K9me3),-1.0,,-999.0,,,,,,,,,,,,,P46100_D_217_A
6038,P46100,E,218,A,2jm1:A,218,Impairs interaction with histone H3 peptides unmethylated at 'Lys-5' (H3K4me0),-1.0,,-999.0,,,,,,,,,,,,,P46100_E_218_A
6039,P46100,E,252,L,2jm1:A,252,Impairs interaction with histone H3 peptides and reduces localization to pericentromeric heterochromatin foci.,-1.0,,-999.0,,,,,,,,,1.0,,,,P46100_E_252_L
6040,P35442,N,702,S,2rhp:A,702,Alters protein stability.,,,-999.0,,,,,,,,,,,-1.0,,P35442_N_702_S
6041,Q96P11,C,308,S,2b9e:A,308,Abolished methyltransferase activity without affecting nucleolar localization,,,1.0,,,,,,,,,0.0,,,,Q96P11_C_308_S
6042,Q96P11,C,359,S,2b9e:A,359,Abolished methyltransferase activity without affecting nucleolar localization,,,1.0,,,,,,,,,0.0,,,,Q96P11_C_359_S
6043,P10721,R,381,A,2e9w:A,381,Reduces autophosphorylation in response to KITLG/SCF.,,,1.0,-1.0,,,,,,,,,,,,P10721_R_381_A
6044,P10721,E,386,A,2e9w:A,386,Reduces autophosphorylation in response to KITLG/SCF.,,,1.0,-1.0,,,,,,,,,,,,P10721_E_386_A
6045,P10721,I,571,A,3g0e:A,571,Reduction in SH2B2/APS binding. Abolishes SH2B2/APS binding,-1.0,,-999.0,,,,,,,,,,,,,P10721_I_571_A
6046,P10721,K,623,M,3g0e:A,623,Stronger interaction with MPDZ.,1.0,,-999.0,,,,,,,,,,,,,P10721_K_623_M
6047,P10721,Y,823,F,4hvs:A,823,No decrease in activity. Leads to autophosphorylation at Tyr-900.,,,0.0,1.0,,,,,,,,,,,,P10721_Y_823_F
6048,Q8IV16,Y,66,A,6oaz:E,66,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_Y_66_A
6049,Q8IV16,L,71,A,6oaz:E,71,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_L_71_A
6050,Q8IV16,T,91,A,6oaz:E,91,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_T_91_A
6051,Q8IV16,L,92,A,6oaz:E,92,Only slightly increased formation of dimers and oligomers. No effect on number of monomers. Loss of LPL interaction.,,,-999.0,,,,,,,,,,,,,Q8IV16_L_92_A
6052,Q8IV16,I,93,A,6oaz:E,93,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_I_93_A
6053,Q8IV16,G,101,S,6oaz:E,101,Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_G_101_S
6054,Q8IV16,T,104,A,6oaz:E,104,Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_T_104_A
6055,Q8IV16,T,105,A,6oaz:E,105,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_T_105_A
6056,Q8IV16,H,106,L,6oaz:E,106,Promotes formation of dimers and oligomers severely reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_H_106_L
6057,Q8IV16,S,107,A,6oaz:E,107,Promotes formation of dimers and oligomers reducing number of monomers.,1.0,,-999.0,,,,,,,,,,,,,Q8IV16_S_107_A
6058,Q8IV16,T,108,A,6oaz:E,108,Retained some interaction with LPL. No effect on number of monomers.,0.0,,-999.0,,,,,,,,,,,,,Q8IV16_T_108_A
6059,Q8IV16,W,109,C,6oaz:E,109,Promotes formation of dimers and oligomers reducing number of monomers. Loss of LPL interaction.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_C
6059,Q8IV16,W,109,P,6oaz:E,109,Promotes formation of dimers and oligomers reducing number of monomers. Loss of LPL interaction.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_P
6059,Q8IV16,W,109,T,6oaz:E,109,Promotes formation of dimers and oligomers reducing number of monomers. Loss of LPL interaction.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_T
6060,Q8IV16,W,109,S,6oaz:E,109,Loss of interaction with LPL. Only slightly increased formation of dimers and oligomers. No effect on number of monomers.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_S
6060,Q8IV16,W,109,Y,6oaz:E,109,Loss of interaction with LPL. Only slightly increased formation of dimers and oligomers. No effect on number of monomers.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_Y
6060,Q8IV16,W,109,H,6oaz:E,109,Loss of interaction with LPL. Only slightly increased formation of dimers and oligomers. No effect on number of monomers.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_H
6060,Q8IV16,W,109,A,6oaz:E,109,Loss of interaction with LPL. Only slightly increased formation of dimers and oligomers. No effect on number of monomers.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_A
6060,Q8IV16,W,109,F,6oaz:E,109,Loss of interaction with LPL. Only slightly increased formation of dimers and oligomers. No effect on number of monomers.,,,-999.0,,,,,,,,,,,,,Q8IV16_W_109_F
6061,Q8IV16,Q,115,K,6oaz:E,115,No effect on number of monomers.,0.0,,-999.0,,,,,,,,,,,,,Q8IV16_Q_115_K
6062,Q8IV16,V,126,A,6oaz:E,126,Promotes formation of dimers and oligomers reducing number of monomers.,-1.0,,-999.0,,,,,,,,,,,,,Q8IV16_V_126_A
6063,P46109,W,160,L,2lqn:A,160,Abolishes interaction with DOCK5.,-1.0,,-999.0,,,,,,,,,,,,,P46109_W_160_L
6064,P54619,D,90,A,4rew:G,89,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Reduced ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,1.0,,,,,,,,,,,,,P54619_D_90_A
6065,P54619,D,245,A,4rew:G,244,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Reduced ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,1.0,,,,,,,,,,,,,P54619_D_245_A
6066,P54619,D,317,A,4rew:G,316,Reduced AMP-activation of phosphorylation of PRKAA1 or PRKAA2. Does not affect ADP activation of phosphorylation of PRKAA1 or PRKAA2.,,,1.0,,,,,,,,,,,,,P54619_D_317_A
6067,Q9NPB6,K,19,A,1wmh:B,19,Loss of interaction with ECT2 and PRKCI.,-1.0,,-999.0,,,,,,,,,,,,,Q9NPB6_K_19_A
6068,Q9NPB6,R,28,A,1wmh:B,28,Slight decrease of interaction with PRKCI. Loss of interaction with PRKCI,-1.0,,-999.0,,,,,,,,,,,,,Q9NPB6_R_28_A
6069,Q9NPB6,R,89,A,1wmh:B,89,Slight decrease of interaction with PRKCI. Loss of interaction with PRKCI,-1.0,,-999.0,,,,,,,,,,,,,Q9NPB6_R_89_A
6070,Q9Y5Y6,H,656,A,5lyo:A,656,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9Y5Y6_H_656_A
6071,Q9Y5Y6,D,711,A,5lyo:A,711,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9Y5Y6_D_711_A
6072,Q9Y5Y6,S,805,A,5lyo:A,805,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q9Y5Y6_S_805_A
6073,P53671,D,451,A,5nxd:A,451,Abrogates kinase activity.,,,1.0,,,,,,,,,,,,,P53671_D_451_A
6074,P53671,T,505,E,4tpt:A,505,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,P53671_T_505_E
6075,P53671,T,505,V,4tpt:A,505,Abolishes cofilin phosphorylation and enhancement of stress fiber formation.,,,1.0,,,,,,,,,,,,,P53671_T_505_V
6076,Q76I76,C,392,S,2nt2:A,392,Abrogates phosphatase activity.,,,1.0,,,,,,,,,,,,,Q76I76_C_392_S
6077,Q14142,K,365,R,6jbm:A,365,More than 50% loss of interaction with MAVS.,-1.0,,-999.0,,,,,,,,,,,,,Q14142_K_365_R
6078,Q14149,E,35,A,6o1e:A,35,Fails to localize to PML nuclear bodies and activate TP53.,,,1.0,,,,,,,,,1.0,,,,Q14149_E_35_A
6079,Q14149,D,67,N,6o1e:A,67,"Forms nuclear bodies, but rapidly diffuses throughout the nucleus under conditions of ATP depletion.",,,-999.0,,,,,,,,,1.0,,,,Q14149_D_67_N
6080,Q14149,G,101,A,6o1e:A,101,Diffuse nuclear localization. Fails to form nuclear bodies in the presence of ATP.,,,-999.0,,,,,,,,,1.0,,,,Q14149_G_101_A
6081,Q14149,W,419,A,6o1e:A,419,"Diffuse nuclear localization, possibly due to loss of DNA or nucleosome binding.",,-1.0,-999.0,,,,,,,,,1.0,,,,Q14149_W_419_A
6082,Q8WVY7,K,44,A,2m17:A,44,No binding to proteasome.,-1.0,,-999.0,,,,,,,,,,,,,Q8WVY7_K_44_A
6083,P10827,S,277,N,4lnw:A,277,No effect on thyroid hormone binding.,0.0,,-999.0,,,,,,,,,,,,,P10827_S_277_N
6084,P10826,E,106,A,1hra:A,26,"As a heterodimer with RXRA, abolishes transcriptional repression on DR1, reduces transcriptional activation on DR5 and binding affinity for DR1 and DR5 DNA elements.",,,1.0,,,,,,,,,,,,,P10826_E_106_A
6085,P10826,R,113,A,1hra:A,33,"As a heterodimer with RXRA, abolishes transcriptional repression on DR1 and reduces transcriptional activation on DR5.",,,1.0,,,,,,,,,,,,,P10826_R_113_A
6086,P10826,M,120,E,1hra:A,40,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces binding affinity for DR1 and DR5 DNA elements",,,1.0,,,,,,,,,,,,,P10826_M_120_E
6087,P10826,T,123,V,1hra:A,43,Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5,,,1.0,,,,,,,,,,,,,P10826_T_123_V
6088,P10826,T,188,I,4dm6:A,190,No effect on transcriptional activation in the absence of hormone.,,,0.0,,,,,,,,,,,,,P10826_T_188_I
6089,P10826,I,191,V,4dm6:A,193,No effect on transcriptional activation in the absence of hormone.,,,0.0,,,,,,,,,,,,,P10826_I_191_V
6090,P10826,L,222,I,4dm6:A,224,Reduced transcriptional activation in the absence of hormone. Even greater reduction in transcriptional activation in the absence of hormone,,,1.0,,,,,,,,,,,,,P10826_L_222_I
6091,P10826,G,223,D,4dm6:A,225,Greatly reduced transcriptional activation in the absence of hormone. Even greater reduction in transcriptional activation in the absence of hormone,,,1.0,,,,,,,,,,,,,P10826_G_223_D
6092,P10826,A,232,S,4dm6:A,234,Reduced transcriptional activation in the absence of hormone. Some further reduction of transcriptional activity in the absence of hormone,,,1.0,,,,,,,,,,,,,P10826_A_232_S
6093,P10826,K,365,E,4dm6:A,367,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,,1.0,,,,,,,,,,,,,P10826_K_365_E
6094,P10826,R,366,E,4dm6:A,368,"As a heterodimer with RXRA, reduces binding affinity for DR5 DNA element and no change in binding to DR1. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,-1.0,1.0,,,,,,,,,,,,,P10826_R_366_E
6095,P10826,R,367,E,4dm6:A,369,"As a heterodimer with RXRA, reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5. Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5",,,1.0,,,,,,,,,,,,,P10826_R_367_E
6096,P10826,S,369,E,4dm6:A,371,Reduces transcriptional repression on DR1 and reduces transcriptional activation on DR5,,,1.0,,,,,,,,,,,,,P10826_S_369_E
6097,P10826,K,370,E,4dm6:A,372,Reduces transcriptional repression on DR1 and reduced transcriptional activation on DR5,,,1.0,,,,,,,,,,,,,P10826_K_370_E
6098,Q99653,D,50,A,2e30:A,50,"Does not reduce calcium-binding, colocalization and interaction with SLC9A1.",0.0,0.0,-999.0,,,,,,,,,0.0,,,,Q99653_D_50_A
6099,Q99653,E,134,A,2e30:A,134,Reduces calcium-binding and SLC9A1-dependent Na(+)/H(+) exchange activity. Does not reduce colocalization and interaction with SLC9A1. Reduces colocalization and interaction with SLC9A1,-1.0,-1.0,1.0,,,,,,,,,,,,,Q99653_E_134_A
6100,Q99653,V,143,A,2e30:A,143,Inhibits translocation to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,Q99653_V_143_A
6101,Q99653,V,145,A,2e30:A,145,Inhibits translocation to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,Q99653_V_145_A
6102,Q99653,I,147,A,2e30:A,147,Inhibits translocation to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,Q99653_I_147_A
6103,Q99653,E,175,A,2e30:A,175,Reduces calcium-binding and SLC9A1-dependent Na(+)/H(+) exchange activity. Does not reduce colocalization and interaction with SLC9A1. Reduces colocalization and interaction with SLC9A1,-1.0,-1.0,1.0,,,,,,,,,,,,,Q99653_E_175_A
6104,Q99653,V,183,A,2e30:A,183,Inhibits translocation to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,Q99653_V_183_A
6105,Q99653,V,185,A,2e30:A,185,Inhibits translocation to the cytoplasm,,,-999.0,,,,,,,,,1.0,,,,Q99653_V_185_A
6106,Q96MK3,Q,258,E,5yh3:A,258,Able to hydrolyze ATP and display some protein kinase activity.,,,-999.0,,,,,,,,,,,,,Q96MK3_Q_258_E
6107,Q96ST2,I,476,A,6emr:A,476,Loss of interaction with PSIP1,-1.0,,-999.0,,,,,,,,,,,,,Q96ST2_I_476_A
6108,Q96ST2,F,477,A,6emr:A,477,Loss of interaction with PSIP1,-1.0,,-999.0,,,,,,,,,,,,,Q96ST2_F_477_A
6109,Q96ST2,S,480,D,6emr:A,480,Phosphomimetic mutant. Moderate increase in interaction with PSIP1.,1.0,,-999.0,,,,,,,,,,1.0,,,Q96ST2_S_480_D
6110,P54727,K,6,A,1uel:A,6,Impairs interaction with EEF1A1.,-1.0,,-999.0,,,,,,,,,,,,,P54727_K_6_A
6111,O43463,W,64,A,3mts:A,64,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,O43463_W_64_A
6112,O43463,Y,67,A,3mts:A,67,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,O43463_Y_67_A
6113,O43464,S,306,A,5fht:A,173,Loss of protease activity.,,,1.0,,,,,,,,,,,,,O43464_S_306_A
6114,Q13472,Y,362,F,4cgy:A,362,Decreased DNA decatenation.,,,1.0,,,,,,,,,,,,,Q13472_Y_362_F
6115,Q9HCN6,K,61,A,2gi7:A,41,Increases collagen binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_K_61_A
6116,Q9HCN6,K,79,E,2gi7:A,59,Dramatically reduces collagen binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_K_79_E
6117,Q9HCN6,R,80,A,2gi7:A,60,Reduces collagen binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_R_80_A
6118,Q9HCN6,N,92,A,2gi7:A,72,Reduces collagen binding (65 to 70%).,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_N_92_A
6119,Q9HCN6,S,94,A,2gi7:A,74,Reduces collagen binding (65 to 70%).,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_S_94_A
6120,Q9HCN6,L,95,H,2gi7:A,75,No effect on collagen binding.,0.0,,-999.0,,,,,,,,,,,,,Q9HCN6_L_95_H
6121,Q9HCN6,R,186,A,2gi7:A,166,Reduces collagen binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9HCN6_R_186_A
6122,P07359,G,249,A,1ook:G,233,No change.,0.0,,-999.0,,,,,,,,,,,,,P07359_G_249_A
6123,P07359,G,249,K,1ook:G,233,Decreased binding to vWF.,-1.0,,-999.0,,,,,,,,,,,,,P07359_G_249_K
6123,P07359,G,249,D,1ook:G,233,Decreased binding to vWF.,-1.0,,-999.0,,,,,,,,,,,,,P07359_G_249_D
6124,P07359,G,249,S,1ook:G,233,Increased binding to vWF.,1.0,,-999.0,,,,,,,,,,,,,P07359_G_249_S
6124,P07359,G,249,V,1ook:G,233,Increased binding to vWF.,1.0,,-999.0,,,,,,,,,,,,,P07359_G_249_V
6125,P02748,F,283,C,6h04:G,262,Creates an artifactual disulfide bond that prevents the conformation change required for oligomerization and pore formation,-1.0,,-999.0,,,,,,1.0,,,,,1.0,,P02748_F_283_C
6126,P02748,V,426,C,6h04:G,405,Creates an artifactual disulfide bond that prevents the conformation change required for oligomerization and pore formation,-1.0,,-999.0,,,,,,1.0,,,,,1.0,,P02748_V_426_C
6127,Q13478,N,297,Q,3wo4:B,297,Decreases the affinity for IL18 suggesting that the N-linked glycosylation contributes to ligand recognition.,-1.0,,-999.0,,,,,,,,,,,,,Q13478_N_297_Q
6128,O95453,I,113,A,2a1s:B,113,Loss of dimerization. Loss of activity.,-1.0,,1.0,,,,,,,,,,,,,O95453_I_113_A
6129,O95453,F,115,A,2a1s:B,115,Reduced affinity for poly(A). Little effect on activity.,-1.0,,0.0,,,,,,,,,,,,,O95453_F_115_A
6130,O95453,F,123,A,2a1s:B,123,Loss of dimerization. Loss of activity.,-1.0,,1.0,,,,,,,,,,,,,O95453_F_123_A
6131,O95453,D,292,A,2a1s:A,292,Loss of function but does not abolish ability to bind RNA.,,0.0,1.0,,,,,,,,,,,,,O95453_D_292_A
6132,O95453,D,292,C,2a1s:A,292,"Loss of function in the presence of Mg(2+) but not in the presence of Mn(2+), Zn(2+), Co(2+) or Cd(2+).",,,1.0,,,,,,,,,,,,,O95453_D_292_C
6133,O95453,K,326,A,2a1s:A,326,Reduced affinity for poly(A). Little effect on activity.,-1.0,,0.0,,,,,,,,,,,,,O95453_K_326_A
6134,O95453,H,377,A,2a1s:A,377,Loss of activity.,,,1.0,,,,,,,,,,,,,O95453_H_377_A
6135,O95453,D,382,A,2a1s:A,382,Loss of function but does not abolish ability to bind RNA. Induces a decrease in degradation of mRNAs containing AREs.,,0.0,1.0,,,,,,,,,,,,,O95453_D_382_A
6136,O95453,D,382,C,2a1s:A,382,"Loss of function in the presence of Mg(2+) but not in the presence of Mn(2+), Zn(2+), Co(2+) or Cd(2+).",,,1.0,,,,,,,,,,,,,O95453_D_382_C
6137,O75129,R,1175,T,5j67:C,1124,"Abolishes inositol-4,5-bisphosphate binding. Strongly reduces affinity for inositol-3,4,5-trisphosphate.",,-1.0,-999.0,,,,,,,,,,,,,O75129_R_1175_T
6138,O60343,R,972,K,3qyb:A,973,Loss of Rab GTPase activation. Only 20% reduction of GLUT4 translocation,-1.0,,1.0,,,,,,,,,,,,,O60343_R_972_K
6139,O60341,K,503,R,5l3f:A,503,Loss of polyubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,O60341_K_503_R
6140,O60341,N,535,A,5l3f:A,535,Strongly reduces demethylase activity.,,,1.0,,,,,,,,,,,,,O60341_N_535_A
6141,O60341,H,564,A,5l3f:A,564,Strongly reduces demethylase activity.,,,1.0,,,,,,,,,,,,,O60341_H_564_A
6142,O60341,K,661,A,5l3f:A,661,Abolishes histone demethylase activity.,,,1.0,,,,,,,,,,,,,O60341_K_661_A
6143,O60341,Y,761,A,5l3f:A,761,Strongly reduces demethylase activity.,,,1.0,,,,,,,,,,,,,O60341_Y_761_A
6144,Q9NZC2,N,20,D,6ymq:G,20,Loss of glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q9NZC2_N_20_D
6145,Q9NZC2,C,36,A,6y6c:A,36,Loss of proteolytic cleavage by ADAM10 and ectodomain shedding. Decreases protein maturation and cell membrane localization.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9NZC2_C_36_A
6146,Q9NZC2,K,48,M,6y6c:A,48,"Loss of LDL, CLU and APOE binding.",-1.0,,-999.0,,,,,,,,,,,,,Q9NZC2_K_48_M
6147,Q9NZC2,C,60,A,6y6c:A,60,Loss of proteolytic cleavage by ADAM10 and ectodomain shedding. Decreases protein maturation and cell membrane localization.,-1.0,,-999.0,,,,,,,,,1.0,,,,Q9NZC2_C_60_A
6148,Q9NZC2,N,68,K,6y6c:A,68,No effect on cell membrane localization.,,,-999.0,,,,,,,,,0.0,,,,Q9NZC2_N_68_K
6149,Q9NZC2,R,76,D,6y6c:A,76,Decreases binding to THP-1 cells.,,,-999.0,,,,,,,,,,,,,Q9NZC2_R_76_D
6150,Q9NZC2,R,77,D,6y6c:A,77,Decreases binding to THP-1 cells.,,,-999.0,,,,,,,,,,,,,Q9NZC2_R_77_D
6151,Q9UBT6,D,198,A,6cst:A,198,Loss of DNA polymerase activity,,,1.0,,,,,,,,,,,,,Q9UBT6_D_198_A
6152,Q9UBT6,E,199,A,6cst:A,199,Loss of DNA polymerase activity,,,1.0,,,,,,,,,,,,,Q9UBT6_E_199_A
6153,P23921,D,57,N,6aui:A,57,Severely decreases interaction with AHCYL1 in the presence of dATP.,-1.0,,-999.0,,,,,,,,,,,,,P23921_D_57_N
6154,P49407,R,169,E,6pwc:A,169,Constitutive active,,,1.0,,,,,,,,,,,,,P49407_R_169_E
6155,P19256,V,37,K,1ci5:A,9,No effect on CD2-binding.,0.0,,-999.0,,,,,,,,,,,,,P19256_V_37_K
6156,P19256,V,49,Q,1ci5:A,21,No effect on CD2-binding.,0.0,,-999.0,,,,,,,,,,,,,P19256_V_49_Q
6157,P19256,V,86,K,1ci5:A,58,No effect on CD2-binding.,0.0,,-999.0,,,,,,,,,,,,,P19256_V_86_K
6158,P19256,T,113,S,1ci5:A,85,No effect on CD2-binding.,0.0,,-999.0,,,,,,,,,,,,,P19256_T_113_S
6159,P19256,L,121,G,1ci5:A,93,No effect on CD2-binding.,0.0,,-999.0,,,,,,,,,,,,,P19256_L_121_G
6160,Q96D96,S,97,A,5oqk:A,97,Loss of a phosphorylation site. Strongly reduces phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q96D96_S_97_A
6161,Q96D96,D,112,A,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_A
6161,Q96D96,D,112,F,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_F
6161,Q96D96,D,112,N,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_N
6161,Q96D96,D,112,S,5oqk:A,112,Alters channel selectivity. Converts the proton channel to an anion channel.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_S
6162,Q96D96,D,112,E,5oqk:A,112,No effect on channel activity and proton selectivity.,,,0.0,,,,,,,,,,,,,Q96D96_D_112_E
6163,Q96D96,D,112,V,5oqk:A,112,Abolishes channel activity.,,,1.0,,,,,,,,,,,,,Q96D96_D_112_V
6164,Q96D96,H,140,A,5oqk:A,140,Exhibits selectivity to protons but sensitivity to zinc ions is abolished,,,1.0,,,,,,,,,,,,,Q96D96_H_140_A
6165,Q96D96,H,193,A,5oqk:A,193,Exhibits selectivity to protons but sensitivity to zinc ions is abolished,,,1.0,,,,,,,,,,,,,Q96D96_H_193_A
6166,Q96D96,R,205,A,5oqk:A,205,Faster channel activation and deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_205_A
6167,Q96D96,R,208,A,5oqk:A,208,Faster channel activation and deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_208_A
6168,Q96D96,R,211,A,5oqk:A,211,Faster channel deactivation kinetics.,,,1.0,,,,,,,,,,,,,Q96D96_R_211_A
6169,O15455,C,95,A,2a0z:A,95,Reduced response to ds-RNA.,,,-999.0,,,,,,,,,,,,,O15455_C_95_A
6170,O15455,C,122,A,2a0z:A,122,Reduced response to ds-RNA.,,,-999.0,,,,,,,,,,,,,O15455_C_122_A
6171,O15455,N,196,G,2a0z:A,196,Reduced expression levels,,,-999.0,,,,,,,,,,,,-1.0,O15455_N_196_G
6172,O15455,N,247,R,2a0z:A,247,Reduced response to ds-RNA. Reduced expression levels,,,-999.0,,,,,,,,,,,,-1.0,O15455_N_247_R
6173,O15455,H,539,A,2a0z:A,539,No effect.,,0.0,-999.0,,,,,,,,,,,,,O15455_H_539_A
6174,O15455,H,539,E,2a0z:A,539,Loss of RNA binding. Constitutive activation of NF-kappa-B.,,-1.0,-999.0,,,,,,,,,,,,,O15455_H_539_E
6175,O15455,N,541,A,2a0z:A,541,Loss of RNA binding. Abolishes activation of NF-kappa-B.,,-1.0,-999.0,,,,,,,,,,,,,O15455_N_541_A
6176,P48740,E,68,A,4aqb:A,68,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_68_A
6176,P48740,E,68,Q,4aqb:A,68,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_68_Q
6177,P48740,Y,77,A,4aqb:A,77,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_Y_77_A
6178,P48740,E,99,A,4aqb:A,99,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_99_A
6179,P48740,D,121,A,4aqb:A,121,Loss of interaction with FNC2 and FCN3 and partial loss of interaction with MBL2.,-1.0,,-999.0,,,,,,,,,,,,,P48740_D_121_A
6179,P48740,D,121,N,4aqb:A,121,Loss of interaction with FNC2 and FCN3 and partial loss of interaction with MBL2.,-1.0,,-999.0,,,,,,,,,,,,,P48740_D_121_N
6180,P48740,F,122,A,4aqb:A,122,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_F_122_A
6181,P48740,S,123,A,4aqb:A,123,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_S_123_A
6182,P48740,E,125,A,4aqb:A,125,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_125_A
6183,P48740,H,237,A,4aqb:A,237,"Loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_H_237_A
6184,P48740,E,239,A,4aqb:A,239,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_239_A
6185,P48740,Y,244,A,4aqb:A,244,"Loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_Y_244_A
6186,P48740,E,262,A,4aqb:A,262,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_262_A
6187,P48740,S,274,A,4aqb:A,274,Partial loss of interaction with FCN2 and FCN3. No effect on interaction with MBL2.,-1.0,,-999.0,,,,,,,,,,,,,P48740_S_274_A
6188,P48740,N,283,A,4aqb:A,283,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_N_283_A
6189,P48740,E,286,A,4aqb:A,286,"Partial loss of interaction with FCN2, FCN3 and MBL2.",-1.0,,-999.0,,,,,,,,,,,,,P48740_E_286_A
6190,P48740,S,646,A,4djz:B,646,No autoproteolytic processing.,,,-999.0,,,,,,,,,,,,,P48740_S_646_A
6191,Q9Y5K5,C,88,A,3ris:A,88,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9Y5K5_C_88_A
6192,Q9UHP3,V,91,A,2mux:A,91,No interaction with SUMO3,-1.0,,-999.0,,,,,,,,,,,,,Q9UHP3_V_91_A
6193,Q9UHP3,I,92,A,2mux:A,92,No interaction with SUMO3,-1.0,,-999.0,,,,,,,,,,,,,Q9UHP3_I_92_A
6194,Q9UHP3,K,99,R,2mux:A,99,Abolishes sumoylation. Decreased enzymatic activity.,,,1.0,,,,-1.0,,,,,,,,,Q9UHP3_K_99_R
6195,Q9UHP3,T,878,I,6hem:A,878,No effect on interaction with SYK.,0.0,,-999.0,,,,,,,,,,,,,Q9UHP3_T_878_I
6196,Q9UHP3,Y,880,F,6hem:A,880,No effect on interaction with SYK.,0.0,,-999.0,,,,,,,,,,,,,Q9UHP3_Y_880_F
6197,Q9UHP3,I,883,S,6hem:A,883,No effect on interaction with SYK.,0.0,,-999.0,,,,,,,,,,,,,Q9UHP3_I_883_S
6198,Q96PU4,K,548,R,4pw7:A,548,No effect on autosumoylation.,,,0.0,,,,0.0,,,,,,,,,Q96PU4_K_548_R
6199,Q96PU4,C,735,S,1z6u:A,735,"No effect on autosumoylation, nor on ZNF131 sumoylation.",,,0.0,,,,0.0,,,,,,,,,Q96PU4_C_735_S
6200,Q96PU8,N,97,A,4jvh:A,97,Decrease in target mRNA abundance and 10-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_N_97_A
6201,Q96PU8,K,120,A,4jvh:A,120,Decrease in target mRNA abundance and 20-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_K_120_A
6202,Q96PU8,R,124,A,4jvh:A,124,Decrease in target mRNA abundance and 20-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_R_124_A
6203,Q96PU8,R,130,A,4jvh:A,130,Decrease in target mRNA abundance and 10-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_R_130_A
6204,Q96PU8,K,190,A,4jvh:A,190,Decrease in target mRNA abundance and 124-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_K_190_A
6205,Q96PU8,Q,193,A,4jvh:A,193,Decrease in target mRNA abundance and 124-fold decrease in RNA binding affinity,,-1.0,-999.0,,,,,,,,,,,,,Q96PU8_Q_193_A
6206,Q9BQF6,F,775,W,3eay:A,709,Slightly increased deconjugation activity.,,,1.0,,,,,,,,,,,,,Q9BQF6_F_775_W
6207,Q9BQF6,V,779,E,3eay:A,713,Reduces deconjugation activity.,,,1.0,,,,,,,,,,,,,Q9BQF6_V_779_E
6208,P34897,E,98,L,5v7i:A,98,"Abolishes serine hydroxymethyltransferase activity, leading to oxidative phosphorylation deficiency",,,1.0,,,,,,,,,,,,,P34897_E_98_L
6209,P34897,K,103,R,5v7i:A,103,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_103_R
6209,P34897,K,103,E,5v7i:A,103,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_103_E
6210,P34897,Y,106,F,5v7i:A,106,"Abolishes serine hydroxymethyltransferase activity, leading to oxidative phosphorylation deficiency",,,1.0,,,,,,,,,,,,,P34897_Y_106_F
6211,P34897,K,280,Q,5v7i:A,280,"Abolishes pyridoxal phosphate-binding, leading to oxidative phosphorylation deficiency.",,-1.0,-999.0,,,,,,,,,,,,,P34897_K_280_Q
6212,P34897,K,280,R,5v7i:A,280,Decreased succinylation level and hydroxymethyltransferase activity.,,,1.0,,,,,,,,,,,,,P34897_K_280_R
6212,P34897,K,280,E,5v7i:A,280,Decreased succinylation level and hydroxymethyltransferase activity.,,,1.0,,,,,,,,,,,,,P34897_K_280_E
6213,P34897,K,302,R,5v7i:A,302,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_302_R
6213,P34897,K,302,E,5v7i:A,302,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_302_E
6214,P34897,K,356,R,5v7i:A,356,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_356_R
6214,P34897,K,356,E,5v7i:A,356,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_356_E
6215,P34897,K,464,R,5v7i:A,464,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_464_R
6215,P34897,K,464,E,5v7i:A,464,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_464_E
6216,P34897,K,469,R,5v7i:A,469,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_469_R
6216,P34897,K,469,E,5v7i:A,469,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_469_E
6217,P34897,K,474,R,5v7i:A,474,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_474_R
6217,P34897,K,474,E,5v7i:A,474,Does not affect succinylation level or hydroxymethyltransferase activity.,,,0.0,,,,,,,,,,,,,P34897_K_474_E
6218,P13796,S,5,A,5joj:A,5,Abolishes phosphorylation and reduces the cell surface expression of CD69 and IL2RA. Reduces association with the actin cytoskeleton.,-1.0,,-999.0,-1.0,,,,,,,,,,,,P13796_S_5_A
6219,P13796,S,5,E,5joj:A,5,Promotes association with the actin cytoskeleton.,1.0,,-999.0,,,,,,,,,,,,,P13796_S_5_E
6220,Q9NWW6,K,16,A,2p0e:A,15,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NWW6_K_16_A
6221,Q9NWW6,D,36,A,2p0e:A,35,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NWW6_D_36_A
6222,Q9NWW6,D,56,A,2p0e:A,55,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NWW6_D_56_A
6223,Q9NWW6,E,98,A,2qg6:A,98,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NWW6_E_98_A
6224,Q9NWW6,D,138,A,2qg6:A,138,Almost no effect.,,,0.0,,,,,,,,,,,,,Q9NWW6_D_138_A
6225,Q96L93,R,1220,A,2v14:A,1220,Abolishes PtdIns(3)P-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_R_1220_A
6226,Q96L93,R,1225,A,2v14:A,1225,Induces a 3-fold decrease in PtdIns(3)P-binding,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_R_1225_A
6227,Q96L93,K,1229,A,2v14:A,1229,Induces a 3-fold decrease in PtdIns(3)P-binding,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_K_1229_A
6228,Q96L93,K,1232,A,2v14:A,1232,Induces a 3-fold decrease in PtdIns(3)P-binding,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_K_1232_A
6229,Q96L93,L,1248,A,2v14:A,1248,Induces a 7-fold decrease in PtdIns(3)P-binding and abolishes endosome localization. Induces a 25-fold decrease in PtdIns(3)P-binding,,-1.0,-999.0,,,,,,,,,1.0,,,,Q96L93_L_1248_A
6230,Q96L93,L,1248,V,2v14:A,1248,Induces a 6-fold decrease in PtdIns(3)P-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_L_1248_V
6231,Q96L93,F,1249,A,2v14:A,1249,Induces a 5-fold decrease in PtdIns(3)P-binding and abolishes endosome localization. Induces a 25-fold decrease in PtdIns(3)P-binding,,-1.0,-999.0,,,,,,,,,1.0,,,,Q96L93_F_1249_A
6232,Q96L93,R,1260,A,2v14:A,1260,Induces a 30-fold decrease in PtdIns(3)P-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q96L93_R_1260_A
6233,Q96L92,H,114,A,6sak:D,114,"Abolishes interaction with ADRB2, sorting and recycling of ADRB2.",-1.0,,-999.0,,,,,,,,,,,,,Q96L92_H_114_A
6234,Q9Y2L1,D,146,N,6h25:J,146,Loss of endonuclease activity,,,1.0,,,,,,,,,,,,,Q9Y2L1_D_146_N
6235,Q9Y2L1,D,487,N,6h25:J,487,Loss of exonuclease activity. Loss of endonuclease activity,,,1.0,,,,,,,,,,,,,Q9Y2L1_D_487_N
6236,Q8TBK2,Y,285,A,3qxy:A,285,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8TBK2_Y_285_A
6237,Q15438,E,157,A,1bc9:A,157,Reduces guanine exchange factor activity by over 90%.,,,1.0,,,,,,,,,,,,,Q15438_E_157_A
6237,Q15438,E,157,K,1bc9:A,157,Reduces guanine exchange factor activity by over 90%.,,,1.0,,,,,,,,,,,,,Q15438_E_157_K
6238,Q15438,Y,187,A,1bc9:A,187,Reduces guanine exchange factor activity by over 90%.,,,1.0,,,,,,,,,,,,,Q15438_Y_187_A
6239,Q15438,M,195,A,1bc9:A,195,Reduces guanine exchange factor activity by over 90%.,,,1.0,,,,,,,,,,,,,Q15438_M_195_A
6240,O95671,S,19,A,2p5x:A,19,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_S_19_A
6241,O95671,S,21,A,2p5x:A,21,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_S_21_A
6242,O95671,R,23,A,2p5x:A,23,Decrease in pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_R_23_A
6243,O95671,R,24,A,2p5x:A,24,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_R_24_A
6244,O95671,E,44,A,2p5x:A,44,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_E_44_A
6245,O95671,Y,57,A,2p5x:A,57,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_Y_57_A
6246,O95671,K,65,A,2p5x:A,65,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_K_65_A
6247,O95671,D,88,A,2p5x:A,88,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_D_88_A
6247,O95671,D,88,N,2p5x:A,88,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_D_88_N
6248,O95671,E,99,A,2p5x:A,99,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_E_99_A
6249,O95671,Q,179,A,2p5x:A,179,Loss of pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_Q_179_A
6250,O95671,Q,179,E,2p5x:A,179,Strong decrease in pyrophosphatase activity.,,,1.0,,,,,,,,,,,,,O95671_Q_179_E
6251,P41743,K,29,A,1vd2:A,20,No effect on interaction with SQSTM1.,0.0,,-999.0,,,,,,,,,,,,,P41743_K_29_A
6252,P41743,D,72,A,1vd2:A,63,"Loss of interaction with ECT2, PARD6A and with SQSTM1.",-1.0,,-999.0,,,,,,,,,,,,,P41743_D_72_A
6253,P41743,E,85,A,1vd2:A,76,Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A,-1.0,,-999.0,,,,,,,,,,,,,P41743_E_85_A
6254,P41743,R,91,A,1vd2:A,82,Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A,-1.0,,-999.0,,,,,,,,,,,,,P41743_R_91_A
6255,P41743,Y,265,F,3a8x:A,256,No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta.,-1.0,,1.0,0.0,,,,,,,,,,,,P41743_Y_265_F
6256,P41743,K,274,R,3a8x:A,265,No effect on activity.,,,1.0,,,,,,,,,,,,,P41743_K_274_R
6257,P41743,K,274,W,3a8x:A,265,Abolishes activity.,,,1.0,,,,,,,,,,,,,P41743_K_274_W
6258,P41743,Y,280,F,3a8x:A,271,No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B.,,,0.0,0.0,,,,,,,,,,,,P41743_Y_280_F
6259,P41743,Y,334,F,3a8x:A,325,No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival.,,,1.0,0.0,,,,,,,,,,,,P41743_Y_334_F
6260,O14672,E,384,A,6be6:C,384,Abrogates APP cleavage. Reduces Notch signaling. Loss of proteolytic activity.,,,1.0,,,,,,,,,,,,,O14672_E_384_A
6261,Q15436,F,628,A,5kyn:A,628,Decreased interaction with MIA3,-1.0,,-999.0,,,,,,,,,,,,,Q15436_F_628_A
6262,Q15436,Y,672,K,5kyn:A,672,Decreased interaction with MIA3,-1.0,,-999.0,,,,,,,,,,,,,Q15436_Y_672_K
6263,Q15436,Y,678,A,5kyn:A,678,Decreased interaction with MIA3,-1.0,,-999.0,,,,,,,,,,,,,Q15436_Y_678_A
6264,Q15436,F,681,A,5kyn:A,681,Decreased interaction with MIA3,-1.0,,-999.0,,,,,,,,,,,,,Q15436_F_681_A
6265,Q15435,D,148,V,6hkw:A,148,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_D_148_V
6266,Q15435,F,170,A,6hkw:A,170,Severely impaired the binding of protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_F_170_A
6267,Q15435,E,192,A,6hkw:A,192,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_E_192_A
6268,Q15435,F,214,A,6hkw:A,214,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_F_214_A
6269,Q15435,D,280,A,6hkw:A,280,Severely impairs the binding of protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_D_280_A
6270,Q15435,E,300,A,6hkw:A,300,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_E_300_A
6271,Q15435,W,302,A,6hkw:A,302,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_W_302_A
6272,Q15435,Y,327,A,6hkw:A,327,Completely abolishes the interaction with protein phosphatase 1.,-1.0,,-999.0,,,,,,,,,,,,,Q15435_Y_327_A
6273,Q16637,E,134,K,4a4g:A,134,Reduces SMN binding to RPP20/POP7. Abolishes the interaction with ELAVL4.,-1.0,,-999.0,,,,,,,,,,,,,Q16637_E_134_K
6274,Q8WXB1,D,94,A,4lec:A,94,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8WXB1_D_94_A
6275,P15309,W,206,F,1nd6:B,1173,"Greatly reduced enzyme activity, marked decrease in structural stability, and increased binding of the inhibitor, L(+)-tartrate.",,1.0,1.0,,,,,,,,,,,-1.0,,P15309_W_206_F
6276,P15309,W,206,L,1nd6:B,1173,"Reduced enzyme activity, marked decrease in structural stability, and increased binding of the inhibitor, L(+)-tartrate.",,1.0,1.0,,,,,,,,,,,-1.0,,P15309_W_206_L
6277,P11509,I,208,S,3ebs:A,208,Increases phenacetin O-deethylation activity 10 fold,,,1.0,,,,,,,,,,,,,P11509_I_208_S
6278,P11509,S,213,A,3ebs:A,213,No effect on phenacetin O-deethylation activity.,,,0.0,,,,,,,,,,,,,P11509_S_213_A
6279,P11509,I,300,F,3ebs:A,300,Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 8 fold,,,1.0,,,,,,,,,,,,,P11509_I_300_F
6280,P11509,G,301,A,3ebs:A,301,Slightly decreases phenacetin O-deethylation activity. Increases phenacetin O-deethylation activity 8 fold,,,1.0,,,,,,,,,,,,,P11509_G_301_A
6281,P11509,S,369,G,3ebs:A,369,Increases phenacetin O-deethylation activity 3 fold. Increases phenacetin O-deethylation activity 38 fold,,,1.0,,,,,,,,,,,,,P11509_S_369_G
6282,P11509,R,372,H,3ebs:A,372,Increases phenacetin O-deethylation activity 2 fold.,,,1.0,,,,,,,,,,,,,P11509_R_372_H
6283,P55055,K,409,R,4nqa:B,410,Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response,,,1.0,,,,,,,,,,,,,P55055_K_409_R
6284,P55055,K,447,R,4nqa:B,448,Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response,,,1.0,,,,,,,,,,,,,P55055_K_447_R
6285,Q8NBP7,C,67,A,2w2n:P,67,Does not affect multimerization or zymogen processing.,0.0,,0.0,,,,,,,,,,,,,Q8NBP7_C_67_A
6286,Q8NBP7,H,226,A,6u26:B,226,Remains in the endoplasmic reticulum and is not secreted.,,,-999.0,,,,,,,,,1.0,,,,Q8NBP7_H_226_A
6287,Q8NBP7,N,533,A,6u26:B,533,1.5 kDa decrease of the apparent molecular mass of pro-PCSK9 and PCSK9 and no effect on processing and secretion.,,,-999.0,,,,,,,,,0.0,,,,Q8NBP7_N_533_A
6288,Q5S007,T,1343,G,6ojf:A,1343,Decreased kinase activity,,,1.0,,,,,,,,,,,,,Q5S007_T_1343_G
6289,Q5S007,K,1347,A,6ojf:A,1347,GTPase-dead mutant. Loss of interaction with SEC16A and impaired ability to recruit SEC16A to endoplasmic reticulum exit sites.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q5S007_K_1347_A
6290,Q5S007,T,1348,N,6ojf:A,1348,Loss of GTP binding. Inhibits autophosphorylation and RAB10 phosphorylation,,-1.0,1.0,-1.0,,,,,,,,,,,,Q5S007_T_1348_N
6291,Q5S007,R,1398,Q,6ojf:A,1398,Decreased kinase activity,,,1.0,,,,,,,,,,,,,Q5S007_R_1398_Q
6292,Q5S007,R,1441,G,6ojf:A,1441,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,1.0,-1.0,,,,,,,,,,,,Q5S007_R_1441_G
6293,Q5S007,Y,1699,C,6xr4:A,1699,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,1.0,-1.0,,,,,,,,,,,,Q5S007_Y_1699_C
6294,Q5S007,K,1906,A,6xr4:A,1906,Loss of kinase activity. Decreases proteosomal degradation of MAPT,,,1.0,,,,,,,,,,,,,Q5S007_K_1906_A
6295,Q5S007,D,1994,A,6xr4:A,1994,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q5S007_D_1994_A
6296,Q5S007,D,1994,N,6xr4:A,1994,Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT,0.0,,1.0,,,,,,,,,,,,,Q5S007_D_1994_N
6297,Q5S007,D,2017,A,6xr4:A,2017,Loss of kinase activity. Decreases proteosomal degradation of MAPT,,,1.0,,,,,,,,,,,,,Q5S007_D_2017_A
6298,Q5S007,G,2019,S,6xr4:A,2019,"Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.",-1.0,,1.0,-1.0,,,,,,,,1.0,,,,Q5S007_G_2019_S
6299,Q5S007,L,2343,D,6vno:A,2343,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_L_2343_D
6300,Q5S007,F,2344,A,6vno:A,2344,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_F_2344_A
6301,Q5S007,S,2345,D,6vno:A,2345,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_S_2345_D
6302,Q5S007,Y,2346,A,6vno:A,2346,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_Y_2346_A
6303,Q5S007,H,2391,D,6vno:A,2391,Increases kinase activity.,,,1.0,,,,,,,,,,,,,Q5S007_H_2391_D
6304,Q5S007,R,2394,E,6vno:A,2394,Decreases WD domain homodimerization. Increases kinase activity and autophosphorylation at Ser-1292.,-1.0,,1.0,1.0,,,,,,,,,,,,Q5S007_R_2394_E
6305,Q5S007,E,2395,R,6vno:A,2395,Decreases WD domain homodimerization. No effect on kinase activity.,-1.0,,0.0,,,,,,,,,,,,,Q5S007_E_2395_R
6306,Q5S007,S,2409,A,6vno:A,2409,Decreases WD domain homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q5S007_S_2409_A
6307,Q9BVS5,D,335,A,2b25:A,192,Loss of ability to catalyze the formation of 1-methyladenosine at position 947 of mitochondrial 16S ribosomal RNA.,,,1.0,,,,,,,,,,,,,Q9BVS5_D_335_A
6308,Q9BVS4,K,123,A,6hk6:A,123,Abolishes autophosphorylation,,,1.0,-1.0,,,,,,,,,,,,Q9BVS4_K_123_A
6309,Q9BVS4,D,246,A,6fdo:A,246,Abolishes autophosphorylation,,,1.0,-1.0,,,,,,,,,,,,Q9BVS4_D_246_A
6310,P06746,K,35,Q,1tv9:A,35,Reduces DNA lyase activity slightly.,,,1.0,,,,,,,,,,,,,P06746_K_35_Q
6310,P06746,K,35,R,1tv9:A,35,Reduces DNA lyase activity slightly.,,,1.0,,,,,,,,,,,,,P06746_K_35_R
6311,P06746,Y,39,Q,1tv9:A,39,Abolishes DNA polymerase and DNA lyase activity.,,,1.0,,,,,,,,,,,,,P06746_Y_39_Q
6312,P06746,K,41,R,1tv9:A,41,Abolishes ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P06746_K_41_R
6313,P06746,K,61,R,1tv9:A,61,Abolishes ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P06746_K_61_R
6314,P06746,K,68,Q,1tv9:A,68,Reduces DNA lyase activity slightly.,,,1.0,,,,,,,,,,,,,P06746_K_68_Q
6314,P06746,K,68,R,1tv9:A,68,Reduces DNA lyase activity slightly.,,,1.0,,,,,,,,,,,,,P06746_K_68_R
6315,P06746,K,72,Q,1tv9:A,72,Abolishes DNA lyase activity. No effect on DNA polymerase activity.,,,1.0,,,,,,,,,,,,,P06746_K_72_Q
6315,P06746,K,72,R,1tv9:A,72,Abolishes DNA lyase activity. No effect on DNA polymerase activity.,,,1.0,,,,,,,,,,,,,P06746_K_72_R
6316,P06746,K,81,R,1tv9:A,81,Abolishes ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,P06746_K_81_R
6317,P06746,R,83,K,1tv9:A,83,Slight effect. Abolishes methylation by PRMT6 and impairs the polymerase activity,,,1.0,,,,,,,,,,,,,P06746_R_83_K
6318,P06746,K,84,R,1tv9:A,84,No effect.,,,0.0,,0.0,,,,,,,,,,,P06746_K_84_R
6319,P06746,R,152,K,1tv9:A,152,Slight effect. Abolishes methylation by PRMT6 and impairs the polymerase activity,,,1.0,,,,,,,,,,,,,P06746_R_152_K
6320,P06744,S,185,A,1jiq:A,185,Retained full enzymatic activity.,,,0.0,,,,,,,,,,,,,P06744_S_185_A
6321,P06744,S,185,E,1jiq:A,185,Decreased enzymatic activity.,,,1.0,,,,,,,,,,,,,P06744_S_185_E
6322,O14519,C,105,A,2kw6:A,105,Does not alter homodimerization.,0.0,,-999.0,,,,,,,,,,,,,O14519_C_105_A
6323,O60759,K,82,E,2z17:A,23,No membrane-association. No change in the binding to CYTH1,-1.0,,-999.0,,,,,,,,,1.0,,,,O60759_K_82_E
6324,O60759,F,90,A,2z17:A,31,No membrane-association. No change in the binding to CYTH1,-1.0,,-999.0,,,,,,,,,1.0,,,,O60759_F_90_A
6325,O60759,I,92,A,2z17:A,33,No membrane-association. No change in the binding to CYTH1,-1.0,,-999.0,,,,,,,,,1.0,,,,O60759_I_92_A
6326,P47989,E,803,V,2e1q:A,803,Strongly decreased activity towards xanthine and hypoxanthine. Increased affinity and activity towards aromatic aldehydes.,,1.0,-999.0,,,,,,,,,,,,,P47989_E_803_V
6327,P47989,R,881,M,2e1q:A,881,Abolishes xanthine oxidase activity.,,,1.0,,,,,,,,,,,,,P47989_R_881_M
6328,P20472,D,52,A,1rjv:A,52,Inactivation.,,,1.0,,,,,,,,,,,,,P20472_D_52_A
6329,P20472,E,63,V,1rjv:A,63,Inactivation.,,,1.0,,,,,,,,,,,,,P20472_E_63_V
6330,P20472,D,91,A,1rjv:A,91,Inactivation.,,,1.0,,,,,,,,,,,,,P20472_D_91_A
6331,P20472,E,102,V,1rjv:A,102,Inactivation.,,,1.0,,,,,,,,,,,,,P20472_E_102_V
6332,Q9NQW7,E,41,A,3ctz:A,41,Reduces activity by 10%.,,,1.0,,,,,,,,,,,,,Q9NQW7_E_41_A
6333,Q9NQW7,W,477,E,3ctz:A,477,Interferes with dimerization and reduces activity by 94%.,-1.0,,1.0,,,,,,,,,,,,,Q9NQW7_W_477_E
6334,Q6P587,H,30,A,6fog:A,30,Impaired oxaloacetate decarboxylase activity.,,,1.0,,,,,,,,,,,,,Q6P587_H_30_A
6335,Q6P587,E,33,A,6fog:A,33,Impaired oxaloacetate decarboxylase activity.,,,1.0,,,,,,,,,,,,,Q6P587_E_33_A
6336,Q6P587,D,102,A,6fog:A,102,Loss of catalytic activity,,,1.0,,,,,,,,,,,,,Q6P587_D_102_A
6337,Q6P587,R,106,A,6fog:A,106,Loss of catalytic activity,,,1.0,,,,,,,,,,,,,Q6P587_R_106_A
6338,O00291,F,432,G,2qa7:C,432,Abolishes HIP1-induced cell death.,,,1.0,,,,,,,,,,,,,O00291_F_432_G
6339,O00299,C,24,S,4jzq:A,24,Loss of dimerization and of ion transport activity.,-1.0,,1.0,,,,,,,,,,,,,O00299_C_24_S
6340,O00299,C,59,S,4jzq:A,59,Loss of dimerization and of ion transport activity.,-1.0,,1.0,,,,,,,,,,,,,O00299_C_59_S
6341,Q96EP1,T,39,A,1lgp:A,39,Abolishes phosphorylation but not autoubiquitination,,,-999.0,-1.0,0.0,,,,,,,,,,,Q96EP1_T_39_A
6342,Q96EP1,R,632,A,2xoy:B,632,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1.,,-1.0,-999.0,,,,,,-1.0,,,,,,,Q96EP1_R_632_A
6343,Q96EP1,C,635,A,2xoy:B,635,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,-1.0,,,,,,,Q96EP1_C_635_A
6344,Q96EP1,C,641,A,2xoy:B,641,Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1,,-1.0,-999.0,,,,,,-1.0,,,,,,,Q96EP1_C_641_A
6345,Q96EP1,R,642,A,2xoy:B,642,Impairs poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1.,,-1.0,-999.0,,,,,,-1.0,,,,,,,Q96EP1_R_642_A
6346,Q96EP1,Q,644,A,2xoy:B,644,Impairs poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1.,,-1.0,-999.0,,,,,,-1.0,,,,,,,Q96EP1_Q_644_A
6347,Q96EP0,Y,82,A,4oyj:E,82,Abolished interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_Y_82_A
6348,Q96EP0,Y,82,F,4oyj:E,82,Reduced interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_Y_82_F
6349,Q96EP0,N,85,A,4oyj:E,85,Reduced interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_N_85_A
6350,Q96EP0,K,99,E,4oyj:E,99,Reduced interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_K_99_E
6351,Q96EP0,N,101,R,4oyj:E,101,Does not affect interaction with OTULIN.,0.0,,-999.0,,,,,,,,,,,,,Q96EP0_N_101_R
6352,Q96EP0,N,102,A,4oyj:E,102,Abolished interaction with SPATA2.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_N_102_A
6353,Q96EP0,N,102,D,4oyj:E,102,Abolished interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_N_102_D
6354,Q96EP0,V,104,A,4oyj:E,104,Reduced interaction with OTULIN.,-1.0,,-999.0,,,,,,,,,,,,,Q96EP0_V_104_A
6355,Q96EP0,C,699,S,6sc8:A,699,Abolishes polyubiquitination activity of LUBAC,,,1.0,,,,,,,,,,,,,Q96EP0_C_699_S
6356,Q96EP0,C,702,S,6sc8:A,702,Abolishes polyubiquitination activity of LUBAC,,,1.0,,,,,,,,,,,,,Q96EP0_C_702_S
6357,Q96EP0,C,871,S,6sc8:A,871,Abolishes polyubiquitination activity of LUBAC,,,1.0,,,,,,,,,,,,,Q96EP0_C_871_S
6358,Q96EP0,C,874,S,6sc8:A,874,Abolishes polyubiquitination activity of LUBAC,,,1.0,,,,,,,,,,,,,Q96EP0_C_874_S
6359,P52333,K,855,A,6gl9:A,855,More than 90% loss of STAT5a activation.,,,1.0,,,,,,,,,,,,,P52333_K_855_A
6360,P52333,Y,904,F,6gl9:A,904,About 40% loss of STAT5a activation.,,,1.0,,,,,,,,,,,,,P52333_Y_904_F
6361,P52333,Y,939,F,6gl9:A,939,About 80% loss of STAT5a activation.,,,1.0,,,,,,,,,,,,,P52333_Y_939_F
6362,O00444,K,41,M,4jxf:A,41,Abolishes ability to phosphorylate CDC25C and CHEK2.,,,1.0,,,,,,,,,,,,,O00444_K_41_M
6363,O00444,D,154,A,4jxf:A,154,Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed.,,,1.0,,,,,,,,,,,,,O00444_D_154_A
6364,Q04206,T,254,A,1nfi:C,254,Abolishes interaction with PIN1.,-1.0,,-999.0,,,,,,,,,,,,,Q04206_T_254_A
6365,Q04206,S,276,C,1nfi:C,276,Loss of phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q04206_S_276_C
6366,P51649,R,213,A,2w8r:A,213,Reduces catalytic activity to less than 15% of wild-type.,,,1.0,,,,,,,,,,,,,P51649_R_213_A
6367,P51649,R,334,A,2w8r:A,334,Reduces catalytic activity to less than 15% of wild-type.,,,1.0,,,,,,,,,,,,,P51649_R_334_A
6368,P51649,C,342,A,2w8r:A,342,Loss of regulation by redox state.,,,-999.0,,,,,,,,,,,,,P51649_C_342_A
6369,P51649,S,498,A,2w8r:A,498,Reduces catalytic activity to less than 15% of wild-type.,,,1.0,,,,,,,,,,,,,P51649_S_498_A
6370,Q04609,N,76,A,5o5t:A,76,Loss of glycosylation. Reduces enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_76_A
6371,Q04609,N,121,A,5o5t:A,121,Loss of glycosylation. Severely reduced enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_121_A
6372,Q04609,N,140,A,5o5t:A,140,Loss of glycosylation. Severely reduced enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_140_A
6373,Q04609,N,153,A,5o5t:A,153,Loss of glycosylation. Severely reduced enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_153_A
6374,Q04609,N,195,A,5o5t:A,195,Loss of glycosylation. Severely reduced enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_195_A
6375,Q04609,N,336,A,5o5t:A,336,Loss of glycosylation. Reduces enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_336_A
6376,Q04609,H,377,A,5o5t:A,377,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_H_377_A
6376,Q04609,H,377,G,5o5t:A,377,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_H_377_G
6376,Q04609,H,377,Q,5o5t:A,377,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_H_377_Q
6377,Q04609,D,379,E,5o5t:A,379,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_379_E
6377,Q04609,D,379,N,5o5t:A,379,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_379_N
6378,Q04609,D,387,E,5o5t:A,387,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_387_E
6378,Q04609,D,387,L,5o5t:A,387,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_387_L
6379,Q04609,D,387,N,5o5t:A,387,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q04609_D_387_N
6380,Q04609,P,388,A,5o5t:A,388,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q04609_P_388_A
6381,Q04609,E,424,A,5o5t:A,424,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_E_424_A
6382,Q04609,E,424,D,5o5t:A,424,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q04609_E_424_D
6383,Q04609,E,424,Q,5o5t:A,424,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q04609_E_424_Q
6384,Q04609,E,425,Q,5o5t:A,425,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_E_425_Q
6384,Q04609,E,425,D,5o5t:A,425,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_E_425_D
6385,Q04609,D,453,N,5o5t:A,453,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_453_N
6385,Q04609,D,453,L,5o5t:A,453,Complete loss of activity.,,,1.0,,,,,,,,,,,,,Q04609_D_453_L
6386,Q04609,D,453,Q,5o5t:A,453,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q04609_D_453_Q
6387,Q04609,S,454,A,5o5t:A,454,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,Q04609_S_454_A
6388,Q04609,N,459,A,5o5t:A,459,Loss of glycosylation. Reduces enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_459_A
6389,Q04609,N,476,A,5o5t:A,476,Loss of glycosylation. Reduces enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_476_A
6390,Q04609,N,638,A,5o5t:A,638,Loss of glycosylation. Abolishes enzyme activity.,,,1.0,,,-1.0,,,,,,,,,,Q04609_N_638_A
6391,Q04609,T,640,A,5o5t:A,640,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q04609_T_640_A
6392,Q9BZR6,R,151,E,1p8t:A,151,Impaired ganglioside binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_R_151_E
6393,Q9BZR6,R,199,E,1p8t:A,199,Impaired ganglioside binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_R_199_E
6394,Q9BZR6,K,277,A,1p8t:A,277,No effect on interaction with MAG.,0.0,,-999.0,,,,,,,,,,,,,Q9BZR6_K_277_A
6395,Q9BZR6,K,277,D,1p8t:A,277,Decreases interaction with MAG,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_K_277_D
6396,Q9BZR6,R,279,A,1p8t:A,279,Mildly decreases interaction with MAG.,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_R_279_A
6397,Q9BZR6,R,279,D,1p8t:A,279,Decreases interaction with MAG,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_R_279_D
6398,Q9BZR6,R,279,E,1p8t:A,279,Impaired ganglioside binding.,-1.0,,-999.0,,,,,,,,,,,,,Q9BZR6_R_279_E
6399,P11802,T,172,A,3g33:A,177,"Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3.",0.0,,1.0,,,,,,,,,,,,,P11802_T_172_A
6400,P11802,T,172,E,3g33:A,177,Retains moderate enzyme activity.,,,0.0,,,,,,,,,,,,,P11802_T_172_E
6401,P11802,P,173,S,3g33:A,178,No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity.,,,1.0,-1.0,,,,,,,,,,,,P11802_P_173_S
6412,O15111,T,23,A,5ebz:A,23,Loss of phosphorylation and decrease of kinase activity.,,,1.0,-1.0,,,,,,,,,,,,O15111_T_23_A
6413,O15111,K,44,A,5ebz:A,44,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O15111_K_44_A
6414,O15111,K,44,M,5ebz:A,44,Loss of autophosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,O15111_K_44_M
6415,O15111,S,176,A,5ebz:A,176,Loss of phosphorylation and of activity.,,,1.0,-1.0,,,,,,,,,,,,O15111_S_176_A
6416,O15111,S,176,E,5ebz:A,176,Full activation.,,,1.0,,,,,,,,,,,,,O15111_S_176_E
6417,O15111,T,179,A,5ebz:A,179,No change in phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,O15111_T_179_A
6418,O15111,S,180,A,5ebz:A,180,No change in phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,O15111_S_180_A
6419,Q12809,F,29,A,2l4r:A,29,Slows down deactivation.,,,1.0,,,,,,,,,,,,,Q12809_F_29_A
6420,Q12809,Y,43,A,2l4r:A,43,Slows down deactivation.,,,1.0,,,,,,,,,,,,,Q12809_Y_43_A
6421,Q12809,N,629,Q,5va1:A,629,Abolishes cell surface expression,,,-999.0,,,,,,,,,1.0,,,,Q12809_N_629_Q
6422,Q12809,S,631,A,5va1:A,631,"No effect on cell surface expression, but changes inactivation kinetics",,,-999.0,,,,,,,,,0.0,,,,Q12809_S_631_A
6423,Q6UVJ0,F,131,D,6z4a:A,131,Fails to multimerize via N-terminus.,-1.0,,-999.0,,,,,,,,,,,,,Q6UVJ0_F_131_D
6424,Q9BRG1,V,124,E,3cuq:C,124,Abolishes binding to CHMP6.,-1.0,,-999.0,,,,,,,,,,,,,Q9BRG1_V_124_E
6425,Q9BRG1,T,126,K,3cuq:C,126,Abolishes binding to CHMP6.,-1.0,,-999.0,,,,,,,,,,,,,Q9BRG1_T_126_K
6426,P49916,K,410,E,3l2p:A,323,"Nearly abolishes ligase activity with blunt-ended DNA, but not with nicked DNA.",,,1.0,,,,,,,,,,,,,P49916_K_410_E
6427,P49916,R,414,E,3l2p:A,327,"Abolishes ligase activity with blunt-ended DNA, but not with nicked DNA.",,,1.0,,,,,,,,,,,,,P49916_R_414_E
6428,P49914,K,10,A,3hy6:A,10,Reduces activity by 93%.,,,1.0,,,,,,,,,,,,,P49914_K_10_A
6429,P49914,R,14,A,3hy6:A,14,Reduces activity by 87%.,,,1.0,,,,,,,,,,,,,P49914_R_14_A
6430,P49914,E,61,A,3hy6:A,61,Reduces activity by 94%.,,,1.0,,,,,,,,,,,,,P49914_E_61_A
6431,P49914,R,145,A,3hy6:A,145,Reduces activity by 98%.,,,1.0,,,,,,,,,,,,,P49914_R_145_A
6432,P49914,Y,153,A,3hy6:A,153,Reduces activity by 97%.,,,1.0,,,,,,,,,,,,,P49914_Y_153_A
6433,P49914,D,154,A,3hy6:A,154,Reduces activity by 99%.,,,1.0,,,,,,,,,,,,,P49914_D_154_A
6434,Q8IZ41,Q,600,L,2p5s:B,600,Favors GTP association.,,1.0,-999.0,,,,,,,,,,,,,Q8IZ41_Q_600_L
6435,P0C0L5,L,1120,P,6ysq:A,1120,"No effect on hemolytic activity, nor on C1-dependent binding to IgG.",0.0,,0.0,,,,,,,,,,,,,P0C0L5_L_1120_P
6436,P0C0L5,S,1121,C,6ysq:A,1121,30-40% decrease in hemolytic activity and C1-dependent binding to IgG.,1.0,,1.0,,,,,,,,,,,,,P0C0L5_S_1121_C
6437,P0C0L5,I,1124,A,6ysq:A,1124,50-60% decrease in hemolytic activity and C1-dependent binding to IgG.,1.0,,1.0,,,,,,,,,,,,,P0C0L5_I_1124_A
6438,P0C0L5,H,1125,A,6ysq:A,1125,"20% decrease in hemolytic activity, 2-fold increase in C1-dependent binding to IgG.",1.0,,1.0,,,,,,,,,,,,,P0C0L5_H_1125_A
6439,P0C0L5,H,1125,D,6ysq:A,1125,"2.5-3 fold-decrease in hemolytic activity, 3-fold increase in C1-dependent binding to IgG.",1.0,,1.0,,,,,,,,,,,,,P0C0L5_H_1125_D
6440,Q8TAI7,F,54,A,3oes:A,54,Partially deficient in guanine nucleotide binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8TAI7_F_54_A
6441,Q8TAI7,L,56,A,3oes:A,56,Partially deficient in guanine nucleotide binding.,,-1.0,-999.0,,,,,,,,,,,,,Q8TAI7_L_56_A
6442,Q8TAI7,D,60,K,3oes:A,60,Significant decrease in NF-kappa B activation.,-1.0,,1.0,,,,,,,,,,,,,Q8TAI7_D_60_K
6443,Q8TAI7,Q,64,L,3oes:A,64,Constitutively active.,,,1.0,,,,,,,,,,,,,Q8TAI7_Q_64_L
6444,O75884,S,75,A,2qs9:A,75,Loss of catalytic activity. Fails to block TGF-beta-mediated anti-proliferative signal in tumor cells.,,,1.0,,,,,,,,,,,,,O75884_S_75_A
6445,P00973,K,66,A,4ig8:A,66,Decreased enzyme activity.,,,1.0,,,,,,,,,,,,,P00973_K_66_A
6446,P00973,D,75,A,4ig8:A,75,Loss of activity,,,1.0,,,,,,,,,,,,,P00973_D_75_A
6447,P00973,D,77,A,4ig8:A,77,Loss of activity,,,1.0,,,,,,,,,,,,,P00973_D_77_A
6448,P00973,D,148,A,4ig8:A,148,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P00973_D_148_A
6449,P00973,E,233,A,4ig8:A,233,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P00973_E_233_A
6450,P00973,C,331,A,4ig8:A,331,Loss of activity,,,1.0,,,,,,,,,,,,,P00973_C_331_A
6451,P00973,F,332,A,4ig8:A,332,Loss of activity,,,1.0,,,,,,,,,,,,,P00973_F_332_A
6452,P00973,K,333,A,4ig8:A,333,Loss of activity,,,1.0,,,,,,,,,,,,,P00973_K_333_A
6453,P20023,R,103,A,2gsx:A,83,No effect on affinity for C3.,,0.0,-999.0,,,,,,,,,,,,,P20023_R_103_A
6454,P20023,D,112,A,2gsx:A,92,Reduced affinity for C3.,,-1.0,-999.0,,,,,,,,,,,,,P20023_D_112_A
6455,P20023,K,128,A,2gsx:A,108,Strongly reduced affinity for C3.,,-1.0,-999.0,,,,,,,,,,,,,P20023_K_128_A
6456,O60502,Y,69,K,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,O60502_Y_69_K
6456,O60502,Y,69,Q,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,O60502_Y_69_Q
6457,O60502,Y,69,S,6hki:B,69,Strongly reduces affinity for glycopeptide substrates. Nearly abolishes enzyme activity.,,-1.0,1.0,,,,,,,,,,,,,O60502_Y_69_S
6458,O60502,D,174,A,6hki:B,174,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_D_174_A
6459,O60502,D,175,A,6hki:B,175,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_D_175_A
6460,O60502,D,175,N,6hki:B,175,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_D_175_N
6461,O60502,V,255,G,6hki:B,255,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_V_255_G
6461,O60502,V,255,T,6hki:B,255,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_V_255_T
6462,O60502,Y,286,S,6hki:B,286,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_Y_286_S
6463,O60502,D,287,A,6hki:B,287,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_D_287_A
6464,O60502,W,679,N,6hki:A,679,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O60502_W_679_N
6465,Q10469,R,198,A,5vcs:A,198,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,1.0,,,,,,,,,,,,,Q10469_R_198_A
6466,Q10469,D,217,A,5vcs:A,217,Nearly abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q10469_D_217_A
6467,Q10469,E,259,A,5vcs:A,259,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q10469_E_259_A
6468,Q10469,Y,294,A,5vcs:A,294,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,1.0,,,,,,,,,,,,,Q10469_Y_294_A
6469,Q10469,N,318,A,5vcs:A,318,Strongly decreased catalytic activity and affinity for UDP-GlcNAc.,,-1.0,1.0,,,,,,,,,,,,,Q10469_N_318_A
6470,Q10469,Y,344,A,5vcs:A,344,Nearly abolishes catalytic activity and strongly decreases affinity for UDP-GlcNAc.,,-1.0,1.0,,,,,,,,,,,,,Q10469_Y_344_A
6471,Q10469,W,346,A,5vcs:A,346,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q10469_W_346_A
6472,Q10469,D,347,A,5vcs:A,347,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q10469_D_347_A
6473,O60504,W,649,F,2ct3:A,42,Loss of SOS-binding ability.,-1.0,,-999.0,,,,,,,,,,,,,O60504_W_649_F
6474,O60504,Y,667,V,2ct3:A,60,Loss of SOS-binding ability.,-1.0,,-999.0,,,,,,,,,,,,,O60504_Y_667_V
6475,O60507,N,262,A,5wrj:A,262,Loss of one glycosylation site. Loss of N-glycosylation,,,-999.0,,,-1.0,,,,,,,,,,O60507_N_262_A
6476,Q96AX1,K,429,D,4bx9:B,429,Disrupts interaction with VPS16. Disrupts interaction with VPS18 and impairs endosome-lysosome fusion,-1.0,,-999.0,,,,,,,,,,,,,Q96AX1_K_429_D
6477,Q96AX1,Y,438,D,4bx9:B,438,Disrupts interaction with VPS16. Disrupts interaction with VPS18 and impairs endosome-lysosome fusion,-1.0,,-999.0,,,,,,,,,,,,,Q96AX1_Y_438_D
6478,Q96AX1,I,441,K,4bx9:B,441,Disrupts interaction with VPS16. Disrupts interaction with VPS18 and impairs endosome-lysosome fusion,-1.0,,-999.0,,,,,,,,,,,,,Q96AX1_I_441_K
6479,P42345,S,2159,A,4jt6:A,2159,Reduces mTORC1-associated S-2481 autophosphorylation,,,1.0,-1.0,,,,,,,,,,,,P42345_S_2159_A
6480,P42345,S,2159,D,4jt6:A,2159,Stronger phosphorylation of RPS6KB1,,,1.0,,,,,,,,,,,,,P42345_S_2159_D
6481,P42345,T,2164,A,4jt6:A,2164,Reduces mTORC1-associated S-2481 autophosphorylation,,,1.0,-1.0,,,,,,,,,,,,P42345_T_2164_A
6482,P42345,T,2164,E,4jt6:A,2164,Stronger phosphorylation of RPS6KB1,,,1.0,,,,,,,,,,,,,P42345_T_2164_E
6483,P42345,T,2173,A,4jt6:A,2173,Increased mTOR kinase activity.,,,1.0,,,,,,,,,,,,,P42345_T_2173_A
6484,P42345,H,2340,A,4jt6:A,2340,Barely detectable kinase activity.,,,1.0,,,,,,,,,,,,,P42345_H_2340_A
6485,P42345,D,2357,E,4jt6:A,2357,"Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization",-1.0,,1.0,,,,,,,,,1.0,,,,P42345_D_2357_E
6486,P42345,V,2364,I,4jt6:A,2364,"Kinase-dead mutant, loss of interaction with TM4SF5 and loss of lysosome membrane localization",-1.0,,1.0,,,,,,,,,1.0,,,,P42345_V_2364_I
6487,Q86W56,N,740,A,4b1j:A,740,Reduced poly(ADP-ribose) glycohydrolase activity.,,,1.0,,,,,,,,,,,,,Q86W56_N_740_A
6488,Q86W56,E,755,A,4b1j:A,755,Abolished poly(ADP-ribose) glycohydrolase activity.,,,1.0,,,,,,,,,,,,,Q86W56_E_755_A
6489,Q86W56,E,756,A,4b1j:A,756,Abolished poly(ADP-ribose) glycohydrolase activity.,,,1.0,,,,,,,,,,,,,Q86W56_E_756_A
6490,Q86W56,A,874,W,4b1j:A,874,Reduced poly(ADP-ribose) glycohydrolase activity.,,,1.0,,,,,,,,,,,,,Q86W56_A_874_W
6491,Q86W56,F,875,A,4b1j:A,875,Abolished poly(ADP-ribose) glycohydrolase activity.,,,1.0,,,,,,,,,,,,,Q86W56_F_875_A
6492,P43246,K,675,R,2o8f:A,675,"No effect on mismatch binding, complete loss of DNA repair function when associated with MSH6 mutant R-1140.",,0.0,1.0,,,,,,,,,,,,,P43246_K_675_R
6493,P39748,R,29,A,5kse:A,29,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_R_29_A
6494,P39748,D,34,A,5kse:A,34,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,1.0,,,,,,,,,,,,,P39748_D_34_A
6495,P39748,R,47,A,5kse:A,47,Significantly reduced exonuclease activity and reduced substrate binding. The positions of the cleavage sites are also shifted.,,-1.0,1.0,,,,,,,,,,,,,P39748_R_47_A
6496,P39748,R,70,A,5kse:A,70,Loss of exonuclease activity and reduced endonuclease activity. Reduced substrate binding.,,-1.0,1.0,,,,,,,,,,,,,P39748_R_70_A
6497,P39748,R,73,A,5kse:A,73,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_R_73_A
6498,P39748,K,80,A,5kse:A,80,No significant effect on exonuclease activity or flap endonuclease activity.,,0.0,0.0,,,,,,,,,,,,,P39748_K_80_A
6499,P39748,D,86,A,5kse:A,86,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,1.0,,,,,,,,,,,,,P39748_D_86_A
6500,P39748,R,103,A,5kse:A,103,No effect on flap endonuclease activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P39748_R_103_A
6501,P39748,E,158,A,5kse:A,158,Loss of flap endonuclease activity and substrate binding.,,-1.0,1.0,,,,,,,,,,,,,P39748_E_158_A
6502,P39748,D,179,A,5kse:A,179,No effect on flap endonuclease activity or substrate binding.,,0.0,0.0,,,,,,,,,,,,,P39748_D_179_A
6503,P39748,D,181,A,5kse:A,181,Loss of flap endonuclease activity but substrate binding activity is retained.,,0.0,1.0,,,,,,,,,,,,,P39748_D_181_A
6504,P39748,S,187,A,5kse:A,187,Fails to translocate from nucleoli to the nuclear plasma.,,,-999.0,,,,,,,,,1.0,,,,P39748_S_187_A
6505,P39748,S,187,D,5kse:A,187,Diminishes nucleolar localization.,,,-999.0,,,,,,,,,1.0,,,,P39748_S_187_D
6506,P39748,R,192,K,5kse:A,192,Impairs ability to localize to sites of DNA replication or repair.,,-1.0,-999.0,,,,,,,,,,,,,P39748_R_192_K
6507,P39748,G,231,A,5kse:A,231,Loss of flap endonuclease activity and substrate binding.,,,1.0,,,,,,,,,,,,,P39748_G_231_A
6508,P39748,D,233,A,5kse:A,233,Loss of flap endonuclease activity and substrate binding.,,,1.0,,,,,,,,,,,,,P39748_D_233_A
6509,P49005,L,217,W,6s1m:B,217,Loss of POLD3-binding in a yeast two-hybrid assay.,-1.0,,-999.0,,,,,,,,,,,,,P49005_L_217_W
6510,P49005,G,224,W,6s1m:B,224,Loss of POLD3-binding in a yeast two-hybrid assay.,-1.0,,-999.0,,,,,,,,,,,,,P49005_G_224_W
6511,P49005,E,231,W,6s1m:B,231,Loss of POLD3-binding in a yeast two-hybrid assay.,-1.0,,-999.0,,,,,,,,,,,,,P49005_E_231_W
6512,Q15907,S,25,N,2f9m:A,25,Dominant negative mutant locked in the inactive GDP-bound form,,1.0,1.0,,,,,,,,,,,,,Q15907_S_25_N
6513,Q15907,Q,70,L,2f9m:A,70,Constitutively active mutant locked in the active GTP-bound form,,1.0,1.0,,,,,,,,,,,,,Q15907_Q_70_L
6514,O15294,W,208,E,1w3b:A,198,Abolishes homodimerization of the TPR domain. Slightly reduced enzyme activity,-1.0,,1.0,,,,,,,,,,,,,O15294_W_208_E
6515,O15294,I,211,D,1w3b:A,201,Abolishes homodimerization of the TPR domain. Slightly reduced enzyme activity,-1.0,,1.0,,,,,,,,,,,,,O15294_I_211_D
6516,O15294,H,508,A,5lvv:A,498,Loss of enzyme activity. Moderate increase in KMT2E ubiquitination. Moderate increase in KMT2E ubiquitination,,,1.0,,1.0,,,,,,,,,,,O15294_H_508_A
6517,O15294,H,568,A,5lvv:A,558,Reduces enzyme activity by about 95%. Moderate increase in KMT2E ubiquitination,,,1.0,,1.0,,,,,,,,,,,O15294_H_568_A
6518,O15294,H,911,A,4gz5:A,901,Reduces enzyme activity by over 90%.,,,1.0,,,,,,,,,,,,,O15294_H_911_A
6519,Q6B8I1,D,97,A,5xjv:B,97,No effect on interaction with MAP3K5.,0.0,,-999.0,,,,,,,,,,,,,Q6B8I1_D_97_A
6520,Q6B8I1,C,129,S,5xjv:B,129,Loss of enzyme activity. No effect on interaction with MAP3K5.,0.0,,1.0,,,,,,,,,,,,,Q6B8I1_C_129_S
6521,Q95460,K,65,A,5d7i:C,43,"Associates with B2M and translocates to plasma membrane in the absence of 6-FP. Impairs recognition by pan-cancer TCR, MC.7.G5.",1.0,,-999.0,,,,,,,,,1.0,,,,Q95460_K_65_A
6522,Q95460,K,65,R,5d7i:C,43,Fails to refold in the presence of 6-FP. Impairs the association with B2M and translocation to the plasma membrane.,-1.0,,-999.0,,,,,,,,,,,-1.0,,Q95460_K_65_R
6523,Q95460,Q,169,L,5d7i:C,147,Able to activate mouse MAIT cells (xeno-reactivity).,1.0,,-999.0,,,,,,,,,,,,,Q95460_Q_169_L
6524,Q95460,C,283,G,5d7i:C,261,No effect on cell surface expression.,,,-999.0,,,,,,,,,0.0,,,,Q95460_C_283_G
6525,P15498,C,529,R,6new:A,529,Abolishes transforming activity.,,,1.0,,,,,,,,,,,,,P15498_C_529_R
6526,P15498,R,696,L,2crh:A,53,Loss of interaction with SYK.,-1.0,,-999.0,,,,,,,,,,,,,P15498_R_696_L
6527,Q9Y3D6,L,14,P,1pc2:A,14,Approximately 40% of cells display fragmented mitochondria.,,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_14_P
6528,Q9Y3D6,L,42,P,1pc2:A,42,Less than 15% of cells display fragmented mitochondria.,,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_42_P
6529,Q9Y3D6,L,58,P,1pc2:A,58,Less than 15% of cells display fragmented mitochondria.,,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_58_P
6530,Q9Y3D6,L,77,P,1pc2:A,77,Less than 15% of cells display fragmented mitochondria. Shows greatly reduced binding to DNM1L.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_77_P
6531,Q9Y3D6,L,91,P,1pc2:A,91,Less than 15% of cells display fragmented mitochondria. Shows greatly reduced binding to DNM1L.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_91_P
6532,Q9Y3D6,L,110,P,1pc2:A,110,Approximately 40% of cells display fragmented mitochondria. No change in binding to DNM1L.,0.0,,-999.0,,,,,,,,,,,,,Q9Y3D6_L_110_P
6533,P10321,S,112,G,1efx:A,88,Impairs N-linked glycosylation resulting in impaired interaction with CANX and CALR chaperones as well as TAPBPL.,,,-999.0,,,-1.0,,,,,,,,,,P10321_S_112_G
6534,Q8NBL1,G,169,E,5l0r:A,169,Loss of O-glucosyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8NBL1_G_169_E
6535,P83110,S,305,A,4ri0:A,305,Abolishes protease activity. Stabilizes the protein.,,,1.0,,,,,,,,,,,,,P83110_S_305_A
6536,Q9Y3D8,H,79,G,3iij:A,79,"Induces homodimerization. Reduces adenylate kinase activity by 72% and ATPase activity by 76%. Significantly changes Cajal body organization in the nucleus, resulting in enhanced apoptosis and reduced proliferation.",1.0,,1.0,,,,,,,,,,,,,Q9Y3D8_H_79_G
6537,O75460,K,599,A,6w3c:A,599,Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest.,,,1.0,-1.0,,,,,,,,,,,,O75460_K_599_A
6538,Q9H3H5,P,30,S,6bw6:A,30,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_P_30_S
6539,Q9H3H5,I,69,N,6bw6:A,69,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_I_69_N
6540,Q9H3H5,L,103,F,5o5e:A,103,Impairs protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q9H3H5_L_103_F
6541,Q9H3H5,A,114,G,5o5e:A,114,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_A_114_G
6542,Q9H3H5,D,115,A,5o5e:A,115,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_D_115_A
6542,Q9H3H5,D,115,N,5o5e:A,115,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_D_115_N
6543,Q9H3H5,D,115,E,5o5e:A,115,Mildly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_D_115_E
6544,Q9H3H5,D,116,A,5o5e:A,116,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_D_116_A
6544,Q9H3H5,D,116,N,5o5e:A,116,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_D_116_N
6545,Q9H3H5,W,122,A,5o5e:A,122,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_W_122_A
6546,Q9H3H5,K,125,A,5o5e:A,125,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_K_125_A
6546,Q9H3H5,K,125,E,5o5e:A,125,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_K_125_E
6546,Q9H3H5,K,125,N,5o5e:A,125,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_K_125_N
6547,Q9H3H5,L,168,P,6fm9:A,168,Strongly reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_L_168_P
6548,Q9H3H5,N,182,A,6fm9:A,182,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_N_182_A
6549,Q9H3H5,N,185,A,6fm9:A,185,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_N_185_A
6549,Q9H3H5,N,185,D,6fm9:A,185,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_N_185_D
6550,Q9H3H5,D,252,A,6fm9:A,252,Reduces binding to inhibitor. Nearly abolishes enzyme activity.,-1.0,,1.0,,,,,,,,,,,,,Q9H3H5_D_252_A
6551,Q9H3H5,V,264,M,6fm9:A,264,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_V_264_M
6552,Q9H3H5,R,301,C,6fm9:A,301,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_R_301_C
6552,Q9H3H5,R,301,H,6fm9:A,301,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_R_301_H
6553,Q9H3H5,H,302,A,6fm9:A,302,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_H_302_A
6554,Q9H3H5,R,303,A,6fm9:A,303,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9H3H5_R_303_A
6555,Q9H3H5,L,385,R,6fm9:A,385,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9H3H5_L_385_R
6556,P41227,K,136,R,6c95:B,136,Loss of its ability to acetylate HSPA1A and HSPA1B.,,,1.0,,,,,,,,,,,,,P41227_K_136_R
6557,P00374,L,23,F,1dls:A,22,Decreases affinity for NADP and dihydrofolate over 10-fold.,,-1.0,-999.0,,,,,,,,,,,,,P00374_L_23_F
6557,P00374,L,23,W,1dls:A,22,Decreases affinity for NADP and dihydrofolate over 10-fold.,,-1.0,-999.0,,,,,,,,,,,,,P00374_L_23_W
6557,P00374,L,23,Y,1dls:A,22,Decreases affinity for NADP and dihydrofolate over 10-fold.,,-1.0,-999.0,,,,,,,,,,,,,P00374_L_23_Y
6558,P00374,L,23,R,1dls:A,22,Strongly decreased affinity for methotrexate. Decreases catalytic rate constant 200-fold. Decreases affinity for NADP and dihydrofolate over 10-fold.,,-1.0,1.0,,,,,,,,,,,,,P00374_L_23_R
6559,P00374,F,32,R,1dls:A,31,Reduces catalytic rate 5-fold. Reduces affinity for dihydrofolate 9-fold,,-1.0,-999.0,,,,,,,,,,,,,P00374_F_32_R
6560,P00374,Q,36,E,1dls:A,35,Reduces catalytic rate 2-fold. Reduces affinity for dihydrofolate 9-fold,,-1.0,-999.0,,,,,,,,,,,,,P00374_Q_36_E
6561,P00374,Q,36,K,1dls:A,35,Increases affinity for dihydrofolate about 3-fold. Reduces affinity for NADPH about 3-fold.,,,-999.0,,,,,,,,,,,,,P00374_Q_36_K
6562,P00374,Q,36,S,1dls:A,35,Increases affinity for dihydrofolate about 2-fold. No effect on affinity for NADPH.,,1.0,-999.0,,,,,,,,,,,,,P00374_Q_36_S
6563,P00374,N,65,F,1dls:A,64,Increases affinity for dihydrofolate about 3-fold. No effect on affinity for NADPH.,,1.0,-999.0,,,,,,,,,,,,,P00374_N_65_F
6564,P00374,N,65,S,1dls:A,64,Increases affinity for dihydrofolate about 15-fold. No effect on affinity for NADPH.,,1.0,-999.0,,,,,,,,,,,,,P00374_N_65_S
6565,P27708,H,1471,A,4c6f:A,1471,No zinc-binding and no catalytic activity.,,0.0,1.0,,,,,,,,,,,,,P27708_H_1471_A
6566,P27708,H,1471,N,4c6f:A,1471,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_H_1471_N
6567,P27708,H,1473,A,4c6f:A,1473,No zinc-binding and no catalytic activity.,,-1.0,1.0,,,,,,,,,,,,,P27708_H_1473_A
6568,P27708,D,1512,N,4c6f:A,1512,No change in catalytic activity.,,,0.0,,,,,,,,,,,,,P27708_D_1512_N
6569,P27708,T,1562,A,4c6f:A,1562,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_T_1562_A
6570,P27708,F,1563,A,4c6f:A,1563,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_F_1563_A
6571,P27708,H,1590,A,4c6f:A,1590,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_H_1590_A
6572,P27708,H,1590,N,4c6f:A,1590,No catalytic activity.,,,1.0,,,,,,,,,,,,,P27708_H_1590_N
6573,P27708,C,1613,S,4c6f:A,1613,Reduces dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_C_1613_S
6574,P27708,H,1614,A,4c6f:A,1614,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_H_1614_A
6575,P27708,E,1637,T,4c6f:A,1637,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_E_1637_T
6576,P27708,H,1642,N,4c6f:A,1642,11.5% of wild-type catalytic activity.,,,1.0,,,,,,,,,,,,,P27708_H_1642_N
6577,P27708,D,1686,N,4c6f:A,1686,Abolishes dihydroorotase activity.,,,1.0,,,,,,,,,,,,,P27708_D_1686_N
6578,P27708,H,1690,N,4c6f:A,1690,3% of wild-type catalytic activity.,,,1.0,,,,,,,,,,,,,P27708_H_1690_N
6579,Q9NR22,C,273,A,5dst:C,273,No effect on homodimerization but decreased homooligomerization,-1.0,,-999.0,,,,,,,,,,,,,Q9NR22_C_273_A
6580,Q9NR22,C,295,A,5dst:C,295,No effect on homodimerization but decreased homooligomerization,-1.0,,-999.0,,,,,,,,,,,,,Q9NR22_C_295_A
6581,Q9NR22,Y,303,A,5dst:C,303,"Decreases homooligomerization and cell membrane localization. No effect on homodimerization, S-adenosyl-L-methionine binding and EWS protein methylation. No effect on homodimerization but loss of homooligomerization and cell membrane localization",-1.0,0.0,-999.0,,,,,,,,,1.0,,,,Q9NR22_Y_303_A
6582,Q9NR22,Y,345,A,5dst:C,345,No effect on homooligomerization. No effect on S-adenosyl-L-methionine binding and EWS protein methylation. No effect on homodimerization but loss of homooligomerization and cell membrane localization,-1.0,0.0,-999.0,,,,,,,,,1.0,,,,Q9NR22_Y_345_A
6583,Q9NR22,R,349,A,5dst:C,349,No effect on homodimerization but decreased homooligomerization,-1.0,,-999.0,,,,,,,,,,,,,Q9NR22_R_349_A
6584,Q9NR22,L,382,A,5dst:C,382,No effect on homooligomerization. No effect on S-adenosyl-L-methionine binding and EWS protein methylation. No effect on homodimerization but loss of homooligomerization and cell membrane localization,-1.0,0.0,-999.0,,,,,,,,,1.0,,,,Q9NR22_L_382_A
6585,P43405,Y,630,F,4fl2:A,630,Loss of interaction with BLNK.,-1.0,,-999.0,,,,,,,,,,,,,P43405_Y_630_F
6586,P08581,Y,1234,F,3dkc:A,1234,Complete loss of kinase activity and of ligand-induced ubiquitination. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2,-1.0,,1.0,,-1.0,,,,,,,,,,,P08581_Y_1234_F
6587,P08581,Y,1235,F,3dkc:A,1235,Complete loss of kinase activity. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2,-1.0,,1.0,,,,,,,,,,,,,P08581_Y_1235_F
6588,P08581,Y,1313,F,3dkc:A,1313,No effect on ligand-induced CBL-mediated ubiquitination,,,-999.0,,0.0,,,,,,,,,,,P08581_Y_1313_F
6589,P08581,Y,1349,F,3dkc:A,1349,No effect on ligand-induced CBL-mediated ubiquitination,,,-999.0,,0.0,,,,,,,,,,,P08581_Y_1349_F
6590,P08581,Y,1356,F,3dkc:A,1356,No effect on ligand-induced CBL-mediated ubiquitination,,,-999.0,,0.0,,,,,,,,,,,P08581_Y_1356_F
6591,Q4G0J3,F,44,A,4wkr:A,44,Reduced binding to U6 snRNA without affecting binding to 7SK RNA. Reduced 2'-O-methylation of U6 snRNAs.,,-1.0,-999.0,,,,,,,,,,,,,Q4G0J3_F_44_A
6592,Q4G0J3,Y,128,D,4wkr:A,128,Loss of 7SK RNA-binding and marked decrease in 7SK RNP complex formation.,,-1.0,-999.0,,,,,,,,,,,,,Q4G0J3_Y_128_D
6593,Q4G0J3,E,130,A,4wkr:A,130,Decreased RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q4G0J3_E_130_A
6594,Q4G0J3,F,168,A,4wkr:A,168,Does not affect RNA-binding.,,0.0,-999.0,,,,,,,,,,,,,Q4G0J3_F_168_A
6595,Q4G0J3,F,451,A,5knw:A,451,Does not affect binding to the 7SK RNA.,,0.0,-999.0,,,,,,,,,,,,,Q4G0J3_F_451_A
6596,Q4G0J3,R,472,A,5knw:A,472,Does not affect binding to the 7SK RNA.,,0.0,-999.0,,,,,,,,,,,,,Q4G0J3_R_472_A
6597,Q4G0J3,Y,483,A,5knw:A,483,Reduced binding to the 7SK RNA. Does not affect binding to U6 snRNA.,,-1.0,-999.0,,,,,,,,,,,,,Q4G0J3_Y_483_A
6598,Q4G0J3,Y,483,F,5knw:A,483,Does not affect binding to the 7SK RNA.,,0.0,-999.0,,,,,,,,,,,,,Q4G0J3_Y_483_F
6599,Q4G0J3,R,496,A,5knw:A,496,Strongly reduced binding to the stem loop 4 of 7SK RNA.,,-1.0,-999.0,,,,,,,,,,,,,Q4G0J3_R_496_A
6600,Q86XR7,P,116,H,2m1w:A,116,Loss of ability to dimerize. Significant loss of RANTES-inducing activity. Loss of ability to induce NF-kappa-B activation.,-1.0,,1.0,,,,,,,,,,,,,Q86XR7_P_116_H
6601,Q86XR7,C,117,H,2m1w:A,117,Loss of ability to dimerize. Loss of RANTES-inducing activity and ability to induce NF-kappa-B activation. Inhibition of TLR4-dependent activation of IRF3 and IRF7. Loss of interaction with TLR4.,-1.0,,1.0,,,,,,,,,,,,,Q86XR7_C_117_H
6602,Q86XR7,Y,154,F,2m1w:A,154,No effect on phosphorylation.,,,0.0,,,,,,,,,,,,,Q86XR7_Y_154_F
6603,Q86XR7,Y,167,F,2m1w:A,167,Complete loss of phosphorylation in response to LPS.,,,1.0,,,,,,,,,,,,,Q86XR7_Y_167_F
6604,Q8NEJ0,D,73,A,2esb:A,73,Abolishes most of in vitro phosphatase activity.,,,1.0,,,,,,,,,,,,,Q8NEJ0_D_73_A
6605,Q8NEJ0,L,102,V,2esb:A,102,No effect on in vitro phosphatase activity.,,,0.0,,,,,,,,,,,,,Q8NEJ0_L_102_V
6606,Q8NEJ0,C,104,S,2esb:A,104,Abolishes most of in vitro phosphatase activity.,,,1.0,,,,,,,,,,,,,Q8NEJ0_C_104_S
6607,Q8NEJ0,R,110,K,2esb:A,110,Abolishes most of in vitro phosphatase activity.,,,1.0,,,,,,,,,,,,,Q8NEJ0_R_110_K
6608,Q8NEJ0,S,111,A,2esb:A,111,Abolishes most of in vitro phosphatase activity.,,,1.0,,,,,,,,,,,,,Q8NEJ0_S_111_A
6609,Q13285,A,269,F,4qk4:A,269,Strongly reduced transactivation.,,,1.0,,,,,,,,,,,,,Q13285_A_269_F
6610,Q13285,G,341,E,4qk4:A,341,Reduced transactivation. Strongly reduced transactivation,,,1.0,,,,,,,,,,,,,Q13285_G_341_E
6611,Q13285,L,344,F,4qk4:A,344,Reduced transactivation. Strongly reduced transactivation,,,1.0,,,,,,,,,,,,,Q13285_L_344_F
6612,Q13285,A,433,F,4qk4:A,433,Strongly reduced transactivation.,,,1.0,,,,,,,,,,,,,Q13285_A_433_F
6613,Q13285,Y,436,F,4qk4:A,436,Loss of transactivation,,,1.0,,,,,,,,,,,,,Q13285_Y_436_F
6614,Q13285,K,440,A,4qk4:A,440,Loss of transactivation,,,1.0,,,,,,,,,,,,,Q13285_K_440_A
6615,Q99638,Y,28,F,3ggr:A,28,Abolishes phosphorylation by ABL1.,,,-999.0,-1.0,,,,,,,,,,,,Q99638_Y_28_F
6616,O75608,S,119,A,6qgs:B,119,Loss of thioesterase and lysophospholipase activity.,,,1.0,,,,,,,,,,,,,O75608_S_119_A
6617,P49137,K,93,R,6tca:G,93,"Kinase defective mutant, abolishes activity.",,,1.0,,,,,,,,,,,,,P49137_K_93_R
6618,P49137,D,207,A,6tca:G,207,"Kinase defective mutant, abolishes activity.",,,1.0,,,,,,,,,,,,,P49137_D_207_A
6619,P49137,T,222,A,6tca:G,222,Strong decrease in kinase activity.,,,1.0,,,,,,,,,,,,,P49137_T_222_A
6620,P49137,T,222,D,6tca:G,222,"Mimicks phosphorylation state, leading to slight increase of basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_222_D
6621,P49137,T,222,E,6tca:G,222,Mimicks phosphorylation state and constitutive protein kinase activity,,,1.0,,,,,,,,,,1.0,,,P49137_T_222_E
6622,P49137,S,272,A,2pzy:C,272,Strong decrease in kinase activity.,,,1.0,,,,,,,,,,,,,P49137_S_272_A
6623,P49137,S,272,D,2pzy:C,272,"Mimicks phosphorylation state, leading to slight increase of basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_S_272_D
6624,P49137,T,334,A,2pzy:C,334,Slight decrease in kinase activity.,,,1.0,,,,,,,,,,,,,P49137_T_334_A
6625,P49137,T,334,D,2pzy:C,334,"Mimicks phosphorylation state, leading to elevated basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_334_D
6625,P49137,T,334,E,2pzy:C,334,"Mimicks phosphorylation state, leading to elevated basal kinase activity.",,,1.0,,,,,,,,,,1.0,,,P49137_T_334_E
6627,P49137,K,353,R,2pzy:C,353,Induces decreased sumoylation and increase in protein kinase activity.,,,1.0,,,,-1.0,,,,,,,,,P49137_K_353_R
6628,O75604,C,276,A,3nhe:A,276,Loss of enzymatic activity. Increases the steady-state level of CCND1.,,,1.0,,,,,,,,,,,,,O75604_C_276_A
6629,O75604,H,549,A,3nhe:A,549,Loss of enzymatic activity. Increases the steady-state level of MDM2 and MDM4 that leads to attenuation of MDM2-mediated degradation of p53/TP53 and MDM4. Increases the level of p53/TP53 and MDM4 ubiquitin conjugates.,,,1.0,,1.0,,,,,,,,,,,O75604_H_549_A
6630,Q13043,K,59,R,6yat:A,59,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13043_K_59_R
6631,Q13043,T,175,A,6yat:A,175,No effect on activity.,,,0.0,,,,,,,,,,,,,Q13043_T_175_A
6632,Q13043,T,177,A,6yat:A,177,No effect on activity.,,,0.0,,,,,,,,,,,,,Q13043_T_177_A
6633,Q13043,T,183,A,6yat:A,183,Loss of activity.,,,1.0,,,,,,,,,,,,,Q13043_T_183_A
6634,P62745,G,14,V,6sge:C,14,No effect on internalization of EGF receptor but decreases trafficking of receptor to the lysosome with associated accumulation in late endosomes.,0.0,,-999.0,,,,,,,,,1.0,,,,P62745_G_14_V
6635,P62745,F,39,G,6sge:C,39,Abolishes binding to PKN1 and trafficking of EGF receptor.,-1.0,,-999.0,,,,,,,,,,,,,P62745_F_39_G
6636,Q53EL6,E,174,A,2kzt:A,174,Reduced inhibition of EIF4A1 helicase activity.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_E_174_A
6637,Q53EL6,E,210,A,2kzt:A,210,Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_E_210_A
6638,Q53EL6,E,249,A,2kzt:A,249,Reduced interaction with EIF4A1.,-1.0,,-999.0,,,,,,,,,,,,,Q53EL6_E_249_A
6639,Q53EL6,L,252,A,2kzt:A,252,Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_L_252_A
6640,Q53EL6,D,253,A,2kzt:A,253,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_D_253_A
6641,Q53EL6,P,255,A,2kzt:A,255,Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_P_255_A
6642,Q53EL6,M,333,A,2zu6:B,333,No effect on inhibition of EIF4A1 and on inhibition of translation,0.0,,0.0,,,,,,,,,,,,,Q53EL6_M_333_A
6643,Q53EL6,E,337,A,2zu6:B,337,No effect on inhibition of EIF4A1 and on inhibition of translation.,0.0,,0.0,,,,,,,,,,,,,Q53EL6_E_337_A
6644,Q53EL6,L,340,A,2zu6:B,340,No effect on inhibition of EIF4A1 and on inhibition of translation,0.0,,0.0,,,,,,,,,,,,,Q53EL6_L_340_A
6645,Q53EL6,H,358,A,2zu6:B,358,Strongly reduced interaction with EIF4A1.,-1.0,,-999.0,,,,,,,,,,,,,Q53EL6_H_358_A
6646,Q53EL6,F,359,A,2zu6:B,359,Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_F_359_A
6647,Q53EL6,H,361,A,2zu6:B,361,Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_H_361_A
6648,Q53EL6,D,414,A,2zu6:B,414,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_D_414_A
6649,Q53EL6,D,418,A,2zu6:B,418,Reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_D_418_A
6650,Q53EL6,P,420,A,2zu6:B,420,Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.,-1.0,,1.0,,,,,,,,,,,,,Q53EL6_P_420_A
6659,Q96KS0,H,297,A,5v1b:A,297,Eliminates hydroxylase activity.,,,1.0,,,,,,,,,,,,,Q96KS0_H_297_A
6660,Q96KS0,D,299,A,5v1b:A,299,Eliminates hydroxylase activity.,,,1.0,,,,,,,,,,,,,Q96KS0_D_299_A
6661,Q96KS0,H,358,A,5v1b:A,358,Eliminates hydroxylase activity.,,,1.0,,,,,,,,,,,,,Q96KS0_H_358_A
6662,Q96KS0,R,367,A,5v1b:A,367,Eliminates hydroxylase activity.,,,1.0,,,,,,,,,,,,,Q96KS0_R_367_A
6663,Q96KS0,R,367,K,5v1b:A,367,Eliminates hydroxylase activity on a HIF1A peptide.,,,1.0,,,,,,,,,,,,,Q96KS0_R_367_K
6664,P04004,T,69,A,1ssu:A,50,Abolishes phosphorylation by CK2 and inhibits adhesion and spreading,,,-999.0,-1.0,,,,,,,,,,,,P04004_T_69_A
6665,P04004,T,69,E,1ssu:A,50,Abolishes phosphorylation by CK2 and enhances adhesion and spreading,,,-999.0,-1.0,,,,,,,,,,,,P04004_T_69_E
6666,P01375,L,105,S,7kpb:A,29,Low activity.,,,1.0,,,,,,,,,,,,,P01375_L_105_S
6667,P01375,R,108,W,7kpb:A,32,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_R_108_W
6668,P01375,L,112,F,7kpb:A,36,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_L_112_F
6669,P01375,A,160,V,7kpb:A,84,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_A_160_V
6670,P01375,S,162,F,7kpb:A,86,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_S_162_F
6671,P01375,V,167,A,7kpb:A,91,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_V_167_A
6671,P01375,V,167,D,7kpb:A,91,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_V_167_D
6672,P01375,E,222,K,7kpb:A,146,Biologically inactive.,,,1.0,,,,,,,,,,,,,P01375_E_222_K
6673,Q14393,R,310,E,2c5d:A,310,Strongly reduced affinity for AXL. Abolishes phosphorylation of AXL.,-1.0,,1.0,,,,,,,,,,,,,Q14393_R_310_E
6674,Q14393,K,312,E,2c5d:A,312,Strongly reduced affinity for AXL. Abolishes phosphorylation of AXL.,-1.0,,1.0,,,,,,,,,,,,,Q14393_K_312_E
6675,Q14393,F,487,A,2c5d:A,487,Decreases activation of AXL.,-1.0,,-999.0,,,,,,,,,,,,,Q14393_F_487_A
6676,Q14393,L,620,A,4ra0:A,620,Reduces affinity for AXL 15-fold and decreases activation of AXL.,-1.0,,-999.0,,,,,,,,,,,,,Q14393_L_620_A
6677,Q14393,Y,660,A,4ra0:A,660,Reduces affinity for AXL 3-fold.,-1.0,,-999.0,,,,,,,,,,,,,Q14393_Y_660_A
6678,Q96PD4,R,77,A,6hgo:C,77,"Significantly decreases the affinity for IL17RA and IL17RC by nearly 5-fold and 200-fold, respectively.",-1.0,,-999.0,,,,,,,,,,,,,Q96PD4_R_77_A
6679,O43504,T,12,A,5yk3:E,12,No change.,0.0,,-999.0,,,,,,,,,,,,,O43504_T_12_A
6680,O43504,T,36,A,5yk3:E,36,No interaction with XABX14-154 (truncated form of HBX).,-1.0,,-999.0,,,,,,,,,,,,,O43504_T_36_A
6681,Q9H9G7,E,638,A,5vm9:C,638,Loss of RNA slicer activity.,,,1.0,,,,,,,,,,,,,Q9H9G7_E_638_A
6682,Q9Y5Z0,D,110,A,4bfb:A,48,Loss of autoproteolytic cleavage.,,,1.0,,,,,,,,,,,,,Q9Y5Z0_D_110_A
6682,Q9Y5Z0,D,110,N,4bfb:A,48,Loss of autoproteolytic cleavage.,,,1.0,,,,,,,,,,,,,Q9Y5Z0_D_110_N
6683,Q9Y5Z0,D,303,A,2ewy:A,241,Loss of autoproteolytic cleavage.,,,1.0,,,,,,,,,,,,,Q9Y5Z0_D_303_A
6684,Q05209,S,19,E,5hde:A,19,Loss of phosphorylation site.,,,1.0,-1.0,,,,,,,,,,,,Q05209_S_19_E
6685,Q05209,R,36,A,5hde:A,36,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_R_36_A
6686,Q05209,R,63,A,5hde:A,63,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_R_63_A
6687,Q05209,Y,64,A,5hde:A,64,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_Y_64_A
6688,Q05209,D,66,A,5hde:A,66,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_D_66_A
6689,Q05209,I,67,A,5hde:A,67,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_I_67_A
6690,Q05209,D,199,A,5hde:A,199,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_D_199_A
6691,Q05209,H,200,A,5hde:A,200,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_H_200_A
6692,Q05209,R,270,A,5hde:A,270,Decreases enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_R_270_A
6693,Q05209,Q,278,A,5hde:A,278,Nearly abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,Q05209_Q_278_A
6694,Q9H4M9,K,468,A,2jq6:A,73,Loss of interaction with MICALL1.,-1.0,,-999.0,,,,,,,,,,,,,Q9H4M9_K_468_A
6695,Q9H4M9,K,483,E,2jq6:A,88,Loss of accumulation at the ciliary pocket. Loss of function in ciliogenesis. Loss of association with tubulovesicular structures and altered MICALL1 localization. No effect on MICALL1 localization,-1.0,,1.0,,,,,,,,,1.0,,,,Q9H4M9_K_483_E
6696,Q9H4M9,W,485,A,2jq6:A,90,Loss of accumulation at the ciliary pocket. Loss of function in ciliogenesis. Abolishes interaction with RAB11FIP2. No effect on MICALL1 localization,-1.0,,1.0,,,,,,,,,1.0,,,,Q9H4M9_W_485_A
6697,Q6PIW4,K,447,A,3d8b:A,447,Inhibits HR-mediated DNA repair.,-1.0,,1.0,,,,,,,,,,,,,Q6PIW4_K_447_A
6698,Q6PIW4,D,500,A,3d8b:A,500,Inhibits HR-mediated DNA repair.,-1.0,,1.0,,,,,,,,,,,,,Q6PIW4_D_500_A
6699,Q53FA7,Y,51,A,2oby:A,51,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q53FA7_Y_51_A
6700,Q53FA7,Y,51,F,2oby:A,51,Increased enzyme activity.,,,1.0,,,,,,,,,,,,,Q53FA7_Y_51_F
6701,Q53FA7,S,151,V,2oby:A,151,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q53FA7_S_151_V
6702,Q8N3R9,F,318,A,4wsi:A,318,Increases interaction with CRB1.,1.0,,-999.0,,,,,,,,,,,,,Q8N3R9_F_318_A
6702,Q8N3R9,F,318,C,4wsi:A,318,Increases interaction with CRB1.,1.0,,-999.0,,,,,,,,,,,,,Q8N3R9_F_318_C
6703,Q8N3R9,D,386,K,4wsi:A,386,Reduces binding to Drosophila crb and causes incorrect MPP5 localization and cell polarity.,-1.0,,-999.0,,,,,,,,,,,,,Q8N3R9_D_386_K
6704,O14862,L,14,A,3vd8:A,1014,Fails to activate interleukin-1 beta production.,-1.0,,-999.0,,,,,,,,,,,,,O14862_L_14_A
6705,O14862,K,160,A,3rn5:A,160,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_160_A
6706,O14862,K,162,A,3rn5:A,162,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_162_A
6707,O14862,K,163,A,3rn5:A,163,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_163_A
6708,O14862,F,165,A,3rn5:A,165,Impairs DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,O14862_F_165_A
6709,O14862,K,198,A,3rn5:A,198,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_198_A
6710,O14862,K,204,A,3rn5:A,204,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_204_A
6711,O14862,R,244,A,3rn5:A,244,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_R_244_A
6712,O14862,K,251,A,3rn5:A,251,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_251_A
6713,O14862,K,309,A,3rn5:A,309,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_309_A
6714,O14862,R,311,A,3rn5:A,311,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_R_311_A
6715,O14862,K,335,A,3rn5:A,335,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_K_335_A
6716,O14862,I,337,A,3rn5:A,337,Impairs DNA binding,,-1.0,-999.0,,,,,,,,,,,,,O14862_I_337_A
6717,O95684,V,74,F,2d68:B,74,Abolishes homodimerization and leads to aggregation.,-1.0,,-999.0,,,,,,,,,,,,,O95684_V_74_F
6718,Q8N4J0,F,313,A,5yf0:B,313,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_F_313_A
6719,Q8N4J0,D,316,A,5yf0:B,316,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_D_316_A
6719,Q8N4J0,D,316,E,5yf0:B,316,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_D_316_E
6719,Q8N4J0,D,316,N,5yf0:B,316,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_D_316_N
6720,Q8N4J0,P,343,A,5yf0:B,343,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_P_343_A
6721,Q8N4J0,L,345,A,5yf0:B,345,Significantly reduces N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_L_345_A
6722,Q8N4J0,H,347,A,5yf0:B,347,Impairs binding to S-adenosyl-L-methionine. Significantly reduces N-methyltransferase activity.,,-1.0,1.0,,,,,,,,,,,,,Q8N4J0_H_347_A
6722,Q8N4J0,H,347,F,5yf0:B,347,Impairs binding to S-adenosyl-L-methionine. Significantly reduces N-methyltransferase activity.,,-1.0,1.0,,,,,,,,,,,,,Q8N4J0_H_347_F
6723,Q8N4J0,Y,386,A,5yf0:B,386,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_386_A
6724,Q8N4J0,Y,386,F,5yf0:B,386,Reduces N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_386_F
6724,Q8N4J0,Y,386,W,5yf0:B,386,Reduces N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_386_W
6725,Q8N4J0,Y,396,A,5yf0:B,396,Reduces N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_396_A
6726,Q8N4J0,Y,396,D,5yf0:B,396,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_396_D
6727,Q8N4J0,Y,398,A,5yf0:B,398,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_398_A
6727,Q8N4J0,Y,398,F,5yf0:B,398,Impairs N-methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q8N4J0_Y_398_F
6728,O95445,Q,22,A,2wew:A,22,Introduces a signal cleavage site. Abolishes interaction with lipoprotein particles. Leads to rapid elimination from plasma.,,-1.0,-999.0,,,,,,,,,,,,,O95445_Q_22_A
6729,O95445,N,135,Q,2wew:A,135,Loss of glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,O95445_N_135_Q
6730,O95445,N,148,Q,2wew:A,148,No loss of glycosylation.,,,-999.0,,,0.0,,,,,,,,,,O95445_N_148_Q
6731,P49354,K,164,N,2h6h:A,164,Reduced activity.,,,1.0,,,,,,,,,,,,,P49354_K_164_N
6732,P49354,N,199,K,2h6h:A,199,Reduced catalytic efficiency.,,,1.0,,,,,,,,,,,,,P49354_N_199_K
6733,P11498,F,1077,A,3bg3:A,1077,"Loss of tetramerization and enzyme activity, resulting in an inactive homodimer.",-1.0,,1.0,,,,,,,,,,,,,P11498_F_1077_A
6733,P11498,F,1077,E,3bg3:A,1077,"Loss of tetramerization and enzyme activity, resulting in an inactive homodimer.",-1.0,,1.0,,,,,,,,,,,,,P11498_F_1077_E
6734,Q13263,C,65,A,6i9h:A,65,Reduces nuclear localization activity of ZNF268,,,-999.0,,,,,,,,,1.0,,,,Q13263_C_65_A
6735,Q13263,C,68,A,6i9h:A,68,Reduces nuclear localization activity of ZNF268,,,-999.0,,,,,,,,,1.0,,,,Q13263_C_68_A
6736,Q13263,L,306,P,6h3a:F,306,Disrupts the interaction with ZNF350 and amost completely relieves the transcription repressive effect of sumoylated TRIM28.,-1.0,,-999.0,,,,,,,,,,,,-1.0,Q13263_L_306_P
6737,Q13263,K,366,G,6h3a:F,366,Greatly reduced interaction with PPP1CA.,-1.0,,-999.0,,,,,,,,,,,,,Q13263_K_366_G
6738,Q13263,I,368,G,6h3a:F,368,Increased interaction with PPP1CA. Greatly decreased phosphorylation on S-824.,1.0,,-999.0,-1.0,,,,,,,,,,,,Q13263_I_368_G
6739,Q13263,F,370,A,6h3a:F,370,Some reduction in interaction with PPP1CA.,-1.0,,-999.0,,,,,,,,,,,,,Q13263_F_370_A
6740,Q13263,F,370,G,6h3a:F,370,Some reduction in interaction with PPP1CA.,-1.0,,-999.0,,,,,,,,,,,,,Q13263_F_370_G
6741,Q13263,C,651,A,2ro1:A,651,Complete loss of the PHD finger-mediated stimulatory effect on sumoylation. Loss of binding UBE2I.,-1.0,,-999.0,,,,-1.0,,,,,,,,,Q13263_C_651_A
6742,Q13263,L,653,A,2ro1:A,653,Greatly reduced sumoylation. Little further effect on sumoylation,,,-999.0,,,,-1.0,,,,,,,,,Q13263_L_653_A
6743,Q13263,L,668,A,2ro1:A,668,Little effect on sumoylation. Little further effect on sumoylation,,,-999.0,,,,-1.0,,,,,,,,,Q13263_L_668_A
6744,Q13263,K,676,R,2ro1:A,676,Modestly reduces sumoylation and repression.,,,-999.0,,,,-1.0,,,,,,,,,Q13263_K_676_R
6745,Q13263,L,709,A,2ro1:A,709,Greatly reduced sumoylation. Little further effect on sumoylation,,,-999.0,,,,-1.0,,,,,,,,,Q13263_L_709_A
6746,Q13263,K,750,R,2ro1:A,750,Some reduced sumoylation and repression.,,,-999.0,,,,-1.0,,,,,,,,,Q13263_K_750_R
6747,Q13263,K,779,R,2ro1:A,779,Abolishes both sumoylation and repression,,,-999.0,,,,-1.0,,,,,,,,,Q13263_K_779_R
6748,Q13263,K,804,R,2ro1:A,804,Abolishes both sumoylation and repression,,,-999.0,,,,-1.0,,,,,,,,,Q13263_K_804_R
6749,Q99418,E,156,D,1r8m:E,156,Inhibits GTP GDP exchange activity. Abolishes recruitment of ARF6 to the plasma membrane.,,,1.0,,,,,,,,,,,,,Q99418_E_156_D
6750,O43181,S,173,A,5xti:BL,173,Loss of phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,O43181_S_173_A
6751,Q16552,R,69,A,4qhu:C,46,Impairs binding to IL17RA and IL17RC.,-1.0,,-999.0,,,,,,,,,,,,,Q16552_R_69_A
6752,Q16552,R,78,V,4qhu:C,55,Decreases the affinity for IL17RA by 5-fold.,0.0,,-999.0,,,,,,,,,,,,,Q16552_R_78_V
6753,Q16552,W,90,V,4qhu:C,67,Has no effect on the affinity for IL17RA.,0.0,,-999.0,,,,,,,,,,,,,Q16552_W_90_V
6754,Q16552,Y,108,I,4qhu:C,85,Decreases the affinity for IL17RA.,-1.0,,-999.0,,,,,,,,,,,,,Q16552_Y_108_I
6755,Q16552,H,109,S,4qhu:C,86,Decreases the affinity for IL17RA.,-1.0,,-999.0,,,,,,,,,,,,,Q16552_H_109_S
6756,P31939,K,66,A,1p4r:A,66,Decreased affinity to FAICAR,-1.0,,-999.0,,,,,,,,,,,,,P31939_K_66_A
6757,P31939,Y,104,A,1p4r:A,104,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_Y_104_A
6757,P31939,Y,104,F,1p4r:A,104,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_Y_104_F
6758,P31939,D,125,A,1p4r:A,125,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_D_125_A
6758,P31939,D,125,E,1p4r:A,125,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_D_125_E
6758,P31939,D,125,N,1p4r:A,125,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_D_125_N
6759,P31939,K,137,A,1p4r:A,137,Decreased affinity to FAICAR,,,1.0,,,,,,,,,,,,,P31939_K_137_A
6760,P31939,K,137,R,1p4r:A,137,Decreased FAICAR cyclization activity,,,1.0,,,,,,,,,,,,,P31939_K_137_R
6761,P31939,H,213,A,1p4r:A,213,Loss of AICAR transformylase activity.,,,1.0,,,,,,,,,,,,,P31939_H_213_A
6762,P31939,H,267,A,1p4r:A,267,Loss of AICAR transformylase activity.,,,1.0,,,,,,,,,,,,,P31939_H_267_A
6763,Q16555,D,71,N,6jv9:B,71,Inhibits axon outgrowth formation in hippocampal neurons and decreases binding to CYFIP1.,-1.0,,-999.0,,,,,,,,,,,,,Q16555_D_71_N
6764,A1Z1Q3,N,92,A,4iqy:B,92,Reduced ADP-ribosyl hydrolase activity,,,1.0,,,,,,,,,,,,,A1Z1Q3_N_92_A
6765,A1Z1Q3,G,100,A,4iqy:B,100,Abolished hydrolase activity and ability to bind ADP-D-ribose.,,,1.0,,,,,,,,,,,,,A1Z1Q3_G_100_A
6766,A1Z1Q3,D,102,A,4iqy:B,102,Reduced ADP-ribosyl hydrolase activity. Reduced ADP-ribosyl hydrolase activity,,,1.0,,,,,,,,,,,,,A1Z1Q3_D_102_A
6767,A1Z1Q3,H,106,A,4iqy:B,106,Reduced hydrolase activity.,,,1.0,,,,,,,,,,,,,A1Z1Q3_H_106_A
6768,A1Z1Q3,G,188,E,4iqy:B,188,Abolishes interaction with ADP-ribosylated proteins. Strongly reduced ADP-ribosyl hydrolase activity.,-1.0,,1.0,,,,,,,,,,,,,A1Z1Q3_G_188_E
6769,P21397,C,165,S,2z5x:A,165,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_165_S
6770,P21397,C,266,S,2z5x:A,266,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_266_S
6771,P21397,C,306,S,2z5x:A,306,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_306_S
6772,P21397,C,321,S,2z5x:A,321,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_321_S
6773,P21397,C,323,S,2z5x:A,323,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_323_S
6774,P21397,C,374,S,2z5x:A,374,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P21397_C_374_S
6775,P21397,C,398,S,2z5x:A,398,No loss of activity.,,,0.0,,,,,,,,,,,,,P21397_C_398_S
6776,P21397,C,406,S,2z5x:A,406,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P21397_C_406_S
6777,P61006,T,22,N,7bwt:B,22,Loss of interaction with MICALL1.,-1.0,,-999.0,,,,,,,,,,,,,P61006_T_22_N
6778,P61006,Q,67,L,7bwt:B,67,Probable constitutively active mutant locked in the active GTP-bound form. Stimulates interaction with MICALL1.,1.0,1.0,1.0,,,,,,,,,,,,,P61006_Q_67_L
6779,P61006,T,72,A,7bwt:B,72,Loss of phosphorylation. No effect on the binding of GDP or GTP. Localizes primarily to the Golgi complex but does not affect membrane localization.,,0.0,-999.0,-1.0,,,,,,,,0.0,,,,P61006_T_72_A
6780,P61006,T,72,E,7bwt:B,72,"Phosphomimetic mutant. No effect on the binding of GDP or GTP. Loss of GDI1, GDI2, CHM, CHML, RABGGTA, RABGGTB, RAB3IP, TBC1D15, and INPP5B binding. Increases localization to the cell membrane.",-1.0,-1.0,-999.0,,,,,,,,,1.0,1.0,,,P61006_T_72_E
6781,Q9UBW5,F,21,A,4avm:A,21,Strongly reduces binding to membranes.,,,-999.0,,,,,,,,,,,,,Q9UBW5_F_21_A
6782,Q9UBW5,V,81,R,4avm:A,81,Abolishes dimerization and membrane binding,-1.0,,-999.0,,,,,,,,,,,,,Q9UBW5_V_81_R
6783,Q9UBW5,S,214,E,4avm:A,214,Abolishes dimerization and membrane binding,-1.0,,-999.0,,,,,,,,,,,,,Q9UBW5_S_214_E
6784,P21399,C,300,S,2b3x:A,300,No effect on aconitase activity or on RNA binding.,,0.0,0.0,,,,,,,,,,,,,P21399_C_300_S
6785,P21399,C,437,S,2b3x:A,437,"Loss of aconitase activity. Leads to constitutive RNA binding, irrespective of iron levels.",,1.0,-999.0,,,,,,,,,,,,,P21399_C_437_S
6786,P21399,C,503,S,2b3x:A,503,"Loss of aconitase activity. Leads to constitutive RNA binding, irrespective of iron levels.",,1.0,1.0,,,,,,,,,,,,,P21399_C_503_S
6787,P21399,C,506,S,2b3x:A,506,Loss of aconitase activity. Leads of iron levels.,,,1.0,,,,,,,,,,,,,P21399_C_506_S
6788,P21399,R,536,Q,2b3x:A,536,Strongly reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P21399_R_536_Q
6789,P21399,R,541,Q,2b3x:A,541,Strongly reduced RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P21399_R_541_Q
6790,P21399,R,699,K,2b3x:A,699,No effect on RNA binding.,,0.0,-999.0,,,,,,,,,,,,,P21399_R_699_K
6791,P21399,S,778,A,2b3x:A,778,No effect on iron-regulated RNA binding. Loss of aconitase activity.,,0.0,1.0,,,,,,,,,,,,,P21399_S_778_A
6792,P21399,R,780,Q,2b3x:A,780,Nearly abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P21399_R_780_Q
6793,P48775,Y,42,A,6ud5:A,42,Reduces enzyme activity by 99%.,,,1.0,,,,,,,,,,,,,P48775_Y_42_A
6794,P48775,Y,45,A,6ud5:A,45,Reduces enzyme activity by 99%.,,,1.0,,,,,,,,,,,,,P48775_Y_45_A
6795,P48775,F,72,A,6ud5:A,72,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P48775_F_72_A
6796,P48775,H,76,A,6ud5:A,76,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P48775_H_76_A
6797,P48775,F,140,A,6ud5:A,140,Reduces enzyme activity by 99%.,,,1.0,,,,,,,,,,,,,P48775_F_140_A
6798,P48775,R,144,A,6ud5:A,144,Reduces enzyme activity by 99%.,,,1.0,,,,,,,,,,,,,P48775_R_144_A
6799,P48775,S,151,A,6ud5:A,151,Reduces enzyme activity by 90%.,,,1.0,,,,,,,,,,,,,P48775_S_151_A
6800,P48775,Y,175,G,6ud5:A,175,Reduces enzyme activity.,,,1.0,,,,,,,,,,,,,P48775_Y_175_G
6801,P48775,H,328,A,6ud5:A,328,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P48775_H_328_A
6802,P22626,Y,276,S,6wqk:A,264,Impairs hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_276_S
6803,P22626,Y,283,S,6wqk:A,271,Slightly affects hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_283_S
6804,P22626,Y,287,S,6wqk:A,275,Does not affect hydrogel-binding.,,0.0,-999.0,,,,,,,,,,,,,P22626_Y_287_S
6805,P22626,Y,290,S,6wqk:A,278,Impairs hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_290_S
6806,P22626,Y,295,S,6wqk:A,283,Impairs hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_295_S
6807,P22626,Y,300,S,6wqk:A,288,Slightly affects hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_300_S
6808,P22626,F,303,S,6wqk:A,291,Impairs hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_F_303_S
6809,P22626,Y,306,S,6wqk:A,294,Slightly affects hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_306_S
6810,P22626,Y,313,S,6wqk:A,301,Slightly affects hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_Y_313_S
6811,P22626,F,321,S,6wqk:A,309,Impairs hydrogel-binding.,,-1.0,-999.0,,,,,,,,,,,,,P22626_F_321_S
6812,Q96BY9,E,148,A,6o2v:A,148,Dominant-negative mutant,,,1.0,,,,,,,,,,,,,Q96BY9_E_148_A
6813,P40199,I,38,A,4wtz:A,4,Loss of homodimerization and heterodimerization with CEACAM8.,-1.0,,-999.0,,,,,,,,,,,,,P40199_I_38_A
6814,P40199,L,53,A,4wtz:A,19,No effect on homodimerization. Reduces heterodimerization with CEACAM8.,-1.0,,-999.0,,,,,,,,,,,,,P40199_L_53_A
6815,P40199,A,55,V,4wtz:A,21,No effect on homophilic and heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_A_55_V
6816,P40199,N,61,H,4wtz:A,27,Inhibits homophilic and heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_N_61_H
6817,P40199,R,62,L,4wtz:A,28,No effect on homophilic cell adhesion. Reduces heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_R_62_L
6818,P40199,I,63,F,4wtz:A,29,No effect on homophilic cell adhesion. Inhibits heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_I_63_F
6819,P40199,S,66,N,4wtz:A,32,Inhibits homophilic cell adhesion. Reduces heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_S_66_N
6820,P40199,L,78,Q,4wtz:A,44,Inhibits homophilic cell adhesion. No effect on heterophilic cell adhesion.,,,-999.0,,,,,,,,,,,,,P40199_L_78_Q
6821,P40199,Q,123,A,4wtz:A,89,No effect on homodimerization. Reduces heterodimerization with CEACAM8.,-1.0,,-999.0,,,,,,,,,,,,,P40199_Q_123_A
6822,P40199,L,129,A,4wtz:A,95,Reduces homodimerization. Loss of heterodimerization with CEACAM8.,-1.0,,-999.0,,,,,,,,,,,,,P40199_L_129_A
6823,Q9NUI1,D,86,A,4fc6:B,86,Reduces enzyme activity by 98%.,,,1.0,,,,,,,,,,,,,Q9NUI1_D_86_A
6824,Q9NUI1,D,137,A,4fc6:B,137,Reduces enzyme activity by 97%.,,,1.0,,,,,,,,,,,,,Q9NUI1_D_137_A
6825,Q9NUI1,D,186,A,4fc6:B,186,Reduces enzyme activity by about 95%.,,,1.0,,,,,,,,,,,,,Q9NUI1_D_186_A
6826,Q9NUI1,D,268,A,4fc6:B,268,Reduces enzyme activity by 97%.,,,1.0,,,,,,,,,,,,,Q9NUI1_D_268_A
6827,Q9H5Q4,G,105,A,6erq:F,105,Abolishes methyltransferase activity.,,,1.0,,,,,,,,,,,,,Q9H5Q4_G_105_A
6828,Q9H5Q4,R,330,A,6ero:A,247,Impairs transcription initiation,,,1.0,,,,,,,,,,,,,Q9H5Q4_R_330_A
6829,Q9H5Q4,R,331,A,6ero:A,248,Impairs transcription initiation,,,1.0,,,,,,,,,,,,,Q9H5Q4_R_331_A
6830,Q86YV5,I,1243,A,5ve6:A,1243,No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_I_1243_A
6831,Q86YV5,F,1271,A,5ve6:A,1271,Decreases homodimerization. Decreases interaction with PEAK1.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_F_1271_A
6832,Q86YV5,R,1278,A,5ve6:A,1278,Decreases homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_R_1278_A
6833,Q86YV5,Y,1282,A,5ve6:A,1282,No effect on homodimerization. Decreases oligomerization. Decreases interaction with PEAK1. No effect on cell migration.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_Y_1282_A
6834,Q86YV5,F,1366,A,5ve6:A,1366,Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_F_1366_A
6835,Q86YV5,W,1382,A,5ve6:A,1382,Decreases homodimerization. Abolished interaction with PEAK1. Decreases cell migration.,-1.0,,-999.0,,,,,,,,,,,,,Q86YV5_W_1382_A
6836,P14550,Y,50,F,2alr:A,49,Complete loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,P14550_Y_50_F
6837,P14550,Y,50,H,2alr:A,49,Complete loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,P14550_Y_50_H
6838,P14550,K,80,M,2alr:A,79,Complete loss of enzymatic activity.,,,1.0,,,,,,,,,,,,,P14550_K_80_M
6839,P14550,H,113,Q,2alr:A,112,Strong decrease in enzymatic activity.,,,1.0,,,,,,,,,,,,,P14550_H_113_Q
6840,P14550,I,299,A,2alr:A,298,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_I_299_A
6841,P14550,I,299,C,2alr:A,298,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_I_299_C
6842,P14550,V,300,C,2alr:A,299,No change in enzymatic activity.,,,0.0,,,,,,,,,,,,,P14550_V_300_C
6843,P14555,R,27,E,1db4:A,7,Reduces bactericidal activity to 20% against B. subtilis and to 4% against S. aureus. Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_R_27_E
6844,P14555,K,30,E,1db4:A,10,Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_30_E
6845,P14555,K,35,E,1db4:A,15,Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_35_E
6846,P14555,G,49,S,1db4:A,29,No effect on integrin binding,0.0,,-999.0,,,,,,,,,,,,,P14555_G_49_S
6847,P14555,K,57,E,1db4:A,37,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_57_E
6848,P14555,R,62,E,1db4:A,42,No effect on integrin binding.,0.0,,-999.0,,,,,,,,,,,,,P14555_R_62_E
6849,P14555,H,67,Q,1db4:A,47,Catalytically inactive but does not affect integrin binding. Impairs leukotriene B4 synthesis in activated neutrophils.,0.0,,1.0,,,,,,,,,,,,,P14555_H_67_Q
6850,P14555,D,68,K,1db4:A,48,No effect on integrin binding,0.0,,-999.0,,,,,,,,,,,,,P14555_D_68_K
6851,P14555,K,72,E,1db4:A,52,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_72_E
6852,P14555,R,73,E,1db4:A,53,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_R_73_E
6854,P14555,R,77,E,1db4:A,57,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_R_77_E
6855,P14555,K,87,E,1db4:A,67,Reduces bactericidal activity to 20% against B. subtilis and to 10% against S. aureus. Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_87_E
6856,P14555,R,94,E,1db4:A,74,Moderately reduced integrin binding. Greatly reduced integrin binding but no effect on catalytic activity,-1.0,,0.0,,,,,,,,,,,,,P14555_R_94_E
6857,P14555,K,99,E,1db4:A,79,Reduces bactericidal activity to 25% against B. subtilis and to 10% against S. aureus. Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_99_E
6858,P14555,R,104,E,1db4:A,84,Reduces bactericidal activity to 18% against B. subtilis and to 12% against S. aureus. Complete loss of bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_R_104_E
6859,P14555,R,120,E,1db4:A,100,Moderately reduced integrin binding. Greatly reduced integrin binding but no effect on catalytic activity,-1.0,,0.0,,,,,,,,,,,,,P14555_R_120_E
6860,P14555,K,122,E,1db4:A,102,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_122_E
6861,P14555,K,127,E,1db4:A,107,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_127_E
6862,P14555,K,128,E,1db4:A,108,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_128_E
6863,P14555,K,135,E,1db4:A,115,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_K_135_E
6864,P14555,R,138,D,1db4:A,118,Impairs bactericidal activity,,,1.0,,,,,,,,,,,,,P14555_R_138_D
6865,Q06830,T,90,A,3hy2:A,90,Abolishes phosphorylation by CDK1,,,-999.0,-1.0,,,,,,,,,,,,Q06830_T_90_A
6866,Q06830,T,90,D,3hy2:A,90,87% reduction in enzymatic activity.,,,1.0,,,,,,,,,,,,,Q06830_T_90_D
6867,P49748,F,458,T,3b96:A,418,Decreased acyl-CoA dehydrogenase activity. Decreased affinity for acyl-CoA. No effect on FAD cofactor-binding.,,-1.0,1.0,,,,,,,,,,,,,P49748_F_458_T
6868,P49748,F,458,V,3b96:A,418,Loss of acyl-CoA dehydrogenase activity. Loss of FAD cofactor-binding.,,-1.0,1.0,,,,,,,,,,,,,P49748_F_458_V
6869,P49748,F,458,Y,3b96:A,418,Decreased acyl-CoA dehydrogenase activity. No effect on affinity for acyl-CoA. Decreased FAD cofactor-binding.,,-1.0,1.0,,,,,,,,,,,,,P49748_F_458_Y
6870,P49748,E,462,D,3b96:A,422,Decreased acyl-CoA dehydrogenase activity. No effect on affinity for acyl-CoA. No effect on FAD cofactor-binding.,,0.0,1.0,,,,,,,,,,,,,P49748_E_462_D
6871,P49748,E,462,Q,3b96:A,422,Loss of acyl-CoA dehydrogenase activity. No effect on FAD cofactor-binding.,,0.0,1.0,,,,,,,,,,,,,P49748_E_462_Q
6872,Q9NWV4,C,33,A,5zrt:A,33,Disrupts protein folding and solubility,,,-999.0,,,,,,,,,,,-1.0,,Q9NWV4_C_33_A
6873,Q9NWV4,C,36,A,5zrt:A,36,Disrupts protein folding and solubility,,,-999.0,,,,,,,,,,,-1.0,,Q9NWV4_C_36_A
6874,Q9NWV4,C,67,A,5zrt:A,67,Disrupts protein folding and solubility,,,-999.0,,,,,,,,,,,-1.0,,Q9NWV4_C_67_A
6875,Q9NWV4,C,70,A,5zrt:A,70,Disrupts protein folding and solubility,,,-999.0,,,,,,,,,,,-1.0,,Q9NWV4_C_70_A
6876,O14649,H,98,N,6rv3:D,98,Greatly reduces pH sensitivity.,,,-999.0,,,,,,,,,,,,,O14649_H_98_N
6877,Q96PX8,V,85,M,4rca:B,85,Does not affect surface expression.,,,-999.0,,,,,,,,,0.0,,,,Q96PX8_V_85_M
6878,P38646,G,489,E,3n8e:A,489,Significant loss of interaction with FXN and ISCU. Significant increase in interaction with NFS1.,,,-999.0,,,,,,,,,,,,,P38646_G_489_E
6879,Q9P0U4,C,169,A,3qmb:A,173,Complete loss of DNA binding activity. No effect on localization in nuclear speckles.,,-1.0,-999.0,,,,,,,,,,,,,Q9P0U4_C_169_A
6880,Q9P0U4,C,208,A,3qmb:A,212,Complete loss of DNA binding activity. No effect on localization in nuclear speckles.,,-1.0,-999.0,,,,,,,,,0.0,,,,Q9P0U4_C_208_A
6881,Q9P0U3,D,441,A,2xre:A,441,No effect on SUMO2 processing and SUMO2 deconjugating activities.,,,0.0,,,,,,,,,,,,,Q9P0U3_D_441_A
6882,Q9P0U3,W,465,A,2xre:A,465,Impairs SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_W_465_A
6883,Q9P0U3,D,468,A,2xre:A,468,Slightly impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,1.0,,,,,,,,,,,,,Q9P0U3_D_468_A
6884,Q9P0U3,F,496,A,2xre:A,496,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,1.0,,,,,,,,,,,,,Q9P0U3_F_496_A
6885,Q9P0U3,R,511,A,2xre:A,511,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,1.0,,,,,,,,,,,,,Q9P0U3_R_511_A
6886,Q9P0U3,W,512,A,2xre:A,512,Impairs SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_W_512_A
6887,Q9P0U3,H,529,A,2xre:A,529,Impairs SUMO2 processing activity. No effect on SUMO2 deconjugating activity.,,,1.0,,,,,,,,,,,,,Q9P0U3_H_529_A
6888,Q9P0U3,V,532,A,2xre:A,532,No effect on SUMO2 processing and SUMO2 deconjugating activities.,,,0.0,,,,,,,,,,,,,Q9P0U3_V_532_A
6889,Q9P0U3,H,533,A,2xre:A,533,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_H_533_A
6890,Q9P0U3,W,534,A,2xre:A,534,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_W_534_A
6891,Q9P0U3,D,550,A,2xre:A,550,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_D_550_A
6892,Q9P0U3,Q,597,A,2xre:A,597,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_Q_597_A
6893,Q9P0U3,C,603,A,2xre:A,603,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_C_603_A
6893,Q9P0U3,C,603,S,2xre:A,603,Abolishes SUMO2 processing and SUMO2 deconjugating activities.,,,1.0,,,,,,,,,,,,,Q9P0U3_C_603_S
6895,Q9ULM3,H,259,A,6lsd:B,259,Strongly reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_H_259_A
6896,Q9ULM3,S,261,A,6lsd:B,261,Strongly reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_S_261_A
6897,Q9ULM3,Y,262,A,6lsd:B,262,Strongly reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_Y_262_A
6898,Q9ULM3,W,282,A,6lsd:B,282,Strongly reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_W_282_A
6899,Q9ULM3,G,283,A,6lsd:B,283,Abolished binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_G_283_A
6900,Q9ULM3,E,284,A,6lsd:B,284,Abolished binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_E_284_A
6901,Q9ULM3,F,285,A,6lsd:B,285,Strongly reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_F_285_A
6902,Q9ULM3,Y,313,A,6lsd:B,313,Reduced binding to histone H3 crotonylated at 'Lys-27' (H3K27cr).,-1.0,,-999.0,,,,,,,,,,,,,Q9ULM3_Y_313_A
6903,P49588,A,448,Q,5knn:A,448,Decreases misincorporation of Cys instead of Ala.,,,-999.0,,,,,,,,,,,,,P49588_A_448_Q
6904,Q16602,W,72,A,6uun:R,72,Strongly reduced affinity for adrenomedullin.,,-1.0,-999.0,,,,,,,,,,,,,Q16602_W_72_A
6905,Q16602,F,92,A,6uun:R,92,Strongly reduced affinity for adrenomedullin.,,-1.0,-999.0,,,,,,,,,,,,,Q16602_F_92_A
6906,Q16602,W,121,A,6uun:R,121,Strongly reduced affinity for adrenomedullin.,,-1.0,-999.0,,,,,,,,,,,,,Q16602_W_121_A
6907,Q9BV47,C,152,A,5gtj:B,152,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9BV47_C_152_A
6907,Q9BV47,C,152,S,5gtj:B,152,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9BV47_C_152_S
6908,Q9H6E5,D,216,A,5wu5:C,216,Abolishes adenylyltransferase activity,,,1.0,,,,,,,,,,,,,Q9H6E5_D_216_A
6909,Q9H6E5,D,218,A,5wu5:C,218,Abolishes adenylyltransferase activity,,,1.0,,,,,,,,,,,,,Q9H6E5_D_218_A
6910,Q9H6E5,R,779,A,5wu1:A,779,Reduced terminal uridylyltransferase activity,,,1.0,,,,,,,,,,,,,Q9H6E5_R_779_A
6911,Q9H6E5,R,783,A,5wu1:A,783,Reduced terminal uridylyltransferase activity,,,1.0,,,,,,,,,,,,,Q9H6E5_R_783_A
6912,Q9BRJ7,K,10,E,5zcj:B,10,Abolishes interaction with TP53BP1.,-1.0,,-999.0,,,,,,,,,,,,,Q9BRJ7_K_10_E
6913,Q9BRJ7,K,151,E,5zcj:B,151,Still able to interact with TP53BP1.,0.0,,-999.0,,,,,,,,,,,,,Q9BRJ7_K_151_E
6914,P30419,G,492,D,5o9v:A,492,Reduced activity.,,,1.0,,,,,,,,,,,,,P30419_G_492_D
6914,P30419,G,492,K,5o9v:A,492,Reduced activity.,,,1.0,,,,,,,,,,,,,P30419_G_492_K
6915,P15374,D,33,A,1xd3:A,33,Decreased interaction with diubiquitin. No accumulation of free diubiquitin. Decreased levels of polyubiquitinated lysozyme.,-1.0,,-999.0,,,,,,,,,,,,,P15374_D_33_A
6916,P15374,C,95,A,1xd3:A,95,Increased interaction with diubiquitin.,1.0,,-999.0,,,,,,,,,,,,,P15374_C_95_A
6917,P15374,C,95,S,1xd3:A,95,Abolishes enzymatic activity. Increased interaction with diubiquitin.,,,1.0,,1.0,,,,,,,,,,,P15374_C_95_S
6918,P47974,E,157,R,1rgo:A,157,Impaired mRNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P47974_E_157_R
6919,P47974,E,195,K,1rgo:A,195,Impaired mRNA-binding,,-1.0,-999.0,,,,,,,,,,,,,P47974_E_195_K
6920,Q8N8N7,Y,64,F,2zb7:A,64,Increases affinity for 15-keto-PGE2. Reduces affinity for NADP and Vmax.,,,-999.0,,,,,,,,,,,,,Q8N8N7_Y_64_F
6921,Q8N8N7,Y,259,F,2zb7:A,259,Increases affinity for 15-keto-PGE2. Reduces affinity for NADP and Vmax.,,,-999.0,,,,,,,,,,,,,Q8N8N7_Y_259_F
6922,P11926,C,360,A,1d7k:A,360,25% decrease of in vitro nitrosylation level.,,,-999.0,,,,,,-1.0,,,,,,,P11926_C_360_A
6923,P06733,M,94,I,2psn:C,93,MBP1 protein production. No MBP1 protein production,,,-999.0,,,,,,,,,,,-1.0,,P06733_M_94_I
6924,P06733,M,97,I,2psn:C,96,MBP1 protein production. No MBP1 protein production,,,-999.0,,,,,,,,,,,-1.0,,P06733_M_97_I
6925,P06733,K,281,R,2psn:C,280,Decreased 2-hydroxyisobutyrylation leading to decreased phosphopyruvate hydratase activity.,,,1.0,,,,,,,,,,,,,P06733_K_281_R
6926,P06733,L,384,A,2psn:C,383,Loss of transcriptional repression and cell growth inhibition,,,1.0,,,,,,,,,,,,,P06733_L_384_A
6927,P06733,L,388,A,2psn:C,387,Loss of transcriptional repression and cell growth inhibition,,,1.0,,,,,,,,,,,,,P06733_L_388_A
6928,P06730,S,53,A,2gpq:A,53,No effect on phosphorylation level nor incorporation into eIF4F complex.,0.0,,-999.0,0.0,,,,,,,,,,,,P06730_S_53_A
6928,P06730,S,53,D,2gpq:A,53,No effect on phosphorylation level nor incorporation into eIF4F complex.,0.0,,-999.0,0.0,,,,,,,,,,,,P06730_S_53_D
6929,P06730,W,73,A,2gpq:A,73,Abolishes binding to EIF4EBP1. Impairs interaction with DDX3X.,-1.0,,-999.0,,,,,,,,,,,,,P06730_W_73_A
6930,P06730,W,102,L,2gpq:A,102,Decrease in mRNA cap binding,,-1.0,-999.0,,,,,,,,,,,,,P06730_W_102_L
6931,P06730,E,103,A,2gpq:A,103,No effect.,0.0,0.0,-999.0,0.0,,,,,,,,,,,,P06730_E_103_A
6932,P06730,D,104,A,2gpq:A,104,No effect.,0.0,0.0,-999.0,0.0,,,,,,,,,,,,P06730_D_104_A
6933,P06730,E,105,A,2gpq:A,105,Decrease in mRNA cap binding,,-1.0,-999.0,,,,,,,,,,,,,P06730_E_105_A
6934,P06730,K,119,A,2gpq:A,119,Higher affinity for EIF4G1.,1.0,,-999.0,,,,,,,,,,,,,P06730_K_119_A
6935,P06730,S,209,A,2gpq:A,209,Abolished resistance to cellular stress and DNA-damaging agents.,,,-999.0,,,,,,,,,,,,,P06730_S_209_A
6936,P06730,S,209,D,2gpq:A,209,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,P06730_S_209_D
6937,O14508,K,87,R,6i5j:D,87,No effect on protein half-life.,,,-999.0,,,,,,,,,,,0.0,,O14508_K_87_R
6938,O14508,K,154,R,6i5j:D,154,No effect on protein half-life.,,,-999.0,,,,,,,,,,,0.0,,O14508_K_154_R
6939,O14508,K,173,R,6i5j:D,173,Increased protein half-life.,,,-999.0,,,,,,,,,,,1.0,,O14508_K_173_R
6940,P17787,F,197,Y,6cnj:B,172,Increases ligand activation in LS and HS nAChR subtypes.,,,1.0,,,,,,,,,,,,,P17787_F_197_Y
6941,Q676U5,V,540,A,5nuv:A,540,Impairs interaction with PPP1CA,-1.0,,-999.0,,,,,,,,,,,,,Q676U5_V_540_A
6942,Q676U5,F,542,A,5nuv:A,542,Impairs interaction with PPP1CA,-1.0,,-999.0,,,,,,,,,,,,,Q676U5_F_542_A
6943,O00602,G,250,F,2jhk:F,221,Inhibits binding to the 9-O-acetylated sialic acid derivatives.,,-1.0,-999.0,,,,,,,,,,,,,O00602_G_250_F
6944,O00602,A,285,V,2jhk:F,256,Inhibits binding to the 9-O-acetylated sialic acid derivatives.,,-1.0,-999.0,,,,,,,,,,,,,O00602_A_285_V
6945,O00602,Y,300,F,2jhk:F,271,Abolishes interaction with all sialic acid-containing glycans.,,-1.0,-999.0,,,,,,,,,,,,,O00602_Y_300_F
6946,P83876,C,38,A,6ahd:O,38,Viable when expressed in S.pombe.,,,-999.0,,,,,,,,,,,,,P83876_C_38_A
6947,P16410,V,45,D,3osk:B,10,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_V_45_D
6948,P16410,L,47,D,3osk:B,12,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_L_47_D
6949,P16410,S,49,A,3osk:B,14,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_S_49_A
6950,P16410,R,70,A,3osk:B,35,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_R_70_A
6950,P16410,R,70,D,3osk:B,35,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_R_70_D
6951,P16410,K,130,A,3osk:B,95,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_K_130_A
6951,P16410,K,130,D,3osk:B,95,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_K_130_D
6952,P16410,E,132,A,3osk:B,97,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_E_132_A
6952,P16410,E,132,R,3osk:B,97,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_E_132_R
6953,P16410,Y,139,A,3osk:B,104,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_Y_139_A
6953,P16410,Y,139,D,3osk:B,104,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_Y_139_D
6954,P16410,I,143,A,3osk:B,108,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_I_143_A
6954,P16410,I,143,D,3osk:B,108,"Strongly reduced interaction with CD80, CD86 and ICOSLG.",-1.0,,-999.0,,,,,,,,,,,,,P16410_I_143_D
6955,Q7Z4W1,N,107,L,1pr9:A,107,Loss of function. Probably due to defects in formation of the active site and binding of coenzyme.,,-1.0,1.0,,,,,,,,,,,,,Q7Z4W1_N_107_L
6955,Q7Z4W1,N,107,D,1pr9:A,107,Loss of function. Probably due to defects in formation of the active site and binding of coenzyme.,,-1.0,1.0,,,,,,,,,,,,,Q7Z4W1_N_107_D
6956,Q96NW4,Q,509,A,4cz2:D,509,Disrupts interaction with RAB32.,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_Q_509_A
6957,Q96NW4,L,513,D,4cz2:D,513,Disrupts interaction with RAB32.,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_L_513_D
6958,Q96NW4,K,546,D,4cz2:D,546,Impairs interaction with RAB32.,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_K_546_D
6959,Q96NW4,Y,550,A,4cz2:D,550,Impairs interaction with RAB32.,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_Y_550_A
6960,Q96NW4,H,712,A,6tl0:B,712,Disrupts interaction with VPS29,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_H_712_A
6961,Q96NW4,L,714,A,6tl0:B,714,Disrupts interaction with VPS29,-1.0,,-999.0,,,,,,,,,,,,,Q96NW4_L_714_A
6962,Q9NQV7,D,199,Y,6nm4:A,199,Increases histone-lysine N-methyltransferase activity,,,1.0,,,,,,,,,,,,,Q9NQV7_D_199_Y
6963,Q9NQV7,K,374,D,6nm4:A,374,Increases histone-lysine N-methyltransferase activity,,,1.0,,,,,,,,,,,,,Q9NQV7_K_374_D
6964,P07602,I,240,C,4v2o:A,46,Strongly decreases stimulation of cerebroside sulfate hydrolysis.,,,1.0,,,,,,,,,,,,,P07602_I_240_C
6965,Q96D46,K,405,A,6lqm:3,405,Reduces accumulation in the nucleus. Loss of nucleolar localization,,,-999.0,,,,,,,,,1.0,,,,Q96D46_K_405_A
6966,Q96D46,K,406,A,6lsr:3,406,Reduces accumulation in the nucleus. Loss of nucleolar localization,,,-999.0,,,,,,,,,1.0,,,,Q96D46_K_406_A
6967,O00167,P,516,R,3geb:A,516,Strongly reduces SIX1 binding.,-1.0,,-999.0,,,,,,,,,,,,,O00167_P_516_R
6968,O00167,A,532,R,3geb:A,532,Abolishes interaction with SIX1.,-1.0,,-999.0,,,,,,,,,,,,,O00167_A_532_R
6969,P51659,Y,347,A,1s9c:G,30,No hydratase activity.,,,1.0,,,,,,,,,,,,,P51659_Y_347_A
6970,P51659,E,366,A,1s9c:G,49,No hydratase activity.,,,1.0,,,,,,,,,,,,,P51659_E_366_A
6971,P51659,D,370,A,1s9c:G,53,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_370_A
6972,P51659,H,406,A,1s9c:G,89,No effect.,,,0.0,,,,,,,,,,,,,P51659_H_406_A
6973,P51659,E,408,A,1s9c:G,91,No effect.,,,0.0,,,,,,,,,,,,,P51659_E_408_A
6974,P51659,Y,410,A,1s9c:G,93,No effect.,,,0.0,,,,,,,,,,,,,P51659_Y_410_A
6975,P51659,D,490,A,1s9c:G,173,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_490_A
6976,P51659,Y,505,A,1s9c:G,188,Completely inactive.,,,1.0,,,,,,,,,,,,,P51659_Y_505_A
6977,P51659,D,510,A,1s9c:G,193,No hydratase activity.,,,1.0,,,,,,,,,,,,,P51659_D_510_A
6978,P51659,H,515,A,1s9c:G,198,Completely inactive.,,,1.0,,,,,,,,,,,,,P51659_H_515_A
6979,P51659,D,517,A,1s9c:G,200,No effect.,,,0.0,,,,,,,,,,,,,P51659_D_517_A
6980,P51659,H,532,A,1s9c:G,215,No effect.,,,0.0,,,,,,,,,,,,,P51659_H_532_A
6981,P56192,A,64,R,5y6l:A,64,Loss of interaction with EEF1E1.,-1.0,,-999.0,,,,,,,,,,,,,P56192_A_64_R
6982,P56192,E,86,R,5y6l:A,86,Loss of interaction with EEF1E1.,-1.0,,-999.0,,,,,,,,,,,,,P56192_E_86_R
6983,P56192,R,857,A,2djv:A,30,No effect on enzyme activity.,,,0.0,,,,,,,,,,,,,P56192_R_857_A
6984,P56192,K,860,A,2djv:A,33,Strongly decreased affinity for tRNA.,,-1.0,-999.0,,,,,,,,,,,,,P56192_K_860_A
6985,P56192,K,863,A,2djv:A,36,Slightly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,P56192_K_863_A
6986,P56192,K,866,A,2djv:A,39,Slightly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,P56192_K_866_A
6987,P56192,K,880,A,2djv:A,53,Strongly decreased affinity for tRNA.,,-1.0,-999.0,,,,,,,,,,,,,P56192_K_880_A
6988,O95271,H,1184,A,4n4v:A,1184,Loss of activity,,,1.0,,,,,,,,,,,,,O95271_H_1184_A
6989,O95271,E,1291,A,4n4v:A,1291,Loss of activity,,,1.0,,,,,,,,,,,,,O95271_E_1291_A
6990,P20701,S,1165,A,2k8o:A,54,Abolishes phosphorylation and MEM-83-activated T-cell adhesion to ICAM1. Abolishes integrin alpha-L/beta-2 activation by CXCL12 and TERF2IP/RAP1. Does not affect heterodimerization of cell surface expression. Does not affect TCR- or phorbol ester-activated T-cell adhesion to ICAM1.,0.0,,-999.0,-1.0,,,,,,,,,,,,P20701_S_1165_A
6991,P07954,T,147,A,5upp:A,147,Does not affect phosphorylation by PRKDC.,,,-999.0,0.0,,,,,,,,,,,,P07954_T_147_A
6992,P07954,S,187,A,5upp:A,187,Does not affect phosphorylation by PRKDC.,,,-999.0,0.0,,,,,,,,,,,,P07954_S_187_A
6993,P07954,T,236,A,5upp:A,236,Abolished interaction with H2AZ1 and localization to chromatin in response to DNA damage.,-1.0,,-999.0,,,,,,,,,,,,,P07954_T_236_A
6994,P07954,T,236,D,5upp:A,236,Phosphomimetic mutant,,,-999.0,,,,,,,,,,1.0,,,P07954_T_236_D
6995,Q9H2G2,K,63,R,2j51:A,63,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9H2G2_K_63_R
6996,Q9Y2Y0,E,56,A,2k9a:A,56,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_E_56_A
6997,Q9Y2Y0,E,57,A,2k9a:A,57,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_E_57_A
6998,Q9Y2Y0,L,60,A,2k9a:A,60,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_L_60_A
6999,Q9Y2Y0,E,74,A,2k9a:A,74,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_E_74_A
7000,Q9Y2Y0,Y,76,A,2k9a:A,76,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_Y_76_A
7001,Q9Y2Y0,F,109,A,2k9a:A,109,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_F_109_A
7002,Q9Y2Y0,D,110,A,2k9a:A,110,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_D_110_A
7003,Q9Y2Y0,M,111,A,2k9a:A,111,Does not decrease interaction with ARL2.,0.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_M_111_A
7004,Q9Y2Y0,L,112,A,2k9a:A,112,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_L_112_A
7005,Q9Y2Y0,F,115,A,2k9a:A,115,Decreases interaction with ARL2.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y2Y0_F_115_A
7006,P09601,D,140,A,1ni6:C,140,Inactive as a heme oxygenase but active as a peroxidase.,,,-999.0,,,,,,,,,,,,,P09601_D_140_A
7009,Q13322,K,300,A,3hk0:A,242,2-fold loss of inositide-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q13322_K_300_A
7010,Q13322,K,305,A,3hk0:A,247,5-fold loss of inositide-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q13322_K_305_A
7011,Q13322,K,308,A,3hk0:A,250,5-fold loss of inositide-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q13322_K_308_A
7012,Q13322,N,355,G,3hk0:A,297,5-fold loss of inositide-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q13322_N_355_G
7013,Q13322,R,520,K,1nrv:A,462,No effect on NEDD4-binding. No effect on the disruption of the interaction between INSR and IRS1 and IRS2.,0.0,0.0,-999.0,,,,,,,,,,,,,Q13322_R_520_K
7014,P35869,R,40,D,5nj8:C,40,Decreases transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_R_40_D
7015,P35869,L,50,D,5nj8:C,50,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_L_50_D
7016,P35869,V,74,D,5nj8:C,74,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_V_74_D
7017,P35869,A,79,D,5nj8:C,79,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_A_79_D
7018,P35869,F,82,D,5nj8:C,82,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_F_82_D
7019,P35869,L,118,D,5nj8:A,118,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_L_118_D
7020,P35869,L,122,D,5nj8:A,122,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_L_122_D
7021,P35869,F,136,D,5nj8:A,136,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_F_136_D
7022,P35869,I,154,D,5nj8:A,154,Interfers with transcription factor activity.,,,1.0,,,,,,,,,,,,,P35869_I_154_D
7023,P28065,K,53,A,6avo:A,33,Impairs correct processing at the consensus site.,,,1.0,,,,,,,,,,,,,P28065_K_53_A
7024,P00966,K,165,Q,2nz2:A,165,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_165_Q
7024,P00966,K,165,R,2nz2:A,165,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_165_R
7025,P00966,K,176,Q,2nz2:A,176,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_176_Q
7025,P00966,K,176,R,2nz2:A,176,Significant loss of acetylation but no decrease in enzyme activity,,,0.0,,,,,,,,,,,,,P00966_K_176_R
7026,P52298,Y,20,A,5oob:B,20,Abolishes mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_Y_20_A
7027,P52298,Y,20,F,5oob:B,20,Strongly impairs mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_Y_20_F
7028,P52298,F,25,A,5oob:B,25,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_F_25_A
7029,P52298,Y,43,A,5oob:B,43,Abolishes mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_Y_43_A
7030,P52298,Y,43,F,5oob:B,43,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_Y_43_F
7031,P52298,N,46,A,5oob:B,46,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_N_46_A
7032,P52298,F,83,A,5oob:B,83,Abolishes mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_F_83_A
7033,P52298,F,85,A,5oob:B,85,Impairs mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_F_85_A
7034,P52298,R,112,A,5oob:B,112,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_R_112_A
7034,P52298,R,112,T,5oob:B,112,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_R_112_T
7035,P52298,D,114,A,5oob:B,114,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_D_114_A
7036,P52298,D,116,A,5oob:B,116,Abolishes mRNA cap-binding.,,-1.0,-999.0,,,,,,,,,,,,,P52298_D_116_A
7037,P52298,F,119,A,5oob:B,119,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_F_119_A
7038,P52298,Y,138,A,5oob:B,138,Does not affect mRNA cap-binding.,,0.0,-999.0,,,,,,,,,,,,,P52298_Y_138_A
7039,P62917,H,209,A,4v6x:CA,209,No incorporation into translating E.coli polysomes,,,-999.0,,,,,,,,,1.0,,,,P62917_H_209_A
7039,P62917,H,209,G,4v6x:CA,209,No incorporation into translating E.coli polysomes,,,-999.0,,,,,,,,,1.0,,,,P62917_H_209_G
7040,Q15386,C,1051,A,6k2c:A,1051,No stimulation of in vitro CAND2 ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,Q15386_C_1051_A
7041,Q15382,R,15,G,1xtr:A,15,Partially resistant to inactivation by TSC1-TSC2.,-1.0,,-999.0,,,,,,,,,,,,,Q15382_R_15_G
7042,Q15382,S,20,N,1xtr:A,20,Deficient in guanine nucleotide binding. Unable to rescue S6K1 from inactivation by amino-acid withdrawal.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q15382_S_20_N
7043,Q15382,T,38,M,1xtr:A,38,"Slightly impairs signaling through mTORC1, but still binds guanine nucleotides normally.",-1.0,0.0,-999.0,,,,,,,,,,,,,Q15382_T_38_M
7044,Q15382,I,39,K,1xtr:A,39,"Impairs S6K1 activation, but still binds guanine nucleotides normally.",-1.0,0.0,-999.0,,,,,,,,,,,,,Q15382_I_39_K
7045,Q15382,E,40,G,1xtr:A,40,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q15382_E_40_G
7046,Q15382,N,41,A,1xtr:A,41,"Impairs interaction with MTOR. Impairs signaling through mTORC1, but still binds guanine nucleotides normally.",-1.0,0.0,-999.0,,,,,,,,,,,,,Q15382_N_41_A
7047,Q15382,F,43,C,1xtr:A,43,No effect.,0.0,0.0,0.0,,,,,,,,,,,,,Q15382_F_43_C
7048,Q15382,L,46,A,1xtr:A,46,Causes slight reduction in S6K1 activation.,-1.0,,-999.0,,,,,,,,,,,,,Q15382_L_46_A
7049,Q15382,T,48,A,1xtr:A,48,Causes slightly reduced phosphorylation of EIF4EBP1.,,,1.0,,,,,,,,,,,,,Q15382_T_48_A
7050,Q15382,V,49,A,1xtr:A,49,Causes slightly reduced phosphorylation of EIF4EBP1.,,,1.0,,,,,,,,,,,,,Q15382_V_49_A
7051,Q15382,E,53,A,1xtr:A,53,Causes slightly reduced phosphorylation of EIF4EBP1.,,,1.0,,,,,,,,,,,,,Q15382_E_53_A
7052,Q15382,Y,54,A,1xtr:A,54,Partially deficient in guanine nucleotide binding. Fully impairs EIF4EBP1 phosphorylation and S6K1 activation.,,-1.0,1.0,,,,,,,,,,,,,Q15382_Y_54_A
7053,Q15382,L,56,A,1xtr:A,56,Partially deficient in guanine nucleotide binding. Fully impairs EIF4EBP1 phosphorylation and S6K1 activation.,,-1.0,1.0,,,,,,,,,,,,,Q15382_L_56_A
7054,Q15382,D,60,I,1xtr:A,60,Deficient in guanine nucleotide binding. Unable to rescue S6K1 from inactivation by amino-acid withdrawal.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q15382_D_60_I
7055,Q15382,Q,64,L,1xtr:A,64,"Has a higher basal GTPase level, however, is still sensitive to TSC2 GAP activity.",,,1.0,,,,,,,,,,,,,Q15382_Q_64_L
7056,O00422,D,118,A,2hde:A,118,Abolishes splicing regulation activity and interaction with RNPS1 and ACIN1,-1.0,,1.0,,,,,,,,,,,,,O00422_D_118_A
7057,O00422,T,121,A,2hde:A,121,Abolishes splicing regulation activity and interaction with RNPS1 and ACIN1,-1.0,,1.0,,,,,,,,,,,,,O00422_T_121_A
7058,O00422,K,126,A,2hde:A,126,No effect on splicing regulation activity.,,,0.0,,,,,,,,,,,,,O00422_K_126_A
7059,Q10471,W,282,A,4d0t:A,282,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q10471_W_282_A
7060,Q10471,F,361,A,4d0t:A,361,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q10471_F_361_A
7061,P10253,W,516,R,5nn4:A,516,Loss of activity.,,,1.0,,,,,,,,,,,,,P10253_W_516_R
7062,P10253,D,518,G,5nn4:A,518,Loss of activity.,,,1.0,,,,,,,,,,,,,P10253_D_518_G
7062,P10253,D,518,N,5nn4:A,518,Loss of activity.,,,1.0,,,,,,,,,,,,,P10253_D_518_N
7062,P10253,D,518,E,5nn4:A,518,Loss of activity.,,,1.0,,,,,,,,,,,,,P10253_D_518_E
7063,Q9BVN2,L,531,A,4giw:A,55,Abrogates nuclear redistribution.,,,-999.0,,,,,,,,,1.0,,,,Q9BVN2_L_531_A
7064,Q9NTX7,H,54,A,2d8t:A,35,"Partially suppression of WNT3A signaling and stabilization of AXIN1, TNKS and TNKS2 with or without WNT3A induction. No effect on TNKS1-binding.",,,-999.0,,,,,,,,,,,,,Q9NTX7_H_54_A
7065,Q9NTX7,W,106,A,3v3l:B,105,No effect on Wnt signaling pathway.,0.0,,-999.0,,,,,,,,,,,,,Q9NTX7_W_106_A
7066,Q9NTX7,Y,108,A,3v3l:B,107,Loss of iso-ADP-ribose-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_Y_108_A
7067,Q9NTX7,R,111,A,3v3l:B,110,Minor effect on iso-ADP-ribose-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_R_111_A
7068,Q9NTX7,W,115,A,3v3l:B,114,Strong decrease in iso-ADP-ribose-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_W_115_A
7069,Q9NTX7,Y,145,A,3v3l:B,144,Loss of iso-ADP-ribose-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_Y_145_A
7070,Q9NTX7,Q,154,A,3v3l:B,153,Loss of iso-ADP-ribose-binding affinity.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_Q_154_A
7071,Q9NTX7,R,163,A,3v3l:B,162,Abolishes the ability to recognize and bind PARsylated proteins.,-1.0,,-999.0,,,,,,,,,,,,,Q9NTX7_R_163_A
7072,Q9NTX7,R,164,A,3v3l:B,163,Loss of iso-ADP-ribose-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_R_164_A
7073,Q9NTX7,K,176,A,3v3l:B,175,Minor effect on iso-ADP-ribose-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9NTX7_K_176_A
7074,P35914,E,37,D,3mp4:A,37,Normal activity.,,,0.0,,,,,,,,,,,,,P35914_E_37_D
7075,P35914,R,41,M,3mp4:A,41,"Reduced activity, and loss of proton exchange.",,,1.0,,,,,,,,,,,,,P35914_R_41_M
7076,P35914,D,42,A,3mp4:A,42,"Loss of activity, and reduced proton exchange rate.",,,1.0,,,,,,,,,,,,,P35914_D_42_A
7076,P35914,D,42,N,3mp4:A,42,"Loss of activity, and reduced proton exchange rate.",,,1.0,,,,,,,,,,,,,P35914_D_42_N
7077,P35914,E,72,A,3mp4:A,72,"Loss of activity, and reduced affinity for metal cofactor and substrate.",,-1.0,1.0,,,,,,,,,,,,,P35914_E_72_A
7078,P35914,D,204,A,3mp4:A,204,"Reduced activity, and reduced affinity for metal cofactor and substrate.",,-1.0,1.0,,,,,,,,,,,,,P35914_D_204_A
7079,P35914,H,233,A,3mp4:A,233,"Loss of activity, and reduced proton exchange rate.",,,1.0,,,,,,,,,,,,,P35914_H_233_A
7080,P35914,C,266,A,3mp4:A,266,Loss of activity.,,,1.0,,,,,,,,,,,,,P35914_C_266_A
7081,P35914,E,279,A,3mp4:A,279,"Reduced thermal stability, but normal activity.",,,0.0,,,,,,,,,,,-1.0,,P35914_E_279_A
7082,P35914,D,280,A,3mp4:A,280,Normal activity.,,,0.0,,,,,,,,,,,,,P35914_D_280_A
7083,P35916,T,446,E,4bsj:A,446,Decreases autophosphorylation on tyrosine residues upon ligand binding,,,1.0,,,,,,,,,,,,,P35916_T_446_E
7084,P35916,K,516,A,4bsj:A,516,Decreases autophosphorylation on tyrosine residues upon ligand binding,,,1.0,,,,,,,,,,,,,P35916_K_516_A
7085,Q9Y371,V,8,M,6upn:A,8,Abolishes interaction with BAX.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y371_V_8_M
7086,Q9Y371,T,145,A,6upn:A,145,Reduced CDK5-mediated phosphorylation and impaired dimerization.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q9Y371_T_145_A
7087,Q9Y371,T,145,E,6upn:A,145,Spontaneous dimerization.,1.0,,-999.0,,,,,,,,,,,,,Q9Y371_T_145_E
7088,Q9H0U4,Q,67,L,5szh:B,67,"No effect on GDI1 binding. Reduces prenylation in vitro, but not in vivo. No effect on interaction with REP1/CHM",0.0,0.0,-999.0,,,,,,-1.0,,,,,,,Q9H0U4_Q_67_L
7089,Q9H0U4,I,73,N,5szh:B,73,Abolishes interaction with REP1/CHM. No prenylation. Much lower GDP/GTP ratio.,-1.0,,1.0,,,,,,-1.0,,,,,,,Q9H0U4_I_73_N
7090,Q9H0U4,S,76,A,5szh:B,76,Abolishes phosphocholination by Legionella AnkX.,,,-999.0,,,,,,-1.0,,,,,,,Q9H0U4_S_76_A
7091,Q9H0U4,Y,77,F,5szh:B,77,Abolishes AMPylation by Legionella DrrA.,,,-999.0,,,,,,-1.0,,,,,,,Q9H0U4_Y_77_F
7092,Q9H0U4,Y,78,D,5szh:B,78,Abolishes interaction with REP1/CHM and GDI1. No prenylation. Much lower GDP/GTP ratio. No membrane association.,-1.0,,1.0,,,,,,-1.0,,,,,,,Q9H0U4_Y_78_D
7093,Q9H0U4,A,81,D,5szh:B,81,Abolishes interaction with REP1/CHM. No prenylation. Lowers GDP/GTP ratio by half.,-1.0,,1.0,,,,,,-1.0,,,,,,,Q9H0U4_A_81_D
7094,Q9H0U4,L,103,R,5szh:B,103,No effect on prenylation.,,,-999.0,,,,,,0.0,,,,,,,Q9H0U4_L_103_R
7095,Q9H0U4,A,110,D,5szh:B,110,No effect on prenylation.,,,-999.0,,,,,,0.0,,,,,,,Q9H0U4_A_110_D
7096,Q9H0U4,N,121,I,5szh:B,121,Prevent formation of autophagosomes.,,,-999.0,,,,,,,,,,,,,Q9H0U4_N_121_I
7097,Q9H0U4,K,137,E,5szh:B,137,No effect on prenylation.,,,-999.0,,,,,,0.0,,,,,,,Q9H0U4_K_137_E
7098,Q9H0U4,G,144,N,5szh:B,144,No effect on prenylation.,,,-999.0,,,,,,0.0,,,,,,,Q9H0U4_G_144_N
7099,Q9P2M4,R,472,A,2qq8:A,457,Loss of inhibition of autophagosome formation,,,1.0,,,,,,,,,,,,,Q9P2M4_R_472_A
7100,Q9P2M4,Q,508,A,2qq8:A,493,Loss of inhibition of autophagosome formation,,,1.0,,,,,,,,,,,,,Q9P2M4_Q_508_A
7101,Q86W24,L,84,R,4n1l:A,84,Increased thermal stability of the Pyrin domain.,,,-999.0,,,,,,,,,,,1.0,,Q86W24_L_84_R
7102,Q9Y376,R,240,A,3gni:A,240,Abolishes activation of STK11/LKB1,-1.0,,-999.0,,,,,,,,,,,,,Q9Y376_R_240_A
7103,Q9Y376,F,243,A,3gni:A,243,Abolishes activation of STK11/LKB1,-1.0,,-999.0,,,,,,,,,,,,,Q9Y376_F_243_A
7104,O75928,C,362,S,4fo9:A,362,Loss of MDM2 and TP53 sumoylation and of autosumoylation,,,-999.0,,,,-1.0,,,,,,,,,O75928_C_362_S
7104,O75928,C,362,A,4fo9:A,362,Loss of MDM2 and TP53 sumoylation and of autosumoylation,,,-999.0,,,,-1.0,,,,,,,,,O75928_C_362_A
7105,P23396,S,6,A,6fec:g,6,No effect on phosphorylation by CDK1. Greatly reduced phosphorylation by PRKCD. Abolishes phosphorylation by PRKCD,,,-999.0,-1.0,,,,,,,,,,,,P23396_S_6_A
7106,P23396,K,18,R,6fec:g,18,No effect on sumoylation. Abolishes sumoylation,,,-999.0,,,,0.0,,,,,,,,,P23396_K_18_R
7107,P23396,S,35,A,6fec:g,35,No effect on phosphorylation by PRKCD.,,,-999.0,0.0,,,,,,,,,,,,P23396_S_35_A
7108,P23396,T,42,A,6fec:g,42,Abolishes phosphorylation by MAPK and translocation to the nucleus following exposure of cells to hydrogen peroxide. No effect on phosphorylation by CDK1 or PRKCD.,,,-999.0,-1.0,,,,,,,,1.0,,,,P23396_T_42_A
7109,P23396,T,42,D,6fec:g,42,Phosphomimetic mutant which is detected exclusively in the nucleus.,,,-999.0,,,,,,,,,1.0,1.0,,,P23396_T_42_D
7110,P23396,T,70,A,6fec:g,70,No effect on phosphorylation by PRKCD. Abolishes phosphorylation by PKB.,,,-999.0,0.0,,,,,,,,,,,,P23396_T_70_A
7111,P23396,T,70,D,6fec:g,70,Abolishes phosphorylation by PKB.,,,-999.0,-1.0,,,,,,,,,,,,P23396_T_70_D
7111,P23396,T,70,E,6fec:g,70,Abolishes phosphorylation by PKB.,,,-999.0,-1.0,,,,,,,,,,,,P23396_T_70_E
7111,P23396,T,70,R,6fec:g,70,Abolishes phosphorylation by PKB.,,,-999.0,-1.0,,,,,,,,,,,,P23396_T_70_R
7112,P23396,K,132,A,6fec:g,132,Does not affect ability to cleave DNA but abolishes binding to 8-oxoG.,,-1.0,-999.0,,,,,,,,,,,,,P23396_K_132_A
7113,P23396,S,139,A,6fec:g,139,No effect on phosphorylation by PRKCD.,,,-999.0,0.0,,,,,,,,,,,,P23396_S_139_A
7114,P23396,S,149,A,6fec:g,149,No effect on phosphorylation by PRKCD.,,,-999.0,0.0,,,,,,,,,,,,P23396_S_149_A
7115,P23396,T,195,A,6fec:g,195,No effect on phosphorylation by PRKCD.,,,-999.0,0.0,,,,,,,,,,,,P23396_T_195_A
7116,P23396,S,209,A,6fec:g,209,Reduced phosphorylation by IKKB.,,,-999.0,-1.0,,,,,,,,,,,,P23396_S_209_A
7117,P23396,K,214,R,6fec:g,214,No effect on sumoylation. Abolishes sumoylation,,,-999.0,,,,-1.0,,,,,,,,,P23396_K_214_R
7118,P23396,T,221,A,6fec:g,221,No effect on phosphorylation by MAPK. Significantly reduces phosphorylation by CDK1 and nuclear accumulation. Greatly reduced phosphorylation by PRKCD. Abolishes phosphorylation by PRKCD,,,-999.0,-1.0,,,,,,,,1.0,,,,P23396_T_221_A
7119,O75923,D,16,A,7k6b:A,16,Fails to bind calcium.,,-1.0,-999.0,,,,,,,,,,,,,O75923_D_16_A
7120,O75923,D,21,A,7k6b:A,21,Fails to bind calcium.,,-1.0,-999.0,,,,,,,,,,,,,O75923_D_21_A
7121,O75923,D,71,A,7k6b:A,71,Fails to bind calcium.,,-1.0,-999.0,,,,,,,,,,,,,O75923_D_71_A
7122,O75923,R,79,D,7k6b:A,79,Moderately increased calcium affinity.,,1.0,-999.0,,,,,,,,,,,,,O75923_R_79_D
7123,O75923,F,80,A,7k6b:A,80,Reduced calcium affinity.,,-1.0,-999.0,,,,,,,,,,,,,O75923_F_80_A
7124,Q9Y4K3,D,57,K,3hcs:A,57,Loss of interaction with UBE2N.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y4K3_D_57_K
7125,Q9Y4K3,C,70,A,3hcs:A,70,"Loss of ligase activity, autoubiquitination and signaling capacity.",,,1.0,,,,,,,,,,,,,Q9Y4K3_C_70_A
7126,Q9Y4K3,I,72,D,3hcs:A,72,Loss of interaction with UBE2N. Has no effect on TRAF3IP2-mediated 'Lys-63'-linked polyubiquitination.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y4K3_I_72_D
7127,Q9Y4K3,L,74,E,3hcs:A,74,Loss of interaction with UBE2N.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y4K3_L_74_E
7127,Q9Y4K3,L,74,K,3hcs:A,74,Loss of interaction with UBE2N.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y4K3_L_74_K
7128,Q9Y4K3,R,88,A,3hcs:A,88,Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis. Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis,-1.0,,1.0,,,,,,,,,,,,,Q9Y4K3_R_88_A
7129,Q9Y4K3,F,118,A,3hcs:A,118,Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis.,-1.0,,1.0,,,,,,,,,,,,,Q9Y4K3_F_118_A
7130,Q9Y4K3,F,118,W,3hcs:A,118,Partially impaired polyubiquitin synthesis.,,,1.0,,,,,,,,,,,,,Q9Y4K3_F_118_W
7131,Q9Y4K3,F,118,Y,3hcs:A,118,Partially impaired polyubiquitin synthesis.,,,1.0,,,,,,,,,,,,,Q9Y4K3_F_118_Y
7132,Q9Y4K3,F,122,A,3hcs:A,122,Loss of TRAF6 homodimerization and partially impaired polyubiquitin synthesis. Loss of TRAF6 homodimerization and impaired polyubiquitin synthesis,-1.0,,1.0,,,,,,,,,,,,,Q9Y4K3_F_122_A
7133,Q9Y4K3,K,124,R,3hcs:A,124,Loss of SUMO1-modification and c-myb-mediated transcriptional repressive activation. Loss of TRAF3IP2-mediated 'Lys-63'-linked polyubiquitination.,,,-999.0,,,,,,,,,,,,,Q9Y4K3_K_124_R
7134,Q9Y4K3,K,142,R,3hcs:A,142,Loss of SUMO1-modification and c-myb-mediated transcriptional repressive activation.,,,-999.0,,,,,,,,,,,,,Q9Y4K3_K_142_R
7135,Q9Y4K3,K,453,R,1lb6:A,453,Loss of SUMO1-modification and c-myb-mediated transcriptional repressive activation.,,,-999.0,,,,,,,,,,,,,Q9Y4K3_K_453_R
7136,P27487,N,85,A,2bgr:A,85,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_85_A
7137,P27487,N,92,A,2bgr:A,92,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_92_A
7138,P27487,N,150,A,2bgr:A,150,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_150_A
7139,P27487,E,205,K,2bgr:A,205,Inhibits dipeptidyl peptidase activity.,,,1.0,,,,,,,,,,,,,P27487_E_205_K
7140,P27487,E,206,L,2bgr:A,206,Inhibits dipeptidyl peptidase activity.,,,1.0,,,,,,,,,,,,,P27487_E_206_L
7141,P27487,N,219,A,2bgr:A,219,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_219_A
7142,P27487,N,229,A,2bgr:A,229,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_229_A
7143,P27487,N,281,A,2bgr:A,281,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_281_A
7144,P27487,N,321,A,2bgr:A,321,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_321_A
7145,P27487,N,520,A,2bgr:A,520,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_520_A
7146,P27487,N,685,A,2bgr:A,685,"Does not inhibit dipeptidyl peptidase activity, interaction with ADA and homodimer formation.",0.0,,0.0,,,,,,,,,,,,,P27487_N_685_A
7147,P27487,H,750,A,2bgr:A,750,Inhibits weakly homodimerization and dipeptidyl peptidase activity.,-1.0,,1.0,,,,,,,,,,,,,P27487_H_750_A
7148,P27487,H,750,E,2bgr:A,750,"Inhibits strongly homodimerization, dipeptidyl peptidase activity, interaction with CARD11 and T-cell costimulation activity.",-1.0,,1.0,,,,,,,,,,,,,P27487_H_750_E
7149,Q9UK39,N,149,A,6mal:A,149,Slightly decreased activity as transcriptional repressor.,,,1.0,,,,,,,,,,,,,Q9UK39_N_149_A
7150,Q9UK39,D,160,A,6mal:A,160,Lack of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_D_160_A
7151,Q9UK39,E,195,A,6mal:A,195,Slightly increased activity as transcriptional repressor. Lack of catalytic activity.,,,-999.0,,,,,,,,,,,,,Q9UK39_E_195_A
7152,Q9UK39,K,219,A,6mal:A,219,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_K_219_A
7153,Q9UK39,H,286,A,6mal:A,286,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_H_286_A
7154,Q9UK39,H,286,N,6mal:A,286,Lack of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_H_286_N
7155,Q9UK39,K,288,A,6mal:A,288,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_K_288_A
7156,Q9UK39,R,290,A,6mal:A,290,Lack of catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_R_290_A
7157,Q9UK39,D,324,A,6mal:A,324,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_D_324_A
7158,Q9UK39,N,326,A,6mal:A,326,No effect on activity as transcriptional repressor.,,,0.0,,,,,,,,,,,,,Q9UK39_N_326_A
7159,Q9UK39,K,365,A,6mal:A,365,No effect on catalytic activity.,,,0.0,,,,,,,,,,,,,Q9UK39_K_365_A
7160,Q9UK39,R,367,A,6mal:A,367,Reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q9UK39_R_367_A
7161,Q9UK39,D,377,A,6mal:A,377,Slightly decreased activity as transcriptional repressor.,,,-999.0,,,,,,,,,,,,,Q9UK39_D_377_A
7162,Q9UK39,H,414,A,6mal:A,414,Decreased activity as transcriptional repressor.,,,-999.0,,,,,,,,,,,,,Q9UK39_H_414_A
7162,Q9UK39,H,414,N,6mal:A,414,Decreased activity as transcriptional repressor.,,,-999.0,,,,,,,,,,,,,Q9UK39_H_414_N
7163,Q9UGI8,C,328,A,2xqn:T,328,Abolishes interaction with ACTL7A.,-1.0,,-999.0,,,,,,,,,,,,,Q9UGI8_C_328_A
7164,Q9UGI8,C,391,A,2xqn:T,391,Abolishes localization at focal adhesions.,,,-999.0,,,,,,,,,,,,,Q9UGI8_C_391_A
7165,P00367,S,501,A,1l1f:A,448,Reduces activity and inhibition by GTP.,,,1.0,,,,,,,,,,,,,P00367_S_501_A
7166,P00367,R,516,A,1l1f:A,463,Abolishes activation by ADP.,,-1.0,-999.0,,,,,,,,,,,,,P00367_R_516_A
7167,P00813,L,58,A,3iar:A,58,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,1.0,,,,,,,,,,,,,P00813_L_58_A
7168,P00813,D,60,A,3iar:A,60,Moderately reduces enzyme activity,,,1.0,,,,,,,,,,,,,P00813_D_60_A
7169,P00813,F,61,A,3iar:A,61,Decreases enzyme activity by reducing maximum velocity,,,1.0,,,,,,,,,,,,,P00813_F_61_A
7170,P00813,L,62,A,3iar:A,62,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,1.0,,,,,,,,,,,,,P00813_L_62_A
7171,P00813,K,64,A,3iar:A,64,Moderately reduces enzyme activity,,,1.0,,,,,,,,,,,,,P00813_K_64_A
7172,P00813,F,65,A,3iar:A,65,Decreases enzyme activity by reducing substrate affinity and maximum velocity,,-1.0,1.0,,,,,,,,,,,,,P00813_F_65_A
7173,P00813,D,66,A,3iar:A,66,No change in enzyme activity,,,0.0,,,,,,,,,,,,,P00813_D_66_A
7174,P00813,M,69,A,3iar:A,69,Decreases enzyme activity by reducing maximum velocity,,,1.0,,,,,,,,,,,,,P00813_M_69_A
7175,P00813,I,115,A,3iar:A,115,No change in enzyme activity,,,0.0,,,,,,,,,,,,,P00813_I_115_A
7176,P00813,N,118,A,3iar:A,118,Moderately reduces enzyme activity,,,1.0,,,,,,,,,,,,,P00813_N_118_A
7177,P00813,M,155,A,3iar:A,155,Decreases enzyme activity by reducing substrate affinity and maximum velocity.,,-1.0,1.0,,,,,,,,,,,,,P00813_M_155_A
7178,P00813,H,157,A,3iar:A,157,Moderately reduces enzyme activity,,,1.0,,,,,,,,,,,,,P00813_H_157_A
7179,P00813,G,184,Q,3iar:A,184,Moderately reduces enzyme activity.,,,1.0,,,,,,,,,,,,,P00813_G_184_Q
7180,P00813,D,185,A,3iar:A,185,Moderately reduces enzyme activity.,,,1.0,,,,,,,,,,,,,P00813_D_185_A
7181,P00813,L,194,A,3iar:A,194,No change in enzyme activity.,,,0.0,,,,,,,,,,,,,P00813_L_194_A
7182,Q09328,E,280,A,6yjv:AAA,280,Decreased catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_280_A
7183,Q09328,E,287,A,6yjv:AAA,287,Decreased catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_287_A
7184,Q09328,E,297,A,6yjv:AAA,297,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_297_A
7185,Q09328,E,429,A,6yjr:AAA,429,Decreased catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_429_A
7186,Q09328,E,520,A,6yjr:AAA,520,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_520_A
7187,Q09328,E,526,A,6yjr:AAA,526,Loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q09328_E_526_A
7188,Q7L0Q8,T,81,S,2q3h:A,81,Loss of binding to PAK3,-1.0,,-999.0,,,,,,,,,,,,,Q7L0Q8_T_81_S
7189,Q7L0Q8,F,83,A,2q3h:A,83,Loss of binding to PAK3,-1.0,,-999.0,,,,,,,,,,,,,Q7L0Q8_F_83_A
7190,Q7L0Q8,F,83,G,2q3h:A,83,Loss of ARHGAP30-binding.,-1.0,,-999.0,,,,,,,,,,,,,Q7L0Q8_F_83_G
7191,Q7L0Q8,F,86,C,2q3h:A,86,Loss of PAK3-binding,-1.0,,-999.0,,,,,,,,,,,,,Q7L0Q8_F_86_C
7192,Q7L0Q8,Q,107,L,2q3h:A,107,Constitutively active. Results in increased rates of stress fiber dissolution and cell migration. No effect on ARHGAP30-binding.,,0.0,1.0,,,,,,,,,,,,,Q7L0Q8_Q_107_L
7193,Q59H18,K,490,R,4yfi:A,490,Loss of autophosphorylation activity.,,,1.0,,,,,,,,,,,,,Q59H18_K_490_R
7194,P54922,S,54,A,3hfw:A,54,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P54922_S_54_A
7195,P54922,D,55,N,3hfw:A,55,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P54922_D_55_N
7196,P54922,D,56,N,3hfw:A,56,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P54922_D_56_N
7197,P54922,D,302,N,3hfw:A,302,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P54922_D_302_N
7198,P54922,S,305,A,3hfw:A,305,Complete loss of activity.,,,1.0,,,,,,,,,,,,,P54922_S_305_A
7199,P08559,S,232,A,6cfo:A,203,Abolishes inactivation by phosphorylation,,,-999.0,,,,,,,,,,,,,P08559_S_232_A
7200,P08559,S,293,A,6cfo:A,264,Reduces enzyme activity. Abolishes inactivation by phosphorylation,,,1.0,,,,,,,,,,,,,P08559_S_293_A
7201,P08559,S,293,E,6cfo:A,264,Interferes with substrate binding.,,-1.0,-999.0,,,,,,,,,,,,,P08559_S_293_E
7202,P08559,S,300,A,6cfo:A,271,Abolishes inactivation by phosphorylation,,,-999.0,,,,,,,,,,,,,P08559_S_300_A
7203,Q13077,K,185,R,3m0d:C,270,Nearly abolished ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,Q13077_K_185_R
7204,Q13077,K,193,R,3m0d:C,278,Nearly abolished ubiquitination,,,-999.0,,-1.0,,,,,,,,,,,Q13077_K_193_R
7205,Q9H492,K,49,A,3wan:B,65,Increases interaction with ATG13 and strongly reduces autophagosome formation.,-1.0,,-999.0,,,,,,,,,,,,,Q9H492_K_49_A
7206,Q9H492,K,51,A,3wan:B,67,Decreases interaction with ATG13 and strongly reduces autophagosome formation.,-1.0,,-999.0,,,,,,,,,,,,,Q9H492_K_51_A
7207,Q9H492,L,53,A,3wan:B,69,Decreases interaction with ATG13.,-1.0,,-999.0,,,,,,,,,,,,,Q9H492_L_53_A
7208,Q9H492,G,120,A,3wan:B,136,No processing of precursor.,,,1.0,,,,,,,,,,,,,Q9H492_G_120_A
7209,P23246,L,535,A,4wij:B,535,Impairs DNA binding and ability to mediate transcriptional activation,,-1.0,-999.0,,,,,,,,,,,,,P23246_L_535_A
7210,P23246,L,539,A,4wij:B,539,Impairs DNA binding and ability to mediate transcriptional activation,,-1.0,-999.0,,,,,,,,,,,,,P23246_L_539_A
7211,P23246,L,546,A,4wij:B,546,Impairs DNA binding and ability to mediate transcriptional activation,,-1.0,-999.0,,,,,,,,,,,,,P23246_L_546_A
7212,P23246,M,549,A,4wij:B,549,Impairs DNA binding and ability to mediate transcriptional activation,,-1.0,-999.0,,,,,,,,,,,,,P23246_M_549_A
7213,P14618,P,403,A,6gg3:B,403,Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A,,,1.0,,,,,,,,,,,,,P14618_P_403_A
7214,P14618,P,408,A,6gg3:B,408,Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A,,,1.0,,,,,,,,,,,,,P14618_P_408_A
7215,P14618,S,437,Y,6gg3:B,437,Unable to bind FBP but still activated by serine.,1.0,,0.0,,,,,,,,,,,,,P14618_S_437_Y
7216,P14618,H,464,A,6gg3:B,464,Abolishes serine binding and allosteric activation.,,-1.0,1.0,,,,,,,,,,,,,P14618_H_464_A
7217,Q14392,C,211,A,6gff:I,211,Abolishes interaction with Latency-associated peptide (LAP) of TGFB1,-1.0,,-999.0,,,,,,,,,,,,,Q14392_C_211_A
7218,Q14392,C,350,A,6gff:I,350,Abolishes interaction with Latency-associated peptide (LAP) of TGFB1,-1.0,,-999.0,,,,,,,,,,,,,Q14392_C_350_A
7219,Q14392,C,436,A,6gff:I,436,Abolishes Cell surface localization without affecting interaction with Latency-associated peptide (LAP) of TGFB1.,0.0,,-999.0,,,,,,,,,1.0,,,,Q14392_C_436_A
7220,P20292,V,20,A,2q7r:C,20,Increased affinity for the inhibitor MK-591.,,1.0,-999.0,,,,,,,,,,,,,P20292_V_20_A
7221,P20292,A,27,V,2q7r:C,27,Strongly decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_A_27_V
7222,P20292,V,30,A,2q7r:C,30,Strongly decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_V_30_A
7223,P20292,D,62,A,2q7r:C,62,Decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_D_62_A
7224,P20292,T,66,A,2q7r:C,66,Strongly decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_T_66_A
7225,P20292,Y,112,A,2q7r:C,112,Strongly decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_Y_112_A
7226,P20292,I,113,A,2q7r:C,113,Increased affinity for the inhibitor MK-591.,,1.0,-999.0,,,,,,,,,,,,,P20292_I_113_A
7227,P20292,K,116,A,2q7r:C,116,Strongly increased affinity for the inhibitor MK-591.,,1.0,-999.0,,,,,,,,,,,,,P20292_K_116_A
7228,P20292,F,123,A,2q7r:C,123,Decreased affinity for the inhibitor MK-591.,,-1.0,-999.0,,,,,,,,,,,,,P20292_F_123_A
7229,O96017,D,347,A,4bdi:A,347,Loss of kinase activity and of the ability to phosphorylate CDC25A.,,,1.0,,,,,,,,,,,,,O96017_D_347_A
7230,O96017,D,368,N,4bdi:A,368,Loss of autophosphorylation activity.,,,1.0,-1.0,,,,,,,,,,,,O96017_D_368_N
7231,O96017,S,379,A,4bdi:A,379,Abrogates autophosphorylation at Ser-379 and prevents ubiquitination.,,,-999.0,-1.0,,,,,,,,,,,,O96017_S_379_A
7232,O96017,T,383,A,4bdi:A,383,Loss of phosphorylation in response to ionizing radiation.,,,-999.0,-1.0,,,,,,,,,,,,O96017_T_383_A
7233,O96017,T,387,A,4bdi:A,387,Loss of phosphorylation in response to ionizing radiation.,,,-999.0,-1.0,,,,,,,,,,,,O96017_T_387_A
7234,O96017,S,456,A,4bdi:A,456,Increased ubiquitination and degradation by the proteasome.,,,-999.0,,1.0,,,,,,,,,,,O96017_S_456_A
7235,O96013,S,445,N,2q0n:A,445,Approximately 30-fold increased autophosphorylation (constitutively active mutant).,,,1.0,1.0,,,,,,,,,,,,O96013_S_445_N
7236,O96013,S,474,E,2q0n:A,474,Approximately 3-fold increased autophosphorylation.,,,1.0,1.0,,,,,,,,,,,,O96013_S_474_E
7237,O94923,Y,146,A,6i02:B,146,Reduces enzyme activity by about 60%.,,,1.0,,,,,,,,,,,,,O94923_Y_146_A
7238,O94923,Y,162,A,6i02:B,162,Reduces enzyme activity by about 75%.,,,1.0,,,,,,,,,,,,,O94923_Y_162_A
7239,O94923,Y,168,A,6i02:B,168,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O94923_Y_168_A
7240,O94923,Y,210,A,6i02:B,210,Reduces enzyme activity by about 30%.,,,1.0,,,,,,,,,,,,,O94923_Y_210_A
7241,O94923,Y,222,A,6i02:B,222,Almost abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,O94923_Y_222_A
7242,O94923,E,499,Q,6i02:B,499,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94923_E_499_Q
7243,O94923,Y,500,F,6i02:B,500,Mildly decreased enzyme activity.,,,1.0,,,,,,,,,,,,,O94923_Y_500_F
7244,O94923,Y,578,F,6i02:B,578,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O94923_Y_578_F
7245,P41235,S,313,A,3fs1:A,304,Abolishes AMPK-mediated phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P41235_S_313_A
7246,P41235,S,313,D,3fs1:A,304,Phosphomimetic mutant that leads to reduced ability to bind DNA.,,-1.0,-999.0,,,,,,,,,,1.0,,,P41235_S_313_D
7247,P42126,E,178,A,1sg4:B,136,Loss of activity.,,,1.0,,,,,,,,,,,,,P42126_E_178_A
7248,Q8NFA2,R,40,Q,2l73:A,40,Loss of ability to activate NOX1 associated with loss of lipid-binding and plasma membrane localization.,,,1.0,,,,,,,,,1.0,,,,Q8NFA2_R_40_Q
7249,Q99714,S,20,F,1u7t:A,20,Decreased dehydrogenase activity. Does not affect mitochondrial tRNA 5'-end processing. Does not affect tRNA methylation.,,,1.0,,,,,,,,,,,,,Q99714_S_20_F
7250,Q99714,K,172,A,1u7t:A,172,Abolishes dehydrogenase activity. Does not affect mitochondrial tRNA 5'-end processing. Does not affect tRNA methylation. Does not affect homotetramerization.,0.0,,1.0,,,,,,,,,,,,,Q99714_K_172_A
7251,P14780,E,402,Q,1l6j:A,402,Loss of activity.,,,1.0,,,,,,,,,,,,,P14780_E_402_Q
7252,P27707,A,100,V,2no9:A,100,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_A_100_V
7253,P27707,R,104,L,2no9:A,104,Strongly increased catalytic efficiency towards deoxythymidine,,,1.0,,,,,,,,,,,,,P27707_R_104_L
7254,P27707,R,104,M,2no9:A,104,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_R_104_M
7255,P27707,D,133,A,2no9:A,133,Strongly increased catalytic efficiency towards deoxycytidine,,,1.0,,,,,,,,,,,,,P27707_D_133_A
7256,P11310,L,86,M,1t9g:C,61,Strongly reduced rate of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_L_86_M
7257,P11310,L,98,W,1t9g:C,73,Strongly reduced rate of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_L_98_W
7258,P11310,L,100,Y,1t9g:C,75,Strongly reduced rate of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_L_100_Y
7259,P11310,I,108,M,1t9g:C,83,Strongly reduced rate of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_I_108_M
7260,P11310,W,191,A,1t9g:C,166,Loss of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_W_191_A
7261,P11310,W,191,F,1t9g:C,166,Reduces rate of electron transfer to ETF about six-fold.,,,1.0,,,,,,,,,,,,,P11310_W_191_F
7262,P11310,E,237,A,1t9g:C,212,Strongly reduced rate of electron transfer to ETF.,,,1.0,,,,,,,,,,,,,P11310_E_237_A
7263,P11310,T,280,E,1t9g:C,255,Narrower substrate specificity. Changed substrate specificity towards longer acyl chains,,-1.0,-999.0,,,,,,,,,,,,,P11310_T_280_E
7264,P11310,E,384,A,1t9g:C,359,Reduces rate of electron transfer to ETF three-fold.,,,1.0,,,,,,,,,,,,,P11310_E_384_A
7265,P11310,E,384,Q,1t9g:C,359,Reduces rate of electron transfer to ETF two-fold.,,,1.0,,,,,,,,,,,,,P11310_E_384_Q
7266,P11310,E,401,G,1t9g:C,376,Changed substrate specificity towards longer acyl chains,,1.0,-999.0,,,,,,,,,,,,,P11310_E_401_G
7267,P11310,E,401,Q,1t9g:C,376,Loss of acyl-CoA dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P11310_E_401_Q
7268,P11310,E,401,T,1t9g:C,376,Loss of acyl-CoA dehydrogenase activity,,,1.0,,,,,,,,,,,,,P11310_E_401_T
7269,Q96JA3,W,407,A,5kdi:A,407,Loss of glucosylceramide transfer activity from the TGN to the plasma membrane.,,,1.0,,,,,,,,,,,,,Q96JA3_W_407_A
7270,P26440,E,286,D,1ivh:A,254,Residual isovaleryl-CoA dehydrogenase activity.,,,-999.0,,,,,,,,,,,,,P26440_E_286_D
7271,P26440,E,286,G,1ivh:A,254,Loss of isovaleryl-CoA dehydrogenase activity. Does not affect isovaleryl-CoA dehydrogenase activity,,,-999.0,,,,,,,,,,,,,P26440_E_286_G
7272,P26440,E,286,Q,1ivh:A,254,Loss of isovaleryl-CoA dehydrogenase activity.,,,1.0,,,,,,,,,,,,,P26440_E_286_Q
7273,P26440,A,407,E,1ivh:A,375,Does not affect isovaleryl-CoA dehydrogenase activity,,,0.0,,,,,,,,,,,,,P26440_A_407_E
7274,Q15717,S,158,A,4ed5:B,158,Decreases phosphorylation by PRKCD.,,,-999.0,-1.0,,,,,,,,,,,,Q15717_S_158_A
7275,Q15717,S,318,A,6gd3:A,318,Decreases phosphorylation by PRKCD. Nearly abolishes phosphorylation by PRKCD and translocation from the nucleus into the cytoplasm,,,-999.0,-1.0,,,,,,,,1.0,,,,Q15717_S_318_A
7276,P11597,T,155,Y,2obd:A,138,Reduces triglyceride transfer and cholesteryl ester transfer 5-fold.,,,1.0,,,,,,,,,,,,,P11597_T_155_Y
7277,P11597,V,215,W,2obd:A,198,Reduces triglyceride transfer 10-fold. No effect on cholesteryl ester transfer.,,,0.0,,,,,,,,,,,,,P11597_V_215_W
7278,P11597,R,218,S,2obd:A,201,Reduces triglyceride transfer 10-fold. Slight reduction of cholesteryl ester transfer.,,,1.0,,,,,,,,,,,,,P11597_R_218_S
7279,P11597,S,247,A,2obd:A,230,Reduces triglyceride transfer 5-fold. Slight reduction of cholesteryl ester transfer.,,,1.0,,,,,,,,,,,,,P11597_S_247_A
7280,P11597,F,282,R,2obd:A,265,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P11597_F_282_R
7281,P11597,F,287,R,2obd:A,270,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P11597_F_287_R
7282,P11597,F,309,D,2obd:A,292,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P11597_F_309_D
7283,P11597,L,313,Q,2obd:A,296,Reduces cholesteryl ester transfer by 60%.,,,1.0,,,,,,,,,,,,,P11597_L_313_Q
7284,P11597,Y,392,S,2obd:A,375,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P11597_Y_392_S
7285,P11597,L,399,W,2obd:A,382,Not secreted.,,,-999.0,,,,,,,,,1.0,,,,P11597_L_399_W
7286,P11597,V,433,R,2obd:A,416,Reduces activity by 60%.,,,1.0,,,,,,,,,,,,,P11597_V_433_R
7287,Q16832,W,52,A,2wuh:A,52,Abolishes collagen binding.,,-1.0,-999.0,,,,,,,,,,,,,Q16832_W_52_A
7288,Q16832,K,608,A,6fer:D,655,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q16832_K_608_A
7289,Q16832,Y,736,F,6fer:D,783,Reduces autophosphorylation. Abolishes phosphorylation by SRC,,,1.0,-1.0,,,,,,,,,,,,Q16832_Y_736_F
7290,Q16832,Y,740,F,6fer:D,787,Promotes autophosphorylation. Abolishes phosphorylation by SRC,,,1.0,-1.0,,,,,,,,,,,,Q16832_Y_740_F
7291,Q16832,Y,741,F,6fer:D,788,Reduces autophosphorylation. Abolishes phosphorylation by SRC,,,1.0,-1.0,,,,,,,,,,,,Q16832_Y_741_F
7292,O95470,E,132,G,4q6r:B,132,No effect on the sphinganine-1-phosphate aldolase activity,,,0.0,,,,,,,,,,,,,O95470_E_132_G
7293,O95470,C,218,G,4q6r:B,218,Loss of sphinganine-1-phosphate aldolase activity.,,,1.0,,,,,,,,,,,,,O95470_C_218_G
7294,O95470,C,317,S,4q6r:B,317,Almost no sphinganine-1-phosphate aldolase activity.,,,1.0,,,,,,,,,,,,,O95470_C_317_S
7295,O95470,K,353,L,4q6r:B,353,Loss of sphinganine-1-phosphate aldolase activity.,,,1.0,,,,,,,,,,,,,O95470_K_353_L
7296,O95477,C,23,S,5xjy:A,23,Mild decrease of palmitoylation. Loss of localization to plasma membrane. Decreased palmitoylation,,,-999.0,,,,,,-1.0,,,1.0,,,,O95477_C_23_S
7297,O95477,S,100,C,5xjy:A,100,Highly decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.,,,1.0,,,,,,,,,,,,-1.0,O95477_S_100_C
7298,O95477,F,593,L,5xjy:A,593,Moderately decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.,,,1.0,,,,,,,,,,,,-1.0,O95477_F_593_L
7299,O95477,K,939,M,5xjy:A,939,Inhibits ATPase activity,,,1.0,,,,,,,,,,,,,O95477_K_939_M
7300,O95477,C,1110,S,5xjy:A,1110,Decreased palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,O95477_C_1110_S
7301,O95477,C,1111,S,5xjy:A,1111,Decreased palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,O95477_C_1111_S
7302,O95477,T,1512,M,5xjy:A,1512,Moderately decreased protein abundance. Does not affect ATPase activity. Moderately decreased phospholipid translocase activity.,,,1.0,,,,,,,,,,,-1.0,,O95477_T_1512_M
7303,O95477,K,1952,M,5xjy:A,1952,Inhibits ATPase activity,,,1.0,,,,,,,,,,,,,O95477_K_1952_M
7304,P49366,N,106,A,6xxm:A,106,Strongly reduced NAD and spermidine binding. Reduced activity.,,-1.0,1.0,,,,,,,,,,,,,P49366_N_106_A
7305,P49366,S,109,A,6xxm:A,109,Strongly reduced spermidine binding. Reduced activity.,,-1.0,1.0,,,,,,,,,,,,,P49366_S_109_A
7306,P49366,E,137,A,6xxm:A,137,Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,1.0,,,,,,,,,,,,,P49366_E_137_A
7307,P49366,D,238,A,6xxm:A,238,Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,1.0,,,,,,,,,,,,,P49366_D_238_A
7308,P49366,D,243,A,6xxm:A,243,Reduces spermidine binding by 98%. Strongly reduced formation of covalent intermediate.,,-1.0,1.0,,,,,,,,,,,,,P49366_D_243_A
7309,P49366,K,287,A,6xxm:A,287,Reduces covalent intermediate formation and deoxyhypusine synthesis by 99.5%. Retains low spermidine cleavage activity.,,,1.0,,,,,,,,,,,,,P49366_K_287_A
7310,P49366,H,288,A,6xxm:A,288,Reduces spermidine binding by 98%. Strongly reduced NAD binding. Strongly reduced formation of covalent intermediate.,,-1.0,1.0,,,,,,,,,,,,,P49366_H_288_A
7311,P49366,Y,305,A,6xxm:A,305,Strongly reduced NAD binding. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P49366_Y_305_A
7312,P49366,D,313,A,6xxm:A,313,Strongly reduced NAD binding.,,-1.0,-999.0,,,,,,,,,,,,,P49366_D_313_A
7313,P49366,D,316,A,6xxm:A,316,Reduces spermidine binding by 98%. Loss of covalent intermediate formation and deoxyhypusine synthesis.,,-1.0,1.0,,,,,,,,,,,,,P49366_D_316_A
7314,P49366,S,317,A,6xxm:A,317,Strongly reduced NAD binding. No effect on enzyme activity.,,-1.0,0.0,,,,,,,,,,,,,P49366_S_317_A
7315,P49366,E,323,A,6xxm:A,323,Reduces spermidine binding by 98%. Strongly reduced formation of covalent intermediate.,,-1.0,1.0,,,,,,,,,,,,,P49366_E_323_A
7316,P49366,W,327,A,6xxm:A,327,Reduces spermidine binding by 98%. Loss of covalent intermediate formation and deoxyhypusine synthesis.,,-1.0,1.0,,,,,,,,,,,,,P49366_W_327_A
7317,P49366,K,329,A,6xxm:A,329,Loss of covalent intermediate formation and deoxyhypusine synthesis.,,,1.0,,,,,,,,,,,,,P49366_K_329_A
7317,P49366,K,329,R,6xxm:A,329,Loss of covalent intermediate formation and deoxyhypusine synthesis.,,,1.0,,,,,,,,,,,,,P49366_K_329_R
7318,P49366,D,342,A,6xxm:A,342,Strongly reduced NAD binding. Strongly reduced activity.,,-1.0,1.0,,,,,,,,,,,,,P49366_D_342_A
7319,Q13257,L,13,A,1s2h:A,13,Leads to formation the closed conformation and homodimerization. Reduces binding to MAD1L1.,,,-999.0,,,,,,,,,,,,,Q13257_L_13_A
7320,Q13257,W,75,A,1s2h:A,75,Prevents interaction with CDC20 and leads to formation of the closed conformation,-1.0,,-999.0,,,,,,,,,,,,,Q13257_W_75_A
7321,Q13257,R,133,A,1s2h:A,133,Prevents aggregation and promotes formation of monomeric protein that slowly interconverts between the open and closed conformation.,-1.0,,-999.0,,,,,,,,,,,,,Q13257_R_133_A
7322,Q13257,L,153,A,1s2h:A,153,Leads to formation of the closed conformation,1.0,,-999.0,,,,,,,,,,,,,Q13257_L_153_A
7323,Q13257,Y,156,A,1s2h:A,156,Leads to formation of the closed conformation,1.0,,-999.0,,,,,,,,,,,,,Q13257_Y_156_A
7324,Q13257,S,170,A,1s2h:A,170,Reduces phosphorylation on serine residues,,,-999.0,-1.0,,,,,,,,,,,,Q13257_S_170_A
7325,Q13257,S,170,D,1s2h:A,170,Abolishes interaction with MAD1L1 and reduces interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_S_170_D
7326,Q13257,S,178,A,1s2h:A,178,Reduces phosphorylation on serine residues,,,-999.0,-1.0,,,,,,,,,,,,Q13257_S_178_A
7327,Q13257,S,178,D,1s2h:A,178,Abolishes interaction with MAD1L1 and reduces interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_S_178_D
7328,Q13257,F,186,A,1s2h:A,186,Prevents formation of the closed conformation and interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_F_186_A
7329,Q13257,T,188,A,1s2h:A,188,Prevents formation of the closed conformation and interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_T_188_A
7330,Q13257,H,191,A,1s2h:A,191,Prevents formation of the closed conformation and interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_H_191_A
7331,Q13257,S,195,A,1s2h:A,195,Abolishes phosphorylation on serine residues,,,-999.0,-1.0,,,,,,,,,,,,Q13257_S_195_A
7332,Q13257,S,195,D,1s2h:A,195,Binds to the N and C-terminus of MAD1L1. Abolishes interaction with MAD1L1 and reduces interaction with CDC20,,,-999.0,,,,,,,,,,,,,Q13257_S_195_D
7333,Q13257,V,197,A,1s2h:A,197,Prevents formation of the closed conformation and interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_V_197_A
7334,Q13257,Y,199,A,1s2h:A,199,Prevents formation of the closed conformation and interaction with CDC20,-1.0,,-999.0,,,,,,,,,,,,,Q13257_Y_199_A
7335,O75143,S,127,H,5xv1:C,127,Abolishes interaction with ATG101,-1.0,,-999.0,,,,,,,,,,,,,O75143_S_127_H
7336,O75143,I,131,D,5xv1:C,131,Decreases interaction with ATG101,-1.0,,-999.0,,,,,,,,,,,,,O75143_I_131_D
7337,O75143,R,133,D,5xv1:C,133,Abolishes interaction with ATG101,-1.0,,-999.0,,,,,,,,,,,,,O75143_R_133_D
7338,O75143,V,134,D,5xv1:C,134,Decreases interaction with ATG101,-1.0,,-999.0,,,,,,,,,,,,,O75143_V_134_D
7339,O75140,S,1188,A,6cet:D,1188,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_S_1188_A
7340,O75140,T,1189,A,6cet:D,1189,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_T_1189_A
7341,O75140,S,1195,A,6cet:D,1195,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_S_1195_A
7342,O75140,S,1201,A,6cet:D,1201,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_S_1201_A
7343,O75140,Y,1203,A,6cet:D,1203,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_Y_1203_A
7344,O75140,S,1207,A,6cet:D,1207,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_S_1207_A
7345,O75140,T,1223,A,6cet:D,1223,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_T_1223_A
7346,O75140,T,1241,A,6cet:D,1241,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_T_1241_A
7347,O75140,S,1244,A,6cet:D,1244,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_S_1244_A
7348,O75140,T,1250,A,6cet:D,1250,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_T_1250_A
7349,O75140,Y,1253,A,6cet:D,1253,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_Y_1253_A
7350,O75140,Y,1256,A,6cet:D,1256,No effect on interaction with KLHL22.,0.0,,-999.0,,,,,,,,,,,,,O75140_Y_1256_A
7351,O75140,K,1574,R,6cet:D,1574,No effect on ubiquitination. Loss of ubiquitination,,,-999.0,,,,,,,,,,,,,O75140_K_1574_R
7352,O75147,F,17,R,2wwk:O,17,Diminishes binding affinity for TTN.,-1.0,,-999.0,,,,,,,,,,,,,O75147_F_17_R
7353,Q9H3S7,L,202,D,5mk2:B,202,Nearly abolishes interaction with CHMP4B. Abolishes interaction with CHMP4B,-1.0,,-999.0,,,,,,,,,,,,,Q9H3S7_L_202_D
7354,Q9H3S7,I,206,D,5mk2:B,206,Abolishes interaction with CHMP4B,-1.0,,-999.0,,,,,,,,,,,,,Q9H3S7_I_206_D
7355,Q9H3S7,F,678,S,5lm2:B,318,Abolishes interaction with UBAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q9H3S7_F_678_S
7355,Q9H3S7,F,678,D,5lm2:B,318,Abolishes interaction with UBAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q9H3S7_F_678_D
7356,P26196,E,247,Q,4ct5:A,247,Abolished helicase activity and ability to regulate RNA metabolism.,,,1.0,,,,,,,,,,,,,P26196_E_247_Q
7357,P26196,Q,320,A,4ct5:A,320,Abolishes interaction with EDC3,-1.0,,-999.0,,,,,,,,,,,,,P26196_Q_320_A
7358,P26196,H,323,A,4ct5:A,323,Abolishes interaction with EDC3,-1.0,,-999.0,,,,,,,,,,,,,P26196_H_323_A
7359,P26196,T,327,A,4ct5:A,327,Abolishes interaction with EDC3,-1.0,,-999.0,,,,,,,,,,,,,P26196_T_327_A
7360,P26196,R,331,A,4ct5:A,331,Abolishes interaction with EDC3,-1.0,,-999.0,,,,,,,,,,,,,P26196_R_331_A
7361,P26196,R,386,E,4ct5:A,386,Abolished ability to regulate RNA metabolism.,,,1.0,,,,,,,,,,,,,P26196_R_386_E
7362,P11441,L,43,A,2dzi:A,50,Reduces tail-anchored proteins delivery.,,,1.0,,,,,,,,,,,,,P11441_L_43_A
7363,P11441,K,48,R,2dzi:A,55,Loss of polyubiquitination by AMFR.,,,-999.0,,-1.0,,,,,,,,,,,P11441_K_48_R
7364,O95786,T,55,I,4p4h:B,55,No IRF3 signaling activity,,,1.0,,,,,,,,,,,,,O95786_T_55_I
7365,O95786,K,99,R,4p4h:B,99,Little or no effect on ubiquitination of the 2 CARD domain. Abolishes ubiquitination by RNF125.,,,-999.0,,-1.0,,,,,,,,,,,O95786_K_99_R
7366,O95786,K,154,R,4p4h:B,154,Reduction of ubiquitination. Reduction of INFB induction.,,,-999.0,,-1.0,,,,,,,,,,,O95786_K_154_R
7367,O95786,K,164,R,4p4h:B,164,Reduction of ubiquitination. Reduction of INFB induction.,,,-999.0,,-1.0,,,,,,,,,,,O95786_K_164_R
7368,O95786,K,169,R,4p4h:B,169,Little or no effect on ubiquitination of the 2 CARD domains.,,,-999.0,,0.0,,,,,,,,,,,O95786_K_169_R
7369,O95786,K,172,R,4p4h:B,172,Complete loss of ubiquitination. No interaction with MAVS/IPS1. No induction of IFN-beta.,-1.0,,-999.0,,-1.0,,,,,,,,,,,O95786_K_172_R
7370,O95786,K,181,R,4p4h:B,181,Little or no effect on ubiquitination of the 2 CARD domains.,,,-999.0,,0.0,,,,,,,,,,,O95786_K_181_R
7371,O95786,K,270,A,6kyv:B,270,No IRF3 signaling activity.,,,1.0,,,,,,,,,,,,,O95786_K_270_A
7372,O95786,N,495,Q,6kyv:B,495,Complete loss of herpes simplex virus 1 UL37-mediated deamidation,,,-999.0,,,,,,,,,,,,,O95786_N_495_Q
7373,O95786,N,549,Q,5f9f:E,549,Complete loss of herpes simplex virus 1 UL37-mediated deamidation,,,-999.0,,,,,,,,,,,,,O95786_N_549_Q
7374,O95786,K,788,R,5f9f:E,788,Decreased polyubiquitination. Loss of function in RIG-I signaling pathway. Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,,1.0,,-1.0,,,,,,,,,,,O95786_K_788_R
7375,O95786,K,849,R,5f9f:E,849,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,1.0,,-1.0,,,,,,,,,,,O95786_K_849_R
7376,O95786,K,851,R,5f9f:E,851,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,1.0,,-1.0,,,,,,,,,,,O95786_K_851_R
7377,O95786,K,888,R,5f9f:E,888,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,1.0,,-1.0,,,,,,,,,,,O95786_K_888_R
7378,O95786,K,907,R,5f9f:E,907,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,1.0,,-1.0,,,,,,,,,,,O95786_K_907_R
7379,O95786,K,909,R,5f9f:E,909,Decreased ubiquitination and function in RIG-I signaling pathway without effect on RNA-binding,,0.0,1.0,,-1.0,,,,,,,,,,,O95786_K_909_R
7380,P61077,N,77,S,3l1z:A,77,Activity is restricted HECT-type and not RING-containing E3 ubiquitin-protein ligases. Exhibits ubiquitin transfer with ARIH1 and PRKN.,,,1.0,,,,,,,,,,,,,P61077_N_77_S
7381,P61077,C,85,A,3l1z:A,85,Loss of function.,,,1.0,,,,,,,,,,,,,P61077_C_85_A
7382,P61077,D,87,E,3l1z:A,87,Has intermediate lysine reactivity.,,,1.0,,,,,,,,,,,,,P61077_D_87_E
7382,P61077,D,87,P,3l1z:A,87,Has intermediate lysine reactivity.,,,1.0,,,,,,,,,,,,,P61077_D_87_P
7383,P61077,D,87,K,3l1z:A,87,Abolishes affect lysine reactivity.,,,1.0,,,,,,,,,,,,,P61077_D_87_K
7384,P61077,D,87,N,3l1z:A,87,Does not affect lysine reactivity.,,,0.0,,,,,,,,,,,,,P61077_D_87_N
7385,P61077,D,117,H,3l1z:A,117,Strongly impairs lysine reactivity but retains some ability to transfer ubiquitin to BRCA1.,,,1.0,,,,,,,,,,,,,P61077_D_117_H
7388,O43314,R,213,A,3t9c:A,213,Reduces enzyme activity by about 99%.,,,1.0,,,,,,,,,,,,,O43314_R_213_A
7388,O43314,R,213,K,3t9c:A,213,Reduces enzyme activity by about 99%.,,,1.0,,,,,,,,,,,,,O43314_R_213_K
7389,O43314,K,248,A,3t9c:A,248,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,O43314_K_248_A
7390,O43314,R,262,A,3t9c:A,262,Reduces enzyme activity by about 99%.,,,1.0,,,,,,,,,,,,,O43314_R_262_A
7391,P51681,Y,3,D,6met:B,3,No sulfation and greatly decreased binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,,,,,,,,P51681_Y_3_D
7392,P51681,Y,3,F,6met:B,3,No sulfation and greatly decreases binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,,,,,,,,P51681_Y_3_F
7393,P51681,S,6,A,6met:B,6,No change in glycosylation status and greatly decreased CCL4 binding. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4,-1.0,,-999.0,,,0.0,,,,,,,,,,P51681_S_6_A
7394,P51681,S,7,A,6met:B,7,No change in glycosylation status and binds CCL4 as efficiently as wild type. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4,,,-999.0,,,0.0,,,,,,,,,,P51681_S_7_A
7395,P51681,Y,10,F,6met:B,10,No sulfation and greatly decreases binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,-1.0,,,,,,,P51681_Y_10_F
7396,P51681,Y,14,D,6met:B,14,No sulfation and greatly decreased binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,-1.0,,,,,,,P51681_Y_14_D
7397,P51681,Y,14,F,6met:B,14,No sulfation and greatly decreases binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,-1.0,,,,,,,P51681_Y_14_F
7398,P51681,Y,15,D,6met:B,15,No sulfation and greatly decreased binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,-1.0,,,,,,,P51681_Y_15_D
7399,P51681,Y,15,F,6met:B,15,No sulfation and greatly decreases binding of CCL4 and CCL5,-1.0,,-999.0,,,,,,-1.0,,,,,,,P51681_Y_15_F
7400,P51681,T,16,A,6met:B,16,Similar decrease in molecular mass when treated with O-glycosidase as for wild type,,,-999.0,,,,,,,,,,,,,P51681_T_16_A
7401,P51681,S,17,A,6met:B,17,Similar decrease in molecular mass when treated with O-glycosidase as for wild type,,,-999.0,,,,,,,,,,,,,P51681_S_17_A
7402,P51681,C,20,A,6met:B,20,Decreases to 40% surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection.,-1.0,,-999.0,,,,,,,,,1.0,,0.0,,P51681_C_20_A
7403,P51681,C,101,A,6met:B,101,Decreases to 40% surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection.,-1.0,,-999.0,,,,,,,,,1.0,,1.0,,P51681_C_101_A
7404,P51681,C,178,A,6met:B,178,Decreases to 40% surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection.,-1.0,,-999.0,,,,,,,,,1.0,,1.0,,P51681_C_178_A
7405,P51681,C,269,A,6met:B,269,Decreases to 40% surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection.,-1.0,,-999.0,,,,,,,,,1.0,,0.0,,P51681_C_269_A
7406,Q9NUW8,H,263,A,1qzq:A,263,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9NUW8_H_263_A
7407,Q9NUW8,K,265,A,1qzq:A,265,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,1.0,,,,,,,,,,,,,Q9NUW8_K_265_A
7408,Q9NUW8,K,265,S,1qzq:A,265,Reduces the activity to nearly undetectable levels.,,,1.0,,,,,,,,,,,,,Q9NUW8_K_265_S
7409,Q9NUW8,N,283,A,1qzq:A,283,No effect.,,,0.0,,,,,,,,,,,,,Q9NUW8_N_283_A
7410,Q9NUW8,Q,294,A,1qzq:A,294,Slightly reduced hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,1.0,,,,,,,,,,,,,Q9NUW8_Q_294_A
7411,Q9NUW8,H,493,A,1qzq:A,493,3000-fold reduction in activity,,,1.0,,,,,,,,,,,,,Q9NUW8_H_493_A
7412,Q9NUW8,H,493,N,1qzq:A,493,15000-fold reduction in activity.,,,1.0,,,,,,,,,,,,,Q9NUW8_H_493_N
7413,Q9NUW8,K,495,A,1qzq:A,495,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,1.0,,,,,,,,,,,,,Q9NUW8_K_495_A
7414,Q9NUW8,K,495,S,1qzq:A,495,125-fold reduction in activity.,,,1.0,,,,,,,,,,,,,Q9NUW8_K_495_S
7415,Q9NUW8,N,516,A,1qzq:A,516,Reduced hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,1.0,,,,,,,,,,,,,Q9NUW8_N_516_A
7416,Q9NUW8,E,538,A,1qzq:A,538,Abolishes hydrolysis of the covalent intermediate between the active site nucleophile and DNA.,,,1.0,,,,,,,,,,,,,Q9NUW8_E_538_A
7417,Q8IXI2,P,13,V,6d71:A,13,Causes constitutive activation inducing an aggregation of the mitochondrial network.,,,1.0,,,,,,,,,,,,,Q8IXI2_P_13_V
7418,Q8IXI2,T,18,N,6d71:A,18,Causes constitutive inactivation.,,,1.0,,,,,,,,,,,,,Q8IXI2_T_18_N
7419,Q8IXI2,E,208,K,5ku1:A,208,Abolishes the formation of thread-like mitochondria.,,,-999.0,,,,,,,,,,,,,Q8IXI2_E_208_K
7420,Q8IXI2,E,328,K,5ksz:A,328,Abolishes the formation of thread-like mitochondria.,,,-999.0,,,,,,,,,,,,,Q8IXI2_E_328_K
7421,Q8IXI2,K,427,V,5ksz:A,427,No effect.,,,0.0,,,,,,,,,,,,,Q8IXI2_K_427_V
7422,Q8IXI2,S,432,N,5ksz:A,432,No effect.,,,0.0,,,,,,,,,,,,,Q8IXI2_S_432_N
7423,O43318,K,34,R,5gjd:A,34,No effect on ubiquitination.,,,-999.0,,0.0,,,,,,,,,,,O43318_K_34_R
7424,O43318,K,63,W,5gjd:A,63,Loss of kinase activity. Loss of autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,O43318_K_63_W
7425,O43318,K,158,R,5gjf:A,158,Abolishes ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,O43318_K_158_R
7426,O43318,K,209,R,5gjf:A,209,Strongly decreases ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,O43318_K_209_R
7427,P63167,T,67,A,6gzj:A,67,Abolishes interaction with PAK1.,-1.0,,-999.0,,,,,,,,,,,,,P63167_T_67_A
7428,P63167,S,88,A,6gzj:A,88,Abolishes growth factor-mediated phosphorylation. Increases BCL2L11 protein level and promotes apoptosis.,,,-999.0,-1.0,,,,,,,,,,,,P63167_S_88_A
7429,P63167,S,88,E,6gzj:A,88,Abolishes homodimerization. Abolishes interaction with BCL2L11 isoform 1 and isoform 2.,-1.0,,-999.0,,,,,,,,,,,,,P63167_S_88_E
7430,P63165,F,36,A,1a5r:A,36,Abolishes binding to PIAS2.,-1.0,,-999.0,,,,,,,,,,,,,P63165_F_36_A
7431,P63165,G,97,A,1a5r:A,97,Abolishes sumoylation of ZBED1.,,,-999.0,,,,-1.0,,,,,,,,,P63165_G_97_A
7432,P56945,L,787,E,3t6g:B,787,Weakens interaction with SH2D3C.,-1.0,,-999.0,,,,,,,,,,,,,P56945_L_787_E
7433,P56945,F,794,R,3t6g:B,794,Weakens interaction with SH2D3C.,-1.0,,-999.0,,,,,,,,,,,,,P56945_F_794_R
7434,P56945,D,797,R,3t6g:B,797,Weakens interaction with SH2D3C.,-1.0,,-999.0,,,,,,,,,,,,,P56945_D_797_R
7435,Q9UHV8,R,53,H,6kjw:A,56,No effect on its haemagglutinating activity.,,,-999.0,,,,,,,,,,,,,Q9UHV8_R_53_H
7436,Q9UHV8,C,136,S,6kjw:A,139,Loss of homodimerization,-1.0,,-999.0,,,,,,,,,,,,,Q9UHV8_C_136_S
7437,Q9UHV8,C,138,S,6kjw:A,141,Loss of homodimerization,-1.0,,-999.0,,,,,,,,,,,,,Q9UHV8_C_138_S
7438,Q96FV9,L,617,P,1wxp:A,64,Loss of ability to induce apoptosis. Interferes with normal response of SaOS-2 cells to radiation.,-1.0,,-999.0,,,,,,,,,,,,,Q96FV9_L_617_P
7439,Q96FV9,W,620,P,1wxp:A,67,Loss of ability to induce apoptosis. Interferes with normal response of SaOS-2 cells to radiation.,-1.0,,-999.0,,,,,,,,,,,,,Q96FV9_W_620_P
7439,Q96FV9,W,620,R,1wxp:A,67,Loss of ability to induce apoptosis. Interferes with normal response of SaOS-2 cells to radiation.,-1.0,,-999.0,,,,,,,,,,,,,Q96FV9_W_620_R
7440,Q96BD8,R,155,A,4c9y:A,24,Abolishes microtubule binding,-1.0,,-999.0,,,,,,,,,,,,,Q96BD8_R_155_A
7441,Q96BD8,S,185,D,4c9y:A,54,Phosphomimetic mutant which strongly reduces microtubule binding,-1.0,,-999.0,,,,,,,,,,1.0,,,Q96BD8_S_185_D
7442,Q96BD8,R,236,A,4c9y:A,105,Abolishes microtubule binding,-1.0,,-999.0,,,,,,,,,,,,,Q96BD8_R_236_A
7443,Q96BD8,S,242,D,4c9y:A,111,Phosphomimetic mutant which strongly reduces microtubule binding,-1.0,,-999.0,,,,,,,,,,1.0,,,Q96BD8_S_242_D
7444,Q96BD8,R,245,A,4c9y:A,114,Abolishes microtubule binding,-1.0,,-999.0,,,,,,,,,,,,,Q96BD8_R_245_A
7445,Q15811,I,1078,K,6gbu:D,5,Abolishes interaction with FCHSD2.,-1.0,,-999.0,,,,,,,,,,,,,Q15811_I_1078_K
7445,Q15811,I,1078,S,6gbu:D,5,Abolishes interaction with FCHSD2.,-1.0,,-999.0,,,,,,,,,,,,,Q15811_I_1078_S
7446,Q15811,R,1119,A,6gbu:D,46,Abolishes interaction with FCHSD2.,-1.0,,-999.0,,,,,,,,,,,,,Q15811_R_1119_A
7446,Q15811,R,1119,E,6gbu:D,46,Abolishes interaction with FCHSD2.,-1.0,,-999.0,,,,,,,,,,,,,Q15811_R_1119_E
7447,Q15811,M,1369,L,1ki1:B,1369,Decreases specificity for CDC42,-1.0,,-999.0,,,,,,,,,,,,,Q15811_M_1369_L
7448,Q15811,L,1376,I,1ki1:B,1376,Decreases specificity for CDC42,-1.0,,-999.0,,,,,,,,,,,,,Q15811_L_1376_I
7449,P30530,E,63,R,2c5d:C,56,Slightly reduced affinity for GAS6.,-1.0,,-999.0,,,,,,,,,,,,,P30530_E_63_R
7450,P30530,E,66,R,2c5d:C,59,Reduced affinity for GAS6.,-1.0,,-999.0,,,,,,,,,,,,,P30530_E_66_R
7451,P30530,T,84,R,2c5d:C,77,Reduced affinity for GAS6.,-1.0,,-999.0,,,,,,,,,,,,,P30530_T_84_R
7452,P30533,H,283,A,2p03:A,249,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_283_A
7453,P30533,K,290,A,2p03:A,256,Reduces competition with MAPT for binding to LRP1,,,-999.0,,,,,,,,,,,,,P30533_K_290_A
7454,P30533,H,291,A,2p03:A,257,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_291_A
7455,P30533,H,293,A,2p03:A,259,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_293_A
7456,P30533,H,302,A,2p03:A,268,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_302_A
7457,P30533,K,304,A,2p03:A,270,Reduces competition with MAPT for binding to LRP1,,,-999.0,,,,,,,,,,,,,P30533_K_304_A
7458,P30533,H,307,A,2p03:A,273,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_307_A
7459,P30533,H,341,A,2p03:A,307,Strongly reduced interaction with LRP1,-1.0,,-999.0,,,,,,,,,,,,,P30533_H_341_A
7460,O14656,K,108,A,6oif:A,108,Loss of ATP-binding. No effect on interaction with KLHL14. Increases interaction with TOR1AIP1 and TOR1AIP2. Abolishes interaction with SLC6A3.,-1.0,-1.0,-999.0,,,,,,,,,,,,,O14656_K_108_A
7461,O14656,N,143,Q,6oif:A,143,Reduces N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,O14656_N_143_Q
7462,O14656,N,158,Q,6oif:A,158,Reduces N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,O14656_N_158_Q
7463,O14656,E,171,Q,6oif:A,171,Loss of ATP hydrolysis. Loss of interaction with KLHL14. Localizes in the nuclear envelope. No effect on interaction with TOR1AIP1.,-1.0,,1.0,,,,,,,,,1.0,,,,O14656_E_171_Q
7464,P49757,T,102,A,5njk:A,102,Loss of AAK1-mediated phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P49757_T_102_A
7465,P22830,F,110,A,2qd1:A,110,Increases activity inhibition upon interaction with PGRMC1.,,,1.0,,,,,,,,,,,,,P22830_F_110_A
7466,P22830,C,196,S,2qd1:A,196,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_196_S
7467,P22830,C,360,S,2qd1:A,360,No loss of activity.,,,0.0,,,,,,,,,,,,,P22830_C_360_S
7468,P22830,C,395,S,2qd1:A,395,No loss of activity.,,,0.0,,,,,,,,,,,,,P22830_C_395_S
7469,P22830,C,403,D,2qd1:A,403,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_403_D
7469,P22830,C,403,H,2qd1:A,403,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_403_H
7470,P22830,C,406,D,2qd1:A,406,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_406_D
7470,P22830,C,406,H,2qd1:A,406,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_406_H
7470,P22830,C,406,S,2qd1:A,406,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_406_S
7471,P22830,C,411,H,2qd1:A,411,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_411_H
7471,P22830,C,411,S,2qd1:A,411,Loss of activity.,,,1.0,,,,,,,,,,,,,P22830_C_411_S
7472,P22830,F,417,L,2qd1:A,417,Decreased activity.,,,1.0,,,,,,,,,,,,,P22830_F_417_L
7473,P22830,F,417,Y,2qd1:A,417,Greatly reduced activity.,,,1.0,,,,,,,,,,,,,P22830_F_417_Y
7473,P22830,F,417,W,2qd1:A,417,Greatly reduced activity.,,,1.0,,,,,,,,,,,,,P22830_F_417_W
7474,P51532,V,1484,A,5ea1:B,1484,No effect on binding to 'Lys-15'-acetylated histone H3.,0.0,,-999.0,,,,,,,,,,,,,P51532_V_1484_A
7475,P51532,F,1539,A,5ea1:B,1539,Abolishes binding to 'Lys-15'-acetylated histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P51532_F_1539_A
7476,P51532,N,1540,A,5ea1:B,1540,Abolishes binding to 'Lys-15'-acetylated histone H3.,-1.0,,-999.0,,,,,,,,,,,,,P51532_N_1540_A
7477,P61586,G,14,V,1cc0:A,14,Increased Rho protein signal transduction. Constitutively active.,,,1.0,,,,,,,,,,,,,P61586_G_14_V
7478,P61586,T,19,N,1cc0:A,19,Decreased Rho protein signal transduction. Decreased substrate adhesion-dependent cell spreading. Decreased stress fibers assembly. Decreased cytoplasmic microtubule organization.,,,-999.0,,,,,,,,,,,,,P61586_T_19_N
7479,P61586,Y,34,A,1cc0:A,34,Abolishes interaction with DGKQ.,-1.0,,-999.0,,,,,,,,,,,,,P61586_Y_34_A
7480,P61586,Y,34,F,1cc0:A,34,Abolishes AMPylation by Haemophilus IbpA.,,,-999.0,,,,,,-1.0,,,,,,,P61586_Y_34_F
7481,P61586,T,37,A,1cc0:A,37,Abolished monoglucosylation by C.difficile toxin TcdA. Abolished O-GlcNAcylation by C.novyi toxin TcdA.,,,-999.0,,,,,,-1.0,,,,,,,P61586_T_37_A
7482,P61586,Q,63,L,1cc0:A,63,Causes constitutive activation.,,,1.0,,,,,,,,,,,,,P61586_Q_63_L
7483,Q96E22,H,100,A,6z1n:B,100,3.5-fold reduction in catalytic activity and no marked change in affinity for FPP and IPP.,,0.0,1.0,,,,,,,,,,,,,Q96E22_H_100_A
7484,Q96E22,G,196,A,6z1n:B,196,Decreases binding to DHDDS.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_G_196_A
7485,Q96E22,K,197,A,6z1n:B,197,Decreases binding to DHDDS.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_K_197_A
7486,Q96E22,I,200,A,6z1n:B,200,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_I_200_A
7487,Q96E22,L,226,A,6z1n:B,226,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_L_226_A
7488,Q96E22,L,230,A,6z1n:B,230,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_L_230_A
7489,Q96E22,G,252,A,6z1n:B,252,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_G_252_A
7490,Q96E22,F,253,A,6z1n:B,253,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_F_253_A
7491,Q96E22,P,255,A,6z1n:B,255,Disrupts NUS1-DHDDS heterodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q96E22_P_255_A
7492,Q96E22,G,292,A,6z1n:B,292,Almost complete loss of catalytic activity.,,,1.0,,,,,,,,,,,,,Q96E22_G_292_A
7493,Q16611,H,164,A,2m5b:A,164,Strongly reduced zinc binding and homodimerization.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q16611_H_164_A
7494,P62166,E,81,T,2lcp:A,81,Reduces calcium binding,,-1.0,-999.0,,,,,,,,,,,,,P62166_E_81_T
7495,P62166,T,117,A,2lcp:A,117,Reduces calcium binding,,-1.0,-999.0,,,,,,,,,,,,,P62166_T_117_A
7496,P62166,T,165,A,2lcp:A,165,Reduces calcium binding,,-1.0,-999.0,,,,,,,,,,,,,P62166_T_165_A
7497,Q9ULG1,E,653,Q,6hts:G,653,Abolishes DNA-dependent ATPase and nucleosome remodeling activities.,,,1.0,,,,,,,,,,,,,Q9ULG1_E_653_Q
7498,P31751,T,309,A,3d0e:A,309,Impairs interaction with TTC3,-1.0,,-999.0,,,,,,,,,,,,,P31751_T_309_A
7499,P31751,T,309,E,3d0e:A,309,Constitutively active,,,1.0,,,,,,,,,,,,,P31751_T_309_E
7500,Q9NQU5,S,560,A,2c30:A,560,Complete loss of PAK6 activation by MAP2K6/MAPKK6,-1.0,,-999.0,,,,,,,,,,,,,Q9NQU5_S_560_A
7501,Q9NQU5,Y,566,F,2c30:A,566,Complete loss of PAK6 activation by MAP2K6/MAPKK6,-1.0,,-999.0,,,,,,,,,,,,,Q9NQU5_Y_566_F
7502,Q86XE5,S,77,A,3s5o:A,77,2-fold decrease in Kcat and a nearly 8-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_S_77_A
7503,Q86XE5,S,77,T,3s5o:A,77,Significant loss of activity.,,,1.0,,,,,,,,,,,,,Q86XE5_S_77_T
7504,Q86XE5,N,78,A,3s5o:A,78,6-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_N_78_A
7505,Q86XE5,N,78,Q,3s5o:A,78,25-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_N_78_Q
7506,Q86XE5,Y,140,F,3s5o:A,140,No change in activity.,,,0.0,,,,,,,,,,,,,Q86XE5_Y_140_F
7507,Q86XE5,Y,168,F,3s5o:A,168,No enzymatic activity.,,,1.0,,,,,,,,,,,,,Q86XE5_Y_168_F
7508,Q86XE5,K,196,A,3s5o:A,196,No enzymatic activity.,,,1.0,,,,,,,,,,,,,Q86XE5_K_196_A
7509,Q86XE5,S,198,A,3s5o:A,198,2.5-fold decrease in Kcat and 4.2 fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_S_198_A
7510,Q86XE5,S,198,T,3s5o:A,198,7-fold increase in KM.,,-1.0,1.0,,,,,,,,,,,,,Q86XE5_S_198_T
7511,Q9H6P5,D,233,A,2a8i:B,233,0.1% enzymatic activity,,,1.0,,,,,,,,,,,,,Q9H6P5_D_233_A
7512,Q9H6P5,T,234,A,2a8i:B,234,Complete loss of enzymatic activity,,,1.0,,,,,,,,,,,,,Q9H6P5_T_234_A
7513,P06729,K,67,R,1hnf:A,43,Loss of CD58 binding.,-1.0,,-999.0,,,,,,,,,,,,,P06729_K_67_R
7514,P06729,Q,70,K,1hnf:A,46,Loss of CD58 binding.,-1.0,,-999.0,,,,,,,,,,,,,P06729_Q_70_K
7515,P06729,Y,110,D,1hnf:A,86,Loss of CD58 and CD59 binding.,-1.0,,-999.0,,,,,,,,,,,,,P06729_Y_110_D
7516,P06729,D,111,H,1hnf:A,87,Loss of CD58 and CD59 binding.,-1.0,,-999.0,,,,,,,,,,,,,P06729_D_111_H
7517,P30626,F,112,L,4usl:A,112,Reduces affinity for calcium 5-fold.,,-1.0,-999.0,,,,,,,,,,,,,P30626_F_112_L
7518,Q8NAV1,D,145,A,4rz9:A,145,Loss of interaction with MFAP1.,-1.0,,-999.0,,,,,,,,,,,,,Q8NAV1_D_145_A
7519,P51668,K,4,E,4ap4:B,4,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_K_4_E
7520,P51668,D,42,R,4ap4:B,42,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_D_42_R
7521,P51668,F,62,A,4ap4:B,62,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_F_62_A
7522,P51668,D,87,R,4ap4:B,87,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_D_87_R
7523,P51668,S,94,E,4ap4:B,94,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_S_94_E
7524,P51668,T,98,E,4ap4:B,98,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_T_98_E
7525,P51668,D,112,R,4ap4:B,112,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_D_112_R
7526,P51668,D,116,R,4ap4:B,116,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_D_116_R
7527,P51668,D,117,R,4ap4:B,117,Decrease in autoubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P51668_D_117_R
7528,Q9UKA1,H,15,A,3u9j:A,15,Abolishes iron-binding and promotes its degradation.,,-1.0,-999.0,,,,,,,,,,,,,Q9UKA1_H_15_A
7529,Q9UKA1,H,57,A,3u9j:A,57,Abolishes iron-binding and promotes its degradation.,,-1.0,-999.0,,,,,,,,,,,,,Q9UKA1_H_57_A
7530,Q9UKA1,E,61,A,3u9j:A,61,Abolishes iron-binding and promotes its degradation.,,-1.0,-999.0,,,,,,,,,,,,,Q9UKA1_E_61_A
7531,Q969V5,H,319,A,6k2k:A,319,Abolishes ligase activity. No effect on mitochondrial localization.,,,1.0,,,,,,,,,0.0,,,,Q969V5_H_319_A
7532,Q969V5,C,339,A,6k2k:A,339,Abolishes ligase activity.,,,1.0,,,,,,,,,,,,,Q969V5_C_339_A
7533,O00257,I,16,F,2k28:A,11,"Reduced interaction with H3C15, H3C1 and RNF2.",-1.0,,-999.0,,,,,,,,,,,,,O00257_I_16_F
7534,O00255,A,187,F,3u84:A,182,Reduced interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,O00255_A_187_F
7535,O00255,M,283,W,3u84:A,278,Loss of interaction with KMT2A and JUND.,-1.0,,-999.0,,,,,,,,,,,,,O00255_M_283_W
7536,O00255,D,290,R,3u84:A,285,Reduced interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O00255_D_290_R
7537,O00255,E,293,R,3u84:A,288,Reduced interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O00255_E_293_R
7538,O00255,E,295,R,3u84:A,290,Reduced interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O00255_E_295_R
7539,O00255,Y,324,A,3u84:A,319,Reduced interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,O00255_Y_324_A
7540,O00255,Y,328,A,3u84:A,323,Reduced interaction with KMT2A.,-1.0,,-999.0,,,,,,,,,,,,,O00255_Y_328_A
7541,O00255,E,371,A,3u84:A,366,Reduced interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O00255_E_371_A
7542,O00255,D,375,A,3u84:A,370,Reduced interaction with KMT2A,-1.0,,-999.0,,,,,,,,,,,,,O00255_D_375_A
7543,Q9HBL8,R,37,A,2exx:A,37,Impairs binding to NADPH,,-1.0,-999.0,,,,,,,,,,,,,Q9HBL8_R_37_A
7544,Q9HBL8,K,41,S,2exx:A,41,Does not impair binding to NADPH,,0.0,-999.0,,,,,,,,,,,,,Q9HBL8_K_41_S
7545,Q9HBL8,Y,81,A,2exx:A,81,Impairs binding to NADPH,,-1.0,-999.0,,,,,,,,,,,,,Q9HBL8_Y_81_A
7546,Q9HBL8,K,133,A,2exx:A,133,Impairs binding to NADPH,,-1.0,-999.0,,,,,,,,,,,,,Q9HBL8_K_133_A
7547,Q9BZP6,D,138,A,3fxy:A,138,Loss of chitinase activity. No effect on protection against apoptosis or on AKT1 activation.,,,1.0,,,,,,,,,,,,,Q9BZP6_D_138_A
7548,P52848,K,614,A,1nst:A,614,Loss of sulfotransferase activity.,,,1.0,,,,,,,,,,,,,P52848_K_614_A
7549,P84243,R,43,K,3wtp:E,42,Reduced binding of histone H1 to histone H3.3-containing nucleosomes.,-1.0,,-999.0,,,,,,,,,,,,,P84243_R_43_K
7550,P83916,I,161,E,2fmm:A,161,Abolishes homodimer formation and binding to EMSY.,-1.0,,-999.0,,,,,,,,,,,,,P83916_I_161_E
7551,P28074,A,108,T,6mse:R,49,"Displays resistance to the bortezomib, a proteasome inhibitor of the chymotrypsin-like activity. Displays high resistance to the bortezomib, a proteasome inhibitor of the chymotrypsin-like activity",,-1.0,-999.0,,,,,,,,,,,,,P28074_A_108_T
7552,P28074,A,108,V,6mse:R,49,"Displays high resistance to the bortezomib, a proteasome inhibitor of the chymotrypsin-like activity.",,-1.0,-999.0,,,,,,,,,,,,,P28074_A_108_V
7553,P28074,A,109,V,6mse:R,50,"Displays high resistance to the bortezomib, a proteasome inhibitor of the chymotrypsin-like activity",,-1.0,-999.0,,,,,,,,,,,,,P28074_A_109_V
7554,Q96PS8,E,27,Q,6f7h:D,27,Abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_E_27_Q
7555,Q96PS8,G,73,A,6f7h:D,73,Increased permeability to glycerol at acidic pH.,,,1.0,,,,,,,,,,,,,Q96PS8_G_73_A
7556,Q96PS8,G,73,F,6f7h:D,73,Abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_G_73_F
7557,Q96PS8,S,77,A,6f7h:D,77,Nearly abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_S_77_A
7557,Q96PS8,S,77,D,6f7h:D,77,Nearly abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_S_77_D
7558,Q96PS8,H,80,A,6f7h:D,80,Abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_H_80_A
7559,Q96PS8,F,85,A,6f7h:D,85,Nearly abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_F_85_A
7560,Q96PS8,R,94,A,6f7h:D,94,Abolishes permeability to glycerol.,,,1.0,,,,,,,,,,,,,Q96PS8_R_94_A
7561,Q96PS8,N,133,Q,6f7h:D,133,Abolishes N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q96PS8_N_133_Q
7562,P35052,N,79,Q,4bwe:B,79,"Protein yield reduced by half. Protein yield reduced by 90%, abolishes N-glycosylation but no effect on secondary structure",,,-999.0,,,-1.0,,,,,,,,0.0,-1.0,P35052_N_79_Q
7563,P35052,N,116,Q,4bwe:B,116,"No effect on protein yield. Protein yield reduced by 90%, abolishes N-glycosylation but no effect on secondary structure",,,-999.0,,,-1.0,,,,,,,,0.0,,P35052_N_116_Q
7564,O60563,C,261,Y,4or5:B,261,Loss of HIV-1 Tat transactivation.,,,-999.0,,,,,,,,,,,,,O60563_C_261_Y
7565,O60566,A,159,W,6tlj:S,159,Loss of interaction with KNL1.,-1.0,,-999.0,,,,,,,,,,,,,O60566_A_159_W
7566,O60566,F,175,A,6tlj:S,175,Loss of interaction with KNL1.,-1.0,,-999.0,,,,,,,,,,,,,O60566_F_175_A
7567,Q9UMR5,S,111,A,1pja:A,111,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9UMR5_S_111_A
7568,Q9UMR5,D,228,A,1pja:A,228,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9UMR5_D_228_A
7569,Q9UMR5,H,283,A,1pja:A,283,Abolishes enzymatic activity.,,,1.0,,,,,,,,,,,,,Q9UMR5_H_283_A
7570,Q9UMR5,H,287,A,1pja:A,287,No effect on enzymatic activity.,,,0.0,,,,,,,,,,,,,Q9UMR5_H_287_A
7571,Q9H0R8,G,116,A,5lxi:D,116,No processing of precursor.,,,1.0,,,,,,,,,,,,,Q9H0R8_G_116_A
7572,Q9UMR2,D,223,R,6b4j:E,223,Impairs interaction with NUP214 and RNA.,-1.0,-1.0,-999.0,,,,,,,,,,,,,Q9UMR2_D_223_R
7573,Q9UMR2,E,243,Q,6b4j:E,243,Loss of activity.,,,1.0,,,,,,,,,,,,,Q9UMR2_E_243_Q
7574,Q9UMR2,I,258,A,6b4j:E,258,Impairs interaction with NUP214.,-1.0,,-999.0,,,,,,,,,,,,,Q9UMR2_I_258_A
7575,Q9UMR2,R,259,D,6b4j:E,259,Impairs interaction with NUP214.,-1.0,,-999.0,,,,,,,,,,,,,Q9UMR2_R_259_D
7576,Q9UMR2,R,262,A,6b4j:E,262,Impairs interaction with NUP214.,-1.0,,-999.0,,,,,,,,,,,,,Q9UMR2_R_262_A
7577,O15264,T,180,A,4myg:A,180,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O15264_T_180_A
7578,O15264,Y,182,A,4myg:A,182,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,O15264_Y_182_A
7579,P57768,R,144,A,5gw1:C,144,Abolishes binding to membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P57768_R_144_A
7580,P57768,Y,145,A,5gw1:C,145,Abolishes binding to phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,P57768_Y_145_A
7581,O75446,C,67,A,2kdp:A,67,Abolishes zinc-binding.,,-1.0,-999.0,,,,,,,,,,,,,O75446_C_67_A
7582,O75446,C,68,A,2kdp:A,68,Retains zinc-binding.,,-1.0,-999.0,,,,,,,,,,,,,O75446_C_68_A
7583,O75446,H,108,A,2kdp:A,108,Retains zinc-binding.,,-1.0,-999.0,,,,,,,,,,,,,O75446_H_108_A
7584,O75446,C,112,A,2kdp:A,112,Abolishes zinc-binding.,,-1.0,-999.0,,,,,,,,,,,,,O75446_C_112_A
7585,Q7RTV0,Y,36,C,7abg:y,36,"No apparent effect on cell growth, localization of SF3B1 protein or formation of nuclear speckles. Alters the structure of the presumed branchpoint (BP) adenosine binding pocket within the splicing factor SF3B complex which may lead to decreased binding affinity and thus affect pre-mRNA splicing.",,-1.0,-999.0,,,,,,,,,,,-1.0,,Q7RTV0_Y_36_C
7586,Q7RTV0,Y,36,E,7abg:y,36,Alters the structure of the presumed branchpoint (BP) adenosine binding pocket within the splicing factor SF3B complex which may lead to decreased binding affinity and thus affect pre-mRNA splicing.,,-1.0,-999.0,,,,,,,,,,,,,Q7RTV0_Y_36_E
7586,Q7RTV0,Y,36,S,7abg:y,36,Alters the structure of the presumed branchpoint (BP) adenosine binding pocket within the splicing factor SF3B complex which may lead to decreased binding affinity and thus affect pre-mRNA splicing.,,-1.0,-999.0,,,,,,,,,,,,,Q7RTV0_Y_36_S
7586,Q7RTV0,Y,36,A,7abg:y,36,Alters the structure of the presumed branchpoint (BP) adenosine binding pocket within the splicing factor SF3B complex which may lead to decreased binding affinity and thus affect pre-mRNA splicing.,,-1.0,-999.0,,,,,,,,,,,,,Q7RTV0_Y_36_A
7587,Q8N4T8,G,9,S,4cqm:F,9,Unable to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q8N4T8_G_9_S
7588,Q8N4T8,R,12,A,4cqm:F,12,Strongly reduced ability to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q8N4T8_R_12_A
7589,Q8N4T8,R,34,A,4cqm:F,34,"Strongly reduced ability to restore growth of an OAR1-deficient yeast mutant. Strongly reduces NADPH-dependent reductase activity with acetoacetyl-CoA and 9,10-phenanthrene quinone. No effect on NADH-dependent reductase activities.",,,-999.0,,,,,,,,,,,,,Q8N4T8_R_34_A
7590,Q8N4T8,S,135,A,4cqm:F,135,Unable to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q8N4T8_S_135_A
7591,Q8N4T8,Y,148,A,4cqm:F,148,Unable to restore growth of an OAR1-deficient yeast mutant.,,,-999.0,,,,,,,,,,,,,Q8N4T8_Y_148_A
7592,Q8N4T8,K,152,A,4cqm:F,152,"Unable to restore growth of an OAR1-deficient yeast mutant. Abolishes NADPH-dependent reductase activity with acetoacetyl-CoA. Strongly reduces NADPH-dependent reductase activity with 9,10-phenanthrene quinone. No effect on NADH-dependent reductase activities.",,,-999.0,,,,,,,,,,,,,Q8N4T8_K_152_A
7593,Q8N4T8,R,168,E,4cqm:F,168,"Strongly reduced ability to restore growth of an OAR1-deficient yeast mutant. Increases NADPH-dependent reductase activity with acetoacetyl-CoA. Reduces NADPH-dependent reductase activity with 9,10-phenanthrene quinone. No effect on NADH-dependent reductase activities.",,,-999.0,,,,,,,,,,,,,Q8N4T8_R_168_E
7594,Q8N4T8,K,169,E,4cqm:F,169,"Unable to restore growth of an OAR1-deficient yeast mutant. Increases NADPH-dependent reductase activity with acetoacetyl-CoA. Reduces NADPH-dependent reductase activity with 9,10-phenanthrene quinone. No effect on NADH-dependent reductase activities.",,,-999.0,,,,,,,,,,,,,Q8N4T8_K_169_E
7595,O95881,C,66,S,2k8v:A,51,Loss of oxidase activity.,,,1.0,,,,,,,,,,,,,O95881_C_66_S
7596,O95881,C,69,S,2k8v:A,54,Loss of oxidase activity.,,,1.0,,,,,,,,,,,,,O95881_C_69_S
7597,Q9H792,F,1609,A,6bhc:A,1609,No effect on interaction with PRAG1.,0.0,,-999.0,,,,,,,,,,,,,Q9H792_F_1609_A
7598,Q9H792,A,1707,D,6bhc:A,1707,Disrupts homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q9H792_A_1707_D
7599,O75449,K,255,A,5zql:A,255,Abolishes ATP dependent microtubule severing activity and localization to spindle poles.,,,1.0,,,,,,,,,1.0,,,,O75449_K_255_A
7600,O75449,D,308,N,5zql:A,308,Abolishes ATP dependent microtubule severing activity and localization to spindle poles,,,1.0,,,,,,,,,1.0,,,,O75449_D_308_N
7601,O75449,E,309,N,5zql:A,309,Abolishes ATP dependent microtubule severing activity and localization to spindle poles,,,1.0,,,,,,,,,1.0,,,,O75449_E_309_N
7602,P20591,S,81,C,4p4s:A,81,"No effect on GTP-binding, nor on viral infection.",,0.0,-999.0,,,,,,,,,,,,,P20591_S_81_C
7603,P20591,K,83,A,4p4s:A,83,Loss of GTP-binding. Loss of potentiation of TRPC6 activity. Loss of protection against viral infection.,,-1.0,1.0,,,,,,,,,,,,,P20591_K_83_A
7604,P20591,K,83,M,4p4s:A,83,Loss of GTP-binding. Loss of protection against viral infection.,,,1.0,,,,,,,,,,,,,P20591_K_83_M
7605,P20591,T,103,A,4p4s:A,103,Loss of GTP-binding. Loss of potentiation of TRPC6 activity. Loss of protection against viral infection.,,,1.0,,,,,,,,,,,,,P20591_T_103_A
7606,P20591,L,612,K,3szr:A,612,"Loss of GTP-hydrolysis. No effect on GTP-binding, nor on potentiation of TRPC6 activity.",,0.0,1.0,,,,,,,,,,,,,P20591_L_612_K
7607,P20591,E,632,A,3szr:A,632,Reduced antiviral activity.,,,1.0,,,,,,,,,,,,,P20591_E_632_A
7608,P20591,R,640,A,3szr:A,640,"Fails to sequester viral nucleoproteins, no antiviral activity.",-1.0,,1.0,,,,,,,,,,,,,P20591_R_640_A
7609,P20591,E,645,R,3szr:A,645,Loss of antiviral activity towards CCHFV and LACV.,,,1.0,,,,,,,,,,,,,P20591_E_645_R
7610,P60228,L,312,D,6fec:3,312,Promotes nuclear accumulation.,,,-999.0,,,,,,,,,1.0,,,,P60228_L_312_D
7611,P17612,K,48,R,4ujb:A,47,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_K_48_R
7612,P17612,L,96,Q,4ujb:A,95,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_L_96_Q
7613,P17612,M,121,L,4ujb:A,120,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_M_121_L
7614,P17612,V,124,A,4ujb:A,123,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_V_124_A
7615,P17612,Q,182,K,4ujb:A,181,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_Q_182_K
7616,P17612,T,184,A,4ujb:A,183,Enhanced basal kinase activity,,,1.0,,,,,,,,,,,,,P17612_T_184_A
7617,P17612,R,195,A,4ujb:A,194,No phosphorylation.,,,1.0,,,,,,,,,,,,,P17612_R_195_A
7618,P17612,G,201,A,4ujb:A,200,No phosphorylation.,,,1.0,,,,,,,,,,,,,P17612_G_201_A
7619,P17612,T,202,A,4ujb:A,201,No phosphorylation.,,,1.0,,,,,,,,,,,,,P17612_T_202_A
7620,P17612,Y,205,A,4ujb:A,204,Loss of allosteric regulation.,,,-999.0,,,,,,,,,,,,,P17612_Y_205_A
7621,P35270,S,213,A,7dsf:A,213,Abolishes phosphorylation by CaMK2. No effect on kinetic parameters.,,,0.0,-1.0,,,,,,,,,,,,P35270_S_213_A
7622,P10301,G,38,V,2fn4:A,38,No effect on interaction with OSBPL3.,0.0,,-999.0,,,,,,,,,,,,,P10301_G_38_V
7623,P10301,S,43,N,2fn4:A,43,No effect on interaction with OSBPL3.,0.0,,-999.0,,,,,,,,,,,,,P10301_S_43_N
7624,Q9H3N1,C,56,S,1x5e:A,34,Loss of reductase activity,,,1.0,,,,,,,,,,,,,Q9H3N1_C_56_S
7625,Q9H3N1,C,59,S,1x5e:A,37,Loss of reductase activity,,,1.0,,,,,,,,,,,,,Q9H3N1_C_59_S
7626,Q9H488,R,240,A,5ux6:A,240,Strongly impaired ability to activate NOTCH signaling.,,,1.0,,,,,,,,,,,,,Q9H488_R_240_A
7626,Q9H488,R,240,C,5ux6:A,240,Strongly impaired ability to activate NOTCH signaling.,,,1.0,,,,,,,,,,,,,Q9H488_R_240_C
7627,Q9H488,M,262,T,5ux6:A,262,No effect on ability to activate NOTCH signaling.,,,0.0,,,,,,,,,,,,,Q9H488_M_262_T
7628,Q9H488,S,356,F,5ux6:A,356,Abolishes ability to activate NOTCH signaling.,,,1.0,,,,,,,,,,,,,Q9H488_S_356_F
7629,Q9H488,R,366,W,5ux6:A,366,Strongly impaired ability to activate NOTCH signaling.,,,1.0,,,,,,,,,,,,,Q9H488_R_366_W
7630,Q92820,C,134,A,1l9x:A,110,Loss of activity.,,,1.0,,,,,,,,,,,,,Q92820_C_134_A
7631,Q92820,H,195,N,1l9x:A,171,Reduces activity 250-fold.,,,1.0,,,,,,,,,,,,,Q92820_H_195_N
7632,Q92820,H,244,A,1l9x:A,220,Loss of activity.,,,1.0,,,,,,,,,,,,,Q92820_H_244_A
7633,Q92820,E,246,A,1l9x:A,222,Slightly reduced catalytic activity.,,,1.0,,,,,,,,,,,,,Q92820_E_246_A
7634,P17948,K,861,M,3hng:A,861,Abolishes enzyme activity. Abolishes interaction with PLCG.,-1.0,,1.0,,,,,,,,,,,,,P17948_K_861_M
7635,P17948,Y,914,F,3hng:A,914,Reduces phosphorylation at other tyrosine residues.,,,-999.0,-1.0,,,,,,,,,,,,P17948_Y_914_F
7636,P17948,N,1050,D,3hng:A,1050,Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells.,,,1.0,,,,,,,,,,,,,P17948_N_1050_D
7637,Q9Y6B7,W,635,A,2mj7:A,37,Decreased interaction with TEPSIN.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6B7_W_635_A
7638,Q9Y6B7,I,669,A,2mj7:A,71,Decreased interaction with TEPSIN,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6B7_I_669_A
7639,Q9Y6B7,A,670,S,2mj7:A,72,Decreased interaction with TEPSIN,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6B7_A_670_S
7640,Q9Y6B7,Y,682,A,2mj7:A,84,Decreased interaction with TEPSIN.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6B7_Y_682_A
7640,Q9Y6B7,Y,682,V,2mj7:A,84,Decreased interaction with TEPSIN.,-1.0,,-999.0,,,,,,,,,,,,,Q9Y6B7_Y_682_V
7641,Q86T24,C,552,R,2lt7:A,552,Abrogates both sequence-specific and methylation-dependent DNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,Q86T24_C_552_R
7642,P46108,D,150,K,2eyz:A,150,Abolishes interaction with DOCK1.,-1.0,,-999.0,,,,,,,,,,,,,P46108_D_150_K
7643,P46108,W,169,K,2eyz:A,169,Abolishes interaction with PEAK3.,-1.0,,-999.0,,,,,,,,,,,,,P46108_W_169_K
7644,P46108,W,169,L,2eyz:A,169,Abolishes interaction with DOCK5. Abolishes RAP1 activation.,-1.0,,-999.0,,,,,,,,,,,,,P46108_W_169_L
7645,P46108,W,275,K,2eyz:A,275,No effect on interaction with PEAK3.,0.0,,-999.0,,,,,,,,,,,,,P46108_W_275_K
7646,Q15084,C,55,S,3w8j:A,55,50% decrease in enzyme activity,,,1.0,,,,,,,,,,,,,Q15084_C_55_S
7647,Q15084,C,58,A,3w8j:A,58,Accelerates dephosphorylation of ERN1,,,1.0,,,,,,,,,,,,,Q15084_C_58_A
7648,Q15084,C,58,S,3w8j:A,58,50% decrease in enzyme activity,,,1.0,,,,,,,,,,,,,Q15084_C_58_S
7649,Q15084,C,190,S,1x5d:A,37,25% decrease in enzyme activity,,,1.0,,,,,,,,,,,,,Q15084_C_190_S
7650,Q15084,C,193,A,1x5d:A,40,Accelerates dephosphorylation of ERN1,,,1.0,,,,,,,,,,,,,Q15084_C_193_A
7651,Q15084,C,193,S,1x5d:A,40,90% decrease in enzyme activity,,,1.0,,,,,,,,,,,,,Q15084_C_193_S
7652,Q9Y580,F,13,A,2m8h:A,20,Decreases affinity for RNA binding. Does not affect The NEXT complex assembly. Impairs snRNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y580_F_13_A
7653,Q9Y580,L,25,E,2m8h:A,32,Impaired interaction with ZCCHC8,-1.0,,-999.0,,,,,,,,,,,,,Q9Y580_L_25_E
7654,Q9Y580,L,29,E,2m8h:A,36,Impaired interaction with ZCCHC8,-1.0,,-999.0,,,,,,,,,,,,,Q9Y580_L_29_E
7655,Q9Y580,K,50,A,2m8h:A,57,Abrogates the interaction with 7SK small nuclear RNA (7SK),,-1.0,-999.0,,,,,,,,,,,,,Q9Y580_K_50_A
7656,Q9Y580,F,52,A,2m8h:A,59,Decreases affinity for RNA binding. Abrogates the interaction with 7SK small nuclear RNA (7SK),,-1.0,-999.0,,,,,,,,,,,,,Q9Y580_F_52_A
7657,Q9Y580,F,54,A,2m8h:A,61,Abrogates the interaction with 7SK small nuclear RNA (7SK),,-1.0,-999.0,,,,,,,,,,,,,Q9Y580_F_54_A
7658,Q9Y580,Y,65,A,2m8h:A,72,"Reduced interaction with ZCCHC8, and impaired interaction with SF3B2/SAP145",-1.0,,-999.0,,,,,,,,,,,,,Q9Y580_Y_65_A
7659,Q9Y580,L,69,E,2m8h:A,76,"Reduced interaction with ZCCHC8, and impaired interaction with SF3B2/SAP145",-1.0,,-999.0,,,,,,,,,,,,,Q9Y580_L_69_E
7660,Q15080,R,58,Q,1h6h:A,58,Abolishes interaction with membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,Q15080_R_58_Q
7661,Q15080,R,60,A,1h6h:A,60,Strongly reduces interaction with membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,Q15080_R_60_A
7662,Q15080,K,92,A,1h6h:A,92,Abolishes interaction with membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,Q15080_K_92_A
7663,Q15080,Y,94,A,1h6h:A,94,Slightly reduces interaction with membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,Q15080_Y_94_A
7664,Q15080,R,105,A,1h6h:A,105,Abolishes interaction with membranes enriched in phosphatidylinositol 3-phosphate.,,-1.0,-999.0,,,,,,,,,,,,,Q15080_R_105_A
7665,Q15080,T,211,A,2dyb:A,211,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q15080_T_211_A
7666,Q15080,T,251,A,2dyb:A,251,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q15080_T_251_A
7667,Q15080,T,274,A,2dyb:A,274,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q15080_T_274_A
7668,Q15080,S,315,A,2dyb:A,315,Reduces phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,Q15080_S_315_A
7669,Q15080,T,327,A,2dyb:A,327,No effect on phosphorylation.,,,-999.0,0.0,,,,,,,,,,,,Q15080_T_327_A
7670,P49116,I,576,N,3p0u:A,595,Reduces interaction with JAZF1.,-1.0,,-999.0,,,,,,,,,,,,,P49116_I_576_N
7671,Q14289,K,457,A,3cc6:A,457,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q14289_K_457_A
7672,Q14289,Y,881,F,3gm1:B,881,Loss of phosphorylation site. Strongly reduced interaction with GRB2.,-1.0,,-999.0,-1.0,,,,,,,,,,,,Q14289_Y_881_F
7673,Q76LX8,E,83,A,6qig:A,83,No change in calcium dependence for proteolysis.,,0.0,-999.0,,,,,,,,,,,,,Q76LX8_E_83_A
7674,Q76LX8,D,173,A,6qig:A,173,No change in calcium dependence for proteolysis.,,0.0,-999.0,,,,,,,,,,,,,Q76LX8_D_173_A
7675,Q76LX8,E,184,A,6qig:A,184,Dramatically reduced affinity for calcium.,,-1.0,-999.0,,,,,,,,,,,,,Q76LX8_E_184_A
7676,Q76LX8,D,187,A,6qig:A,187,Dramatically reduced affinity for calcium.,,-1.0,-999.0,,,,,,,,,,,,,Q76LX8_D_187_A
7677,Q76LX8,E,212,A,6qig:A,212,Dramatically reduced affinity for calcium.,,-1.0,-999.0,,,,,,,,,,,,,Q76LX8_E_212_A
7678,Q76LX8,S,399,A,6qig:A,399,No effect on cleavage of VWF and little change in secretion of ADAMTS13. Abolishes secretion of ADAMTS13,,,-999.0,,,,,,,,,1.0,,,,Q76LX8_S_399_A
7679,O75626,P,84,G,3dal:A,47,Protein instability caused by increased susceptibility to proteasomal degradation.,,,-999.0,,,,,,,,,,,-1.0,,O75626_P_84_G
7679,O75626,P,84,K,3dal:A,47,Protein instability caused by increased susceptibility to proteasomal degradation.,,,-999.0,,,,,,,,,,,-1.0,,O75626_P_84_K
7680,O75626,I,107,G,3dal:A,70,Protein instability caused by increased susceptibility to proteasomal degradation.,,,-999.0,,,,,,,,,,,-1.0,,O75626_I_107_G
7680,O75626,I,107,K,3dal:A,70,Protein instability caused by increased susceptibility to proteasomal degradation.,,,-999.0,,,,,,,,,,,-1.0,,O75626_I_107_K
7681,O75628,T,94,N,2nzj:B,94,No endothelial cell sprouting.,,,-999.0,,,,,,,,,,,,,O75628_T_94_N
7682,P45452,E,223,A,4g0d:A,223,Abolishes enzyme activity.,,,1.0,,,,,,,,,,,,,P45452_E_223_A
7683,P42330,K,75,E,4zfc:B,75,No effect on 17beta-HSD activity.,,,0.0,,,,,,,,,,,,,P42330_K_75_E
7684,Q9BRA2,C,43,S,1wou:A,43,Loss of peroxidase activity.,,,1.0,,,,,,,,,,,,,Q9BRA2_C_43_S
7685,Q9BRA2,C,46,S,1wou:A,46,Loss of peroxidase activity.,,,1.0,,,,,,,,,,,,,Q9BRA2_C_46_S
7686,P09012,T,11,V,1fht:A,10,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P09012_T_11_V
7687,P09012,Y,13,F,1fht:A,12,Substantially reduces RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P09012_Y_13_F
7688,P09012,N,15,V,1fht:A,14,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P09012_N_15_V
7689,P09012,N,16,V,1fht:A,15,Substantially reduces RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P09012_N_16_V
7690,P09012,R,52,Q,1fht:A,51,Abolishes RNA binding.,,-1.0,-999.0,,,,,,,,,,,,,P09012_R_52_Q
7691,P30989,C,381,S,6up7:R,381,Abolishes palmitoylation,,,-999.0,,,,,,-1.0,,,,,,,P30989_C_381_S
7692,Q92622,C,912,G,6wcw:A,912,"Disrupts interaction with Rab7, translocation to cytoplasm",-1.0,,-999.0,,,,,,,,,1.0,,,,Q92622_C_912_G
7693,Q92622,C,915,G,6wcw:A,915,"Disrupts interaction with Rab7, translocation to cytoplasm",-1.0,,-999.0,,,,,,,,,1.0,,,,Q92622_C_915_G
7694,Q92622,H,920,L,6wcw:A,920,"Disrupts interaction with Rab7, translocation to cytoplasm",-1.0,,-999.0,,,,,,,,,1.0,,,,Q92622_H_920_L
7695,Q92622,C,923,G,6wcw:A,923,"Disrupts interaction with Rab7, translocation to cytoplasm",-1.0,,-999.0,,,,,,,,,1.0,,,,Q92622_C_923_G
7696,Q9Y232,S,521,A,2gtr:A,184,Abolishes CoA-binding and ability to inhibit histone crotonylation.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y232_S_521_A
7697,Q66K64,V,90,D,6ud7:A,90,"Abolished interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_V_90_D
7698,Q66K64,L,91,P,6ud7:A,91,"Abolished interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_L_91_P
7699,Q66K64,W,112,R,6ud7:A,112,"Abolished interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_W_112_R
7700,Q66K64,F,129,S,6ud7:A,129,"Abolished interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_F_129_S
7700,Q66K64,F,129,V,6ud7:A,129,"Abolished interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_F_129_V
7701,Q66K64,V,182,D,6ud7:A,182,"Decreased interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_V_182_D
7702,Q66K64,C,196,Y,6ud7:A,196,"Decreased interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_C_196_Y
7703,Q66K64,Q,232,R,6pai:C,232,"Decreased interaction with RBM39 in presence of indisulam, without affecting interaction with DDA1 and DDB1.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_Q_232_R
7704,Q66K64,L,244,P,6pai:C,244,"Decreased interaction with DDB1, DDA1 and RBM39 in presence of indisulam.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_L_244_P
7705,Q66K64,T,420,P,6ud7:A,420,Decreased interaction with DDA1 and RBM39 in presence of indisulam.,-1.0,,-999.0,,,,,,,,,,,,,Q66K64_T_420_P
7706,Q66K64,E,444,K,6ud7:A,444,Decreased interaction with DDA1 and RBM39 in presence of indisulam.,-1.0,,-999.0,,,,,,,,,,,,,Q66K64_E_444_K
7707,Q66K64,V,453,D,6ud7:A,453,Decreased interaction with DDA1 and RBM39 in presence of indisulam.,-1.0,,-999.0,,,,,,,,,,,,,Q66K64_V_453_D
7708,Q66K64,D,475,H,6ud7:A,475,"Decreased interaction with RBM39 in presence of indisulam, without affecting interaction with DDA1 and DDB1.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_D_475_H
7708,Q66K64,D,475,N,6ud7:A,475,"Decreased interaction with RBM39 in presence of indisulam, without affecting interaction with DDA1 and DDB1.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_D_475_N
7708,Q66K64,D,475,V,6ud7:A,475,"Decreased interaction with RBM39 in presence of indisulam, without affecting interaction with DDA1 and DDB1.",-1.0,,-999.0,,,,,,,,,,,,,Q66K64_D_475_V
7709,P53396,K,540,R,6uuw:A,540,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_540_R
7709,P53396,K,540,Q,6uuw:A,540,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_540_Q
7710,P53396,K,546,R,6uuw:A,546,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_546_R
7710,P53396,K,546,Q,6uuw:A,546,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_546_Q
7711,P53396,K,554,R,6uuw:A,554,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_554_R
7711,P53396,K,554,Q,6uuw:A,554,Decreased acetylation and increased de novo lipid synthesis,,,1.0,,,,,,,,,,,,,P53396_K_554_Q
7712,P53396,H,760,A,6uuw:A,760,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,P53396_H_760_A
7713,Q14376,S,132,A,1i3k:A,132,Loss of activity.,,,1.0,,,,,,,,,,,,,Q14376_S_132_A
7714,Q14376,Y,157,F,1i3k:A,157,Loss of activity.,,,1.0,,,,,,,,,,,,,Q14376_Y_157_F
7715,Q14376,C,307,Y,1i3k:A,307,No effect on activity towards UDP-galactose. Loss of activity towards UDP-N-acetylgalactosamine.,,,1.0,,,,,,,,,,,,,Q14376_C_307_Y
7716,P22455,K,503,R,6jpj:A,503,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,P22455_K_503_R
7717,Q14596,K,12,A,2g4s:A,12,No effect on interaction with SQSTM1.,0.0,,-999.0,,,,,,,,,,,,,Q14596_K_12_A
7718,Q14596,D,50,R,2g4s:A,50,Loss of interaction with SQSTM1.,-1.0,,-999.0,,,,,,,,,,,,,Q14596_D_50_R
7719,P41220,L,79,A,2af0:A,79,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_L_79_A
7720,P41220,E,86,A,2af0:A,86,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_E_86_A
7721,P41220,L,87,A,2af0:A,87,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_L_87_A
7722,P41220,S,90,A,2af0:A,90,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_S_90_A
7723,P41220,K,102,A,2af0:A,102,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_K_102_A
7724,P41220,F,105,A,2af0:A,105,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_F_105_A
7725,P41220,C,106,S,2af0:A,106,Changes specificity and confers GNAI1 binding,,1.0,-999.0,,,,,,,,,,,,,P41220_C_106_S
7726,P41220,I,110,A,2af0:A,110,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_I_110_A
7727,P41220,E,111,A,2af0:A,111,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_E_111_A
7728,P41220,L,114,A,2af0:A,114,Near loss of EIF2B5 binding and inhibition of in vitro translation,-1.0,,1.0,,,,,,,,,,,,,P41220_L_114_A
7729,P41220,N,149,A,2af0:A,149,"Decreases GTPase accelerating function but has no effect on translation inhibitory activity, suggesting that its role in translation is independent of its effects on G proteins.",,,1.0,,,,,,,,,,,,,P41220_N_149_A
7730,P41220,N,184,D,2af0:A,184,Changes specificity and confers GNAI1 binding,1.0,,-999.0,,,,,,,,,,,,,P41220_N_184_D
7731,P41220,E,191,K,2af0:A,191,Strongly increases affinity for GNAI1 and GNAI3,1.0,,-999.0,,,,,,,,,,,,,P41220_E_191_K
7732,P41222,K,59,A,4ory:F,59,Increases enzyme activity about two-fold.,,,0.0,,,,,,,,,,,,,P41222_K_59_A
7733,P41222,M,64,A,4ory:F,64,Reduces enzyme activity almost ten-fold.,,,1.0,,,,,,,,,,,,,P41222_M_64_A
7734,P41222,C,65,A,4ory:F,65,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,P41222_C_65_A
7735,P41222,L,79,A,4ory:F,79,Reduces enzyme activity over ten-fold.,,,1.0,,,,,,,,,,,,,P41222_L_79_A
7736,P41222,F,83,A,4ory:F,83,Reduces enzyme activity about five-fold.,,,1.0,,,,,,,,,,,,,P41222_F_83_A
7737,P41222,L,131,A,4ory:F,131,Reduces enzyme activity almost ten-fold.,,,1.0,,,,,,,,,,,,,P41222_L_131_A
7738,P41222,Y,149,A,4ory:F,149,Increases enzyme activity about two-fold.,,,1.0,,,,,,,,,,,,,P41222_Y_149_A
7739,Q8IV48,K,92,A,1zbh:A,92,"Does not inhibit RNA-binding to the stem-loop structure. Does not inhibit RNA-binding to the stem-loop structure, when associated with A-104.",,0.0,-999.0,,,,,,,,,,,,,Q8IV48_K_92_A
7740,Q8IV48,R,96,A,1zbh:A,96,Does not inhibit RNA-binding to the stem-loop structure.,,0.0,-999.0,,,,,,,,,,,,,Q8IV48_R_96_A
7741,Q8IV48,K,99,A,1zbh:A,99,Reduces slightly RNA-binding to the stem-loop structure.,,-1.0,-999.0,,,,,,,,,,,,,Q8IV48_K_99_A
7742,Q8IV48,K,104,A,1zbh:A,104,"Does not inhibit RNA-binding to the stem-loop structure. Does not inhibit RNA-binding to the stem-loop structure, when associated with A-92.",,0.0,-999.0,,,,,,,,,,,,,Q8IV48_K_104_A
7743,Q8IV48,R,105,A,1zbh:A,105,Inhibits RNA-binding to the stem-loop structure.,,-1.0,-999.0,,,,,,,,,,,,,Q8IV48_R_105_A
7744,Q8IV48,Y,109,A,1zbh:A,109,Reduces slightly RNA-binding to the stem-loop structure,,-1.0,-999.0,,,,,,,,,,,,,Q8IV48_Y_109_A
7745,Q8IV48,Y,110,A,1zbh:A,110,Reduces slightly RNA-binding to the stem-loop structure,,-1.0,-999.0,,,,,,,,,,,,,Q8IV48_Y_110_A
7746,Q8IV48,K,111,A,1zbh:A,111,Reduces RNA-binding to the stem-loop structure but not 3'-end histone mRNA exonuclease activity,,-1.0,1.0,,,,,,,,,,,,,Q8IV48_K_111_A
7747,Q8IV48,K,112,A,1zbh:A,112,Reduces RNA-binding to the stem-loop structure but not 3'-end histone mRNA exonuclease activity,,-1.0,1.0,,,,,,,,,,,,,Q8IV48_K_112_A
7748,Q8IV48,D,234,A,1zbh:A,234,Inhibits 3'-end histone mRNA exonuclease activity.,,,1.0,,,,,,,,,,,,,Q8IV48_D_234_A
7749,Q8IV48,M,235,A,1zbh:A,235,Inhibits RNA-binding to the stem-loop structure and 3'-end histone mRNA exonuclease activity.,,-1.0,1.0,,,,,,,,,,,,,Q8IV48_M_235_A
7750,Q8IV48,D,298,A,1zbh:A,298,Inhibits 3'-end histone mRNA exonuclease activity.,,,1.0,,,,,,,,,,,,,Q8IV48_D_298_A
7751,Q13394,R,51,C,5eom:C,51,Decreased protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q13394_R_51_C
7752,Q13394,R,247,Q,5eog:B,247,Decreased protein stability.,,,-999.0,,,,,,,,,,,-1.0,,Q13394_R_247_Q
7753,Q92530,V,6,R,2vt8:B,6,Abolishes homodimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q92530_V_6_R
7754,Q92530,I,83,E,2vt8:B,83,"Abolishes interaction with FBXO7, but has no effect on homodimerization",-1.0,,-999.0,,,,,,,,,,,,,Q92530_I_83_E
7755,Q92530,I,90,E,2vt8:B,90,"Abolishes interaction with FBXO7, but has no effect on homodimerization",-1.0,,-999.0,,,,,,,,,,,,,Q92530_I_90_E
7756,Q92834,V,36,F,4qam:A,36,Does not reduce interaction with PDE6D.,0.0,,-999.0,,,,,,,,,,,,,Q92834_V_36_F
7757,Q92834,R,323,E,4qam:A,323,Abolishes interaction with RPGRIP1.,-1.0,,-999.0,,,,,,,,,,,,,Q92834_R_323_E
7758,P11309,H,68,Y,1xr1:A,68,Increased kinase activity.,,,1.0,,,,,,,,,,,,,P11309_H_68_Y
7759,P11309,P,81,S,1xr1:A,81,Decreased kinase activity.,,,1.0,,,,,,,,,,,,,P11309_P_81_S
7760,P11309,N,82,K,1xr1:A,82,Decreased kinase activity.,,,1.0,,,,,,,,,,,,,P11309_N_82_K
7761,P11309,L,193,F,1xr1:A,193,Decreased kinase activity.,,,1.0,,,,,,,,,,,,,P11309_L_193_F
7762,P41240,Y,304,F,3d7u:A,304,Decreases activity by two-thirds and alters conformation.,,,1.0,,,,,,,,,,,-1.0,,P41240_Y_304_F
7763,P41240,S,364,A,3d7u:A,364,Strong decrease of phosphorylation by PRKACA (catalytic subunit of PKA).,,,-999.0,-1.0,,,,,,,,,,,,P41240_S_364_A
7764,P14151,N,60,Q,3cfw:A,22,Loss of one glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,P14151_N_60_Q
7765,P14151,N,104,Q,3cfw:A,66,Loss of one glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,P14151_N_104_Q
7766,P14151,E,126,D,3cfw:A,88,Impairs interaction with cognate oligosaccharide. Abolishes cell rolling on glycan ligands.,,-1.0,-999.0,,,,,,,,,,,,,P14151_E_126_D
7767,P14151,N,177,Q,3cfw:A,139,Loss of one glycosylation site.,,,-999.0,,,-1.0,,,,,,,,,,P14151_N_177_Q
7768,P20337,T,86,A,3dz8:A,86,"Loss of phosphorylation. No effect on GDI2, CHM and CHML binding.",0.0,,-999.0,-1.0,,,,,,,,,,,,P20337_T_86_A
7769,P20337,T,86,E,3dz8:A,86,"Phosphomimetic mutant. Loss of GDI2, CHM and CHML binding.",-1.0,,-999.0,,,,,,,,,,1.0,,,P20337_T_86_E
7770,Q14116,K,40,A,1j0s:A,4,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_K_40_A
7771,Q14116,L,41,A,1j0s:A,5,Impairs binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_L_41_A
7772,Q14116,K,44,A,1j0s:A,8,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_K_44_A
7773,Q14116,R,49,A,1j0s:A,13,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_R_49_A
7774,Q14116,D,53,A,1j0s:A,17,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_D_53_A
7775,Q14116,M,69,A,1j0s:A,33,Impairs binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_M_69_A
7776,Q14116,D,71,A,1j0s:A,35,Impairs binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_D_71_A
7777,Q14116,R,94,A,1j0s:A,58,Impairs binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_R_94_A
7778,Q14116,M,96,A,1j0s:A,60,Impairs binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_M_96_A
7779,Q14116,K,115,A,1j0s:A,79,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP resulting in impaired IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_K_115_A
7780,Q14116,K,120,A,1j0s:A,84,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP resulting in impaired IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_K_120_A
7781,Q14116,D,134,A,1j0s:A,98,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP resulting in impaired IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_D_134_A
7782,Q14116,R,140,A,1j0s:A,104,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_R_140_A
7783,Q14116,G,144,A,1j0s:A,108,Abolishes binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_G_144_A
7784,Q14116,H,145,A,1j0s:A,109,Abolishes binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_H_145_A
7785,Q14116,D,146,A,1j0s:A,110,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_D_146_A
7786,Q14116,K,148,A,1j0s:A,112,Abolishes binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_K_148_A
7787,Q14116,D,168,A,1j0s:A,132,Reduces binding to IL18R1 and the ability to induce IFNG production.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_D_168_A
7788,Q14116,R,183,A,1j0s:A,147,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_R_183_A
7789,Q14116,M,186,A,1j0s:A,150,Reduces binding of the preformed binary complex of IL18 and IL18R1 to IL18RAP.,-1.0,,-999.0,,,,,,,,,,,,,Q14116_M_186_A
7790,P20338,G,51,A,2bme:A,48,10-fold decrease in ZFYVE20 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20338_G_51_A
7791,P20338,G,51,L,2bme:A,48,10-fold decrease in ZFYVE20 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20338_G_51_L
7792,P20339,G,54,Q,1r2q:A,54,Strongly decreases ZFYVE20 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20339_G_54_Q
7793,P20339,A,56,E,1r2q:A,56,Strongly decreases ZFYVE20 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20339_A_56_E
7794,P20339,F,57,A,1r2q:A,57,Strongly decreases RABEP1 and ZFYVE20 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20339_F_57_A
7795,P20339,W,74,A,1r2q:A,74,Strongly decreases RABEP1 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20339_W_74_A
7796,P20339,Q,79,L,1r2q:A,79,Loss of GTPase activity. Does not inhibit filopodia formation.,,,1.0,,,,,,,,,,,,,P20339_Q_79_L
7797,P20339,Y,82,A,1r2q:A,82,Strongly decreases RABEP1 binding affinity. Impairs endosome fusion.,-1.0,,-999.0,,,,,,,,,,,,,P20339_Y_82_A
7798,P20339,S,84,A,1r2q:A,84,Loss of phosphorylation. No effect on GDI1 and GDI2 binding.,0.0,,-999.0,-1.0,,,,,,,,,,,,P20339_S_84_A
7799,P20339,S,84,E,1r2q:A,84,Phosphomimetic mutant. Loss of GDI1 and GDI2 binding.,-1.0,,-999.0,,,,,,,,,,1.0,,,P20339_S_84_E
7800,P20339,Y,89,A,1r2q:A,89,Strongly decreases RABEP1 binding affinity.,-1.0,,-999.0,,,,,,,,,,,,,P20339_Y_89_A
7801,P20339,K,116,E,1r2q:A,116,No effect on RABEP1 binding affinity.,0.0,,-999.0,,,,,,,,,,,,,P20339_K_116_E
7802,P20339,R,120,E,1r2q:A,120,No effect on RABEP1 binding affinity.,0.0,,-999.0,,,,,,,,,,,,,P20339_R_120_E
7803,Q14623,E,95,G,3k7g:B,95,Increases the lysosomal degradation of the indian hedgehog protein N-product.,,,-999.0,,,,,,,,,1.0,,,,Q14623_E_95_G
7804,P36776,K,529,R,7ng5:A,529,"Abolishes ATPase activity, and presumably ATP-driven protein unfolding, but does not block access to the proteolytic active site or prevent a substrate from binding to it.",,0.0,1.0,,,,,,,,,,,,,P36776_K_529_R
7805,P36776,W,770,A,7ng5:A,770,"Has low basal, but normal stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_W_770_A
7806,P36776,W,770,P,7ng5:A,770,"Has normal basal, but low stimulated ATPase activity, and abolishes peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_W_770_P
7807,P36776,S,855,A,7ng5:A,855,"Lacks both ATPase and protease activity, but retains DNA binding activity.",,0.0,1.0,,,,,,,,,,,,,P36776_S_855_A
7808,P36776,T,880,V,7ng5:A,880,"Enhances the basal, but not the stimulated ATPase activity.",,,1.0,,,,,,,,,,,,,P36776_T_880_V
7809,P36776,G,893,A,7ng5:A,893,"Has low basal, but normal stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_893_A
7810,P36776,G,893,P,7ng5:A,893,"Has normal basal, but low stimulated ATPase activity, and abolishes peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_893_P
7811,P36776,G,894,A,7ng5:A,894,"Enhances the basal, but not the stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_894_A
7811,P36776,G,894,S,7ng5:A,894,"Enhances the basal, but not the stimulated ATPase activity, and retains peptidase activity.",,,1.0,,,,,,,,,,,,,P36776_G_894_S
7812,P36776,G,894,P,7ng5:A,894,"Enhances the basal, but not the stimulated ATPase activity, and abolishes peptidase activity.",,,-999.0,,,,,,,,,,,,,P36776_G_894_P
7813,P41595,L,132,A,5tud:A,132,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_L_132_A
7814,P41595,D,135,A,5tud:A,135,Abolishes agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_D_135_A
7815,P41595,V,136,A,5tud:A,136,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_V_136_A
7816,P41595,S,139,A,5tud:A,139,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_S_139_A
7817,P41595,T,140,A,5tud:A,140,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_T_140_A
7818,P41595,V,208,A,5tud:A,208,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_V_208_A
7819,P41595,L,209,A,5tud:A,209,"No effect on agonist binding. Strongly increases dissociation of bound lysergic acid diethylamine, without affecting binding affinity. Reduces signaling via arrestins, but has no effect on signaling via the phosphatidylinositol-calcium second messenger system.",,-1.0,-999.0,,,,,,,,,,,,,P41595_L_209_A
7820,P41595,K,211,A,5tud:A,211,Impairs protein folding and stability. Strongly reduced cell surface expression.,,,-999.0,,,,,,,,,1.0,,-1.0,,P41595_K_211_A
7821,P41595,F,217,A,5tud:A,217,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_F_217_A
7822,P41595,M,218,A,5tud:A,218,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_M_218_A
7823,P41595,A,225,S,5tud:A,225,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_A_225_S
7824,P41595,W,337,A,6dry:A,337,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_W_337_A
7825,P41595,F,340,A,6dry:A,340,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_F_340_A
7826,P41595,N,344,A,6dry:A,344,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_N_344_A
7827,P41595,L,347,A,6dry:A,347,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_L_347_A
7828,P41595,V,348,A,6dry:A,348,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_V_348_A
7829,P41595,L,362,A,6dry:A,362,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_L_362_A
7830,P41595,E,363,A,6dry:A,363,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_E_363_A
7831,P41595,V,366,A,6dry:A,366,No effect on agonist binding.,,0.0,-999.0,,,,,,,,,,,,,P41595_V_366_A
7832,P41595,Y,370,A,6dry:A,370,Slightly decreases agonist binding.,,-1.0,-999.0,,,,,,,,,,,,,P41595_Y_370_A
7833,P41594,S,613,A,6n51:A,613,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_S_613_A
7833,P41594,S,613,K,6n51:A,613,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_S_613_K
7834,P41594,S,614,D,6n51:A,614,Decreased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_S_614_D
7835,P41594,K,665,A,6n51:A,665,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_K_665_A
7836,P41594,E,770,A,6n51:A,770,Increased constitutive signaling activity.,,,1.0,,,,,,,,,,,,,P41594_E_770_A
7837,Q9NZ08,Y,438,F,6mgq:C,438,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9NZ08_Y_438_F
7838,Q96HE7,C,85,A,3ahr:A,85,Alters protein folding and stability. Loss of regulatory disulfide bond formation and increased activity towards P4HB,,,1.0,,,,,,-1.0,,,,,-1.0,,Q96HE7_C_85_A
7839,Q96HE7,C,85,S,3ahr:A,85,Induces a decrease in activity.,,,1.0,,,,,,,,,,,,,Q96HE7_C_85_S
7840,Q96HE7,C,241,A,3ahr:A,241,No effect.,0.0,,0.0,,,,,,,,,,,0.0,,Q96HE7_C_241_A
7840,Q96HE7,C,241,S,3ahr:A,241,No effect.,0.0,,0.0,,,,,,,,,,,0.0,,Q96HE7_C_241_S
7841,Q96HE7,N,280,A,3ahr:A,280,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96HE7_N_280_A
7842,Q96HE7,N,384,A,3ahr:A,384,No effect on activity.,,,0.0,,,,,,,,,,,,,Q96HE7_N_384_A
7843,Q96HE7,C,391,A,3ahr:A,391,Alters protein folding. Prevents formation of regulatory disulfide bond and down-regulation of activity. Decreases association with P4HB.,-1.0,,1.0,,,,,,-1.0,,,,,-1.0,,Q96HE7_C_391_A
7844,Q96HE7,C,394,A,3ahr:A,394,Retains activity towards P4HB. Does not act as a dominant negative mutant. Induces defects in folding. Remains associated with P4HB.,0.0,,1.0,,,,,,,,,,,-1.0,,Q96HE7_C_394_A
7845,Q96HE7,F,395,D,3ahr:A,395,Increased catalytical activity.,,,1.0,,,,,,,,,,,,,Q96HE7_F_395_D
7846,Q96HE7,C,397,A,3ahr:A,397,Acts as a dominant negative mutant,,,1.0,,,,,,,,,,,,,Q96HE7_C_397_A
7847,Q13485,R,416,S,1dd1:B,416,No effect on heterotrimerization. Partially diminished transcriptional activation.,0.0,,1.0,,,,,,,,,,,,,Q13485_R_416_S
7848,Q13485,R,496,S,1dd1:B,496,No effect on heterotrimerization. Partially diminished transcriptional activation.,0.0,,1.0,,,,,,,,,,,,,Q13485_R_496_S
7849,Q13485,R,502,S,1dd1:B,502,No effect on heterotrimerization. Greatly reduced transcriptional activation.,0.0,,1.0,,,,,,,,,,,,,Q13485_R_502_S
7850,Q13485,R,515,S,1dd1:B,515,Reduced heterotrimerization.,-1.0,,-999.0,,,,,,,,,,,,,Q13485_R_515_S
7851,Q13485,K,519,R,1dd1:B,519,Abolishes ubiquitination.,,,-999.0,,-1.0,,,,,,,,,,,Q13485_K_519_R
7852,Q16849,N,506,A,2qt7:B,58,Reduces N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q16849_N_506_A
7853,Q16849,N,524,A,2qt7:B,76,Reduces N-glycosylation.,,,-999.0,,,-1.0,,,,,,,,,,Q16849_N_524_A
7854,Q16849,G,553,D,2qt7:B,105,Impairs normal processing and leads to retention in the endoplasmic reticulum and degradation.,,,-999.0,,,,,,,,,1.0,,,,Q16849_G_553_D
7855,O75151,Y,7,A,3kqi:A,7,Abolishes binding to H3K4me2 and H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,O75151_Y_7_A
7856,O75151,W,29,A,3kqi:A,29,Abolishes binding to H3K4me2 and H3K4me3.,-1.0,,-999.0,,,,,,,,,,,,,O75151_W_29_A
7857,O75151,H,249,A,3ptr:B,249,Abolishes demethylase activity.,,,1.0,,,,,,,,,,,,,O75151_H_249_A
7858,O75151,Y,321,H,3ptr:B,321,Does not alter iron-binding nor activates histone demethylase activity.,,0.0,0.0,,,,,,,,,,,,,O75151_Y_321_H
7859,Q16539,A,34,V,2lgc:A,34,Lowered kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_A_34_V
7860,Q16539,K,53,R,2lgc:A,53,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_K_53_R
7861,Q16539,K,54,R,2lgc:A,54,Impairs MAP2K6/MKK6-dependent autophosphorylation.,-1.0,,1.0,-1.0,,,,,,,,,,,,Q16539_K_54_R
7862,Q16539,Y,69,H,2lgc:A,69,Lowered kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_Y_69_H
7863,Q16539,D,168,A,2lgc:A,168,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_D_168_A
7864,Q16539,T,175,A,2lgc:A,175,No effect on either the kinase activity or tyrosine phosphorylation.,,,0.0,,,,,,,,,,,,,Q16539_T_175_A
7865,Q16539,D,176,A,2lgc:A,176,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_D_176_A
7866,Q16539,D,177,A,2lgc:A,177,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_D_177_A
7867,Q16539,T,180,E,2lgc:A,180,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_T_180_E
7868,Q16539,Y,182,F,2lgc:A,182,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_Y_182_F
7869,Q16539,A,320,T,2lgc:A,320,Lowered kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_A_320_T
7870,Q16539,F,327,L,2lgc:A,327,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_F_327_L
7871,Q16539,F,327,S,2lgc:A,327,Emulation of the active state. Increase in activity,,,1.0,,,,,,,,,,,,,Q16539_F_327_S
7872,Q16539,W,337,R,2lgc:A,337,Loss of kinase activity.,,,1.0,,,,,,,,,,,,,Q16539_W_337_R
7873,O75154,Y,737,S,2hv8:E,737,Abolishes Rab11-binding.,-1.0,,-999.0,,,,,,,,,,,,,O75154_Y_737_S
7874,O75154,I,738,E,2hv8:E,738,Abolishes Rab11-binding.,-1.0,,-999.0,,,,,,,,,,,,,O75154_I_738_E
7875,O75154,D,739,A,2hv8:E,739,Abolishes Rab11-binding.,-1.0,,-999.0,,,,,,,,,,,,,O75154_D_739_A
7876,O75154,M,746,S,2hv8:E,746,Abolishes Rab11-binding.,-1.0,,-999.0,,,,,,,,,,,,,O75154_M_746_S
7877,O75154,E,747,A,2hv8:E,747,Abolishes Rab11-binding.,-1.0,,-999.0,,,,,,,,,,,,,O75154_E_747_A
7878,Q13241,Q,79,A,3cdg:E,79,Has no impact on the affinity for HLA-E.,0.0,,-999.0,,,,,,,,,,,,,Q13241_Q_79_A
7879,Q13241,Q,112,A,3cdg:E,112,Abolishes binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_Q_112_A
7880,Q13241,F,114,A,3cdg:E,114,Abolishes binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_F_114_A
7881,Q13241,T,146,A,3cdg:E,146,Has no impact on the affinity for HLA-E.,0.0,,-999.0,,,,,,,,,,,,,Q13241_T_146_A
7882,Q13241,N,148,A,3cdg:E,148,Has no impact on the affinity for HLA-E.,0.0,,-999.0,,,,,,,,,,,,,Q13241_N_148_A
7883,Q13241,N,158,A,3cdg:E,158,Has no impact on the affinity for HLA-E.,0.0,,-999.0,,,,,,,,,,,,,Q13241_N_158_A
7884,Q13241,N,160,A,3cdg:E,160,Abolishes binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_N_160_A
7885,Q13241,L,162,A,3cdg:E,162,Abolishes binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_L_162_A
7886,Q13241,D,163,A,3cdg:E,163,Impairs binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_D_163_A
7887,Q13241,E,164,A,3cdg:E,164,Impairs binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_E_164_A
7888,Q13241,D,168,A,3cdg:E,168,Reduces binding to HLA-E.,-1.0,,-999.0,,,,,,,,,,,,,Q13241_D_168_A
7889,P26678,R,13,A,1zll:A,13,Abolishes phosphorylation by PKA.,,,-999.0,-1.0,,,,,,,,,,,,P26678_R_13_A
7890,P26678,R,14,A,1zll:A,14,Abolishes phosphorylation by PKA.,,,-999.0,-1.0,,,,,,,,,,,,P26678_R_14_A
7891,P26678,S,16,A,1zll:A,16,Abolishes phosphorylation by PKA.,,,-999.0,-1.0,,,,,,,,,,,,P26678_S_16_A
7892,P26678,T,17,A,1zll:A,17,No effect on phosphorylation by PKA.,,,-999.0,0.0,,,,,,,,,,,,P26678_T_17_A
7893,Q99707,D,963,E,2o2k:A,963,Decreases binding to MTRR,-1.0,,-999.0,,,,,,,,,,,,,Q99707_D_963_E
7894,O14793,D,267,N,5ntu:A,267,Decreases SMAD3 protein signal transduction,-1.0,,-999.0,,,,,,,,,,,,,O14793_D_267_N
7895,O14793,F,268,L,5ntu:A,268,Decreases SMAD3 protein signal transduction,-1.0,,-999.0,,,,,,,,,,,,,O14793_F_268_L
7896,O14793,E,312,Q,5ntu:A,312,Slightly decreased SMAD3 protein signal transduction.,-1.0,,-999.0,,,,,,,,,,,,,O14793_E_312_Q
7897,O14793,F,315,Y,5ntu:A,315,Increases SMAD3 protein signal transduction,1.0,,-999.0,,,,,,,,,,,,,O14793_F_315_Y
7898,O14793,V,316,M,5ntu:A,316,Increases SMAD3 protein signal transduction,1.0,,-999.0,,,,,,,,,,,,,O14793_V_316_M
7899,O14793,L,318,M,5ntu:A,318,Increases SMAD3 protein signal transduction,1.0,,-999.0,,,,,,,,,,,,,O14793_L_318_M
7900,O14793,H,328,Q,5ntu:A,328,Increases SMAD3 protein signal transduction.,1.0,,-999.0,,,,,,,,,,,,,O14793_H_328_Q
7901,O14793,G,355,D,5ntu:A,355,Increases SMAD3 protein signal transduction,1.0,,-999.0,,,,,,,,,,,,,O14793_G_355_D
7902,O14793,E,357,Q,5ntu:A,357,Increases SMAD3 protein signal transduction,1.0,,-999.0,,,,,,,,,,,,,O14793_E_357_Q
7903,O14793,A,366,G,5ntu:A,366,Increases SMAD3 protein signal transduction.,1.0,,-999.0,,,,,,,,,,,,,O14793_A_366_G
7904,O95822,C,206,S,4f0x:A,206,Abolishes formation of disulfide-linked homotetramers. Abolishes the cooperative enzyme kinetics that are seen under oxidative conditions.,-1.0,,1.0,,,,,,,,,,,,,O95822_C_206_S
7905,O95822,C,243,S,4f0x:A,243,Does not abolish formation of disulfide-linked homotetramers. No effect on development of cooperative enzyme kinetics in response to oxidative conditions.,0.0,,0.0,,,,,,,,,,,,,O95822_C_243_S
7906,O95822,S,290,F,4f0x:A,290,2-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,O95822_S_290_F
7907,O95822,E,302,G,4f0x:A,302,Decreases catalytic activity. Increases affinity for malonyl-CoA.,,1.0,1.0,,,,,,,,,,,,,O95822_E_302_G
7908,O95822,S,329,A,4f0x:A,329,110-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,O95822_S_329_A
7909,O95822,H,423,N,4f0x:A,423,7-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,O95822_H_423_N
7910,O95822,Y,456,S,4f0x:A,456,3.5-fold reduction in catalytic activity.,,,1.0,,,,,,,,,,,,,O95822_Y_456_S
7911,P21860,K,742,M,3kex:A,723,Strongly reduced autophosphorylation.,,,1.0,-1.0,,,,,,,,,,,,P21860_K_742_M
7912,P21860,Y,868,E,4riw:C,849,Strongly reduced tyrosine phosphorylation.,,,-999.0,-1.0,,,,,,,,,,,,P21860_Y_868_E
7913,P22607,K,508,A,4k33:A,508,Loss of kinase activity. Abolishes ubiquitination.,,,1.0,,-1.0,,,,,,,,,,,P22607_K_508_A
7914,P22607,Y,577,F,4k33:A,577,Minor effect on kinase activity.,,,0.0,,,,,,,,,,,,,P22607_Y_577_F
7915,P22607,K,650,D,6pnx:A,650,Constitutively activated kinase.,,,1.0,,,,,,,,,,,,,P22607_K_650_D
7916,P22607,K,650,L,6pnx:A,650,Constitutively activated kinase.,,,1.0,,,,,,,,,,,,,P22607_K_650_L
7917,P22607,Y,724,F,6pnx:A,724,Strongly reduced kinase activity. Strongly reduced mitogen activity.,,,1.0,,,,,,,,,,,,,P22607_Y_724_F
7918,Q5MJ70,D,97,N,5uq1:D,97,Loss of CDK2 activation,-1.0,,-999.0,,,,,,,,,,,,,Q5MJ70_D_97_N
7919,Q5MJ70,E,135,Q,5uq1:D,135,Loss of CDK2 activation,-1.0,,-999.0,,,,,,,,,,,,,Q5MJ70_E_135_Q
7920,Q16288,K,572,N,6kzd:A,572,Loss of autophosphorylation and loss of NTRK3 signaling.,-1.0,,1.0,-1.0,,,,,,,,,,,,Q16288_K_572_N
7921,Q9BZB8,F,314,A,2mkh:A,239,Abolishes stress granule assembly and correct localization in dcp1 bodies.,,,-999.0,,,,,,,,,1.0,,,,Q9BZB8_F_314_A
7922,Q9BZB8,H,545,A,2m13:A,545,Abolishes stress granule assembly and correct localization in dcp1 bodies.,,,-999.0,,,,,,,,,1.0,,,,Q9BZB8_H_545_A
7923,Q96FW1,Q,33,R,4ddi:A,1033,Impairs inhibition of UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_Q_33_R
7924,Q96FW1,I,37,T,4ddi:A,1037,Impairs inhibition of UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_I_37_T
7925,Q96FW1,Q,39,L,4ddi:A,1039,Does not affect activity in DNA repair and ability to inhibit UBE2N/UBC13.,,,0.0,,,,,,,,,,,,,Q96FW1_Q_39_L
7926,Q96FW1,P,87,G,4ddi:A,1087,Slightly improves ability to cleave 'K63'-linked ubiquitin.,,,1.0,,,,,,,,,,,,,Q96FW1_P_87_G
7927,Q96FW1,D,88,E,4ddi:A,1088,Abolishes hydrolase activity in vitro. Abolishes ability to inhibit RNF168,,,1.0,,,,,,,,,,,,,Q96FW1_D_88_E
7928,Q96FW1,C,91,A,4ddi:A,1091,"Prevents RNF128 autoubiquitination, and stabilizes RNF128 in vivo. Abolishes both ubiquitin-binding and adduct formation with ubiquitin-vinylsulfone.",-1.0,,-999.0,,,,,,,,,,,,,Q96FW1_C_91_A
7929,Q96FW1,C,91,S,4ddi:A,1091,Abolishes hydrolase activity in vitro. Does not affect ability to inhibit RNF168. Abolishes ability to inhibit RNF168,0.0,,1.0,,,,,,,,,,,,,Q96FW1_C_91_S
7930,Q96FW1,A,116,T,4ddi:A,1116,Does not affect ability to inhibit UBE2N/UBC13.,0.0,,0.0,,,,,,,,,,,,,Q96FW1_A_116_T
7931,Q96FW1,T,134,R,4ddi:A,1134,Impairs inhibition of UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_T_134_R
7932,Q96FW1,D,137,G,4ddi:A,1137,Impairs inhibition of UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_D_137_G
7933,Q96FW1,R,176,L,4ddi:A,1176,No effect on RNF128.,0.0,,-999.0,,,,,,,,,,,,,Q96FW1_R_176_L
7934,Q96FW1,F,190,S,4ddi:A,1190,Fails to inhibit ubiquitin conjugation by UBE2N/UBC13.,,,1.0,,,,,,,,,,,,,Q96FW1_F_190_S
7935,Q96FW1,C,212,A,4ddi:A,1212,No effect on RNF128.,0.0,,-999.0,,,,,,,,,,,,,Q96FW1_C_212_A
7936,Q96FW1,Y,261,H,4ddi:A,1261,Impairs inhibition of UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_Y_261_H
7937,Q96FW1,P,263,L,4ddi:A,1263,Fails to inhibit ubiquitin conjugation by UBE2N/UBC13.,-1.0,,1.0,,,,,,,,,,,,,Q96FW1_P_263_L
7938,Q96FW1,H,265,A,4ddi:A,1265,Abolishes ability to inhibit RNF168,-1.0,,-999.0,,,,,,,,,,,,,Q96FW1_H_265_A
7939,Q96FW1,H,265,R,4ddi:A,1265,Abolishes hydrolase activity in vitro.,,,1.0,,,,,,,,,,,,,Q96FW1_H_265_R
7940,Q9NYV4,D,877,N,6td3:B,877,Abolishes kinase activity.,,,1.0,,,,,,,,,,,,,Q9NYV4_D_877_N
7941,Q9Y5N6,Q,129,A,6kvg:A,129,Abolished DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5N6_Q_129_A
7942,Q9Y5N6,R,137,A,6kvg:A,137,Abolished DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5N6_R_137_A
7943,Q9Y5N6,K,168,A,6kvg:A,168,Abolished DNA binding.,,-1.0,-999.0,,,,,,,,,,,,,Q9Y5N6_K_168_A
7944,P62487,H,14,E,6o9l:G,14,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_H_14_E
7945,P62487,E,33,K,6o9l:G,33,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_E_33_K
7946,P62487,K,41,E,6o9l:G,41,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_K_41_E
7947,P62487,T,90,A,6o9l:G,90,Reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_T_90_A
7948,P62487,N,93,A,6o9l:G,93,Reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_N_93_A
7949,P62487,K,94,E,6o9l:G,94,Reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_K_94_E
7950,P62487,F,107,E,6o9l:G,107,Reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_F_107_E
7951,P62487,S,109,A,6o9l:G,109,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_S_109_A
7952,P62487,H,111,E,6o9l:G,111,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_H_111_E
7953,P62487,R,151,E,6o9l:G,151,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_R_151_E
7954,P62487,D,153,E,6o9l:G,153,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_D_153_E
7955,P62487,F,158,A,6o9l:G,158,Strongly reduces RNA-binding.,,-1.0,-999.0,,,,,,,,,,,,,P62487_F_158_A
7956,P20592,K,131,A,5uot:0,131,Loss of GTP-binding and localization to nuclear pore. Disruption of nuclear import.,,-1.0,-999.0,,,,,,,,,1.0,,,,P20592_K_131_A
7957,P20592,T,151,A,5uot:0,151,Defective GTP-hydrolysis. Disruption of nuclear import and cell-cycle progression.,,,1.0,,,,,,,,,1.0,,,,P20592_T_151_A
7958,Q9Y2I1,R,49,A,3p0c:B,49,Inhibits targeting to endosomes.,,,-999.0,,,,,,,,,1.0,,,,Q9Y2I1_R_49_A
7959,Q9Y2I1,Y,50,A,3p0c:B,50,Inhibits targeting to endosomes.,,,-999.0,,,,,,,,,1.0,,,,Q9Y2I1_Y_50_A
7960,Q96PZ0,D,294,A,5kkp:A,294,Loss of function.,,,1.0,,,,,,,,,,,,,Q96PZ0_D_294_A
7961,Q9BQ69,D,160,A,6lh4:A,160,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BQ69_D_160_A
7962,Q9BQ69,D,167,A,6lh4:A,167,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BQ69_D_167_A
7963,Q9BQ69,N,171,A,6lh4:A,171,Reduced enzyme activity. No significant effect on affinity for substrate.,,,1.0,,,,,,,,,,,,,Q9BQ69_N_171_A
7964,Q9BQ69,N,174,A,6lh4:A,174,Slightly reduced ADP-ribosyl hydrolase activity,,,1.0,,,,,,,,,,,,,Q9BQ69_N_174_A
7965,Q9BQ69,D,184,A,6lh4:A,184,Slightly reduced ADP-ribosyl hydrolase activity,,,1.0,,,,,,,,,,,,,Q9BQ69_D_184_A
7966,Q9BQ69,H,188,A,6lh4:A,188,Reduced enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BQ69_H_188_A
7967,Q9BQ69,S,268,A,6lh4:A,268,No significant effect on enzyme activity.,,,0.0,,,,,,,,,,,,,Q9BQ69_S_268_A
7968,Q9BQ69,G,270,E,6lh4:A,270,Loss of enzyme activity.,,,1.0,,,,,,,,,,,,,Q9BQ69_G_270_E
7969,Q9BQ65,H,120,A,4h7w:A,120,Abolishes exoribonuclease activity.,,,1.0,,,,,,,,,,,,,Q9BQ65_H_120_A
7970,Q9BQ65,H,208,A,4h7w:A,208,Abolishes exoribonuclease activity. No rescue of the molecular phenotype caused by USB1 depletion.,,,1.0,,,,,,,,,,,,,Q9BQ65_H_208_A
7971,Q14974,I,178,A,1qgk:A,178,Largely reduced binding to FxFG repeats and reduced nuclear import.,-1.0,,1.0,,,,,,,,,,,,,Q14974_I_178_A
7972,Q14974,I,178,F,1qgk:A,178,Loss of binding to FxFG repeats and reduced nuclear import.,-1.0,,1.0,,,,,,,,,,,,,Q14974_I_178_F
7972,Q14974,I,178,D,1qgk:A,178,Loss of binding to FxFG repeats and reduced nuclear import.,-1.0,,1.0,,,,,,,,,,,,,Q14974_I_178_D
7973,Q96E14,K,24,A,3mxn:B,24,"Abolishes interaction with RMI1, TOP3A and BLM.",-1.0,,-999.0,,,,,,,,,,,,,Q96E14_K_24_A
7974,Q96E14,W,59,A,3mxn:B,59,According to PubMed,,,-999.0,,,,,,,,,,,,,Q96E14_W_59_A
7975,Q96E14,K,100,A,3mxn:B,100,"Does not affect interaction with RMI1, TOP3A and BLM.",0.0,,-999.0,,,,,,,,,,,,,Q96E14_K_100_A
7976,Q96E14,K,121,A,3mxn:B,121,According to PubMed,,,-999.0,,,,,,,,,,,,,Q96E14_K_121_A
7977,Q96E14,W,135,A,3mxn:B,135,"Abolishes interaction with RMI1, TOP3A and BLM.",-1.0,,-999.0,,,,,,,,,,,,,Q96E14_W_135_A
7978,Q9UJX6,D,350,K,6q6h:N,350,"Impairs UBE2S-mediated polyubiquitination, decreasing substrate affinity, does not affect UBE2C-mediated multiubiquitination",,-1.0,-999.0,,-1.0,,,,,,,,,,,Q9UJX6_D_350_K
7979,Q9UJX6,D,353,K,6q6h:N,353,"Impairs UBE2S-mediated polyubiquitination, decreasing substrate affinity, does not affect UBE2C-mediated multiubiquitination",,-1.0,-999.0,,-1.0,,,,,,,,,,,Q9UJX6_D_353_K
7980,Q6ZRY4,L,49,E,2m9k:A,49,Strongly reduces homodimerization and interaction with EEF2. Strongly reduces NOG mRNA binding. Loss of function in gastrointestinal smooth muscle cell differentiation.,-1.0,-1.0,1.0,,,,,,,,,,,,,Q6ZRY4_L_49_E
7981,Q6ZRY4,L,49,Q,2m9k:A,49,No effect on homodimerization. No effect on function in gastrointestinal smooth muscle cell differentiation.,0.0,,0.0,,,,,,,,,,,,,Q6ZRY4_L_49_Q
7982,P21266,Y,120,A,3gtu:B,119,No effect.,,,0.0,,,,,,,,,,,,,P21266_Y_120_A
7983,P21266,Y,120,F,3gtu:B,119,Strongly increased catalytic activity.,,,1.0,,,,,,,,,,,,,P21266_Y_120_F
7984,P21266,N,213,F,3gtu:B,212,Strongly increased catalytic activity.,,,1.0,,,,,,,,,,,,,P21266_N_213_F
7985,P21266,N,213,G,3gtu:B,212,No effect.,,,0.0,,,,,,,,,,,,,P21266_N_213_G
7986,A2RUC4,R,108,A,3al5:B,108,Abolishes enzyme activity and ability to bind tRNA.,,-1.0,1.0,,,,,,,,,,,,,A2RUC4_R_108_A
7987,A2RUC4,R,149,A,3al5:B,149,Abolishes enzyme activity and ability to bind tRNA.,,-1.0,1.0,,,,,,,,,,,,,A2RUC4_R_149_A
7988,Q460N3,H,559,Y,4f0e:B,537,Abolishes catalytic activity.,,,1.0,,,,,,,,,,,,,Q460N3_H_559_Y
7989,Q460N3,G,560,A,4f0e:B,538,Slightly reduces catalytic activity. Abolishes activity,,,1.0,,,,,,,,,,,,,Q460N3_G_560_A
7990,Q460N3,Y,604,C,4f0e:B,582,Reduces catalytic activity 20-fold. Abolishes activity,,,1.0,,,,,,,,,,,,,Q460N3_Y_604_C
7991,Q9UJX2,N,339,A,6q6h:V,339,Inhibits APC/FZR1 E3 ubiquitin-protein ligase complex activity,,,1.0,,,,,,,,,,,,,Q9UJX2_N_339_A
7992,Q9UJX2,E,374,A,6q6h:V,374,Inhibits APC/FZR1 E3 ubiquitin-protein ligase complex activity,,,1.0,,,,,,,,,,,,,Q9UJX2_E_374_A
7993,Q460N5,G,1055,E,3q71:A,1055,Abolishes interaction with PARP10.,-1.0,,-999.0,,,,,,,,,,,,,Q460N5_G_1055_E
7994,Q16665,S,247,A,4h6j:A,247,Constitutive kinase activity.,,,1.0,,,,,,,,,,,,,Q16665_S_247_A
7995,Q16665,S,247,D,4h6j:A,247,Impaired kinase activity.,,,1.0,,,,,,,,,,,,,Q16665_S_247_D
7996,Q16665,L,795,A,1l8c:B,118,Inhibits interaction with EP300 and transactivation activity.,-1.0,,1.0,,,,,,,,,,,,,Q16665_L_795_A
7997,Q16665,C,800,A,1l8c:B,123,Blocks increase in transcriptional activation caused by nitrosylation.,,,-999.0,,,,,,,,,,,,,Q16665_C_800_A
7998,Q16665,C,800,S,1l8c:B,123,Abolishes hypoxia-inducible transcriptional activation of ctaD.,,,-999.0,,,,,,,,,,,,,Q16665_C_800_S
7999,Q16665,N,803,A,1l8c:B,126,Recruits CREBBP. No enhancement of CREBBP by Clioquinol in the presence of FIH1. No change in nuclear location nor on repression of transcriptional activity in the presence of histone deacetylase inhibitor.,0.0,,-999.0,,,,,,,,,0.0,,,,Q16665_N_803_A
